>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 1; Drug: PCAP2 10 然
bLhbLibLgbLsbLgLsbRiRsmbRibRgbRgLsbRgbRsbRgbLsbRgbRgbLsbLsbRgbRibLsbLs
bRsbRsRsmbRibRgbLsbRsbRsbRsbRsbRgbRgbLobLsbLibRsbRsbLsbLsbLgbLgbLsbLsb
LsbLsbLsbLgbLsbLsbLsbLsLsmbLsbLsbLsLsmbRsRsmbLsbLsbLsbLgbLsbLsbLsbLsbL
sbRsbLsbLsbLgbLsbLgbRsbLsbRobRsbRiRsmbRgbRsbLsbRsRsmbRgbRgLsbLsbRgbLoR
sbLgbLibRsbLgbLsbLsRsbLgbLgbRgbRcbRgbRsLsbRsRsLsmbRsbRsbRgbRgbRgbRhbRg
bRsbRgbLsbRsbRsbRgbRgbRgbRsbRsbRgbRsRsmbRsbRgRsmbRsRsmbRgbRgRsmbRsbRsR
smbLsRsbRsbRsbRgbRsbRsbRgbLsbLcbLgbLgbLgbLsbLhbLgbRgbLsRsbLibRsLsbRebL
ibLsbRgbRhbLibLgbLebLsbRsbLjbRsbRibRsbLsbRgbRgbRsbLsbLjbLhbLgLsbRsbLgb
LsbLgLsbRsbLgbRsbRgbLiRsbLgbLibLgbLgbLgbRibLibLibRgbLjbLgbRgRsmbLsbLgb
LgbLgbLgbLgbLgbLibLgbRsbRgbLsbRgRsmbRgbRcbRibRjbRibLgbRiRsLsmbLgbRsbRg
bRsbRsbRgbRsbLsbRsbRiLsbLgLsbRgRsmbLsRsbRsbLsbRgRsRsmmbLsbRgbRsbRgbRsb
LsbRibRgbLsbLgbLsbRibLsbRgbLsbRgbLsbLsbLjbLgbLibLgRsbRebRcbRgbRibRsbRi
bLiRsbLibRibRhbRgbRebRgRsmbRsbLgRsbLgbLgbRgbLcbLcbLibRibRgbRgbRgbRsbRs
bRibRgRsmbLgbRgbRsbRsbLsRsbRgbLsRsbRgRsmbRsbLsbRsbRgbRsbLsLsmbLcbRebLj
bRgbRgbRsRsmbLsbRgbLsbLjbLobLibRibLibLgbRgRsmbLibLibLgbLhLsbLibRsRsmbR
gbRibRgbRgbRibLgLsbLsbLhbLgbLgbRgbLibRsbRsbRjbRibRgbRgbLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 2; Drug: PCAP2 10 然
bRcRsmbRibRgLsbLsbRhbRsbRibLsbRhbRhbRiRsmbLgbLibLibLsLsmbRgbLcbLcbLiLs
bLiLsbLibLcbLiRsbLibLgbLibRcbLsbLjbLcbLibLcbLcbLhbLgbRgbLgbLgbLgbLsbLs
bLgbLgbLsbLgbLgbRgbLhbLcLsRsmbLiRsbLcLsmbLgbLibLibLibLiRsLsRsbLibLibRs
bLgbRsbLgLsbLsbLsLsLgLsmbLiLebLgbLgbLgbLsRsbRsbLgbLsRsbLgbRebRibRibRib
LibLiLsbLgbLgbRsbRjbRhbLsbRoRsmbRhbLebLgbRcbLgbRgbLiLsbLgbLsbLsbLgbLsb
LsbRsbLsbLgbRsbLsbLgbRsbLibLgbLcbLhbLcbLibRcbLcbLibLobLibLiLsbLjbLcbLc
bLjbRcbLgbRsbRibRoRsmbRibRcRsmbLebLibLjRsbLsbRgbRgbLibLgbLsbLgbLgbLgLg
LgbLsbLsbLgLsbLsbLgbLgRsbLibRsRsmbRsbReRsmbRcbRgbLsbLibRibLhLsbRcbRhRs
RsmmbRcRsmbRibLgbLgbRsbRgbRibRsbRgbRibRibRgRsmbRgbRiRsmbRgbRsbRgbRgbLg
bRibRsbLsbRgbLgbRcbRhbRibRgbLibLgbLsbLgLsbLgbRgbLhbRgbLcLsmbLiLsRsbLgb
RgbRibRsRsmbsbRgbRsbRgbRgRgRgbRcbRgbRgbLgbRgbRgbRsbRsbRsbRgbLsbReLsbRo
RsLsmbRcbRiRsmbRibLiRsbRhbLgbLjbRgRsmbLsbRgbRsbRsbRgRsmbRgbRgbRgbRsbRc
bLhbLgRgbRgbRgRsmbRgbRgbRgbLsbRgbLgLsbRgbRgbRsRsmbRgbRgbRiRsRsmmbRgbRs
RsmbRgRgRsmbRgbRgbRgbRgbRsbRgbRgRsmbRsbRiRsmbLjbLcbRcRsmbLcLsmbLoLsmbL
sLcbLhbRibLibsbLgbLsbLgbRgRsmbLgbLgbLsbLsbLibLsLsmbLgbLsbLjbRiLsbLhbLc
bRcRsmbRhRsmbRgbLsbLjbRiRsmbRibLsbRgRsmbRsRsmbRgbRgbRgLsbRgbRsbRgRsmbR
gbRgbRgbRgRsmbRsbRgRsmbLsbRgbsbLebLiLsbLibRebRhbLgRsbRcbLgbLgbRibRsLsb
RgbLsbRsbRgbLsbRgbRgbLsLsmbRgbRsbRgbRgbRsbRgRsLsmbRgbRgbRgRsmbRgbRsRsm
bRgbRgbRgbRsLsbRgbRgbRgRsmbRsbRgbLgRsbRgRsmbRgbRsRibRsbRgbRgbRsbRsbRib
RcRsmbRcRsmbRcRsRsmmbRgRsmbLsbRibRgRsmbRgbRgbRgRsmbRgbRgbRibRgbRgbRgbL
gbLcbLhbLeLcbLobRgbLhRsbLibRjRsmbLiLsbRjbsbRhbRcRsmbLibLcbLcbLiLsbLgbR
ibRcbRiRsmbRgbRgbRiRsmbLsbLsbRiRsmbRsbRibLgRsbLhbLiLsbRobLgbRoRsLsmbRi
bRsbRgbRsbRgbRsRsmbRgbRgbRsbRgRibRgRsmbRgRsmbRgbRgbRgbRsbRcbRcbRhbRhRs
mbLjbLcbLibRibLhLsbRcbRiRsmbLsbRibLsbRiRsmbRgbRgbRgRsmbRgbRgbRgRgbRgbR
gbRgbRibRoRsmbRiRsmbRcRsmbRibRiRsmbLsLibLcbLiLsLgRgbRjbRibRgRsmbRebRib
RcRsmbRcbRcbRcRsmbLjbRsLobLcbLobLsbLhbLsbLibLgRsbLsbLcLsLgLsmbRibRsRgb
RibLjbLcRsbLsLsmbLgbLsbLgbRsbLiRsbLsbLcbRiRsmbRibRibRgbLibLcbLibLibLiR
sbLiLsbLgbLgbLgbLsbRsbLgLsbLgbLgbRsbLcbLcbLgbLgbLgbLiLsbLgbLhbRgRsmbLc
LsmbLgbLgbRsbLgLsbLgbLgRsbLgbLgbLsbLgLsbLsbLgbLgLsbLgbLoRsbRgRsmbRsRsm
bRgbRsbRibRsbRcbRiRsRsmmbsbRiRsmbRibRsbRiLsbRsbRsbRgRsmbRgbRgbRsbRgRsm
bRgbRhbRibLibLiLsbLgbLgbLgbLcbLiRsRsmbLibLibLibLsbLgbRsbLibLgLibLgbLsb
LiLsbRjRobRcbsbRibLibLibLgbLgLsLsLgLsLsmmbLgLsLibLgLsbLgbLgLsRsbLgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 3; Drug: PCAP2 10 然
bRsbRgRsmbRsbRgbRiRsmbRgRsmbRgbRgbLsbRgbRgRsmbRgbLsbLsbRgbLoRsbLcRsbLi
bLgbRcbRjbRibRgbRgbLsbLsRsbRsbRibRobRibRjbRibRsbLjbLcbLhRsbLgbRsbRsbLg
bLgRsbLhRsbLgbRsbRgbLcbLibLgbLsbRhbRibRcbLsbLsbRibLsbLsbLsbRgbRsbRsbRs
bRsbRsbRgbRgRsLsmbLsRsbLsRsbLsbRgbRsbLsRsbRsbRgLsbRgbRsbRgbRgbRibLibRg
bLjbLgbRiRsmbRgbRibRiRsmbRgbLsbLgbLsRibRiLsbRgLsRsbLgbRiRsmbRsbRsbRsRs
mbRsbRsbRgRsmbRgbLsRsbRgbsbRsbRsbRsRsmbRsbRsbLsbRsbRgRsmbRgbRgbRgbRsbR
sbRsRsmbRgLsbRsRsmbRsLsbRsbRsbRsbRsbRgbLsbRgbRibRsbLjLsmbLibLjbLibRgbL
gbLsRsbRsbLhbLsbRjbLgbLgbLibLhbLibLgbRsbRsbRibRsbRsbRgbRsbRsbRgRsmbLsb
sbRsRgbLsbRsbRgbRsRsmbRsbRsbRgbRgbRsbRgbRgbRsbLsLsLsmmbRgbRjbRibLsRiLs
bRjRsmbRebRiRsmbRibRibRgbLibLgbLsbLgbLibLsbLgLsLsLsmmbLgRsLsbLgLsbLsRs
bRsbLgLsbLgbLgbLgbLgbRsbLgbLsbLgbLsbLgbLiRsbLibLibLgbLgbRgbRcRsmbRcbRg
bRsbRsbRhbRgbRgbRgbRsbRgbRsRsmbRsbRsbRsRsmbRhLsbRibRibRgbRibRibRgbRsbL
sbRsLsRibRsbRgbRsRsmbRgRsLsmbRgbRsRsmbRsRsmbLcbLcbLsbLgbLgLsbLsLsmbLgb
LgbLgLsLsmbLsLsmbLgbLgLsbLgbLsRsbLgLsLsmbLgbLgbLgbLsbLibLoLsmbLhbLhbLi
bRsRsmbLgbLgLsbLsbLgbLgRsbLgbLgLsbRsbLgRsbLgLsbRsLsbLgLsbLgbLsbLgLsbLs
bLgRsLsbLgbLsbLgbLgbLibLgLsbLgbLibLibLsbRgbLgbLobRsbLcbLcbLibLibRgbLgb
RibRsbRgbRsbRsbRgbRgbRgbRiRsmbRsRcbRibRjbRibLsLsmbLsbLhLsbLhRsbLgbLcbR
ibLgbLiLsbLsbLibLsbLibLiLsbRiRsmbRibRibRcbRibLsbRibRjbRiRsmbLsbRgbRgbL
sbRsbRgRsmbRgbRgbRsbRgRsLsmbRsRsmbRgbRgRsmbRgRsmbRgbRsbRsRsmbRhbRgbRib
RgRsmbRjLsbRcbRiRsmbRgRsmbRjbRjRsmbLsbRgbRgbRhbRibRsbRibLsbRsRgbRiLsbL
sRsbRsRsmbRsbRsbRgbRgbLsbRsbRgbRgbRgbRgbRsbRsRsmbRgbRgbRsbRgbRgLsbRsRs
mbRgbRgbRgbRsbRgbsbLsLsmbRsbRsRsmbRsbRsbRgbLgbRibLjbLhbRhbRibRgbRiRsRg
mbRsbRsRgbRsRsRsmmbRgbRgbRgbRgRsRgmbRgbRsRsmbRgbRsbRsLsRsbRsbRsbRibLib
RebRhbRiLsbRibRibLhbLcbRjbLcbLibLgbLsbLgLsbLgLsbLsLsmbLgbLsLsmbLgbLgLs
LsmbLsbLgbLgLsbLgbLgbLsLjbLobRsbLgbLgbRsLgLsbLgbLgbLsbLgLsbLgbLgbLgbLg
bLgbLgbLgbLgbLsLsmbLsbLgbLgRsbLcbLjbLjRsbLibLgbLsLsmbLgbLgbLgbLsbLhbLg
bLgRsbLibLcbLiRsbRsRsRimbRsbRgbRiRiLsbRgbRgRsRiLsRsmbRgbRgbRgbRgbRiRsR
sRsmmmbRibRiRsRsmmbRgRsmbRgbRgRsmbRgbRsbRiRsmbRsbLibRhbRibRsbRsbRgbRgR
ebRgbRiLsbRibRhbRhRsmbRhbLcRsbLcLsmbLgRsRsmbLebLgbLgLibRgbLibLgRsbRsLs
bLgbLcbLhLsbLgLsLsmbLhbLgLsLsmbLgbLgbLgbLgbLgLsbLsbLgbLgbLgbLgbRjbLibL
gbRsRsmbLsbLibLsbLgbLsbLsLibRibRibRibLsbRgbRgbRgbRgRsmbRgbRgRsmbRgRiRs
RsmmbRgbRgbRsbLsRsbLsbRgbLsbRgbRibRiRsmbRibRibRibLhbLhRsbLibLsbLebRibR
hbLgbRibRiLsbRgbLhbLjbLhbRgbLibLsLsmbLiLsbLsLsmbLgRsbLsbLgbLsLsmbLgbLg
bLsbLsbRsbLsbLgbLgbLgLsbLgbLsbLibRhbRibRgbRgRsmbRgRsmbRgbRgbRgLsbRgbRh
bRcbRhbRibRjbRiRsmbRsbRgbRgLsbRsbRgbRgbRsbRgbRgRsmbLjbRibRhbRibRibRcbR
gbRcRsRsmmbRgbRjbRebRhbRibRgbRibRibLjbRsLcbLhbRjbLcbLgbLhRsbRgbRibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 4; Drug: PCAP2 10 然
bRibRgbRgbRgbRsbRsRsmbRsbRobRgbRgRsmbLsbLsbRgbRsbRgbRjbRgbRgRsmbRgbRib
RgbRgRsmbRsRsmbsbRiRsmbRsbRgbRsbRsbRsbRsbRgbRsbRsbRgbRibRgbRibRgRsmbRg
bRgbRgbRgbRsbRsbRgbRgbRibRiRsmbRgbRsbLsbLsbLgbRsLsbRiRsmbRgbRgLsbRgbRi
bRhbRibRibRgbRibRgbRgbRgbLsbLsbRibRibRgbRgbRsbLsbLsbRgbLsbRiRsmbRsbRgb
RiLsbRibRgRsmbRgbLgLsbRgbRsbLoRsbLsbLsbRsbRsbRgbRibRgbLsLsmbLsbRsbRgbR
sbRsLsbRsRsmbRsbRsRsmbRsRsmbRsbRsbRsbRgbRgbLsbLsLsmbRsbRgbRgbRcRsmbRsR
smbLgbLebLeLsbRgbRsbRgRsmbRsbLsbLsbRibRsbRsRsmbRsbRsbRgbLsbRsbRsRsmbRs
RsLsmbRsbRsLsbRsbRgbRsbRsbRsRsmbLsbRsbRgbRjbRgbRsRsmbRsbRgbRibLsbRsbLs
bLgbLgbLsbLgbLsLsmbRsbLgbRsbRsbLsbLibRgbLgbLsLsmbLgbLsbLsLsmbLsbLsbLsL
smbLgbRsbLsbLsbLsLsmbLsbLgLsbLsLsRsmbLsbLsLsmbRsLsbLsRsbLsbLgbLgbLgbLs
bRsbLgbLsLsmbLgLsbLsbLsLsmbLsbLsbLsRsbLsLsmbLgbLsRsbLsbLsLsmbLsbLsbLsb
LgbLsbRsbLgbLsbLgbRsLsbLgbLsLsmbLgRsbLsbLsbLgLsbRsLsbLgbRsbLgbLsbLgLsb
LsbLgbRsbLgbLsbLsLsmbLgbRsbLsbLgbLsbLsbLgbLgLsbLsLsmbLsLsmbLsLsmbRsLsb
LgbRsbLgbLsbLsbRsbLsbLsLsmbLgbLsLsmbLsLsmbLsbLsbLsLsmbLsLsmbLsbLsRsbLs
LsmbLsbLgbLsbLgLsRsbLgbLgbLgRsbLsLsmbLsLsmbLgbLsbLgLsbRsbLgbLgbLsbLgbL
sLsRsmbLsLsmbLsbLgbLsLsmbRsLsbLgbRsRsmbLgbLsbLgbLsbLsbLsbLgbLcLsmbLsbL
ibLibLgbLsbLgbLgbLsbLsbLsbLsbLsbLgbLsbRsbLgbRsbLgbsbLsbLsbLsLsmbLsbLsb
LsLsmbLsbLsbLgbRsLsbLsLsmbLsbLgbRsLsbLsbLgbLsbRsbLgbLsbLsLsmbLsLsmbLgL
sbRsbLgbLsbLgbLsbLsbLsLsmbLgbLgRsbLgbRsLsbLsLsmbLgbLsLsmbLsRsbRsbLgRsL
sbRgbLsbLsbLsbLgRsbLgbLgbRsbLsRsbLsbLsLsmbLgbLgbRgbLibLiLsbLiRsbLsbLib
LibLsbLsLsmbLgbLsLsLsLsmmmbLsbLsLsmbLgbLsbLsbLsLsmbLgbLsbLsbLsbLgbLsLs
mbRsbLibLsLibLiLsbLibLgbLsbLibRsbLgbLsbRsbLgbLsbLgRsbLgbLgLsbLsbLsbLgb
LsbLsRsbLgLsbLgbLsbLsbLgbLsLsmbLsbLsLsLsLsmmmbLsbLsbLgbLsbRsbLgbRsbLsb
LgbLgbLsLsmbRsbLgbLgbLibRjRsmbRcbRgbLsbRsbRgbRsbLsbRgbRsbRjLsbRhLsbRib
LhbLgRsbLibLiRsbLcbLibLgbLibLibRgRsmbRcbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 5; Drug: PCAP2 10 然
bRgbRibRibRgbRibRibRibRibRibRibRgbRibRgbRibRgbRgbRsbRibRhbRibRgbRgbRgb
RgbRgbRsbRsbLibRsLibLhLsbLsbRsRsmbRjbRibRibRsbRsbRgbLsbRgbRsbRsbRgbRgb
RebRiRsmbRjbRgbRgbRsbLgLsbRsLsbRgbRibRibRsbLgLsbRoLsbRiRsmbRgbRsRsmbRi
bRgbRgbRgLsbRibRsbLsbLsbLgbLsbRhbRsbRsbRgbRibLgLsbLibLgbLgbLiRsbLsbLsb
LgbLgbLgbLgRsbLsbLsLsmbLgbLsLsmbLgbLsbRsbLsbLgbLsbLgbLsbRsbRsLsLsmbLsb
LsbLgLsbLsLsmbLsLsmbLsbLsbLsbLgbLsbLsbLsbLsbLgbLsbLsbLgbLsbLsbLgbLsbLs
bLsbLsbLsbLsLsmbLsbLsbLgRsbLsbLsbLsLsmbLsbLsbLgbLsbLsLsmbLsbLgbLsbLsbL
gbLgbLsLsmbLsbLgbLsbLgRsbLsbLsLsmbLgbLsbLsbLgRsbLsbLgbLsLsmbLsbLsbLsbL
sbLsLsmbLgbLsbLsbLsLsmbLgbLsLsmbLgbLgbLgLsbLsRsbLsLsmbLsbLgbLsbLsLsmbL
gLsbLsbLsLsmbLsbLsLsmbLgbLsbLsLsmbLgLsbLsbLsbRsbLsbLgbLsLsRsmbLgbLsbLg
bLsbLsLsmbLsbLsbLsRsbLgLsbLsbLgbLsbLsbLsbLgbLgbLsbRsbLgbLgbLsbLgbRsbRs
bsbLsbLgLsbRsbLgbRsLsLsmbLgbLsbLgbLgbLsbRsRsmbLgbLgLsbRsbLsbLcbLcbLgLs
bRsbRcRsRsmmbRgbRsRsmbRgRsmbRiLsbRgbRgbLsLsmbRhbRgbLsbRibRsbRsLsbRgbRg
bRgbRsbRgbRsbRiLsbRsbRibRhbRibRgbRjbRgbRsbRgbLsbRiRsmbRgRsmbRgbRgRgRsm
bRiLsbRibRsbLgbRibRgbRgbRgbRgbRgRsmbRgLsbRgbRsRsRsmmbRgbRgRgbRgbRgbRgb
RibRgbRgRsmbRgbRsLsbRobRcbRebRibRgbRgbRibRgbRiRsmbRibRibRgLsbRgbRiRsmb
RsbRibRcbRibRgbRibRibLgbRsbRgbRgbRgbRgbRgbRibRsRsmbRsRsLsmbRiRsLsmbRsb
RgbRgRsmbRiLsLsmbLibLgbLibLsbLhbLcLsmbLgLsbRgbRsbRibRgRsmbLsbRibRibRiR
smbRsbRgRsmbRiLsbRiRsmbRgbLsRsbRgbRsbRgbRsRsmbRgbRgbRsbRgLsbRhbRibRgRi
bRgbRgbRgReRsmbRibRgRsmbRsRsmbLsbRhRsmbRiRsRgmbRgbRgbRiRsmbRebRgbRgRsm
bRsbRgRsmbRsbRgbRibRgbRhbRsbRhbRsbRgRsmbRgbRgRsmbRibRgbRsbRgbRibLiLsLs
mbsbRibRsbReRibRhbRiRsRsRsmmmbRgbLgbRebLgbRibRibRgLsbLsbRsbRgbRibRibRg
bRgbRgbRgbRgRsmbRsbRebLebLcbLsbRiLsbRibRgbReLsbLgbLgbLgbLgRsbLsLgLsLgL
sbLgbLgbLgbLgbLsbLgbLcLsmbLibRibRsbLcbRsbLibLsbLibLibLiLsbLsbRgbRibRgb
RsbRgbRsbRgRsmbRgbLgbRgbRiRsmbLgbRgbRgRsLsmbLsbRobRcbRhbRhbRgbRgbRsbRg
bRgRsmbRgbRiLsbRhLsbRgbRgbRibRibLgbLebLsLcLsmbLgbRgbLibLsRsbLgbLiLsbLc
bRibLibLhbLsbLgbLgbLsbLsbLiLsbLgLsRsbLgLsbLgbRjbLhbRibLhbLcbLibLibLiRs
bLibLgLsbRgbLibLgbLsbLgbLgbLgbLgbLgbLsLsmbLgbLgbLgbLgRsbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 6; Drug: PCAP2 10 然
bLsLsmbLibLibLgbLcbLcbLibRsbLibLcbRgbLobLcLsmbLibLsbLoRoLgbLiLgLsbLgbL
gbLsbLgbLsbLgbLsRsbRjbLobLibRsbLgbLibLsbLibLcLsmbRhbLibRgbRibLjbLgbLcb
LebLiLsbRebRcLsLsmbRgRcbLgLsbLcbLobLhbLobLhbLgbLiRsbLgbLgbLgLsbLiRsbLs
bLibRsbLsbRcLsbRhRsmbLgbLebLgbLgbLgRsbLsbLsLsLsmmbLgLsbLgbLgbLhbLiLsbR
sLsbLibLsbRsbRibRhbRibRgbLsbRsbRgbLcbLoLsmbLgbRgbLgbLcbLhLsbRgbRiRsmbL
ebLhLsLsmbLibLgbLibLhbLeLsbLiLgLsbLibLibLgLsRsbLgbLgbLgbLgLsLsmbLgbLsL
smbLgbLsbLgbLsbLgbLsbLgbLgLsbLgbLgLsbLgbLgbLsLsmbLgLsbLsLgbLgbLgbRgbLi
bLcbLcbLcLsmbLibLgbRsbLiRsbLgLsbLsbLgbLgbLgLsbLgbLgbLgbLsbLgRsbLsbLgbL
gbLgLsbLgbLgLsbLgbLgbLgbLgbRsbLgbLgLsbLgbLgRsbLgLsLsmbLgRsbLgLsbLsbLgb
LsbLgbLgLsbLsbLgbLsbLgLsbRsbLgLsbLsbLgLsbLgbLgbLgLsbLgbLgbLgbLgLsbLsbR
sbLgLsbLgbLgLsLibLibLiLsbLgbLgbLgbLsbLgbRiRobRgbRsbRibRsRsmbRgRsmbRsbR
ibLgbRibRgbRsRsmbRgbRgRsmbRgRsmbRsbRgbRsbRgbRsbRcbRibLgbLibLgbRebRobRg
LibRcbLibRebRobRgbLcbLgbRcRsmbRebRgRsRsmmbLebRibRgbLsbRgbRgRsmbRgbRgRs
mbRsbRgbRgbRgbRsRsmbRgbRgbRiRsmbLcbLsbsbRibRibLcbLsLsmbLgbLgbLcbLgbLiL
sbLibLgbLsbLgbLgbLiLsbLgRsbRibLcbLebLhbLjbLsLsmbLsLsmbLsLsmbLgbLgbLgbL
gLsbRsbLjbRsbLiLsbLsLsmbLgbLsLsmbLgbLsbLgbLsbLgLsbLgRsbLgLsbLsLsmbLsbL
gbLsbLgLsbLgLsbLgLsbLgbLgLsbLgbLsbLiLsbRgRsLombLibLcbRiRgRsRimbRjbRiRs
mbRibRebRsRsLsRsmbRibRgbRsbRgbRjbLgbRjbRcbRgbRibRgbLcbRsbLhbLsbLjbRcbL
sbLibRibRjbLebLgbLebLhbLibRjRibRhbLcbLcLsmbLcLsmbRgbRcbLcbRcRsmbRcRsmb
RhbRcbRibLibRcbRsRsmbRiRsLsmbRsbRibRgbRcbRibRgbRiRsmbLgbRsbRibLobLebLi
bLibLiLsbLgbLgbLgbLgbLgbLgLsbLgLsbLgbRibRobRgbLsbRibRgbLsRsbRgbRcbRcRs
mbRgRsmbRiRsmbRibRsRsmbRibRcbLibLcbLobLjLsmbLcbLibRsbLibLgLsbLgLsbLgbL
gbLsbRsLsbLsLsmbLobRsbLcbLcbLhbLsbRoLsbRhbLgbRibRebLibLiLsbLsbLcbLhbLc
LsLsLsmmmbLibLgLsbRgbRibLgLsbRgbRgbRgbRgbLsbRgbRibRibRcRsmbRiRsmbRibRi
bRgRsmbRgbLgbRcbRcbLjbRobLgRibRgRsmbRsbRgbRgLsbRibLgbRgbRibRgbLcLsLsmm
bLsRgbLeLsbLgbLgbLsbLgbLgbLibLeLsbLgLsbLgbLgbLgbLgbLgRsbRibRiRsmbRsRsm
bRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 7; Drug: PCAP2 3 然
bLsbRsRsRsmmbRibRgbRsbRgbRibLsbRgbRsRsmbRgbRibRgbLsbRgbRibRsbLsbLgbRib
RsRsmbRibRgbRgbRgbRgbLsbRibRibRsbRgbRgbRgbRsbRsbRibLgbRgbRibRsbLjbRibR
sbRgbRsbRgbRsbRsbRsRsmbRsRgbRgbRsRsmbRsbLsLsmbLsbLibLgRsbRgLsbLsbLgbRs
bLsbLgbLsbLsbLsRsbLgbLgbLgbLsbLsLsmbLgbLsbLsbLgbLsLsmbLgbLgbLgbLgLsbLg
bLgRsbLsLsRsmbLsLsmbLgbLsbLsbLsLsmbLsLsmbLsLsmbLsbLgbLgbLgLsbLgbLgLsbL
gbLsbLsLsRsmbLgbLgbLsRsbLsbRsbLjbLsbRgbLgbLsbLgLsbRsbLoLsLsmmbLgbLgRsb
LibLiLsbLsbLgRsbLsbLgLsbRsbLgbLsLsmbLgbLsLsmbLgbLgbLsbLsLsmbLgLsbLsLsm
bLgbLsLsmbLsbLgbLiRsbLibLgbRsbLhbLsbLhbLibLsbRsbRibRcbRgbLgbRibRgbRgbR
gbLjLsmbRhbLgbRibRibLsbRiRsmbLgbRiRsmbRgbRiLsbRgbLgRsbRgbRibRgbLsbRgLs
bRsbRgbRgbLsbRiRsmbLsbRgRsmbRgbRgbRgRsmbRsbRgbRgbRsLsbRgbRgbRgRsmbLsRs
bsbRgbLsbRgbRgbRsbRgbRsbRsRsmbRgbLsLsmbLebLgbLgbLgbLgLsbLgbLsbLsbLsbLg
bLgbLgbLsbLsLsLsmmbLgbLgbLgbLgbLsbLsbLibRcbRsbLcLsmbLgbLgbLsbLgbLsbLgb
RsbLiLsbLcbLcbLjbLibLgbLgbLgbLgbLgRsbRgbLcbLibLgbLsbRgbRiLsbRibRgbLgbR
ibRgbRgbRgbLiRsbLjbRobLgbRhbLjbRobRobRibLibLiRsbLgbLhRsbLcRsbLibLjbLib
LhbLibLgbRsbLhLsbLsbLibLibLiLsLgbLgbLgbLgbLgLsbLgbRcRoLsbRibLsbRcLsRsb
RcbLibRibLcbLcbLiLsbLgLsbRgbLibLibLsLsmbRsLgbRsbRsbLoRcbRibRgRsmbRgbRg
bRsbRgbLsLsmbRgbRgbRgbRgLsbRgRsmbRgbLcbLhbLcRsbLebLgbLcbLhLsbLhbLibLiL
sbLgbLgbLgbLsLsmbLgbLgbLgRsbRsLsLsmbLsbLgbLsbLgLsbLsbLgbRgbLibLgbLibLi
bLibLgbLsbLiLsbLgLsbLgbLgbLgLsbLgbLgbLsbLgbRobRibRsRsmbRgbRsbRgbRgbRsb
RgRsmbRgbRgbLcRsbLsbLjbsbLgLsbLsbLgbLgbLsbLibRjbRcRsmbRgRsmbRgbRsbRgbR
sbRgbLsbRcbRcRsmbRhbRibRibRgbRiLsbRsbLsbLcbLibLgbLibLhLsbLeLsbLiLsbLsb
LhbRgbLibRsbLgbLgbLsbLsbRibLsbRcbRiRsmbRgbRsbRgbRsbRgbRgbRgRsmbRsbRgbR
gbRibLobLibLgbRsbLiLsbLgbLgbLsbLgbLgbLgbRsbLebLgbLcRsbRsRibLgLsbRgbRib
RsRhbRcbRibLcLsmbLibLcRsbLibLsbLhbLibLcbLebLibLibLgbLcLsmbLibLibLsbLiL
sbLsLgbLsbLgbLsLsmbLiRsbLcbLibLgbLibLcLsmbLhbLgbRiRsmbRgbLsbRibRgbLsbR
jbLsbRsbRibLsbRgRsmbRgbRgbRgbRgLsbRibLjLsmbLcLsmbLibLhbLgbLibLhLsbLsbL
gbLgLsbLsbLgbLsRcbRhLsbRgbRgbRsbRgLsbRibRsbRgbRibRgbRibRibRgbRsbRibRsR
gbRgRsRsmmbRsbRgbRgbRgbRgbRgbRgRsmbRsbRsbRgbRgbRsbRgbRsbRgbRgLsbLeLsbL
sbLhbLgbLgbLgbLgbLgbLgLsbLgbLgbLgbRsLsbLgbLsbRsbLibLgbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 8; Drug: PCAP2 3 然
bLeRsbLgLsbLibLsLsmbLgbLgbRgRsmbRcbLsRibRgbRhbLcbLcbLsbLcRsbRsbLsbLcLs
mbLcLsmbLiLgLgbLsbLgbLgbLobLcbLcbLgbLgbLcbLibLsbRiRsmbReLsbRcbLgbLcbLs
bLiRsRsRsmmbLobRcbRcbLibRsbLibLsbRcRsmbRgbRgbRsbRgbLoLgLsRsbLibLsRsbRs
bRibRiLsLsLsRsmmbLcbLibLcRsLgbLsbLcbLibRjbLibLgLsLsmbRjbRcbLcbLibLgbLg
bLsbLsbLgbLgLibLhbLiLsRsbLgbLhLsbLgLsRsbLibRcbRiRsmbLjbLcbLibLgLsbLgbL
sbLgbLgLsbLsbLsbLibRcbLcbRgbLebLibLgbRgbLgbLgbRsbLcRsbLgbLgbLibLibRsbL
cbLgbLgbLgLsbLgbLsLsmbLgRsbLibLsbRcbLgbRsRsmbRibLsLsmbRibRcRsRsRiLsmmb
RhRsmbRgbRgbRgbRibRiRsLsmbRsbLgbLiLsbLgbLgbLgbLgbRcbLhbLiRsRsmbLcbRsbR
ebLobLgbLsLsLiLsRsmbRgbLibLgbLibRsbLibLsbLgLsbLiRsbRcRsmbRgbRgbLsbRsbR
gRsRsmmbRsRsRgmbRsRsmbRgbRgbRgbRgbRgbRgbRgbRgbRgRsmbRsRgbRgbRsbRgbLsbL
cbLgbLsbLsLsmbLiLsbRsLsbLgbLgbLsbLsbLgbLgbLgLsbLgbLsbLsbLgLsRsbRgbRsLi
RsbRebRgRsmbRgbRgbLsbRsRgbRgbRgbRibRgbRsRsmbLsbRibRgRsmbLgbRhRsmbRsRsm
bRhbLibLhbLibRsbLiRsbLgRsbLgbLgbLgbLgbLhbLiLsbLibLgbLibLgbLgbRsbLgbLsL
gRsLsbLgLsbLsbLgbLsbLgLsRsbLsbLsbLcbLcbLhbLhLsbLibLgbRsbLsbLgbLgbRsbRe
bRiRsRsmmbRgRsmbRgbLsRgbRgbRgRsmbRsRsmbRsRsmbRgRsmbRgRsmbRgbRgbRgLsbRs
bRgbRgRsmbRsbRgRgbRgRsmbRgRsmbRgRsmbRgRsRsmmbRgbLgbRsRcbLcbLobLiRsbLsb
LiRsbLgLsbLgbLgbLgLsbLgbLgbLsLsmbLgLsbLgbRcRsmbRhLsbLibRcbLgLebLibLgbL
gbLgbLsRsbLgbLgbLgbLgbRsbRjbRhbRgbRsbRgRsmbRgbRiLsbLgbRcbRibLgLsLibRcb
RgbRgRsmbRgRsmbRsbRgbRsbRgRsmbRgLsbRgbRsbRgbRgRsRgmbRgbRgLsbsbRgbRsRsm
bRgRsRsmmbRgbRiRiRsmbRgRsmbRiLsLsmbLcbLoRsbLsLsmbLhbLsLsLimbLgbLsbLgbL
gbLgbLgbLgbLsbRcbRiRgbRgRsRsRsRsmmmmbRgRsRsmmbRgRsmbLsRgbRiLsbRcRsmbRi
bRgRsmbLjbLibLiRsLsbLgbLgbRgbLoLcRsLgRsLsbLcbLsRsbLgbLgLsbLgbLcbLoRsbL
hLsbLibLgbLiLsbLgbLgLgRsLgLgbLgbRjbLibLcbLsbLhRsbLibLiLsbLgbLgbLgbLgbL
gbLsbLgbLiRsbLiRsbLcbLibLibLgbLgbLsbLiRsRsmbLcbLibLgLsbLiRsbLgLsLgbLsb
LgLsbRjbRgbRcRsmbRiLsbRgLsbRsRsmbRhbRgLsbRgLsbLcLsLimbRsLsbLgbLgRsbLgL
sbLgbLsbRebRcbLsLsmbRibRibRsRsRsmmbRibLgbRgbRsbRibLsbsbRgbRgbRgbRibRsb
sbRiRsmbRgbRgbRgRsmbRsRgbRsbRibRiLsbRcbLhbLsbRcbRcbRcbRjbRcLsRsbLgRsbR
sbRgbLibLoRsbLiRsbLibLsbLibLgbLgbLibRcbRsbRcbLsLgbRsbLhLiLgLsLgLsbLgbL
sRsbLgbLgLsbLsbLiRsbRobRibLsbRiLsbRsRsmbRgbRgbRsbRgRsRsmmbRgRgbRgbRgbR
sRsmbRibRiRiLsbRgbRgbRgbRsRgbRsbRgbRgbRgRsmbRgbRgbRcLsbLsLsmbLibLobLsb
LgbLibLsbLgLsbLgbLsLsmbLgLsbLgbLgbLgbLgLsbLibRcbRsbRibLsbRgRsmbRgbRgbR
ibLgbRibRibLgbRcbLibRibRibRsbRiLsbRgbRgbRiLsbLcbLcbRgbLgbLiLsbLsbLgbLg
LsbLsbRsLsLgLsbLgLsbLgbLgbLgbLibLiRsLsLcbLcbLgLsbLiRsbLobRsRgbLsRiRsmb
RgRgbRiRsmbRsbRgRgRsmbRgbRsRsRgRsmmbRgRsmbRgbRgbRgbRgbRgbRsbRibRibLibL
hbRsLgbLgbLgLsbLgbLgbLsbLgbLgbRjbLhbLsbRoRsmbLhRsbLiRsbsbLgbLgbLgbLgbL
gbLgbLgbLgbLsRsbLgbLgbLgbLgbLgbLsLsmbLsLsmbLgLsbLgbReLsRsRsmbRhbRsbLcL
smbLibLgbLgbLgbLgbLsRsbLgLsbLgLsbLgLsbLsLsmbLgLsbLsLsmbLgRsbRsLgLsbsbR
jbRcbRiRsmbLcLsmbLgLsbLgbLgbLgbLgLsbLgbLgLsbLsRsbLgbLgLsbLgbLgbLgLsbLs
LsmbLgLsbLgbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 9; Drug: PCAP2 3 然
bRgbRgbLgbLgbLsbLsbLgbRgRsmbLgLsbLiRsbLibLibsbLgbLibLsbLsbRgbRgbRjbLjb
RgbRgbRgbLgbRgbRsbRgbRgbLsbRsbRsbLcbLgbLibLgbRsbLgbRgbLgbLgbLgbLjRsbRi
RsmbRjbRibLsbRgRsmbRsLsbRgbRgbRgbLgbRgbRgbLgbRibRibRgLsbRibRibRibRgbRg
LsbRgbRibRgbLsbRsbRibRgbRsbLsbLsbRgbRgbLsbLsbLgbRsbLcbRgbRjbRibRibRcbR
cbRhbRibRgbRsbRgbRsbLsbRsbRsbRsbRsbRgbRgbRsbRgbRsbRsbRgbRsbRgbRhbRibRi
bRsbRibRibRgbLgbLgbLgbLhRsbLibLsbRsbLibLsbLgbLhbLibLsbRsbRgbRibLhbRiRs
mbRsbRsbRsbRgbRsbRgbRsbRgbRsbRsRsmbRsbRsRsmbRsbRsbRsbRsbRsbRgRsmbLsbRi
bLsbLsbRgbLjbLcbLgLsbRsbLgbLgbRsbLgbLgbLgbLgbRgbLsLibLibRsbLsbRsRsmbLg
bLgLsbRjLsbLibLsLsmbLsbLsRsbLsbLgbLsbLgbRgbLgbRsbLibLibRsbRgbRgbRjbRib
RibRibRibRgbRgbRibLcbLibLsbLsbLsbLhbRsbRcbRibRcRsmbRhLsbRibRsbRhbRsRsm
bRgbLsbRgbRgbRibRgbLibLsbLiLsbLsLsmbLsbLgbLsbLgbRsbLgbRgbLibLgbLgbRcbR
ibRhbRibRgbLgbLsbRjbRibRsbRibRgbRcbRgbLgbRsbLgbLgbLibLgbLsbLgbRgbLgbLh
bRgbRibLiLsbLibRsbLhbLgbLgbLgbLsbLibLsbLsbRgbRsbRcbRibLibLsbLgbRhbRibR
ibRgbLgRsbRsbRsbRgbRgRsmbRsbRsbRgbRsbRgbRsbRgbRsbRsbRsbRsRsmbRsbLsbRgb
RgbRsbRgbRgbRibLiLsbRsbRibRibRgRsmbRgbRgbRsbRibRsbRsbRsbRgbRsbRsbRgbRs
RsmbRsbRgbRsRsmbRsbRgRsmbRsbRsbLsbRgbRgbRibLhbRcLsbRhbLsbLibLsbRcLsbRi
bRgbLsbRsbRsbRgbRsRsmbLsRsRsmbRgbRgRsmbRsbRsbRsbRgbRgbRsbRsRsmbRgbRsRs
mbRsRsmbRsbRgbRobRiRsmbRsbRgbRgbRibRibRjbRgbLgbLgLsbLsbLibLsLsmbLgbLgb
LgLsbLgbLgbLgbLgbLsLsmbLgbLsbLgRsbRsbLsbLiLsbsbRsbLgbRsbLgbRsbLgbLgbLg
LsbLsbLgLsbLsbsbLgLsbRgbLhbLcbLibLsbRibRibRsbLsbRsbRibLsLsmbRgbRibRhbR
ibRibLibLsbLgbRsbLgbLgbLgbLgbRjbLcLsmbRgLsbLibRcLsbRiLsbLgbRhRsmbRgbRg
bRibRgbRgbRgbLsbRsRibRgbLsbRsRsmbRgbRgbRgbRsbRsRsmbRgbRsbRsRsmbRsbRgbR
gbRsbRgbRgbRgbRsbRgbLsRsbRibLjbRibLibLcLsmbRsbLgbLibLibLgRsRsmbLsbRgbL
cLsLsmmbsbLsbLibRsbLgbLgbLibLibLgbRgbLibLsbLsbRgbRgbLsbLhLsbLgbRibLhbL
ibLibLibLibLgbLjbRebRibLgbRgbRgbRsRsmbRiRgRsmbRgbRgbRgbRgbRsbRgbRgbRsb
RgbRsbRgbRgbRsRsmbRgLsbRsbRsbRgbRsbRsbRsbRgbRgbRgbRgbRgbLsbRsbRgbRsbRg
bLsbRsRsRsmmbRsRsmbRsRsRsmmbRgbRgRsmbRgbRgRsmbLsbRgRsmbLsLsmbRgbRsbRgb
RibRsRsmbRsbRsbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 10; Drug: PCAP2 3 然
bRgbRsbRibRgbRgbRgbRsbRsbRsbRgbRebRibRgbRibLsbLsbRibRibRsbRgbRsbRgbLsb
RsbRibRcbRhbRsbRsbRibRgbRgbRsbRibRcbRgbRgbLsbRjLsbRibRgbRgbRgbRsbRibRc
bRibRsbRgbRjbRgbRgbRgbRsbRgbRibRibRibRgbLsbRjbRibRsbRgbRgbRsbLsbLibRsb
LcbLgbLsbLgbLgbRsbLgbLsbLsbLsbLgLsbLgbLsLsmbLsbLgbLsbLsbLgbLsLsmbLsbLs
bLsbRjbRgbRjbRibRsbRsbRgbRgbRgbLsbRgbRsbRsbRibRiLsbRibRgbLgbRgbRgbRgbR
gbRsbRgRsmbLsbRgbRgbRgbRsbRsbRgbLhbLibLsbLgbLibRsbLsbLsbLgbLsbLsbLsbLs
bLsbRsbLgbLgLsbLsbLsbLsbLsRsbRsbLgbRsbLcRsbLibLibRgbLsbRgbRgbLgbRsbRgb
RsLcbLibLibRcbRcbLgbRgbRsbRsbRgbRsbRsbRsbRsbRgbRsbRgbRsRsmbRgRsmbRsRsm
bRgbLsbLsbRgbRiLsbRcRsLsmbRgbRgbRgRsmbRgbRibRsbRgbRgbRibLsbLsbLsRsbLgb
RiRsmbRgbRsbRgbRsRsmbRgbRgbRsbRsbRgbLsLsmbRsLsbRgbRgbRgbRgbLsbLsbLsbLs
bRgbRgbRgRsmbRhbRibRsbRgbRgbRgbRgbRsbRibRgRsmbRgbRgbRgbRgbRgbRgbRgbRib
LsbRibRsbRjbLobRgbRgbRsbRsbRgbLsbLgbRibRgbRgbRgbRgbRgbRibLsbRgbRsbRgbR
sbRsbRgbRsbLsRsbRebRcLsbRiLsbRibRhbRgbRgbRgbRsbRgbRsbLsbLsbRgbRibLsLsm
bRsbRgbRsbRsLcbRiRsmbRibRibRibRcbRhbRgbRebRgbRsbRgbRgbLibLibLibRsbRibR
gRsmbRgbRgLsbRgbRgbRgbRgbRsbRsRsmbRsRsRsmmbRsbRsbRsbRgbLsbLgbRibRsbRgb
RsbRgbRsbRgbRsbLsRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsLsbRsbRgbRsbLgbRob
RibRgbRsbRibLsbRcbRibRgRsmbRgbRsbRsbLsbLgbLsbRjbRgbRgbRgbRsbRsbRsbRgbL
sbRgbLsbRsbRgbRgbRgbRgbRgbLsbRsbRgbLgbRhRsLsmbRibRgbRibRibRsLsbRjbRcbR
iRsmbRgbRsbRgbRibLsbRgbRsbLsLsmbRsbRcbRgbRsbLgbLgbRibRgbRsRsmbRgbRgbRg
bRgbRgbRgbRgbRgbRgbRgRsmbRgbRgbRsbRsRsmbRgbRgbLcbLibLsbLsbRhbRibRgRsmb
LsbRsbRsbRsbRsLsbRgbRgbRgbRgbRsbRsbRgbRgbRgbRgbRgbRgbRgbRsbRsbRsbRsbLj
bRgbRibRsbRgbRgbRgbRsbRgbRsbRgbLsbLsbRhbLgbRsbRgbRgbRsbRgbRsbRsbRgbRgb
LgbRibRibRibRgbRgbLsbRjbRgbRsbRsbRsbRgbRsRgbRsbRsbRgbRsRsmbRgbRsbRsRsm
bRsbRgbLsbRibLgbRibRgbRgbRibLsbRibLsbRgRsmbRgbRgbRibLibRsLsbRibRsbRgbR
gbRsRsmbRgbRgbRsbRsRsmbRgbLsbRgbRgbRgbRgbRsbRgbRgRsmbRsRsmbRgbLsbRgbRs
bRgbRgbLsbRgbRgbRgbRgbRgbRgbRgbLsbRsbRgbRsbRsbRgbRsbRgbRgbRgbLsRsbRsRs
mbRsRsmbRgbLsbRgbRgbRsbRgRsmbRgbRgbRsbRgbRgbRsbRsbRgbRsbRgbRgbRgbRsbRg
bRgbRgRsmbRgbRsbRgbRgbRgbRsbRgbRsbRgbRgbLsbRgbRgbLsbRgbRsbRgbRgbRgbRsb
RgbRgbRgbRsbRgbRsbRiRsmbRsbLgbRsbRgbRsbRsRsmbRgbRsbRgbRsbRsbRsbRgbRsbR
sbRgbRsRsmbRsbRgbRsbRsRsmbRsRsmbRsbRgbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 11; Drug: PCAP2 3 然
bRhbLsbRhRsmbRibLcbRgbLsbRibRibRgbLgbLgbRsbLcLsmbLsLsmbLgbRgbLobLcbLib
RgbLgbLsbLsbLcbRcRsmbRcbLgbRgRsmbRsbRgbRgbRsbRsbRsbRgbLgbRgRsmbRsbLsbL
sbRgbRgRsmbLjbLobRsbLgbLsbLgRsbLcbLjbLiLsbLsbLibLcbRsbLsbRgbRsbRobRgbR
ibRsbRgbRgbRsbLcbLsbLgbRsLsbLsbLgbLsbRgbLibLsbLsbLgRsbLsbLgbLsbLsbLgbR
ibRgbRibLsbLgRsbLgbLsLsmbRsbLsbLsbLsbLsbLsLsmbLsbLgbLgbRcbRsbRgbRibRsR
smbRsbRsbRsbLsbRgRsmbLgbRgbLsbRgbRgbLgRcRsmbRsRsmbRibLebRcbRobRgbLsbRg
RsmbRgbRgbLgbLgbLgbLcbLcLsLsmmbLibLgbRcbRibLgbLgbRibLsbRgbRgRsmbRsbRsb
RsbRsbRgbLsbRgbRgbLsbRsbRgbRgbRgbLgbLgbRgbRgbRgbLjbRiRsmbRgbRgbLsbRgbL
sbRsbRsbRsbLsbRgbRsbRsRsmbRsbRgbRgbRgbLgbRgbLsbRgbRgbRsRsmbRsbsbRgLsbR
sbRsbRgLsbRsbRsbLsRsRsmbRgbLsbRsbRsbRsbRsLsbLsbRgbLgbRgbRgbRgbRsbRgRsm
bRsbRsbRsbRgbRgbRsRsmbRsbRsRsmbRsbRsbRgbRsbRsbRsbRgLsbLsbRsbRsbRgbRsbR
sbRsbLsbRsLsbLsbRsbRsbRsbRsRsmbRsbRsbRsbRgbRsbRsbRgbRgbRgbRgbRsbRsbRsb
RsbRgbRsbRgbRsbRgbRsbLsbRsRsmbRsbRsbRgbRgbRgbRsbRsbRsbRsbRgbLsbRgbRsbR
sbRgRsmbRsRsmbRsbRsbLsbRgRsmbRsbRgbRgLsbRgRsmbLsbRgbLsbRibRgbLgbRibRcb
Rgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 12; Drug: PCAP2 3 然
bLibLsbLibLgbLibRcRsmbLsbLsbLobLibRgbRgbRgbRsbRsbLgbRsbLsbRsbRgbRibRoR
smbRgRsmbLsbRgbRjbLobRgbRgbRibRgbRgbRgbRsRsmbRsbLhbRgbLgbLgbLjbLiLsbLg
bRgbLcbLibLibLsbRsbLsbLhbLsbLgbRsbLibLcbLibLgbLjbLjbLgbLgbLobLibLibLib
LibLgbLgbLsbLgbRebRcbRsbRgbRsbRsbRsbRsbRibRibRsbRsRsmbRsRsmbRsbRsRsmbR
gbRsbRsbLjbLgbLsbRsbLgbLsbLibLgbRibRebLsbRibRgbRgbLcbLobLgbLgbRjbRobRs
bRgbLgbLibLibLgbLsRsbLcbRebRiRsmbRgbLobsbLibLsbRgbLibRsbLsbLgbLgLsbLsb
LgbLgbLcRsbLgbLsbRsRsmbRsbRsbRgbRgbRgbRsbRsbRsbRsbRgbRgbLgbLebLiLsbRsb
LgbLsLsmbLsbLsbLgbLsRsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLgbLcbLgbRsbLsbLsbRs
bRsbRgbRibRsbLgLsbLcbLgbLsbLgbLgbLsbLsLsmbLsbLsLsmbLsLsmbLsbLsbLsbLibL
cLsmbLcLsmbLibLiLsbLibLsLgbRgbLcRsbLibLhbLibLsbLsbLcbLgbLgbLsbLcbLsbRs
bRobRibLsbLsbRsbRgbRcbRgbRsbRiLsbRsbRsbRsbRgbRgbRsbRgbRsbRsRsmbRsbRsbR
gbRgbRsbRgbRsbRgbRgLsbRgbRcbLgbRgbLgbLsbRgbRgbRgbRsRsmbRgbLsRsbRsbRsbR
sbRsbRsbRgbLsbLsbRgbRibRibRsbLsbRgbLsbRsbRibLsbLibLgbLgbLsbLsbLgbLsbLs
bLgbLgbLsbRsbRcRsmbRgbRgbRsbRsLsbRsbRgbLsbRsbRgRsmbRsbRsbRsbRsbRsbRobR
gRsmbRjbRcbLgbRiRsmbRgbRgLsbRsbRsbRsbRsbRsbRsbLsbRsbRgbRgbRcbRibLsbLgb
LgbRgbRsbLibLgLsbLsbLsbLgbLsbLsbLsbLgbLgbRsbLsbLsbRsbLsbLsbLgbRsbRcbLs
bRsbRcbRsbLsLsmbLsLsmbLgLsbRsbRsbRgbLgbLsbLjbLibLhbLgLsbRgbRsbRsbLhbRs
LsbLobLiRsbLsbLgbLibLgbLgRsbLsbLsbsbLsbLibLcbRsbRgbRsbRsbRgbRgbRsLsbRs
RsmbRgbRgbRgbRcbRiRsmbLgbLgbRgbRgRsmbRibRsRsmbRsRsmbRsbRgbRgbRgbRgbRsb
RgbRgbRibRibLgbLsbRsbRgbRsbLsbRgbRiRsmbRsbRsbRgbRsbRgRsmbRibRsbRgbLsbR
gbRgbRgbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 13; Drug: PCAP2 1 然
bRgbLibLcbLgbRgbRgbLgbLcbRsbRibRcbRibLjbRibLcbLcbRibRgbLibRgbLcbLjbLib
LhbLibRsbLibRhbRgbRcbRcbRhbRsbRjbRibRsLsLsmbRgbRgbLjbLobRhbLjbRibRibLh
bRgbRjbRcLsbRhbLibRobRcbRgbRgbLsbRgbRsbLjbLcbLibRjbLcbRibLcbLiRsbLibRg
LsbRgRsmbRcbRibLgbRibRcbLibLsLsmbLsbRcbRiLsbLibLibLiLsbRsRsmbLgbLgbLib
LibRibRhRsmbRebRgbLsbLsbRibRjbLjbLjLsmbRsbLgLsbLgbLsbLsbLsbLgbLgLsbLgR
sbLgbLsbRsbRcRsmbRsbRiLsbRiLsbLiRsbLgbLgbLgbLsbLsLsmbLsbLsbLgLsbRgbLsb
RjbRibRsbRgbRgbRgbLgbLsbRgRsmbRgbRgbLgbRgbRibLjbLcbRsbLgbLsbRsbLgRsbLs
bLgbLgbRsbLsbLsbLibLibLgbLgbRhbLibLibLhbRgRsmbRibRiRsmbRgbRgLsbRgbRgRs
mbRsbRgRsmbRsRsmbLcLsmbLibRsbLibRgRsmbLibRsbLgLsLsmbLgLsbLgbRsRsmbRoRs
mbLsbLcLsmbLibLgLsbLibLhbLibLsRgbLobLgbRhbLcbRobRcbRsbRsbRhbRgbRsLsbRs
bRibLoLsmbRsbLibRsRsmbLcbRgbRjbRgbRibLsbRsbRibLsbRgRsmbRgbRibRsbRsbRgb
RgbRibLsbRcLsRsbLjLgbLcbRsbLhbRgbLhbRgbRibRibRsbRgbRsbRgbRgbRgbRgbRgbR
sRsmbRsbRgbRibRsbRibRsbRsbRsbRgbRgbRgbRsbRsbRsRsmbLcbRsLsbLibRgbLhbRgL
sbLibLgbRsbLibLsbLsbLiRsbRsbLibRiLsbLcbLibRgbRgLsbLhbRjbRcRsmbRgRsmbLs
bRcbLibLgbLobLgLsbRgbRsbLgbLgbLsbLgbLsbLgbLsLsmbLsLsmbLsRsbLibLhRsbLib
RibLhLsbLcLsmbRgbLcbLsbLibLhbLsbRgRgLsbRgbRibRgbRgbRgRsmbLgbRibLsbRiRs
RsmmbLsLsLsmmbRibLsRsbRgbRgLsbRsbRibLsbRibLjbRibRcLsbRcLsbRibLgbLibRsL
sbRjRsmbRiRsmbRgbLsbRgbRgbRgbRgbRgLsbLeLsbLgbRsLsbLiLsbRgbLgbLhLsbRjbL
iLsRsbLgLsbLgbLsbLgbRebRhRsmbLgbRgbRgbLgbRgbRgbRsbRgbRgbLsbRiRsmbLjbRs
LcbLiLsbRsbLiLsbLibRgbRjbLjbLibLsbLgbLgLsbLsbRgbLhbLhbLhbLsbRgLsRsbRsb
RgbRgbLcbLibRjbLibRcbRgbLsbRgbLgbRgbRibRgbRgRsLsmbRgbRgbLgRsbRgbRhbRib
RibRsbRibRibRsbLsbRgbRsbRgRsmbRgbRgbLsbRgLsbRgbRgbRsbLebRsbLgbLsbLgbLg
bRgbLsbLgRsbsbLobRebRibLgbRiRsmbLsbRsRsmbRibLgbRgbRgbRiLsRibRgbRsbRibR
ibLgbRgbRibLsbRgbLsbLcbLhLsLsmbRgbLgbLgbLgbRsRhRsmbLhLsbRsbLibRsbRjbRc
bLibRgbRibLsLsRsmbRcLsbRibLhbLobLibLjLsmbLibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 14; Drug: PCAP2 1 然
bLsbLsbLgbLgbLsbLsbLsbLhbLibLsbRgbLibLsbLcbLibRgbRgbRibRgbRsbRgRsmbRgb
LsbLgRsbRsbLgbLibLiLsbRgbRgbLgbLjLsmbRsbLsbRjbRsLsLsmbLibLcbLgbLsbLsbL
sbLgbLgbLgbLsLsmbLsbLsbLsbLsLsmbLsbLsbLgbLsbLsbRgbLgbLsbLsbLsbLsLsmbLs
bLgbLsLgbLibLgbLsbLsRsbLsbLibLgbRobRhbRgbLgbLsbRiRsmbLsRsbRsRsmbRibRgR
smbRsbRsbRgbLebLibRsLsbLgbLsLsmbLgbLgbLsbLsbLsbLgbLgRsbLibLibRibLgbLgR
sbLsbLibLgbRsbRsbLsbLgbLgbLgbLsbLsbLsbLsbLsbLsbLgbLgRsbLsbLgbLsRsLsbLs
bLsbLsLsLsmmbLsLsmbLgRsbLgbLgbLgbLsbLsbRsbRcRsmbLcbRgbRiLsbRgbLsbLgbLg
bRjbRgbRgbRibRsRsmbRsRsmbRsbRgbRsRsLsmbRgbRibRhbRibLgRsbLgbLgbLsbLibLs
LsmbLgbRsbLsbRcbRibLsbLsbRibLsbLsbRibLgbRiLsbRgbLgbLsbLgbRibRgbRgLsbRg
bLgRsbLgbRhbLsLsmbLsbRsbRsbRgbRsbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbR
gbRsbRgbRsbRgbRgLsbLsbLsbRibRsbLsbRsbRsbLsbRgbRsbRsbRgbRgbRsbRsRsmbRgb
RsbRsRsmbRsbRsbRsbRgbRsbRgbLjbsbLsbRsRibRcbRgbRsRsmbRsbRcbRgbLibRsbRsb
RibLsRsbRsRsLsmbRsRsmbRsbRsRsmbRgbRgRsmbRsbRsLsbRgbRsRsmbRsbRsRsRsmmbR
sbRsbRsbRgbRsbRsRsmbLsbRsRsmbRsbRsbRsbRgbRgbRgbRgbLjbLcLsmbLibLgRsbRsb
LgbLgbLgbRsbLibRsRsLsmbLsbLsbLgbLsLsmbLsbLsbLibLcbRgRsmbLibLgbLjbLgbLs
bRsbRsbLibLgbLgbRsbLgbRsbLibLibRgRsRsmmbRgbRgbRhbLsbLgbRhbLsbRibLsbRsR
smbRibLsbLsbRgbRiLsbLsRsbRgbRgbLsRsbRgbRgbRgbRgbRgbLgbLsLsmbRgbRgbRgbR
ibLsbLgRsbRgbRibLsbRgbRgbRsbRsbRsbRsbRsRsmbLsRsbLsRsbRsbRsRsmbRgbRgLsb
RsbRsbRgbRgRsmbRgbRsbRsbRsbRsbRsbRsbRsbRgbRsbRsbRsbRgbLsbRgRsmbRsbRgbR
gbRgbRgbRgbLgbRgbRgbRgbRgbRsbRgbRsbRsbRgbRgbRsbRsbRgLsbRgRsRsmmbRsLsbR
sRsmbRsbRsRsmbRsRsmbRgRsmbRgRsmbLsbRgbRgbRgbRsbRsbRsbRsbRsbRgbRgbRsbRg
bRsbRgbRgbRsbRsbRgbRgbRibLgbLgbLhbRsbLibLibLsbLsbRsLcbLgbRgbLiLsbLgbLg
bLgbRgLsbLgbLgbRgbRibRgbRgLsbLsbRsbRsbRsbRsbRibRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 15; Drug: PCAP2 1 然
bRsbLgbLgbRcbRjbRobRibRcbRibLsbRibRgbLgbRhbRibLibLgbRcbLjLsRsmbRibRsbR
iRsmbLsbRibLsbLsbRgLsbRsLsbRgbRsbRgbRhbRibRibRibRgbRhLsbRibLibLibRebLg
bRibRgbRsbRiLsbLibLsbRjbRibLgbRcbRibRsbLgbLsbRgbLjbLibLiRsbLsbLgbLgbLs
bLgRsbLgbLiRsbLibLcbLhbLjbLibLgbLgbRibLibLibRiRsmbLibLcbRjbRibRgbRibLg
bRgbLsbRibRgbLgbRcbRcbRcbRhbLebLgbLgbLgRsbLgRsbRjRsmbRibRibRsbRsLsbRgb
LjbLibLgbLgbLsbLgLsbLgbRsbLibRjbLgLsbLsRsbLgbLgbLgbRibLgbRibRibRibRgbR
cbLibRjbRibRsbRibRibRhbRibRiRsmbRibRibRiRsmbRgbRsbRhRsmbRsRsmbRgbRgbRi
RsmbRgbRgbRgLsbLjbLibRsbRobRibRgbRibRgbRibLsbLibLibLibRibRgbRibRibLgbR
ibRibLgbRibLgbRhbRibRcbRhbRiRsmbRibRgbLgbRibLgbRgbRgRsmbRibRsRsmbLhbRi
bRgbRibRiLsbRcbRgbLeLsbLgbLgbLsbLgbLgbLgbLgbLibRgbLibLsbLgbLsbLgbLgbLg
bLsLsmbLgbLgbLsbLgLsbRgbLgLsbLgRsbLsbLgbLsbLgbLgbRjbRsLjLsLsLsmmmbRhbL
ibLgRsbLgbRsbLgbLgbLgbLsbRsRsmbRsLsbLsRsbLsbLgbLsLsmbLsbLgbLgbLgbLgbLi
bLcbLibLgbRjbRiRsmbRsRsmbLjbRhbRebLibRsbLibRcbRobLgbRcRsmbLgbRibRhbRgb
RsbLgbLsbLibRsbLsLsmbLgbLgRsbLgLsLsmbLgbRsbRsbLgbLgbRobRibRsbRibLsbRib
RsbRgbLsbRgbRgbRgRsmbRgbLsRsbRgbRgbRibRibRgbRibRibRibLsbRibRibRibRibRg
bRsbLgbRjbRibRsbRgRsmbRgbRgbRgbRgRsmbRsRsmbRsbRgbRgbRgLsbRsbRsbRsbRgbL
sRgbRgbRgbRgbRgbRgbRgbRibLjbRibLgbRcLsbLibsbRibRsbLsRsbRgbRgbRgbRgbRgb
RsbRgbRsRsmbRsbRgRsmbRsbRgbRsbRgRsmbRgRsmbLsRgbRgRsmbRgbRgbRgbRgbRcbRi
bRobRibRhbRgbLsbLcRsbLibLgbLgLsbLcbRsbLibLsbRsRsmbLibRsbLibRgRsmbLibRg
bLibLgbLgbLgLsbLsbLsbLgbLgLsbLsbLibLiRsbLiRsbLgbRhbRiRsmbRgbLgbRiLgbRi
bLjbRibRsbRgRsmbRgRsmbRsbRgRsmbRgbRgbLsbRibLobLobRgRsLsmbRhbLsbRibRsbR
gbRgbLsbReRsLsmbRibRhRsmbRibRibRgLsbRgbRgbRsbRsbRibLsbRsbRgbRgbRgbRgbL
sRsLsbRibRsbRsbRibRsbRgRsmbRsbRsbRgbRgRsRsmmbRgLsbLsbRgbRgRsRsmmbRgbRs
bRgbRgbRgbRgbLsLsmbRhbRgbLhbRibRiRsmbRsLsbRgbLsbRgbRgbRsbRiRsmbLsbRiRs
mbRiLsbLsRsbRibRgbRibLsbRiLsbRgbRibRibRiRsmbRhbRgbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 16; Drug: PCAP2 1 然
bLsRsbLgbLsLsmbLgbLcbLebLcbLcbLeLcbLsbLjbLibLgbLcbLcbLibLgbLibLcLsLsmm
bLgbLsbLgbLgRsbLgbLgbLgbLgbRsbLgbLibLsbLiLsbLsLsmbLgbLgbLsbLiRsbLgLsLg
bLgbLgbLsLsmbLgbLsbLsbLibLgbLibLeRsbLibRcbRhbLgbLgbLebLebLhbLcRsbLgbLg
bLgbLgbLgbLgbRebRibLibLgbLibLgbLgbLgRsbLibLgbRsRsmbRsbLgbRjbRgbRsbLjbR
gbLgbLgbLsbLgbLgbLgRsbLebLhbLibLibLeLsLgRsLsbLsbLsbLsbRobRjbLsbLibRobL
iRsbRibRebRgRsmbLibLgbRcRsRsmmbRhbRsLsRsbLsbLibLgLsbLibLgLsbLgbRsbLgbL
ibLgbLsbLgbLsbLsbLsbLgbLgbLcbLibLibLebLibLcbLibLgbRiRiRsmbLgbRibRgbRgL
sbRsLsbRgbRgRsmbRgbRsbRgbRgbRsbRibLebLhbRcbRjbLgRsbLjbLsbLsbLsbLibLebL
ibLiRsbLhbLjbLgbLebLjbLibLibLgbLiRsbLjbLsbLgbLgbLgbLsbLsbLsbLsbLjbRsRs
mbLibLibLgbLgbLsbLgbLsbRjbLsbLibLgbLgbLgbLgbLcbRibRsRsmbRhbRibRcLsbLsb
RcbRsRsmbRsbRcLsbLsbRcbLgbRibRibRibRibRibRibRibRhbRgbRsbLsbRgbRsbLsbRi
RsmbLgbLebLcRsbLcbLibRgbRgbRsRsRsmmbLsbRcbRgbLiRsLsbLibLgbLsbLgbLsbRsb
LgbLsbLgbLsLsmbLsbLgbLgbLsbLsbLsbReRsmbRibRiRsmbRcbRiRsmbLgLsbRcbRibLs
bRgbRgbRgbRgbRsbRgbRsbRsbRobLgbRcbRhRsRsRsmmmbLgRsbLsbRiRsmbLsbLsbRgbR
gbRgbRsbRsbRsbRgbRgbLsbRsbLjbLebLcbLgbLsbLcbLgbLgbLibLsbLhbRsbRsbLgbRe
bRibRibRgbRhbRgbRsbLhbLgbLgbLgbLgbLgbLgbLgbLgRsbLsbLsbLsbLgbLsbRjbRebL
cbLgbLsbLgbLsbLgbLgbLgbLsbRsLsbLgbLgRsbLgbLsbLgLsbLgbLgbLgbRsLsbLsbLgL
sbLgbLgbLsbLgbLsbLjbRgbRgbRsbRsbRgbRgRsmbRjbRsbLsbRcbRgbRibRgbRsbRgbRs
bRgbRgbRsbRjbRsbRsRsmbRsbRgbRgbRgbLsbRgbRgLsbLsbRgbRgbRibRsbLibLcbLsbL
sLsmbLibRebRgRsmbRsbRgRsmbRgbRgbRgbRgbRgbRsbRsbRsLsbRgRsmbRgRsmbRgbRsb
RgbRgbRgbRsRsRsmmbRsbLsbRsbLsbRgbRsbLsbRgRsmbRsRsmbRgbRgbRgbRjLsLsmbLc
bLibLgLsbLgbRjLsbLibLhLsbLibLibLibLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 17; Drug: PCAP2 1 然
bRibRhLsbRsbLsbRibRgbRhbRhbRhRsmbLibLebLibRcLsbLibLiLsbRjbRobRibLsbRgb
RibRgbRgbLsbRibLgbRibLsbRibRsbRcRcbRoLsbLgbRhbRgLsbLibRcbRhbLibLibRsbR
hbRgbLhbLcbRebLebRsRsmbLibRjbRcRsmbRibLjbLcbLhbLcLsmbLcbLibLsbRcRsmbRc
RsmbLgbLjbLibLsbLgbLsbLgbLsbLgbLgbLgbLibLjLsmbLcbLcbLhbLgbLsbRsbLibLsb
LgLsbLibRsbLobLgbLibLgbLibLgbLgbRsbRobRiLsbLsLsmbRsbLcLsmbLobRibRsbLsb
RjbRibRgbRgbRibLiLsbLcbLibLsLsmbLiLsbLcbLibRibRibRgRsLsmbRgRsmbRsbRgbR
sbRgRsmbRsbRgbRsRsmbLsbLcLsmbLibRgbLsbLibRjLsbLebLibLcRsbLjLsmbLiLsbLi
LsbLibLsbLgbLgbLgbLsbLsbLgbLsLsmbLgbLsbLsLsmbLsbLsbLgbLsbRobLgbLgbLibL
cbLibLcbLgbLgbLgbLgbLgbRjbRoRsmbRibLcbLibLsbLgbLsbLiLsbRgbLgbLgbLsbRgb
LgbLhbLcbLcbLibLibLsbRgbRobLobRibRgbRgbRgRsmbLjbRgbRiRsmbRgbRgbRgRsmbL
cLcbRgbLibRsbLibLsbLiLsbLgbLgLsbLsLsLsmmbLgLsbLsbLgLsbLhLsLsmbLgLsbLgb
LsbLgbLsbLgbLgbRjbLibRcbRhbLjbRhbLjbLcbLsbLhbRgbRsbLcbRgbLiLsbLgLsbLib
RsbLibRsbRgbLgbLgbLgbLsbLgbLsbLgbLsbLgLsbLsbLgbLgbLgbLgLsbLibRhLsbLiLs
bRgbLcbRibLcbLsbRgRsmbLiLsbRgbLiLsbRgbLibRsLsbRsbsbLgbLgLsbLgLsbLgLsbL
hLsbLgbLgbLgbLgbLgbLgbLsLsmbLgbLgbLgbLgbLsLsmbLgLsbLgbLsbLgbLgbLgLsbLg
bLgbLgbLsbLgLsbLgbLgLsbLgbLgbLgbLgbLgbLgbLgRsbLgbLgbRjbRibLcbLibRhbReL
sbRobRiRsmbRgbRibRibRcbRhbRgbLcLsmbRsbLibRsbLibRsbRsLhbRgbLgbLibRgbLiR
sbLcbLcbLibLibLibRcbRibLcbLcbRgbRibRgbRsbRgRsmbRgbLsbRgbRsRsRsmmbLcbLs
bLcbLsLsmbRjbRhRsmbLcbLcbRcbRcRsmbRhbRibRgbRgbLgbLcbLibLcbLcbLcLsmbLib
LsbLsbLgbLgbLibLhbLibLsbLiLsRsbLcLsmbLsRsbLhbRsbLiLsbLgbLgbLgLsbLgbLgb
LgbLgbLsbLibLgbLgbLgbLgbLgbLgbLgbLgbLsbLgbLgbRsbLibRgbLcbLobLeLhLsLsmb
LibLibRjbRcbRiRsmbLgbRibRibRgbRgbRgbLsbRibRgbRibRgbRsbRgRsmbRgbRgRsmbR
sLcbLsbLsbLgbLgbLgbLgbLibLgbLgRsbLjbLoLsmbLcbLcbRgbLhbRsbLibRgbLibLibL
gbLgbRgbLgbLgbLgbLibLsbLgbLgbLsbLibLibLibLgbLsbLsbLibLibLsbLsRsbRhbRcb
LjbRobLsbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 18; Drug: PCAP2 1 然
bRhbLgbRgbRgbRgbLsbRgbRsbRgbRgbRgbRgbRgbLibLgbRibRibRgbRsbRiLsbLgbRgbR
ibLgbRibLgbRibRgLsbRgbRibRibLhbLibRgbLsRsbRcbRhbRgbRibLibLibLgbRsbRsbR
sbLgbLgbRsbLgbRoRsmbRibLjbRcbRcbRoLsbRebLgbRcbRhbRgbRgbRcbRsbRiRsmbLgb
RibRgbRiLsbLcbLibRgLsbLsbLsbLgbRgbLiRsbLibRjbLhbRcbRcbRgbLibLibRjbRibR
gbRibLhbLibRhbLcbLjbRiLsbRcbRsbRhbRobRcLsbLsbRiLsbRjbLjLsLsmmbRgLsbLgb
RjbLjbRcbLiLsbRcRsRsmmbRibRjbLoLsmbLjbLsbRjLsbRsbLgbRibLsbLgbRgbRgLsbL
gbRibLgbRiLsbLgbRcbLibLgbRgbLgbLgLsbLibRgRsmbLoLsmbLgbLgbLibRhbLsbLsbR
gbRibRgbLsRsbRgbRgLsLsmbRgbLgbRcbRhRsmbLhLsbLibRcbLjbLobRgbLobRibRgbRg
bRgbRibRsbRibRcRsRsmmbRhbRjbRibRgbLsbRibRgbLsbRgLsbLibRiRsmbRgbRgbRsLs
bRgbRgbRgRsmbRsbLibLsbRgbRibRibRjbLgbRibLgbRgbLsbLsRibRgbLsbRgbRgbRgbR
gbLsLsmbLibLgbLobLibRgbLsRsbRgbRibLjbLobRibRgbRgbLsbRibRgbRgbLgbLsbRgb
RibLgbLobLgbRjbLcbLibRibLgRsbRgbLgbLcbLgbRcbRgbLjbLiLsbLgbRgbLgbLcbLgb
LgbLgbLibLibRibLibRgbRibLcbLiRsbLibRjbRcRsmbLgbRibRgbRgbLibLgbRjbRibRi
bRibLsbRsRgbRgbLsbRgbRgbRibRgLsbLibRgbLjbRibLgbReRgbLeRsbLiLsbLsbRsLsb
LsLsmbLibLsbLibRsbLibRgbRjbRhbRgbRjLsbLibRiLsbRgbRibRgbRgbRsbLsbRgbRgb
LgLsbRgRsmbRcbRibLhbLgbRcbRibLibRiLsbLgbLhbRcbRcbLhbRjbRgbRgbRgbRiLsbR
gbRibRgRsmbRibLibRebLebLibLgbRjbLibRcbRibLgbRiRsmbLgbRibRibRgbLgbRibRg
bRiLsbLjbLoRsbRjbLcbRjbLgbRibRcbLgRsbRsLsbRibLjbRibLsbRhbRhbRcbRgbLiRs
bLsbLgbRcRsmbRhbLibRcRsmbRhbLsbRgbRgLsbRiRsmbRibRibLebLibLcLsmbLsRsbLg
bRsLsbLibLgbLgbRgbLibRgRsLsmbLibsbLgbRjbLsLsmbLgbLibRjbRcRsmbRgLsbRibL
ibRcbLjbRibRgbRibLjbRhbLibRiLsbRibLgbRibLgLsbRsbRgbRgbRhbRgbRgbLhbLibL
gbRsbRibLsbRgbRgbLjbLebLibRcbLcbRcbLgbLcbRcbRcLsbRibLjbRjbRiLsbRsbLiLs
bRibRcbLjbRcbLibLebLib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 19; Drug: Control
bLibLgbLiLsbRibLibRgbRgbLgbLibRsbRjbRgRsmbRsbLsbLsbRibLsLsmbRsbLsbLsbL
sbLgbRebRibRsbRsbRgbLsbRibLcbLgbRsbLgbRobRcbLibRgbRjLsbRiLsbRsbRibRibR
gbRgbRgbLgbRgbRgbLjbLgbRcbRjbLcbLhbLibLcbLgbLsbLibLsbLobRgbRgbRcbLjbRg
bRibRsbRsbRsbLsbRsbRgbsbRgbRsbRsbRsbRsbLsbRsbRsbRsbRgRsmbRsbRsbRsbRibR
cLsLsmbRibLgbLgbRsbLgRsbLgbRsbLibRsbLsLsmbLgbRsbLgbRsbLgbLgbRsbLcbRgbL
sbRgbRgbLjbLgbLsLsmbLgbLgbLsbLsbLsLsmbRcbRhLsbLsbRgbLsRsbRgLsbRsbRgbLs
bRsbRgbRibLgbRsbRsbRsbLgbLibsbRiRsmbLsbRsbRsLsbRibLcbLgbLsbLgbRgbLcbRg
LsbRiRsmbLibLgbRgbLibRsbLgbLsbRsbLiRsbRsbRsbLgbLgbLsbLgbLgbRsbRgRsmbLj
bLibRsbRsbRgbLgLsbLgbLgLsbLgbLsbLgbLsbLjbRsbRgLsbRjbLebLhbRsbLgbLsbRsR
smbLgbLsbLgbLsbRsLsbLsbLgbLsbLsbLgbLgbRgbLjbRsbLgbLhbRgbRjbRgRsmbLjbRs
bLsLsmbLgRsbLibLsbLgbLsbLgbRsbLgbLsbLgbLgbLsbLsbLoLgLsbLibLjbRsbLsbLgL
sbLgbLgbRsbLgbLsRsbLsRsbRsbLgbLsLsmbLgbLgbLgbRjbLgbLgbRgbLjbLsbLsbLgbL
sbLgLsbLgbLsbLsbRsbLgbRsRsmbRgbRgbRsbLsbRsRsmbRgbRsbRsbLsbRgbLsbRgRsmb
LsbLgbLjbLsbRsbRsbRgbRgbRgbRibLjbRibLsbRgbsbLsbLsbRsRsmbLsbRsbRsbRgbRs
bRgbRsRsmbRgbRgbLsbRgbLgbRiLsbLgbLcbLiLsbLgbLibLsRsbRgbRgbLibRjbRcbLgb
RsbRgbRgbRsbRsbRsbLgbLibLsRsbRcbLjbRgbRgbRgbRsbRgbLsbRgbRsbRibRibRibRg
LsbRgbRgbLibLgbLgbLsbLsbRsbRsbLsbsbLgbLgbRgbRcbRibRgbRibRgbLgbRgbLjbRj
bRiRsmbLgbLgbLsbRgbRibLgbRibRgbRsbRsbRgbLjbRibRsbsbLgbRgbRsbLgbLsLsmbL
sbsbLcbRgRsmbRjbsbLhbLgbLcbLibLsbsbsbRsLobRgbLibLsbRsbLgbRsbLiRsbRsbLs
LsmbLgbLsbLgLsbLsbRsRjbLibRgbRcLsbLsbRibLgbRibLgbRsRsmbRgbRibLgbRibLsb
LcbLsbRgbLsRsbLgbRsLsbLsRsbLgbLsbLsbLsbsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 20; Drug: Control
bLgbRsbLgRsbLgbLgRsbLgbLsbLibLgbLsbLibLsbLsbRsbLgbLgbLibLsbRgbLsRsbRoL
sbLgbLsbLgbLcbLsLsLsmmbRgbLsLsmbLsbRsbLobLgbLibLsbRgbLcbLhbLgbLgbLibLg
bLgbLgbLgbLcLsmbLsRsbLsRsbLsbLiLsbLsbLibLsbLsbRgbRsbLgbLibLiRsbLiRsbLg
bRgbLsbRgbRsbLsbRibLcbLgbLgbLgbLsbRsbRsbLjbRsbLibLsLsmbLibLibLcbLgbRgb
RgbRibLsbRsbRibRgbRsbRgbRgbLsbLcbLgbLgbRsbLsbLgbLsbLsbLgbLsbLsbLsbLsbL
cbLgbLgbLibLibLsbLgbLgbLsLsmbLgbRgbLgbLgbLgbLsbLgbLhbRsbRibRsRgbLjbLib
RsbLgbLsbLgbRsbRsbLibLgbLsbLgLsbLsbRsbLgRsbRsLsbLsbLsbRsbLsbLgbLsbLgbR
sbRsbRcbRibLgbRibRibRsLgbRibRsbRgbRgRsmbRgRsmbRsbRgRsmbRiLsbRcLsbLibLg
LsbLgbLgRsbLgLsbLibRiLsbLgbLgbLiLsLsmbRgbLgbLgbLsbLgbLsbLgbLsbLsbLsLsm
bLgbLsbLsbLgbLsbLsbRjbLibLgbRsbLgbLsbLgbLsbLgbLibLgbLsbLsbLgbLsbLgbLgb
LsbLsbLsbLsbLgbLgbRjbRibRgbRgbRsbRsbLibLibLgbLgbRibLsbLgbLgbLgRsRsmbLs
bLgbLgbLsLsmbLsbLgbLgbLgLsbRsLsbLgbRsbLsLsmbLgbLgbLsbLsbLgbLgbLgbLgbLs
bLsLgbLgLsbLsRsbLibRsbLgbLiLsbLsbLgbLgbLgbLgbLsbLsbLsLsLsmmbLibLgbLgbL
ibLgbLgbLgLsbLgbLsLsmbLsLsmbLgbLgbLsbLsbLsbLgLsRsbLgbLgbLgbLgbLgbLgLsb
LgLsbLsLsmbLsbLsbLgbLgLsbLgbLsbLsbLgRsbLgbLgbLgbRsLjbRsbLgbLgbLgLsbLgL
sbRsLgbLgLsbRsbLgbLgbLgbLgbLsbLgLsbLsRsbLjbLgbLsbLsbLgbLsbLgbLgLsbLsbL
gbLgbLgbLgbLgbLgLsbLgLsbLsbLsbLsbLjbLsbLgbLsbLgLsLsmbLgbLgbLsRsbLgbLgb
LsbLsbLgbLsLsmbLgLsbLgRsbLsbLgbLsbLgbLgbLgLsbLsbLgbLgbLgbLgbLgbLsLsmbL
gbLgLsbLgbLsLsmbLsbLgbLsbLibLsbLgLsbLgbLgbLsbLgLsbLibLgbLgbLsbLibLgRsb
RsbLibLgbLsbLgbLsbLibLsbLgRsLsRgLsbLcRsbRgbRjbLjLsmbLiLsbLgRsbLgLsbLgb
LsLsmbLsbLgbLgbLsbLsbLsbLsLsmbLgbLgbRcbRiRsLsmbLgRsbRhbLgbRhbLsbRobRsb
RsbRibRgbRhbRibRsLsbLsbLhbLcbLgbRibRcRsmbRsbRgbRsbRgbRgbRsbRsRsmbRgRsm
bRsbLsbRgRsRsmmbLhbsbLibLiLsbLsbLgbRgbLibLgbRsbLgbLgbRsbLgbRjbRcbRhbRh
bLsbLibRobRibRibLsbRhbRibRiLsbLgbLibLgbRgbLgLsbLibLgLsbLsbLsbLgbLgbRsb
LgbLsRsbLgLsbLgbLsbLgLsbLgLsbLsbLsbLgRsbLgRsbLgbLgbLgbLsLsmbRobRiLsbLs
bLcbLibLgLsbLgbLsbLgbLibLgbLgbRsbRgbLebRibLibRsLsbLgbLsbLibRgbRsLgLsbL
gLsbLsbLgbLsbLjbLsbLgRsbLgbLsbLgRsbLsLsmbRsbRebRgbRibRgbRibRibLgbLgbLc
bLgbLsbLgbLibLsbLcbLibLcbRgbRsbLsbRgbRobLgbLgbRobLjbRcRsmbRsbRibRsLsbR
gbRgRsmbRsbRgbRgbLsbRgbRjbRsRsmbRgRsmbRsbRsRsmbRgRsmbRsRsmbRgbRgbRgbRg
bRsbRgbRgbRsbRgbLsbRiRsmbLsLsmbRgbRgbLgLsbRsbRibRgbRgbRsbRgbRibLebLcbL
cbRibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 21; Drug: Control
bLgbRobRibRgbLsLsmbRiLsbRibRsbRibRibRgbLibLsbRgbRibLsbRgbLgbRgbRgbRsbR
gbLgbRgbRgbRgLsRsbLsbRgbRgbLgbRibLsbRgbRgbRsLsbsbRsbRgbRgbLgbRiLsbLsRs
bRiLsbLibRibRgbRgbLsbRsRgbLsbRgbRgRsmbRgbRsbRcbRhRsmbRibRcbRibRgRsmbRg
bRibRgbLibRsbRsbLgbLiLsbLsbLgbRsRsmbLsbRjbRiRsmbRsbRgbRgbRsbRsbRsbRsbR
sbRgbRgbRgbLjbRiLsbLgbRgbRgRsmbLgbRibLsbLiLsbRcbRibLsbRgbLsbRibRsbRgRs
mbRsbRgbRgRsmbRgbRgbLjbLcbRcRsmbRgbRgbLibLgLsbRsbLcbRgbLibRgbRcbRsbRgb
RgRsmbRsLsbRgbRgbLsbLsbRgbRgRsmbRgRsmbLsLsmbRiLsbRgLsbRgbLsbRgbLsbRiRs
mbRgbLsbRsbRsbRgbRgbRgbLsbRgbRgbLgbRhbLibRibRibLjbRiLsbRgbRgbRgbLhbRib
RsbRgbLsbRgbLsbRgbRibRsbRgbRgRsmbRgbRsbRsbRgbRgbRgbRgbRsbLsbRgbRsLsbRs
bRsbRgbLsLsmbRgRsmbRsbRgbRgRsRsmmbRgRsmbLsbRgbRgbRgbRgbLsbRgbRsbRiRsmb
RgbRgLsbRgRsmbRsRsmbRgbRgbLsbRgRsmbRibRsbRsbRsbRiLsbRgbLibRgbRgLsbLibR
gbRgLsbRgbLsbRgLsbRgRsmbRsbRgbRgRsmbLsLsmbRsbRgbLsRsbRibRgRsmbLsbRgbRg
bRgbRgLsbLibRiRsmbRsbRibRsbRibRgbRgbsbRsbRgbLsLsmbRgbLsRsbRibLsbRgbRgb
RsbRgbLsbRgbRgbRgbLgbLjbLiLsbLsbRsbLgbLsbLibRibLjbLgbRebRibRgbLgbRiRsm
bRibLgbRibLsbRiRsmbLsbRgbRgbRsbRgbRsRsmbRsbRgbRgbRgbRgbLgbRibRiRsmbLib
LgbRcbRibRiLsbRgRsRgmbRsbRibRgbRgbRgbRibLgbLgbRibRgRsLsmbRgRsmbRgbRsbR
sbRgbRsbRsbRgbRsbRgbRgbRgbRibRibRibRibRibLjbRiRsmbRibRgbLsbRgbRgbRsbRg
bRsbRsbRiRsmbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbLsbRgbRgbLgbRiRsmbRiRsmbsbR
gbRgbRgbRgbRgbLsLsmbRsRsmbRgbRsbRgbLsbRgRsmbLsbRgRsmbLsbRgbRsRgRsmbRgb
RsbRgbRgbRsRsmbRgbRgbRgbRgbRsbRgRsmbRgRsmbRgbRgLsbRibRgbRgbRgbRgbRgbRg
bRgbRsbLgbRibRibRsbRgRsmbRgbRgbRgbRgbRgbRgbRgbRhbLgbRgbRgbRibRiRsmbRgb
RgbRgRsmbRsbRgbRgbRgbRgbRgbRsbLsbRsbRibLsRsLsbRgbRgbLsbRibRgLsbRsbRiRs
LsRsmbRgbRgbLsbRibLgbRibRgbRgbRsbRgRsmbRgbLsbRgbRgbRgbRgbLgbRgbRibRibL
gbRgbLgbRibRgbRgbLgbRibRgbRgbRibLsLsmbRibRgbLgbRgbRgbRgbRgLsbRgbRgbLsb
RgbLgbRgbLgbRibRgbLsbRgbRgbRgbLsbRgbRgbRibRgRsmbRgRsmbRgbRgbRgRsmbRgbR
gbLsbRgRsmbRgbRgbRsbRgRsRsmmbRgRsRsmmbRgbRgbRgbRgbLsbRgRsmbRgLsbRiRsmb
RibLgbRibLibLhLsbRjbLobLhbRiRsmbRibRibRibRcLsbRibRcbRibRiRgRgbRgbRgbRs
bRgbRgbRgbRgbRgbRgbRgbLsbRgbRgbRgbLsbRgbRgbRgbRgbRsbRgbRsbRgbRgbLsRsbR
gbRgbRsbRgbLsbLsbLhbLgbRcRsmbRgLsbRgLsRsRsmbLsRibRsRsmbRgRsmbLsbRgRsmb
LsbRgRsmbLsbRsbRgbRsbRgbRsbRgbLsbRibLsbRiRsmbRsbRgbLsbRibRgRsmbRibLibR
ibRgbRgbLgbLcbLibRsLsbLgbLiRsbRgbReLsbRgRsmbRgbRsbRgbLsbRgbRgbRsbRgRsm
bRgbRgbRgbRgRsmbLsbRgbLsbRgbRgbRgbRgbRibRibLibRgbRgbRgbLgbRgbRgbLgbRib
RgbRsbRsbRibRgRsmbRgbRgbRgbLsbRgbRgbRgbRgbRgbRgbRibLgbRibRgbRgRsmbRgbR
ibRibRgbRgbRgbLgbRibRsbRgbRibRsbRsLsbLsbRgRsmbRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 22; Drug: Control
bsbLcbLcbLibLibLibsbLibsbRgbLsbRsbsbRibLsbRcbLgbLibLgbLgLsbLgbRsbLgbLg
bRjRsmbRsbRjbLebLcbLibRjbLgbLsLsmbLgRsbLibLgLsbLhbRiRsmbRgbLjbLgbRcbRi
bLjbRibRgbRsbRgRsmbRgbRsbRibRgbRibRsbRobRibLsbLhbLsbLiRsbRgLsRsbRsRsmb
RjbRibLsbRgbRsRsmbRsLsbRgbRgbRcRsmbLibLcbLobLcbRjbLcbLsbLgbRsRsmbLsbRs
bRcbRhbLjbRcbRcLsbRibLsbLibLsbRjbRcLsbRcLsbLgbLcbLibLibRgRsmbLgbRsbRsb
LibLgRsLsLsLsmmbRsLsbRsbLgbLgLsbLgLsbLgbLsbLsbLsLsmbLsLsmbLgbLgLsbLgbR
sbLsbLgLsbLgbLgbLsLsmbLgLsLibLgbLgbLgbLgbLgbLgbLsbLgbLgRsbLgbRsbLgbLgb
RobRiLsbRgbRgbLsbRsbRgbRgbRibRsbLjbLhbLiLsbRgRsmbLsbLsbLgbRjbRibRibLgb
LcbRsbRhLsbRibRgbLobLobLcbLiRsbRibRibRcLsbRcbRibRibRibRgbRgbRgbRgLsRsb
LsbRgbLsLsmbRsRsmbRibLhbLibLsbLgLsbLgbRgbLsbLsRsbLgLsbLsLsmbLgbLsbLsbL
gLsbLgbLsbLgbLsRsbLsLsLsmmbLsLsmbLgbLsLsmbLsLsmbLgLsbLsbLsbLgbLgbRsLsb
LgbLgbLgRsbLgLsbsbLhbRgbLibLjbLcbLcbLhbLgRsbRgRsmbLibLgbLibLgbLgbLgbLg
bLsLsLsmmbLibRjbLgbLgbRsbLgbLgbLsbLsLsmbLsLsmbLsLsmbLgbLsbRsLsbLsLsmbL
sbLgbLgbLgbLsLsmbRsbLibLgbRgbLgbLsbLsLsmbLgbRsLsbLgbRsbLsbLgbLgbLsbLsL
smbLsLsLsmmbLgbLgbLsbLsLsmbLsLsmbLsLsmbLgLsbLgRsbLibRibRgbLsbLibLgbsbR
ibRhLsbLgbRgbRsbRhbLgbRsRsmbRiRsmbLsbLebLibRjbsbLiRsbRsRsmbLsbLibRsRsm
bLiLsbLiLsbLibLgbLsbsbLsbRsbLiLsbRcbsbRibsbsbRgbLgbRgbRsbRgbRgLsbLgbRg
bRgbRgbRgLsbLsbLcbLiRsbRjbLibLgbRgbLgbLgbLsbLgbLgbLgbLsbLgRsbRsbLgbLcL
sLsmmbLibLcbRgbLjbLgRsLsbLgRsbRgbLibLiRsbRibRibRgbLjRsbLibLibRsbLsbLgb
RibRibRibRgbLsbLgbLibLibRgbRibRgbLobLcbRcbLgbRsbLgLsbLsbLgbRsbRjbLsRiL
sbLcLsmbLcRsRsmbRsbRjbsbRibRsRgbRgbRgLsbLhbLgbLsbRcRsmbLjLsmbLcRsbRjbL
ibLibRgbRibRgRsmbRgbRgbLsbRsbLcLsmbRjbRiLsbLsRsLsLsmbRibLsbRoRsmbRcbRs
bLjbRjbRibRgbLsLsmbRgLsLsmbRsRsmbRgRsmbRgbRgbLsbRgbLsbRgbRgbRgbRsbRgbL
gLsbLsRgbLsbRibLgbRgRsmbRibLgRsbRgbLebLiLsbLiRsbRiRsmbRcbRgbRgbsbRgRsm
bLsbLsbLsbLgbLhbLiRsbRsbLgbLiRsbRibRjbRibLjbLcbLibLiRsbRgbRibRgbRibRhb
RcbRhbLgLsbLsbRgbLgbRjbRhbRibRgbRcLsbRgbLiRsbLcLsmbRcbRcbRibLsbLgLsbRs
LsbRhbRgbRgbRgbRsbRgRsmbRgbRsbLebRsbRibLebLsbLibRsbLgbRcbRcbRhbRgbRgRs
mbsbLgbRobRgbRsbRgbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 23; Drug: Control
bLibRiLsbRoLsbLgbLgbRibRgbRobRgLsbLgbRibLibLjbRcbRibRgbRibRgbLiLsbRibR
jbRhLsbRgbLibLgbLibLgbRibLjbLgbLgbLsbLsbLgbLsbLgbLsbLibLgbLiRsbLhbLibR
sbLjbLgbLgbLgbLjRsbLhbLcbLsbRibRibRgbLsbRsbRibLsRsbLjRsbRcbLjbRiLsbRsb
LjbLgbLgbLgbLhbLcbLhbLibRcbRibLgbLibReRsmbRibLjbRibLjbLibRcbRibRhbLgbR
gbRgbLgbRgbRgbLsbRgbRibLjbRgbLcbLgbLgbLsbRsRsmbLibRsbLsbLgbLgbLsbLgbRs
bLsbLgLsbLsbRsbLsbLgbLsbLibLgbRsbRsbLsbRsbLgbLsLsmbLgLsLsmbLsRsbLgbLgb
LgbLiRsbLhbLcbRgbLibLgbLgbLgRsbLsbLibLsbLsLsmbLhbLobLibRibRgbLgbLjbRjb
RgbRibLsbRibRibRibLsLgbRgbLgbRsbRibRgbRgbRsRgbRgbRgbRsbRgRsLsmbRsbLsbL
sbRgbRgbRgLsbLsRsbRgRsRsRsmmmbRgbRsbLsbRjbRsbLsRsbLgLsbRgbLsbLsbRgbRgb
LgbRjbLsbRgbRsbRgLsbLjbRsbRgbRgbRsbRgbRsLsbRgbsbRsRsmbRjbRsbLsRsbsbRsR
smbRsLsbRjbRsbRsbRgbRsbRsbLsRsbRgbRsbRgbLsbLsbRgRsmbLsbRsbLcbLgRsbLgLs
bLiLsbRgLsbLiRsbRjbLgbsbRjbRjbRiRsmbsbRgbRgbRibRibRgbRsbRsRsmbRsRsmbLs
bRgbsbLsRsbRsRsRjmbsbLsbLsbRgRsmbRsbRgbRsbRgbLsRsbRgLsbRgbRsRsmbRgbRsb
RgbsbLsbLsbRibLgbRgbRgbRgbLsbLsbRsbRgbRsbRgRsmbRsbRgbLsbRsbLibLgbLibRc
RsmbLcLsmbLgRsbRcbLobRjbLiLsbRibRgRsmbRsbRgbRgbsbRcbLibLibLjRsbLibLgbL
sbLiRsbRjbRibRgbRgbRsbRsbRsRsmbRsLsbRgbLsRsbRsLsRsbRgbLsbRgRsmbLsbLsbR
sbRsRsmbRsRsmbRsbsbRsRsmbRgRsmbRsbRgbRsbRgbRgLsbRgLsbRsRsLsmbRgbRsbRsb
RsbLsbRgbRsRsmbRsRsmbRgbRsbLgRsRsmbRsbRgRsRsmmbRsLsbRgRsmbRsbRgbRsRsmb
RgbRgbRsbRsbRgbRgbRgbLjLjbLgbRsLgbLibLgLsbLibLibLsbLgRsbLgbRsbLgbLsbLg
bLsbLgbRjbRgbRgbRgRsmbRgbRgLsRsbLjbLgLsbLibRibRgRsLsmbRgbRgLsbRibRgbRg
RsmbRsbLjbLjbLgbRjbRibRibRibLgbLjbRhbRgbRgbRsbLsbRgbLsbRgLsbLsbRgbRgRs
mbsbRsbRgbRsLsbLsbRsRsmbRsRsmbRsbRsbRsbLsbRsbRsbRsbRsRsmbRgbRsRsmbRgbL
sbRgRsmbRgbRsbRgbLgbRsbLsbRsRsmbRsRsmbLsbRsbRsRsmbRgRsmbRsbRgLsbRsbLsb
RgbLsbRsRgbLsLsmbRibLjbRcbLhbLcbLgbLgbRsbLiRsbLgbLibLsbRibRibRgbRgbRgb
RsbRgbLsLsmbRsRsmbRsbRsbRsRsmbLsbRsLsbRsbRgbRsbRsbRgRsmbRsRsmbRgbRgRsm
bRgbRsbRsbRgRsmbLgbRgbLsbRgbRjbsbRsbLsRsRsmbLsbLsbRsbRgRsmbRgRsmbRsbRg
bLsbRgbRgbLsbRgbsbRsbRsbLsRsbRsbRsRsmbRgbRsRsmbRsRsmbRibLsRsbRsRsmbRgR
smbRsbRgbRgbRgbRgRsmbsbRgRsmbsbRgbRsbRgRgbRsbRsbRsbRsbRgbRsbRsbRgbRgbR
gbRgbLhbRibRgbRjbRsRsRsmmbRsbsbRsRsmbRsRsmbRgbLsRsbsbLsbRsbLsbRsRsmbRg
bRgbRgbRgbRgbRsbRsRsmbRgbRsbRjbRsRsmbRsLsRsbRsbLsbRjbLsbsbLsRsbRsbRgbR
sRsmbRgbRgRsmbRsRsmbRgRsmbRgLsbRsbRgbRiRsmbRgbRgbRsbLhLsbLibRjbLiRsbLi
RsbLgbLgbRjbLcbLhRsbRhbRhbRgbRgbLgLsbLgLsbLjbLgbLibRhbRibLsbRjbsbLsRsb
LsRsbRsbRsbLsbLsbRgbLjbLhbLsbLhbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 24; Drug: Control
bLgbLsbLsLsmbLgLsbLsbLgbLgbLsRsbLgbLgbLsRsbLsRsbLibLgbLgbLibLsbRsbLgbR
sbRsbLgbRsbRsLhbRhbLibLgbLiRsbLibRibRibLibLibLsbLibLsLsmbRsbLibRgbRibL
hbLgbLibLgbLhbLibReRsmbRibLgbLgbLibLiRsbRibRgbsbLjbRebLibRjRsRsmmbLibL
gbLsbRebRobLibRibRgbLibRibRcbRgbLgbRibRhbRsbLsbRgbLjbRibRgbRgbLsbLcbLj
bLibLgbLibRibRjbRsbRhbLgbLcbLibLgbLiRsbLgbRebLgbLgbLsbLgbRsbLibLgbLsbR
hbLjbLgLsbLibRgbLibLgbRgbRjbRebRjbRgbLgbRibLgbRgbRgRsmbRgbRgbLsLsmbRjb
RgbLsbRibLjbLjbLgbLiRsbRsLsRsbsbLibRibRgbRgbLgbRsbRibRgbLjbLjbLjbLiRsb
RjbLgbLgbLibLibLgbRibRgbLjbRobLcRsRsmbRsbLgbLgbLgbRsbRjbRcbRgLsbLjbLib
LgbLgbLgbLgbLsbLgbLgbLiRsbRebLhbLcbLcbRcbRcRsmbLsbLcRsbLgbLgbLgbRgbLgb
LsbLsbLgbLsbLgbLgbRgbLibLgRsbRsbRjbLsbLibRsLsLgbLsLsmbLgbRsbLgbRcbLjbL
ibLibLsLgbLsbLgRsbLsbRjbLibRibLibLgbLsLsLsmmbRsLsLsmbLsLsmbLgbLsbRsbLg
LsLgLsbLgLsbLgbLgbLgbLgbLgbLgbLsbLgRsbRsLibRcbLibLgbLgLsbLsLgbRsbLsbLi
RgbLgbLibLgbLgbLsbLsbLebRsbLibLgbLgbLgRsLsbLgbLsbLibLgLsbLgbLgbLgRsbLg
bLgbLgbRsbLgRsLsbLgbLgbLsRsbLgbLgbRsbLhbRiRsmbLibRjbLibLsbLibLgLsbLsbL
iLsbLsLsmbLgbLgLsbLsRsbLsLgbRjbRiLsbRibRhbRebRibLhbRjbLcbLibLsbRsbLgbL
gbRsLsbLgbLibRibLgbLgRsbLsLsmbLgbRjbLsLsmbLsLsRsmbLsLsmbLibLsbLsbLsbLg
bLgbLibLgbLgbLgbLsRsbRgbLibLgbLsbRcbLhbLibRibLibLgbLsbLjbLsbRsbRsbLiLs
bLsbLjbLsLsmbLgLsbLgbLgLsbLsbLgbLgRsbLsLsmbRhbRibLjbRhbLibRhbLcbLibRgb
LibLgbLgbLsbRgbLiRgbRsLcbLcLsmbLcbsbLjbLibLgbRjbRcbLjbLsRsbLsbLibLsbLg
LsRsLsLgbLgLibLgbLiLsLgLsbLgbLgbRsbLgbRsbLgbLgbLgRsbLibLgbRsbLgbLgbLgL
sbRebRhbLjbRsRcLjbRhLjbLhbLiLsbRsLsbLgbRgbLgLsbLsLsmbLgbLgLsbsbRsbRibL
jbLsLcbLebRibRhbRcbLsbRgbLcbLgbRcbRcbLibRibRhbRhbLsbLsbLibLiLsbLgLsbLg
bLsbLgbLgbLgLsbLsLgbLsbLgbLgbLgbLgbLgbLsbLgbLgLsbLsbLgbLiRgbLibLgbLgbL
gbRsRsmbLgbLgbRsbLibLibLgLsbLgbLgbLgLsLgLsLgbLsbLgbLgRsbLgbLgLsbLgbLgb
LgbLgbLsRsbLgRsbRebReLsbLgRsbRjbRcRsmbRiRsmbLgLsbsbLgLsLsLsmmbLibLibRj
bLibRsbLgbRgbLiRsbRgRsmbLibLgbLsLsmbLibLgLgbLgbLgbRjbLhbRebLgRsbRibRib
RcbLiRsbRibRhLsbLgbRiRsmbRgbRgbRgbRsRsmbRgbLjbRgRsmbRsbRsLsbRgbRgRsRgm
bRgbRgLsRsbRgRsmbRsbRgbRsbRsbRgbRgbRsbRgRsmbLsbRsbRcbRhLsbRcbRhbRiRsLs
LgmbLsbLebLiRsbRebRhLjbRsbLhbRsbLibLsbLibLibRsbLgbLgLsbRsLsLibLgbLsbRc
bRibLjbRibLsbRgbRibLgbLcbLibRjbLcbRgbLibLgbRsbLgLsbLgLsbRobLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 25; Drug: PCAP2 10 然
bLgbLhbRsLgbRgLsbsbRsbLgbRjbLgbLsbRgbRjRsmbRcbLcbLjbLebLgbLsbRsLsLsmbL
ibLsbLgbLibRgbLgbLgbLibLiRsbLgbLgbRsbRgRsRsLsmmbRgbRibRsbRgbRgbRsbLebL
eLsbLsLiLsbLsbLsbLgbLiRsbLsLsmbLgbLsbLgbLsbRsLjbLsbLgLsbLibRcbLjLsmbLh
LsbLibLgbLgRsbRsRsLsmbLsLibLebLiLsbLgbLiLsbLcLsmbLgbLibLibRsLsLsmbsbRs
LsbLsbLsbLsbLgLsbLsbLgbLgLsbLgbLgLsbLgbLgbRobRsbLgbLgLsbRcbLibLibLiLsb
RsbRibRsbLibLgbLgbLsbLgbLcLsmbLgbLsbLjbLibLgbLgbLhbRiRsmbRgbRgbRsbRsbL
gbRgbLcbsbLcbLibLibLsbLgbLibLgLsbLgbLhbLibLibLsbLibLgbLgbLgbLgRsbLgbLs
bRsbRebLgbLjbLgbLsbLsbLsbLjbRsbLibLibLhbRcRsmbLibLibLgbLgbLibLibRsRsmb
RgbRsbLhbLibLibRsbLsbLgbLiLsbLgRsbLgbLsbRsbLiRsbRebLibRsbLsbLsbLjbRsbL
gbLsbLgbLgbLgbLsbLsRsbLsbLgLsbLgLsbRjbLibLgbsbRcbLjbLcbReRsmbRcbRsbLgb
RgbRgbRgbRsbLjRsbLjbLgbLgbLsbLgLsbLibLgbLsbRgbRcbRgbLsbLebRjbRcbLibLib
RcbRsbRcRsmbRgbRsRcLsbLgLsbLibLgbLgbLsbReRsmbRiRsmbLobRobLebRebRibLgbL
sbLsbRcbRibLjbLeLsbLibLebRcRsLsmbLgbLgbLgLsbsbLsRsbRgbsbLsbRsLsbLsbRcb
LjbLsbRjbLobLiRsbLhbRgbRcbLgbLsbLjRsbLhLsLsmbLcbLibLibLhbLibLgbsbLjbLs
bLgbLgbLjbLgLsbLsLjbLsLsmbsbLsRsRsmbLjbLsbRgbRjbRcLsbRsbLebLibRcbLibRe
bRsbLebLhbRcbRcbRgbLsLsRsmbLjbLibsbLsRsbLsbLsbRjbRsbsbRsRsmbLsbLsbRsbL
ebLibRhbRcbRsbRsbRibRsbRgbLcRsbLgbLiLsbLsbLhbReRsmbRgbLiLsbRgLsRsbRebL
ibLgbLsbLsbRebRgbRsbLeLsbRjbRcRsRsRsRsmmmmbRgbRgbRsbRsbsbLgRsbRsbRoLsb
LgbLgbLibLgbRcbRsbRsbLsbLsbRsLsRsLsLsmbRsbRsbLjbLibLibRcbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 26; Drug: PCAP2 10 然
bRgbRsLsbRibRhbRibRibRibRgRsmbLsbRsbRsRsmbRibLsLsRsmbLsbRgbRibLgbRsbRg
bRsRsmbRgRsmbRgRsmbLsbRgbRsbRsRgRsmbRsbLsbRibRjbRhbRhbRibRibRiRsmbRgbR
ebLcbLiRsLsbRhbRgbLsRsbRsbRgbRsbRgRsmbRsRsmbRibRgbRsbRgRsRsmmbRsbRgbRi
bRhbRhRsLsmbRjbRiRsmbRibRibRsbLsbRibLjbLebLoRsLsbRibLhLsbLgLsbRsRsmbRg
bLcRsRsRsmmbsbReRsmbRgbRsbRibRgbRgbRgRsmbRgbRsRsmbRsbRgbRgbRiLsbRibRcb
RibRcbLgbRibRgbRgbRsbRgbRsbsbRsbRgbRgbRgbRgbRsbRgRsmbRgbRsRsmbRsRsmbRg
bLsRsbRgbRgbRibRcbRhbRcbRgbRgbRgbRsbRgbRgbRiRcbRhbRhRsmbRgRiRsmbLsbRgb
RsbRibRgbRgbRgbRgbRgbRgRsmbRgRsmbRgbRgbRgbRgbRgbRgbRcRsRsmmbRcbRibRiRs
mbsbRsbRibRsbRiRsmbLsRsbRgbRsbRgRsmbRgbRsbRgRsmbRgbRgbRgRsmbRgRsmbRgbR
gbRibRcbRibRibLsbRgRsmbRsbRgbRgbRgbRgbRgbRsbRgRsmbRgbRsbRgbRgbRsbRgbRg
RsmbRiLsbLgbRsRsmbRgbRhRsmbRcbLhbRcbRhbRiRsmbRgbRsRsmbRgLsbRgbRsRsmbRs
RsmbRgbRgRsmbRgRsmbRgbRgRsLsmbRgRsRsmmbRgbRgRsmbRibRgbRgbLsbLcbLhbLcbR
sbLibRjbRhbRgbRsbRgbRsbRsRsmbRsRsmbRgbRsbRibLgbRibRgbLsbRibRcbRcbRibRi
bLsbRgbRgbRgbRgbRgRsmbRsRsmbRsbRsRsmbRsbRgbRgbRsbRgRsmbRsRsmbRgbRgbRgL
sbRgbRgbRgbRgbRsbRgbRgbRgbRgbRsRsmbRsbRgbRsbRgbRsbRibRcbRcbLsbRhLsbRgb
RgbRgbRgRsmbRgbRsbRsRsmbRgbRgbRsbRgRsmbRgRsmbRsRsmbRsbRsbRgbRgbRsbLgbR
sbRiRsmbRgbLsbLjbLhLsbLsRsRsmbLgbLgLsbLebLcLsLsRsmmbRgbLsRgbRcbRgbLsbs
bLsbLcRsbLsbLgbLcbLhLsLsmbLiLsbLgbLgbLgRsbLibRgbLcbLcLsLsmmbRibLsbLcbL
ibLgbLibRjbLcbLibLeLsbLgLsbRebRiRsmbRsbRiRsmbsbRsbRgbRgbRgbRgbRgbRebRs
RsmbRgbRsRsmbRgRibRgbRgbRsbRgLsbRgbRgbRgRsmbRgbRgbRgRsmbRgRsRsmmbRgbRg
bRgbRgbRgRsmbRgRsmbRsbRsbRsbRiRsmbRgbRsRsmbRgbRgbRgbRgbRgbRsRsmbRgRsmb
RgbRgbRsbRgLsbLsRsbRibRsbRsRsmbRgRsmbRsRsmbRsbRsbRiRsmbRsbRgbRsbRgRsmb
RsbLsbRibRgbRgbRgRsmbLsRsbRibRiRsmbRibRsbRcRsmbRibRibRcbLibLcLsmbLhbLg
bsbLgbLhRsbLsRsbLgRsLsbLgbLobLcLsmbLibReLsbRibLgbRiRsRsmmbRgbLgbRcbRcR
sLsRsmbLebRibRcbLgbRhbRgRsmbRgbRsbRgbRgbRgbRsbRgbRgbRsbRgbRsbRsbRgbRsb
RgbRsbRsbRsLsRsLsbRgbRsbRgbRgbRsRsmbRsbRgbRsbRgRsmbRcRsmbRhbRibRsbReRs
mbRsbLsLcLsmbLiLsbRjbRsbRcbLsRsbRcbLibRgRsmbRibLsRsbRibLgRsbRgbRsbLsRg
bRgRsmbRgbRsbRsbRgbRiRsRsRsmmmbLcbLobLsbLibRjbRoRsmbRibLgbRhLsbLsRsbRi
bRsbRgbRgRsmbRgbRgbRgbRgLsbLgbRcRsmbLsbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 27; Drug: PCAP2 10 然
bLgLsbLibRcLsRsbLgbRiRsmbLsbRgbLsbLsbRibLgLsbRgbRgRsmbRgbLgbRcbRiRsmbL
ibRhLsbRiRsmbRibRiLsbRgRsRsmmbRgbLjbLjbLgbLgLsRsbLgbLgbRsbRgbLibLgbLib
LgbLiRsRsLsmbRgbLcbLibRgLsbLibRsbLgbLgbRsbLibLsbRobLsbLgbLsbLsbLgbLibL
iLsbLibRgbLibLgLsLsmbLgbLsbLsRsbLsbLiRsbLsbRcbRhbLibLibLibRsLsbLsbRsLs
bLgbRsbRjbRhLsbLibsbLiRsLsbRsbLgbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsbRsbRsLs
bLsbLgLsbLsbLgbLgbLibLcbLiLsbLjbLgRsbLgbLsLsmbLsbLsbLsbLgLsbLsbLgbLgbL
iLsbLibLibLgbRsbRhbRgbRgRsmbRibRsbRibRibRsbLgbLibLsbLibLgbLhLsbRibRsbL
sbRibRsbRcbRcbRibRibLjbLcbRjbRcbLjbRiRsLsmbRibRibRsbRgRsmbRgbRjRsmbRsR
smbRgbRsbRsbRsbRsbLjbReRsmbRhRsmbRibRgbRhbRcbLibRsbRiRsmbRsbLibRgbRgbR
oRsmbRibRsLibLgbLgbLsbLsbRsbLsbLgRsbRsLsbLgbLgbLhbRibRibRobLhbLgbRsbRs
LsbLcbLcbRgbRsLsbRsbLjbLhbLibLgbLcLsLsmmbLibLsRsRsmbRiRsmbRsbRsbRgbRgb
RsRsmbLcLsmbLibRhRsLsmbLcbLsbLiLsbLiLsbRibRsbLhbLhLsRsbRgbLoLsmbRsRsmb
LsLsmbLiLsbLgbRsbLgbLsLsmbLhLsLsmbLgRsbRsbLgbLibRjRsmbLcbLcRsbLibLibLi
bLgbLgLsbLsbLsbLsbLgbLsLsRsmbLgbLsLsmbLsbLsbLgLsbLsbLgbRsbLsbLhbLcbLeb
LiLsbLcLsmbLsbRsLsbRsbLibRsbRcbRibLsbRgbRsbRiRsmbRsbRgRsmbRsRsmbRgbRgb
RsbRgLsbLsbRgbLsRsbRgbRgbRsbLibLsbLhbLgLsbLgbLhbLcbLcbLiLsbLibLgbLsbLg
bLgbLsbLgRsbLgbLoLsLsmmbLgLsRsbRoLsRsbLgbRibRsLsbRgbRgbRhRsmbRibRgbLgb
LibLsbLgbLsbLsRsbLsbLsbLgbLgLsLsmbLsLsmbLgbLgbLsRsbLsbLgLsbLgbLgbLsLsm
bsbsbsbLsbLsbLgbLgLsbLgLsbRsbLgbLgbRcRsRsmmbRcRsRsmmbRibRcRsmbLsRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 28; Drug: PCAP2 10 然
bsbRsRsmbRgbRcbRhbRiLsbRgbRhbRgRsmbRsRsmbRgbRsbRgbRsbRgbRgbRsbRgbReRcb
RcRiLsRsRgbRgbRgbRgbRgbRgbRgRsRsmmbRgRsmbRiLsRsbRgbRgbRgbLjbLobLsbLibL
hbLgbLgbLgRsbLsbRcbRjbRcbRiLsbRcbRiRsmbRiRsRsmmbRibRibRsbRobLibLgbLgLs
bLeRsbLibLgLsLsmbLgLsbLgLsbLiLsLsmbLgRsbLgbLgLsbRsbLhbLhbLgRsbLgLhLsbL
ibLgLsbLgLsbLgbLsbLgbLibLibRebRoRsmbRiLsRsRgRsmbRiRsRsmmbRgbRgRgRsmbRg
bRgbRgRsmbRgbRgbRgbLjRsbLibLibLgbLgLsbLgbLeRsbLiLsbLgbLgLsbLsbLibLgbRg
bLibLibLhbLibLibLiLsbLgbLibLibLgRsbLsbLibLgLsLsmbLgbLgLsbLgLsbLgbLgbLg
LsRsbLibLgbLgbLhbLgbRgbRibRibRgbRgRsRsmmbRgbRgbRgRsmbRgRsLsmbRgRsmbRgb
RgRsmbRgRsmbRibRgRsmbLsRiRsmbRgRsmbRgbRgbRcbRsLcRsbLcbLgbLgbLsbLiLsbLg
bLgbLgbLgbLhLsbLgLsLgbLgLsbLiLsbLgbLgbLsbLgRsbLcRsbLiLsbLgbLgbRebRibLe
bRjbRcbRhbLibRgRsmbRcbRgbLsbRcRsmbRgRsmbRgbRgbRgbRiLsbLhbLjbLcbLibLibL
gbLiLsLsmbLgbLibLgLiLsRsbLgLsbLgbLgbLgbLibLibLgbRibRibRcbRhRsmbRgbRibR
gRsmbRgbRgbRgbLcRsbLiRsbLgbLgbLgLsbLibLgLsbLgLsbLgbLgbLgLsbLgLsLsmbLgL
sbLgLsLgbLgLsbLiLsbLgbLibLgbLgLsbLgLsRsbLsbLgLsLsmbLgbLiLibLgRsbLgbLgb
LsLsmbLgLsbLibRibReRsmbRibRgbRgbRibLibLcbLsbLcLsmbLsbLiLsbLgbLgbLgbLgR
sbLibLsLsmbLibLgbLgbLibLgbLibLgRsbLgLsbLgLibLibLgLsLgLgLsbLgbLgbLgbLgL
sbLiLsbLiLsbLsLgLsLsmbLibLgbLgLsbLgbLibLibRibRcbRibRoLsbRhLsbLeLsbLibL
gbLgLsbLsbLgbLibLgbLgLsLgLsLsmbLibLgbLsLgLsbLgbLgbLgbLgbLebLgRsbLcRsbL
gbLiLsbLsbsbLobLibLsbLibLiLsbLgbLgLsLsRsmbLgbLiLsLsmbLsbLgbLgLsbLibLgL
sbLgbLgRsLgLsbLgbLgLsbLgLsbLgbLgbLgLsbLgLsbLgLsLgLsbLgbLiRsRsmbRsbLsbR
obRiRsmbRgRsmbRsbRhbLgbRcbRgRsmbRibRsbRgbRiRsmbRgRsmbRibRibRgbRibRgRsm
bRibRibRgbRobRcbRhRsRsRsmmmbRibRgbRiRsmbRiRsmbRibRgbRibRgbRgbLjbRibLcb
LiRsbRsbLcLsmbLsbLgbLgbLgLsbLgLsbLgbLgLsbLibLgbLcbLiLsbRebRhbsbRsRsmbR
ibLgbRcbRobRiRsmbRiRsmbRgbRsbRibRgbRibRgRsLsRimbRgbRiLsbLhbLoLibLibLjb
LgRsbLgbLgLsLsmbLgbRsLgbLgLsbLebLibLsbLgLsbLibLgLsbLibLiRsbLibLgRsLgbL
iLsbLgLsbLgbLgLgLsLsLsmmbLgLsbLiLsRsbLgbLiLsbLgbLgLsbLhbLobLiLsbLiLsbL
iLsLsLimbLiLsbLiLsbLiLsbLibLgbLgLsbLgLsbLgbLiLsbLgbLgLsbLgbLgbLgLsbLib
LibLsLsmbRcbRhLsLsmbRcbRcRsmbRibRibRiRsmbRgbRgLsbRgbRgbRgbRgbRgbRibRgb
RiRsmbRgRsRsmmbRgbRgbRsRibRgRsmbRgbRgbRgbRgRsmbRhRsmbRgRiRsRsmmbRibRiR
smbRgRsmbRgbRibRgbRgRsRsmmbRgRsmbRiRsmbRgbRgbRibRibRgbRgRsmbRgbRgRsmbR
gLsbRgbRebRobRgbRgbRgbRsbRhbRgbRsbRoLsLsmbRgbLgbRsbRhbRibRsbRibRgbRgbR
gbRgRsmbRgRsmbRgbRsRiRsRiLsmbRibRiRsmbRiRebRiRsmbRgbRgbRsRsmbLgbLgbLiL
iLsbLibsbLcRsRsmbLcbLcbLiLsRsLsbRsbLgbLgbLgbLgLsbLgRsLsbLsbRoRsmbRcbRi
bLsbRiRsRsRsmmmbRgbRgRsmbRgbRsRgRsmbRibRgbRgbRgbRsRgbRibRibRgRsmbRibRg
bRibLgbLebLibLgbLgLsLsmbLiLsbLgbLgbLibLgbLgbLiLsbLgbRsLgLsbLeLsLsmbLgb
LibLgbLgLsbLsbLibLgLsbRsLgLsbLibLgLsbLgLsbLiLsbRoLsbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 29; Drug: PCAP2 10 然
bRcbRjbRcbRgbLgbRibLsbRibLgbRibRsbRgbLsbRsbRgbRhbRibRgRsmbLsbLgbLiLsbL
sbLgLsbLsbLgRsbRsLsbLgbRsbRsRsmbLibLcbRsLgbLgLsbRsbLibLiLsbLsLsmbLibLg
bRgbLsbLsbLhbRjbRgbRsbRjbRcRiLsLsmbRsLsRsbRsbRiRsmbLsbRgbLjbRebRobLibR
gbLsbLgbLcbLibLgbLsbLsbLgbLgRsLsbLgLsbLgLsbLibLgbLgbRsbLcLsmbLsbLsbLgb
LsLsmbLsbLsbLsLsmbLsbRsLsbLsLsmbLgbRsbLgbLsbLsbLgLsbLsbLgbLsbLsbLgbRjb
sbLsRsbLgbRjbRcbRibLgbRibRsbRgbRgLsbRgbRsRsmbRgbRhbRibRsbRgbRsbLebLibL
ibLgbLsbLsLsLsmmbLsLsmbLgLsbLsbLgLsbLsbLsLsmbLgbLsbLsbLsbLsbLsRsbLgbRj
bRcbRgbRgbRsRsRsmmbRsbRgbRsbRgbRsbRgbRsbRsbRsbRgbRgRsmbRsbRibLibLibLcb
LiLsbLgLsbLgbLgbLgLsbLibRsbLgLsbLgLsbLgbLgbLgbLsbLgbRsbLgbLsbLsbLsbLgL
sbLgLsbLgbLgbLsbLsbLsbLsbLsbLsbLibLcbLcbRhbRsbRgRsmbRgRsmbRgbRgbRgRsmb
RsbRgbRsbRgbRgbRhRsRsmmbRhbRsbRjbRgRsmbRgRsmbRgbRsbRgbRgbRsbRsbRgbLsRg
LsbRgbRgbRgbRsbRgbRsRsmbRgRsmbRgbRsbRsbRgLsbRgbRsRsRimbRobRebRcbLjbLcL
smbLibLsbLsbLgbLsbLsbLgbLgbLgbLsbLsbLsbRjbRcbRgbRgbRsRsmbRgbRgbRsbRsbR
gLsRsbRsbRsbRgbRgRsmbRgbRgbRgbLgbRgbLibLsbLgbLgbLgbLgbLsbLsbLsbLsLsmbL
sbLgbLsbLgbLsbLhbLhbsbLgbRsbRcLsbRgbRibRoRsRsRsmmmbRgRsmbRibRgbRgbRgbR
gbRgbRsbRgbRgbRcbRibLiLsbRgRsmbLiRsbLibLsbLgbLsbLgbLgbLgbLgbLsbLgbLgbL
sLsmbLsbLgbLgbLgbLsbLsbLsLsmbLgbLgbLsbLsbRgbLgbRcbRhbRibRgbRgbRgbRgbRg
bRgbRgbRcbRhbRgbRibRibRgbRibRsLsbLsbLsbLsbRcRsRsmmbRgbRsLsbRibRgbRgbRs
bLsRsbRgbRgbRgbRsRsmbLgRsbRobLcbLhbLgLsbLgbLsbLgbLsRsRsmbLsbLsbLgbLsLs
mbLgbLgbLsbLsbLgbLgbLgLsbLhbLibLibLsLsmbLibLsbLgbLgLsbLgbLsbLsLsmbLsbL
gRsbLgbLgbLgbLgbLsLsRsmbLgbLsbLgbLsLsmbLgbLgbLsbLsbLgbLsbLgbLsbLsbLgbR
sbLibRobRibRsRsRsmmbRgbRgbRgbRgbRgbRgbRgbRgLsbLebLcbLgbLjbLibLibLibLgb
LebLgLsbLgbRsbLgbLsbLgbLgbLgbLsLsmbLgbLgbLgbLsbLsbLobLibLgbRibLebLiLsb
LgbRsLgbLgbLgbLsbLgLsbLgbLgRsbLgRsbLgbLgbLgLsbLgLsbLgbLgbRgbRobRsbRibR
gRsRsmmbRgbRgbRgRsmbLsRsbRgRsmbRgbRgbRgRsmbRgbRgbRgbLebLcRsbLgLsbLgbLg
LsbLgbLgLsbLsbLsLsmbRebRiLsbRsbRgRsmbRgbRgbRgbRgbRgbRsRsmbRsbLeLsbLibL
gbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 30; Drug: PCAP2 10 然
bLgbLibLhbLcbLibLsbLibLiLsbRsLoLsmbLcbLibLgbLgbLgbLgbLcLgbLjbLiLsRsbLg
bLgbLgbLgLsbLgRsbLgbLgbLibLcbLibLibLsbLgbLibRjbRcbRsRsmbRibLgbLcbLsbLs
bLhbLibLsbLsbLsLsmbLhbLiLgbLgbLgbLgbLgbLgbLgbLsLsmbLibLgbRsbLibLibLgbL
sbLsRsbLsbLibLgLsbRsLgLsbLsLsmbLsbLsbLgbLgbLsbLgbLibRobRibRgbRibRsRsmb
RibRgbRebRibRsbLsbLsbRgbRibRsbRibRhbRgRsmbRgbRibRibRsRsmbRiLsLsmbRhbRi
bRgLsbRhbRibRgbRgbRiRsLsRgmbRiLsbRiLsRsbRsbRgRsmbRgRsmbRibRsbRcRsRcRgm
bsbRgbRibRsRsmbRibRgbRgRsmbRsbRgbRgbRibRsbLsbRgbRgbRgbRsbRsbRgbRgbRgRs
mbRsbRobRibLsbRsbRibRsLsbRibRsbRibLsbLiLsbLcbLiLsbLgbLgRsbRsRsmbLiLsbR
sbLgRsbLsbLgbLgbLsbRsbRcbRgLsbRibLcbRhbRgbLgbRibLjLsmbRebLibLgbRcRcLsb
RcbRiRsmbRgRsmbLsbRgbRibRsbRibRsRsmbLsbRsbRhbRhbLsbRsbLsRsbRibLsbRcRsR
smmbRiLsRsRsmbRgbRgRsmbRgbRgbRgbRibRsbRhLsRgbRibRgbRgbRgLsbRsbRiLsbLgb
LcLsmbLgbLibLgLsbLgbLgbLgLsbLgbLgbLgRsbRgbRcbRiRsmbLsbLsLsmbRcRsmbRgbR
iRsmbRibRgRsmbRgRsRsmmbLsRsbRgRsmbRibRgRsmbRibRsbRsLsbLsbRiRsmbRgbRgbR
gbRgbRgbRgRsmbRgbRgRsmbRsRsmbRiLsbRibLiLsLsLsmmbLgbLibLgLsRsbLgbLgLgbL
iLsLibLgLsbLiRsbLiRsbLgbRgbLiLsbLgLsbLsbLsLsLsLiLgLsmmbLgLsbLgbLgLsbLg
bLiLiLsbLsbRgbLibLcLsmbRsLsLsmbRjbRgbRgbRgbRgbLsbsbLsRsbRsbsbsbRgRsRsL
smmbLsRsbRibLiRsbRibRibRsbRcbRcRcRsmbRgbRiRsRgmbRgRgRsRsRgRsmmmbRgbRgb
RgbRgRsRgmbRiLsLsmbLsRgbRiLibLiRsbLibLgLsbLsbLsbLsbLgbLgbLsbLibLcbLcLs
mbLgbLiLgLsbLgbLgLsbLcbLiLsLsmbLgbLibLiLsbLgLsbLgLsLgbLgLsbLgbLgbLgbLg
bLgbLeLiLiLsbLgbLgbLgbLgLsbLgLsLsLsmmbLgbLsbLsbLhLgbLibLgLsLsmbLgbLsLg
bLgLebLsLsmbsbRjbLibsbLsbLhLsbLgLsbLgbLgLsbRebRgbRibRgbRgbRgbRgbRsbRsL
sbReRsmbRsbReRiRsmbRiRsRgRsmmbsbRgbLsRsbRgLsbRibRibRiRsRimbRgRsmbRgRsR
smmbRsbRgbLibLsbLgbLeLsLgLsbLgbLsbLgLibLiLibLgLsLgLsbLobLebLsLsmbLgLsL
smbLgLsbsbLsLsmbLgLsbLgbLsbsbsbLgbLgLsLsRsmbLsbLibLgbLgRsbLibLgbLgbLgb
LgLsLsLsmmbLsbLgLiLsbLgbLgLsbLibLgbLgbLcLsLsmmbLcbRebLgbLcbLsbRsLsbLsL
smbLcLsmbRibLhbLsbLgbLsLsmbRgbRgbRcRsmbRsbLcbLiLsLsmbRgRsLsmbRibRibLib
RhRsmbRgbRsbRsRsmbRibRebRebRcRsmbRcRsmbRhbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 31; Drug: PCAP2 3 然
bRsbRsbLsbLsbLsbLsbLgbLsbRsbRsRsmbRsbRgbLgbRsbRgbLsbLsbLgbRsbLgbLgRsbR
sLsbLsbLsbRsbLsbLsbLgbLsRsbRsbRjbRibRgbRgbRsbLsbLsbRgbRsbRgbRgbRsbLsbR
ibRgbLsbLsbLsbLsbLgbLsbLibLibRsbRsbRsbRgbLibLibLgbRsbLcbLibLsbLsbRsbLi
bLsLsmbLsbLgLsbRsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsRsbLsbLsbLsbLsbLsbLsbLs
bLsbRsbLiLsbLsbRsbRgRsmbRcLsbRgbRgbLsLsmbLsRsbRgbRsbRsRsmbRgRsLsmbRsbR
gbRgbRsbRsbRsRsmbRsbRsbRgbRiLsbRibRsbLsbLsbRsbLgbLsbLgbLsbLgbRsbLgbLgb
LsbLsLsmbLsbLsbRsbRjbRhbRibRgbRgbRgLsbRgbRsbLsLsmbRsbRgbRgbRsbRgbRsbRg
bRgbRsbRsLsbRgbRibRhbRjbRibRibLibLgbLgbLsbLibLiLsbRibRgbLsbLibLhbLhbLg
bLsbLsLsmbLsbLsRgbLjbLgbLsbRsbRhbRiLsbRibRsbRgbRsbLsbRsbRsbRsbRsbRjbRg
bLcbRibRsbRsbLibRcbRgbRiRsmbRibRgbLsRsbLiRsbLgbLsLsmbLsbLgbLsRsbLsbLgb
LgbLsbLsbLsbLsbLsbRgLsbLsbLsbLsbLjbLhbLibLcRsbRibRgbRsbRgbLsbRsbRsbRgb
RsbRsbRgbRsbRgbRgLsbLsbRgbRibLsbLibLebLsbLgbLgbLsbLsbLgbLsbRsLsbLgbLgb
LsbLsbRgbLgbLgbRsbRsbRgbRgLsbRebLsbLsbLgbLgbLgbLgbLjbRsbRgbLsbRsbRcbLs
bRsbLsbLgbLsbLsbLsbRsbRobRgbLsbRgbRsbLsbLgbRsbLsLsmbRsLsbLgbLsRsbLsbLs
bLgbRgbLjbLcLsmbLibLibLibLgbLsbLgbRsLsbRsbRhRhLsbRiLsLsmbRibLjbRebRibR
sbRgbLsbLjbLsLhbLsLsmbRgLsbLgbRsbLibRgbRebRibLsbRsbLsbRsbRsbRgRsmbLsbR
gbLibLcLsmbRsLsbRsbLsbLjLsRsmbLsbRgbLgbLsbRsLsbLsbLsbLgbRjbRebRibRsbRi
bRibLsbLsRsbLsbLsLsmbLsbRiRsmbLsbRgRsmbRgbRgbRsbRgbRsbRgLsbRgbRgbLgbRg
LsbRibRiRsmbRhbLhbLibLgbLgbLcRsbLibLsbLgbLgbLsbLgbRgbLgbLgbRsbLsLsmbLi
bLsbLcbRibRgbRsbRjLsLsmbRsLsbLsRsbRgRsmbRsbRsbRsbRsbRiLsbRcbLsbRcbLsbL
sbRjbRibLsbRgbLsbRgRsmbRsbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 32; Drug: PCAP2 3 然
bLsbRsbRibLgbRhbRcbRsRsmbLgbRsbRcRsmbRgRsmbLsbLgLsbRjbRibLsbLgbRgbRgbR
sReRsRsmmbRhbRibLsbRibRsbRsbRsbRsbRgbRgbLsbRgbRgRsmbRsbRgRsmbRsbRsbRgb
RsbRgbRsbLsbRgRsmbRgbRsbRgbRgRsmbLoRsbLibLsbLibRgbLgbLgbLsLsmbLgbLobRs
bRgLsbLsbLobLgbLsbRgbLibLiRsbRsLgLsbLsbRsLsbRgbRibRgbRsRsmbLsRsbRgbRgb
LsLsmbRgbRgRsmbRgbRgbRsbRgbRsbRsbRgbRsbRgRsmbRgbRsLsbRsbRgbRiRsmbRsbRs
bRgbRsbRsbRgbRgRsmbRgbRgRsmbRgRsmbRsRsRgmbRsLsbRgLsbRgbRsbRgbRsbRgbRgb
RgbRsbRgbRgbRsbRgbRgbRsbRgRsmbRgbRgbRsRsmbRgbRgbRibRgRsmbRgbRgbRgbRgbR
ibRiRsmbRgbRgbRsbRsbRgbRgbRgbRsbRgbRsbRgbRgbRsbRsbRsbRgbRgbLsbRgbRsLsb
RsbLsRsbRsbRsbRgbRsbRsbRgbRgbRgbRgbRsbRsbRsLsbRsbLsbRgbRsbRibRsbRsbRgb
RsbLsbRgbRgbRsbRgRsmbRgRsmbRgLsbRgbRobRobRebRibLjbLobLgbLgbLibRsbRgbLc
bRjbLibLsbLgbLgbLgbLgbLjbLibLgRsbLgbLgbLsbLgLsbRsbLsbLsbLgbLgbLsbLgbLg
bLsbLgbRgbLgbLjbsbRsbLgbLsbLgbRhbLsRebRcbLsbLsbRobsbLsbRibRobRgbRebRsL
sbLcLsmbRsbLcRsRgbRsbRcbLsbRgRsmbRgbLsbRsbRgRsmbRsbRibLsbRgbLeLsbRgbLg
bLgbLibLibRjbRobRsbRgbRsbRsbRsbRgbRgbRsbRgbRsbRsbRgbRsbRsbRsRsmbRgbRiL
sbLgbLsbReLsbRgbRgbRibLsbLsbRgbRgRsmbRgbRsbRgbRsbRgbLsbRibLgbLcbLhLsbR
sLsbLsbLibLgbLgbLsbLgbLgbLgLsbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbL
gbRgbLgbLibRobRsRsmbRibRsbRobLgLsbLibRgbLcbLsbLibLibRgbRibRgbRgbRgbRgb
RgbRgbRsbRgbRsbRsbRsbRsbLsbLcbLobLiLsbLgbLgbLgLsbLgbLgRsbLgbLgbLsbLgbL
gbLgbLgLsLsmbLsLsmbLgbLsbLgbLgbLgbLgbLsbLgLsbLgLsbLsLsmbLsbLsbLgLsbLgb
LgLsbLgbLgbLgbLobLhLsbLgbLsbLcbLcbLgLsRsbRsLsbLjbLcbRsbRsLsbLgbLgbLibL
ibLgbLsbLsbLibLsbLgbLgbLgbLgbLgbLsbLsbLsbLgLsbLgbLsLsmbLgbLgbLsbLgbLsL
smbLgbLgbLgbLsbLgRsbReRsmbRsbRibRgLsbRgbRgbRgbRsbRgbLsbRebLibLgbLcbLib
LsbRsLsbLsbLgLsbLgLsbLgbLgbLeLsRsbLgbLgLsbLgbLgbLgbLgLsbLgbLibLgLsbLgb
LgbLsbLgLsbLgbLgbLobLibLhbLsbLgbLgbLsbLgbLgbLgbLgbLgbLgbLsbLgLsbLgbLgb
LgbLsLsLsmmbLgbLgbLgbLsbLgbLgbLgbLgbLsbLgbRgbRgbRebLibRsRsmbLgLsbLgbLs
LsmbLgbLsbLgLsbLgbLgbLgbLgbLgbLsbLgbLgbLsbLgbLsLsRsLsmbLgbLgbLgbLgbLgb
LgbLgbLgbRsbLibRgRsmbLgbLsbRebRiLsbRsLgbRjbRibRibsbLgbRgbsbLgbRibLhbLc
bLobRibLibLgbLgbRsbLgbLgbLibLgbLgRsbLhbLgbLsLsmbRsbLibRebRcbRcbLeLsbLc
bLsbRsLsbLgbLgLsbLgbLgbLgbLsbLsbLgLsbLsbLgbLsbLsbLsbLgbLsbLgbLsbLgbLsb
LsbLgLsLsmbLgbLgbLgbLgbLgRsbLibLebLcbLiLsLsmbRcbRibRiRsmbRcbRgbRcbRiRs
mb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 33; Drug: PCAP2 3 然
bLcbLcLhbLgbRcLsbLcbLcLgLsbRhbLgLsbLcRsbRjbsbLhbLgbRsbLibLcbLibLibLibR
gbLibLibRgbRcbRiRsmbLobLsRgbLiLsbRgbRcbRebRcLsbLibLgLibLcLsmbLcLibLibL
sbLibLibLibLgbRgbRhRsmbLjbRhbLcbRgbRsbLgLsbRsbLhbRibRcbRiLsbRibLcbLcbR
cbLjbRhbRoLsbLibLibLgbLgbRebLjbLiRsbRcbRcLsbRgbRhbLebLcRsbRibLjbRcLsbR
ibRibRgbLibLgLsbLebRcbRcbRgbLsbRcbRibRgbLgbLgbLgLsbRjbLgbRsbLgbLgbLhbL
ibRsbLobLjbRsbLsbLgRsbRgLiRgbRsbLgbLibRsbLjbRcbRibRebRibLsbLibLsbRjRsm
bLcRsbLgbLcbRhbRiLsbLibRhLsRsbRsbRsbRibRiRsmbRgbLgbRcLsbLiLsbRibRebRib
RcbRgbRsbRebRsRsmbRhbLibLjbRibLgbLcbLibRsLsbLgbRsbLiRsbLsLsmbRsbLgbLib
RsbLsbLgbRsLsbLgbLibRgbLibRsRsmbLibLgbLsLsmbLgbLgbLsLsmbLsLsLsmmbLgLgb
LsbLgRsbLgbLsbLgLsRsbLsLsmbLsbLgRsbLgLsLsmbLsLsmbLgbLgbLibRibLiLsbRgbL
ibRsbRsRsmbLibLibLibLgRgbRebsbRgRsmbRsbRsbRsbLsRsbRibLgbLcbLgbLsbRsbLi
bLgbLsbLibLgbLsbLgbRcbRiLjbRiRsmbLsbRiRsLsmbRjbRiLsbRibLgbRibRjbLgbRjb
LsbRibRibRsbRsRsLsmbRgbRsLsbRgbRjbLsbLsbRibRcbLgLsbRgbLhbLhbLsbLsbRgbR
jbRiRsmbRcLsbRgRsLsmbRgLsbRcbLgbRhLsbRgbRgbRebRgLsRgRsmbRsLsbRsbRgbLjb
RibLibRgbLcbLibLcbLsbRgbLcbRibRcLsRsbLsbRgbLobLgRsLsbLsbLsLsmbLgLsbLgL
sbLgbLgLsbLgbLoLsmbLgbLjbLgbLgbLgLsbLgbLgbLgbLibLhbLcbLiRsLsbLgbLiLsbL
gLsbLgRsLgbLibLgbLsbLcLcbsbLiLsLsLsmmbLgRsLsbLgLsRsLsbLgbLgLsbRsbLsbLi
bLgbLsbLibLsLsmbLjbRsLsbLgbLibLiLsRgbLsbLjbLibLebRsLsbLiLsbRsbLiLsbLsb
LsLsmbLgbLsbLgbLsLsLgmbLgLsbLibLcbLgbRcbRgbRjbLsbRjbRhLsRiLsLsmbRhRsRs
RsRgRsmmmmbRgbRgbRgbRibRebRjRsRgmbRgbRgbRgbRgRsmbRjbRsRgbRgLsbRsbRgbRg
LsLsmbRsbRgbRgbRgbRsLsbRiLsbLjbLgLsbLgbLsbLgRsbLgLibLgbLgbRhbRiLsRsLsb
RiLsRsbRsbRiLsbRsbRibLiLsbRgLsbLgbLhbRibLcRgbRcLsbRcbRhbRgbRhLsbsbRiRs
LsRsmbRsRsmbRsbRsbRgRgbRgLsbRsRsmbRsRsmbRiLsbRsbRiRsmbRcRsRimbRgbRiRsR
smmbRibRibRsbRibRgRsmbLgbLebLgbLgbLgLsbLsbLgbLgLsbLgbLiRsbLhbRgbLibLhL
sbLgbLibLsLsmbLgbLgbLgLsbLgbLsLsmbLgLsbLsbLsbLgbLgbRgbLsbLgbLsLgLgbLgb
LibLgLsLsmbRjRsmbLibLiRsbLgLsbLgbLgLgbLsRsbLgbLgLsbLgbLiLsbLibLsbRjbLi
bLgbLgLsbLgLgbLgbLsbLgbLgbLgbLgbLgbRsbLsLgbLgbLibLgLsbLgLgLsLsLgmbLgbL
gLsbLsbLibLgRsLgbLiRsbLiRsbRcbRiRsmbRiLsbLsbRibLsbRibRgLsRsbRsLsbRiLgb
RgLsbRhRgLsbRibRcLgbLibLgLsbLgbLsbLgbLiLsbLhRsLgRsbRibRcbLgbRgbRgRsRsm
mbRgRsmbRsRsLsRgRgRsmmbRiLsRsLsbRibRsbRsRgRsRgRsLsmmbRgbRgbLsbRgbRibRg
RsmbRibLsbRgbRgbRgbRiLsLsmbLgLsRsbRiLsbRgRsmbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 34; Drug: PCAP2 3 然
bRcRsmbRiRsmbLgbRsbRsbRcRsmbRibRgRsmbRiRsmbRibLgbRsbRibRgbRhbRibLgbRoR
smbRsbRibRgbRsbRgbRsbRibRgbLsbRgbLsbRobRgbRibRsbLsbRibRgbRibRsbRibRibR
cbRgbRsbRibRibRsbRgbRsLsbRibRsbRsbRsbRgbRibLgbLsbRjbRibRsbRgbRsbRibRsb
RibRibRgbRsbLgbRibRgbRgbRgRsmbRgbRsbRgLsbRgbRgbRgRsmbRibRcRsmbRgbLsbRc
bRibRgbRibRgbRibRgbRsbLsbRgbRgbRgbRsRsRsmmbRgbRgbRsbRgRsmbRsbRobLsbLgb
LsbLebLoRsbLibRhbLgbRibRsbRibRsbRgbRgRsmbRibRibRibRibLgbRobLgbRibRgbRc
bLgbLsbRsbRibRhbRsbRsbRgbRgbRsbRgbRgbRgbRgbRgbRsbRsbRoRsmbLibLgbRgbLib
RsbLgLsbLsbLsRsbLibRhbRcRsmbLsRsbRgbRibLsbLibLibRibRcbRgbRgLsbLjbLibRi
bRibLsbLjbLhbRjbLebLhbRcbLcbLiRsbLcbRhRsmbLcRsbRgbLebLcRsbRibLcbRsbLiL
sbLsbLgbLsRsLsbLgLsbLhbLiRsbLsbRsbRgbRsbRibRsbRsbRgRsmbRsbRgbRgbRsRsRs
mmbRgbRsRsmbLsRsbRsRsmbRsbRgbRgbLgbRgRsmbRgbRgRsmbRsLsbRgRsmbRgbRgbRgb
RgbRsbRgbRgbRgRsmbRsbRgRsmbRgbRgbRsbRgbRibRsbLsRgbRgRsmbRsbRsbRsbRgbRs
bRsbRsLsbRgLsbRgbRsbRgbRgbRgbRsbRgbRgRsmbRsbRgbRsbRsbRgbRsRgRsmbRgbRgb
RgRsmbLsbRgbRgbLsbLebLhbRgbRgbLcbLcRsLsbLcbLcbLgbLgbRsbLgbLgbRebRgbRsb
RsbRsbRgbRgbRsbRsbRjbLsbRsbRgbRsbRgbLsbRgbRgbRsbRsbRjbRgbRsbRgbRgbRgbR
gbRgLsbRjbRgbRgbRgbRsRsmbRgbRsbRgbRgbRgbLsRsbRsbRsbRsbRgbRibRsbRgbRsbR
gbLjbLgRsbLiRsbRgLsbLibLgbLjbRhbLjbRgRsLsmbRgbRgRsmbRsbRgbRsbRgbRsbRgR
smbRgbRibLgLsbRobLgbRsbRcRsmbRsbRcbRcRsmbLsbRgbRoRsmbLebRgRsmbLcbLhbRs
bLcRsbRhbsbRsbRobRcbRjbRibRibRgbRsRsmbRgbLsbRgbRsbRsbRsbLsbRsbRsbRsbRi
RsRsmmbRsRsmbRgRsmbRsbRgbRsRsmbRgbRgbLsRsbRgbRgbRsbRgbRgbRsRsmbRgbRgRs
mbRsbRgbRgbRgbRgbRsbRsRsmbRgbRsbRibRsbRgbRsbRgbRgbRsbLibLibLibRjbLcbRs
bLgbRgbLibLgbLsbLibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 35; Drug: PCAP2 3 然
bLibLgbLibLibLgRsbLsLsmbLgbLiRsbLibLibLgbLiLsbLgbLsbLgbLsbLibLiLsbLiRs
bLiLsbLcbLgbLgbLgbLsbLsbLgbLsbLsbLsbRsLgbLsbLgbLgLsbLsLsmbLsbLgbLsbLsb
LsbLsLsmbLgbLgbLsRsbLsbLgLsbLibLsbLgLsbLgbLiRsbLcbLcRsbLjbLibRsbLibRsb
RjbRcbRhbRhLsRsbLhbRsbRgbLcLsmbLiRsbRgbLibRgbLhbLhbLibLibLsbLibLsbLgRs
bLsLsmbLgRsbLgbRsbLiLsbLiLsbLibLgbLibLibLibLibLibLibLsbLibLgbLsbLgbLgb
RsbRobRsbLgbLibLibLibLsbRsbLhbRsRsLsLgLgmbLobLgbLsLsmbRsRsmbLgLsbRsbLs
LgbLsbLjbRgbRgbRjbRobsbRebLiLsbLsbLiLsLsmbRgbLibLibRcbRebLibLsbLgRsbLg
RsbLsbLsbLsbLibLibLibRsbLgbRgbRebRgbRgbRsbRsbRsbRsbRsRsmbRsRsmbRgbRgbR
gbLsbRsbLcLsmbLsbLibRgLsbRsbRsbLsbLibRgLsbLcbLcbLiLsbLgbLsbLgLsbLsbLgR
sbLsbRsbLgbLgbLgbLcbLibLibLgbLibRsbRgbLgbRsbRsbRibRgRsmbRsbRsbRibRgbRs
bRsbRsbRgRsmbRsLsbRgbRhbRsLsbRsRsmbRsRiLsbRgRsmbRgbRsbRsbRgbRsbLobRgbR
sRgbRsbRsbRsbRsbRgbRibRibRiLsbRibRsbRiLsbRgbRsbRgbRsRsmbRgbRsbRgRsmbRg
bRsbRsbRsbRsbRsbRgbRgbRgbRgbRsbRgRsmbRsbRsRsmbRsbRgbRgbRsbRsbRsbRsbRgb
RsbRgbRgbRsbRsbRsRsmbRsbRgbRgRsmbRgRsmbRsbRsbRgbRsbRgbRsbRsRsmbRgRsmbR
gbRgRsmbRgbRgbRsbRgRsmbRgLsbRgbRgbRgbRgbRsbRsbRsbRgRsRsmmbRsbRsRsmbRsb
RsbRsbRgbRsbRsbRgLsbRgRsmbLgbRgbRsbRgbRgbRgRsmbRsbRgbRsbRgbRgbRgbRsbRs
bRgbRsRsmbRsRsmbRgbRsbRgRsmbRsbRgRsmbRgRsmbRgRsmbRgbRgbRsRsmbRgbRsRsmb
RgbRgbRsbRgbRsRsmbRgbRgbRgbRsbRsbRsbRsLsbRsbRgbRgbRgbRgRsmbRsbRgbRsbRg
bRgbRsbRsRsmbRsRsmbRsbRgbRgbRsbRsbRgbLcbRiRsRsmmbRgbRgbRsRsmbRgbRsRsLs
mbRsbRsRsmbRgbRgbRgbRgbRgbRsbLsbRsbRgbRoRsRsmmbRcRsmbLobRibRsRgbRibRsb
sbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbRsLsbRgbRgbRhRsmbRibRhbRgbLgbLibLgbLgb
RobRibRsbRhRsmbRiRsmbRgbRgbRgbLsRsbRgbRgbRgbRgbRgRsmbLsbRibRgbRcbRibRg
bLsbLibLsbLgbLsbLgbLgLsLsmbLgbLsbLgbLsbLgbLgLsbLgLsbLiRsbLgRsbRsbLgLsR
sbLiRsbLgLsbLsbLsbLgLsbLgbLgbLgLsbLibLibLgbLibLiLsbLgLsbLgbLgLsbLsbLgL
sbLsbLgRsbLiLsbLhbLgRsbLgbLhLsLsmbLgRsbLsbLgbLsbLsbLgLsbLsbLgLsbLgbLsb
LgLsbLgbLiRsLsbLcbLiLsbLcLsLsLsmmmbLgLsLsmbLsbLgLsbLsLsmbLgLsbLibLibLi
LsbLgbLiLsbLiLsbLsbLgLsbLgbLgbLgLsbLgbLgbLgLsbLgLsbLibLibsbLiRsbLibLib
LgbLiRsbLgbLgLsbLgbLgbLgLsbLgbLgbLgbLiLib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 36; Drug: PCAP2 3 然
bRsbRgbLsbRgbRsbRgbRgbLjbLcbRibRcbRiLsbRgbRgbLgbRcbRibRgbRsbRibRgbRsbL
sbRgRsmbRsRsmbRgbRiLsRsbRibRgbRgbLjbLgbLgbLsbLsbLgbLgbRcRcbRgbRgbRsbLs
bRgRsmbLsbRgbLsbRibLgLsbRgbRsbRsbRgbLsbRsbRgbRgbRgbLsbLgbRiRsmbRibLibR
hbRgbRgbRgbRsbRsbRsbRsbRsbRgbRsbRsRsLsmbRsbRsbRgbLgbRgbRgbLjbRibRiLsbR
ibLgbLgbLgbLgbLjbRcbRgRsmbLgbRgbRsbLsbRsbRibLcbLjbLsLsmbsbLibRcbRibLsb
RgbRsbRgLsbRgbLjbRibRgbLgbRibLgRsbRibLgbRgbRgbRsbLsbRibRgbLibLiLsbLgRs
bLgbLhbLcbLgbLgbLgbLgbLsbLsLsmbLgbLgbLsbRsLsbLsLsmbLgbLsbLsbLsLsmbLgbL
gbLsbRsbLgbLsbLsbRibRgRsmbRibRiLsbRjbLsbLgLsbLgbRebLibLibLjbRebLsbRgbL
gRsbRibRcbLsbLgbLsbLsbLgRsLsbLhbLgbRgbRgbLsbRgbLsbRsbRsbRgbRgbRibRibRi
bLibLibLgbRsbRsbRgbRjbRgbRibLobLibLsRsLsbLgbLcbLibLgbRgbRibLjbLibLsbLg
bLgbLsbRsbLcbLibLgbLgbLgbLibLgbLsRsbLgbLgLsbLsbLsbLgRsbLsbLgbLgbRsbLgb
LgbLsbLsbLgbLgbLsbRsbLgbLsbLgbLgbLsbRsLsbLgbLsbLgbLcbLibLibLibLibLgbRg
bLgbLcbLibLibLibLibLibLibLgbLsbRgbRhbRibRgbRibLgbLibLgbRgbLcRsbLgbLgbL
sbLgbRgbLgLsbLgbLsbLsbLsbLsLsmbLgbLsbLsbLsbLsbLsbLsbRsbRsbRibRgbRibLib
RgbRibRibRibRibLsbLibLgbLgbsbRgbLibLibLgbLsbRsbLibLebLgbLgbRgbRsbRsbRg
bRibLjbRibLjbRhbLibRgbRgbRgbRsbLsbRgRsmbRgbRgbRgbRgbRibRibRibLsbLgbLsb
LgbRsbLibLgbLgbLsbRsbLgbRsbLibLgLsbRgbLsbLibLibRibRibRcRsmbRibRgbRibRg
bRsbLgbLgbLgbRcbRibRsLsbRibRcbRibRgbLibLibRibLcbLgbLsbLgbRgbLibLgbLsRs
bLgbLsbLsbLsbLsbLgLsbRsbLgLsbLibLcRsbRibLgbLhbLsbRsbLibLgbLgbLsbLgbRsb
LsbLibRcbRcbRgbRibLibRsLsbLjbLibLsbLgbRcRibLsbRibLjbLjbLibLgbRcbRgbRgb
RsbRsbRiLsbLibLhbLgbLgbLsbLgbRsbLsbLsbLsbLgbLibRibLjbLgbLgbLsbLgbLiRsb
LcbLgbRgbLibLibLibLibRebRibLsbRibRsbRgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 37; Drug: PCAP2 1 然
bLibLcbLsbLgbLgbLgbLsbLhbLgbLcbLobLibLgbLobLgbRgbLgbLcbLobLgbLgbLsbRgb
LsbLsbLibLhbLgbLsbLgbRgbLgbRsbLgbRsbLgbLsbRsbLgbLgbLgbLgbLgbLgbLgbLgbL
sLsmbLsbLgbLgbLsLsmbLgbLibLgbLsLsmbLgbLgbLsbLgbLgbLsbLibRcbLgbLsbLgbLi
bRsRsmbLgbLgbRgRsmbLhbRgbRjbRhbLgLsbRgbRibRgbRgbRgbRgbRgbRgbRgbLgbRibL
sLsmbRgbRgbRgbRibLgbRibRibLsRsbRibRsbRgbRgbRgbRsbRgbRsbRgLsbRgbRgbRgbR
gbRgbRgbRsbRgbRsbRgbLsbRibRgRsmbLsbRibRibRgbRiRsmbRibLgbRsbRsbRgbRiRsm
bLsbRgbRgbRgbRgRsmbRsbRgbRgbRgbRibRgbRsLsbRgbRgbRgbRgbRgbRgbRgRsmbRgbL
sbRgbRgbRgbRsbRgbRgbRgbRgbRgbRsbRgbRgbRgbRsbRgbRgbRgbRsbRgbLsbRgbRgbRg
bRgbRgbRgbRgRsmbRgbRgLsbRgbRgbRgLsbRgbRgbLsbRibRsbRgbLsbRibRgbLsbRibRg
bLgbRhbRgRsmbLgbRhbRcbLgbLsbLgbLiLsbLsLibLgbRjbRcLsLgbRibRgbRgbRsbRsbR
sbRgRsmbRsRsmbRgbRgbRsLsbRsbRibRgRsmbRgRsmbLsRgbRgbRgRsmbRgbRgbRgbRsbR
gRsmbRgbRgRsmbRgbRgRsmbRgbRsRsmbRgbRgbRgbRsbRgbRiLsbLgbRibRgbRsbRibRsb
RgbRgbRgbRgbRgbLsbRgbLsbRibLgbLjbLibLgbLgbRjbLhbRgbLibRsbRjbRcbLsbRgbR
cbLgbLibLcbRgbLcbLibLhbLibLiLsbLibRsbLjRcbRgbRcLsbRibRibLsbLibLgbLgbLs
bLgLsbLgLsbRsLsbLgbLgbRjLibRebRcLsLsmbLgbRibRcRsmbRsLsRsbRsbRibRgbRgbR
sbRoLsRsbLibLgLsbLibRgbLcbLibRgbRgbLibRhbRsbRcbLgbRobRcbRgbRjbLjLsmbLi
bLgbLgbRsLsbLgbLsbLsbLsbLsbLsRsbLgbRgbLibRsbRsbLgbLgbLgbLgbRgbLgbLibRs
bLibRibRoRsRsmmbRsRsmbRoLsRsbRibLsbRhbRibRsbRgbLsbRgbRgRsmbRsbRgbRgbRi
bRsbRgRsmbRgbRgRsmbRgbRgbRgbRgLsbRgRsmbRgbRsbRgRsmbRsRsmbRgbRgbRgbRgbR
iRsmbRgbRsbRgbRgbRsbRgbLcbLoRsbLcbLcbLgbLgbLibRibRhbRibRiLsbRibRgbRhbR
gbRiLsbLgLsbRhbRsbRiLsbRibRgbLgbRibRgbRsbRgbLgbRibRgbRsbRgbRgbRgbLgbRi
LsbRgbRcbLgbRsbRsbRibRsbRgbRgbRgbRgbRgbLsbRibLgLsbRsbRibRsbRibRiLsbRgb
RibRgbRsbRgbRgbRgbRgbRiLgbLhbLibRgbRhbRgbRgbRibLsbRibRsbRibRsbRgbRsbRg
LsbRgbRhbLgbLgbLsbRiRsmbRobLibRgbRibRgRsLsmbRgbRsbRgbRgbRgbRsbRsbRiLsL
sRsmbRsRsmbRgbRgbRsbRiRsmbRgbRgbRgbRgbRgbRsbRibRsbRgbRgbRsbRibLgbRiRsm
bLgbRcbLsbLgbRibRibRgbRgbLsbRgbRgbLgbRgRsmbRgbLgbLsbRgbRgbLsbRgRsmbRib
LgbRgbRiLsbRgRsmbRsbRgRsmbLgbRibRsbRsbRgbRsRsRsmmbRgbRsRsmbRgbRgbRgRsm
bRgbRgbRgbRgbLjbLcbRcbRgbRgRsmbRsbRgbRibRgRsmbRgbRgbRgbRsRsmbRgRsmbRsb
RgbRgbRgbRgbRsbRgRsmbRgbRgbRgbRgbLobLoRsLsbLiRsbRjRibRibRsbRgRsmbRgbRg
RsmbRgbRgbRgRsmbRgbRgbRgbRgRsmbRgRsmbRsbRgRsmbRgbRsbRibRsLsRsbRgbRgbRg
bRgRsmbRgbRgbRsbRgRsmbRsbRgbRgbRgRsmbRgRsmbRsbRibRgbRgRsmbRgbRgbRsbRgb
RsbRsbRebRobLjLobLiRsbLgRsbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 38; Drug: PCAP2 1 然
bLsbLgbLsbLsbLgLsbLsbLgbLgbLsbLsbLgbLsbLgLsbLsbLibRgLsbRsbLgbLgLsbLsbL
ibLsRgRsmbLcbLibLgbRsLsbLcbLgbLgbLsbRsbLgbLibLgbLgbLsbLgLsbLgbLsLsLsmm
bLgLsbLsbLsbLgbLsbLsLsmbRsbLhbLiRsbLiRsbLsLsmbLibLgbLgbLgbLgbRsbLgbLgb
LgRsbLsbLgbLsbLsbLgbLsbLsLsmbLgbLgbLsbLsbLgLsRsbLsbLsbLsbLgLsbLgLsbLgb
LsbLgbRsbLgbLsbLibRsbLsLsmbLgbLgLsbLgLsbLsbLgbLsbLgbLsbLgbLsbLgLsbLgbR
sbLibRsbLsLebLibLibLibRgbRibRibLgLsbRcRsmbLgbRhbLgbRhbLgbRhLsbLsbRgbLs
bRgbRsbRgbRsbRgRsmbRibRsbLsbLjbLibLgbLgbRsLsbRsbLibRsRsmbLibRgRsmbLiLs
bRsRsmbLgbLgbLsbLgbRibRcbRgRsmbRsbRgLsRsbLsbRgbRibLgbRhRsmbLgbRcbRcbRi
bLgbRgLsLsmbRcRsmbRibLgbRgbRgbLsbRgRsmbRibLgbRgbRsbRiLsbLsbRibLgbRgbRi
bLsbRgbRibLgbRgbRgbLsbRcbLibLcLsmbLgLsbRsLsbLsbLgbRsbLgbLgLsbLsbLsbLsb
RsLgbLgbLsbLsbLgbLgbLsbLgRsbLgLsbLgLsbRjbRcbLgbRibLsLsmbRcLsbRgbRsRsmb
RsRhbLsbLgbRcbLsbLgbRibLsRsbRibLgbRhbLgLsbRcLsbRibRsbRsbRiRsmbRgbRgLsb
LgbRgLsbRgbRgRsmbLsbRsbRgbRgbLsbRgbRsbRsRsmbRsRsmbRsbRgRsmbRgbRsbRiLsb
LgbRgbRsbRhLsLsmbRgbLhbLcRsbRsbLgbLgbLsbLgbLsbRsLsbLiLhbLgRsbRibRibRib
RgbLgbRgbRgbRgbLsbRsbRgLsbRgLsbLsbRibRcbRiLsbLgbRhbRibLgbLeRsbLibRjbRc
bLgbRhbLgbRibRsRsmbRsLsbRgbRsbRsbRsRsmbRgRsmbRgbRgbRgbRibLibLjbLibLgbL
ibRgbLgbReRsmbLhbLibLibLibLibRsbsbLibRgbLsbLgbLgbLibLibLhbLcbRgbLgbLcb
LhbRibRsbLgbLibLgbLgbRgbLgbLiRsLsbRgLsbLgbLsbLsbLgbLsbLsbLsbLgLsbLsbLg
bLsbLgbLgbLgbLgbLsbLsbLsLsmbLgbLgbLsbLsbLgbLsbLgbLsLsmbLgbLsbLsbLgbLgb
LsbLgbLsbLgRsbLsLsmbLsLsmbLsbLsbLgbLgLsbLsbLgbLgbLgbLgLsbLgbRsbLgbLgbL
sbLsbLgbRgbLsbLgbRsbRjRhbRiLsbLgbRhbRgbRgbLjbRibRgRsmbRibRsbRibRibLsLs
RsmbLibRcbLsbRiLsbLgbRibRgbLgbRcbRibLibLibLgbLgbRsLsbLibLsbRsRsmbLiLsb
RsRsmbLgbLgLsbRsbLsbLgbLsbLsbLsbLsbLsbLgbLsbLsbLsbLgbLgbRgbLsbLibRjbLj
bRgbLgLsbRsLsbRcbRcbRhLsbRgRsmbRhbLgbRiLsbRibLsbRgLsbRhbRcbLgbLibLsbRi
bRibRgbRsRsmbLsbRibLgbRiLsRsbRiLsbLgbRsRibRgbLgbRibRsbRsbRgRsmbRgbRsbR
sbRgbRibRgLsbRgbRibLgbRibLgLsbRiRsmbLsbRgbRsRsRsmmbRibLsbRibRgbLsRsbRh
bRgbRgbLgbRgRsmbRsLsbRibLsbLgbRgbRsbRsbRgbRgbRgbRsbRgRsmbRsbRgbRsRsmbR
gbRgbRsbRsbRgRsmbRsRsRsmmbRibRiRsmbRsbRgbLsbRibRcLsbRgbRgbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 39; Drug: PCAP2 1 然
bRgbRibLgbRgbRsbRgbLgbRibRcbRibRsbLibRibRcbLjbLcbLgbRjbRcbRcbRhbRhbRib
RgbRhbLjbLcRsbLsbLibLiRsbLcbLibRiRsmbLgbRgbRibRsbRibLsbRgbRsbRgbLsbRgb
RgbLgbRibRibLjbRibLobLibRcbRhbRibLsbLjRsbRibLcbLiRsLsbLgbRjbLcbRgbLgLs
bLgbLgbLgLsbLgLsbLsbLgbLgbLibLhbLibRgbLgbLibLgLsbRsRsmbLibRhbLjbLcbLhb
LibLgbLibRgbLhbLibLsLsmbLgbLgbLibLsbRgbLibLgRsLsbLsbRsRsmbLgbLsbLgRsbR
sbLgbRebRibRibRibRgbLjbLcbRgbLibLgbLiLsbLgbLgbLsbLgbLgbLsbLgLsbLgbLsbL
gbLsLsmbLgbLgbLsbLsbLsbLgbRgbLgbRjbRhbLibRibLsbRgbRsbRiLsbLgbRoLsLsmbR
hbRibLgRsbLibLsbLibLibLgbLgbLgbLoRsbRibRibRgbLobLgbLgbLgbLibRcbLsbRsbL
hRsbLibLibLibLibLgbRsbRsbLgbLibLgbLsbLgbLsLsmbLgbLsbLsbLgbLgbLgbLsbLgL
sbLgbLsLsmbLsbLgbLsbLsbLsLsmbLgbLsbLsbLgbLgbLibRgbLgbRjRhbRibRibRgbLgb
RgbsbsbRgbRsbRgRsmbLsbRiLsbRsbRhbLgbRgbLcLhbRjbLibLgLsbLgLsbLgbLsbLgbL
gRsbLhbRjbLgbLgbLsLsmbLgRsbLsbRsRebLobLhbLgbLibLgbLsbLsbLsbLgbLsbLgbLg
LsbLsbLgbLgRsbLsbLgbLgbLgbLsbRsbLsbLsbLgbLibLgRsbLgbLsbLibLgbLgbLibLgb
LsRsbLsbRjbRgbRgbRsRsLsmbRgbsbRgbLgLsbRsbRsbLcRsbLhbLgbLgbLibLhbLgbRgb
LgbLjbLibRgbLiLsbLgLsbLgbLgbRsbLsbLgbLoLsmbLhbLgbLcbRibsbLgRsbLgLsRsbL
gbRsbLgLsbLgbLgbLibLsbLsbLgbLiRsbLgbRgbLibLsbLgbLsbLsbLgbLgRsbLsbLgLsb
LgbLgbLgLsbLsLsmbLsbLgbLgbLgRsbLgbLgbLsbLgLsbRsLsbLsbLgbLgbLgLsbLgbLgb
RsLsbLsbLgLsbLsbLsLsRsmbLgbLsbLsbLgLsbRsRsmbLsLsRsmbLsbLgLsbLgbLgbLsLs
mbLgbLsbLgbLsLsmbLgbLsbLgLsbLgLsbLgLsbLgbLsbLsLsmbLsbLsbLsLsmbLsbLsbLg
bLgbLgbLsLsmbLgLsbLgbRsLgRsbsbLsbLgbRsRsRsmmbLgbLgbLgbLsbLgLsbLgRsbLsb
LsRsbRsbLsLsmbLgLsbLgLsbLgbLgLsbLibLgbRsbLiRsbLgbLgLsbLgbLsbLsbLgbLgbL
gbLsbLgbLgbLgbLsLsmbLsLsmbLgRsLsbLgbLgbLgbLsbLsbLsLgbLgLsbLgLsbLgLsbLs
bLsLsmbLgbLgLsRsbLgLsbLgbLsRsbLgbLgbLgLsbLgbLgRsbLgbLsLsmbRsbLibsbLgLs
bsbLgbLgbLgbLgLsbLgLsbLgRsbLgbLgLsRsbLgbLsbLgbLgbLgbLgbLsRsbLgbLgbLgLs
bLgLsbLgbLgLsbLgLsbLgbLgbLgLsbLgbLgbLgLsbLgLgLsbRsLgLsbLgbLgbLgbLsLsmb
LsRsbLgbLgLsLsmbLgbLgbLgLsbLgLsbLgLsLsmbLgbLsbRsLgLsLgLsLsmbLgbLgbLgRs
bLgLsRsbLgbLgbLgbLgbLgbLgbLgbLgLsbLsbLgbLgbLgbLgLsbLgbLgbLgLsbLgbLgLsb
LgbLsbLgbLgbLgbLgbLsbLsbLgRsbLgbLsLsmbLgbLgLsbLgbLsbLgbLgbRsLgbLgbLgLs
bLgbLsbLgbLgbLgbLgbLgLsbLgbLgbLgbLgbLgbLgLsbLgRsbLgbLgbLibLgbLgbLgbLgb
LiRsbLcbLibRgbLjbLebLsbRibLibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 40; Drug: PCAP2 1 然
bRsbRsbRobLgbRcbRgbRiLsbRcbLhbLibRhbLibRcRsmbRibRsbRibLgbLibLgbLibRgbL
gLsbLgbLgbLgbLoLiLsbLibLgbLibLgbLgbLsbLgbRcbRibRibRibRibRhbLcbRjbRcbRo
bRibRiLsbRgbRibLjbLcbLcbLibLibRsbRgbRibLibRiRsmbLgbRibLsRsbRgbRsbRsbLs
bRsbLsbRsbRiRsmbRsLgbLibLhbRjbRcRsmbRibLjbLcRsbRsbRcbRhbRcbLebRcbRibLi
bLhbRcbRibLgbRibLsRsbLsbRibRsbRgbRgbLgbRibLgbRgbLsRsbRgbsbRsbRsRsmbRgb
LgbRibLsbLebLcbLibRibLcbLhbLibRgbRgbRibLsbRsbRiRsRsmmbLjRsbRsbRgRsmbRs
bRsbRsbRgbLsLsmbRsbRgbLsbRgbLsbRgbRgbRgbLjbLobRsbLibLsbLibRjbLhbRibLob
LcLsmbLiLsbLcbRgbLgbLgbRcbRcbRibRgbLsbLgbRibLsbRgbRsRsmbRgRsmbRgbLsRsb
LsbRgRsmbRsbRgbRsRsmbRiRsmbRsbRibRsbLgRsbRgbRibRsbRsbRsbRgbRsbLsbRibLs
bRgbRibLsbRibLsbRsbRgbLibRibRibLgbRibRgbRibLibLsbRiRsRsmmbRsRsmbRsbRgR
smbLgLsbRgRsmbRgbRgbRsbLsbRibLsRsbLsbRgRsmbRiRsmbLgbRgbRgRsmbLgLsbRibR
gbLsbRgbLsbRgbRsbRgbRsbRgbRgbLsbRiRsmbLsbLsbsbRgbRsbRgbRgbRsbRgbRgbRsR
smbLgLsbRibRsbRgbRibLibRgbRiRsmbLcbLgbRsLsbLibRsbLibRebRiRsmbRsbRgbRgR
smbRsRsmbRgbLsbRgbRsbRgRsmbLsbRgbRsbRsbRgbRibRsbRgbRgbLgbRhbLsbRiRsmbL
gbRgbRgbLsbRgbRgbLsbRgbLsbRiRsmbLsbRsbRgRsLsmbRgbRsbRgbRgRsRsRsmmmbRgb
RgbRsbRgbLsbRgbRsRsmbRjbLsbRsbRsbRibLcbLibLhLsbLgRsbRjRsmbLcbLcbRibLib
RsbLibLsLsmbRgLsbLibLgbRsbLibRgbLibRsLsbLibLibRhbRcbRgbRiRsmbRsRsmbLgb
LeLsbRgbRcRsmbRiRsmbLsLsmbRgbRsbRgbRgbRgbRsRsmbRgbRgbRgRsmbRsbRgbLsRsb
RgbRgbRsbRibLsbRgLsbLgbRibRibLcbLcbLiRsbRgbLibRsbRjbLcRsbLiRsRsmbLcLsm
bLibRgbRgbLobLibRjbLibRsRsmbLiLsbRgbLsbLibRjbLibRhRsmbRgbRsbRgbRgbLsRs
RsmbRsRsmbRgbRgbLgbRibLsbRgRsmbLsbRgbRiRsmbLcLsmbRsRsmbLgbLsbLsbLgLsbL
gbLgbLgLsbRjbLgbLgbLgbRgRsmbRcRsmbLsbRibRsbRgRsmbLsRsbRibLjbRsbRiRsmbL
gbLeLsbRgbLiLsLsmbRsbLgLsbLgbLsLsLsmmbLsbLgbLsbLsbLsLsmbLgbLsLsmbLgbLg
bRjbRobRgbRgbRsbRgbLgbRibRgbLsbRgRsmbLgbRgbLsbRibRgbLcbLhRsbRcbRjLsbRi
bRgbRgbRsRsmbRgbRgbRsbRibLhbLhbLgLsbLibRsbLgbLgbRcbRcbLgbRibLibLhbLgbL
sbLsLsmbLgbLgbLgbRsLsbLsRsbLsbLgbLgbLgbLgbLsLsmbLsbLgbLsRsbLsbLgbLgLsb
LgbLgbLsRsbLiRsbRobRcbRsbRsRsmbRibLgbRgbRgbRibLebLgLsbLgbLgbLsbLsbLgbL
sRsbLsbLsbLsbRhbRcRsmbRhbLjbRcbRiLsbRibRcbRcbRhbRsbLcLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 41; Drug: PCAP2 1 然
bRibRibLsbRsbRibLsbRgbRgbRsbRibRsbRsbRgbLsbRiLsbRsbRgbRsbLsbRiLsbLsbRg
bRgbRgbLsbRibRsbRibLgbRgbRgbRsbRibLgbRgbRsbRsbRiRsmbRsbRgbRgbRsbRgbRgb
RgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRsbRgbRsbRgbRgbRgRsmbRgbRgbRgbRgbRgbLsbR
gbRsRsmbLsbRibRsRsmbRgLsbRgRsmbRgbRsbRsbRsbRibLcbsbReRhbLcbLiLsbLibLjb
LhbRibLibRgbLgbLibRgbLgLsbLgbLsbLgbLsLsmbLgbLsbRsbLiRsbRjbsbLjbRsbRcbL
gbRcbLjbRibRsbRgbRsLsbRsbRgbRgLsbRgbRibLgbRibRibRgbRgLsbRibRsbRiRsLgmb
RibRiRsmbRsLsbRibLsbRibLgbRibLgbRibLsRgbRgbRgbRgbLgLsbLjbLibRhbLcbLcLs
mbLhbLibLsbLgbRcbLsbRiRsmbRiLsLsmbRhbLsbLgbRjbLsRcbRebRibRibRsbRgbRibL
gbRibLsbRsbRgbRsbRibRsbRsbRgbRgbRgbRgbRgbRgLsbRsbRgbRgbRgRsmbRgbRgbRgb
RsbRsbRgRsRsmmbRgRsmbRsbRgbRibRgbRgbRgbRgRsmbRsbRgbRgbRgbRgbRgbLgbRgbR
gbRgbRgLsbRgbRgbRgbRgbLsbRgbRiRsmbLgbRgbRibLsbRgRsmbRsRsmbRgbRgbRsbRgR
smbRsbRsbRgRsLsmbLsLsmbRiLsbLsbRsbsbRsbRgRsmbRibRiLsbRcbRhbRibRibRgbRs
bRibLgbRgbRgbRibRsRsmbRgLsbRsbRibRsbRsbRgbRgbRgbRgbRsbRsbRgbRibLsbLcbL
gbLgbLgbLgbLgbRcbLgbLcbRgLsbLcbRgbLsLsLsmmbLcbLgbLgbLgbLsbRgbLibRsbLgb
LsbLgbRsbLhRsbRgbLibLgbRsbLgbRgbLhbRibRcbRgLsRsbRgbRsbLsbRsbRsbRsbRcbR
ibLibLibLgbLsbLgbLgbLsbLgbLsbLgbRsRsmbLibRgbRobRgbLsbRgbRcbRsbRgbLjbLi
bLgLsbLsRsbLsbLibRibsbRoLsbRsbRibLsRsbRibRsbRsbRgbRgbRsbRgbRibRibLgbRs
bRgbRibRiLsbRgbRgbRsbRgbRgRsmbRsRsmbRgbRgbRsbRgbRgbRgbRsbRgbLjbRibRsbR
gbRibLsbRibRgbRsRsmbRgbRgbLsbRgbRgbRgbRgbRgbLsbRibLsbRibRsbRsbRsbRsbLs
RgbRgbLsbRgbRgbRgbRgbRsbsbRgbLgbRgRsmbRgbRgbRgbLsbLsbRsbLebLgbLsbLsbLi
RsLsbRsbLgbLgbRcbRcbLibRcbRibLsbRcbRibRibLgbLgbLgLsbRcbRibLibLgbLiLsbR
obRibRhbRgbLsbRiRsLsmbRgbRibRsbLsbRgbLsbRgbRsbRgbRsbRgbRgRsmbRsLsbRibR
sbRgbRgbRgbLgbRibRiRsmbRsbRgbRsbRgbLsbRgbRgbRgbRgbRgbRgbLsRsbLsbRibRgb
RgbRgbRsbRgbRiLsbLibLibLgbsbLibLhbRcbRcbRoLsLsmbRcbRhbRibRgbLgLsbRiRsm
bRsbRgRsmbRgRsmbLsbRgbRsbRsbRibRsbRibRgbRgbRgbRgbLgbRgbRibRgbRsbRcbLgb
RsbRobLgbRcbRsbRgbRgbLibRgbRibRsbRobLhbRsbRcLsbLcbLcbRgRsmbLibLcbRgbRi
bLobRibLcbRgbLhbRjbLgbLgbRobLsbRobRgbLgbRcbRibRsbRibLjbRibRsbRgbRibRiL
sLsmbRgbLgbLjbRhbRgbLcbLgbLibLoRsbRibRibRibRsbRsRsmbRsbRsbRgbRsbRsRsmb
RgbRsbRsbRibLsbRibLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 42; Drug: PCAP2 1 然
bRsbRibRhbLsbRibLsbLibRcRsmbRibLibRibRiLsbLgbRjbRibRibLgbLgbRsbRcRsmbR
ibLibRhRsmbRsbRgbLsbRgbLsRsbLebLcRsRgbLhbRgLsbLsbLhRsbLoRsLibRibRgbRsR
smbRsbRibRcbRibRibRiLsbLsbRibRsRsmbRgbLsbRgRsmbRibRhLsbRhRsmbRcbLgbRhR
smbRgbLsbRhbRiLsbRgbRsbLsbLgbLibRgbLibRsbLgbRibLhbRsbLhbRsbLcbRsbRibRc
bRhbRibLsbLibLibLsbLsbLgbLsbLiLsbLgbLgbLsbLsbRjbRcbRsLsbRgbRibRgbRibLs
bRibLgLsbRgLsbRgbRgRsmbRibLgbLebLibLsbLgbLgbLsLsmbLgLsbLgLsbLsLsmbLgbL
sbLsbLgbLibLcbLcbLibLibLibLgbLsLsmbLoLsmbLgLsbLgbLgbLsLsmbLgLsbLsLsmbL
gbLgbLgbLgbLsbLgLsRsbLgbRsbRibRoLgRsbRiRsmbRibLgbRiRsmbLgbRiRsmbRsLsbR
gbRgbLgLsbRhbRcRibRcRsmbRibRsbRibLjRsbRibRiRsmbRgRsmbRgbRgbRgbLsbRibRs
bRgbRsbRgbRgbRibRgbRibRiLsRgbRibRsbRgRsRsmmbLsRsbRgRsmbRgbRsRsmbRgbRgb
RgbRgbRgRsmbRsbRsbRsbLsbLsbRibLebLgLsbLiRgbLiRsbLsRsbLsbRsbLhRgbRcbRib
LgLsbRiRsLsmbRgbRgbRgbRsbRgbRgbLgbRibLsLsmbRgLsbLsbRibRsbRgbRgRsmbRsbR
gRsmbRsbRgbRgbRgbRgbRgbLibLobLgbLibRiLsbRcRsmbRgbRgbRgRsmbRsRsmbRgbRsb
RgbRibRgbRgbRgRsmbRsbRgbRgbRgbRgbLgbLobRgbLgbRsbLhRsbLoLsLsLsLimmmbLib
LgbLgRsbLgLsbLsLsmbLgbLgLsbLgbLgbLgLsbLgLsbLgbLgLsbLgbLgLsbLgbLsbLgbLg
bRobRsbRiRsmbRgbRgbRgbRsbRsbRiRsRsmmbRibRiRhRgbRibRgbRgbRgbRgRsmbRgRsm
bRgbRgbRgbRgbRgbRgRsmbRgRsmbRsbRibRiRsmbRgRsmbRgbRgbRgbRgbRgRsmbRgbRgb
RgbRgbRsRsRsmmbRsbLsbRobRhbRcbRgRsRsmmbRgRsmbRgbRgbRgRsmbRgbRgbRgbRgbR
gbRsRsmbRgRsRsmmbRibRgbRgbRgbRgbRgbRgbRgbRsbRgLsbRibRhbRgbRgRsmbRgbRgR
smbRgbRsbRiRsmbRgRebRgRsRsmmbRgbRgbRgRsmbRiRsmbRgRsmbRgRsmbRgbRibRiRsm
bLsRibLcLsmbLcbRibRhbRiRsRsmmbRgbLjbLobLiLsRsbLiLsbLgbLgbLibLgLsbLibLh
bLcbLibLibLibRsbLiLsLsLsLsmmmbLibLsLsmbLgLsbLgbLgLsbLgbLgbRgLsRsbLcbLc
LibLibLgLsbLgLsbLgLsbLcLiLsLsmbLiLsbLgbLhRsbLcLsmbLgbLsbLcbLgbRgbLgbLi
bRsbLgbRjbRhbRibRsbRibRgbRgbRgRsmbRgbRsbRgRsRsmmbRgbRgbRgbRgbRgbRgRsmb
RgbRgbRiRgbRgLsbRgRsRsmmbRgbRgbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbRsR
smbRibRgRsmbRgbRgbRgbRgbRgbRgRsmbRibRgRsmbRiRsmbRgbRibRgbRsRsRsmmbRhRi
RgbRhRsmbRgbRgbRgRsmbRgLsbRgbRgbRsLsRsbRibRgbRgbRgbRgbRgbRgbRgRsmbRgbR
gbRgbRgbRgRsmbRgbRgLsbRgbRgbRgbRgRsmbRgbRgRsRsmmbRiRsmbRgRsmbRgRsmbRgb
RgbRgbRsRsmbRgRsmbRgbRgbRiRsmbRibRibRibRgRsmbRiLsbRiRibRgbRibRgRsmbRgb
RgbRgbRgbRibRsRsRsmmbLgbLcbLhRsbLhbLiLsbLibLgbLgbLgbRjRcRsmbRiRsRsmmbR
gRsmbRgRsmbRgbRgbRgbRgbRgbRsRsRsmmbLsRobLcbLcbLsbLiLsbLgbLgbLsbLgLsbLi
bLsbLgbLgbLgbLibLgbRsRsmbRiRsRgRsmmbRgbRgbRsbRgbRiRsmbRgbRgbRsbLsbRobL
obLibLgbLgbLgbLgbLgbLgbLgbLgbLgLsbLgbLgbLgbLgbLgRsbLgbLgbLsLibLcLsLsmm
bRjRsmbRcRsmbRibRgRsmbRibRgbRgbRgbRgbRgbRgbRgbRgbRgRsmbRgRsRsmmbRibRib
RgbRgbRgRsmbRgbRgbRgbRgRsmbRibRibRgbRgLsbRgbRgbRgbRgRsmbRsbRibRibRgRsm
bRibRiRsmbRgbRgLsbRibRgbRibRgRsmbRgRsmbRgRsmbRibRgRsmbRibRibRib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 43; Drug: Control
bLcbLcbLhbLiLsbLibRcbRibRhbLcbLobLhbLibLjbRibLgbRebRcbLibLgLsbRibRcRsm
bRibLgLsbLgLsRsbRcbLibRibRsbRgbRiLsbRgRsmbLjbRibLsbLgbRcRsmbLibRcLsbRc
bRgbRgbRcbRsbRiLsRsbLsbRsbRjbRibRsLsbLhbLcLcbLgbRhbLibLsbLgbLsbLsbLsLs
mbLgbRsbLgLsbLgbLgbLsbRsbLsbLgLsbLsbLsbLgbRsbLgbLsLsmbLgLsbLsbLgbRsbLg
LsbLgbRsRsLsmbLgbLibRjRsmbLibRcbRgbRsbRgbRgbRsRsmbRsbRsRsmbRsbRibLsbLj
bRibRsbRgbRiLsbLibRsbRhbLgbRibLgbRiRsmbLsbRgbLsbRibRgbLgbRibLsbRibRsbR
gbLsbRiRsmbRgbRcbLibLgLsbLgbLsbLibLgLsbRsbLgbLgbLgbLgRsbRjbLhLsbLcbLib
RcbRcbLgLsbRibRgRsmbRcbRsLibRcbLgbRgbLsbRcbLibLsbRcbLibRibLsbRibLiLsbR
gLsbRsbRgbRgbRsRsmbLsbLsbRibLsbRibLsbRibRsbRiLsLsmbLgbRsbRsbRgbRiLsbLg
bRhbRhRsmbLibLgbLsbRhbRhLsLsmbRebRibRsbRcbRiRsmbLsbLsbRgbRgbRgbRibLgbR
gbRsRsLsmbRgRsmbRsRsmbRgbRgbRsbLsbRgbRgbRgbRsbRiLsbLibLjbLiRsbRsbLibRg
LsbLgbLgLsbLeLsbLibRsbLgbLgbLgbLsbLgbRsRsmbLsRsLgbLgLsbLiLsbLgbLgbLgbL
gLsbLsbLgbLgbLgbRsLsLsmbLgbLgbLgbLgRsbLgbRsbLgLsbLsLsLsmmbLgbLgbLgbLgb
RjLsbLgbRsbLgbLgbLibRsLsbRgLsbRsRsmbLibRgbLibRcLsbLjbRcbRibLgbLgbRsbLj
bLiLsbLobLcbLibLibRsbLgbLgLsbRsbRsbLibLsbRgbLibLsbLgbLgbRsLsbLiLsbRsbL
ibLsLsRsmbLgbLgLsbRgbLgbLgbLgbRibLibLgRsbLsbRjbLcLsmbLgRgbRhbLhbLgbLib
LibLibRiLsbLsRsbRsbLhbLgbRgbLibLgLsbLgLsbLgbLgLsbLgbRgbRibRgbRsbRgbRgL
sbLgbRgbLsRsbRsbRibRsbRgbRsbRgbLgLsbRsLsbRiLsbLsbRsLsbRcbLsbLiLsbRcRsm
bLibRibRgbRgbRgLsbLjbRibRsbLgLsbRibLgLsbRcbLsRcLsbLibLgLsbLgbLiLsbRgbL
ibRsRsmbLgLsbLsLsmbLgbLgbLgbLsbLgbRsLsbLgbRsbLsbLgbLsbLgbRsbLgbLgbRgLs
bLgbRsbLgbLgbRsbLgbLgbLgbLgbLgLsbRsbLgbLgbLgbLgbRgbLgLsbLgRsbLibRsbLib
RsbLgbRsbLgbLsbLgbRsLsbLgbRgbLibRsbRcbRgbRiRsmbRcRsmbLgbLgLsbLgbRjRsmb
RcLsLsmbLgLsbRcbRgbRsLsbRiRsRsmmbLgbRibRsbRgbRgbRgbLjbRiRsLsmbRgbRsRsm
bLsRsbRibLgbRhbLgRsbRiRsmbRsbRibRsLsbRgbLsLsmbRibRgbRsbRgbLgbRiRsmbRsb
RsbRibLsbRibRgbRgbRgbRsLsRsbRgbRsbRgbLgbRibLsbLsRiRsmbRgbLjbRcbLsLsmbL
gbRibLsbRhbRibLibRsbRobRhRsmbLiRsbLsLsmbRgRsmbRcbRebRibRgbLhbLibRebReb
LsbRhLsbRsbRsbLsbRhLsbLibLjbLhLsbLibRebLcLsmbRibRcbRhbRibRcbRiRsmbRgbL
sbLibRjbLcbRebRgbRgbLsbRgbRgLsLsmbLjbLcbLiLsbRsLsbRhbLsbLsRiRsmbRgbRsb
RibLgbLjbRiLsbLsbRiRsmbRsbRgRsLsmbLgbRiRsmbLjbRibLgbRiLsRsbLgbRibRgbRg
bRgLsbRgbRgbLsbRsbRgbRsLsbRhbLibRhbLibLcbLiRsbRjbLiLsbLibLhLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 44; Drug: Control
bRgbLgbRiRsmbRhbRibRgbRsbRiLsbLsRsbRibRsbLsbRgbRgbRgbRhbRibRgbRgbRibRg
bRsbRgbLsbRgbRsbRgbRgbRgbRgbRgbRibRgbRsLsbRsbLgbRhbRibRsbRgbLsbRgRsmbL
gbRgbRgbRgbRgbRsbRgRsmbLsbLsRsbRgbRgbRgRsmbRsbRgbRgbLsbRsbRsbLsbRsbRib
RgbRibRibLsbRibRibRibRsbRsbRgbRgbLsbRsbRgbRsbRsbRsbRgbRgbRgbRsbRgLsbRs
bRgbRsbRgbRsbLsbRsbRgbRgRsmbLsbLsbRsbRsbRgbRsbRsRsmbRgbLsbRgbRgbRgbRgb
RgbRsbRsbRibRsbLsbRibRgbRsbRgbLsbRgbRgbRgRsmbRsbRgbRsbRgbRsbRgbRsbRsbR
gbRgbRgLsbRsbRgbRsbRibRiRsmbRgbRgbRsbRibRgbRgbRsRsmbRsbRgbRgbRsbRgbRsb
RsbRsbRgbRgRsmbRsbRgbRsbRsbRsbRgbRgbLsRsbLsbRgbRsbRsRsmbRsRsmbRgbRgbRs
bRsbRsbRsbRsbRgRsmbRgbRsRsmbRsbRgLsbRsbRsbRgbLsbRgbRibLgbLsbRibRsbRgbR
gbRgbLgbRibLgbRsbRgbRsbRgbRgbRgbLsbRgbRgRsmbRsbRgbRsbRgbRgbRgbRgRsmbRs
bRgbRiRsmbRgbLsbRibRgbLsbRsbRgbRsRsmbRsRsmbRgbRsbRsbRgbRsbRgbRsbRgRsmb
RsbRgbRsbRgLsbRsbRgbRsbRgbRsRsmbRgbRsbRsbRgbRgbLsbRsbRgbRsbRsbRgbRsRsm
bRgbLsRsbRsbRgbRgbRsbRsbRgbRgbRgbRsbRsRsmbRsRsmbRsLsbRgbRgbRsbRsbRgbRs
RsLsmbRgbRgbRsbRsbRgbRsbLsbRgbRsbRgbRgbRgbRgbRgbRibRgbRsbRgbRsbRgbRibR
gbRgbRsRsmbLgbRibRgbRhbRgbLgbLgbLgbLibLibLibLibRsbRgbRsbRgbRgbLsbRsRsm
bRsbRsbRgRsmbRsRgbLsbRgbRsbRsbLgbRgbRsbRsbRgbRsbRgbRgbRgbRsRsmbRsRsmbR
sbRsbRsRsmbRgbRgbLsbRsRsmbRsbRgbRsbLcLcbRsbLibRgbLgbLgbLgLsbLgbLsbLsbL
gbLgbLsbRsbLsbLgbLgbLgbLsbLsbLgbLsbLgbLgbLgLsbLgLsbLsbLsbLsbLgbLgbLgbL
sbLsbLgbLgbLsbLgbLgbLgbLgbLsbLsbLgbLgLsRsbLgLsbLgLsbLgbLsbLsbLgbLgbLsb
LsbLgbLgbLsbLgbLgbLsbLgLsbLsbLsbLgbLgbLgbLgbLsbLgbLgbLgbLibLsbRsbLgbLg
bLsbLgLsbLsbLsLsmbLsLsmbLgbRsbLgbLgLsbLsbLsbLgbLgbLgbLgbLgbLgbLsbLgbLg
bLgbLgbLgbLgbLgLsbLgbLgbLgbLgbRgbLobLobRsLibRjbLjLsmbRebRhRsmbLsbRibLs
RsbRgbRsbRsbRsbRsbRgbRgbRsbRgbRsbRgbRsbLsRsbLsbLebRcRsmbLibLgbRcbLsbRi
bLgbRiRsmbRibRib

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 45; Drug: Control
bRjbRgbRsbRgbRsbLjbLhbRebRiRsmbLsbLsbRgbRgbRgbRgbRsbRgbRgbRsbRgbRgbRsb
RsbRgbRsbRsbRsbRsbRsbRgbRgbRgLsbLibRgbRgbRsbRgbLsbRsbRsbRgbRhbRcbRibRi
bRsbLhbLgLsbRsRsmbLiLsbLsbLsRjbRcbRgbRgRsmbRsbRgbRsbRsRsmbRgRsmbRgRsmb
RsRsmbRsbRgbRsbRcbRiRsmbRibRsbRhLsbRhbLibLhbLgbLibLibLgRsRsmbRibRiLsbR
sbLgLsbLsRsbLgbLgbRsbLsbLgbLgbRsbLsbRsbLgbLsbLsRsbRsRsmbLsbLgbLgbLgbLg
bLgbLiRsbRebRiRsmbRgbRsbLsbRgbRgbRibLsbRsbRsbRibLjbRcbRsbRcRsmbLibRcbL
gbLgbRibRcbRibRibRsLsbLibLgbRcbRhLsRsbLgbRsbLibLibLibRsbLgLsbRsbLsbLgR
sbLgbLgLsbRsbLibRsbLsbLgLsbLsbLgbLgRsbRsbLgbLgLsbRgbLgbRebRibRsbRgbRsL
sbLsLsmbRsbRgbRgbRsbRgbRsbRsRsmbLsbLsbRsbRibRsbRgbRgbLsRsbRgbLsbRgLsbR
sbRgbRgbRsbRgbRgbRgbRgbRsbRsbRsLsbRsLsbRsbRgbRgbRsbRgbRsbRgRsmbRgbLsbR
gbLsbRsbRsbRsbRibLsbRsbRgbRsbRsbRsbRsbRsbRsbRsbRgbRgbRgbLgbRgRsmbRgbRg
bRgbRsbRgbLsbRsbRsbRgbRgbRgbRsbRsRsmbRsRsmbRgbRgbRgbRgbRsbRgbRsbRgRsmb
RgbLjbRgbLhbLibLsRsbLobLibLgbLcbLgbRgbRcbLjbRibRibLsbRgbRgRsmbLsbRsbRg
bRgbRgbRgbRsbRgbLsLsmbLsbRgbRibLibRiRsRsmmbRsbRgbRgbRobRsRsmbRibRgbRib
RgbLgbRibLgbRibRsbRgbRsbRgbRgbLjbRibRcbRhbRhbLibLcbLsbRsbRgbLibLsbLgbL
gbLsbRhRsmbLgbRibRgbRgbLsbRgbRsbRgbLsbLsLsmbRsbRsbRgbRgbLgbRsbRibLgbRg
RsLsmbRsbRgbRgbLsbRgbRgbLsbRsbLsbRgbLsbRgbRgbLsbRgbLsRsbLsbRgRsmbRsbRg
bRsbRgbRgbLebLhbRjbRcbLgbRibLsbLhbLcbLhbLibLibRgbRibLgbRgbRsbRsbRgRsmb
RgbRsRsmbRgbRsbRsbRgbLgbRibRgbRebRibRsbRgRsmbRgbRgbRgRsmbRibRgbRgRsmbR
gbRgbLgbRibLjbRibLgbLcbLgLsRsbLsRsbLgbRhbRgbLcbLibRcbRgbRgbRgbRgLsRsbR
gbLsRsbRsbRsRsmbRsbRgbRgbLgbRgbRsbRgbRsbRsbRgRsRsmmbRsbRgbRsbRgbRgbRsb
RsbRgbLsRsbRgbRgbRgRsmbRgbRgRsmbRgbRsLsbRgRsmbRgRsmbRsbRgbRiRsmbRgbRgb
LhbLcbLcbLibRgbRgbLhbRcbLcbRcbRcbLibRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 46; Drug: Control
bRsbLsbRsbRgbLsbRgbRibRiLsbLsbLsbLsbLgbRsbLsbRjbRcbLsbRgbRgbRgLsbLsbRg
bLsbRgLsbRgbRgbRcRsmbLcbLgbRgbRcbRcbRibLibLsbRsbRcbRibRibRibLebLhbLsbR
ibRibRibRibLibLgbRsbRsbLsbRsbRgbRgbRgbRsbRgbRsRsmbRgbLsbRgbRgRgbRsRsmb
RgbRgbLgbRgbRsbRsbRsbRgbRgbRsbLsbRgbRsbRgbRgbRsbRgbRjbRcRsmbRibRgLsbLg
bRsbLibLgbLgbLsbRgbLgbLgbLgbRsbLgbLibRjbLgbRobLcbLcbRiRsmbRgbLcbRgbLgb
RgbRgbRgbRgbLsbLsbRsbRgbRsbRibLgbRsbRgRsmbLsbRgbRsbRgbLsbRgbRsbRgbRsbR
sbRgbRgbRsbRsbLsbRgbRsbRgbRsbRgRsmbRgbRgbRsbRsLsbRsRsmbRgbLsbRsbRsbLsb
RgbLsbRgbRsbRsbRgbRgbRsbRgbLcbRsbLsbsbLgbLgbRsbLibLibRjbLcbRhbRgbRsbRg
bRjbLgbRibLsbRcbLgbLsbRgbLsbLcbLgbRgbRgRsmbLgbRgbRgbLgbRhbLgbLgbRgbRib
LgbRgbRsbRsbRgbRsRsmbRsbLsbRibLsbRibLgbRibLibRibRsRsmbRgbRgbLsbRibLsbR
gbRgbLsbRiRsmbLibRibLsbRibLgbRgbRibLgbRgbRsbLsbLibLibLgbRgbLcbLgbRibRg
bRsbRjbRibRgbLgbRiLsbLgbLsbRibRgbLcbLhbLgbRgbLibRgbRcbRcbRgbLibRibLgbL
ibLgbLjbLgbRebRcRsmbLjbRibRgbRibLgbRgbLsbRgRsmbRgbRgbLsbRgbRsbRgbRsbRg
bRsbRibRibRgLsbLibRgbLgbLgbLibLibRibLgbLgRsbRgbLgbLgbLsbLgbLgbLgbRebRs
bLsbRibLsbRgbRgbRgbLsbRgbRsbRsbRgRsmbRsbRgbRgbLgLsbRibRsbLjbRgbRgbRsbR
gbRsbRgbLjbRgbRgbRsbRgbRgbRibLsbRgRsmbRsbRgbRgbRgbRgbRsbRsbRgbRgbLsbRs
bRgbRsbRgbLsRsbRibLsbRgbRgbRsbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 47; Drug: Control
bLsbLiLgbLibLibLsRsbLgbLibRsbRgbLsLibLgbLsbLiRsbLsbLgbLsbLgbLibLgbLgbL
gbLgbLhbLcLsmbRcbLobLibLsbLgbLgbLsbRsbLgbLgRsbLgRsbLsLgbLgbLsbLibLsbLg
bLgbLibLgbLsbRgbRiLsbRgbRgLsRgRsRgmbRgRsmbRgLsbRsbRsbLibRjbRhbLjbLcbLi
bLhbLibLcbLsbLibLsbLiRsLsbLgbLgbLgbLsbRsRsmbLgbLgLsRsbLgbRsbLgbLibRhbR
cLsbRcLsbLsbRibRgbRgbRgbRgbRsbRgbRsbRsLsbRsLsbRsRgRsmbRgbRgbRgRsmbRgbR
gbRgbRgbRgbRgbRgRsmbRsbRgbRgRsmbRgbRgbRsbRgbRgbRsbRsbRgbRgbRgbRsbRgRsm
bRgbRgbLsbRgbRsbRgbRgbRgLsbRgRsmbRsbLsRsbRsbRsbRsLsbRgbLsbRgbRgbRsbRsR
smbRibRgbRgRsmbRgRgLsRgRsmbRgRsmbRsbRgbRibRgbRgbLgbRibRsbsbRgbRgbLgRsb
RibLcbLoRsRsmbLsbLibLibRcbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbRgbRgbRgRsmbRg
bLgbLobLiRsRsmbRgRsmbLgbLgbLsbLsbLgbLgbLoRsbLcRsbRibRhbRibRgbLsbRibRgb
RgbRgbRgbRgRsmbRsbRsbRgbRsbRgRsmbRsbRgbRgbRgbRsRsRsmmbRgRgRsRsmmbRsRsL
smbRgbRgRsmbRsbRgbRgbLsbRibRsRsmbRgbLsbRgbRgLsbLsRgbRgRsLsmbRgbRgRsmbR
sbRgbRgbRsRsmbRgbRsbRiLsbRsbRsRsmbRgbRgLsbRgbRgbRgbRibRgbRsbRgRsmbRsRs
mbRgRsRsmmbRgbRgbRsbRibRgRsmbRgbRgRsmbRgbRgbRgRsmbRgbRgbRgbRgbRsbRgbRg
RgRsmbRgRsRsLsmmbRgRsmbRgbRsbRgLsbRgbRgbRgbRgbRgbRgbRgRsmbRgbRgbRgbRgb
RgbRgRsmbRgbRsbRgbLjbRsLhbLibRgbLhRsbsbLiLsbRjbRsbRebRibLobLiRsRsmbLgb
LibLiLsLsLgLgLsLsmmbLgbLgbLgbLgbLsLsmbLgbLgbLgbLsRsbLgbLiRsRsLsmbRsbLi
LsLebLgLsbLgbLgbRsbLgbLgLsbLgbLgLsbRsbLibRsbLgLsLsmbLsbLgbLsbLibRsbLib
LsbLgLsLsLsmmbLgbLgbLgbLgbLsbLsbLgbLiLgbLgLsLsmbLgRsLgbLsRsbLgLsbLsbLg
bLgbRobLsbRiLsbRgbRibRgRsmbRgbRgbRsLsbRgbRgbRgRsRsRgRsRsmmmmbRgbRsbRgR
smbRgbRgbRgRsmbRgbRgbRgbRgLsbRsbRgbLsbRiRsmbRgbRgbRgbRgbRgbRgRsmbRgbRg
RsmbRsbRgRsmbRgbRgbRgRgbRgbRgbRgbRgbRibRgbRibRgbRgbRgbRgbRgbRgbRgbRgRs
mbRgbRiRsmbRgbRgRsmbRgbRgbRibRgbRgRsmbRibRgRsmbRgRsmbRgbRgbLsbRiRsmbRg
bRsRgRsRsmmbRgbRgRsRsmmbRgbRgbRsbRjbRgLsRsbRgbLsbRgRsRsmmbRgbRgbRgbRgL
sbRgLsbRgbRgbRgbRgbRgbRcbRibLsbLiRsbRsLgbRsRsmbLsLsmbLgRsbLgbRobRibLgR
sbRiRsLsmbLsLsmbRhbRsbRobLsbLsbRibRgbRgRsLsmbRgbRgbRsbRgbRibRgbRgbRgbR
sRsmbRgbRgbRgbRgbRgbRgRsmbRgbRgbRgbRgRsmbRgbRsRgRsmbRgbRsbRgbRgRsRsmmb
RgbRgbRgbRgRsmbRgbRgbRgbRgRsmbRgRsmbRsbRsbRibLsbRgbRibLibRcbRibLsbLgbR
cRsmbRsbRgbRsLsbRgbRgRsLsmbRgbRgRsRsmmbRgLsbRgRsmbRgbRgbRgbLsRgbRgRsmb
RgbRsRsmbRgbRgbLsbRgbRibRsbLsRgRsmbRgbRgRsRsmmbRgbLcbLibLgRsbLsbLsbLcb
RsLsbLibRsbsbLiLsbRjbRhRsmbRiLsbRsbRgbRsbLjbRcbRibLibRhbRibLsbLhbLcRsb
LgbRgbLibLsLibsbLsbLgbLgLsRsRsLsmbLibLgLsbLiLsbLsLsmbLgbLgbLgbLgbLgLsb
LgbLgLibLgbLgbLgbLsLsmbLgbLgLsRsbLsbLgLsbLgbLgLsbLsbLgbLsbLgbLgbLibLib
RsRsmbRgbRhbRsbRgbRgbLsRgRsRgmbRgbRsRsmbRgbRsRsmbRgRsLsmbRgRsmbRgbRgbR
gbRgbRgbRgbRgbRgRsmbRgRsmbRgbRgRsmbRgRsmbRgbRgbRgbRgbRgbRgbRsbLjbLcbLi
bRgRsLgmbLiLsbLgRsbRsbLgLsLsmbLcbRgbRcbLjbLobLsbLcbLsbLibLgbLgbLgLsLgb
LgbLgbLgLsbLgLsbLgbLgbLibRgbLgbLgbLsbLgbLsbLibLgbLgLsbLgbLgbLgbLgbLgbL
iLsbLgbLgbLgbLgbLgbLgLsbLgLsbLgbLsbLgbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102056; End: 102556;
Recording: 1-1; Individual: 48; Drug: Control
bRcbRhbLsRgbRibRsbRcbLibLibLgLsbRebRcbRibRgbRgLsbRibRcbRgLsbLsbLgbRcbL
sbRsLsbRgLsbRgbRgbRsLsbRgLsbRcbLgbLcbLibLsbRcbLcbRobLiLsbLibLobLcbLsRs
bLgbLgbLgbLgbRgbLhbRhbLibLcbRhRsmbRhbRgRsmbLhbLibLiLgbLsbLsLsmbRsRsmbL
gbLgbLsbRsLsbLsRibLgbLcbRgbLebLcbRgbLgbLgbLgbLgbLibLgbRsRsmbLibLgbLgbL
gLsbLgbLgLsbLgbLibLgLsbLgbRsbRsbRsbLibRebRhbLjbRcbLiRsbRjbRobLsbLgbRjb
LgbLgbRebLgbLibLibLjbRgbLgbRgRsmbRgbRibRsbLhbLiLsbRjbLibRsLsbLgRsbLsbL
sbLgbLibRsbRcbLibLgbLgLsbLgRsLsbLgbLgbRsLsbLsbLsLsmbLgbLjbLhbLsbRjbRsb
LsbLgbLgbLgLsbLsbLsbLjbLhbLcbLsbRobLibLibLiLsLsmbLgbRsLsbLgbLgbLsbLsbL
hbRgbLsbLjbLcbRcbRgbRebRebLibLibRebRebLsLsmbLgLsbLsbLgLsbLgbLsbLgbLgbL
sbLsbLgbLgbLgLsbLgLsbLgbLgbRsbLgLsbLgbLgLsLsmbLgbLgbLgbRcbRcRsmbLjbLib
RsbLgbLgbRgbLcbRsbLibLsLsmbRjbLibLgbLgLsbLsbLsLsmbLgbLsbLgbLjbRcbLibLg
LsbLsbLgLsbLsLsmbRsbLsbLgbLsbLsbRsbLibRgRsmbLgbLibLgLsbLsbRcbRgbLcbLsb
LgbLgbLgbLsbLgbLgbLgbLsbLgLsbLgbLsLsmbLgbLgbLsbLgLsbLibLgbLgLsbLgbRsLs
RsbLgbLsbLjbLibLsbRebLgbLgbLsLsmbLsbLgbLgLsbLsbRsLjbRsLsbLibLsbRsbLiRs
bRsLsbLibLsLsmbRgbRcbRebRsLsbRjbLjbRgbRcLsbRcLsbRjbLoRsbLibLibLsbLiLsb
RsLsbLgbLcbRcbRjbRcbLjbLiRsbLobLcbLibLsLsmbLgbRsbLiRsbLgRsbLsbLsbLgLsb
RebRibRgbLgbRgbRoLsbLiLsbLgbLibLsbLgbLgbLsbRjRoLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 1; Drug: PCAP2 10 然
bRibRgbLgLsbRsbRsbRibRgbRgbRsbLsbRsbRsbRgRsmbLsbLhbRsbRgbRgbRgLsbRsbLs
bRsbRgbRsbRibRgbRsbLgbRsbLibLcbRsbRgbLgbRsbLgbLsLsmbLgbLgbLgbLsbLsbLsb
RjbRjRsmbRebRebRcRsmbRjbRibRgbRsRsRsmmbLsbRsLsbRsbRsRsLsmbRgbRgbLibLiR
sbReRsmbRsbLsbRgbRsbLgbLgbLgbLgbLgbLgbLgbLgbRgbLsbRsbLgbLgLsbLgbLgbLgL
sbLgbLsbRsbRcbRsbLsRsbLgbLsbLcbLibRsbLgbLsbRgbRgRsmbRsbLsbLjbLgbRjbLib
LsbRcbLsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 2; Drug: PCAP2 10 然
bLgbLhbLibRgbRibRcbRiLsRsbRsbLjbLcRsbLhRgbRibRgbRgbRgbRgbRibLibRcbLibL
ibLgLsLgLsLiLsLgLgLiLsbLgLsbLsbLgbLgbLgbLgbLgbRobRibRgbRgLsbReRsmbRgbR
ibRiRsmbRcRsmbLcbLcbLhbLgbRjbRsbRibRsbReRsmbRibRiLsbLsRsbRiRsmbRsRsRsm
mbRibRiRsmbRibRibRcbLibRcRsmbRsbRgRsmbLeLsbRcbRiLsbRgbRgbRsRgbRgbRibRg
bRgRsmbRgbRibRgbRgbRcbRibRibRgbRsRiRsLgmbRgbRgLsRibRgbRiRgbRgbRgbRgRgb
RgRsmbRgbRibRgbRgbRgbLebLcbLsbLibReRsmbRiRsmbLgLsbRgRsmbRsbRiRsRsLjmmb
RhbLgRsRibRgbRgbRsbRiRsRgRsmmbRiRsRsRgRsRsRimmmmbRiRsmbRiRsmbRgLsbRibR
gbRgbRsbRebLcbLgbLibLcLsmbLcbLibLcLsmbRsLsbLibRsbRcbRcLgbLebLiLsbRcbRc
LgbRcLjbRiLsbRgbRgbRsRsmbRgRsmbRgbRgRsmbRgbRgbLsbLjbLhbLibLsbRjbRcbRob
LibLibLgbLibLgbLgbLgbRgbLibLhbLhbLibRgbLcbRebLgbLjbLibLgbLgbLgbLgRsbLi
bLibLgbLgbLsbLibLgbLsRsbLsbLibLgbLgbLibLgbLebLcbLcbRcbRcbLcbLibsbRjbRc
bRsbRobRgbLebRsbLibLsbLgbLiRsbLgbLgbLiLibLebRgbLebRiRsRsmmbRibRibLsbRi
bRgbRgbLsbRcbLibLsLibLgbLibRsbRoRsmbRgbLebLibRsbLgbLsbLibRgbLibRsbLgbL
ibLcRsbRsbRibRgbLcbLiRsbRgbLgbLibRgbRjRsmbRcbRsbRsbRcbLgbRebLgbLgbRibR
ibRsbRhbRsbLjbLibLsbRsLsbRgbRcbLjbRcRsmbLgbLcbLiLsbRsbLibLgbLgbLibLgbL
gLsbLgbLgbLibRhbRobRibRiRsmbRibRgbRsRsmbRgbRgbRgbLsbRibReRcRsmbRiRsRsm
mbLsbRgRsmbLsbLobLibLgbLgbLgbLgLsbLgLsbLiLiLeLsbLgbLgbLiLiRsLibRsLibLi
LsbLeLsbLgbLgbLibLiLsbLgbRgLsbRgbLobLobLiLsLsmbRsbLobLcbLcbLcbRgbRoLsL
smbRibRibRgbRsbRiRsmbRgbRgbRgRsmbRgbRsbRgbRgbRgRsmbRgbRgbRgbRgLsbRgRsm
bRgbRgbRgbRsbRgbRgbRsbRgbRgbRcbRcbRibLibLibLgbRgbLsRsbLibLsbRsLsbLibLg
bLsLsmbLgbLgbLgbRsbRcbRgRsmbRgbRsbRgbRgbRgbRgRsRsmmbRgRsmbRibRgbRgbRib
LgLsLibLibLibLgbRebRcRsmbLgbLgbRcRsmbRibLsbRiLsbRcRsmbRcbRsbRebRgbRgbR
gRsmbRgbRgRibRgbRgbRgRsmbRgbRsRsmbRgbRsbLsbLcbLibRebRgbRiLsRsbRebLibLg
bLibLgbLibLcbLibLgbLebLibLcbRcbRcbLebLibLsbLgbLgbLiLsLsmbReRsmbLsbRibR
sRsmbRgRsmbRsbRobLibLgbLgbLjbRebRibLsbRgbRgbRgbRgbRgbRgbRibRgbRiRsmbLg
bRibLcbLiLsLsLsLsmmmbsbLgbLgbRsbRiRsmbLsRsbRgbRgRgbRoLsbLgbLibLgbLgbRs
bLgbLgbLgbLgbLgLsLgbRebRibLsbLjbLcbRsbLibLgLsbRjLiLsbLibLibLibLibLiRsb
LgbLibLobLgbRgbRibRsbRiRsmbRgbRiRsmbRobRibRibRibRgbRsRsmbRgbRgRiRsmbRg
bRgbRgbRgbRsbRgRsmbRibRgbRsbRibRgbRsbRibRiRsmbLcbLibLebReRsmbRoRsmbRhb
RgbRiRsmbLibLibLgbRsbRcbLibLebRsbLsLsmbRsLsRsbLgbRsbLgbLgbLgLsbLgLgLsL
smbLsLsmbLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 3; Drug: PCAP2 10 然
bRcbRibRgbLsbRgbRgLsbRgbRgbRsbRgbRgbLcbLibsbLibRsbLsbLcbRgbLjbLcbRibLh
bLibLgLsLsmbRjbReRsLsmbRobRhRsmbRgbRsRjbRgbRhbRibRhbRhbRibRiRsRsmmbRib
LgbLsLsmbRhRsmbRibRcbRibRibRibRibRsRsmbLsRgbRgbRsbRgbRgbRgbRgbRebRibRi
bRibRibRiRsRsRgmmbRgbRgbRgRsmbRgbRgbRgRsmbLgbRibRgbLebLcbLgbLgbLgbLgbL
gLsbLsbLgbLgRsbLgLsbLgbLgLsbLgbLiLsbRibRibRgbRgbRsbRsbRgbRgRsmbLjLsmbR
gbLjbRcbRhbRhbRhbRibRibRgLsbLsbRgbRgLsbRgbLibLjbLhbRibLcRsbLcbLgbRsbRi
RsmbRibRsRsmbRgRsmbRgRsmbRsbRgbLsbRcRsmbRhbRibRgLsbRibRibRgbRgbRsbRgbR
gbRhbLjbLcbLibLibLibLsLsmbLsbLibLgLsbLgbsbLgbLsbLsbLgbLgbLgRsbLgbLsbLs
bLgLsbLgbLgbLgLsbLgbLsbLsbLiRibLibsbLibRgRsmbLibLsbLsbLgLsbLgbLsbLgbLg
bLgbLgLsbsbLgbLsLsmbLsbLiLsRsbRsbLhbRgbRibRibRiRsmbLsbRgLsbRcbRgbRgbLs
bRcbRcbRibRiRsmbRsRsmbRhbRiLsbRiLsbRibRibRibRibRgbRgbRgRsmbRgbRgbRgbRg
bRibRiRsmbRibRibRhbRibRibRhbRibRsbRibRgbRsbLsRsbRibRgbLibLjbLhbRgbLgbL
ibLcRsbLibRsRsmbRgRsRgmbRgRsmbRgbRgRsLsmbRgbRgbRsRsmbRsbRgRsRimbRgbReb
RgRsmbRsbRgReRsmbRsbRjbLcbRebLgbRiRsmbRgbRhbRgRsRsmmbRsRsLsRgmbRsbLsRs
bRgbRgbRgRsLsmbRgbRgRsmbRgbRibsbsbRgLsbRgbRsRsmbRsbRgbRgbRsRsmbRgbRgRi
RgRsmbRgbRgbRgbRgRsLsmbsbRgbRgbRgbRsbRcRsRsLgRcmmbRgbRgbRsbRhbLibLgbRj
bRiRgbRgRsmbRsRsmbRgRsmbRsbRgbRgbRgbRsLsbRgbRgbRgbRgRsRsmmbRgbRsbRcLsb
RjbRiRsmbRgbRiLsbRibLibRgbRgLsRsbLjbLibLsbLgbLibRgRsLsmbLgbRjbRcbRgbRs
bRgRsmbRsRsmbRgbRsRsmbRgRsmbRsbRsbRgbRsRsmbLsbRgbRgbRgbRgbRgbRgbLjbLcb
RgbLgRsbLiRsRsmbRibRibRgRsRsmmbRgbRgRsmbRgRsmbRgbRgbRgRsmbRgbRsbReLsLs
mbRsbLeRsbLiLeRsbLgbLsLsmbLgbLsbLebLgLsbLgLsbLiLsLibLibLgLsLsLsmmbLgRs
bLsRsbLgRsbLiLsbLgbLgbLsLsmbLiRsRgbRhbRhbRgbRibRibRgbRiRsmbRgbRgRsmbRs
bRgbRebRgbRjbRhbRcRsmbRibRcbReLsbRibRjbRhbRibRhRsmbRibRhbRibRgbLibLhbL
cbLgbLsbRibLgbRebRibLsbLgbLgbLgbLgbLsbLsbRcRsmbRibRibRibRibRibLibLgbLg
LsbLgbLgbRgbRjRsmbRibLsbRsRsmbRsRsmbRibLgbLgbRibRcRsmbRibRibLjbLobLibR
gbRgbLcbLibRgbRgbLhbLcbRsbLsbLgbLiRsbLsbsbLsbLsbLgbLsbLgbLsbLsbRsbRjbR
sRsRsmmbLgbRjbRiRsmbRibRgbLcbLcbLgbLsbLgLsbLgRsbLgRsbLibRjbLibLsbRgbLo
bLiRsbLhLsbLibLhbLgbRhbRibRgbRsRsmbRsRsmbLsbRsbRsLsbRibRgbRgbRgbRjLsLs
mbRibRibRhbRibRsRgRsRsmmbRjRsRsmmbRhbRibRibRiRsmbRgbRibLibLebLhLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 4; Drug: PCAP2 10 然
bLgLsbRibRgbRgbRgbLgbRgbRgbLebRhbRibLgbRibRcLsbRcbRgbLgbLibLsbLgbLsbRs
bLibLiLsbLsbRsbLgbLsbRoRsmbRhbLebLhbLsbLibLsbLgLsbLsbLsbLsbLgbRsbLgbRs
LsbLsbLgbLsbLsLsmbRcbRcbRibLiLsbLgbLibLgbLsbLgbLsLsmbLsbRsLsLsLsmmbLgb
LsbLsbLgbLgbLgbLgbRgLsbLgbLsbLgbLgbLsbRsLsbLgbLgbRsbsbLsbLgLsbRsbLgbLs
bLgLsbRsbLgbLsbLgbRsRsmbLgbRgbLibLsbLsbLgbLsbLsbLsLsmbLgbLsbLsbLgLsRsb
LsbRsLsbLgbRsbLgbRsbLgbRsbLsbLgbLgbRsbLiRsbRgRsRsmmbLibLgbLibLibRhbLgb
LgLsLsmbRsbLibLibRiRsRsmmbRgbLhbRsLsbLgbLgbRsbLsRsbRsbLgbRjbLibLgbLgbL
gLsRsbLsLsLsmmbLsbLsbLgbLgRsRsmbLsRsbLgLsbRsbLgbLgbLsbRsbLgbLsbLsbLgbR
sbLgbRsbLgbLsbLgbLgbLsbLgRsbLgLsLsmbLgbLgbLgbLgLsbRsbLgLsRsbLgbLgLsbLs
bLsRsbLgbLsLsLsmmbLgLsbLsLsmbLsbLgbLsbLsbLsbLgLsbRsLsbLgbLsbLsbLsbLgLs
bRsbLgbRsbLibRsLsbLgbLsbLgbLsLsLsRsmmbLsbLgbLsbLgbRsbLgbLgLsbRsbLgLsbR
sLsbLgLsbLgbLgbLsbLsLsmbLsbLgbRsbLsbLsbLsLsmbLgbRsbLsLsmbLgRsbRsbLsbLg
bLgbLsRsbLgbLgLsbRgbRjbRiLsbRcbRobLibLiLsbLgbRsbRsbLgbLsbLgbRsbLsLsmbL
sbLsRsbLsbLsbLsbLibLgRsbLsbLcbLcLsmbLsRsbLcbLibRgbLibLsbLibRsbLgbLgbLi
bLhbLhRsRsmbLibRibRibRgbsbRcbRcbLsbLhbLgbRsbRobRsRsmbRgbRobLsbRsbRiLsb
LiRsbLibRsbLgLsbRsbLgbRsbLgbLsLsmbLsLsLsmmbLgbLgLsbLsbLcbLgbRgbLsbRiRs
mbRibRcbRibRsbRcbRgbRcbsbRsbLgbLgbRgbLgbLgbRgbLibRsbLgbRsbLgLsbLgbLsRs
bLgbLsbLgbLgbLsbLsbLsbLgbLsbLgLsbRsLsbLgLsbLsbLgbLgbLsbLsbLsbLsLsmbLgb
LsbLsbLsRsbRsLsLsmbLgbLsbLsLsmbLsbLgbLgbLgbRsbLgbRsbLgbLgbRsbLgbLgbRsb
LgbRsRsmbLsbLgLsbLsbLgbLsbLgLsbLsRsbLsbLsRsbLgbLsbLsbLsbLgbRsbLgLsbRsb
LgbLsbLsRsbLsbLsbLgbLgbLsbLgbLsbLgbLsbLgbLgbLsbLsbLsbLgbLsLsmbLhbLibLh
bLibLgbLgLsbLgbLgbLsLsLsmmbLsbLsbLsbLgbLsbLsbLsbLsbLgbLgbLsbLgbRgbLgbL
gbLsbLsLsLsmmbLsLsmbLgRsbLgbLsbRsbLgbLsbLgbLsbLsbLsbLsbLsbLsbLgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 5; Drug: PCAP2 10 然
bLsbLgbLgbLgbLgbRjbRjbRibRhRsmbLcbLiLsbLsbLibLgbLgbLgbLgbRsbLiLsbsbRgb
LibLsbRgLsbLsLiLsbLgbRsbLhbLgbLgbRibRhbRibRsbRsbRiRsmbLsbRgbRgRsmbRsbR
gbRsbRibLsbRiRsmbRibLgRsbRibRibLgbRibRgbRiRsmbRgbRgbRgRsmbRsLsbRsbRgbR
sbRgbRgbRgRsmbLgRhLsbRcbRgbLgbLibLgbLsbLgbLsbLgbLgLsbLgbLsbLsbLgbLgbLg
bLgbLsLsmbLgbLsbLgbLgLsbLsbLsbLgLsLsmbLgLsbLgRsbLgbRjbLjbRjbLgbLgLsbLg
RsbRgbLgbLgLsbLgbLsbLgLsbLgbLgbRobRibRgbRgRsmbLsbRsLsbRgLsbRsbRgRsmbRs
bRgbRgLsbRgRsmbRgbRhbRiRsmbRibRibRgbLsRgbRgbRsbRgRsmbRsRsmbRgbRibRgbRg
bRgbRsLsbRgbRgbRgbRgbRiLsbRhbRgbRgbRgbRgbLsbRgbRgbRibRibLsbRgbLoLsmbRg
bRgLsbRgbLsbRiLsbLhbRibRibRgbRgbRgRsmbRsRgbLsRgbRgbRiLsbRsRsmbRgbRgRsm
bRsRsmbRgbRgbRgbRgbRgRsmbRgRsmbRsbRgbRgbRgRsmbRgbRgbRgbLsbRgRsmbRiRsmb
RsbRiRsmbRhbReRsmbRgRsmbRhbRgbRgbRsRsmbRibRibRsbLgbRgRsmbRibRgbLsbRgbR
gbRsbRsbRibRiRsmbRgbRgbRgbRgbRgbRsbRgbRiLsbLgRsbRgbRibRgbLebLibLgbLgbL
sbLgbLsbLsbLsbLgbLgbLsbRsbLsLsRsmbLgbLgbLibLiLsbLgbLcbLsbRibRibRsbRgRs
mbRebRsRsmbRiRsmbRgRsmbRgbRibRgbRgbRgbRgbRsbRgbRsbRgbRgbRgbRgbRgRsmbRg
bRjbRgbRgbRiRsRsmmbRgbRgRsmbRsRsmbRgbRsbRibRgbRgRsmbRjbRhbRsbRsbRgbReb
RsbRiRhbRgbRhbLsRsbRibRgbRsbRsbLsbLcbLibRsbRebRcRsmbRibRgbRibRgbRibRcb
RibRgbRjbRgbLsbRibRgbRsbRgRsmbRgbRgbLebLiLsbLiLsbLeLsbLibRibRgbRgbRgbR
gbRgbRgbRgbRgbRgbRebRobRibRhbRgbRgRsmbRgbRgRsRsRsmmmbRgbRgbRibRebRgbRg
bRgbRgRsRsmmbRibRebRobRgbRibRebLsbRibRcRsmbRibRcRsmbRibRgRsmbRgbRgReRs
RsmmbRibRgbRgRsmbRgbRgRsmbRibRibRgRsmbRgbRgbRgbRsbRhbRsbLgbRiRsmbRibLs
RsbRibRiRsmbRhRsmbRibRgbRhRsmbLsRsbLeLsbLjLibLebLebLgbLgbLgbLsbLgbLsbL
sbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 6; Drug: PCAP2 10 然
bRgbRsbRhbRcRsRsRsmmmbRiRsmbRhbRgbRgbRsRsmbRgRsRsRsmmmbRgbRgbRgbRgbRgb
LsRobRobRibRibRgbRgbRgbRsbRgRsmbRsbRibLcLsLsmmbLsbLebRgbLoLgbRiLsbRsLs
LsmbLcbLobLcbLeLsbLiLsbLgbLgLsLsmbLibLgLsbLibLgbLibLiLsbLgbLsLibRjbLcb
LcbRcbRibRcLsbRobRibRibRiRsmbRgbRebReRsmbRgbRiLsbRhbRgbRgbLcbLsRsbLibL
sbLgLsbLsbLibLgbLgLsLsmbLeRsbLcbLcLsmbLgLsbLgbLibRebRobLiRsRsLsmbRhbsb
RibLsbRgbLgRsbRcbRcbLiLgbLgLsRsbLgbLibLcLsmbLsbLgLsbLgLsbLgbLsLsmbRebL
gbLibLgbLgbLsbLgLsbLgLsbLgRsRsmbRgbRsbRgbRsRsmbRgbRsbRgbRgLsbRebRibRgb
RhbLjbRebLiLsbLcbLjbRcbLgLsbLgbLsbRebRhRsmbRibLiRsbRcbLgLsbLjbRebRjRsm
bRgbRgRsRsmmbLsLsmbRgRsmbRsbRgbLgbRhbRcRsLsmbRjbRcbRibRebLcLsmbLhbLgbL
gLsbLibLibLgRsbLsbLsbLgbLsbLsLsmbLgLsbLsReLsbLgbRgLsbLjbLsLsmbLgbLiLsb
RsbLibLcbLhLsbLiLsbRsLiRsbLjbRgbLsbLgbLgbLgbLeLsbLsLsmbLiLsRgbRgbLjLsm
bLebRgbRjbLjbsbRgbRgbRgbLsbRibLgbRebLcLsmbLcbLcbLhbLiRsRsmbRsRsmbLgLsb
LsbLibLgbLcbLcbLhbLcbLiLsbLgbLgbLgbLgbLsbLsbLsbLgbRcbRiLsbRgbRiLsbRiRs
mbLgbRibRcbRcRsmbRibLibRgbLcLsLsmmbLibLgbLgbLgbLgbLsRsbLsbLgbLgbRsbLib
LiLsbLcbLcLsmbLibLgLsbLgbLgbRgbRhbLcbLeLsbLjbLsbLgbRebRoLsbRibRibRgRsm
bRgRsmbRcbRgbLhbLiRsbRsbRobRiRsmbRsbRsbRgbRsRsmbRgbLgbRjbLobLgLsbLsbLs
LhLgbLsbLhbLibLsLsmbLgbLgbLsbLgbLibLsLsmbRjbRibLibLhbRsbRebRibRcbLcbLc
bLcLsmbLebLibRgbRobRsRjbLibLjbLgLgbLgbLsLsmbLcbRibLcbLhRibRibRgbRgLsbR
gbRjbLsbRcbRibLebRibRgRsmbRgbRgRsmbRgbRgbRsbRgbRgbRgbRsbRgbRjbLgRsbLsb
LgbLebRsbLsRsbLcbLgbLebLcLsmbLhLsbLibLibLgbLgLsbLgbLeLsbLgLsLsmbLgRsbR
ebRgbRiRsmbLjRsbRibLsbRsbRibRgbLgRsbRcRsmbRoRsmbRibRcbRibRcbRcbLcLsmbL
iLsbRgbLsbLebLiLgLsbLgbLgbLibLgLsbLobLibLgbLibRjbRiRsmbRcbRcbRibRcbReR
smbRcRsmbLeLsbLibLsbRcbLebLsbRibRibRgbRgbRgbRgbRgbRsbRsbRgRsmbRgbRgbRg
bRebLcbReRsmbLgbRgRsRsmmbRiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 7; Drug: PCAP2 3 然
bRsbLhbLibLibLgbLibLgbLgRsbLgbLgbLgbLgLsbLgbRjbRobRiLsbRgLsbLsbRgbRgbR
gbRgbRgbRgbRgbLjbLcbLgbLgLsbLgbLgbLsbLsbLsbLgbLsRsbLgbLsbLgbLgbLgbLgLs
bLgbLcbRsbRibRgRsmbLjRsbLobLibLgRsbLgbLgbLgbLsbLgbLgbLgbLsbLsbLgbLgbLg
bLgLsbLgbLsbLgbLgbRjbRcbRibLsbRiRsmbLsLsmbRgbRsRsRsmmbRgbRgbRgbRgbRgbR
gbLhbLcbLibRsbRsLgRsbRsbRcbRibLsbRgbLsRsbRsbRcbLgbRibRgbRgbRgbLgbRibLs
RibRcRsLsmbRibRgbRiRsmbRgbRsbRsRsmbRgbRgRsmbRgbRsLsbRgbLsbRgbRibLibRhb
RgRsmbLsLsmbRhbRiRsLsmbRgbRsbRgbRibRgbRsRsmbRgbRsbRsbRgbLsbRiRsmbLsbLs
bRcbRcbRiRsLsmbLsbLhbLiLsbLgbLsbLgLsbLgbLgbLgbLsbLhbLibLgLsRsbLsbLiLsb
LgbRgbLhRsbRcbRcbRsbRsbRiLsLsRsmbRibRcRsmbLibLcbLsLsmbLsbLgbLgbLgbLgLs
RsbLgRsLsbLsbLgRsbLgLsbLcbLcLsLsmmbLgbLgbLibRsLsbLobLhbLgbRebRhLsbRibR
gbRsbRgLsbRibRgbRsbRgRsRsmmbRgbRsRsmbRgRsmbRgbRgbRgbRibRgRsmbRsbRgbRgb
RgRsmbRgbRgbRgbRgbRgbRgbRsbLsbRgRsmbsbRgbRgbRgbRgbRgbRgbLsbRgRsmbRgRsm
bRibRibRgbRgbRgbRsbRgbRsbRgRsmbRgbRgbRsRsmbRgbRhRsmbRgRsmbRgbRgbRsRsmb
RoRsmbLiRsbRsbLibLcbRsbLgbRsbLibLibLcbRjRsmbRgLsbRsbRsbRebRhbLsRsbRgRs
mbRgbRgbLsbLoRsRsmbRsbLjbRgRsmbRgbLibLibLgbLgbLgRsbLgbLgbLgbLgbLsbRebR
ebLsLsmbLgbLibLsbLgbLibLgbLjbLcbLiRsbLibLhbLcbLgbLsLsmbLgLsbLgbLgbLsLs
mbLibRjLsbLjbRsbRibLibLjbLsLsLsmmbLgbLibLsLsmbLgLsbLgbLgbRjbRcLsLsmbLi
bLibRoLsbLgLsbRjRsmbRgbRgbRibRgbLjbRcbRebLcbRsLcbLibLgbLgbLgbLgbRcbRib
RsbRgbRgRsmbRgbRgbRgbRibRjbLhbRebRjbLgbLjbLobLibLjbLibLibRsLsbLhbRjbRc
RsmbRgRsLsmbRgbRsbRgLsbRgbRgbRjbLsbRjbsbRgbRibRibLsRgLsbRsbRsbRjbRsbRs
bRsbRgbRgbRgbRgbRsbLjbLsLcbLsbLgbLgbLgbLgLsbRebLcbLobLibLcbLcbRgbLsbRi
LsRsbLhLsbLebLsbLgbLsLsLsmmbLsbLgbRebRsbRgbRsRsLsmbRjbRsLsbRgbRgbRgRsm
bRsbRjbRibLibLgbLgbLgbLgbLgbRcbLsbRibRgbRibRsbRgbRgbRgbRgbRgbRibRibRgb
RhRsmbLcbLibLhbLibRgbRsbLibLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 8; Drug: PCAP2 3 然
bLgbLgbLiRsbRcbRcbRsbLsbLhbLiLsbsbRcbRoLsLgbLibLibLgbLgbRsLsbRebRibRib
RsRsmbRgbRibLgbRibRibLgLsbLhLibLsbRebRibLhLsbLibLgbLgbLgRsLsRsLgLgbLsL
smbRsbRobRibLsbRhbLibLhbLibRsRsmbLiLsLibLsbLiLgLsbLgLsbLgbLibLcbRgRsmb
RiRsRsmmbRgbRibRsbRgbRgbRgbRgbRgRsmbRsbRgRsmbRgbRibReRsLsmbRibLibLibLg
bLsbLgRsLsbLsbRsbLibRsLgRsbLgLgLsLgbLgRsLsbLgbLsbLgRsbLgRsLsbRcbLsbRsb
RsbRibRgRsmbRgbRgbRiRhbRgbRibRgbRgRsRsmmbRgbRoRsmbRebLibRgRsmbLibRsbRs
bLcbLgRsbLgLsbLgbRsbRcbRsbRiRsmbRgbRgLsbRsRiRsRsRiRgmmbRgbRgbRgbRgbRsb
RsbRgbRgRsmbRgRsmbRgbRsbRgbRsbRgbRgRsRsmmbRgLsbRsRsmbRgbRgbRgbRgbRgbRi
LsRsbRsbRsbRibLsRsbRgRsmbRgRsmbRgRsmbRgRsmbRsRsmbRsbRgRsmbRgbRsRsRiRsm
mbRgRsmbRgbRgLsbLhbLibLsbLgbLobLcbLcbRgRsRsmmbLcbLibLiLsbLgRsbLibRsRsm
bLiLsbLgbLiRsbLgbRgbLgbLgLsbLgbRsbLgbLibLibLcbLsRsbLcLsmbRgbLgbLgbLhbL
obLibLgbRebRgbRgbRgbRiLsLgbLebLgbLgbLsbLgLsbLgbLgbLgbLgLsbLgbLsLgbLibL
cRsbRibRgbRgbRsRsmbRcRibRibRjbRgbLcRsbRobRgRsmbRsLsRsbLiLsbLibRsbRcbRi
bRgbRgRsmbLjLsmbRjbRibRgbRgbRgRsmbRsbRsbRgbRgbLobLsLcRsRsmbLiRsLsbLgbL
gLsbRgbRcLsbLgbLibLgLsbLgRsbLgRsbLgRsbLsbRobRgbRsbRgbRgbLsbRibRgbRgbRs
RsmbRgbRgRsmbRgRsmbRgbRgbRgbLsbRgbRgbRibRgbRgbRgbRgRsmbRgbRiRsmbRgRsRs
mmbRibRiLsLsmbRobLcbLgbRsLsbLcbLibLgbLgLsLsmbLgbLibLcRsbLebLibLibLcbLg
bRgbRiRsmbRgRsRsmmbRgbRgbRgRsRimbRgbRgbRgbRsbRibLjbLobLibRsbLobRsbRgbR
gbRgRsmbRgRsRgmbRibRjbLcbLhbLsbLcRsbRibLibLjbLgLsbLibLcbRebLsbRsbLgbRs
bLgbLsbLgbLgbLgLsbLsLsmbRcRsmbRibRsbRgbLsbRgbRgRsmbRsRsmbRibRsRsmbRgRs
LsmbRibRibRibRiLsRsbRcbRhbLcLsmbLcLsmbLhbLiLsbLibsbLsbLgbRgbLsbLibLgLs
bLgbRsbRjRsmbRcRsmbRibRsbRsRgbRiRsmbLsbRibRgRsRsRsRiRgmmmbRsRiRsRsmmbR
gbRgbRgbRgRsmbLjLibLibLgbLoRsbLsbLoLsmbLsRsbRibRibLsbRibLjbLibLgbRsLsb
RebRibRgRsmbRgbRgbRgbRiLsLsmbLsRsbRgbRibRgRsRsRgmmbRebRebRebLjbLcLsmbL
iLsRsbLgLsbRhbLjbRebLsbLjbRcbRsbRibRgRsRgRsmmbRgbRgbRgbRibRgbRoLsLsmbR
ibLsbRibRgbRgLsbRgbRgRsmbLsbRibRsbRgRsmbRgbRgbRibRgbRgRsmbRsRsmbRiLsbR
oRsmbRibLhLsbLgbLgbLgbLgLsbRebLgRsbReRsmbLsbLibLgLsbLhRsbRcbLcLsmbLgbL
gbRebRibRsLsbRsbRgbRibRsbRgbRgbRgbRebLgbLibLibLgbLsLsmbLgbLgLsbLiRsbLi
bsbLcLsmbLsbLobLcRsbLibLhbLibRsRsRsmmbLgLsbRsbLgbLgbLibLibRsRsmbLibLgL
sbLgbRebRcbRjLcbLibLgbLgLsLsmbLgbLoRsRsRsLcmmbLoRsbLiLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 9; Drug: PCAP2 3 然
bRsRsRsLsmmbRsRsmbRgbRgbRgbRsbRgbRsRsmbRgbRgbRgbLsbRgbRsbRgbRgbLsRsbRg
RsmbLgbRgbRgbRgbRibRgbLibLgbLgbRibRibRgbRgbRsRsmbLgbRibRsRsmbRgbRgbLgR
sbRgRsmbRsRsmbRgbRsbRsbRgbRgbRgbLsbLsbRibRiLsbRgRsLsmbLsbRibRiLsbRgbRg
bRgLsbLibRgbRgbRgbRsbRgRsmbRgRsmbRsRsmbLsRgRsmbRsRsLsmbRsbRgbRgbRsLsbR
gRsmbRgbRsbRgbRgbRgRsLsmbRgbRgRsmbRsbRsbRgbRsbLsRsbRgbRibRgRsmbRsRsmbR
sRsmbRgbRgRsmbRsbRsRsRsmmbRgbRgbRgbRgbRgbRsbRsbRgbRgbRgRsmbRgbRibRgbRg
bRsbRgbRgbRgbRgbRgbRsbRgbRgRsRsmmbRsbRgRsmbRgbRgbRgbRsbRgRsmbRgbRgRsmb
RgbRgbRgRsmbRgRsmbRgRsmbRibRgbRgbRgbRgbRgRsRsmmbRgbRgbRgbRgbRsbRgbRgbR
sbRgbRsbRgbRgbRgRsmbRsRsmbRgbRgRsmbRgbRgbRsRgRsmbRsbRsbRsRsmbRgbLsRgbR
gLsbRgRsmbRgbRsbRgRsmbRgbRsbRgRsmbRgbRgbRgbRsbRgbRsbRgRsmbRsRsmbRiRsmb
RgbRsbRsRsmbRgbRsRsmbRgbRgRsmbRgbRgbRsRsmbRgbRgbRgbRgbRgbRgbRgbRsbRgRs
mbRgbRgbRgbRgbRgbLsRgbRgbRsbRibRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgRsmb
RgLsbRgbRgbRgRsmbRsRsmbRgbRgbRgRsmbRgRsmbRgbRgbRgbRsRsmbRsbRgbRgbRgbRi
LsbRsLsbLsbRibRibLgRsbRiLsbRsRiRsRsmmbLsbRgRsmbRgLsbRgRsmbRgbRsbRgbRgb
RsbRibRgbRgRsmbRgbRgLsbLsbRibRgbRgLsbRgbRibRgbRgbLjbLibLibRjbLiLsbLgbL
ibRgbLibRsRsmbRsbRsLibLgLsbLgbRsbRgbLcbLsbLsLcbLibLibRibRgbLibRsbRjbLc
LsmbLsbLgLsbLgbLgbRsbLgbLgbRsLsbLsbLibRgbLibLgLsbRjbLsLsmbLgbLgbLsbLiL
sbLgbLgLsbLsLsmbLsbLcbLsbLgbLsbLibRcbRibRgbLibRiRsmbLsRsbRibRgbLgLsbRi
bRgbRgbLgbLgbRhbRibRgbRgbLibRibRgbRgbRgRsmbRsRsmbRgbRgbRgRsmbRgbRgbRgb
RgbRgbLsbRgbRsbLsbRibLsbRgRsmbRgbRsRsmbRgbRsbRgbRgbRgbLgbRibRsRsmbRgbR
sbRgbRgbLsbLsbRibLsbRibRgbLgbRgRsmbRibRsbRsRsmbRgbRgbRsRsmbRsbRsbRsbRs
bRgbRgbRgRsmbRgbRsbRsbLsbRgRsRsmmbLsbRibLsbRsRsmbRgbRsbRgbLsRsbRsRsmbR
sbRsbRsRsmbRgbLsbRgbRgbRgRsmbRsbRsbRgbRgbRsbLsRsbRgbLsbRgbRgbRibRgbLsb
RibRgbLsbRgbRgbRsbRiRsmbRgbLsbRiRsmbRsbRgbRsbRgbRgbRsbRgbRgbLgRsbRgRsm
bLsbRsbRgbRsbRgbRgbRsbRsbRsbRgbLsbRiRsmbLsbRgbRsbRsbRgRsmbRsbRsbRgbRsb
RgbRsbRgbRgbRgRsmbRgbRsRgbLsbRgbLhbLibLibRgbLibLgbLsLsmbLibLgLsbRibLhb
RibRibLsbRibLgbRibLsbRgbLsbRgRsRsmmbRsbRsbRgbRgLsbRsRsmbRgbLsbRgbRsRsm
bRgbRsbRsbRsbLjbLcbLibLgbLhbLsbLsbLgbLibRgRsmbLsRebRgbLebLibRgbLibLibR
jRsmbLibLgbLsbLibLibLgbLsbRgbRgbLibLsbLibLgbLibLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 10; Drug: PCAP2 3 然
bRiRsmbRgbLsbLjbLibRsbRjbRgbRibRsbRgbRsbRgbRgbRsRsmbRgRsmbRgbRgbRgbRsR
smbRibRibRsbRibRgbRsbLsbRhRsmbRgbRsbRgbRgbRsbLsbRsbRibRgbRsbRgbRsbRsbR
gbRsLsbRgbRgbRgbRsbRgbRgbRsbRsbRgRsmbRsbRgbRgbRgbRibRgbLgbLsbLgbRjbRib
RgbRgbLsbRsbRgLsbRgbRibLsbLsbRhbRsbRsbRsbRibRgbRibRibLgbRibRibRiRsmbRs
bRsbRibRgbLsbRsbRsbLsbRgbRibLsbRibRgbRsbRsbRibRgbRgbRgbRsbRsbRibRsbRsb
RgbRsRsmbRgbRsbRsbRgRsmbRgRsmbRsbRgbRgRsmbRgbRsbRgbRgRsmbRgbRgRsmbRsbR
gbRsRsmbRsbRgbRsbRgbLsbRsbRgbRgbRsbRsbRsbRgbRsbRsbRsbRsbRsRsmbRgbRgbLs
bRsbRibRsbRsRsmbRsbRibRsRsmbRsbRibRgbRgbRsbRsbRgbRgbRsbRgLsbRgRsmbRsbR
sbRgRsmbRgbRsRsmbRgbRgbRsbRgbRgbRsbRgRsmbRgbRgbRiLsLsmbRibRgbRibRiLsbR
gbRsbRibRgbRgbRsbRgbRsbRsbRsbRgbRgbRgbRsbRsbRsbRibRsbRsbRgbRgbRgbRgbRs
bRsbRsRsmbRgbRgbRibRsbRsbRsbLsRsbRgbRgbRiLsbLsbRsRsmbRibRgRsmbRsRsmbLs
bRgbRjbRsbLsbRibRsbRsRsmbRgbRgbRgbRgbRsbRgRsmbRgbRgbRgbRsbRgbRgbRgRsmb
RgbRgRsmbLsLsmbRgbRgbRgbRsbRgbRsbRgbRgbRgbRsbRgbRsbRgbRgbRgRsmbRgbLsRs
bRgbRsRsmbRgbRsbRgRsmbRsbRgbRgbRgbRgbRgbRgRiRiRsmbRibRgbRgbLsbRgRsRsmm
bRgbLsbRgbRsRsmbRsbRgbRgbRsbRgbRgbRgbRgRsmbRibRsbLsbRiRsmbRgbRsbRgbRgb
RgbRsbRgbRgbRgRsmbRgbRgLsbRsRsmbRgbRsbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbRs
bRgbLsbRibRsbRgbRgbRgbRgbRsbRgLsbRgbLsbRsRsmbRgbRsRgbRgbRgbRgbRgbRgbRs
RsmbRgRsmbRsbRsbRgbRsbRgbRgbRgbRgRsmbRgbRgbLsbRsRsmbRgbRgbLsbRsbRsbRgR
smbRgbRgbRsbRgbRgRsmbRgbRsbRgbRgbRsRsmbRsbRgRsmbRgbRebRsbRiRgbRgbRgbRs
bRgbRgbRsbRgbRgbRgbRsbRibRgRsmbRgbRgRgbRgRsmbRgbRgbRgbRgLsbRsbRibRsRsm
bRsbRibRsbRsbRsRsmbRgRsmbRsbRsRsRgmbLgbRsbRgbRgbRsbRgLsbRsbRgRsRsmmbLs
bRgbRsbRhbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgRsmbRsbRgbRibRgbLsLsmbLsb
LsbRibRgbRsRsmbRgbRgbLsbRsbRsbRsbRgbRsbRsbRgLsbRgbRgbRgbRsbRgbLsbRgbRi
RsmbRsRsmbRgbRsbRgbRgbRgbRgRsmbRsbRgbRsbRgbRgbRgRsmbLsbRsbRgbRsbRgbRgb
RgbRsbRgbRgbRsbRgLsbRsbsbRgbRsbRsRsmbRsbRgbRsbRgRsmbRgRsmbRgbRgbRgbRsb
RgRsmbRgbRgbRgbRgRsmbRgRsmbRsRsmbRgbRgbRgbRsbRibLsbRiRsmbRsbRgbLsbRgbR
gbLsbRgbRgbRsbRgbRsbRsbRgbRibRgbRgbRgbRgbRgbRgbRsbRgbRgbRsbRgbRsRsmbRg
bRsbRgbRsbRgbRgbRgbRsbRibRgbRgbRgbRsbRsbRgRsmbRsbRgbRgbRgbRsbRgbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 11; Drug: PCAP2 3 然
bLgbRgbRgbRibRgbLjLsmbRibRgbLsbRgbRibRibRsbLgLsbLgbRhbRhRsmbRsbLibLiLs
bLsbLgbLgbLsbLgbRsbLgLsbRsbRsbLgbLsbLgLsbRsbLgLsbRgbLgbRoRsmbRibLsbRsb
RgRsmbLgbRibRibLobLibRjbRsLibLgbRgbLcLsmbLibLgbLibRibRcbRibLgbLoRsbLcb
LgbLsRsbRsbRibLcbLibLgbLsbLhbLcbLebRsbLgbLibLiLsbLoLsmbLcbLiLsbRcbRcRs
mbRibLgLsbLibLjRsbLgbLgbLsbRsbLsbRibLgbLgbLibLgbLgbRgbLgbRgbLibLibLibL
gbRgbLgbLsbLsbLsRsbRcRsmbRsbLsRsbRibLsbRgbRsbRsbRsRsmbLsbLsbRsbRgRsmbL
cbLibLibLibLgbLgbLsbLsbLgbLgRsbLiLsRsbLibLibLgbRsbLibRjbLibRebRcbRcRsm
bLibRibRsbRsbRgRsmbLsbRsbRgbRgbRgbRibRibRibRgbLgbRcRsmbRsbLsbRgRsmbLsR
sbRgbRsRsmbRgbLsbRgbRgbRibRebRhbRgbRjbRibRsbRgbRgbRiRsmbRcRsmbLobLjLgb
LhLsbLsbRsbRebRgbRsbRgbRsbRgLsbRiRsmbLcbLibLgRsbRcbRcbRibRgbLgbLgbRibR
hbRgbReLsbRgbRibRibRibRgbLibLebRcbLjbLcbLibLibLgbRgbLgbRhbLjbLjbReRsmb
RhRsmbRhbRiRsmbLhbLjbLebLhbLibLibRjbLhbLibRebRcbRcRsmbRibLibLiLsbLgbLs
bRjbLibLiLsbLcbLibLibRjbRcbRcbRibRibRgbRgbRibLcbLcbRgbReRsmbRibLcbLibL
gbLibLibLsbLibRibRibRibRibLgbLsbRgbRgbRgbLsbRgbRgbRibRiRsLsRsmbLsbLsLs
mbRhbLsbLgbLsRsbLiLsbLgbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 12; Drug: PCAP2 3 然
bRsbLsbRgbRgbRsbRsbRsbRsbRgbLsbRcbRibRgbLgbLsbRsbRgbRgbRgbRgbRsbRgbRsb
RgbRgbRgbRsbRobRsLsbLiRsbRsbRgbRgbRsbRsbRgbRgbRsbRgbLsRgRsmbLsbRjbRibR
sLsbRgbLibRibRgbRgbRgbRsRsmbRsbRsbRgbRibRgbLsbRgbRgbRsbRsbRgbRgbRhbRgb
RgbLgbLsbRgbRsbRibRgbRsbRsbRgbRsbRsbRsbRsbRsbLsbRgbRgbRgbRsbRibRibLgbR
sbRsbRgbRgbRgbRgbRgbRgbLgbRgbRgbLsbRsbRgRsmbRgRsmbLsRgbRgbRgRsmbRgRsmb
RsbRsRsmbRgbRsRsRsmmbRsbRgbRgbRgbRgbRsbRgbRgbRgbRhbRibRiRsmbLsbLjbLjbR
cbRcRsmbRibRgbLsbLsbRgbLsbRiLsbRgbRsbLgLsbLobLobLibRgbRgbRgbRgbRsbRgbR
gbRgbLobLibRjbLcbLcbLcbRjbRgbRgbLobLcbLibLibRgbLibRgbRgbRjbRgbRgbRsbRg
bRsbRsbRgbRsbLgbRgbRibLibRjbRhbRibRgbRsbRsbLsbRcbRjbLibLibRsbLsRcbRgbR
sbRsbRgbRsbRsbRsbLsbRgbLebRebRibRibRsbRsbRsbRgLsbRsRsmbRsbRgRsmbRgbRsb
RgbRgbRsbRsbRsbRsbRgRsmbLsRsbRgbRsbRsbLsbRgbRgRsmbRgbRgbRibRgRsmbRgRsm
bRgRsmbRsRsmbRgbRsbRgbRgbRsbRgbRgRsmbLebLibLcbLcbLebLebLsbRibLibLhbLsb
LgbLsbLibRsLsbRsbLhbRsRsmbRjbLibLgbLgbLgbRsbLsbLibRibLjbLibLhbLibLgbRs
RsmbLsbRgbRibRgbRsbRgbLcRsbRsbLibLsbLgbLsbLibLsbRibRibRgbLcbLibRebRibL
sbRgbRsbRsbRsbRsbRsbLsbLibLobRsbLgbLibRibLobLcbLibRibRgbRibRgbRcbRgbRs
bRsbRsbRibRgbRsbRgbRgbRsbRsbRsbRgbRsbLcbLibRgbLgbLgbLhbRgbRgbRgbRibLsb
LgbRgbRgbRgbRsRsmbRgbRsbRgbRsbRibRcbRhbLgbLhLsbRjbRibRibRsbLebRhbLcbRh
bLgbRgbRgbRsbRsbRgbLcbLhbRibLgbLgbRgbRjbRgRsmbRsRsmbRsRsmbRsRsmbRgRsmb
LsbLsRsbsbRibRsbLsbRgbRgbRgbLsbRsbLjLeLsbLibRsbLibRgLsbLhRsbRibRgbLibL
sbLsLsmbLgbLsLsmbLgbLgbRgbLcbRgbRgbRgbLobRcRsmbRibRsbRgbRsbRgbRgbRsRsL
smbRgbRgbLsbRgbLsbRsbLebLibLhbRgRsmbLcbRsbLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 13; Drug: PCAP2 1 然
bRjbRcbLjbRibRsbRgRsmbLebLcbRiRsmbLgbLsLgbLgbLsbLgbLsbLgbRsbLgRsbLsLsm
bLsLsmbLsLsmbLsbLsbLgLsbLgbLsbLgbLgbLsLsmbLsbRsbLsbRcbRibLjbRibLebLhbR
gbLcbRibRgbRcbRibLibLgbRebRibRibLcbLibLsLsmbLgLsbLsbLsbLsbLibLibRsbRiR
smbRgbRcbRsbLjbRhRsmbLsbRibRgbLjLsmbRibLgbRgRsmbRgbRoRsmbRhbRibRsbRgbR
gbRgbRgbLsbLcbLibRjbLiRsLsbLibRjbLibLhbRgbRjbRibLobLgLsbLsbRgbLgbLcbLs
bRibRgbRgbRgbRibRsbRsbRgbRsbRgbLsbRgbLsbRgRsmbRsbRibRobRibRjbRcbLsbRib
RiLsbRgbRgbRgbRgbRgbLsbRibRgbRgRsmbRsbRcbLgbRgbRgbRgbRgbRibRgbLsbRgbLs
bRgbRsbRhbRgbLcbLsbLcRsbRcbRjbRjbLobLebRebLjbLibRjbRobRcbRcbRibRgbLoRs
bLobRhbRcbRhbRibLibLsbRibLsbRibLsbRgbLsbRibRgbRsbRsbRsbRibRsbRibRgbRsb
RgbLsbRgbRsbRgbRgbRsbRgbRsbLgbRibRgbRgbRsbRjbRgbLsbRgbLsbRibLsbRibRsbR
gbRgbRgLsbRgbRgbRgbRgRsmbLsbRgLsbRgbRgRsRsmmbRgRsRsmmbLgRsbRiLsbRgRsmb
LsbRgbRsbRgRsRsmmbRgRsmbRgbRgbRgbRsbRgbRsbRgbRgbLjbLcLsmbLibRjbLibLsbR
sbLibLsbRsLsbLgbLsbLgbLhbLcRsbRhbRgbRsbRibRcRsmbLibRgbRcbLgbRcbRcbRibR
iLsbRhbRgLsbRsRsmbRsbRgbLjbRcbLibLcbLhbRgbLgbRjbRgbLjbLcbLjbRcbLiLsbLc
bLibLibRgbLhLsbLhbRibLjbRsLcbRiRsmbLgbLcbLcbLibLsbRgbRhbRgbLgbRebRhbLh
LsbRsRhbRibRsbRhLsbRiRsmbRgbRibRibRibRgbLcbLgLsbLsbRgbLebRsbRgLsbLcbRg
bLiLsbRsbLsbLiLsbLgRsbLgLsbLsLsmbLsbLgbRsbRcbRibRibRibLhRsbLsbRhbRibRg
bRsbLsbsbsbLsbRcbRsRsmbLsbRibRsbRgbRsRsmbRgLsbRgbRsRsmbLsbRgbRgbRgbRsR
smbRgbRsbRibRgbRgbRsbRgbRgbRgbRgbLcbLibRgbLgbLgbLsbLhbRhbRcbRsbRsbRiLs
bRgbRgbRgRsmbRsbRgbRhbRgbRgbRsRsRsmmbRibRsbLjbRcRsmbRcbRcbLsbLgbLibLsb
LgLsLsmbLgRsbRsLsbLiRsbRgbLcbLibLgbRgbLsbLcbLcLsmbLhbLsbRhbRgbRsRgRsRs
mmbRsRsmbRgRsmbRsbRgRsmbLsbRibLsbRgbRgbRgbRgbRgbRgbRgbLhbLiLsbRsbLibRg
bRcbRibLsbRibRsbLcbLiLsbLibRsbLibLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 14; Drug: PCAP2 1 然
bRsbRsbRsbRgbRsRsmbRsbRgbRgbRsbRsbRgbRgbRsbRgRsmbRsRsmbRgbRgbRsLsbRgbR
gRsmbRsRsmbRsbRsbRsbRgbRsbRsbRsbRsbRsRsmbRsRsmbRgbRsbRgbRgbRgbRgbRgRsm
bRsbRgbLsbRgbRsbRsbRsbLsbLcbLibLibLhbLibLiRsbLgbLsRsbLsRsbLibRsbLiLsbR
cbRhbLsbLsbRibRsbRiLsbRibRgLsbRsbLgbLjbLiRsbRgbLibLibRibLjbLibLgbLibLs
bRgRsmbRcbRsbRsbRgbRsbRgRsmbRgbLgbRsbRsRsmbRcLsLsmbRibLsRsbLgbRcbRsRsm
bRibRgRsmbRgbRsbRsbRgbRsbRiRsmbRgbRgbRgbRsbRsbRgbRgbRgbRsbRsbRsbRgRsmb
RgbRsbRgbRgbRsRsRsRsmmmbRgbLsbRsbRgLsbRgbRgRsmbRgbRgbRgRsmbRsbRsbRgbRg
bRgRsmbRgbRgbRsbRsbRsbRsbLsbRgbRgbRgbLsbRgLsbRgbRsbRsbRsbRsRsmbRsbRsRs
mbRsbRsbRgRsmbRgbRgbRsbRgbRgbLjLgbLibRjbRcbLhbLibRcbRhRsmbRcRsmbLgLsbL
sbRsbLjLsmbLibRsbLhbLibLgbLibRsRsmbLibLibLgbLsbRibLcbLibLgbRsRsmbLgbRs
bLibRjbLibLibLsbLsbLgbLgbLgbRgbLsbLiRsbRcbLsRsbRibRibRsbRgbRgbRsbRgbLs
bRsbRgLsbRsbRgbRsbRsbRsbRsbRibRsbLsRsbRsbRsbRgbRgbRsbRsLsbRsbRsRsmbRsb
RsbRgbRsbLjRsbLjbLibLiLsbRjbLhRsbLibRsbLibRjbRhbRsbRsbRibRiRsmbRgbRibR
ibLibLibLibRsbLsbLibRgbLibLibRgbLibLgRsbRsbLibRsbLibLibRibRsbRsbLibLsb
LsLsmbLgbRobLsLsmbRcbRsbLgbRibLgbRsbRgbRsbRsbRsbRsbRgbRgbRgbLgbRsbRibL
sLsmbRsbLsRsbRsbRibRibRibLgbLgbLgbLgbLsbRcbRiRsmbRhbRsbRibLibLsbRgbRgR
sRsmmbRgbRgRsmbLgbLjbLcbLibLibLgbRibRibRsbLgbRsbLcbLibLibLgbLsbLsbLiLs
bLibRgbLhbLibLibLibLgbLgbReRsmbRsbRhLsbLsbLsbRibRsRsmbRsRsmbLsbLgbRhbR
ibRsbRibRjRgbRjRsmbRibRhRsmbRebRsbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 15; Drug: PCAP2 1 然
bRhbRibRsbRibRibLgbRsbRsbRibRgbRsRsmbRgbRsbRgbRsRsmbRibLgLsbRibRibRhbR
sbRibRibRiRsLsmbRiLsbRgRsmbRgbRsbRgbRgbRsbRgbRcbLgLsbRgbRcRsmbRibRiRsm
bRgbRibLcbRibRgbRibRsbsbLsbRibRsbRgbRgRsmbLgRsbRgbRgbRgbRsbRgbRsbRgbRs
bRgRsmbRiLsbRcLsbLhbLibRibRcbLgbRibLsbRgLsbRgbRgbRibRiRsmbRibRibRhbReb
RgbRgbRsbRgbRibLsLsmbRgRsmbRsbRsbLgbRgRsmbRgbRgRsRsmmbRgLsbRsbRgbLsLsm
bRgRsmbRsbRiRsmbRgRsmbRgbRgbRgbRgbRsbRibRsRsmbRsbRgbRiLsbLibRgbRhbRcbR
eRsmbRhbRibRhbRiRsRsRsRsmmmmbLobLhbRebRibRgRsmbRgLsbRgbRgbRgbRsRsmbsbR
gRsmbRgbRgbRgRsmbRgbRgbRsbRgRsmbLsRgbRsbRgbRsbRibRsbRsbRibRgbRiRsmbLsb
RgbRibRgbLgbRibRsbRgbRsbLgbRiRsmbRgbRgbRsRsmbRgbRgbRgbRgbRgbRgbRgbRsbR
gbRgbRsbRgRsmbRgbRgbRgbLsRsbRsRsmbLgbRibRsbRgbRgbRgbRsbRgbRgbRgbRgLsbR
gbRgbRgbLsbRgbRgbLsLsmbRibRgbRgRsmbLsbRgRsmbRibRsbRgRsmbRgbRsbRiRsmbRg
bRgLsbRgbRgbRgbLsbRsbRsbRgRsmbRgbRgbLsbRibRgbLjbRcbLebRgbLsRcbRhbRgbRi
RsmbRcRsmbRibRgbRgbRibRiRsmbRgbLsbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRsbRgR
smbRsLsbRibRgbRsbRgbRgRsmbLsbRibRsbRgbRgbRcbRcRsmbRhRsmbRcbRgbRgRsmbRg
bRiRsmbRgbRgbLsbRgRsmbRibRgbRgLsbRgbRgbRgbRgbRsLsbRibRgbRsbLjbLcbLiLsb
RcbRibRibRsbRgbRibLgbRgbRsbRibRgbRsLsRsbRgRsRsmmbRgbRgbRiRsmbLsLsLsmmb
LibLcbRjbLgbLiRsLsbRhbRibRgbRibRsLsbRgbRcLsRsLsbRiRsmbRgbRhbRgbRcbLgRs
bRibRgbLsbRibLsRsRsmbRsbRgbRibRgbRiLsbRgbRgbRobLebRobRibRgbRgbRibRgRsm
bRsbRgbRgbRsRgbLgLsbRgbRgbRsbLcbLibRjRsmbRibRsbRsRgbRgbLsbRcbLcbLibLcb
RiRsmbRsbRgRsmbLsbRibLsbRgbRsbRgLsbRgbRgbLgbRibLsbRgbRcbRibRgRsmbRgbRg
bLebRjbRcbLcbLcbLcbLeLsbLibRcbRibRibLsRsLsbRibRsbRibLgbRibRsbRgRsmbRib
RgbRgbRgbRsbRgbRsRsmbRgRsmbRibRgbRsbRibRgbLsbRgRsmbRsbRgbRsLsbRgRsmbRg
bRgbRgbRgbRibRgbLibRjbRiRsmbLgbRgbRgRsmbLjbLibLgbRobLsbRibLsbRsbRibRsR
smbRibRsbRibRibRgbLibRiRsmbRgbRsbRgbRgbRsbRgbRgbRgbRgbRgbRgbLsRgbRgRsm
bLgLsbRibRgbRsbRgbRsRsmbRgbRgbRgbRgbLsbRibRgbRgbRgbRgbRgbRsbRgbRgbRgLs
bLsbRiRsmbRsRsmbRgbRgRsmbRsbRiLsbRgbRsbRibRgbRsbRgbRgLsbLgbRibRgbLgbRi
RsmbRgRsmbRgbRgbRgbRibRibRhbRcbRibRibRgbRgbRsRsmbLgbRgbRgbRibRsbRgbLsb
RibRgLsbRsRgRsmbRgbRgbRgbRgbRgbRgbRgbLgbRibRgbRhLgbRhbRibLibRebRgRsmbR
ib

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 16; Drug: PCAP2 1 然
bRsbRgbRebRgbLcbLibRsbRgbRibLsbRgbLeLsbLsbLgbRsbLsbLibLsbLgbReRsmbRgbR
sbReLsbRhRsmbRgRsLsmbRgbLebLgbRibLsbLsbRgbRgRsmbRgRsmbLsbRgRsmbRsbRgbR
gbRsbRgbRgbRsLsbRgbRgbRsbRgbRgbRgRsmbRsRsmbRgbRgbRgbRiRsmbRgbRgRsmbRgR
smbRgbLcLsLsmmbLsRsLsbLsbLgbLeRsbLgLsbLiRsbLgbLibLgbLgLsbLgRsbLgbLgLsb
LsbLsbLgbRebRibRgbLsbRsbRgbRsRsRsmmbRsbRgRsmbLsbLjbRhbRgbRgbLgbRibRsbR
gbRgbRsbRsbRsbRsbRsbRgbRsbRgbRjbRsbRgRsmbRgbLsbRgbRgbRgbRsbRgbRiRsmbRs
bRgRsmbRsbRsbRgbRgbRgbRsbRgRsmbRsRsmbRsRsmbRsRsmbRgRsmbRgRsmbRgbRgRsRs
mmbRgbRgbRsRsmbRsbRgRsmbRsbRebRgbLsbRsbRebRsbRgbRsbRgLsbRgbRgbRgbRsRsm
bRgbLsbRgLsbRgbRsbRgbRiRsLsmbRibRibRgbRsbRgbRgRsmbRgbRgbRgbRsRjbRebRib
RgbRibRgbRsRsmbRgbRsbRibRgbLcbLsbLibLgbLgbLsbLsbLsbLgbLcbRcbRibRibRsbL
gbLiRsbLcLsmbLgbLgbLebLgbLsbLgbLgbLgbLsRsbLgbLgbLgbLgRsbRjbRcbRibRiLsb
RibLgbLgbLeLsbLebLibLsbLsbRsbLibLsbRgbLiLsbLsbLgbRgbRgbRsbLgbRibRobLsb
LsbLsbLsbRgbRjbLebLjRsLcbLebLsbLsbLgbLgLsbLsLsmbLsbLgLsRsbRsbRgbRsbLsb
LobLebLobLsbLgRsbLebLsbRsbLsLsmbLebLjRgRsmbLgbLhbLsbRgbRsRsmbLsRsbRgbR
gbRsbRsbLebLcbLgbLibRcbLebLgbRcbRgbRsbRsbRsbRhbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 17; Drug: PCAP2 1 然
bRibRgbRgbRgbLsbRhbLgbRibLjbLcRsbRibLhLsbLsbLiLsLsmbLgbLgbLgbLsbLgbLgb
LgLsbLgbLgbLgLsbLgbLgbLgbRgbLgbLibLgbLgbLgbLgbLgbLsbRjbRcbRgbRgbRgbRgb
LjLcbLgbLgbLgbLgbRsbRgbRsbRebRibLebLhLsbRgbLgbLgbLgbLgbLgbRsLsRsbLsbLi
bLgbLgbLgLsbLgLsbLgRsbLgbLgbRgbLibLsbLibRsLsbLgLsbLgbRgbLibLgbLgbLgbLg
LsbRsbLgbLgbRsbRgbLgbLgbLgbLsbLsbLgbLgbLgbLgbLsbLsbLgbLgbLsbLgbLsbLgbL
sbLsbLgbLgbLibLcbLcLsmbLhbLgbLsbLcbLgbRgbRgbRibRgbLcbLhbLsbLgbLsbLgbLs
bLsbLibRgbLsRsbLibLgbLiRsbRsbLibLsbLsbLibLsbLgbRgbLgbRsbLgbLgbLsbLsbRg
bLibLgbRgbLjRsbLibLhbLcbLhbLhbLgbRgbLsbLibRsbLibLgbLsbRgbLibLibLibLhbL
ibLhbLibRibRibRcLsbRibRgbLebRibRibLebLcLsmbRgbLcLsmbLsbLgbRgbRebRibLgb
RibLcbRebRgRsmbRgbLcbRjbRjRgbRgbRgbRgRsmbRsbRibRgbRgbRgbRsbRsbRsbRiLsb
RcbRsbLgbLibLsbRcRsRsmmbRgbRgbRsbLjbLebRjbLhbRsbRjbRibRibRiLsbRsbRibLc
bLibRhbRiRsmbRgRsmbLcbLgRsbLiLsbLgbLgLsbRsbRcbRibRgbRgbRgbRgbRsLsbLgbL
cbLiLsbLgbLiLsLsmbLjbRcbLcbLiLsbLibLhbLcLsmbLibLiLsbLjRsRsmbRcbRobLjbL
cbLibLcbLcLsmbLhbLhLsbLibLgbLhbLcLsmbLebLcbLibRsbRsbLsbLibLgbLgbLgLsbL
gbLgbLgbLgbLcbLibLhbLgbLcbLgbLibLobLibLibLibLibLgbLcbLcbLcbLsbLhbLgbLs
bLsbLibLsbLsbLsbLgbLsbLgbLsbLgbLibRgLsbLibLgbLsbLiLsbLcbLhbRhbRgbRgLsR
sbRgbLcbLgLsbLsbLgbRsbLgLsbLgLsbRjbLjLsmbRsbLgLsbLsbLsLsmbLgbLgbLgbLgL
sbLgLsbLgLsbRsLsbLgbLgbLgbLsbLgbLgbLsbLgbRgbLgbRcbRiRsmbRsbRibLjLcLsmb
LsbLibLgbLhbRcRsmbRsbLibLibRsbLibLgbLibLobLhLsbLibLsbLibRobRiRsmbLebLi
bRsbLsbLibLgbLgLsbLgbLgbLsbLgbLgbLsbLgbLgbRgLsbLibLgbLsLobRobRibRsLcbL
cbRibRjbRibRgbLjbLibLgbLgbLsbLgbLibRcbRcbLsbRsbRibLjLebLsLsmbRgbLibRsb
LgbLgLsbRgbLibRebLibRcRsmbRibLebLgbRsbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 18; Drug: PCAP2 1 然
bLsbRsbLcbRcbRhRsmbLsLsmbRibLjbRhLsbLibLibRcbRoRsmbLebLsLibRjbRcbRibLi
bRibRcbLibLhbLibLgbLgbRjbRcbLsbRibLgbRgbRgbLgbLjbLibLjLsmbRcbRibRibLcb
LcbLibRcbRcbLcbLebLcbRebRhbLgbRibRcbLibLobLcbLcbRhbRibLibLebLibLobLcbL
hbLjbRcbRhbLibLcbReRibRcRsLsmbLebRebRgLsbRgbLsbRibLsbRgbRgRsmbLsbLjbLc
bRcbRobLhbLcbLsLsmbRgRsmbRjRsmbRibLhbRhbLjbRiRsmbLebLcbRibLcbRcbRcbLjb
RcbRibLhbLebLibRcbLsbLcLsmbLiLsbRcbRcRsmbRcbLcbLobLiLsbLgLsbRibRcbLgbR
cbLebLcLsLsmmbRjbRcbLjbRcbLgLsbRiLsbRibLsRjRsmbLibRibRgbRsbRgbLsbRsLsb
RgbRgbLsLsmbRgbRiLsbRcbLebLcbRgbLcbLcLsmbLsRgbLgbLibLsbLobRcbRcLsbLibR
cbLgRsLsbLgbRgbRibLsbRgbRhbRcbLebRebLgbRjbRsbRibRibLibRibLjbRcbLibRcbR
hbRiLsbLsbLibLibRcbRcbLibRibRcbLibRgbRibLcbLsbLiLsbRcLsbLjLhbRebRhbLjb
LibLgbLibRcbRgbRibLjbRibRibRcbLhbRiRsmbRsRcbLibRgbLcbRgbRiRgbLibLhbLgb
RhbRcbLgbRhbLhbLcLsmbLibRebRibRcbRibRsbRgbRgbLsbRsbRgRsmbRgbRgbLsbRgLs
bLjRcbRiLsbLcLsmbLhRsLsbLhbLcbLiLsbLiLsbLibRjbLibLiRsLsbRjbLcbLhbLgLsb
RsLsRsbLibLiLsLsmbLibRcbRcbRcRsmbLjbRhbLjbRcbLibLobRsbLibRjbLhbRgbLibR
jbRoLsbLjbRcbRibRsbRhbLibLibLiLsbRsRsmbLhbLcbLibLcbLibRgLsbLgbLgbLgbLg
bLgbLgbLibRcLsbRibLjbLhLsbLibLgbLsbRjbRcbLiLsbRibRibLjbLcRsbRibRcbRcbL
ibRiLsbRhbLjbRibRibRsbRsbLsbRgbRgbRcbLcbLhbLgRsbRjbRjbRibLoLsmbLcbRhbR
cbRsbRiRsmbLgLsbRgLsbRsbRgbRgRsmbLoLsmbLgLsbLibRsbLiRsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 19; Drug: Control
bRsbRsbLsbsbLsbLsbLgbLsbLgbLgbLsbLsbLgbLsbLsbLsbRsLsbLsbLjbsbRjbLsbRgb
RhbRsLsbRibRsbsbRsbRgbRsbRgbRsbRgbRsbRgbRgbRsbRgbLsbRgRsRsmmbRsbRobLiL
sbLibRgbLhLsbLcRsRsmbRgbLhbRgbRjbLcbLibRgRsmbLhbRgbRsRsmbLibLjbLebLibL
gbRgbLjbLobLsbRcbRibLibLjbLibLsbLgLsbLsbLgbLsbLgbLsbLsbRsbLsbLgbsbsbRe
bRiRsmbLsbRgbRgLsbLjbLcbLsbLgbLgbLsLsLsmmbLgbLsbLsbLsbLsbLsbLsLsmbRsbL
sbLsbLsbsbLgbLgbLgLsbLgLsbLgLsbLsbLsbLgbLsbLsbLgbLsbLsbsbLgbLsbLgLsLsm
bLsLsmbLgbLgbLsbLgbLsbLgbsbLsbRsLjbLsLsLsmmbLsbLsbLgLsbLobRsbRsbRcbLsR
sbRibLsbRgbsbRsbRgRsmbLjbRsbLsbLsRsbRsbRibRgRsmbRgbRsbRsbRgbRsbRsbRsbR
ibLibLcbRsbLibRgbLgbLgbRsbLgbLsbRsbLgbLsLsmbLsLsLsmmbLgbLsbLsLsmbRsbRs
bsbLgbLsbLjbLsLsmbLsbRsbLgbLoRebRsbRsRsmbsbLgbLcbRgLsLsmbLsbRcbRjbRgbR
gbLgbRsbLibRsbLgLsLsmbLsbLsbRsbLsbLgbRsLsbLsbRsLgbsbLgbRgbLiLsbRsLsbRs
bLgbLgbLgLsbRsbLcbRhbLjbLcbLibLgbRsbLgbLibLsbLsbLgbLsbRsbLsbRibLobRsbL
ibLsbRsLsbLgbLgbLgbRsbLgLsbLgbLgbLgbRsLgbRgLsbLgLsbLsbLgbLgbLgbLsbLgbR
obRgbLsbRsbLcbRsbLgbLsbRgbLgbLgbRgLsbRebRibRgbRsbRgbLsbLsbRgbLsRsbLjbL
cbRibLgbLgbLgbLsbRsRsmbLsbLsbLsbRsbLsbRsLsbLsbLsbLsbLsbLgLsbLgbLsbLgbL
gbLgbLsbLsbLobRsbRcbLsbRjbLjbRcbLjbRgbRibsbsbLgbRibLsLsmbRsLsbLsbsbRsb
LcLsmbLgbRsbLsLsmbsbRcLsbLhbLgbLgbLsbRsbLibRgbRsbLsbRhbsbLcbRgbLsbLsbL
sLsmbLsbLgLsbLgbLsLsmbLgbLsbLsbLgLsbRcbRibRibRgbRsbRsbRsRsmbRgbRsbLsLs
mbLjbLgbLgbsbLsRsbRsLsbRsLibRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 20; Drug: Control
bLgbRgbsbLgLsbLsbLgLsbLhbRibRgbRgRsmbRsbsbRgRsRsmmbRsbRgbRgRsmbRsbRgbR
gRsmbRsRsmbRgbRsbRsbLsbRsbRsRsmbRgbRgbRgbRgbRgbRgbRgRsmbRgbRgRsmbLsbRg
LiLsbLiLsbLibRgbLibLsbLebRgbRibRiRsmbRgbRsRsmbRsbRgbRgbRgbRgbRibLgbLib
RibRiRsmbLsbRsbRibRgRsmbRsbRibRgRsmbRgRsmbRgbRgbRsRsmbRgbRgLsbRsbRsbRg
bRsbRibRgbRgbRgbRgbRgbsbRgbRgbLsbRgbRibRgbRibLcbLibLgbLgRsbLhbLebLcbLc
bLibLibLgbLgRsbRgbLobLgRsbRjbLgbLcRsbRibLgbLcbLhLsbRgbLibLsbLgbLgbLsbL
jbLsbRcbRibLgLsbRibRgbRgbRgbRgbRsbRgbRgbRiRsmbRcbRhbRcbLsRsbRibRsbRgbR
sbRgbRsbRsLsbLsbRibRsbRibRgRsmbRgRsmbRgbRgbRsbRgbRgLsRsbLgbLebLibRgbLi
LsbLgbLgLsbRsbLgbLgbLsbLsbLgbLgbLgbLsbLgbLgbLcbLsbLgbReRsmbRgbRgbRsbRs
bRibLsbRsLcbLhbRgbLibLgbLgbRgbLibLgLsLsmbLhRsbRgbLibRsbLibLgbLgbLgLsbL
gbLsbLgLsbRsbLgbRsbLsbLsbLibsbRsRsmbRsLgLsLsmbRsbLgbLgbLgbLsbRsbLgbLib
LiLsbRibRcRsmbRiRsmbLgbRibLcbLobLgbLcbRibRgRsmbRjbRsRsmbLsbRsbRgbRgbRg
RsmbRsbRgbRgbRgRsmbRgbRsbsbRgbRgbRgbRsLsbLsbRibLsbRsbRgbRgLsbRsLsbRgRs
mbRgbRgbRsbRgbRgbLjbLibLibLcbRibRgbRcbRcbLibLibLgbRgbLibLgLsbLgbLsbRsb
LgbLibLgbLsbLgbLsbLsbLjbLsbLgbRsLeLsRsbRgbRgLsbRibRsbRsbRsbRiRsmbRibLg
bRibRsRsmbRibLgbRgbRjbRsbRgRsmbRgbRsbRgRsmbRgbRgbRgbRgbRsLsbRgbRgbRgbR
gbRsbRgRsmbRgbRgbRgbLsbRoLsbLjLsmbLiLsbRjbLiRsbRsbLibLgbLgbLgbLgbLsbLs
bLsbLgLsbRjbLibLibRsbLgbLsbLsLsmbLgbLgLsLsmbLibLgLsLsmbRsbRjbLiLsbLhbL
sbLgLsbLsLsmbLcLsmbLsbLgbLiLsbLgbLebRgbRcLsbLsLsmbRgbRsbRiLsbRgbRsbLsR
sbRsbRgbRgbRsbRgbRsLsbRsbRgbRgbRsRsRsmmbRsRsmbRgRsmbRgbRgbRsbRsbRsbRgR
smbLgbLcbRgbsbLobLgLsbLhbLjbLsbRsRsLsmbRsbLgbLgbRgRsmbLibLgbLgbLjbRsRs
mbRgbLjbLhbLsbLiRsbLgbLsbLjbLgbRiLsbLgbLibLibRjbLibRjbLjbLsbLibLgbRsbR
sbLjbLcLsmbRsbLhRsbRgbLsbRibRobLgbRgbLhbRebRiRsLsmbLsbLebLibRgbLibLhbR
ibLgLsbLiLsbLsbLibLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 21; Drug: Control
bLsbRgbRsbRgRsmbRgRsmbRgbRgbLsRsbRgbRgbLsbRibRgbRgbRgbRsbsbRsbRgbRgbRg
bRgbRgbRgbLgbRhRsmbRgRsLsmbRibRgbLsbRgRsmbRsRsmbRgbRgbRgbRgbRgbRgRsmbR
gbRgbRgbRgbLsLsmbRgRsmbRgbRgbRgbRsbRgbRsbRgbRsLsbRibRgbRgbRgbRgbRibLsR
sbRgLsRsbRsbRgbRgbRsLsbRgbRgRsmbRgbLsbRgbRgbRgbRgbRgRsmbLsbRibRgbRibLg
bLgbRibRgbRgbRgRsmbRgbRgbRgRsmbRgbRgRsmbRsRsmbRgbRgRsRsmmbRsbRgbRgRsmb
RgbRgRsmbRgbRgbRgbRgbRgbRsbLsbRgbRgbLgbRiRsmbLsbRibRsbRibRgbRgbRgRsmbR
gbRgbRgbRgbRsbRibLjbRiRsmbRhRsmbRcbRibLibLibLgbLsbLgbRgbLgbLibLsbLgbLi
bRcbRsbRcbLgbLibLgbRobLgbRhLsbRgbLiLsbLibRjbRibRibRiLgRsbRgbRgbRgbLgLs
bRgbRgbRgRsmbLsbRibRgbRgbRgbRhbLibLiLsbRgbRibRgbLsbRibRgbLsbRibLgRsbRi
RsRsmmbLsLsmbRiLsbRibRgbRgbLsbRgbRsbRgbRgbLsbRgbRgRsmbRgbLgbRibRgRsmbR
gRsmbsbRsbRgbRgbRgbRgbRgbLsbRgbRgRsmbLgLsbRgRsmbRsbRibRgbRgbRsbRgRsmbR
gbRgbRgbRgbLsbRgbRgbRgbRgRsmbRgbLsLsmbRiRsmbRgbRgLsbRgRsmbRgRsmbRsbRgb
RgbLsbRgbRgbRsRsmbRgbLsRsbRgbRgbRsbRgbRgbRgRsmbRgRsmbRgbRgbRsbRsbRgbRg
bRgbLsLsmbRibLsbRibRgbLgbRgRsmbRiRsmbRgbRsRsmbRgbRgLsbRgbRsbLsbRgbRsbR
gbRgbRibRibRibLiLsbLcbRgLsbLgbLiRsbRibLibLibLgbLiLsRsbRgbLibLgbLsbLsLs
mbRibRhLsbRiRgbRibRgbRgbLgLsbRibLgbRiRsLsmbLsbRgRsmbRgRsmbRgbRsRsmbRgb
RgbRgbRsbRsbRibRhbRcbRibRgbRibLgbRgRsmbRsbRibRibRgRsmbLsbRibsbRgRsmbRg
LsbRgbLgbRcRgRgbRgRsmbRibRgbRgLsbRgbRgbLsbRsbRgbRgbRsbRgbRgbRgbRgbRgbR
gbRsbRsbRgbRgbRgbRgbLsRsbRgRsmbRsbRgbRgbRgbRgbRsbLebLibLiRsbLgbRibRhbR
cbRgbLgbRsbRibLjbRhbLsbRiLsbRibRcbRibRhbRgbRibRgbRgbRgbRgRsmbRgbRgbRgb
LsbRgbRsbRibRgLsLgRsbRibRgRsmbRgbRsbRgRsRsmmbRgRsmbRgbRgbLsbRgRsmbRgRs
mbRibLibLhbLibRgbLgLsbLgbLcbsbRiRsmbLobRjbLhRsbRsbLgbLsbLgbRsbLgbLsbRs
bLgbLiRsbRsbLgbLgbLibLibLgbLgbLgbRsRsmbLibLgbRsbLhbRcbRiRsmbRibRsbRgbR
sbRgbRsbRgbRgbRgbRgbRgbRsbRgbRsbRsbRgbRsbRsbRgbRsbRiRsmbRgRsmbRgbRgbRg
bRgbRgbRgbRgbLsbRsbRsbRgbLsbRgbRgRsmbRgRsmbRibRsbRgbRgbRgbRgbRsbRgRsmb
RgRsmbRgbRgbRgbRgRsmbLgbRgbRibLcbLcLsLsmmbLibLiRsbRsRsmbLibLgbLibLgbLg
bLgRsbLgbLgbLgRsbLgbRsbLgbRsRsmbLgbLhLsbRsRsmbLgbLgLsbLiRgLsbLhbRsbLob
LsLsmbRsbLgbLgbRsbLgbLgbLsbLsbLgbLgbLgRgbLgbLgbLgbLsbLgbLhbLiRsbLgRsbL
gbRgLsbLiRsbLgLsbLgbLibRsbRebRibLsbRsbRgbRsbRgbRgRsRsRsmmmbRgbRgbRoLib
LgLsbLcbRibRjbRibRgbRgbLebLhbRjbRcbRiRsmbRgLsbRsbRgbRgbRsbLsbRgbRibRiR
smbRibRiLsbRgbLiRsbRibRgbLsbRgRsmbRsbRgRsmbRgbRgbRgbRsbRiRsmbRsbRgbLsb
RgbRgbRgbLibLsbRibRgRsmbRgbRgbRgbRsRsmbRgRsmbLsRsbRgRsmbRgRsmbRgbLsbLs
RgbRgbRgbLsRsbRgbLsbRibRgRsmbRgbLcbLgbLgbLgbLsbLsbLgbLsLsmbLgbLsLsmbLs
bLgbLgbLibRcbRgbRebRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 22; Drug: Control
bLcbLsbLiLsbRsbRjbRgbLcbRibRibLgLsbLgbRiLsbRsbRsLsbRsbRiLsbLcbLibRgbLi
LsbLsbLgbLsbLsbRsbLgbLgRsLsbLsbLgbLgbLsLsmbRsbLibRsLsbRsbLibRjbLgbLgbL
gbLgbRsbLibLsbRjbRibLsbLsbRebLsbRcbLebLibLibLgbLsbLgLsLsmbLgbLsbLgbLib
LsRsbLibLgbLgbLgbRsbLsbLibLsbLgbRsbLgbLgbLibRgbRibRibLjbLibLcRsbLgbLib
LiLsbRgLsbRjbRgbRsbRibRibRsbRhLsbRcbRgLsbRgbRiRsmbLibLiLsbLiRsbLsbLibR
ibLhbLibRsbLibRgRsmbLsbLibLsbLgRsbRibRgbRgbRibLjbLibLsLsmbLibRjbLibLsb
LibRhbRibLibLibRcbRhLsbLjbRibLcbLhbRgbLibRgbLibLgbRgbLibLsbLgbLsbLgbRs
bRsbRsbLibLsRsbLibRsbLgbLgbLsbLgLsbLgbLsbLsbLsbLgbLgbRjbsbLgbLgLsbLsLs
mbLgbRgbLgLsbLgbRsLsbLgRsbLsbLgbLsLsmbLsLsLsmmbLgbLsLsmbLgbLsbLgbRsbLg
bLgRsbRsbRsbLgLsbLcbRsbRgbRibRgbRibLjbLibLibLgbRsbLibRsbLgbLgbRibRiLsb
LgbRhbRgRsmbLjLibLiLsbLsbLibRsbRjbRibRibRgbRgbRibRhLsLsmbRcLsbRiLsbRgb
RgRsmbRgbRgbRsbRgbLsbRgLsbRibRoLsbRcbRgLsbLibLgLsLsmbRsbLibRsbLsbLsbLg
LsbLsbLgLsbLsbLsbLsbRsbLibLsbLgbLsbRsbLibLgbLsbLgbLsLsmbsbLgbLgLsbLsbR
sLsbLgLsbLsbLsbLibRsRsmbLgbLgbLgbLibLgLsbRgbRibRgbRibLgLsbRoLsbRgRsmbR
ibRgbRcbRgbRgbRcbRobRhLsbRibRgbRibLjbRibsbRgbRgLsbLgbRiLsLsmbRiLsLgRsb
RhLsbLsbLjbLibLibRsbRsbLgbLgbRsbLgLsbRgbLibLjbLsbRgRsmbRjbRibRibRgRsmb
RgbRibLhbRibLhbRibRsbRgbLsRsbRgbRgbRgbLgbRgbLsRiLsbRgbLsbRibRiLsbRcbRg
bRgLsbLibLibsbLgLsbLgRsLsbLgbLgbRsbLibRsbLgbLgbsbRsbLibLsbRgLsbLgLsbLs
bLgbRsbLiRsbLsbLgbRsRsmbLgLsbLgbLgLsbLgbLsbLgRsbLsbRsLsbLsLsmbLgbLsLsm
bRsbLjbLsbLsbLibRcLsbRibRcbRgbRcLsbRcbRcbRibRgbLcLsmbLgbLhbRjLsbsbLgbR
sbLsbLcbRsRgbLcLsmbRibLsLsmbLhbRjbLgbLgbLsbLsbLgbRsbRsbsbLgbLsbLgbRsbR
sbLiLsbRjbLsbLibRgbRcRiLsbRcLsbLjbRcbRhbRgRsmbLgbLgbRjbRibRcbLibRcbLgb
RcbLibLiLsbLiRsbRiLsbRcbsbLgbLobRsLobLgbRgbLibLsbLgbRjbRcbRhbRibLsRsLs
bLgbLgLsLsmbLibLiLsbRgbRcbLhbLiLsbLibLgRsbRiLsbLibRgbLibsbLsbLsbLgRsbR
sbLsbLobRgbRibRsRsmbRiRsmbLgbLibRibRibRgbLobLcbRgbRjbLibLibRibRhLsbRoL
sLsmbRsbRcbLibRjRsmbRiLsbRibRgbRibLsLsLjmbLiRsbLoRsbRiRsmbLiLsbLobLobL
ibLibLgbLsLsmbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 23; Drug: Control
bsbLhbLcbRjbLibRibRhbLgbRjbLsbLgbRsbRsbRgbRgbRgbRgbRsRsmbRgbRgbRgbRgbR
gbRgRsmbRsbLgbRgRsmbRgbRsbRsbLsbLibLgbLgLsbLgbRgbLgRsRsmbRsLsbRjbLiLsb
RjbLebRjRsmbLcbRjbsbLsbRjbsbRsbRgbLjbLjbsbLibRibRgbRgbRgbRsbRgbLsRsbRg
bRsbRgbLsbLibRcbRibLjbLjbLgbLiRsbRjbLiRsbRibRgbRsbRsbRgbLgbLhbLgbLcbRe
bLcbRcbRhbRgbLsRsbLsRsbRiLsbLjbRibLcbRiRsmbRgbLsbRjbsbLsLsmbLsRsRsmbRg
bRsbLsbsbsbLsRsbRsbRgbRgbRgRsmbLsbRgRsmbsbRsbRsbRsRsRsmmbsbRsbsbRsbRgb
LsRsbRgbRgbsbLsbRgbLsLsmbRsLsbLhbRibRgRsmbLjbLibLgbRgLsbLgbRsbLgbLgbLi
bLhLsbLhbLgbLsbLgbLgRsbsbRjbLebRjbRjbRiLsbRgRsmbRsbRgRsmbRgbRgRsmbLsLs
RsmbRgbRgRsmbLsbLgbRsbRjbRsRsmbLgbRsbRsbRgbLsRsbRsbRgbRgRsmbRsbRgbRgRs
mbRgbLgbLhbLgbLiLsbLibLgbLgbLibLcbLcbLobRjbLibLgLsbLsLsmbLiRsbRjRsmbLi
bRjbLjbLibRjbLcRsLsbLgbLgbRsLsbRjbRjbRsbRgbLsRsbRsbRsbLsbRhbLibRgbRgLs
bLgbRgRsmbLjbLcbRjbRibRgbRgRsmbRsbRgbRsbRgbLgbRibLsRsLsbRcbLiLsbLsbRsb
RsbLsbLjbRibLibRibRibRsbRobLhbRibLobRibLibLhRsbRhbRibRsbLjbLhbLibRhbRo
bLhbLibLobLcRsbRcbLhbLibLgbLsbLjbsbLsLsmbRjbRibRgbRgLsbRsRsmbRgbRsbLsb
RgbLsbLsRsbRsbRgbsbLsbRibLgLsbLibLgRsbLgbLsbLsbLeRsbRsbRgbLcbRjbLgbLgR
sbRcbRibLgbRgbLsbsbsbRsLsbRibLgbRgbRgbsbRsbLsbRsbRgRsmbsbRgbRsRsmbLsLs
mbRgbLcbLhbRjbLcbRsbRhbLjbLiLsbLibRjLsRsbRobLjbRiLsbLcbLgbRjbLcbRibRcb
LjbLgbLsbRcbLgRsbRsbRgLsbLsRsbRgRsmbRgbRsbRgbRibRsbLsbRgbLgRsbRibsbRcb
LjbRsbLobRibLibRhbRgbRsbRcbLibsbRsbRibRsRsmbsbRgRsmbRsbRsLsbRhbLgbRhLs
bLgbRibLjbRibLjbRibRgbRgLsbLjbRibRgbRsRsmbLsbsbRsbsbLsLsmbLsbsbRgRsmbR
sbRgbLgRsbRgbLsbRiLsbLgbRgbLobLgbRjbLiRsbRjRibLcbLgbLgbRcbRibLsbRgRsmb
sbRibLhbLobRjbLibLgbLsLsmbLgbLgbLibLgbLgLsbLsbRjbRiLsbRsbRgbRsbRibRgRs
mbRgbRsbRsbRgbRgbsbRsRsmbLhbRcbLjLsmbLibRjbLcbRgbLhbRgRsmbLjbLgbLiLsbR
ibRhbRgbRgbLsbRsLsbRgRsRsRsmmmbLsbRgRsmbRsbLsbRhLsbLibRgbRgbLcLsLsmmbR
obLjbLibLgbLgbRgbRoRsmbRgLsbRsLsbRsbLsRsbLgbRsbsbLsRsbRgbLsbsbLjbLibRj
bLjbLhbRjbRjbRgbLsbRgbRgbLsbRgbLgRsbRgbRgbRsbLgbLcbRhbRgbLebLibLibLgbR
iLsbLibRgbLhbRibRcbRgbRgbRgbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 24; Drug: Control
bRsbRgLsRsbLsRsbLjbRcbRsbLgLsbLgbLgbLgRsbLgbLgbLgbLsLsmbLgLsbRsbLgbLgb
RjbRiRsmbRiLsbLjbLiLsbLgbsbLsbLsbLgbLgbLsLibLgbLsbLgbLgbLgbLgbLsbLsbLs
RsbLsbLgRsbRjbRobRiRsmbLjbRhbLsbRibRibRibLiLsbLsRsbRibRcbRcLsbRsLsbLib
RsbLsbLgRsbLgbLsbLgbLsbLgbLsbLgbLgbLgbLgLsbLsbLgbLsRsbLgLsbLgLsbLsbLgL
sbLibLsRsbLgbLgLgbLsbLiRgbLibLgbLgRsbLgbLsbLgLsbLgbLsbRcbRiLsbLsbRibRg
bRibRgbRcbRgbLsbRgbRhLsbLsbRsbRgbRibLgbRgbRgbLjbRiLsLsmbRibLsbRgbLhbLc
bRcbLsRsbRobRiLsbLgbRibLcbRsbLhbRibRobRcRsLsmbRebRiRsmbRiRsLsmbLgbRibR
sbRgRsRsmmbRsbRsbRsRsmbRgbLsRsbRiLjbLibLibRjRsmbRcRsmbLsbLgRsbRgbLcLsR
smbLibLiRsRsmbRibRibRgbsbRsbRgbRgbRsbLjbLhbLgbLgbLibLibReRsmbRobRcbLgb
LibLgbRcbRgbRgLsbRgRsLsmbRsbRibLjbsbRibRgbRsLsbLsbLjbLibLgbLiRsbRjbLsR
sRsmbLgbLhRsbRibLiLsbLgbLgbRjbRibLibLibLgbLgbLgbLgbLsbLgbRsbLibLibRcRs
mbRsbRcbRgbRgbRibRiLsLsmbLgbLjLsmbRhbRibLhbRcRsmbRsbRgbRgbRsRsmbRgbRsb
RsbRibRgbRibRibLgbRibRsbRsbRgbRgbRgRsmbRsbRgbRgbRgbRgbRgbRsbRgbRgbRgLs
bRgbRibRgbRsbRiLsbRiRsmbRsbLjbRjbRiLsbLcbRhRsLsmbRsRiRsmbRsLsbRsbRjbRs
LsbRgRsmbRsbRgLsbRgbRgbRgRsmbRgbRgbRgbLsbRsbLcbLgRsbRcbLgbRgbRsbRibLgb
RsLsbRhRsmbLibRhbLhbLjbLcbRibRhRsmbLsRibRsbRgbRgLsbRibRsbRibLsbRiLsLsm
bLebRgbLibLgbRebRibLsbLoRsLsbRcRsmbLcbRcbRsbLsbRsRhbLgbRgRsmbRhbRobRcb
RhbRsbLgbRibRsbRgbRgbRsbRgRsmbRgbRsRsmbRgLsbRsbRgbRgbLsLsmbRibLjbRgbsb
RiRsmbRsbRibRsbRsRsmbRgbRibRgbRgRsRsmmbRsRsRsmmbRsLsbRgbsbRgbRsRiRsmbs
bRgRsmbRsbRibRsLsbLsRgbRsbRgLsbRibRsbRgRsRsmmbRhbLgbLsbLjbRjbLhbRgbLib
RcbRobLibLgbRsbRcRsLsmbLsbRibRibLibRibLsbRiRsmbsbsbRgbRsRsmbsbRsbsbRsb
RsbRgbRiRsLsmbRsbRsbRgbRibRgbRibLsbRgbsbRgRsmbRsbRsRsmbRgbRsbRsbRsbRgb
RgbRibRgbRgbRibRiLsbRsbsbRibRsLsbRsbRgbRsbLcbLibLcbLcbRcbLibRcbRcbRhbR
gLjbRhbRgbRsbRgbRgbRgbLsbLjbLibLgbLibRjbLcbLgbLibsbRjbRoLsbLjbLibLiLsb
RsbLgbLgbRsLsRsbRjbLsLibRjLsbLibLgRsbRjbRibRibRsbRibRgbRsbRcLsLsmbRebR
ibLsLsmbLhbLhbRgbLibRcbRcbRcbLibLgLsbLgRsbLcRhbRcbLcbLcbLsbLcbRjRsmbLc
bRibRcbRcbLibLibLcbLgbLibLgbLgbLibLgRsbLsbLibsbRjbRgbRgbRsbRgbRjbLhbRc
bLcbRcLjbRsbRibRsbLcbLgbLibLgbLsLsmbRsbLsLgbsbRsbLjbReLsbRibLsbRiRsmbL
sbRiLsbLjbLiLsbLibRsLsbRsLiLsbLgbLsbLeRsbRibRibRsbRibRgbRgbRsbRgLsbLsb
RgRsmbRsbRsbRibRsLsbLsRsbRiLsbsbRsLsbRsRsRsmmbRgRsRsmmbRgbRsbRsLsbRgbR
gRibRgRsmbRsbRibRsbRiRsRsRsmmmbRsbRgLsbRgbRgbRgbRgbsbRgbRgbRsbLgbRsbRi
bRsbRsbLsbRgRsmbRsbRgbRsbRgbLibLgbRcbRcbRhbLibRiLsbRibRibRsbRsbRiRsmbR
sbRgbRgRsmbRsbRsLsbRsbLsbRsbRsbLsbRgbRibLgbRiRsmbRsbRsbLsbLjbLibLiRsRs
mbRjbLcRsbRsLibLsbLsbLibRsbLibLibRiLsbLibLcLsmbRgbLibLgLsbLiRsLgbRjbLi
bLibLgRjLsbLsbLgbLibRjbLgLsbLgbRsbRjbRhbRibRibRiLsbLsRsbLibRjbRhbLjbLh
bLgbRsbRsLjbRsbLiRsbLsLsmbLsbLibRgbLcbLgbRsbRiRsmbRcbLiLsbLjLsLimbLgbL
sb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 25; Drug: PCAP2 10 然
bLebRebLgbLibLgbLsbRibLibLebReLsbRgbRgbRibRcbLcbRhbRibRsbLsbRsLsbRibRg
bRsbRgLsbRgbRhbLhLsbLgbLsLibLibRsbRgRsmbLibRcbRsbRgbRibRsbLjbLcbRcbLiL
sLsmbLibLcLsmbLhbLibLgLsbLibLibLcbRebRgbRsbLhLsbRgbLibLibLsbLsbLcbLgbR
ibRiRsLsmbRsbRgbRsbRgbRgbRgbRgbLsbLhbLcbLhbLcbLsbRsbRibLjbLcbLgbRsLsbR
jbRibRjbLsbRjbRiRsmbRgbRgRsmbRsbRgbRgbLsbRiRsRsmmbLgbRibRsbLsbLjbRhbRc
RsmbLsbLsRsbRjbRsbRgRsmbRsbRsRsmbRgbRsbRgbRgbRgbLsbRgLsbRgbRsbRiRsmbLg
bRcbLiLsRsbLgbLibLjbLgbLjbsbsbRcbRcbLiLsbLsLebLibRobRcbLgRsbLibLibLgbs
bRcbLcbRcbRcRsmbLibLibLibLgbLgLsbRsbLsbRjbRcbLsbLibRobLsbRiLsbLgbLsbRs
bLgbLibLgbLibLjRsbRjbRcRsmbRgbLsbRgRsmbRsbLsRsbsbRsbLibLgLsbLgbLsbLsbL
gbLgbRsbLsRsRsRsmmbRibLjbLibRcbRcbLgbRhbRgbRgbRgLsbRgbRgbRsRsmbRiLsLsm
bLhbRcRsmbRcRgbLgLsbLibLgbLsbLsbRsbRsbRsbRsbRgbLgbLcbLsbRsbLcRsbRebRgL
sbRgRsmbRgbRgbRgbRgbRgRsmbRsbRibRjbRhRsmbLsbLcbLeLsbLebLsbRsLgbLiLsbRs
LjbLsbRsbLibLsbRgbLibLsbLgbLcbLebLgbLsbLgLsbLgLsbLsbRsbRjbLgbLibRcbRcR
smbLibLiLsbLcbLebLsbLibRgbLibLgbRibRjRsmbRcRsmbLgbLgbRcbLgbRgbRiRsmbRs
bRsbRsbRgbRhRsmbLebLcbRsLsLsmbLibRsbLibLgbLgbLgbLebRsbLgbRsLsbLgbRsbLi
LsbLgbLgbLgbLebRjbLgbRebRiRsRsmmbLebLibLcbLgbLeLsbLgLsLsmbLsbLgbLgbLgb
LgbLjbsbLgbLsbLsbLsbLgbLgbsbRsbLibLgLsbLgbLgbLgbLibLcbLgbLibLibLgbLsbR
sbLcbLibRgbLibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 26; Drug: PCAP2 10 然
bRsRsmbRgbRsbRgRsmbRgbRiRsmbRibRhRsRsmmbLgbLeLsbLgbLgbLgLsbLgbRsbLgLsb
RgbLibLcLsmbLibLibLgLsbLgbLoRsRsmbRiRsmbLcbLibLgbLgbLgbLgbLgbLsbLgbLgL
sbLgbLsbLgbLsbLgbLgbRebsbLsRcbRgbLgbRiRsmbRiRsRsmmbRsbRgbRgbLsbRgbRgbR
sbRsbRiRsmbRcbRibLibLibRcbRcRsmbRgRsmbLgRsbRgRsmbRiRsmbLgbRhbRhbRibRgb
RibRgbRgbLcbLibLhbLgbLgbRcbRgbRgLsbRgbRcbRcbRhbRhLsbRgRsmbRgbRgbRsbRsb
RgRsmbRgbRgbRsRsmbRsRgbRsbRgbRgRsmbRgbRsbRsbRsbRgbRgbLjbLcbLibRjRsmbLi
LsbRcbRcbLjbLsbRsLsRsbRsbsbRhbRobRibLsbRibRgbLjbLgbRebLcLsmbLibLsbRcRs
mbRibRhRsmbRibLsbLjbLibLgbLgbLsbLgbLgbLgbLibLibRhbRsbLibLibRjbRhLsbRsb
RgRsmbLsbRgRsmbRsbRgbLsbRgbRgbRgbRgbRgRsmbRsbRgbRgbRgbRsbRgRsmbLcbLiLs
bRjLsbLibRsbLiRsLsRsbRebRhbRgRsmbRgbRsbRgbLsbRhbLiRsbRibLsbRibRgbRgbRg
bRgbRgbRsbRgLsbRgbRsbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsbRiLsbLcbLcbRsbLi
bLcRsbRsbLgbRebRhbLcbLgbLgbLgbsbLsbLgLsbLibRgbLibLgbLgbLgbLgbLgbLgbLgb
LgbLgbLgLsbLgbLjbLsRsbLhbLgbRgbRcbRsbRcbRiRsmbRcRsRsmmbRiRsmbRgbRsRsmb
RgbRgLsRsbRsbRgbRgbRgbRgbRgbRgbRgRsmbRgRsmbRgRsmbRsRsmbRgbRgbLcbsbLcbL
cbLcbLgbLsbLobLibLibLsbLsbLgbLgbLgbLsLsmbLiLiLsbLgbLgbLgbLgLsbLgbLgRsb
LgbLgbLgLsbLgbLgbLsLsmbLgbLgLsbLgbLiLsbLcbRibRcRsmbRibLgbRibRgbRgbRgbR
gRsmbRsbRgRsRsmmbLgbRgRsmbRgRsmbRibLhbsbLcbLibRsbLcbRgbLibRgbRcbRiLsbL
gbLjbRjbRgbRibRiRsmbRhRsmbLiLsbRcbLgbRibLsbRsbRsRsmbRgLsbsbRgRsmbRgRsm
bRsbRsRsmbRibLibLcbLgbLhbLcLsmbLibRhbRibLjbRibRibRsbRgbRgbRgRsmbRibRgR
smbRgbRgbRgRsRsmmbRgRsmbRgbRgbRgbRsRsmbRgbRgbRsbRgRsmbRgbRiRsmbLibLoLs
mbLibRgbLhbLobLcbLcbLcLsmbReRsmbReRsmbLibRobRibRhRsRsmmbRgbRibRcbLibRc
RsmbRcbRgbRsbLcLsmbLibLobLhbLgbLibLgbLsRsbLsbLsRsbLgbLgbLsbLgbLgbLsbLg
bLgLsbLgbLsbLgbLgbLsLsmbLgbLgbLgLsbLgbLcbRhbRgRsmbRgbRgbRgbRgbLjbRjbRo
bRibLibLibRsbLgbLsbLgLsRsbLgRsbLgbLgLsbLgbLgbLgLsbLgbLgbLgbLgbLgbLgbLs
bLsLsmbLgbLgbRgbRhbRibRibRgRsmbRiRsmbLjbLcRsbRgbLibLgbLsbLgbLgbLgLsbLg
bLgbLgbLsbLgbLgbLsbLgbLsbLgbRcbRibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 27; Drug: PCAP2 10 然
bsbRhbRibRiRsmbRsbLgbRoRsmbLiLsbRibLsbRhbLebLcLsmbRibLibLgbRsbLsbRsRsm
bLgbLsbLgRsbLsbLgbLgbLsLsmbLsbLsbLgRsLsbLgbLgbRgbRjRsmbRcbLgRsbLjbLibR
cbRcbLjbRibLsbRcbLibsbRiRsmbRgbLgbRiLsbLsbRgbRcbRhRsmbLgRsbRcbRiRsmbRg
bRcRsmbLgbRsbLgbLgbLsbRsRsmbLsbLsbRsbLgbLgbRobRgbLiLsbLibLgbLeLsbLcbLc
bRcRsmbRcbRsbLgbRsbLibLibLgbLgbLgRsbLiLsbLgbRoLsbRgRsmbLsbRibRsbRiRsmb
LjbLhbLibLsbLsbLgbRcRsmbRibRoLsLsLsmmbRcRsLsmbRsbLsbRcRsmbRgbRibRibLhL
sbLgbLibLgbRsLgRsbLgbLsbRsbLibLsbLsbLsbLsLsmbLgbLgRsLsbRcbLjbRibLgbRib
LgRsbRcbLibRcLsbLibRcbRcbRsbRgbRcRsRsmmbLjbRibLsbRiRsmbRsbLsLsmbRgbRgR
smbRgbRgbRgbLjbLhRsbLibRsbLsLsRsmbLibLsbRsbLsbLibRsLsbRoRsmbLjbLeLsbLc
LsmbLcLsmbLgbRiRsmbRibRsbLjbLobReRsLsmbLibLibLsbLsbLcLsmbLcLsmbLiRsbLi
bRobLiLsbLjbLibRsRsmbLoLsLsmmbLibLgbLsbLibLgbLsbLsbLgbRoRsmbRibLsbRgbR
ibLsbRgbRgbRsLsbLsLsmbLjbLibRsLsbLibLsbLsLsmbLgbLsbLiRsbRibLgbLgbLsLsm
bLgbRsRsmbLgLsbLgbRgbLgbLgbLsbLgbRjbRcRsmbRcbLebRjRsmbRibLjbRcbRhbLgbL
gbRhRsmbLsbRibRgbRgRsmbLgbRsLsbRgRsmbRsRsmbRgbRoRsRsmmbRiRsmbRibRiRsmb
LgRsbLsbLsbRiLsbRibLsLsmbLsLsmbRibRgbRsbRgbRibRcbRibLibLiRsLsLsmbLsbRc
bRhbRibLsbLsbRobRhbLgbLgbLibLgLsbLgbRobLebLibLsLsmbRobRcbRcbLeLsbRibRi
bLsbRibRibLgbRgbRgbRsbRgbRsbRgbRiRsmbRgbLebLiRsbRjRgbRsRsmbRgbRgbRgLsb
LhLsbLsbLoRsbRibRgRsmbRsbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 28; Drug: PCAP2 10 然
bLibLgLsbLgbLgLsbLsRsbLhbRcbRcbRiRsRimbRiRsRimbRibsbRiRsmbRibRibRgbRoR
sRimbRhLsbRiRsRsRgmmbRiRsmbRgRsmbRibRiLsbRiRsmbRgbReLsbRcbRhbLcbLcbLgL
sbLgbLibLibLiLsbLgbLibLgbLiLsbLgbLgLsbLgbLgbLibLibLsbRhbRibLsbRibRcRsm
bRiRsmbRiRsRsmmbRibRiRsLsmbRibRebRhbRsRcRsmbRiRsRsmmbRiRsmbRibRgbRiRsR
iLsmbRiRsmbLsLsmbLjbLhbLiLsbLgLsbLgbLiLsbLgbLgbLiLsbLgRsbLgLsbLgbLgLsb
LgLsbLgLsbLibLgLsbLibLgLsRsbLgbLgLsbLibLiLsbLgbLgbLiLsLiLsbLgLsLsmbLgL
sbLgbLgbLgbLgLsbLgLsbLgbLiLiLsRsRsmbLiLsbLibLgLsbLgLsbLgRsbLgbLoLsLcmb
RgRsmbRibRiRsRsmmbRgbRgRsmbRibRiRsmbRgbRibRiRsRsmmbRibRgRsmbRibLibLebL
hbLgLsbLgLsbLgLsbLgbLgbLgLsbLgbsbRsbLgLsbLgbRcbRibRibRgRsLsRimbRibRgbR
iRsmbRiRsmbRibRgbRcLsbRhbRcRsmbRibLjbLcbLgLsbLgLsbLgbLgbLgLsbLiLsbLgLs
bLgRsbLiLsbLibLibRobRcbRhbRcLsbRcRsmbRgbRjbRcbRgRsmbRibRiRsmbRiRibRibR
gbRibRgbRgbRgbRgbRcRsmbRgbRsbRibRiRsmbRgbRgRsmbRgRgbRiRgbRibRgbRgbRgbL
ebLgbLsbLobLgbLiLsbLgLsbLgLsbLgbLgbLgbLgbLgLsbLibLibLiLsbLiLsbLgLsLsmb
LgLsbRhbRcbRhRsmbRibRibRgbRiRsmbRibRgRsRsmmbRgRsmbRibRiLsbRgbLibRhbRgb
LjbRhRsRsmmbRibRiRgbRiLsbRibRiRsmbRibRgRsmbRiRibRobRibRhRsLsmbRgRsmbRi
RsmbRiRsmbRgRsmbRgbRiRsRhmbRibRgbRobRibRgbRsbRibRibRibRgbRsbLibLjbRgbR
ebLjbLsbLcLsmbRobRiRhRgbRiRsmbRgbRibRgRsmbRgbRsRsmbLebLhbRjbRhbRiRsmbR
iRsmbRibRibRgbRgbLebLiRsbRjbRcbLcRsbLhbLibRsbLhbLibLsbRsbLibLibLgbRebL
sbLibLgbLgbLsbRobLjbLoRsbRebRibRgbRibRgbRiRsRsRgRsmmmbRiReRsmbRgRsRimb
RgRsmbRiRsmbRibReRsmbRibRiRsmbRiRsRsmmbLsbRsbLcbRebsbRibRsbRgbRibRgbRg
bRgbRgbRsRibLcbLgLsbRcLsRsbRgbRsbsbLjbRiRsmbRibRsRsmbRsbLcbsbsbRsbRcbL
gbRibRhRsmbRgbRgbRgbLcbLibRcbRcbRsbLhbLgbLibLsbLgbLgLsbLsLsmbLsbLgbLsL
smbRsbLcLsmbRhLsbsbRebRibRibRiRsmbRiRsmbRibLobLobLhbLsbRgbsbsbLcbLsbLg
LsbLgbLibRsbLibLhbLcLsmbLcbLgbLhLsbLiLsbLsLsmbLgbLsLsLsmmbLhbLsbLgbsbL
iLsbLgLsbLgLsbLgbLgbLgLsLsmbLibLcLsmbLhbLgbRcRsmbRsRsmbRgRsmbRsbLebLgb
LibLgbRibLiRsbLgbLgLsbLgLsLsmbLgbLgRsLsbLgbLgbLiLsbLgbLgbLgbLgbLgLsbLg
bRcbRgbRibRgRsmbRibRgRsLsmbRgbRiRsmbRgRsmbRiLsbRibRgRsmbRibLobLsLibLgb
Lib

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 29; Drug: PCAP2 10 然
bLgbLgbLsLsmbRhbLsRobRibRgbRgbRgRsmbRgbRgRsmbRgRsmbRsRsmbRgbRgbRsbLebL
ibLibLiLsLsmbLgbLgLsbLgbLgbLgbLgbLgbLgbRsbLgbLgLsbLgLsLsLsmmbLgbLsLsmb
LgbLsbLcbRibRgRsmbRgRsmbRgbRgbRsbRgbLgbRcbRcbRhbRgbRibRgRsmbRgbRgbLsRg
RsmbRgbRgbRgbRgbRsbRsbRgbRgRsmbRgbRsbRgRsmbLgbLgbLsLsmbLgbLgbLgLsLsmbR
ebRsRsmbRgbRgbRgbRgbRgbRsbRgbLibLhbLsbLgLsbLjbRgLsbsbLibLcbLjbLgRsbLgR
sbLgLsbLsLsmbLgbLjbRsRsmbLsbLgbLgbRibRobRibRgbRgbRgbRgbRgbLsbRobRiRsLs
mbRcbRiRsRsmmbRgbRgRsmbRgbRgbRgbRgbRibRibRgRsmbRgbLsbRgbRgbRgRsmbRibRc
bRgbRgbRibRgRsmbRgRsmbRgbRgbLsRsbRibRsRsLsmbLsbRgRsmbRgbRgbRsbRgbRgbRg
bRgbRiRsLsmbLsbRhRsRsmmbRgbRibRgRsmbRsRsRsmmbRgbRgRsmbRgRsmbRgRsmbRgbR
sbLebLgbLgbLgbLgbLsLsmbLgLsbLgLsbLsbLsbLsLsmbLgLsbLgbLsbLgLsbLgbLgbLgb
LgbLgLsbRjbRobRibRgRsmbRgbRgbRgbRgbRgRsmbRgbRgbRgbLsbRcbRcLsLsRsLsmbLs
bLhbLgbLgbLgLsRsbLgbLgbLgbLgbLgbLgbLgbLgLsLsmbLgLsbRsbLgbLsLsmbLgbRcbR
iRsRsmmbRcbRgbLsbRsbRsbLsbRcRsmbRsbRgbLsRsbRgRsmbRgbRgbRgbRsbRgbRibLsb
RibRiRsRsmmbLsbRgLsbRgbRsRsmbRgbRgbRgbRsbRgbRiRiRsRgRsmmbRgbRibRgbRgbR
gbRsbRiLsbLcbLibLgbRsbLgbLgLsRsbLsbLgbLsbLsLsmbLgbLgLsbLgbRhbsbRhbLsbL
ibLsbLgLsbLsLsmbLgLsbLgbLgbLgLsbLgbLsLsmbLgbLgLsbLgbLgLsbLgbLgLsbLgbLs
bLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgLsbLgbLgLsbLgbLgbLgbLhbLgbLgbLgbLgbLg
LsbRebRcRsmbRiRsmbLoLsmbRcRsLsRsmbRhRsmbLhbLeLsbLsbLgbLgbLsLsmbLgLsbLg
bLgLsbLgLsbLgLsbLibLgbLgbLgLsLsmbLgbLgLsLsmbLgLsbLgbLgLsbLsLgbLgbLgLsb
LgbLgbLgbLgbLgbLgbRjbLiLsbRobRgbRgRsmbLobLcbLsbRgbRcbRibRibRgLsRsbRcbL
gbRgbRibRhbRibRsbRiRsmbRgbRsbRibRiLsRsbRgbRgbRgRsmbRsRsmbRsbRgLsbRibLg
bRgbRhRsmbRhbRgRsRsmmbRgbRibRgRsmbRsRsmbLsbRgbRibLgbLgbLgbLgLsLsmbLgLs
bLgbLgbLsbLgRsbLgbLgLsbLgbLgbLgLsbLgbLgbRjbRoRsmbRgbRgbRgbRiRsLsmbRgRh
LsbRibRgRsmbRgbRgRsmbRibLsbRibRgbRgbRgbRgRsmbRgbRiRsmbRsbsbRgbRiRsmbRg
bRgbRibRgRsmbRgbRgRsmbRgRsmbRgbRgbRgbRgbRgbLebLiRsbLgbLgbLgbLgLsbLgbLg
LsbLgbLgbLgbLgRsbLgLsbLgbLsLsmbLgbLgbLgLsbLgbLgbLgbLgLsbLibLibLgbLibLg
bLgLsLsmbLsLsLsmmbLgLsbLsbLibLibRsbLgbLibLsbLibLgbLgLsbLgbLgbLsbLsbLgb
LgbLgLsLsmbLibLibLibLgLsbLjbLgbLgbLgbLgbLgLsbLgLsbLgbLgRsbLgbLgbLgLsbL
iLsbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 30; Drug: PCAP2 10 然
bRgbRsbRiRsmbRiRsRsmmbRcRsmbRiRsmbRsbLobRsbRhbRsbRibRiRsmbRgRsRsmmbRcR
smbRhbRgRsmbRiRsmbRgbRgRsmbRcbRhbRcbRsbRibRsRsmbRgbRgbRebLjbLgbRgRsRom
bRcbRgRsmbRibRhbRsbLsbRhLsbRobRgbRgbLsbLiLsbLgbLgbLgRsbRcbRhbRsbRiLsbL
sRsRsRgRsmmbRgLsRsbRgbRgbRibRgbRcbRibRhbRjbRiRsmbRgbsbLgRsbRsRsmbRcRsR
smmbsbRgRsRsmmbRgbRhbRgLsLsmbRsRsmbLiLsbsbLjbLibLgLgbLiRsbLgLsbLgLsbLg
LsbLgLgLsLgbLgbLsLiLsLiLsbLobRgRsmbLsbRoRsmbRibRibRgbRibRgRgbRobLsbLsb
RoRsmbRsRsmbRgbRibRgbRsbRhRibRibRiRsmbRibRiLsbRgRsRimbRgRsmbRsbRsbRibR
gbRgRsmbRiRsmbRibRiRsmbRcRsLgmbLcbLgbLcbLsbRebRgbRibLsRcLsLsmbLibLibLs
bLgbLgbLgbLgRsRsRsmmbLiLsbRibLcLsmbLsbLgbLsbLgbLiLgbLsbLgbLgLsbLgbLsbL
gbLgbLgLgLsbLgLgbLiLsbLsbLibLgbRcbsbRsbReRsmbRcRsRimbRibRibRgbLsRibLgb
LjbRcbRiRsmbLsRsbRiLsbRibRibRibRgRsmbRiRsRsmmbRibRgRsRsmmbRgbLjbRgRsmb
RgbRgbRgbRgbLsbRcLsbRcbLiLsLgLgbRcRsmbRsbsbsbsbRgbRsRsmbRsbLgbRsbRibRs
RsmbRebRcbRgbRibRjbRsRsmbRgRsmbRiRgbLhbRibLsbLcbLibRcbRgbRgbRgbRgbRoRs
LsmbRsbLsbLgbLsbLibLiLiLgLsbRhbRcRsRsmmbRibLsbRibRsRsRsmmbRiLsbRhbRhbR
ibLebLgbLcbLgRsbRsbRiRsmbRgbRsRsmbRiRsmbRgbRibRsRsmbRgRsmbRibRgRsmbRib
RsRsmbRgbRibRgbRhbLsbRibRsbLsbRcbLsbRcbLobLgbLibLgbLgLgbLgbLgRsbLgbLgL
sbLibLgbRsbRibRcbRgbRiRsmbRcRsRsmmbRhbsbRgbRsbLsbLsbLjbLiLsbLibLgbLgbL
sLsmbLsbRsLsbRcRsmbRsbRibLgbRibRcRibRsbLjLsmbLhbLibLibRibRgRsLsmbLiLsb
LgbLsbLsbLsbsbLibLiLsbLiLsbLiLgLsLsmbLgLsbLoLsmbLhbLiLsbLibRcbRjbRcRsm
bRgRsRsmmbRgbRibRiRsmbRibRgRsmbRgRsmbRjbRsbRgbRgRsmbRibReRsmbLobRhbRsb
RcbRsRsRsmmbRiRsRgRsmmbLsbRcRsRcRsLsmmbRcRgbRgbRgbRgbLsLsmbLibRgLsbRcb
RcRsmbRiRsmbRobRhbRsbRoRsRsRgmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 31; Drug: PCAP2 3 然
bLsbLsbLsbLsbLgRsbLsbLgbLgbLgbRsbLsbRsbLgbLgbLgbLgbLsbRsbRgLsbLsbLgbLs
bLibRsLsbLsLsmbLgbLsbLsbLgbLsbLsbLgbLsbLiLsbLgLsbLgbLibLiLsbLgbLgbLibL
sLsmbRsbLgbLsbLsbLsbLgbLsbLsbLgbLsbLsbLgLsbLsLsmbLgbLgRsbLibRibRgbRobL
sbLgLsbLsbLgbLsbLgLsbRsbLgbLsbRebRhbRgbRjbLgbRsbRebLsbLgbLgbLgbLsbLsbL
sbLsbRsbRcbRiLsbLsbRgLsbRgbRsbLsbRgbRgbLjLgbLgbRibRibRibRcbRgbRgbRibRg
bRsRsmbRgbRgbRgLgbRgRsmbRsbRgbRgbRsbLsLsmbRgbRgbLsbRgbLgbLcbLsbLsbLhbL
ibLibLgRsbLsbRsbLcbRjbRcbRibRgbRsbRgbLsbRgbRsRsmbLsLsmbRgbRgbRsbRgLsbL
gbRsbRgbRibRgbRgbRsbRsbRsbRsbRsbRsbRibLebsbLgLsbRgbRsbLhbLgLsbRsbLsRsL
sbLgbLhbLgLsbLgbLsbRsbLgbLsLsmbLgbLsbRsbLsbRsbLgbLgbLhbLsbLgbLgbLjbLgb
LgbRgLsbLgbLgbRebRibRgbLgbLgbRgbLsbLgbRibRibRgbLsbRgbRsbRgbLsbRgRsmbRg
bRsbRsbRsbRsLjbsbRsbLcbLgbLgbLsbLsbRsbLiLsbLgbLgbLsLsmbLgbLgbLsbRjbRob
RgbRjbRsbLibLsbLsbLgbLgbLsLsmbLsLsmbLsbLgbLjbRgbReLsbRgbRsbRgbRsbRgbRg
bLhRsbRsbLgbLgbLgbLsbLgbLsbLgbLsbLsbLsbLsbLgbLsbLsbLsbLsRsbLjLsmbLcbLs
bLsbLgbLsbLgbLsbLsbLsbLsbRsbLsbLsbLsbRjbRgbRgbLeLsbLibsbLsbLsbLsbLsbLs
LsmbLsbLsLsmbLsbRsbRgbRgbLsbLsRsbLgbLsbLsbLsbLgbLsbLsbLgbRsbLgbLgbRibL
gbLgLsLsRsmbLgLsbLsbLgbLsbLsbLsbLsbRsbRsbLcbLobLibRsbLgbLsbRsbRgbRgbRh
bRsbRgRsmbLgbRgbRgbLjbRjbLebLebLgbLgbLsLsmbRsbRsbRobRgbRsbLgbRgbLibRjb
RibLjbRibRsbRjbRibRcbRjbRibLsbRgbRsbRgbRgbRgbLsbRgbRsRsLsRsmbLsRsbRgLs
bRsbRsbLebLgbLibLhbRiLsbRgbRsbRgbRsbRsbRsRsmbLsbRsbRgRsmbRgbRsbRsbRgbR
gbRgbRgbRcbRibRsbLgbLgLsbLgbRsbLgbRjbLobLsLsmbRgbLsbLcbLgbLgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 32; Drug: PCAP2 3 然
bLgbLibRcbRibRebRgRsmbLsLhbRcbRibLsLsmbLcLsmbLsbLgLsbLgLsbLgLsLsmbLgbL
gLsbLgbLgbLgbLgLsbRsbLibLcbRibRiLsbLsLsmbRjbRibRgbLibRcbRhbRhbRsbRgbLg
RsbLhLsbRsbLgLsbLgbRsbRsRcbRhbRgbRiRsmbRsbLsbRibRgbRcbLhbLcbRjbLoLsmbR
sbLgbLibRgbLibLibRibRsbRgbRcbLibRibLobLcbRibRjbRcbRibRibLsbLgbRibRhLsb
LibLjbRcbRobLibLsRsbRgbRcbRsbRsbRiRsmbRsbRgbLcbRebRcbRcbLcbLcLsmbRibLh
LsbLibRsbLsbLgbLsbLgbLsbLgLsbLgLsbLgbLgbLgLibLgbLibLgbLgbLobRhbRgbRgbR
iRsmbRgbRsbRsbRgbRgbRgbRgbRsbLjbLhbLsbLibLsLsmbLgbLgbLgbLhbRgbRiRsmbRh
bRsRsmbLgbRcbRsbLsbRhRsmbRsRsmbRobLgbLgbRjRsmbRiRsmbLsRsbRibLcbRcbRsbR
iLsbLhbLcbRsbLgbLsbLgbLgbLgbLgbLsbLgbLgbLsbLgbLgbLgbLgbLgLsRsbLsbLsbLg
LsbLgbLgbLsbLgLsbLgbLgbLsbLgbLgbRsLgbLgLsbLsbRhbRcbLebRcbRgbRgbLjbLcbL
ibRsbLgbLgbLgLsbLgLsbLgbLgbLgbLsbLgbLsLsmbLgbLgbLgbLgbLgbLgbLgbLgbLgbL
gbLgbLgbLgLsbLgbLgbLgbLsbLgbLgbLgbLgbLsbLgbLgbLgLsbLgbLgbLsbLgbLobLobL
iLsbLibRsbRjRsmbRhbLebLcbLgLsbLgbLsbLgbLgbLgLsbLsbLgbLgbLgRsbLgbLgbLgb
LgbLgLsbLgLsbLibLgLsbLgbLgbLgbLgLsbLgbRibRobRsbRibRgLsbRoRsmbRgbRgbRcR
smbRhbRgbRgLsbRjLsbRiRsmbRgbLcbLcbRsLsbRsbLgbLgbLsbLgbLsRsbLgbLgbLsbLg
bLgbLgbLgLsbLgLsbLeLsbLgbRjbRcbRgbRiRsmbRgbRgbRgbRgLsbRgbRgbRsbRsLsbRg
RsmbRsbRgRsmbLgbRiRsmbRsbRcbRibLsbRibRsRsmbRiLsbRgbLibLcbLibLsbRgbRibR
cbRgRsmbLsbRsbRiRsmbRgbRgbRsbLobLibLsbLgbLsbLgbLgbLgbLibLgbLgbLgbLgbLg
LsbLgbLgbLgbLgLsLsmbLsbLgbLgLsbLgbRgbRebRgLsbRsbReRsRsRsmmmbRibRjbRiRs
mbRsbRibRsRsmbLibLhbLiLsbLgbLgLsbLgbLsbLgbLgLsbLibLgbLgbRsbLgbRjbRibRg
RsmbLgbRibLgbRsbRibLcbLsbRhbRgbRgbRgbRgbsbRsbLjbRibRibRiLsbLebRsbRiRsm
bRgbRgLsbRgbRgRsmbRsRgbRgbRebLibLgRsbRibRibRibRsRsmbRsRsmbRsRibRsRsmbR
gbRsbRgbRgbRgbRgbLsbRgbLsbRhbRhbRgbRsLsbRsbRhLsbRgbLebLsbLiLsbLsbLsbLs
bLibRsbLiLsbLgLsbLsbLgbLgLsbLgbLsbRgbRebRiRsmbLsbRgbLsbRsLobLgLsbLgbLg
LsbLgbLgbLgbLsbLgbLsbLgbLgbLgbLgbLsLsmbLgbLgbLgbRgbLgbLgbLgbLgbLsbLsbL
gbLgbLgLsbLsLsmbLsbLgbLgbLcbRcLsbRibRibRgRsmbLgbRiLsbRgbRsbRcLsbRcbRgb
LsRgbRgRsmbRsbRgbRgbRibLibLibLgbLgbLgLsbLgbLgRsbLgbLgbLgbLcbLibLibRgbR
ibRgRsmbRsRsmbRcbRgbRiLsbRsbLsbRibRhbRgbLgbRgbRhbLsbLsbRhbRgbLsbRsbRib
RgbRsRgbRsbRgbLjbLcbLiLsbLgLsbLgbLgbLgbLgLsbLgbLgLsbLgbLgbLibLgbLgbLhb
LsbRibRhRsmbRgbLjbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 33; Drug: PCAP2 3 然
bLhLsLsLimbRcRcLsbLibLcbRgRgbRoRsmbRhLsRgbRcRsLsRsmbsbRibRsbRibRhLsbRi
bLgbLgbLgRcbRgRsRsmmbRgRsRgRsRgmmbRgbRgRsmbRgbRibRiLsLsLsmmbRiRsmbRgbR
gRsLsmbRgRsRgLsRiRimbRsbRsbLcbLsbLhbRjbLgbLgbLsLiLgLsbLgbLsLgbLsLsLimb
LsLsmbLgLsLsLgLgmbLgbLgbLgLsLgLsLsmbLgbLibRsbLsbLibLibLcLhbLibLiLsbLib
RsbRibLjLoRgbRhbLsbRibLsbRiLsbLgbRcLibsbRibRiRsmbRiRsmbRiRsLsmbLcbLiLg
RsbLgbLgbRsLgLsbLgLgbLgLgLsLgbLsLiLsLsLimbLsLsmbLgbRcbRhLsbRgbLsbRiLsR
sbRgbRsbRgbLsbRgbLcbRhLsbRiLsbLsbRgbRgbRgbLoRgbRcbRibLsbRgLsbRsbRgbRgb
RgLsbLsbRibLiLsRsbLsLsRiRsmmbRibRsbRiLsbRiLsbRcRibRhLsbRibRgbRcRsmbLib
LcbRsbRcbRibLgbLsbRhRsmbRgbRsRibRsbRiRsmbRsbRgbRgRsmbRgLsbRibRgbRsLsRs
LsbRsbRiRsRsmmbRgbRsRsmbRgbLsRgbRgRsmbLebLibRibRibLcbLcLsmbRsbLibRjbRh
bLoLsLsmmbRjbRcbLgbsbRhRsmbRgRsmbRsbRgLsbRibLsbRgbRsbRibLsbRibLsbRcbLh
bLgbLsLgbRcRsmbRgbLcbLibLgbLgbLsLgbLsbLgbLgbLgbLgbLgbLgLsbLgbLsbLsLgLs
bLsbLgLgbRsLsbLsbRhbRiLjbRiLsRsbRsbLibLgbLsbLgLsbLsLsmbLgbLgLsLsmbRsRs
mbLgbLgbLgbLibRgbLibLgbRsbLgLsLgbRsLsbLgLsbLgbLsbLgbLibRobRsRsmbRgbRsR
smbRiLgbsbLibLiLsbLsLsmbLgbLiRsbRsRsRgmbLibLgLsbLgLsLgbRsLgLgLsLgLgLsb
LgbLsLsmbLgbLgbLsLgLsLgbLsbLgLsbLsbLiRsbRgbLibLibRsLsbLgbLiLsbRsbLgbLi
bRsbLibLgbLgbLsbLgLsbLsbLsbLibLsbLgbRsLsbLibLsLsmbLgLsbLgLgLsbLsbLgLsL
smbLgbLgRsbRsLgbRsbLibRibRcbLgbLcbRibRcbsbLjLgLsbLcLsLsmmbRsbRsbLsLsmb
LibLgbLgbLgbLsLsLgLsLgLsLgmbLgRsLsbLgLsLsmbLgbLgRsbLgbLcLhbRsLcbLgbLsb
LibRcbRcbLjbsbRibLsLsmbRoRgbRgRsmbRibLsbRibRiLsbLcbLhLsLgLsbLibLibLgbR
sbLgLsbLgLsLsmbLiRsbRsRsmbLibLcLsmbRibRhbRcbRiLsRsLsbLsRsLsbRcLsbRgRsm
bRgbRgbLsLsmbRgbRoLsbRhbLcbLhbRibLcLcbLgbLcbRgLsbLiLsbLgbLsbLgLsbLgbLs
bLsbLcbLgbLiRibLcbLibRjbRcLgbRibRgbRsRsmbRibRgbRgbRgRsmbRsbRgRgRsRgmbR
gbRgLsbRibLibLcbLsLgbLibLgbLgbLgbRsbLiLsbLgbLgbLgbLsLsmbLsbLgbRsbRjbLi
bRgbLiLsbLgbLsbRcbRiLsRsbRhRsmbRibRcbRhbLsbRcLsbsbLsbLsbRhLsRsLgbRsbRi
bRhbLcbRibRsRsmbRiLsbLsbLcbLiLsbLsLsmbRsbLiLsbLsbLgbLgLsbLiLgbLgbLgLsb
LgbLsbLibRsbLiRsRgbLiLsbLiLsbLsLsmbLsbLgLsbRjLoLcLsRsmbRsRsmbRgbRgbRsL
sbRgbRgbRgLsbRgRsmbRgbRsbRcRibRcRsmbLsRsbRiRsmbRgbRiLsLsmbLsLsmbRibRib
LcbLcLsmbRsLsbLsLiLsbRsLsLsmbRsRcbRcLgbRibRsbRgbRibRibRibRhRsmbRcLgLsb
RcbLgbRiLsbRgbRgRsRgRsmmbRsLsbRsbRgLsbRibLeLsbLsLsmbLsLsmbLsLsLsmmbLiL
sbLsLsLsmmbLgbLgbLsLsmbLsLsmbLsLgbLgbLgLgbLgRsLsbLgLsbLgLsbLsbLsbLgLsb
LgbLgbLgbLsbLibLibLibRgbLibRhbRibRgbRsbRgbRgRsmbRsbRsbLsLsmbRibRibLibR
ibLebLcbLgbRibLhbLiLsbLibRgbRcbRcbRcbRiLsbRcbRsbRiLsbRcLsbRibRgbLhbLcb
LsbLcbLsbRibRcbLobLcbRgLsRsbLobRsbLcbRsbRsbLcLsRsmbRsLsbLibLsLsLsmmbLi
bRsbLgLsbLsLgLsbRjbRibLcbLgbLgLsbLgLsbRsbLgbRsLsLsmbLgbLsLsLsLsmmmbLeb
LgLsbRsbLgbLgbLsLsmbRcbRibLsbRgbRgRsmbRcLsbLcbLibRgbRgbLcbLibRibLcbRjb
LibLibLsLsmbLgLsbLgbLgLsLgLsLgbLgLsbRsLgLsbLsbLibLsbLgLsbLgLsbLgLgLgLs
bLgLsbLsLsRsmbLgbLgbLgbLgLsbLgbLgbLgLgbLibLibLgbRhbRcRsmbLebLib

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 34; Drug: PCAP2 3 然
bLsbRgbLsbRibRoRsmbLsbRjbRibRgbRibRgbRsRsmbRgbRsbRsRsmbRsbRgbRgbRsbRgb
RsLsbRsbRgbRgbRgbRgbRsbLsbRcRsmbRibLsbLsbLibLibRcbRhbLgbLgbLgbLhbLibRc
bLibLgbLgbLsbLibLibRsLsbLgbLgRsbLgbLgbLgLsbLgbRjbLhbLsbLgbLgbRsbLhRsbL
ibLgbLgbLsbLgbLibLiRsRsmbRgbLiRsbLsLsmbLhbRjbLibLgLsbLibLsbLgLsbLgbLgb
LgbRjbRoRsmbRsbLgbRsbLiRsbLibLiRsRsmbLibRgbRhbLjbLiRsbRsbLibLgbRsbRibL
hLsbLibLgbRsbLgbLhRsbLcLsmbLsbLibLiLsbLgbLgbLgbLgbRgbLgbLgLsbLgbLsRsbL
gbLgbRgLsbLibRhbRcbLgbRgbRsbRsLsbRgRsmbRibRsbRgbRgRsmbRgRsmbRsbRgbLjbL
hbLibLgbRsLsbLgbLcbLcbLcbLhbRsbLibLsbLsbLgbRsbLgbLgbRsbLhbRibLibLsbLib
LibLibRsbLibRsbLgRsbLgbRsbLcRsLsbRibLsbLcbLcLsLsmmbLsbLcbLcbLsbLsbLiRs
LsbLcLsmbRibLibLcbLgbLiLsbRgbLiLsbLgbLsbLgbRsbLgbLgbLgbLsbLsbLgbLhbLgb
LcLsmbRibRsbRsbLcbRsbLibLgbLsRebRibRibRsbRsbLsbRibRgbRgbRhbLcbLsbLcRsb
RcbLgbLobRhbLibLibRsbLgLsbLsbLgbLsbLgbLgbLsLsmbLgbRgbLgbLgLsRsbReRsmbL
gbRsbLsbRibLsbRgRsmbRibLgbRibLgbRsRsmbRgbRgbRsbRgbRsRsmbRibLjbLcbRjbLi
bLobRhbLsbRcbLjbRjLsRsbLibsbRsbRibLsbRibLsRsbRgbRgbRsbRgbRgbRsbRgbRgbR
ibRgbRsbRgbLsbRobLcbLjbLhRsbRjbLhbRgbLhbRgbLibLgbLgbRgbRebLgbRgLsbRsbL
jbLibRsLsbRjbRiRsmbRsbRibLgbRsbRgbRgbRgLsbLsLsmbRgbRgbRsbRgbRgRsmbRgbR
gbRsbRgRsmbRsbRsbRgbRgbLsbRibLsbLhbRsbLibRcbLhbLiRsbRjbLibLgbRsbLgbLsb
LgbLgbLgRsbRsLsbLgbLibRsbLgbRgbLgbLgbRsbLgbLgLsRsbRgbRjbRcRsmbLebLibLi
RsbRjRsmbLiLsbLibLgbRsbLibLgbLgbRjbLsbRcbRgbRgbLsRsbRgbRgRsmbLsRsbRsbR
sbRgbRgbRgbLsbRsbRgbLgbRibRgbRgbLibLgbLgbLgLsbLgbRsbLgbRsbLgbLgLsbLgbL
sbRsbLgbLgbLsLsmbLsbLibRoRsmbLjbRhbRsLsbRgbRgbRgbRibLsbRgbRgbRsbLjLoRs
bRjbLhRsbLgbLsbRsbLgbLgbLgbLgbRgLsbLibLgbLsLcbRebLcLsmbLobLibLsbLhbLsb
RsbLgbLsbLgRsbRsbLgbRsLsRsbRsbLibRsbLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 35; Drug: PCAP2 3 然
bLgbLgbLgbLgRsbLgbLgbLgbLgbLgbLgLsbLgbLgLsbLebLhbsbLhbLgLsbLgbLgbLgbLs
bLgLsbRsbLhbLhLhbLibLibLgbLgbLsbLgbLgbLgbLgLsbLgbRsLsRsbLsbLgbLgLsbLiR
sbRsLcbLgbLsbLiLsbLibLgbLgbLgbLgbLgbLgLsbLgRsbLgbLsbLibLsbLgbLgLsRsbLg
bLgLsbLhbLgbLgLsbLiLsbLgbLgbLgbLsLsmbLgLsbLgLsbLsbLsRsbLgbLsLsmbLgbLsL
smbLgbLgbLgbRsbLibLibLgbLcLgbRgbLcbLhbRiRsmbLibLibRsbLgbLsLgbLsbLgbLgb
LsLsmbLgbLsLsmbLgLsbLgbLgLsbLgbLsbLgbLgbLgLsbLcLsLiLsmbRsbRcRsmbRgRsmb
RsbRgbRsbRsbRgbRgbRsbRsbRgbRsbRsbRsbRsbRgLsbRgbRibRsLsbRsbRgbRcbRiRsmb
RsRgbRgbRgRsmbRgbRgRsmbRgLsbRgbRsbRgbRgbRsRsmbRgbRgbRsbRgbRgbRgbRsbRsb
RgbRgbRsbRsbRsRsmbRgRsmbRsbRsbRsbRsbRgbRsRsmbRgbRgbRsRsmbRsRsmbRsbRgbL
ebLhRsbLgLsbLsbLgbLsLsmbLgLsbLgRsbRibLebLgLsRsbLsbLgLsLsmbLgLsbLgLsbLs
bLgbLsbLgbLgbLsbLgbLibLibLibLgLsbLiLsbLgLsbLgbLgbLsbLgbLgLsbRgbLgbLgbL
gbLgbLgRsbLsLsmbLibLiLsbLsbLsLsmbLibLgbLsbLgbLsbLgbLgLsbLgbLibLiLsLsmb
LgbRgbRcbRgbRsbRiLsbRsRsmbRgbRgbRgbRgbRgbRgRsmbRgbRsbRgbRgbRsbRsbRgRsm
bRgbRgbRsbRsRsmbRgbRgbRsbRgRsmbRsRsmbRgbLibLcLsRsmbLgRsbLibLgbLsbLiLsb
RsbLcbLhbLibLgbRcbRiRsmbRgRsmbRgLsbRgbRgbRgbRgbRsbRsbRsRsmbRgbRsbRsbRs
RsmbLsRsbRsbRgRsmbRsbRsbRsbRgbRsRsmbRsbRsbRsbRgbRgbRsbRsbRsbLsbLjLcLsm
bLgRsbRobLjbLsRsbRcRsmbRiRsmbRsbRgbRsRsmbRgbRgbRgbRgbRgbRsbRsRsmbRsbRg
bLsbRgbLjbLsLsLsmmbLgbLgLsLsmbLgLsbLgbLsbLgbLhbLsbLgbLgbLjbRsbRhbRibRg
bRsbRsbRsRsmbRgbRsRsmbRsbRsbRgbRgbRgbRsbRsbRsRsmbRgbRgbRsbRsbRsbRgRsmb
RsRsmbRgbRgbRsbRgbRgbRsbRsbRsbRsbRgbRgbLgbLcbLibLgbLibLibLgbLgRsbRgbRi
RsLsmbRgbRsRsmbRsbRsbRgbRsRsmbRsRsmbRgbRgbRgbRsbRgbRsbRsbRsRsmbRsbRsbR
sbLjbRcbLjbRsbRhbRobRgbRgbRsRsmbRsbRsbRgbRgbRsbRsbRsbRgbLsbLsbLcbLibLg
bLibLiLsLsmbLgbRsLsbLjbLibLgbLibLgbLsbLsbLgbRgbRsbRebRgbRgbRgbRgbRgbRg
bRgbLsbRebRgbLibLgbRgbRgbRgbLsbLsbLcbLjbLiLsbLgbRgbRgbRgbRgbRsbRgbRsbR
sRsmbRsbRgbRsbRsRsmbRsbRsbRgbLsbLibRsLsbLibLsbLgbLsbLgbLibLebRsbLiLsbL
gbRsbLibLgbLgbLgbLgbLsbLgLsbLgLsbLgbLgLsbLiLsLsmbLibLgbLgbLiLsbLsbLgbL
gbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 36; Drug: PCAP2 3 然
bLibLsbLsLsmbLgbRsbLhbRgbRjbRcbLgbLjbLibLgbRjbLibLsbRsbLebLobRgbRsbRib
RibRgbLgbLibRjbRgbLsbRgbRgbRgbLibLsbLgbLsLsmbLsbLsLsmbLgLsbLsbLgbRsRsm
bLgbLgbLsbLgbRgbRjRsmbRibLsbRibLgLsbRibLgbRgLsbRgbRgbRsbRsbRsbRgbLsbRg
bRsLsbRgbRgbLgbRsbRibRgbLjbRibRsbRgbRsbLsbLsRsbRibRgbLsLsmbRgbLsRsbRgb
LsbRgbRgbRgbLibLjbLhbLsRsbLiLsbLgbLgbLgbLgbLsbLsbLgbLgbLsLsmbLsbLgbLib
LgbLgbLgLsbLgbLgbLsbLgbRsbLgbRsbLsbLibLsbLgbLgRsbRjbRcbRibRsbLgbRibLgb
RgbRgbLjbRgbRgbRsbRgbRgbLgbRgbRgbRsbRsbRgbRgbLsRsbRgbRibRgbLgbRgbRgbLg
RsbRibLgbRgbLsbLhbsbLobRgLsbLsRsbLhbRiLsbLgbLgbRgRsmbLibLsRsLsbRcRsmbR
ibRgbRgRsRgmbRgbLjbRjbRgbLsbRgLsbRgbRsbLsbRgbLgbRgbRsbRgbLsbRgbLsRsbRs
LsbRsbRgbLgbLibLgbLsbLgbLsLsmbLsbLsbLgbRjRsmbLgbLsbLsbLgbRsbLsbLgbLgbL
gbLsbLsbLgRsbLgbLsbLgbRgbLiLsbLgbLgbLibRsbRebRgbRsbRgRsLsmbLgbRgbRgbRs
bLjRsbLobLibRgbLcbLebLsbLgbLsbLjbLibLibRgbLcbLgbLibLgbRhbRgbRsbLsbRibL
gbRhbLgbLgbLjbLibLgbLiRsbLibLibLgbLibRgbRgbRgbRgbRibLsbRgbLgbRgbLsbRib
RgbRgbLsbRibRsbLibRgbRgbRsbRgbRsLsbRgbLjbLcbLiRsbRsbLibLibLcbLsbRibLib
LsbRgbLsbRibLebLgbLgbLsbLsbLibRsLsbLibLsbRsbLgbLgbLgLsbLsbLgbLsbLsbLgb
LsbLsbLsbRsbLgbLsbLgbLsbLgLsbLgbLsbLsbLjbLsbRcbsbLsbRibLsbLebLgbRsbLiL
sbLsbLgbRsbLibLgbRgbLhbRgRsmbRcbRsbLgLsbLsbLgRsbLgbLgbLgbLsbLsbLgbLsbL
gLsbLgbLgbLsbRsbLgLsbLgbLgbLgLsbLgbLgLsbLsbLgLsbLgbLgbRgRsmbLgbLgbLgbL
sbLgbRsbLgbLsLsmbLgbLsbLgbLgbLsbRsbLsbLsbRebRibRgbRgbRiRsmbRibRiRsmbLs
bRibRgRsmbLsRsbRibRgbRgbLgbRgbRgbRgbRsbRgbRgbRibLebLgbLibLsLsmbLibLsbR
sbLsbLgbLsRsbLsbLgbLgbRsbLgbLgbLsbLgbLsbRsbLgbLgbRgbLgbLgbLgbLcLsmbLib
LgbRgbRgbRibRgbRgbRsbRgbRgbRgLsbRgbRhbRibRgbLibRsbLgbLgbLiLsbLsbRgbLib
RjbLsbLsbLgbLgbLgbLsbLgbLsbLgbLsbLsbLsbLsbLhRsbLiLsbRgLsbLsbRgbLibLgbL
gbLgbLgbLobLcbLibLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 37; Drug: PCAP2 1 然
bLsRsbRobRibLsbRoLsbRibLibLjbLcbLcbLsbRibLsRsbRhbLgRsbRhbRgbRsLsbRsbRh
bRibLgbRibLsbRibRsbRibLsbRgbRsbRibRsbRgbLibRsbLobLibLgRsbRjbLibLibRhbL
hbLcRsbLebLhbLibLgLsbLgbLibRgbLibLgRsbRoRsmbRhLsbLgbRcbRhbRibRibRgRsmb
RibLsLsmbRibRgbLsbRgRsmbRgbRgbRgRsmbRgbRgbRsbRgLsbRgLsbLsbRibRsbRiLsbR
sbRibLibLhbLibLibLgbLhbRhbRibRiRsLsmbRhbLgbRibLsRsbRgbRibLsbRsbRsLsbRs
LsbRgRsmbRgbLsbRgbRsbLhbLgbLcbLcLsmbLsbLibRcbLcbRjbRcLsLsmbRibLgRsbRib
LsRsbRibRsRsmbRgbRsRsmbRgbRgbRgbRgRsmbRgRsmbRgbRgbRgbRgLsbRgLsbLjbRibR
sbRibLgbRgbRgbRgbRibLebLoRsRsmbRibRhRsmbRibRgLsbRgbRgbLgbRgbRibLsbRibR
gbRgbRsbRgbRibLibLibLgLsbLibRcbRibLsbRgbRgbRibRibRgLsbRgbRibRgbRsbRgbR
gbRsbRgbRgbRgbRgbRgbRsRsmbRgbRgbRgbRgRsmbRsRsmbRibRgbRgbRgRsmbRgbRsbRg
bRgbRgRsmbRsbRgbRgbRsbRgbRgbRgbRsbRsbRgbRgbLjbsbRhbRgbLsRsbLobLibRobRi
RsmbLsbRgbRgRsmbRgbRgRsmbRgLsbRgRsmbRgbRgbRgRsmbRgbRsbRgbRgbRsbRgbRgRs
RsmmbRsRsmbRgRsmbRibRgRsRgmbRgbRgLsbLsbLiLsbLsLsmbLiRsbRjbRcbRsbRsbRib
RsbRgbRgbRgbRsbRibRibLebLiLsbLibLgRsbRcbRcLsbRsbRoLsRsbLgbRcbRoRsLgmbR
cbRibRgRsmbLsRsbRibLsbRibRgbRcbRcbRibRiLsbRibRgbRgbLgRsbRibRgbRgbRgRsm
bRgbRsbRgbRsbRgbRsbRgbRsbRibRgbRsbRgbRgbRgRsmbRgbLjbRibRgRsmbRgRsmbRgb
RsbRgLsbRgbLsbRibRgbRiLsbLgbLgbLcRsbLibLsbLibLgbLgbLsRsbLibRibRcbRgbRs
bRibRgbRsRsmbRgbRgbRgbRgbRgbRhbLsbRibRibRcbRcbRibRiRsmbRibLsbRiLsbLsLs
mbRibLebLiRsbRcLsbRibRsbRsbRgbRgRsmbRgbRgbRgbRgbRsbRgbRibLjLsmbRsbRibR
gbRgbRgbRgRsmbRgbRgbRsbRibRgbRgbRibRsbRgRsmbRsRsmbRibRgbRgbRgbRgRsmbRg
bRgbRsbRgbRgbRgRsmbRgbRsbRgbRgbRgbRgbRgRsmbRsbRgbRgbRgbRgbLsRsbRibRgbR
sRsmbRgbLsbLcLsmbLgbLgbLibLibRgLsbLobRebRgbRibRhbRibRibLjbRcbLgbRibLsb
RiRsmbRgRsmbRsRsmbRibRibRsbRhbLibLcbRibLoLsmbLoRsbRgbRcbRiRsRsmmbRgbRi
RsmbRjRsRsmmbRibLsbRibLgbRcbRibRiRsmbRibLgbLcRsbRiRsmbRobRcbRgbRsbRgbR
ibLgbRibRsbRgbRiRsRsmmbRsRsLsmbRgbRgRsmbRgRsRsmmbRgbLsbRgbRgRsmbRgRsmb
LgbRibRgbRsbRgbRgbRgRsmbRgbRgbRgRsmbLsbRgRsmbRgbRiRsmbRiLsbLjbRsRhRsmb
RiLgLsbRiLsbLgbRhLsbLgbRiRsmbLobLibRgbLibLgbLsbLgbLsRsbRsLiLsbRgbLibLs
bLiRsLsbLiRsbLobLhRsLsbLiLsbLgbLgbLsbLgbRhbRsLsLsmbRoRsmbRiLsbRiRsmbRi
b

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 38; Drug: PCAP2 1 然
bLgbLsbRjbLobLgbLgbLgbRsbLibLgbsbRgbLibLgbLsRsbLgbLgbLgbRsbRsLgbLgbLgb
RgbLgLsbLiRsbRgbLgbRsbLhbRgbRcbRcLsbRgbLsbRgbRibRcbLibRcRsmbRsLgRsbRib
RibLgbRcbRiLsbLgbRsbLgbRibRiLsbLsbRcbLgbRibRgbRgbLgbRgRsmbRsLsRsbRgbRg
RsmbRgbRgbRsbsbRsbRgbRsbRgbRgRsmbRsbRibRibLibRgRsmbLjbRjbRibRgbRgRsmbR
gRsmbRsbRsbRgbRgRsmbRsRsmbRgbRgRsmbRgLsbRgbRsbRibLgbRgbRgbRgbLgLsbRhbL
gbRgbRgRsmbRgRsmbLsbRgbRgbRsRsmbRgbLsRsbRgbRiRsmbRgbRgbLsbRibLsbRgbRgb
RibLsbRgbLsbRiLsbLsbRibLgbRgbRgbLsbRgRsmbRibRgbRgbRsbLsRsbRcbLsRsbRibR
gbRsbRgbRgbRgbRgbRgRsmbRsbRsbRgRsmbRsRsmbRsbRgRsmbRibLgRsbRibLgbRgbRgb
LsbRgbRsRsLsmbRgRsmbRgbLsbRgbRgbRgRsmbsbLsbRgRsmbRibLsLsmbRsbRhLsbRiLs
bLhbRgbRgbRibLgRsbRgRsmbRgbRgbRgbRibRibRgbRgbRibRiLsbLsbLgbLhbLoRsbLgb
RgbLhbLgbLgbRsbLgbLgbLgbLgbLgbLsbLgLsbLsbLgbRgbLibLgbRsLsbLgRsbLgLsbLg
RsbLibRgbRhbRibRsbRhLsbLgbLsbRiRsRsmmbRgbRhbRgbLibLsbRcbRibLsbLcbLgRsb
LgbRgbLgbLgbRsRsmbLgRsbRsbLibRsbLiLsbLgRsbRsbLiRsbRibLibLgbLsbLiRsRsmb
LibLgRsRsmbRsbLhbRsbLiLsbLgbLsbLgbRsbLibRgLsLsmbLgLsbLgbLsbLibLsbLibRs
RsmbLhbRgbLibRsbLgLsbLgbRgbLibLsbLsbLgbLsbLgbLgbLsbLgLsLsmbLgbLsbLibLg
LsbLgbLgbLsbRsRsmbLsbLibLgLsbLgbRsbLsLsmbLgbRgbLgbLgLsbLsLsLsmmbLgbLgb
LsLsmbLibRsbLgbRgbLiRsbLgbLgbLsLsmbLsbLgbLsbLgbLgbLgbLgLsbLgbLgbLsbLgb
RsbLgRsLsbLibLgbLgbLsbLgRsbRsbLgbLgbLsLsmbLgLsbLgbLgbLgbLgbLgLsRsbLsbL
gbLsbLgbLsLsmbLgbLgbLsbLgLsbLgbLgLsbLgbLsbLsbLsbRibRibRsbRebRibRcbRgbL
cLsmbLibRcbRcLsbRhbLibRhbLibRibRcbLibRhLsbLgbLcRsbRsbLibLgbLsLsmbLgbRj
bRgbRibRgbRibRgbRsLsbRsbRgbRiLsbRibLibRsbRibRsbRibRgbRgLsbRgbLjbRibRiR
smbLgbRgbLjLsmbLibRcRsmbRoLsbRgbRsbRgbRcbLibRcbLgbRhLsbLgbLibLiRsRsmbR
jbLsLgbLgbLcRsLsbLgbLsRsbLgbLgLsbLgbLgbLgbRgbLgbLsbLsbLsLgbLsLsmbLgbLg
bRsLsbLgLsbLsbLsbLsbLgLsLsRsLsmbLgbLgbLgLsbLgbRsbLgLsLsmbLsLsmbLgbLsbL
gLsbLsLsmbLgbLsbLgLsbLsbLgLsbLgLsbLgLsbLgLsbLgbRjbLibsbLgbLgbLgbLgRsbL
gbLsLsmbLgbRsbLgbLgLsbLgbLgbsbRsbLgLsbLgbLsLsLsmmbLgLsbLgLsbLgbLsbLgbR
sRsmbLgbLsbLsRsbRjbRiLsbRibRhbRgbLiRsbLibLiLsLsmbRobRiLsbLsRsbRiRsmbRi
LsbLsRsbLcbLibLibLiLsbRgbRibRibRcLsbsbRgbLibRibRiRsmbRgbLgbRgLsbRibLiR
sbRgbRgRsmbRsbRibRiLsLsmbLibRcbRibLhbLgbLcbLcbRibLcbRgLsbLcbRgbLcbRgRs
mbLiRsbLibLgbRsbLibRsbLgLsLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 39; Drug: PCAP2 1 然
bLsbLgbLgbLgbLgbLgbLgbLsbLgbLgbLgbLsbLgbLgbLgbLsLsmbLgbLsLsmbLgbLgLsLs
LgmbLgLsbLgbLgLsbLgLsbLgLsbLgbLgbLgbRsLsbLgLsbLgLsLsmbLgbLsbLgbLgbLgbL
gbRsbRebRiLsbRhbRibRgbLsbRcbLgRsbRibRhLsbLibRhbRibRibRgbLgbRhbRobLhbLg
bLgbLgbRcbRibLjbLibLgbLjbRsbLgbLgbLgLsbLsLsmbLgbLsbLgbLibLibLgbLgbLgbL
ibRjbRhbLibRibRhbLibRibLcbLibRebRibLjbLcbLgbLgbLgbLgbLsbLsLsmbLgLsbLgb
LgbLgLsbLgbLgbLibRcbLcbRjbRobLgbRiRsmbRgRsmbRcbRibRibRibRsbRibRgbRgbRi
bLgbRhbLibLobRjbLobLgRsbLgRsbLibLsbRsbLibLsRsbLgLsbLgbLsRsbLgbLgbLiLgb
LsbLgbLsbLgbLsbLgLsbLgbLgbLgbLgRsLsbLsLsmbLsbLgLsbLgbLsLsmbLsbLgbLsbLs
LsmbsbLgbLsLsmbLgbLgbLgbLgRsbRsLsbLgLsRsbRsLsRsbLgbLgLsbLgbLgbLsLsmbLg
LsbRsbLgbsbLsbLsbsbLsbLgbLgLsbLgbLgbLgbRsbsbLsbLsbLgbLgbLgLsbLsbLgLsbL
gbRsbLgLsbRsbLgLsbLsLsmbLgbLgbLgbLgLsbReLsbRobRgRsmbRgbRgLsbRibLibRibR
ibRobRibRibRsRsmbRgbRsRgRsmbRsbRgRgRsmbRiLsbLgLsbRgRsmbRgRsmbRgbRibLiR
sbLobRjbLobRjbLcbLhRsbLgLsRsbLsRsbLsLsmbRjbLiRsbLibLcRsLsLsmbRibLcbLib
LibLibLibLsbLgLsbRobRibRhbRibRgbRibRibsbRgbRgbRgLsbRgbRiLsbRibLjbLjLiL
sbLsbRsbLgbLgbLgbLsbLsbLgLsbLgbLsbLsbLgLsbLgLsRsbRsbLgbLgbLgbLgLsbRgbR
obRhbRibRibLcbLibRjbRoLsbLhbLibLgbLsbLgbLsLsmbLsbLgbLgbLgbLgLsbLgbLsbL
sLsmbRcbRibLjbRiRsmbLsRsbRgRsRsmmbLsbRibLsbRgRsmbRiRibRibRgRsmbRibLsbR
iLsbRiRiRsmbRgbLgbLibLsbLibLiRsbLsRsbLibLobRcbRcbRoRsmbRhRsmbRcbRgbRib
LibRsbRibLcbLgbLgRsbRcbRcbRsbRgbRgbRgbRsLsbRgRsmbRgbRsbRgbRgbRgRsRsmmb
RsbRgbRsbRsRibRgbRgbRgbRsLsRsbRsbRgbRibRsRsmbLebRsRcbRibLhbLibLsRjbRoL
sLsmbRcRsmbRibLcbLgbLgbLibLgbRcbRibRcbRhbLibRhbRcbRcbRibRgbLcbLgLsbLgR
sbRsRsmbLgbRsLibLgbLgbLgbLibLoRsLsbRibLcbLiLsbLsLsRsmbLibLobLcbRcbLcbL
gLsbRcbRoRsmbRibRhbRsbRibRcLibLsbRcbLhbRcbRibRibLibRibRiLsbRibRgbLsbRg
bRgbLgbRgbRgbRgRsmbRgbRgbRsbRsbRsRgRsmbRgbRsbLjbLobLgbRcbRibRgbRsLsbRg
bRgbLgbRgbRgRsmbRgbRgbRsbRsbsbRgbRgLsRsbRiRsmbLgbRgbRgbRsbLsbRcbRcbRib
RibRgbRgbLsLsmbLcbLgbLgLsbRebLhbLiRsbRhRsmbRibLsbRibRsbRgbRgbRgbRgbRiL
sbLsRcbRibRgbRiRsmbLcbLgbLgLsbLiRsRsmbRgbLiLsLsmbLgRsbLcbLsbRjbRibRgbs
bRibRhLsbRcbLhLsbLibRgbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 40; Drug: PCAP2 1 然
bRgRsmbRsbLgbLsRsbLgLsbRjbRsbRoLsLsmbRgbRibRgLsbLiLsbRcbRcbRhbLibLgbRg
bLgbLiLsbLsLsmbLgbLgbLgLsLsmbLsbLgbLgbLsRsbRgbLebLsbLgbRgRsmbLgbLsbLgb
LgbRgbLcbRibRjRsmbRibRibLsbRgbRsbRgbLgLsbRiRsmbRsbRgbRsLsRsbRibLsbRsbR
ibRsbRgRsmbRsbRgbLsbRhLsbLebLcbRibLibRsbLibRgbRebRibRsbRgRsmbLsbLsRibL
sbLsbRibLcbLibRsbRsbLgbLgbRsbLgbLibLiRsbRebLibLsbLsbLcLsmbRibLiLsbLgbL
sbLibRhbLhRsbLgbsbLsRsbLhbRgbLgbLgbLsbLsbLsbLgbLsbLgLsbLgbRsbLgbLgbRgb
LgbLibRgbLsbLiLsbLcbRcbRhRsmbRgbRcbLibRibRgRsmbRgbRgbRgbRsbLibRhRsmbRg
bRibLiRsbRhbLgbRiLsbLgLsbLjbLiLsbLgbLsbLsLsmbLsbLsbLgbLgbLgbLsbLgbLgbL
gbLgbLgbLsRsbLibRgbLibRgbLiLsbLgbLsbLiRsLsbRjRsmbLiLsbLsbLgbLsbLsbLgbL
gLsbRcbRgbLsbLebLiLsLsLsmmbLsbRsbLibRjbRcbRibLcbRsbLibLsbLsbLibLibRsbL
sbLibLsbRgbLibRsbLgbLsbLsbLsbLsbLibRgbRcbRibRsbLgbRobLsRsbLjbRcbLcbLgL
sbLgbRgbRoRsmbRibLebLcbLibRibRsbLhbLgRsbRebRcRsmbLhbRsbLibLsbLsbLsbRsb
LgLsbLgbLsbLsbLgbLsbLsbLgbRgRsmbLgbLgbRjbRcbRsLsbRhbLibRibRibRsbRgbRgL
sbLjbRibRibLibRhRsmbLibLebLgLsbRgLsbLibLgbLgbLsbLgbLgbRgbLgbRsLsbLsbLg
bRsbLgbLgbLsbLsLsLsmmbLgbLgbLgLsbRjbRjRsmbRibRgbLjbRcLsbLibRcbLjbLebLg
bRsbLgbRsbLsbLgbLgbRgbLibRcRsmbRibRibLsbLjbRcbRcRsmbRiRsmbRibRgLsbRibR
sbRibRgbRgbRgbLcbLibLhbRibRobLsRgbRgbRcbLebLgbLibLgbLgbLsLsLsmmbRsLsbR
sLsLsmbLgbLsbLsbLsbLibLsbLgLsbLsRsbLgbLsbLgbRsbLsbRjbRibRibRgbLgbLebLg
bLiLsbRsbLgbLgbLsLsmbLgLsbLsLsmbLgbLgbLsbLsbLgbRgbLiLsbLsRsbRcbRibLgbR
ibLgbRgbRibRibLhbRgbLcRsbRibLhbRgbLhbRjbLibRjbRjRsmbRiRsmbLjbRibRgbRib
LibLibLhbLsbLibRsbLgLsbLgbLsbRsbLsLgbLgbLsLsmbLgbLgbLgLsbLgbRjbRsbLibL
sbLgbLgLsbLgbLsbRgbRhbRgbRgbLjRgRsmbRiRsmbRibRgbLjRsbRgbLsbRibRsbRgbRs
bRibLebRibRiRsmbLgRsbRibRgbLobLibLibLgbLgbLsbLsbRsbLibLsLsmbLsLsLsmmbL
gbLsbLgLsbRgRsmbLiLsbLgLsbLibLsbLsLsmbLsLsmbLgbLgbLsbRibLibLibRgbsbsbL
sRsbLibRgbLiLsbLgbLsbLhbRibLibLgbRgbLibLsbLgbLgbRsbLgbRgbLiLsbLgbLsbLs
bRsRsmbLibRgbLibRjbRcRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 41; Drug: PCAP2 1 然
bRsRsRsmmbRsLsbRiRsmbLsbRibRsbRgbRsbRgRsmbRsbRiLsRsbRhbsbLibRcbLsLsRsm
bRibRibLcbLcbRsbRibLhbRsbLibLcbRibLgbRsLgbLgLsbRsbLcbRsbRiRsmbRibRgbRg
bLsbRgbLsbLjbLhbLgbRgbRcbRcbLiLsbRobLsbLsbRhbLsLsmbRcbRhRsmbRibLhbLhbL
ibRibRibRgRsmbRgRsmbLsbRgbRgbRibLibRhbLjbLcbRibLcbRgbLhbRibLhbRgbLibRg
bLoRsbLcbLibRgbRhbRgbLcbLibLsbRsLsbLgbLgbRgRsmbLcRsbRsbLsbRjbRibLjbRcb
LsbLsRsbRcbRgbRsbLgbRibRibLcbLcbRsbRjbLiRsLsbLibRgLsbLgbLibRjLsbLgRsbL
sbLgbRjbLibRsbLsbRsbLcbRgbRibRcbRgbRgbRsbRiLsbLibRhbRsbRgbRgbRgbLiRsbR
hbRiRsmbRibLsbLcbLsLiLsbRjbLcbRibRcbLjbRhbRibLibRsbLsRsbRcbRsLibRhbRsb
LsbRgbRibLjbLibLibLgbLgbRibLibRcbLgbRhbRsRsmbLgbRcbRibRgbRebRcbRibRgRs
mbRgbRgbLsbRibLgbRhbRsbRgbRgbRgbRgbRgbsbRibRgbRgbRsbRgbRgbRgbRsbRgbLsb
RgbRsbLsbRgbRibRgbLcbRhbRibRsRsmbLsbRgRsmbRgbLsbRiRsmbRibLjbLcbLibLgbL
gbRgbRjbLibLibRibLcbRibRcbRgbLgbRibLsbRgbRgbRsRsmbRibRgbRgRsmbLgbRgRsm
bsbRsRsRsmmbsbLsbRsbRibRgbRsbRgbRgbRsRsmbRsRsmbRsbRgbRsbRibRgbRsbRgbRg
LsbLhbRcbRibLgbLhbLsbRsbRobRcbRcbLibLibLsbRobRibRibRibRgbRgbRibRcbRiRs
mbLibRibLsbRsbRgbRiRsmbLgbRibRgbRgbLcbLcbLibRiRsmbLibRsRobLgbRhbRgbRib
RibRsbLibRgbRhbRgbRgbRgbRgbRibLsLsLsRsmmbRibLcbLcbLibLgbRgRsmbRgbLcbLg
bLsbRiRsmbRsRsmbRgbRsbLcbLsLsLsmmbLibLhbRgbLgbLgbLgbRgbRsbLibLsbRcbRhb
RibsbLsbRgRsmbRsbsbRibLjbLcLsmbRibRcbsbRibLjLsLsmmbRibRgbRsLsbLsbRgbRg
bRibLjLsLsmmbLibLgLsRsbRjbRhbRsRsmbRgbLibRsbLsbLsbRcLsbRgbRibLibRiRsmb
RiRsmbRibRibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 42; Drug: PCAP2 1 然
bRgRsmbRiRsmbRibRibRibLgbLsLsmbLcLsmbLgRsbLgbLgbLgbLgLsbLgbLgbLibLibLg
bLgbLgbRgbLibLcbLhRsLsbLibLibLgbLgLsbLgbLcbLgLsbLiLsbLgbLgbLgbLgbLsbLs
bLgLsbRjRsRoRsmmbRiRsmbRgbRgRsmbRgbRgbRgbRgRsRsmmbRibRiRsRsmmbRibRgbRg
RsRsmmbRiRsmbRgbRsbRibRgbRgRsmbRgbRgbRibRgbRibRgbRibRgRsmbRibRgRsmbRib
RgbRiRsmbRgbRgbRgRsLsmbRiRsmbRgbRgbRibRgbRgRsmbRgbRgbLgbLcbLcbLgRsLsbL
sLibRsLeLsRsbLibLhbLibLgbLgbLiRsLgbLgbLgRsbLgbLgbRsLsbRcbRhRsRsmmbRiRs
RsRsmmmbRibRgRsmbRgbRgbRgRsmbRgRsmbRibRibRiRsmbRibRibRibRgbRibRhbRgbRg
bRibRgbRgbRgbRgRsmbRibRibRgbRibRgbRibRsbLeLsbLobLgbLiLsbLgbRgbLibLibLg
bLibReRsmbRibRiRibRgbRgbRgbRgbRgbRgRsmbRibRgbRiRsmbRgbRgRsmbRgRsmbRibR
iRiRsmbRgbRgbRibRibRgbRibRobReRhbRgbRibRgbRibRgbRibLebLcbLgRsLsbLiLsLi
LsbLibLibLgbLgbLgLsbLgbLgbRobLgbLgbLgbLgbLgLsbLibLgbLibLgbLgbLiLsRsRsm
bLibLiLgbLgbLgLsLgbLgbLibLiLsbLgLsbLibLgLsbLgbLgLsbLgLsLsmbLibLgLsbLgL
sbLgLsbLgLsbLgbLgbLgbLgbLsbLgLsbLgbLiLsbLgLsbLiLsLiLsbLibLgbLiLsbLgbLg
bLibLgLsbLgbLgLsbLibLgLsbLgbLgLsbLgbLibLgbLibLgbLsbLhbRiLsbRgbRhbRgbRs
LsbRgbRiLsbLsbRibLhbLcRsbLibLibLiLgbLgbLgLsLsmbLibLgbLiLsbLgbLgLsbLgRs
LsbLibLgLsbLgLsbRebLgLsbLgbLgLsbLgLsbLgbLibLgbLgLsLsmbLgLsbLgbLgLsLsmb
LibLgbLgbLgbLgLsLgbLgLsbLgbLgRsLsbLibLsbLibLiLsLgbLgbLgbLgLsbLgbLgbLsb
LibLgbLgbLibLgLibLgbLgLsbLgLsbLgLsbLibLgbLgbLgbLgLsbLgbLgbLgbLgLsbLsbL
gbLiRsLsbLgLsbLgLsbLgbLcbLibRhbRcbRsbRsLsbRiRsRsRsmmmbRsLsbRgbRgRsmbLs
RsbRgbRhRcRhbRiRsmbRgbLsbRgbRiLhbRibLeLsbRcbLcbRcRsmbLgbRibLobLibRgbLi
bLgbLgbLgbLiLgbLgbLgLsbLibLgbLgbLgLsbLgLibLgLsLiLsbLgbLgbLgLsbLgbLgLsb
LgbLgbLgbLgbRgbLiLsLsmbLgbLgbLgbLgbLgbLgbLgLsLsRsmbLgbRgbRcbRgbRibLgRs
LsbRoLsRhRsRimbRsLsbRiRsmbRibLsbRiRsmbLsbRhbLsbRiRsmbRgbRgRsmbRgRsmbLs
LsmbRibRsLcLoRsLsRibLjbLibLgbLgLsbLgLsbLgbLgLsbLgbLgLgbLgLsbLgbLgLsbLg
bLibLsLsRsmbLsRsLibLsbLiRsbRjbRobRibRgbRgbRgbRgbRgbRgbRsRsmbRgRsmbRgbR
gbRiRsLsmbRgbRsRsmbRibRibRgbRgbRgRsmbRgbRgbRgRsRsmmbRsbRgRsmbRgbRgbRgR
smbRgRsmbRgbRgbRgRsmbRgbRgbRiRsmbRgbRibRgRsmbRgbRgRsmbRgbRgRsmbLgbLcbL
ibLsLsmbLibRsbLibLiRibRibRgRsmbRibRibRgbRgbRibLcRsbLibRjbRcbLibLgbLgbL
gRsbLgLsbLgLsbLgLsbLiLiRsbLibLgbLgLsbLgLsbLgLsLsmbLibLgbLgLsbLgLsbLgLs
bLgbLgLsbLgbLgbLiLsbLgLsbLgbLgLsbLgLsbLgbLgLsbLgbLgbLgLsbLgLsbLgLsbLgb
LgbLsbLiLsbRsbLibLgbLgbLgLsbLgLsLgLsLgLsbLgbLgLsbLgbLgbLgLsbRsRobLhbLs
bLgLsRsLsbLgbLgbLsLsmbRcLsbRibRibRiRgRsmbRiRsmbLgbRibRgLsbRgRsmbRgbRgb
RsbRiLsbRgRsmbRhbRibRibLobLiLsbRsbLgbLgLsLsmbLibLiLsLiLsbLgLgbLgbLgbLg
bLgLsbLgbLgbLsLgLsbLiLiLibLgbLgLsbLgLsbLgLsbLiLsRsbLgLiLibLgbLgbLgbLgb
LgbLgbLgbLsLsmbLsLsLsmmbLibLgLsbLgbLgbLgbLgLsbLgbRhbRcRsmbLgbRibRgbRgb
LcbLhbLgLsbLsbLiLsRjbLhRsbLsbLobLibLgbRsbLiRsbLibRsbLibsbLgbLgbRsLgbLg
LsbLgbLgbLgbLiLsbLgbLgbLgbLgbLgLsLsmbLgLsbLgLsbLgLsbLgbLgbLgLsbLsbLgbR
sbLibRhbRhbRiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 43; Drug: Control
bRcbLgbRibLsbRibLsbRhLsbRibRsbRsbLibLgbLgbLgbRsbLgbRsbLgbRebRiLsbRhbRi
bLsbRibLsbRgbRgLsbRgbLgbRibRsRsmbLsRibLgbLsRiRsmbRgbRgbRsbRgbLsbRgRsmb
RgRsmbRgbLsbRibLgbRibRgbRgbLgbRiRsmbLsLsmbRiRsmbLibRcbLebLgbLhLsLsmbRg
RsmbLiLsbLgbLgLsbLsbLgLsbRjbRsbLsLgbLsLsmbLgbRgLsLsmbRsLsRsbRsLgbLsbLg
bLsbLgbLgbRsbLgbLgbRjbRsRcbRsbRgbRgbLsbRgbRsRsmbRgbRgbRgbLsbRibLsbLsLs
mbRibRgRsmbRgbRsbRgLsLsmbLgbRibRsbLsbRibLhbRcbRobLcLsmbRsbLsbLgbLibRsb
RcRsmbRhbLibRcRsmbRibLsbRsbLibLibRsbLhbLcbRsbRibRsRsLsmbRsbRhRsmbLsRsb
RcLsbRcbRcbLsbRcbLgbRcbLsbRgbLjbLhRsbLgbLsbLgbRjbLgbLgbLibLhbLibRibRsb
RgbLcbLibRjbLibRjbLibLibLcLsLsmmbRhbLgbRsbLibLgbRgbLgbLgbLgbLsbLiRsbLs
LsmbRgbLiRsLsbRsRsmbLsbLgbLgbLibRsLsbLibRgbLgbRcbLgbRibLsbRiRsmbLgbRib
LjbLcbLhLsbRsRsmbRibRjbRibRibRsbRsbRgbLgbLsbRibRsbRsbRsbLsLsmbRgbRgbRg
bRgRsmbLsRsbLsbRibLgLsbRiRsmbLgbRibLgbRiRsmbLsbRgbRgbRsbRgbRsbRgbRgbRg
bLgbRibRsbRgRsmbLsbRiRsmbRgbRsbRgbRgbRgbLsbRibLgbRibLsRsbRibLsbRgbRibR
sbRgRsmbLsLsmbRiRsmbRsbRgbRsbRsbRgbRgbRsbLgbLibLibLgLsbRgbLgbLgbLsbLgb
RsbLgbLgbRsLgbLsLsmbLgbRjbLiRsbLsbRsbLibLgbRgLibRsbLgbLgbLgLsbLgLsbLsL
smbRgRsmbLibLsbLgLsbLgbLgbLgbsbRsbLibLgbLgbRsbLgLsbLsLsmbLgbLgbLsLsmbL
gLsbLibLibRgRsmbLgLsbLgbRgbLibRsbLibLsLsmbLgbLsbLgbLgbLgbLsLsmbLgLsbLg
bLgbsbRcbRibLjbRcbLibRibLsbLiRsbRhLsbRsbLsbRiRsmbRgRsmbLsbRibLsbRibRgb
LjbRiRsmbLsRsbRiRsmbLsbRibLgbRibRgbRsbRgbLsbRibRsbRibRgRcbRibRcbRhbRsb
RgbRgRsmbRoRsRsmmbRibRsLsbRibRsbLcbRsbLiRsLsbLgbRsbLgLsbRsLgbLsbLgbRjb
LibRsLsbRsLgbLgbLgbLgbLgLsbLgbRjbRjbRcbRgbLsbRhbLgbRcbLibRibRibLgbLsbR
cbLibRcbLibRoRcbRgbLhbRsbRebRcbRgRsmbRgLsbLsLsmbRiRsmbLjbLcbLgRsbRibRg
bRibRgbLsbRibLsbLhbLibLibLsLcbRibRiRsmbRgbRiRsmbRsLsbRgLsbRgRsmbLgbRsb
RsbRibRsbLsbLhbLhbRebRibLcLsmbLiLsbLibLsLsmbLgbLgbRibLcbRjbRcbLjbRhLsb
LgbRcbLsbLibRibRsbLjbRibRiRsmbRsbRgbLgbRibRgRsmbRgbLcLsmbLhLsbRgbLiLsb
LibRgbLgbLgbLgbRgRsmbRsbLgLsbLibRgbRsLiLsbRgbLgbLgbRjLsbLgLsbLsLgbLhbR
sbLgbLsLsmbLgbRsbLgbLgbRsbLsLsmbLgbRgbLgbLgbRsbLibRjbLgbLgbLjbRcbRibLj
bRiRsLsmbRsbRibLibRhRsmbRcbLgLsbRiRsmbLgbRgbRiLsbRhbLjbLcLsmbLibRjbLib
RcbLsLsmbLsRsbRhbLjbRibRsbRibLgbRibRgRsmbRcbLibLgLsbRsRsmbLibLcbRibLcb
LgbRhbLcbLibLhbRibRsbRjbRjbLjbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 44; Drug: Control
bRgbRhbRgbLsbRgbLgbRgbRgbRsbRgbLsbLsbRgbRgbLsbLsLsmbRgbLjbLhbLgbLgbLib
LibRjbRcRsmbRgbLsRsbRgbLsbLsbRibLgbRibLsbLsRsbLobLhbRgbLhbRjbLgbLgbRgb
LgbLgbRsbLsbLgbLgbLsbLsbLgbRgRsmbLsbLsbLgbLgbLsLsmbLgbLsLsmbLsLsmbLgbL
gbLgbLgbLsbLsbLsbLsbLgbLsbLsbLsbLgbLsbLgbLgbLsbLgbLsbLgbLsbLsbRsLsbLgb
LsbLsbLsbLsLsmbLsbLgbLgbLgbLsLsmbLsbLgbLsbLibLsbLsLsmbLgbLgbLgbLgbLsLs
mbLgbLgbLsbLgbLgbLsbLgbLgbLgbLgbLgbLgLsbLgLsbLgbLgLsbLgbLgLsRsbLsbLgbL
gbLgbLgbLgbLgbLsbLsbLgbLgbLgbLgbLgbLgbLgbLsbLgLsbLgbLgbLgbLgbLgLsbLgbL
gbLgbLgbLgbLgbLgbLsLsmbLgbLgbLgbLgbLgLsbLsLsLsLsmmmbLgbLgLsbLgLsbLgbLg
LsbLgbLgLsRsbLsbLgLsbLgLsbLgbLsbLgbLgbLgbLsbLgRsbLgbLsbLgbLgbLgbLgLsbL
sbLgLsbLsLsmbLoLsmbLsbLsRsLsbLgbLgbLgbLsbLgbLsbLgbLgbRsbLgbLsLsmbLgLsb
LsLsmbLgLsbLgbLgLsbLgbLgbLgLsbLgLsLsmbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLg
bLgbLsbLgbLgbLgbLgLsbLgbLgbLibLsbLgbLgbLgbLgbLsbLgbLgbLgbLsbLgbLgbLgbL
gbLgbLgbLgbLgLsRsbRsLgRsbLsLsmbLsbLsLsmbLgbLgbLgbLgbLgbLgLsbLiLsbLgbLg
bRgLsbRobRobLibLgbLsLsmbLgbLgLsbLgbLgbRsbLsbRgLsbLsbLibLibLgbLgbLibRgb
RcbRibLsbRiRsmbRibRsbRcbLsbLsbRobRsbRgbRsbRgbRgbsbLsRsbRgbRgRsmbRsLsbL
gbRcLsbLsRibRiRsmbLsbLjbLibLgbRsbRjbLiRsbLsbLsbLsbLgbLsbLgbLsLsmbLgbLs
bLsbLsRsbLsLsmbLgbLsLsmbLsbLsbLgbLsLsLsmmbRsLsbLsbLgLsbLsbLgbLgbLsbLsb
LsbLsbLsbLgbLgbLsLsmbLsLsmbLgbLgbLgbLsbLgbLsLsmbLsbLgbLsbLsLsmbLgLsbLs
bLgLsbLsbLsLsmbLgbLgbLgbLgbLgbLgbRsbRsbRsbLiLsbLgbRcbRibRgbLgbRgbRsbRg
bRgRsmbRsbRgbLsbRibLibLebLibLgbLsbRsbLgLsbRsbLsbRsbRjbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 45; Drug: Control
bRsbLgLsLsmbLgbRcbLsbRibRgbRgbLgbLcbRebLcbLibRcbRcRsmbLgbRcbLiRsbRsbRg
bRsbRiRsmbRsbRsbRsbRgRsmbRgbRgbRsRsmbRgbLsbRgbRgbRsbRgRsmbRsbRgbLsbRsb
RgbLgbRibRgbRgbLsbRibLgRsbRibRgbLiLsbLcbLgLsbLgbLibLgbRgRsmbRjbRibRgRs
mbLgRsbRibRgbRsbRgRsmbRgbLsbLsbLsbRgbRgbRgbLgRsbRibLgbLhbLiLsbRjbLibRe
bRgbLsLsmbRgbRgbRsbRhbRibRgRsmbRgbRgbRgbRgbRgRsmbRgRsmbRsbRibLsbRgbRsb
RsbLsbRibRgbRsbRgRsmbRgbRsbRgbRsbRgbRgbRsbRsRsmbRsbRgbRgbRsbRgbRibRgRs
mbRsLsbLgbLoLsmbLcRsbRgbLibRjRibRgbLsbRgbRsbRiRsmbLgbRgbRgbRgbRcbLibRc
bRgbRhbRgLsbLgbRoRsmbRgbLsbLgRsLsbRibLsbRgLsbRiRsmbRgRsmbRsbLhbRibRiRs
mbRgbRsbRgbRgbRsbRsRsmbLsbRgbRsbRsbRgbLgbRibLsbRgbRibRibLhbRibRsbRgbRs
bRibLgbRgbRgbLsbRgbRgbLsbLsLsmbLebLibRcbLjbLhbRjbLibLcbRibRiRsmbRgbsbR
gbRgbRgbRcbRcbLgbLcbRibLgbRcbLjbRcRsmbLibRibRgbRgRsmbLsbRgbRgbLcLsRsmb
LhbLiRsbRsbLgbLsbLsbLsLsmbLsbRjbLcbLjbLhbRibLjbLgbRjbRhbLjbRgbRsbRgbRs
bRgbLjbRgbLjbLiRsbLsRjbRcbLibLhbLibLsbLgbLsLsmbRgbLibRsbLibLsRsbLgbRcb
RibRgbRgbRsbLhbRcRsLsmbLjbRibRgRsmbRgbRsbRgRsmbRsbLcbRobRsbRgbLcbLhbRj
bRcbLibRibRsbRgbRgbRgRsmbRgRsmbRsRsmbRsbRiLsbLsbRgRsmbLsbRgbRibLgbRiLs
bRgbRsbRgbRsbRgbRibLibRhbRsbLhbLibRcbLhbRibRgbRgbLjbLjbRebRsbRgbRgbLsb
LcbLcbRibRibRhbLgLsbRiRsmbLcbRibRjRsmbRibRgbRgbLsbRibRsbRibLgbRibRibRs
RibLibRgbRcbLjbLcbRjbRibRsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 46; Drug: Control
bReRoRsRsmmbLibRsbLibLgRsbLiLsbRjbLcbLibRibRgbLiLsbLgRsbRgbLgbLgbLgbLg
bRgbLibRgbLgbLsRsbLgbRgbRjbRibRgbLsbRgbRsbRgbLgbRibLsbRjbLibRibRsRsmbR
sbRgbRsbRgbLgbRgRsRsmmbRgbLsbRgbRgRsmbLgbRgbRsbRgbRsbRgbRsbRgbRsbRgbRg
bRgbRsbLsbRsbRgbRsbRgbRgbRgbRgbLsRgbLiRsbRibRjbLibRgbLebRebLibRhbRibLi
bLjbLebRhbRgbLibLgbRgbLgbRsbRhbRibRibLebLebLiLsbLsbRgbLibLgbRcbLibLebR
ibLibLgbRibRsbRjbRibRibRgbLsbRgbRgbLsbLcbRjbRcbLgbRiRsmbRibRgbRgbLjLhb
LiLsbRibLsbLgbLgbRgbLgbRsbRjbLebLiLsbLsLsmbLgbRsLjbRgbRsbLibRgbLibRjbL
sLsmbLsRsbLibLibLjbLebRgbLibLsbLsbLibRgbLgLsbRgbLebLibLibRgbLcbLgbRibL
sbLjbRsbRibLjbsbRiRsmbLhbRjbLsbLcbRibLjbLibRjbRibRgbRgbRibLcbLcbLcbLib
LgbRhbRgbLsbLebLhbLgbRgbLsbLcbLjbLibRibLiLsbLsbLibRgbLibLibRsbRibRsbLi
RsbLgbLsbLsbLgLsbRsbRsbLhbLcbLgbLgbLgbLibLgLsbRjRsmbRebLgbRsbRgbLebLib
LgLsbLsbLgbRsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 47; Drug: Control
bLgbLgbLgbLgbLgbLgLsbLsbLibLgLibLgbLgbLsLsmbLgbLgbLgbLgbLgRsbLgbLgbLgL
sbLgbLgRsbRjRsmbLgbLgLsLsmbLgbLgbLgbLgbLgbLjRsRsmbRgRsmbLgbLgbLgLiLibL
gbLgbLgLsLibLgbLgbLgbLsRsbLiLsbLgbLsLsLimbLgbLgbLsbLgbLgbLgbLgbLgbRsbR
sbLgbRcbRiRsmbLgbLcLsmbLibLsbLgbLsbLgbLobLcbLiLsbLhbRsbLiRsLsbLgbLsbLs
bLcbRhbRibRibRibRibRgbLjbRibRiRsmbRgRsmbLjbRibLsRgbRgRsRsmmbRgbRibLibR
obRiLsbRhbRibRgbRsbRibRgbRgbRgRsmbRgbRsbLsbRgRsmbRsbRgbRgbLjbLiRsbLsbL
gLsLsmbLsLgbLgbLgLsLsmbsbLgLsLsmbRgRsmbLgbRjbRjbRjbRjbRibLibLibLgbLgbL
sbLgLsbLgbLgLsbLgLgLsbLgLsbLsbLgRsbLgRsLsbLgbLgbLgbLgbLgbLgLsbLgLsbLgb
LgbLibRsbLgRsbLiLsbLgLsbLgbLsbLgLiLsRsLsbLgbLsbLgbLgbLgbLgbLsbLgLsbLgL
sbLgbLgbLgLsbLgbLgbLgLsbLsbLsLgbLgbLgbLgbLgRsbsbLgbLgbLgbLsLsmbLsLgbLg
bLsRsbLsLgLsbLgbLgbsbLgbLgbLgbRcRsmbLjbLcbLgbLsbLiLsLsmbLsLsmbLgLgbLgb
LgbLsLsmbLsLgbLgbLgbLsbLibLibLgbLsLsmbLgbLgbLgbLgbLgbLgbRsbLsbRcbRhbLi
bRhbRibLsbRiRsmbRgbRsRsmbRsRgbRcbLgbRiRsmbRgbRgbRgbRgRsmbRibRsRsLsRgRs
mmbRgbRgbRsbLibLgLsbLsbLibLsbLgRsbLgbRsbLgbLgbLibLibLgLsbLgbLgbLgbLgbL
gbLgbLgbLgbLgRsbLsbLgbRsRsmbLgLibLgbLgbLgLsbLsLsmbLsLsRsmbLgbLgbLgbLgb
LibLgbLgbLgbLsbLsbLgLsbLgbLgbLgbLgLsLsmbLgbLgbLiRsbLgbLhbRjbLhbLgLsbLg
bLgLsbLgbLgLsbLgbLgbLgbLgbLgbLgbLsLsmbLgLsbLgLsLsLgmbLgbLsLsmbLgLsbLgb
LgbLgRsbRgRsmbLiLsbLgbLgbLgLsLsLgmbLgbLgbLgbLgRsbLsbsbLgLsbLgLsbLgLsbL
sLsmbLgbLsbLgbLgbLgbLgbRsLsbLgbLiRsbLsbLsLsmbLgbLgRsLsbRsbRcbRibLcbReb
LsbRcbRibLsbRibLjbRcbRibRcLsbLgRsbRcbRiRsmbLcbLsbLgLsbLgRsLsbLgbLgbLsb
LgbLsbLgbLgLsbRsbLiRsbRsbLibLgbLgbLgbLgLsbLsbLgbLibRsLsbLgLsbLsRsbLgbL
gLsbLgbLobLgbLsbLcbLibLgbLgLsbLgbLgLsLgLsbLgbLgbLgLgLsbLgRsbLgbLgbRgbR
jbRcRsmbLsLjbLcLsmbLgLsbRobRibRgLjbRgbsbRibLsbLsbRhbLhbLibLibLgbRebRib
LibsbLibLsLsmbLgbLgLsbLsLsmbLsbLgbLobRibLjbRcRsmbLsLsmbLhbRobLsbRoLsRs
bRgbRsbRibRgbRgbRibRsbRsRgbRgbRgRgbRgLsRsbRgbRiLsbRgRsmbRsRsmbRgbRgbRs
bLjbLgbRcLsbLjbRhLsbLsbRgbRsbRibLsbRgbRgbLsLsmbLcLsmbLgbLgLsbLgLibLgbL
gbLgLsLsLgmbLgbLgbLgbLgRsLgbLgbLgbLgbLgbRcbRibRibRgbRgRsmbRgbRgbRgbRgb
RiRsmbRgRsmbRgbRsbRiRgRgbRgRgRgRsmbRsbRgbLhbLibLiRsbLhLsLobLiLsbLiLsbR
gbLhbLiLsbRsbLibLobLobLibRjbLhbLgbLgLsRsbLgbLibLgbLgbLgLsbLgbRjbRhbRgb
RgLsbRgRsmbLgRiLibLcbLobLgLsbLoLgLsbLgbLgbLibRobRibLcbLibLgLsbLgLsbLgL
sbLgLsLgbLgbLgbRjRjbLibLibLgbLgLsLiLsbLsLsLsmmbLgLsLsmbLsbLgbLgLsbLsbL
gbLgbLiLsbLgbLgbLgbLsRsbsbLgLsbLsLsmbLgbLgbRcbRgbRgbRhLsRsbRibLsbLcbLg
bLsbRibRibRgbRgbRgbRgbRgRsRsRgmmbRgRsRsRimmbRgbRgRsmbRsRsmbRibRgbRgbRg
RsRiRimbRgbRgbRgbLibLgbLgbLgRsbRibRgbRsRsRimbRsLsbRsLsbRibLsRgbRgRsmbR
gbRgbRsbLgbRebLgbRcbRsbLgbRiLsbRgbRgbRgbRgbLsbRsRsmbRgbRgRsmbRgbRibRgb
RgbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 102558; End: 103058;
Recording: 2-1; Individual: 48; Drug: Control
bLibLgRsbLsbLgbLebLobLcbLibLibLsbLsbLibLgbLibLgLsbLgbLgbLgbLgbLgLsbLsR
sbLgbLgbLgLsbLgbLgbLgbLsbLgbLsLsmbLsRsLsbLgbLsbLgLsbLgLsbLgbRjbLgbLiLs
bLgbLgbLsbRsbLgbLgbLgbLgLsbLgLsLsmbLgbLgbLgLsbLgLsbLgLsLsmbLgbLgLsbLgb
LsbLgbLgbLgbLjbRhbRgbReRsmbLhbLcbLibLgLsbLgbLsRsRsmbLgLsbLsbLgbRsRsmbL
gLsbLibLgbLgLsbLibLgbLibLgbLgbLgbLgbLiLsbLgbLgbLsbLgbLgbLgbRjbRcbRsRcb
LcbLgbRcbRcbLcbLcbLhbLibRsbRgbRcbRoLsbRibRgLsbRibLcbLcbLgLsRsbRgbRiRsm
bRibRgLsbRgbRsbRgbRgbRoRsmbLgbRgLsbRsbRcbRiRsmbLjbLibLibLibLibLsbRcbLi
bLibRsbLibLsbLoLsmbRibLcbRibRibRsbRgLsbRsbLjbLibLgLsbLgLsbLgbLgRsbLsbL
sRsbRsbLibRebRobLgbRcLsbRcbRibRhbRjbRhbLibRibRgbRsbRgRsRsmmbRgRsmbLgLs
bRgbRsbRiLsbLhLsbLgbLsbLgbLgbLgbLgbLgbLgbLsbLgLsbLsbLgLsbLibRgbLibLgbR
sbLgbRsbLibLobLiRsbLibLibRibRibLebLibLgLsbRgbLibLgLsbLsbLgbLsbLgbLgbLg
bLgbLsbLgbLgbLgbLgbLgLsbLgLsbLsbLibRhbRcLsbLjbLiLsbLiLsbLgbRgbLibLgbLg
bLsbLgbLgLsbLgbLsRsbLgbLsbLgbRsRsmbLgbLgbLibLgbLgLsbLsbLgbLgLsbLgbLsbR
sbLgbLgbRjbLibLiLsbLsbLibLsLsmbLgbLgbLgbLsbRgbRcbRhbLebRcbLibLcbLsbLcb
LibRcLsbLcbLhRsbRhbRhbRgLsbRsRsmbRgbsbRibRgbRsbRsbRgbLjbRcbLjbRcLsbLib
RcbRcbRibLibLgbLgbLgLsbLgbLgbLgbLgbLsRsLsbLsbLiLsbLibLgLsbLgbLgbLgbLgb
LgbLgbLgLsbLgbLsbLhbRiRsmbRjbLibLgbLsbLgbRsLsbLhLsbRcbLcLsmbLgLsbLgLsb
LgbRsbLibRsbLibRiLsbLiLsbLgbLgbRsbLgbLgbRsbLgLsbLgbLsbLgbLgbLgbLgbLgLg
bLgbLgbLgbLgbLgbLgbLgLsbLgLsbLgbLgbLgbLgLsbLgbLibLgLsbLgLsbLgLsbLgbLgL
sbLgbLgLsbLgbLgbLgLsLsLgLsmbLgRsbLeRsRsmbLhbLibLjbLibLgbRgbLgbLgbLgbLg
bLsbLgbLgbLgLsbLgLsbLibLgLsbLgbLgbLgLsbLgbLgbLsbLjRsbRgbLiRsbRsLsbRsbR
cbRcbLjbRobRgbRcbLgbRhbLibLibLgbLgbLiLsbRsLsbLobRgbRcRsmbLhbLobRcbRcRs
mbLcbLcbLgbRsbRsLsbRibRhLsRsbLsLhbRgbRcbLgbRgbRibRhbRiLsbLgbRcRsmbLsbR
cLgbLibRcbRgbRsbRcbLcbLhbLibLgbRsLsbLsbLhbRjRsmbLobLoRsLsbLibRiRsmbRib
LcbLcbLgbLgbLiRsbLsbLcRsRgbLibLebRgbLsbLibRsRsmbLsbLiRsbRcbRibLjbLcbRs
bLgbLsbLgLsbLgbLgbLgbLsbLgbLgLsbLgbLgbLsbLgbLgbLgRsbsbLiRsLsbLsbRhbRcb
RgbRgbLsbLjbLibLsbRsRibLebLgRsbLsLsmbLiRsbRiLsbLobLcbLibRhRsLsmbRsLsbL
ibLcbRhLsbRgbRibRgbLsbRhbLiRsbRgbRcbRibRiLsbRgbRjbRibLcbLcbRgRsmbRhRsm
bRibLsbRgbRgbLgbLjbLibRcbLjbLhbLsLgLsbLgbLgbLgbLsbLgRsbLgbLgRsbLgbLgbL
sbLgbLgbLsLsmbLsLsmbLgbLgbLgbLgbRcbRcbRcRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 1; Drug: PCAP2 10 然
bLibRsbRgbRsbRjLsbRsLsbRgbRsbRsbRsbLcLsmbLibLiLsLsmbRsbRiRsmbLsbLgbRsb
RsbLsRsLsbLgbLsbLsbLsLsmbLgbLsbLgbRiRsmbRgbRsRsmbLcbLibLsbRsbRsRsmbLgb
LsbRibRgbLgbLcbLibRgbRgbRsbRibRsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 2; Drug: PCAP2 10 然
bLsbLibLsLgLsbLgbLgLsbLgbLgbLiLsbLgbLsbLsbRsLsbLsLgbLsbRgbLgbLgLsbRjbR
jbRibRsbRcbRiRsmbRsbRhbRgbRsRsmbRgbRsbRhbRgbRsbRcRsRembRsRsRsmmbRgRsmb
RiRsmbLhbLsLsmbLibRibRsbLsbLhbLibLsbLsbLcbLsbLhbLhLsLsLgLgLsmbLcbLsbRc
bRsRgbRgRsmbRgRsmbReLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 3; Drug: PCAP2 10 然
bRibLsbRsbRgbLgbLebLibRsbLsbLibLgbLsLsmbLsbLgbRgbLibLjLsmbLjLsmbLhbLeb
LcbLcbLebLibLebLcbLcbLebRibRhbRjRgbRiLsbRgbRsRsRsmmbLsbLsRsbRsbsbLgbLg
bLgRsbRjbRibRgRsmbRiRsmbLibLjLsmbLgbLsbRsbRgbLsbRgLsbRibLjbLsbLibLjbLj
bLibLibRjbRhRsmbRjbRhbRiRsRsmmbRibRebRiRsmbRgRsmbRsbRgbRiRsmbRebRhbRsR
sRsRsmmmbRibsbsbRiLsbRsbRgbRebRibRhRsmbRgRsmbRibRhbRibRsRsmbRibRsRsmbR
sbLsbLsbRcbRgbRgbRiRsRsmmbRibRgbRgRsLsmbRgbRsbLsbsbsbRjbRgbRsbRgbRgLsb
RgRsmbRgbRhRsmbRjRsmbRsRgRsmbRjRsmbRgbLhbLhbRibRhbRibRgRcbRsRsmbLsbRib
RibLsbRebRibRgbRiRsmbRiRsmbRhRsmbRibRiRsmbRibRibRcbRibRibRebRgbRgbRsbR
sRsmbRhbLsRsbLsLsLsmmbRsbRsbRsRsmbRgRsLsmbRiRsRgmbRsRsmbRcbLgLsbRhbRgR
gRsLsmbRiRsmbRgRsRsmmbRsRsRsmmbRgbRobRibRjbRiRsRgmbRibRgbRiRsmbRobLsbL
sbRhRsmbRgRsmbRibRibRcbRhbRcRsmbRgRsmbRcbRiRsmbRgbRiLsRsbRgbRsRsmbsbsb
sbLsbsbLsRgbRibRcRsmbRcbRebReRsmbRjbRcbRgbRgbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 4; Drug: PCAP2 10 然
bLgLsbLsbLsbLgbLsbLsLsmbLgLsbRsLsbLgLsbLsLsmbLgbLsLsmbLsbLgbLsbLgbRsRs
mbLgLsLsmbLsbLsbLsbRsbLgLsbLsbLgLsbLsbLsbLgbLgbLgbRsLsbLgbLsLsLsmmbRsb
LibLsLsmbLgRsbRsbLgbLgLsbRsLsbRsbLgbLgbLsbRsbLgLsbRsRsmbLgbLsLsmbRsLsb
LgbLgRsbLsbLsLsRsmbLsLsmbLsLsmbLgbRsLsbLgbLsbLsbLsbLgLsbRsbLsbLgbLsbLg
bLgLsbLgbLgbRsbLsbLgbRsbLsRsbLsbLgbLsLsmbLgbRsbLsbLgbLgbLsbLgbLgbLgbLs
bLgLsRsbLsbLgbRsbLgbRgRsmbLsbLgbLgbLsbLgbLsLsmbLsLsmbLgbLsbRsbLgbRsLsb
LsbLgbLsbLgbRsbLsbRsbLgbLsbLsLsmbLgLsbLsLsLsmmbLgbLgbLsbLgbLgbLsbLgLsb
RsbLgbLsRsbRsbLsLsmbLgbRsbLgbRsbLsbLgbLsbRsbLsbLgbLsLsmbLgbLsbLgbRsLsL
smbRgRsLimbLsbLgbRgbsbLgbLgbLibRsbLgLsbLgLsLsmbRsbLgbLsbLsLsmbLsLgbRsb
LgbLsbLsRsbLgRsbLgbRgbLgbRsbLgbLsbLgLsbRsbLsbLgbLsLsmbLgbLsRsbLsLsmbLg
bLgLsbLsbLibLgbLgbLsbLsLsLsmmbLsbLgbLgbLsLsmbLgLsbLgbLgLsbLgbRsLsbLgbR
gbLibLsLsmbLgbLgRsbLgbLsbLgbLgbLgLsbLgLsRsbLibRiRsmbLjLsmbLibLgbLibLgb
LgbLgbLgLsbLiRsbRsbLibLiLsbRibRgbRhbRsbRsbRoRoLsbLhbRsLsbLgLsbLgbLhbLi
bRgbLhbRiRsmbLsRsbLcbLcbRibLebRsbLibRgbLibLgLsbRgbLgbRsbLiLsbLibRjbLib
LgLsbLgLsbLgbLgbRsbLgbRsLsbRsRsmbLgbLgbLgbLsbLgLsbLsLsRsmbRsbLgbRsbLsb
LgLsbRjLsbLgbRsbLgbRsbLsbLgbLsbLgbLsbLgbLsbLgbLsRsbLsLsmbRsLsbLgLsbLsb
LsbLgbLgbLsRsbLsbLgLsbRsLsbLgbLsLsmbLgbRgbLiLsbLgbLsbLgbRgRsmbRsRsmbLi
bLsbLiLsbRsbLgbLgbLsbLsLsRsmbLsbLgLsbRgRsmbLgbLsbLgLsbLgbRsLsbLsLsLsmm
bLsbLgLsbLsLsmbLsLsmbLgbRsbLgbRsLsbLsbLobRhbRsbLibRsLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 5; Drug: PCAP2 10 然
bLgbLibLibRsbRgbLibLgbLgbLgbLsbLgbLsbRsbLhLsbLiLsbLhLsbLibLiLsbLsLsmbL
gLsbLgbLiLsbLibLgbLsbRcbRgbLsbRcbRgbLgbLgbRibRibRsbRgbRsRsmbRgbRgbLsbR
iLsbRsRsmbRsLsbLsbRgbRiRsmbRgbRgbRibLebLcLsmbLibLgbLibLcbLcbLsbLgLibLg
bRsLsbRjRobRibRibRsbRgbRgbRgbRsbRsbRgbRsbRgbRgbRgRsmbLsbLsbRhbRgbRsRsR
smmbRsbRsbLsRsRsmbLsbRgRsmbRgbRgRsmbLsbRiRsmbRsbRsRsmbRibRgbRgbRgbRgbR
gbRgRhbRsRsmbRgbReRsmbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgRcRsmbRiRsmbRibR
gbRgRsmbRgbRiRsmbRgbRgbRgbRsbRgRsmbRsbRgbRibRgLsbLsRsbRgbRgbRibRgbRgbR
sbRibRsbRgbLsbRgbRsbRsRibRgbRsRibRgbRgbRgbRgbRgbRgbLsLsmbRgbRgRsmbRsbR
gbLsbLsbRsbRebRgbRgRsmbRgRsmbRgbRgRsmbReRgbRiRgbReRsmbRebRhbRgbRibRgbR
gbRgRsmbLsbRiLsbRsRsmbRgbRgRsmbRgbRsbRgbRgRsmbLgRsbRsbRibRgbRsbRibLsLs
mbRgbRsbRgbRgRsRsmmbLjbRcbLhbLhbRcbRhbRsbRobLiLsbLgbRibRcbRgRsmbRhbRsR
smbLsbLgLsbLhbRiRsmbRibRsbRebLeLsbLibLhbLgbRsLsLsmbRhbRibRsbRcbRgbRgbR
cbRibRgRsmbRcbRgbRiRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 6; Drug: PCAP2 10 然
bRjRsmbLeRsbLsbRibRgbRsbRgbRgbRgbRgbRsLgbLjLsLsmmbLiLsbLgLsbLgbRsbLoLs
mbLeLsbLebRibLibLgLgbLgLsbLebLiLsbLsbLibLgRgLsbLgbLiLeLsbLgbLobLiLsbLs
bRjbRsbLgbLsLsLsmmbRcLsbRibRoRsmbRgbRibRoRsmbRebRgRsmbRibRibLgbRiRsmbR
gbRcRsmbRcbRgbRgRsmbRibRibRiRsmbRcbRebLcLsmbLebLebLcbLibLhLsbLibLsLsmb
Lsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 7; Drug: PCAP2 3 然
bLgbLgLsbLgbLgbRsbLhLsbLoLsmbLibLibLgbLgbLgbLgbLgbLgbLgbLgbLgRsbRebRgR
smbRgRsmbRgRsmbRsRsmbRgRsmbRgbRsbRgbRsbRsRsmbRsbRgLsRsLsbLebLibLgbLgLs
bLgbLgbLsbRsbLsbLgbLsLsmbLgbLsbLgbLgbLsbLgbLgLsbLgbLgbLgbLsbLsbLgbLgbL
gbLgbLgbLsbLsRsbLibLsbRibRibLsLsRsmbRibRgbRgRsmbRsbRgRsmbRsbRibLiRsbRi
bRgbRgbRgbRsRsmbRgbRsbRgbRgbRgbRgbRgbRgLsbRsbRcbRibRsbLiRsbLgbLgbLgbLg
LsRsLsbLgbLgLsLsmbLgbLsLsmbLgbLgbLsbLgbRcbRobLsbRsRgLsbRgbRsbRgRsmbRgL
sbRsbRsbRgbRsbRgbRgbRgbRgbRgbLsbRgbLsbRgbRsbRgRsmbLcbLcbLsLsmbLgbLgLsb
LgbLgLsbLsLsmbLgbLibRcRsmbRiRsmbLcLsLsmmbLibLgbLsLsmbLgbLgbLgbLgbLgbLg
bLgbRsLgbLgbLgbRsLsbRebRibRiRsmbRibRhbRiRsmbRiLsbLhLsbLhbRgbLibLgbLsbL
gbLgbLgbLsLsmbLgbLgLsbLgbLgLsbLgRsbLgRsbLgLsbLgLsLsmbLsbLgLsbLsbLgbLgb
LsLgbLgbLgbLsbLgLsbLgbRoLsbRgRsmbRgLsRsbRibLibLjbLibLsLsmbLgbLibLgbLsb
LgbLgRsbLgLsbLgLsbLgLsRsbLsLsmbLsbLgbLgbLsbLgbLgLsRsbLgRsbLgbLgRsbLgRs
bLgbLsLsmbLgbLgbLgRsbLgbRjbLibLgbRgbRsLsLsRsRombRsLsbRgbLsbRgbRiRsmbLo
bRgLsbRsbLiLsbLgLsbLgbLgbLgbLgLsbLsbLgbLgbLgLsbLgbLgbLgbLsbLgbLgLsbLgb
LibRcbRsbRoLsbLgbRibRgRsmbRoRsmbRcbRibRiRsmbLsbRibRgbLcLsmbLjLsmbLeLsb
LjLsmbLibLhbLgbRgbLibLsLsmbLsbLibLgLsbLgbRibRgbLsRsbRgbLiLsbLgbLgLsRsb
LsLsLsLsmmmbRiLsRsbRgbRsbLibLgbLgbLsLsmbLsbLsbLsLsmbLsbLsbLgbLsbLsRsbL
gLsbRsLsbLgLsbRgbLgbLgbLsbLsbLsbLsbLgLsbRsLsbLgLsLsmbLibRgbLibRjRsmbRi
RsmbRsbRgbRgbLjLgbLjbLiLsbLsRsbLibLsLsmbRsRsRsmmbRgbRsbLsbLsbLgbLjbLsL
smbsbRgbsbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 8; Drug: PCAP2 3 然
bRgbRgbRgbRgbRiRgbRgRsRsmmbRgbRgbRibRgbLsbRgbRsRsmbRgbRgbRiRsRgmbRgbRg
RsRsmmbRgbRiRsmbRibRgbLcbLcbLsbLhbsbLsbLgRsbLibLibLcbLibLgbLiLsLsmbRsb
LgbLgLsLsmbLgbRebRcRsmbRibRgRsmbRgRsRsmmbRgRiRiRsmbRsbRgRsmbRgbRgRsmbR
gbRgbRgbRgbRobRcbLsbLcbLgRsbLgLsbLibLoLcbLcbLgbLgbLgLsbLgLsbLgbLobsbLc
LsmbLibLgbLgbLgLsbLgbLgbLgbLgbLgbLgbRcRgbRibRgRsRgmbRsRgbRgbRsRgRsRsRi
RiRsmmmbRgbRgbLobLibLgbLibLgbLiLsbLsLsLgmbRobRibRgbRgRsRiLsmbRgRsRgmbR
gbRobsbLiLsLiLsbLiLsLgLsbLgbLgLiLsLiLgbLgRsbReRsmbRgRsmbRsbRcbLibRibRi
RsLgmbRsbRiRsmbRsRiRsmbLjbLhbLgbLgLsLgLsLsLgmbLgbLibLibLcbLgbLgbLibLgb
LgbLgbRsRsmbLibLgbLgLsRsLsLsmbLsRsbLcbRgbLcbLcRsbLgLsbLsbLjLibLgLsbLgL
sbLgbLgbReRsRimbRgRsmbRibRgRsmbRibRgbRgbRibRgRsmbRibRgRsmbRgbRcRsmbLib
LcbRsLgbRjbLibLgbLgLsbLsbLgbLgbRibRibRgbRgbLebLgbLibLiRsRsmbRibRcRsmbL
jRsbRibRgbRgRsmbRsRgbRgbRgbRgbRgbRiLibLhRsbLibLsbLgbLgbRgbLcLsmbLobLib
LsbLhbLiRsLsbsbLgbLgbRebLjbLibLsLsmbLgLsbLgLsbLsbLgbLgLsbLsRsbLobRgbRg
bRgbLgbRsLsbsbLsRsRsmbRgbLjbRgRgRsRsRsmmmbRgbRiLsRsRgbRgbRgbRgLsbLgLsb
RgRsmbRiRsmbsbsbRsbRiRsmbRgbRgRsmbRgRsRsmmbRgRsmbRgbLhbLibRibRgbRgbRgb
RsbRgbLsbRcLsbLsLsmbLgbLgbLibLsbLgRsLsbLoRsLcbLsbRcbLobLoLsmbLsLsmbLsb
LgbLgbLgbLcLsmbRsbLcbLgLsLsmbLiLsbsbLsbLsLgLgbLebRgRsmbRgRiRsRgRgRiRgR
smmbRgRsmbRgRsmbRsbRibRibRgbRgbRgbRgRsmbRgbRgRsmbRibLiLibLiLsLgbLgbLgb
LgLsbLgbLgbLgRsbRcRsRsmmbRgbRgbRgRsmbRgRsmbRgRsmbRiRsLsmbRgbRiLsRsbLsb
RgRsmbRiRsmbRgbRgRsRsmmbLsbLjbLiRsbRsLibLgbLgLgbLgRsLsbRobRgLsbRgRsmbR
sRgbRgRsmbRibRgbRiRsmbRgbRgbRgRibRgbRhbLgbLhbLiLsbLiRsbLgbLgbLgbLsLsLs
mmbLgbLgbLgbLgbLgbLgbLcRsLgbRgbRgbRgbRgRsmbRgbRgbRiLsbsbLibLibLgLgRsbL
sbLgbLgbLibLgLsbLobLgLsbLibsbLcbLiRsbLsbLibLsbLgbRjbRcbRgbLsbRiRsmbRib
LgbRgRsmbRgLsbRgRsRsmmbRgRsLsmbRgRsmbRgbRibRgbRgRsmbRgbRsbRgRsmbRsbLsb
RibRibLsbLobLibLgbLgbLgLsbLgbLgbLgbLgRsbLgbLsbLgbLibLcbLibLgbLibLgbLib
RobRebRsbLgbRsRsRiRsmmbRsRsRsmmbRgRsLsmbRgbRsbRsRgbRgRsmbRgbRgbRiRsmbR
gbRgbRgbRgbLsRsbRibRibRgRsmbRgRsRsRsmmmbRibRgbRgRsmbLcbLhbLibsbLiRsbLi
bLobLcRsbLgLsbLgbLgbLgLsLgbLgRsbLgbLgRsbLibLibLgRsLsLsLcmbLgRsbLgbLgbL
gbLgbLgbLcLsmbLibLcbLibLgbLgbRsLgLsbLgbLgbLoLsLcmbLibLiLsbLsLsmbLgLsbL
gbLibLobLiRsbLjbLibLgLsbLgbLgLsLiLsbLsbLsbLibLsLsmbLgbLgbLsbLgLsbLsbLi
bLgLsbLgbLgRsbLibLcRsbLhbLibLhbLgLsbsbLgbLsbLsbReRsmbRibRcRsLsRsmbRgbR
ibRgbRibRgbRgbRoRhLsbRhRsmbRgbRgRibRibRgbRsbRgbRgRsmbRgRiRgRsmbRgRsmbR
ibRibRgbRsbLsbRcbLibLgbLibLgbLgbLsbLgbLgbLsbLgbLcbLcbLhbRjbRcRsmbRcbRh
bLcLsmbRsLgbLibLgRsbLsLsmbLgLsbLgbLgbLgLsbLgbLgRsbLhRsbRcRsmbLibLibLjb
LobRibRsbRiRsmbRsbRcbLhbRibRgbRgRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 9; Drug: PCAP2 3 然
bRgbLsbLsbRiLsbLsbLgbRibRgRsmbRibRgRsmbRgRsmbRsRsmbLsRsbRibLgbRcbRcRsm
bRibRhbRgbRgbRsbRgbLsbRsbRsbLsRibRsbRsbRgbRsRsmbLsbLsRsbRibRibLgbRgbRg
bLcbLibLsbLgbLibLhRsbRibRjbRibRsbRsbRgbRgbRgbRsbRgbLsbRibRibRgbRibLibL
gbLsbLiLsRsbRcbRibRgbRsbRsbRsbRgbsbRgbRgbRsbRsRsmbLsRsbRsRsmbRgbRgbLsb
RgbRgbRsbRgbRgbRhbRibLgbLgbRcRsmbRgbLsbRiRsmbLsbRgbLsbRgRsmbRgbRsRsmbR
sbLsbRsbRsRsmbRgbRsbRsbRsbRgbRgbRsRsmbRsLsbRsbRsbRsRsRimbLsbLsbRibLsbR
sbRiRsmbRsbRsRsmbRgbLgbRhbRibLibLjbLcbLcbLibLiLsbLibLibRsbRcbLsLgbLhbL
sbLgLsbReRsmbRibLgRsbRsbRiRsmbRsRsRsmmbLgbRiRsmbRsbRsbRsbRgbRgbRsbRgbR
gbRsRsmbRgbRsRsLsmbRgbRiRsmbRsbLsLsmbLcbLgbLsbLgbRibLhbRsRsmbRgRsmbRsb
LebLiLsbLgbLibLgLsbRibRcbRibRsbLsbRsbRsbRgRsmbRsbRsbRgbLibRibRgbRcbRhb
RgbRsbRibRgbLsLsmbRsbRsbRgbRgbRgbRgbRsbRiRsmbRsbLhbsbLibLgbRcbRibRsbRs
bRhbLsLsmbRibRgbLgbRgbRgbRsRsmbLsLsmbRhbRibLibLsbRhbRibRsbRgbRibLsbRcb
RsbLibLcbLibRsbLcbRsbRgLsbsbLibRcbRiRsmbRiRsmbLjbRgbRibRibRibRgbLsbLeb
RgbLibLgbLsbLsbRsbLibRgbLgbLibLsbLcbRibRibRhbLibLgbRjbLibLgbLgLsLsmbLs
bRgRebRgbRgbRgRsmbRsRsRsmmbLsbRgbRsbRgbRsLsbLsbLsbRgRsmbRibRgbLsbRoLsb
RgbRgbRjbRgbRibRibRgbLgbLgbLibLibLgbLibLibLiLsbLgbLsbLibLgbLsbLgbLgLsb
LgbLgbLgbLibLibLgbLsbRibRgbLjbLsbLebLibLsbLgbLgbRgbRcbRgbRsbRgbRcbRibR
ibRobRibLgbLgbRcbRgRsmbRsbRiRsRgRsmmbRgbRgbRgLsRsbLgRsRsmbsbLiLsbLibRs
LsbRebLibLsbLgLsbLgbLsbLgbLhLsLsmbLcbLgLsbLcbLhbLibLsbLsbLcbLsbLsbLsRs
bRsbRcbsbLjbRiLsbLjbLcbLsLsmbLibRsbLgbLibLsbLsbLsbLgbRgbLibLsbRjbRhbRg
bRgbLsbRsbRgbRgbLsbRgLsbRgbRsbRgRsmbRsbRgbRgbRiRsRgRsmmbRsbRgbRsbRsbRg
bRgbRsbRgRsmbLsbLsbRiRsmbRsRsRsmmbLsbRsbRgRsmbRgbRsbRgbRsbRsbRsRsRsmmb
RsbRgbRsbRsbRsRsmbRgRsmbRgbRgbRgbRgRsmbRgbRgRsmbRgRsmbRgbLjbRhbRebRibR
iRsmbRibRgRsmbLjbLhLsbLibLhLsbLibLjbRgbLgbLibLgbLcbLibLgbLgbLsbRsbLsbR
ibRgbRsbLsbRibRsRsmbRsbRsRsmbRsbRgRsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 10; Drug: PCAP2 3 然
bRgbRgbRgbRsbRgbRibRgbRsbLsbRibRsbRsRsRsmmbRsbRsbRgbRsbRgbRgRsmbRsbRgb
RsbRsbLsRibRgbRgbRgRgbRgbRgbRsbRibRiRsmbRsbRibLibRsbRcbRgRsmbRsRsmbRgb
RsbLgbRibRsbRsbRsbRgbRsLsRsbRgbRgbRgLsbRsbRsbRsbRsbRsbRibLsbRgbLsbRgbL
sbRsbRgRsmbRgbRsbRsbRgbRgbRgbRgbRsbRgbRsbRsbRgbRibRsbRgbRsbRgbRgbRgbRg
RsmbRgbRgRsmbRgbRgbRsbRgbRgbRsbRgRsmbRsbRgbRgbRsbRgbRgRsmbRsbRgbRgbRsR
sRsmmbRgbRsbRgbRgbRgbRibRibRgbRsbRgbRgbRsbLsbRibRgbRgbRgbRgbRgbRsbRgRs
mbRsbRgbRgbRgbRgbRgbRgbRgbRsbRsRsmbRsbRgbRsRsmbRsbRgbRgRsmbLsbRgbRgbLs
bRsbRgbRgbRgRsmbRsbRsbRgbRgbRgbRgbRsbRgRsmbRgbRgbRgRsmbRgRsmbRsRsmbRgb
RgbRsbRgbRgRsmbRgbRgbRsbRgbRgbRgbRgbRgbRgbRsbRsbRgRsmbRgbRgbRgRsmbRgRs
mbRgbRgbRgbRgLsbRgbRgbRgbRgbRgLsbRgbRgbRsRiRsmbRibLsbRibLsbRibRsbLsbRi
bRsRsmbRsbRibRsbRgbRgRsmbRsbRgbRgbRgRsmbRsbRgbRgbRgbRgbRgbRgbRsRsmbRgb
RsRsmbRsbRgbRgbRgbRgbRgbRsRsmbRgbRgRsmbRsRsmbRgbRgbRsbRgRsmbRsbRgbRgbR
gbRsbRgbRgbRgbRsbLsRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgRsmbRsbRgbRgbRgb
RgbRsbRgbRsbRsRsmbRgbRsRsLsmbRgRsmbRgbRsbRsLsbRgRsmbRgbRsbRgRsmbRsRsmb
RgbRsbRsbRgbRgbRgbRgRsmbRsbRgbRgbRibRsRgRsRiRsmmbRsbRgLsbRibRibRiRgbRs
bRibLsbLsLjbLebLsLsLsmmbRibLiLsbLgbRsbRibRsRsmbLibLsLsmbLgbRgbLsbLibLg
bLsRsbLsbLgbLsLsLsmmbLibRsRsmbRgRsmbRgbRsbLsbLibLgbLibRgbLsLsmbLsRsbLg
bLgbLsLsmbLibRibLsRsbRgbRsbLgbLsLsmbLiLsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 11; Drug: PCAP2 3 然
bRcRsmbLgRsbRsbRibLjbRibRsRsmbRgbRgbLibRgbRcbLgbRgbLsRsbLsbRibRsbLsbLg
bRibLsbRiLsbRhbRibRibRgbLsbLjbLhbLcbLibLgbRibRibRsRsmbRsbLcbLibLgbRsbR
sbLgbLsbLgRsbRsbLsbLjbLobRibRiRsRsmmbLibLibLibRjbLebLibLjRsbLjLsmbRiRs
RsmmbRibRebRebRcbRibRibReRsmbRibLsLibRsbRibRibRibRgbRsbRibRcbReRsmbRib
RibRiRsmbRibRsbRgbRgbRsbRsRsmbRgbRgbRsRsmbRiRsmbRibRjbRcRsmbRibRsbRgbR
gbRsbLsRsbRcbRgbRgbRgbRgbRibRsRsmbRsbsbLibRgRgbRjbRgbLgbLcbLsbRsbRjRgb
RjbRsbRsbRsbReRsmbLibLebLobsbRsbRsbLsbLsbRibRgbRsbRebRibRgLsbRgbLiLsbL
sbRgRsmbLgLsLsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 12; Drug: PCAP2 3 然
bRcbRibRsbRgRsmbRsbRgbRsbRsbRsbRgbLsRsbRgbRibRgRsmbLsbLsbLsbRsbRibRgbR
sbRsbRgbRsbRgbRsbRgbRcRsmbRibRsbRgbRgbRgbRgbRgbRgbRsbRsbRsbLobRgbRibRg
bRsbRgRsmbRsRsmbRgbRsbRsbRgbRsbLsRsRsmbRsbRgbRgbRsbRgbRgRsmbRgbRgbRgRs
mbRgbRsbRsbRgbRsbRgbRsRsRsmmbLgbsbRsbLjbLibLibRcbRgbLgbLcbRgbLgLsbLgbL
obLhbRgbRibRgbRgbRsbRgbRgbRsbLsbRibRgbRgRsmbRgbRgbRgbRgbRgLsbRgbRsbRgb
RgbRgbRgbRsbRgbRcbLjbRibRgbRgbRsbRibRgbRgbRgbRibRsbRsbRgbRgbRgbRgRsmbR
gbRgbRgbLsbRsbLsbRsbRibRsbRgbRgbLsRsbRgbLsbRgbRgbLjbRibRgbRgbRgbRsbRsb
RgRsmbRibRgbRsbRsbRgRsmbRsbRgbLsbRsRsLsmbsbsbRsbLsRibRgbRgbRgRsmbRsbRs
RsmbRgRsRsmmbLsbRgRsmbRsbRsbRsbRgbRgbRsbRgbRgbRgbRsRsmbRgbRsbRgRibLsbR
gbRgLsbLsbRsbRsLsbRiRsRsmmbRsbLsbRgbLsbRsbRgbRsbLcbRjbRibRgbRgbRsbRibR
obRebLibLcbLobRsbRgbLgbRibRsbRgbRgbLcbLcbRgbLgbLgbLgbRsbLgbRjbLgbLibRs
bRjbLcbRgbLibLibLibLgbLibLgbLgbRgbRgRsmbRgbRsbLsbRgbRobRcbRhbRgbLibLgb
RsbLgbLibRgbLoRsbLobLcbLgbLobLsLsmbRsbRsRsmbRsRsmbLcbLsbLgbRsbLsbLsbRs
bLsbLgbLcbLobLgbLsbRibRobRcRsmbLgLsbLsbLibRsbRsbLsbLsbLjbLsbRsbLgbRcbL
sRgbRsbLcbRsbLsbLsbLsbLgLsLsmbRsbLoRsbLgbLsbLgbLiRsbRsbRebRgbLsbRgbLsb
RgbRgbLsbRgbRgbRgbRcLsbRcbRcbLjbLsbRgbRjbRsbRgbRgbRiLsbRcbRhbRebRibRsb
RgbRibRgbLsbLsbLgbLsbRobLgbRsbRsLsbLsbRsbRhbRsbLsbRgbRsbRsbRgbRcbRibRg
bLibLsbLebLhbRibRgbRsbRgbRgbRibRgRsmbLsbRgbRgbRsRsmbRgbRgbRobRgbRibRgb
RibRgbRsbRgbRgbRgbLsbRcbRgbLsbLsbRgbRgbRgbRgbRsRsmbRsbRsbRhbRcbRcbLsbL
sbLibRhRsmbRhRsmbRjbRsbRgbRsbRgbRsRsmbRsbRsbRgbRibRibRibLsLsmbLsbLibLc
bLob

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 13; Drug: PCAP2 1 然
bRibRgbRsRsRsmmbRgRsmbRsRsmbLgbRobLgbLjLsmbRhbLgbRhbRhbLjbLcbLhbRgbRib
LgbRibRgbRgRsmbRgbRgbRgbRgbRgbLcbLgbLiLsbLgbLgbRsbLgbLgbRgbLgbRebRsbRo
LgbRcbRibRibRsRsmbRgbRcbRgLsbRsbRsbRcbRobRiRsmbRgbRcbRgbLcbLcRsbLgbLgb
LgbRsLgbLgbLcbRgbRgbRibRibRhRsmbRgbLgbRgbLgbLsbLibRibLjbLgbLgbRsbLgLsL
smbLgLsRsbLgbLgbLsbLiRsbLcbLgbRsbRcbRsLsbRgbLsbRgbRgbRgbRgbRsbRsbRsbRg
LsbRgbRsbRgRsmbRgbRsbRgRsmbRgbLsbRgbRgRsmbRgRsRsRsmmmbLsbRgbRgbRgbRgbR
ibLcbRsLiLsbLgbRgbLiRsbLsbRgbLgbLiRsbLgLsbLgbLgbLsLsmbLgLsbLgbLgLsbLgL
sbLiRsbLibLgbRgbLcRsbRgbLhbLibLsbRgbLcbLsbLibLiRsbRgRsLsmbRibRhbRsbLeb
LgbRgbLgbLsRsbLsbLsbLgbLsbLsLsmbLgbLgbLsbLsLsmbRsbLibLgbLsbLsLsmbLgbLg
bLgbLgbLgLsbLgbLsLgbLgLsbRgbLibRobRibLsbRiRsmbLgbRhLsbLgbLibRjbRibRgbR
gbRgbRgbRsbRibRobLibRsbRibRiRsmbRiRsmbRiRsLsmbRgbLcbLibLibRhbLiLsbLibR
jbLcbLiRsbLsbRibRibRsRsmbRsRsmbRiLsbLsbLsbLobLgbRsbLibLibRsbLcbLsbRhRs
mbLibLgLsbLgbRsRsmbLibLgbRsbRebRibRibLsbRgbRgbRgLsbRsRsmbRsbRgbRgbRgbR
gbRgbRgRsmbRgbLsLebLibLgbLgbRgbLibLgbReRsmbRsbRsRsmbRibLgRsbRibLsRsbRi
RsmbLsRsbRgbRgbRibRgbRgbRsRsmbRgbRgbRgbRgbRgRsmbRgbRsbRgbRgRsmbLgRsbLc
bLibLsLsRsmbLibLgbRsbLsbLgLsbLgbLgbLgbLsbLgbRjRsRcmbRiLsbLgbRgbRibLgbR
gbRibLjbLjbLhbRjbLsLsmbLsbLgbLgbLcbRibLcbLcbLibRgRsmbRibLsbRgbRgbLcbLc
bLibLiLsbRgbLgbRjbRhbRsbRibRsbLibLcLsmbLjLsmbLiLsbLgbLgRsbRsRsmbRcbRib
RgRsLsmbRsbRcLsbLgbLebLiLsbRgbLcbLiLsbRhbRhbRibRsbRibLiLsbLoLsmbLibRsb
LhRsbRsbRsRsmbLhbRjbLgbLgLsbLgRsbRcbRiRsmbRhbLjbRjRgRsmbRgbRjbRgbLiLsb
RibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 14; Drug: PCAP2 1 然
bRjRgbRgbRjbRgRsmbRibRgbRsbRgbLsRsbRebRibLsbLgLsbLgbLsbLjLsmbRibRjbRib
LgbLsLsmbLsLsmbLgbLjbLgLsbLgbLgbLgbLsbLsLsLsmmbRjRsmbRsRsmbRibRibRsbLi
bRgRsmbRjRsRsmmbRsRsmbRgbLgbLgbLibLibLgbLsLsmbRsbRiRsmbRcbLjLsLsRsmmbR
ebRiRsmbRgRsmbRsbRjRsmbRsbLsbRgbRibLsRsLsbRsbRcRsmbRgbRiLsbLgbLsLsmbLg
bLsLsmbLsbLcbLgbLgLsbLgbLsbsbRjRsRsmmbRsbLsRsbRgbRsRsmbRgbRsbLjLsmbRjb
RjbRjRsRsmmbRgbRgbsbRibRgbLsbsbRsbRgbRibRibRjRsmbRgRsmbRsRsmbRsbRgbRgb
RgbRgbRsRsmbLsbRibRgbRibRgRsmbRgbRsbRgbRgbRgbRhbRibRgbRgbRgRsmbRgbLgbR
hbRcRsmbRsbLsbRsbRsbRsbRgbRgRsmbRgbRgRsmbRgbRjbsbLsbLsbLsbRcLsbRiRsmbR
sbRgRsmbRgbRsbRsbLsbRgbRiRsmbRsbRibRgbRgRgbRsbRsbRsbRsbRibRibRsbLsbRsb
LsbLjLsmbRibLsbRibRgRsmbRibRsbRsbRibRsbLsbLiLsbLgbLhbLsLsmbRgbLsbLiRsb
LgbLibLsbLsbRsLsbRsbLibLgbLgbLsbLsLsLsmmbLsbLgbRibRgbRcbRsRsmbRgbRgbRi
bRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 15; Drug: PCAP2 1 然
bRibRibLebRcbRcRsmbLhbRcRsmbRiRsRsmmbRcbLibRebRcbRhbRiRsmbRibRiRsmbRcb
LcbLsbsbLcRsbLcbLibLsbReRsmbRcRsmbRibRhbRibRgbRgbRsbLgbRebRgbLjbLgbRcb
RsbLjbRebRiRsmbLsbRsbRiLsRsbRsRsmbRibRsbRgbRsbRgbRgbLsbRsbRiRsmbLsbRgb
RgbLsLsmbRgbRibRiRsmbRsbRsbRgbRgbRgbRibRgbRgbLgbRibRgRsmbRibRgbLcbLhbL
cbRhbLcbLebLhbLgRsbRsbRcbLibRibRgbRiLsLsmbLsbRgbRgLsbRgbRsbRgRsRsmmbRg
bRiRsmbRsbRibRgbRsbRgbRibRibRgbRibRibRgLsbRibRibRgbRsLsbRibRgbRgLsbRgb
LibRibRsbRibRsbRiRsmbRgbRgbRgbRsbsbRibRibRsbLsbRiRsmbRgbRgbRgbRsRsmbRi
bRcbRcbRgbRgbRibRgbLsLsmbRsbRsRsmbRgRsmbRsbRsbRsbRgbRsbRsbRibRgLsRsbRg
bLsbRibRsbRgRsmbRsbRgbLgbRgbRibLgbRiRsRsmmbRsbRsbRsbRibRsRsmbRibLsbRiR
smbRsRsmbRgbRiRsmbRgbRiRsmbLiRsbRibLsbRgRsLsmbRsRsmbRsbRsLsbRgbRgbRgbR
sbRgbRgbRgbLgbRibRgbRsbRibLsbRibRgbLgbRibRiLsbLsRsRsmbRgRsmbRgbRgRsmbR
sbRibLsbRiRgRsmbLsbRibRgbRgbLsbRobRcRsmbRebRiRsmbRibRibRibLibRibRoRsmb
RibRhbRgbLsbRibRibRgbRibRgbRibRgbLcbLibReRsmbLgbRibRsRsmbRgRsmbRsbLsbR
iLsbRgbRgRsmbRsRsmbRsbRgRsmbRibRsbRgbRgRsmbLsbRibRsbReRsRsmmbLibRgbRgb
RgRsmbRgRsmbRgbRiRsmbRgRsmbLsbRibRgRsmbLgbRiRsmbRsbRgRsmbRgbRgbRebLgbL
ibLcLsRsmbRibLcbLcbRjbLcLsmbLcbLibLsbRsbLcLsmbRjbLibRjbLiLsbLsbLibLgbL
ibLgRsbRjbRcbLgbRgRsmbRibLsbRgbLsbRgbRgbRgbRgbRgbLibRibLsbRibRsbRibLsb
RibLgLsbRibLsbLsbRsbRiRsmbRgbRsbRgbRgbRgbLsbRgRsRsmmbRsRsmbRsRsRsmmbRg
bRibRibRgLsbLibLjbLibRjbRebRibLsbRibRiRsmbLgRsLsbRibRibRgLsbRibRgbLgbR
ibLsbRibRgbLgbRgRsRsmmbRsbsbRiLsbLsbRibRibLgbRgRsmbRsbRgbLsbRiRsmbRgbR
gbLsLsmbRgbRgbRgbRgbRgRsmbRgbLsbRgbRgRsmbRsbRibLebRibLcRsbLiRsbRobLgbR
hbRsRsmbRgbRsbRgbRgbRgbRgbRgbLgbRgbRgRsmbRgbRsbRgbRsbRsLsbRibRsbRibLsb
RibRsbRgbRgbRibLsbRsbRiRsmbRgbRgbRsbRibRibRsbRgbRsbRgRsmbRsLsbRibRgbRs
bRibRgbRibRgbRsbRibRsbRgbLgbRsbRibRsbRsbRsbRibRgbRgbRsbRgbRgbRgbRibRsb
RgbRibLgbRcbRhbRcbRgbLcbRcbRcbLsbRibLjbRiRsmbRcbLgbRsbRgbRibLsbRibRsbR
gbLsbRibLsbRgbRgbRgbRgbRgLsbRsbRgbRgbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 16; Drug: PCAP2 1 然
bLebLebLebLcbRcbRebRebLgbLiLsbLsbLgbLibLsbRsbLgLsbLgbLsbLsbRjbRcRsmbRi
RsLsmbRibLsRsbLsbLsbLiLsbLcbLcbLibLiLsbLsbRebLjbLsbRgbLsLsmbRsRsmbRsbR
sbRgbRgLsbRgbRsbRgbRsbRsbRsbReLsbLsbRgbLsbRsbLebLgbLhLsbRsbRcbLhbLgbLg
bLgbLsbLsbLsbLiLsbRsLsbLsLsmbRebRibRgbRcbRsbRjbRgbLsbRgbRsbLsbRgRsmbLs
bRgRsmbRgbRsbRgbRsbRjbRibRgbRcRsmbLsbRsbLebLjbLibLjbLcbLgbLsbLgbLgbLib
RcbRjbRgbLgbRgbLsbRibLsbRsRsmbRsRsmbRgbLsbRjbRsbRsbRsbRsbRgbRgbRsbRsbR
sbRsbRgRsmbRsbRsbRsbLjbLcRsLsbLgbLjbsbLsbLgbLebLgbLgbLibLgRsbLibRsbRsb
LgbRiRsmbLjbLjbLsbRsbRgbRsbLcbLgbLebLsRsbLsbRhbRibLsbRsbRgbRsbLsLsRsmb
LebLibRgLsLsmbLjbLibLibRebLcbLgbLiLsbRgbLgbLebRsbRgbLsbLgLsbLsbRcRsmbR
ebRgLsbRsbLgLsbRibRsbRsbRsbRgbRsbRsbRgRsmbRsbRsbRsbRsbLsbRgbLjLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 17; Drug: PCAP2 1 然
bRcbRgbLcbLjLsmbRgbRcbRibRgbRgbRgbLcbLhbLibRcbRiLsbLjbLibLsbLsbLibLsLs
mbRsbLsbsbLgbLsbLsbLibLgbLsLsmbLgLsbLgbLgbLsLsmbLgbLgbLgbLsbLgbLgLsbLg
LsbLgLsbLgbLgLsbLgbRsbLibLsLsmbLsbLgbLgLsbLgLsbLgLsbLgbLgbLibLgbLgbLgb
LgbLgbLgbLgbLgbLgbLgbRgbLgbLgbLgLsbLsbLgbLsRsbLsLsLsmmbLgbLgbLgbLgLsbL
gLsbLgbLsbRsbLibLgLsbLgbLgbLibLibLgbLibLibRcbRcbLeLsRsbLibRcbRcbLebLiR
sbRobLebLgbRsbLiLsbLsbLibLgbLgbRobRhbLcbLibLgLsRsbLsbLsbLgbLgbLgbRsbLi
bLibLcbLcbRhbLcbLiLsbRsRsmbRgLsbLiLsbLgbLgLsbLsbLgbLsbLibRsLsbLibLibLs
bRgLsLsmbLgbLgbLgbLsbRibLsbLhbRsbsbLsbRjbRibLjbRibRgbRsbRgRsmbRgbLcbLi
LsbLgLsbLibRsLsbLgLsbLgbLgLsbsbLgbLiRsbRsbLibRsbLsbLiRsbLgbLgRsbLoLsmb
RcRsmbRgbLjbLibLibLsbLgbLgLsbLsLsmbLgbLgbLsbLgLsbLgbLsbLgbLgbLgbRgbRjb
RjbRiLsbLcbRjbLcLsmbRsbLibRsLsbRsbLibLsbLsRsbLiLsbRjbLibLsbLgLsbLgbRgb
LgbLhbRhbLgbLsbLibRsbLgbLgbLgbLgbLsbLgbLgbLsbLgbLsLsmbLgbLgLsbLibLgbRg
bLiLsbLgbRjbLibRcRsmbRibLcbLibRsbRsbLibLgbLsbLgLsbLgLsbLgbLgbLgbLgbRsb
LsbLibRsLsbRjbRhbLcbLcRsbRgbLsLsmbLiLsbLsbLsbLgbLgbLgbLgbLgbLgbLgbLgbL
gbLgbLgLsbRebRiLsbRibLobLibLsbLsLsmbLsbLgbLoLsmbLsLsmbLsbLebLgRsbRjbLi
bRhbLiLsbLsLsmbLgbLgbLgbRgbLhLsbLsbLibLsLsmbLsbLgbLsbLgbLsbLgbLsbLgLsb
LiLsLsmbLibLgbLgbRsbLibLgRsbLibLsbLgbRcbRgbRsbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 18; Drug: PCAP2 1 然
bLcbRcbLobRibLhbLibLgLsbLgbLgbReLsbLjbRobRebLsbRgbRjbLjbRibRibLjbRcLsb
RhbRibRgRsmbLibRjRhbRibRiLsbRibLiLsbLibRibRiRsmbRibRibLcbLgbLibLsbRgLs
bLgbLgLsRsbRibRcbRgRsmbRgRsmbRsbRgbRgbLsbLgbRhbLibLebLibRgbLibRgbLhbRe
bRebRhbLibLoLsmbLgbRibLibRjbRobLgbRoRsmbLibRhbRgbRgbLjLsmbRibRibLiLsbL
cRsbLiLsbRgbLibLgbLcbRibRgbRibRibRgbRiLsbRgbLhbLcbLsbLsbLgbRcRsmbLebLi
LsbReRsmbRcbLjbLibLibRjbLcLsmbRcbLcLsmbLibRebRcLsbLsbRibLsRsbRgbLsbRgR
sRsmmbRgLsbLgbLhbLgLsbRjbRsRcbLhbLgbRgbLgbLgbRsbLgbLibRsbRjbRcbRhbLsbR
gbRsbLcbLibRsbRsbLgLsbLibRebLsbRobRsbRibRsbLsbRsbRgbRgbLgbLcbRjbRsbLcb
LibRibRcRsmbRibLhbLebLibRobLjbRibRibLhbLcbRsbLiLsbLgbLgbRgbLgbLgRsbsbs
bsbLgRsbLibRjbLcbLsLsmbRebRcbRgbLgbRgbRibLjbRcLsbLibRibRgbLcLsmbLibLib
RibLcbRgbLibRjbLcbRibLibLgbRsRcLsbRgbRgRsmbRgRsmbLgLsbRgbRgbRiLsbRsRsm
bRsbLcbLiLsbLjbLibLebRsbRgbRibRgbRsbRiRsmbLgbRgbRgbRgbRgbRgRsmbRsRsmbR
gRsLsmbLibLgbRhbRebLgLsbLgbsbLgbRebRjRsmbRgLsbLgLsbLgbRiRsmbRgbLjbLgLs
bLsbRsbLsLsmbRebRsLsbRgRsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 19; Drug: Control
bLjbLibLgbLgLsbLsbLsbLsbLsLsmbLsLsmbLsbLsbRsbLsbLgLsbLgbLsbLsbLgbRsbLs
bLsbLgbLgbLsbLsbLsbLgbLsbLsbLsbLsbLsbLsbRgbLgbRjbRebRibRibRgbRgbRgLsbL
ibsbLsbLsbLsbLsbRjbLcbLsbRsbLsbLsbRsbRsbLsbLsbLgLsbLsbLgbLgbLsbRsbLgbR
cbRgbLjbRgbLobRsLsbRgbRgbLsbLsbRjbRsLsbRibLibLjbLsbLsbLsRsbRsbLsbLsRsb
LsRsbLsbLsbRsbLsbLgbLgbLgbLsbLsbRobRgbRsbRgRsmbRgbRsbRsbLgbLjbLjbLsLsm
bLgbLsbLgbLiLsbRhbRsbRhbRibLgbLcbLibRgbLsbRebsbRgbRsbRjbRibRibRsbLsbLg
bLsbLsbLgbRsbRjbRjbRhbRcbRebRibLjbRsLsbRiRsLsmbLsbLsRsbRsbRsbRsRsmbRib
RgbRgbLgbLgRsbRsbRjbRibRsbRibRsbRsbRsbRsbLgLsbLgbLgbLsbLgLsbRobLibLsbL
gbLgbRgbRibRgbLjbLsbRgRsmbLsbLhLsbLiLsRsbLsbLgLsRsbLsbLgbLgLsbLsbLsbLg
bLgbLsbRsbRobRgbRgbLcLibRobRebLcLsmbRgbRsbRsRsmbLjbLsbLjbRsLsbLsRsbLsb
RsbLsbLsbLgLsbLsLsmbLgbLgbLsLsmbLsbRsbLsbLgbLgLsbLgbLsbLibRsbRgbLsRsRs
mbLcbRsbLibLgbRgbLgbLgLsbLgbLgbRsbLgbLgbLgbLsbLgbLgRsbsbRiRsmbLjbLibLg
bLsbLsbLgbLgLsbLsbLgbLsbLcbRgLsbRibRibRibLsRsbsbLsbRjbLgbRgbLibRibRgbR
sbRgbLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 20; Drug: Control
bRsbLgLsbLibLgbLgbLsbLiLsbRgRsmbLibRsLsbLibLsLsmbLgbLgbLgbLgLsbLsbLgRs
bLgbLgbRjbLibLgbLibLibLgbLgbLgbLgbLgbRsbLibLiRsbRgLsbLibLiRsbLgbLjbsbR
sbLgLsbLgLsbLgbRsbLgbLgLsRsbRsbLgbLgbLsbLgbLsLsmbLsLsmbsbLsbLsLsRsmbLs
bLgbLsLsmbRsbLgbLibLgbLgbLgbLsbLgbLgbRgbLibRgbLiLsbLsbRjbRibRgbRibLjRs
bLobLibRjbLsLsRoLsmbLsbRhbLsRsbRibRgRsmbRgbRgbRgbRgbRgbRsbLsbRgbLsbRib
RsRsmbRgbRgbRsbRgbRgbRgbRgbLgbRsLsRsbsbsbLhbLiLsbLibLibLgbLsbRcbRiRsLs
RsmbLsbRhLsbLsbRibLsbRsRsmbRiRsmbRgbLsbRibLgbRiLsbRgLsbRcbLibLgbLibLgb
LgbLibLgRsbLsbRgRsmbLgRsbLibLibLibRgbLibRgbLsLhbLibLgbLgbLgLsbRgbRsbLg
bLibRsbLiRgbLibLiLsbRgRsmbLibLsLsmbLgLsbLgbLgbLgbLgbLgbLsbLgLsbLgbLgbR
gbRjbRsbLgbLsbLsLsmbLsLsmbLgLsbLgLsbLsbLgbRgbRsbLgLsbRsLsRsbLiRsbLgbLg
bLgbLgbRsLsbLgbLibRgbLhLsbLgbLgbLgbLsbLsbLsbLgRgRsLsmbLibLgLsbLgbLsbLg
LsbLgbLsRsbRsLsbLsLibLsbLsbLgbLsbLgbLgbLgbRsLsbLsRsbLsbLsbLgbLibLgbLib
LibLgLsbRgbLjbRebRgbLcbLiLsbLsLsmbRjbRebRgbRgbRsbRgLsRsLsbLsLsmbRiRsmb
LsLsmbRgbRjbsbRsRsmbRsbRiRsmbRgbRgbRgRsLsmbRgbRibLcLsmbLibLgbLgbRibLgb
LgbLgbLgLsRgbLsbLgbLiLsLsRsmbLgbLsRsbLsbRsbLgbLsLsmbLsbLgLsbLgbLsbLsbL
gLsbLgbLgbLgbLgRgbLgbRjbLibLgLsbLgbLgLsbLibLsbLgbRsLsbLgbLgLsbRsbLgbLs
LsmbLgbLgbLsbLgRsbLgLsbLgbLgbLsbLgbLgbLsbLgbRjbLibLibLsbLsbLgbLsbRsbLs
bRsbLsbLsLsmbLgbLgbLgbLgLsbLgbLgbLsbLgbLgLsbLsbLsbLgbRsbLsbLgbLibLsbLg
LsbLsbLsbLgbLsbLibLgbRgbLgbLsbLsbLgbLiLsbLgLgbLsbLgbLgbLgbLgbLsbLgbRsb
LjbLgbLgLsbLgLsbLgLsbLgbLgbLgbLgbLgbLsbLsbLgLsbLgbLsbLsbRsbLgbLcbLsbRg
bLgbLibLgbRgbLgbLiLsbLsbLsLsmbLsbLsbLsbsbLsbLgLsbLgLsbLgbLgbLgbLgbLsbL
gbLgbLgbLgbRgbLibLgbLsbLgbLgbLgbLgbLsbLiRsLsbLgbLgLsbLgbLiRsbLgLsbLsbL
sbLibLibLsRsbLsbLibLgbLgbLjbLcbRgbRgbRgbRibRgRsmbRsbRsbRgbRgbRgbRgbLsb
RgbRgRsmbRgLsbRiRsmbRgRsmbRsLsbRsRsmbRgRsmbRgbRsbRobLhLsbLibLiLsbLgbLs
bLgbLsbLgbLgbLsbLsbLgbLgLsbLgLsbLsbLgbLsbLgbLgLsbRgLsbLgbLsbLgLsbLsRsb
LsbLgbLgLsbLgbLgbLsLsmbLsbLsbLgbLgbRgbLiRsbLgLsLsmbLsLsmbLsbLsLsmbLgbL
gbLgbLgbLgLsbRgbLiLsbLgLsLsmbRgbLgbLgbLgbRgbLgLsbLsbLgLsbLsbLsbLsLsLsL
sLsLsmmmmmbLgbRgbLgLsbLgbLgbLgbLsbLibLgRsbLsbLhbRsbLsbLibLibRgbLebRgbL
cLgRsRgbLobRsbRibLhbLgLsbLgbLgbLgbLsbLgbLhLsRsbRibRsRgbLcbLiLsRsbLibLs
bLsLsmbLsbLgbLibLcbRiLsbRgbLhbLibLibLgbRiLsbLgbLgbLibLgbLsbLhRsLsbRgbL
ibLsbLsLsmbLsbLsbLgbRgbLgbLgbLgbLsbLgLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 21; Drug: Control
bsbRgbLhLsbLgbLiLsbRobRgbRgbRgbRiRsRsmmbRhbLibRcbRibRibLiRsbRgbRgbRgRs
mbLsRsbRibRsbRgbRsRsmbRsRsmbRsRsmbRgbRgRsmbRsbRgbRgbRsbRsRsmbRgbRgRsmb
RsbLsbRsbRgbRgbLsbRgbRgbLsbRgRsmbRgbRgbRgbRgbRsbRsbRgbRgRsmbLgbLcbLcRs
bRibRebRibRibRsRsmbRiRsmbLgbRcbRibRsLsbRgbRgbLsbRibRsbRgRsmbRgbRgbRgLs
bRgbLsbRgbRgbRsbRgbLsbRiRsmbRibRibRibRgbRibRsbRgbRgbRsbRgbRgbRgbLgLsbR
sbRgRsmbRgbRsbRgRsmbRgbRgRsmbRsbRibRgbRibRgbRgbRsbRsbRgbRsbRgbRgbRgRsm
bRgbLgbRgRsmbLsRgRsmbRgRsRsLsmmbRgRsmbsbRibRsRsmbRgRsmbLsbRibLgbRiRsmb
LsbRgbRgbLsLsmbRgbRgbLjbLjbLhbLsbRgbLhRsbLsbRjbLjbLibLgRsbRibRibRsRsmb
RgbRgbRgRsmbRgbRgbRgRsmbRgLsbRsbLgbRgbRgbLsbRgbRgbRgbLgbRgbRgbRibRibRh
bRibRgRsmbRibRgRsmbRgbRgbLsbRibLgbRibLjLsmbLcLsmbLibLibRiRsmbLgbLgbLsb
LgbLgRsbRgbLgbLgbLsLsmbRsbRjbRiRsmbRgbRgbRgRsmbRsbRsRsmbRgbRsbRgRsmbRs
bRgbRgRsmbRgbRgbRsbRgbRgbRgRsmbRgbRgbRsbRibRgbRgbRsRsmbRgRsmbRibLiLsbL
ibLhbRibLhbLgbRcRsmbRcLsbRhLsbRibLgbRibRgbRgbLsbRgbRsRsmbRgbRsbRgbRgLs
bRgLsbRgbRgbRgbRgbRsbRgbRgbRgbRsRsmbRgbRgRsmbRiRsmbRibRcbRibLgbRiLsbRg
bRgbLsbRgbRgbRsRsmbRgbRgbRgbRgbRibRgbRsRsmbRgRsmbRsRsmbRgbRsbRgbRsbRsR
sRsmmbRgbLjbLobLibLcbRiRsmbLcbLgbRgbLibRgbLhbLibLiLsbLsbRhbRgRsmbRibRg
bRgRsmbRgRsmbLsLsmbRhbRobRibLibLgbLgbRcRsmbRibRgbLgbLibRjbLibRgbRjbReb
RsbRgbRgLsbRsbRgbLsRsbRsRgbRsbRgbLsLsmbRgbRgRsmbRgbLsbRgRsmbRgbLsbRgLs
bRgbRgbRgRsLgmbRgbRgRsmbRgbLgbRibLobLgbLgLsbLsbLibRjbRcbRsbLsbRibRgbLs
bRsRsmbRgbRgbRgbRgbRsLsbRgbRiRsmbRoRsmbRibRibLsRibRgRsmbRgbRibLsRsbRgR
smbRgbLsLsmbRgbRgRsmbRgbRgbLsbRgbRgbLgbRgRsmbRibLjbLoRsbLgbLgbLgbLgbRs
bLgbLgbLgRsbRsRsmbLgbLsbLsbLsbLgbLsbLsbRgbLgbLgbLsbLsbRgRebRsRiRsRsmmb
RgRsmbRgbRgbRgbLgbRgbRgRsmbRsbRgbRgRsmbRsbRgbRgbRgRsmbRsRsmbRgRsmbRgRs
mbRgbRsbRgRsmbRgbLsRgbRsRsmbRgRsmbRsbRgbLgbRiLsbLsbRibLgbRgbRgbLgbRgbL
sbRibRibLgbRsbRcbRibLgbLcbLibRhbRcbRgbRsbRibRsRsmbRsRsRiRsmmbLsbRgbRgR
sRsmmbRsbRgRsmbRgbLgRsbRibLcbLgbLgbLsbLsbLsbLsLsmbRsbLibRjbLgbLibsbRhR
smbRibRsRsmbRibRsRsmbRgbRgbRsRsmbRgbRsbLsbRgbRgbLsbRgbLjbRcRsmbRgRsmbL
gbRgRsRsmmbRgRsmbLobLiRsbRcbRibRsbRgbRiRsmbRgbLgbRibRibRgbLsbRgRsmbRgR
sRsmmbRgRsmbRgbRsRsmbRgbRgbLgbRibRibRsbLgbLibLcbRcLsbRcRsRsmmbLgbRibLs
bRgbLgbLcbLoRsbLcbRiRsmbLsRsbRgbRcbRsbRibRgbRgRsmbRsRsmbRgbRgbRgbRsbLs
RsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 22; Drug: Control
bLiRsbRcbLibLgbLgbLsbLsbLsLsmbLiLsLsmbRsLsbLsbLgbLibsbLsbRcbRhbLiLsbRo
bLhbLibLiRsbRibLobRgbRjbRgbLjRsbLcLsmbLibLibLiRsLsbRjbLgLsbLibRcbLjbLi
bLgbsbRsbLiRsbLgbLsLsmbRsbLgLsbLgbRgbLcbRgbLgbRgRsmbRibRgbLsbRhbLibRob
LsbRibRibRgbRgbLjLsmbLgbLjLsmbLgbRibRjbRibLcbLhbRsLsbLobLibRibRibLjLsm
bLcbLcbRcbLgbLsbRsbRjbRibRiRsmbLibLjbLhbRgbLcbRcbRibRgbRgRsmbRsbLibRib
RibLsbLsLsmbRgbRibRibRgbRsbRgbLsbLgbRhbRhLsbRibLiLsbRibRgbRgbRjRsRsmmb
RibRibRjbRjRsmbRibRgbLibLhbRiRsmbRobLibLcbRiRsRsmmbRcLsbRcLsLsmbLsbRgb
RgRsmbLsbRcLsbRcbRibRgbRibRiRsmbRibRhbRhbRibRgbRsbRjRsmbLcbLibRsbRgbLi
bLsRjRsmbRjRsRsmmbRjRsmbRiRsmbRjRsmbRgbLjbRsbRibRibRsbRjRsmbRjRsmbRgbL
gLsbLgbRjbRhbLcbLcbLsbLsLsLsmmbRgbRibRcbRiLsbRibRjRsmbRibRibLibLgbLsbR
gbLibLhbRgRsmbRsbRibRgbRgbRsRsmbRjRsmbLjbRgbRgbRjRsmbRjRsRsmmbRgbRgbRs
RsmbRgbRsRsmbRsRsmbLsLsmbRjbLjbRgbLsRsbRibRgbRgbRgbRsbLsbLsLsmbLibRjbR
cLsbRibRgLsbRibRsLsLsmbLsLsLsmmbLsLsLsmmbRjRsmbRibRgRsmbRgbsbRibRibRsL
sbLebLobRsbLiLsbLibLsbLsbRiRsmbRjRsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 23; Drug: Control
bRgLsRsbRgbLobLgbLgbLibLsbRiLsbRgbRgbRgbRsRsmbRsbLgbLsbRsRsmbRsbRsRsmb
RsRsmbRsbRjbRsRsmbRsRsmbsbsbRsRsmbRsRsLsmbRgbRsbRgRsmbRsLsbRgRsmbRsbRg
bLsbRgbsbRsLsbRsRsLsmbRsbRgRsmbRgbRsbRgbRsbRsRsmbsbRsbLsRgbRgbRsbRgbRg
bLsbLsbRgbLsbRgbsbRgbLjbRibLsRsbLgbRibLjRsbRibLoLsmbLibLoRsbLhbLcbRebR
oRsmbLibLcbLibRhbRsbRcbLhbRiLsbLsbRibLsbRgbRiRsmbsbLgbRgRsmbRibRsbRgbR
gbRsbLsbRibLsbRgRsmbRibLgRsbRobRgbRgbRibRjbRgRsRsmmbLsbRgbLsbRgLsbRsbR
sRsmbRgbLjbLcbLibRibLcLsRsmbRibRjbRgbRgbRsbRgRsmbRsbRsbRgLsbRgbLsbLsbR
ibLsbsbRsbRgRsmbRjbRsRsmbRsbLsRsbRsRsmbRgbRsbRsLsRsLsbRgLsbRgRsmbRgbRg
bLsbRgRsmbRgbLsbsbRsbRsRjbRsRsmbRsbRsbRsRsLsmbRgbRsLsbRgbRgbRgbRsbRgLs
bRsLsbRsbLgbRgbLhbLgbRhbRibLibLsbRhbLsbLsbRgbRgbRibRgbLsLsmbRibLsbLgbR
gbLibRibLhbRcbRcbRibRiLsbLgbsbRoLibRhbRsbLsRsbRibLgbRgbRgbRibRgbRsbRgb
RgbRgbRsbLjbRhLsbLsRsRsmbRibRsbLjbRsbRgbRgbRgbRgbLsbLjbRibRgRsmbRsbRgb
RgbRgbRgRsmbRibLjbRibLjbLiRsbRebRcbRobRibLhbRibLcLsmbLgbRgRsmbRjbRibRg
bRgbRgbRgbRgbLsbsbRgbRsbRsbRsbLsRsbRsbLsbRibRgbLsbRsbRgbRsRsmbRgbRgbRs
bLsbRgbLhRsbLibLibLibRhbLcbRjbRibRibRsRsmbRgbLsbRsbRgbLgbRgbRgLsbLjbsb
RgbRsLsbLsbRsbRgbLsbRsbRsbRgbRgbRobLebLcbRobLcbLibLgbRgbRiRsmbRgbRsbRg
RsRsmmbRsbRgRsmbLsbRjbsbRsbRsbRsRsmbRgbRgbsbRgRsmbRgbRgRsmbRgbLsbRsbRg
LsbRgbLsbRgRsmbRgbLsbLsRsbLsRsbLgbRibLibsbRibsbLsbsbLiRsbRcbLsbRobLgbR
ibRhLsbLibRibRgbLgRsbRgbLibRjbLibLgbRcbRiLsbRgLsbRibRgbLgLsRjbsbLsbRsb
sbRgbRibLhbRobRcbRjLsbLibLcbRhbRjbLobRebLobLgLsLsmbLcbRjbRibLcRsbReRsm
bRibRgbLjLobLibRjbRjRsmbLsbRgbRgRsmbRsbsbsbRibRgbLsbRibRibLgbRsbRgbRgb
RgbRgbLsbRsbsbRsRibRgbLsbRsbLsbRgbLjbsbLsbRibRgbLsbRsbRgbLgbRsbRgRsmbR
gRsmbLsbRgbRgbRgbLjRgbRgRsmbRsbRgbRsLjbLibLgLsbLjbLsbLibRibLoRsbRjbLhb
RcbRcbLcbRibRgbRsbRibRgbRsbRibLibRhbLjbsbLsbLibLjbRsbRhbRcbLibsbRsbRib
RgbRhbLibRjbRcbLibRibRgbLjbRcbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 24; Drug: Control
bLiRsRsmbRjbRcbRsRsmbRibLjbRibRgbRgbRsbRgbRsbLsbLcbLgbRcbLiLibLgbRsbLg
bLgbRjbRcbRibLsbRibRsbLcbRhbRiRsmbRgbRgbLsbRgbRsRsmbRgbLsbRsbRsbRgbRsR
smbLsbRsRibLjbLcbLsbLiRsbLibRsbRsbLibLibLgLgbLgbLgbRsbLgbLsbLgbRsbLgbL
gRsbLgLsbLsbLsbRsLsLsLgmbLgbLsLsmbLgbLgbLiLsbLgbLgLsbLgLsbLgbRjLsbLgLs
LsLsRsmmbLsbRcbRgbRibRcRsmbRiRsmbRcbRibLgbRibLsbRibLjbRibRsbRgRsmbRsRs
mbRsbRibRgbRgRsLsmbRgbRsbRgbRgLsbRibLgbLjbRibRiRibRgbLsRsbRibRgLsbRsLs
bRgRsmbRsbRgRsmbRsbRsRsLsmbRgRsmbRgRgRsmbRgbRsbRsRsmbRgRgbRgRsmbRgbRsb
RgRsRsmmbRsbRiRsmbRgbRgbRsbsbRsRsRgmbRgRsRsRsmmmbRgbRibRgRsRsmmbRsbRsL
sbRgRsmbLsRsbRibsbRibLgLsbRgbLsRsbRibRsbLebLibLibLcRsRsmbLibLhbLibLgbR
jRsRhmbLjLsmbLibLhbLsLsmbLgbRcRsmbLibLiRsbRsbRjbLcbLsbLcbRsLcbLsRibReb
RibLibRibLibLiLsbLgRsbLibLcbRhbLcbLsbLibLgLsbLsbLibRsbLgbLsbLgbLgbLgbL
sLsmbLsLsmbsbRsRsLgLgmbLgbLgbRjbRcbLibLibLcbLibLsbRgbLhbLgbLsRsLgLsbLg
bLgbLsbsbLsLibRsbLsbLgbLgLsLsmbLsbLgbLsbLgbLibLgbRjbLsbRoRsmbRcbRcbLib
LibRhRsmbLcbRcbRsLcbRibRjbLcbLgbRsRsmbLibLgbLsLsmbsbLsbRcLsLobRebRsRcb
LgbLjbRcRsmbRobsbLgbRcbLsbRiRsmbRsbRgbLgbRiRsRsmmbLsbRibRsbRsbsbRgRsmb
RgbRgbRgbRgRgRsmbRgbRsbRgbRgbRsRsmbRgRgbsbRsbRsbRgRsRsmmbRgbRsRsmbRgbR
gRsmbRsbRsbRsbRjbRiLsbLcbRiLsLsmbLhbRjbRgbRcbLebRcbsbLgbRibRcRsRsRcmmb
LibLiRsbLhLsbRgbLibRgbLjbLgbLgLsbLgLsLsmbLgbLsbLsbLjbLsbLgLsLsmbLsbLsb
LsbLgbLsbLgbLgbLgLsbLgLsbLsbRsbLgLsbLgbLgRsbLsRsbLgbLiLsbLcLsmbRcbLibL
gLsbLhbRhbLhbRcbRcRsmbRebRiRsmbRhbLjbRcLsbRibRgbRgbRsbRgRsmbRsRsmbRibR
sbRgbRgbRgbRsbLsbRsRsmbRsbRibRsbRgbRibRgbRsRsmbRsRsmbRgLsbRgRibRsLsbLs
bRsRsRsmmbRgbRsbRibRgbRgbRgbRsRsRsmmbRsbRgRsmbRgLsbRgbRgbsbRgbRgbRsbRg
bRsbRgbRgbRsbRiRsRsmmbRsRgbLsbLsbRgLsbRcLsRsbRibLsLsmbRgRsmbRgbLgRsbRi
bRsbRsbRgbRsbRsbRsRsmbRsRsmbRsbRsRsmbRgRsmbRgbRgbRgRsmbRsRsRsmmbRgbRgb
RgbRsbRgbRsbLobLoRsbRgbRgbRgbRgRsmbRgbRsbRgRsRsmmbRsbRgbRgbsbLsLsmbLib
RcbRhbLhbRjbLgbLjbLibLiLsbsbRjbRsbLhbRoRsmbRcRsmbLcbLebRsbLibLibRgbLcb
LibRgbRsbLiLsbsbsbLgbLjbLsbRsbsbLsbLgbLgRsbLsbLsbLgbsbRcbRsbRhbLsbLibR
cbRcLsbLgbLgbRibRibLiRsbLsbLgRsbLgbLsbRjbRcbRgbLgbRibRibLsbRgbRsbRiRsm
bRgbRsbRibLgbRibRsRsmbRibRgbRsbRgbRgbRgbsbRsbRjbLsbRsbRsbRgRsmbRgbRgbR
sbRsbRibRsbRgbRsRsRsmmbRgbRsbRsbLsbsbsbRiRsmbRsbRsRsmbRsbRsRsmbRsRsmbR
gbRsbRibLsbRgbsbRgbRgbRsbRgbLjbRsLsbLsbRsRibLsRsbRsbRsbRiRsmbRgbRsbRgR
smbRsRsmbRgbsbRsbRgbRsbRgbRsbRsbRgbRgbRgbRgbRgRsmbRgRsmbRgbRsbRgbRsbsb
LsbRgbRsbsbRgbRsbRibRibRsbRsbRiRsmbRgbLgbRgbRsbLsbRsbsbLsbRgbRgbRgRsmb
RgbRgbRgbRibRgbRiRsmbLgbLobLibLgRsbRcbLcbRcRsmbsbRibRiLsbLsLibRhbLgbRi
bRgbRsbRgbRsbRibRsbRgbsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 25; Drug: PCAP2 10 然
bLgbLgbLsbRgbLhbLebRgbRibLgRsbLobLgbLgLsbLgLsbLgbLgRsbLsbLgbLgbLgbLsbL
sbLgbLsLsmbLgbLgbLgbLiLsbLibLhbLibLibLgbLibLgbLgbRibLgbLgbLgbLgbLgbLsb
LgbLsbLgRsbLgbLgbLibLiRsbLgbLgbLgbLgbLgRsbLibLiLgbLgRsbLgbLsbLsbLgbLsL
smbLgLsbLsLsmbLgbLsbLgbLgbLgbLgbLgbLgLgbLgbLibRcbLgLsbLsRsbRebLcLsmbLc
bLhbRjbLcbLebRcRsmbRgbRgbRsbRgbLgbLcbLgbLgbLsbLsbLgbRebRsbRsbRgbRgbRgb
RgbRsbRsbLsbRgLsbLsbLsbLcbRsbLsbRhbLibLhbLibRgbLcLsmbsbLgLsbLgbLgbLgLs
bRsbLhbLibLsbRebLcbLsbReRsmbRiRsmbRsbRibRsRsmbRgbRsbLcbLsbRsbLjbsbRebR
jbLsbRsRsmbRsRsmbRebLibLebLhbLgbRgbLjbLsbLibRsbLgbLsbLgbLgbLgbLgbLibLg
bLeRsbRgRsmbRgbRiRsmbRsbRsbRgbsbRgLsbRsbRsbRibRsbLgbRcbRebRjbRiRsmbReb
RibRgbRgbRsbRsbRgbRsRsmbsbRsbRgbRgbRgbRibLsLsmbRgbRsbRgRsmbRsbRsbRibRg
RsmbLjLsmbLjbRsbRjbLjbRebRsbRsbRgbRsbRgbRsbRsRsmbRgRsmbRgRsmbRsbRgRsmb
RgbRgbRsRsRsmmbLsbRibRgRsmbLsbRgbRgbRgRsmbLsbRibLobRcRsmbRgbRgRsmbLjbR
ibRgRsmbLjbRsbRsbLsbRiRsRsmmbLgbRsbRiRsmbRsbRjbLsbLsbRiRsmbRgbRgLsbRgb
RgbRsbLsRgLsbRgbLcbLibRgbReRsRsRsmmmbRgbLsbRgbRgRsmbRgbRgbLgbRcbRcbRcb
RibLhbLjbLsbRebRjbRsbRsbRiRsRsmmbRgbRsRsmbRsbLgbLsbLsLsmbRebRibLsbRsbL
ibLgbLibLgbRibLsbRjbRibRgRsmbRgbLsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 26; Drug: PCAP2 10 然
bRcbRcRsmbRibLjbLibRgLsbLibLgbLsbLgbRgbLgbLgLsbLsbLgLsbLgbLgbLgLsbLgbL
gLsLgLsbLgbLsbLgbLgbLgbLibRiRsmbRibRibRgbLjbRgbRgbRcbRcbRibRcbRibRgbRc
bLsbRgbRcLsbRgbRhbRcbRiRsLsmbRibLjbRhLsRsbLhbRjbRsbRibRgbLobLcbLcbRsbL
sbRcbLcbLcbRcRsRsmmbRgbLsbRgbRsbRgbRsbRgbRsbRgbRgLsbRgRsmbRgbLjbLcRsbL
cbLcbLcbLsbsbLoLsmbLsbLgLsbRsLsbLgLsbLsLsRsLsLgLsLsmmbLsLsmbLgbLgbLgLi
bLgRsLsbLgbLgRsbRcbRcRsmbRibRiRsmbRgbLsbRgbRgbRobLgbRibRgbRibLhbLhbLib
LcRsbLcRsLsbLhbLgLsbLsbLgLsbLgLsbLgbLgbLsRsbLgLgbLgLsbLgbLgbLsLsmbLgbL
sLsmbLgbLgRsbLibLgLsbLgbRhbsbRibRiRsmbRibLjbRcbLsbRsLcbLiLsbLgbLsbRcbR
cRsmbRibLgbLjbLhbLiLsRsbRgbLhbRcbLjbLhRsbRcbsbLgbLcLsmbLoLsLsmmbLhbLib
LgLsbLsLsmbLoLsmbRcRsmbRhbLsLsmbRibRiRsRsmmbLeLsbLibLcbLhbRsbRcRsmbRcR
smbRibLsbRcRsRsmmbRibRhbRhbRgbRcbRgbRgRsmbRsRsmbLsbRgbRgbRsbRgbRgbLgbR
ibRgRsmbRsbRiRsmbRibRsbLibLhbLsbLsbLgLsbRsbLgbRjbRcbLsRsbRibLgbLcbLgbR
cbRgbRgbRsbRibRsbLjbLobRjbRibLgbRgbRgbRsbLsbRiRsRsmmbLsbRcbRibRebRgbRs
bRcRsmbRcbRgLsbLgbLhLsbLsbLgRsbRsbLgLsbLsbLsbRebRibRibRgRsRsmmbRsRsmbR
sbRgbLsbLcbLgbLgbRsbLibLsbLgbLsLsmbLgbLgbLgbLgbLgbRjbLibRcbRhbRibRhRsR
smmbRcRsmbRhbRibRcbRgbLgbRgRsmbRibsbRiLsbRibRibRibLsbRibRibRsRsmbRgRsm
bRgRsRsmmbRsRsmbLsRsRsmbRsRsmbRgRsmbRsbRibRcRsRsmmbRibLgbLcbLibLcbRibR
eRsmbRiRsmbRibRiRsmbRgbsbRsbsbRibRgRsmbRgbRsbRgbRsbRgbRsRsmbRgbRsbRgbR
sRsmbRgbLsbLcRsbLgLsbLiRsLsbRebLjbLiLsLsmbRjbRcbRgbLsRsbRgbRgbRgbRibLi
RsbRcbRhbRgbLsbLebLgbLsbLgbRjbLiLsbLgLsbLsRsbLsbLcbRibRgbRgbsbRsbRgRsR
smmbRibRibRiRsmbLcbLcLsmbLsbLgLsLsmbRsbLibsbLsbRsLgbLsbLsbLgbLsbRebRib
RgbRsRsmbRibRgbRsbRsRsmbLsbsbRgbRsbLsbLobsbRsRsmbLcbLibRcbRsbRcRsmbLib
RgbRibLsbRibRgRsmbRiRsmbRhbLsbLsbRiRsmbLgbRsbRsRibRgbRsbLsbRibRcbRcbRg
bRgbRiRsRsmmbLcbLiRsbLsbLgbLgbLsbLsbLgLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 27; Drug: PCAP2 10 然
bRgbRgbLsLsmbRgRsmbRsbRsRsmbRiRsmbRcRsLsmbRsbRsbLcbLhbLgRsbRsRsmbLgbLi
bRsbLsbLeLsbLcbLgbLgbRibRhLsbLcbRiRsmbRsLsbRsbRsbRgbRgRsRsmmbLsbRsbLsb
RgLsbRgRsmbLsLcLsmbLgbLsbRsbLgLsbLgbLsbLsbRjRsmbRjRgbRcbLhLsbLiLsLsmbR
sbRobRsLsbRgRsmbRibRsRsRsmmbRibRgRsmbRgRsmbRsRsmbLcLsmbLcRsbRhbLsbRhbL
gLsbRsbRiRsRsmmbLebRiLsbRsLsRsbLiLibRcbRebRgbRsRsmbRsbLibLoRsbRsbRsbLh
bRsbLsbLsbLgbLgbRgbLsbLgbRoRsmbRsbLgbRibRgbRgRsmbRsbRjbRobLebLcbLcLsmb
LsbLsLsmbLgbRsbRcbRhbLsbLgbRsbRjbRibLsbLsbRibLsLsRsmbLgbRhbRgRsmbLgbRi
bRgLsbRgbLhbLsbLsbRgbRsbRgbRgRsRsmmbLsbRsLsbRgbRgbRgbRgbLsbLsRsbRgbRsR
smbRgbRsRsmbLsbRgbRsbRgbRgbLgbRsbRgRsmbRsRsmbRibReRsmbRgRsRsmmbRsRsmbL
ibLibLgRsbLibRgRsmbLgbLsLsmbLibRiRsmbLibLcbLgbRsRsmbLibLhRsbRibLibLibR
gbLcLsLsmmbLcbLiLsbLsbLcbRibLgbLibLgbLiLsLsmbLiLsbLgRsbLgbRjbRgbRgRsmb
RsbRibLgbRsbLsbRgbRobLibLsLsmbLsLsLsRsmmbLgbLgbLgbLgLsbLsLsmbLgLsbLgLs
bLsbRsbRsbLgbLibLgbLsLsmbRoLsRsbRcbLebLgbRgbLjLsmbLibLsbLibLhbLebLibRj
bLjbLiLsbRsbLcLsmbLiLsbLiLsRsbLsLsLsmmbRjRsmbRibLsbRsbRsbRsbLjbRcRsmbL
sbLgbRsbRoRsmbLibLibLsbLcLsmbLcbLcLsmbLgbLibLgbLsbLgbLobLhbLgbLibLiRsb
sbRsbLgLsbLsLsmbLobLibLgbRjbRcbRibLibRcbLsLsmbRgbRibRibLibRsbsbLcbRjbR
obRiRsmbRsbLgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 28; Drug: PCAP2 10 然
bLsbLsbLgbLhLsbLjLsmbLsLgbRgbRgbRiRsmbRgRibLebsbLhbLgbLibLgbLgbLgLsbLs
LsmbLgLsLsmbLgLsbLgbLgLsbRsbLiLsbLgbLiRsbRgbLcbRsLsbLiLsLsmbLibLibLsbL
cbLsbLibLgbLgLsbLsbLgbLgbLsLsmbLgbLsbLgLsbLgbLgLsLsmbLgLsbLgbLgbLgbLcb
LsbRgbLhbLibRjbLcbLibLcLsmbRiRsmbRgbsbRcbRgRiRhbRgRsRimbRgbRiRsmbRgbRi
RibRobLgRsbRcbLiLsbLiRsLsbLibLiLsbLgbLgbRobLsbLcbLhbLhLsbLsbRsbRiRsmbR
iRsmbRibRgbRsbRsbLsbsbLibRsLsbLibLgbLsLsmbRsbLcLsmbRsbLiLsbLsbLibLgbLs
LsmbRgRsmbRcRsmbRjbRcbRibRcRsRsRsRsmmmmbRgRsmbRsbRoLsbRsbRsbLibLgbLgLs
bLhbLsbLiRsbLiLsbLgRsbLgRsRsmbLiLsbLgbLsRsbLsbLsbLcbLgLsbLsLgbLsRsbLgb
LgbLgbLgbLhbLiLsbLcbLsbLcLsmbLsbLgbLgbLobLgLsbLibsbLgbLibLgbLhbLcbRgbR
sbLibLgLsbLsbLgLsbLsbLgbLcbLgbLsbRiRsmbRcRsmbLsRsbRsRsRsmmbRcbRibLiLsb
LgbLgbLgLsbLgLsbRcbRiRsmbRsbLjbRjbRgbRgbRgRsmbRiRsmbRgbRgRsRsRsmmmbLgR
sbsbRiRsmbRcLsbLcbRsRsRsRsRsmmmmbRgbRsbLjbLiLsbLsbRsLsbLcbLobLgbRgbLjb
LgbLsbLsbLsbLsbLhbLgbLgbLsbRjbRgbRsRsmbRsbLibRsbLsbRsLsbRcRsmbRhLsRsbR
ebRgbRgbRsbLibLsbLcLsmbLiLsbLhbLsLsLsmmbLsRsLsbLobLsbRsbLibRiRsmbRsbLs
bLjbLcbLgbRsbRsbRgRsmbRgRsmbRsbRgbRiRsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 29; Drug: PCAP2 10 然
bLcLsmbLibLgbLgbLgLsbLibLgLsbLgbLgLsbLgLsbLgLsbLgbLgbLgLsbLgbLgRsbLgLs
bLibRcbRsbRcbRsRsmbRgRsmbRgbRgbRgbRgbRgLsbRgRsRsmmbRgbRibRhRsmbRgRsmbL
sbRiRsmbRgbRsRsmbRebRibRgRsmbRiRsmbRgLsbRgbRsbRgbRiLsLsmbRcbRgbRsbRhbR
gbRgbRgbRgbRgbRgRsmbRgbRcbRiRsRsmmbRiRsRsmmbRibRibRibRibLsbRgbRgbRgbRg
bRgbRibRiRsmbRiRsmbRgbRgRsmbRgbRgRsmbRgbRgbRgRsmbRgRsmbRgbRiRsRsRgRsmm
mbRiRsmbRiLsbRsRsLsmbLsbRoRsmbRgbRsbRsRgbRibRgbRgbRgbRgbRibLgbLiLsbLiL
sbLgLsbLgbLgbLgbLgLsLsmbLgbLgbLgbLgLsbLgbLiLcLsLgLsRsLsmbLibLgbLgbLgbL
gbLgbLsbLsLsmbLgbLgbLgLsLsmbLsbLgbLgLsbLsLsmbLgbLgRsLsbRsbLhbLhbLiLsLg
bLibLgbLgLsbLgbLsRcbRcbLsbRsbRibRsRsmbRgbRgbLsbRgbRgRsmbRsbReRsRsmmbRh
RsmbRibRgbLjbLoRsbLiLsbLgbLgbLgbLgbRsLsLsmbLgLsbLibLsbLsLsmbLgbLsLsmbL
ibLibLgLgbLibLgbLgbLgRsbLgLsbLsRcbRibLgbsbLcbLhbLiLsbLcbLgbRiRsmbRgbRs
bRgbRgRsmbRcbRgRsmbRibRgRsRsLsmmbRgbLeRsbLibLibLgLsbLgLsLsmbLgbLgbLgbL
gLsbLgbLgLsLsmbLgbLiLhLgLsbLiLsbLiLsbLgbLgbLgLsbLgLsLsRsLsmbLsLsmbLgbL
gLsbLibLebLibLgbLibLiLsbRcbRibLoLsRsmbLgbLgbLgbLsbLgLsbLgbLgLsbLibLgLs
bLgLsLsLgLsmbLgLsbLgbLgLsbLibLgbLgLsRsbLgbLgLsbLgbLibLgbLgbLgbLibLgLsL
smbRsLgLsLsmbLgbLgbLgLsbLgbLgLsLsmbLgbLgbLgbLibLhbLgbsbLgbLibLgLsbLgbL
gLsbLgbLgbLsbLsLgRsbRgbRcbRgbRibRiRsRsmmbRibLgbRgbRsbRgbRiRsmbRgRsLsmb
RsbRibRsbRcbRiRsmbLsbLsbRgRsmbRibRgbRibRhRsmbRcLsbRibLcRsbRhbRcbRgRsmb
LsRsbLgbLibLsLgbLsbLgbRjbRibRibLcbLgbLgLsbRsbLibRsLsbLgRsLsbRjbRcbRibR
gbLjbRcbRiRsmbLsRsbLsbRgRsmbRibRgbRgLsRsRsmbRgbRcbRiRsmbRsRsmbRiRsmbRg
bRgbRoLsbRsbLsbLibLgbLgbLgbLgbLgbLeLsLcLsLsmmbLsbLibLgbLgLsLsmbLgbLgRs
bLgbLgbLgLsbLgbLsLsmbLsbLgLsbLsLsmbLgbRsRobRgbRibRgRsRsmmbRgRsmbRgbRgR
smbRgRsmbRebRiLsRsbRsRsmbRsbRiRsmbRgbRsRsmbReRsRsmmbRcbLiLsbLgbLibLgbL
gLsbLibLcbLgbLgbLibLgLsbLgbLsLsLsmmbLgbLgbLiLsbLibLgLsLsmbLsbLibLgLsbL
gbLgbLgbLgbLgbLgbLcLhLsLsmbLgLsbLsbLibLgLsLsmbLgLsbLgbLgbLsLsLsmmbLsLs
mbLgbLgbRjbRibRibRibLcbLcbLgbLgbLsbLgLsbRgLjbLoRsbRgbRsbRsRsmbRiRsmbLs
bsbRsbRgbRgLsbRgbRcRiRsmbRgbRibRgRsmbRsbRibReRsRsRgLsLsmmmbLsbRcbRgbRg
RsmbRgRsmbRsbRgbRsLsbRgbRgRsmbRsRsmbRgbRgbRobRgRsmbRgRsRsmmbRsbRibRgRs
mbRebLcbLcLsmbLgLsLsmbLiLsbLibLgbLgbLgLsbRsbLibLgbRebsbRcbRsbRsbRibRgR
smbRsbRsbRsLjbRiRsmbRgRsLsmbRcbRgbRgbRgbRiRsmbRgbRgbRsbRiRsmbRoLsLsmbR
gbLibLsLsmbRsLgbLibLcbLibLsbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 30; Drug: PCAP2 10 然
bRhbRibRcbRibRcbRcbRcRsRsmmbRcRsRsmmbLibRgbLsbRsbRsbRsbRsRsmbsbsbLsbRs
bRsbRsbRsbsbsbLsLsRsRsLsmmbsbRsLsbRsbsbLsLsRsLsLsRsmmbRsLsbRsRsmbLsRsb
LsRsLsLsmbRsbLsbLsLsmbRsbLsRsbLsbLsbsbLsRsbLsbRsbRsbRsRsmbsbLsbLsLsmbs
bRsRsmbRsbRsbRsRsmbLsbRsRsmbLsRsbLsRsbLsbLsbsbLsLsmbsbRsbRsbsbRsLsRsRs
mbRsLsRsbRsLsbLsLsmbRsbRsbRsbRsbLsLsmbRsbRsbLsbLsbLsbRsbLsbLsbLsRsbRsb
LsbLsRsbLsbRsbLsbRsbLsRsbRsbLsbLsLsmbLsbRsLsbLsbLsbRsbRsRsmbLsbRsbRsbL
sLsmbLsbRsRsmbRsbRsRsmbLsbLsRsbLsbsbLsbsbLsbRsbRsbLsbRsbRsLsbLsbLsLsRs
mbLsbRsbRsbLsbRsbLsbRsRsmbRsbsbRsbLsbLsbRsbLsbRsbLsRsbRsRsmbLsbLsRsbLs
bLsbLsbRsbsbLsbRsbLsbLsbLsbRsbRsRsmbLsLsmbRsbLsbLsbLsRsbLsbLsbLsbRsbLs
bRsbRsbRsRsLsLsRsmmbLsbLsRsLsRsbRsbLsbLsbLsbRsbRsbLsRsbLsbLsRsbLsbLsLs
RsLsmbLsbLsbRsLsLsLsmmbRsbLsbLsbLsRsRsmbLsRsbLsbLsbRsLsLsRsLsmbLsbRsLs
bLsLsmbRsRsmbRsbLsLsRsmbRsLsbRsRsmbLsbRsbsbLsbLsbRsbRsbRsbLsbRsLsRsbLs
RsRsmbLsRsbRsRsmbLsbLsLsmbLsRsbRsbLsLsmbRsbRsbRsbLsbLsbRsLsbLsbRsbRsbL
sbLsbLsbRsbRsRsmbRsbLsbLsbLsbRsbRsbRsbLsbLsbLsbLsbRsRsmbLsRsbRjbRsbRsb
RsRsmbRsbLsbLsbRsbRsbLsbRsbRsbRsbRsbRsbLsLsmbLsbLsRsbLsbRsRsmbLsbLsRsL
sbLsbRsRsmbRsRsmbRsbLsLsmbRsbRsRsmbRsbLsbRsbRsRsmbLsLsmbLsRsLsbLsbRsbR
sbRsbRsbLsbRsbLsbLsRsbRsbLsbRsbLsbRsbRsbRsRsmbLsbRsRsmbRsbLsbLsLsmbLsb
LsbLsbLsbRsbLsbRsbRsbRsbRsbRsbRsbLsRsbRsbRsbRsbLsRsbLsLsmbRsbLsLsmbLsb
LsbLsbRsbLsbLsbLsbRsbRsbLsbLsbRsbLsbRsbLsLsmbRsbLsbRsLsbLsLsmbLsRsbRsb
LsbRsRsmbLsLsmbLsbLsLsRsLsmbRsbRsLsbLsbLsbLsRsLsbRsbRsbRsbRsLsbRsbLsbL
sbLsbRsbRsbLsRsbLsbRsbRjbRsbRsbLsbLsbRsbLsbLsbLsbLsbLsbRsbLsbLsLsRsmbL
sbRsbLsbRsbRsbLsbRsLsbRsbRsLsbLsLsmbLsLsmbRsbRsbLsbLsLsmbLsbLsbRsbLsRs
bRsbLsbLsRsbRsLsbRsbRsbLsbRsRsmbLsbRsbLsbRsbLsbRsbLsLsRsmbRsbRsLsbRsbL
sLsmbRsLsbRsRsmbLsbLsRsLsRsbLsbRsbLsbRsRsRsmmbRsLsbLsbRsbRsbRsbLsbRsRs
mbRsbLsbRsbLsbRsbRsbLsbRsbLsbLsbRsbRsbLsbLsLsmbLsbLsLsmbLsbLsbRsLsbRsb
LsRsbLsbRsLsbLsbRsbLsbRsLsbLsRsbLsbLsRsRsmbLsRsbLsbLsbRsbLsbRsbLsRsRsm
bLsbLsbRsbRsbRsbRsLsbRsbRsRsmbLsRsbLsbRsbRsbLsbRsLsbLsRsLsbRsRsmbLsRsb
RsLsbRsRsmbLsRsLsbRsbRsbRsbLsRsLsRsRsmbLsbRsbRsLsbRsbLsLsmbLsLsmbLsLsm
bLsbLsLsmbLsRsbLsbRsbLsbRsbRsbLsRsbLsbRsRsmbLsRsbRsbLsbRsbsbLsbRsLsbLs
bLsbLsLsLsmmbRsRsmbsbLsbRsRsmbRsRsmbRsLsbLsbRsbLsRsLsbRsRsmbRsRsRsmmbR
sRsmbLsRsbRsLsbRsLsLsmbRsRsLsRsmbRsRsmbLsbLsbRsLsbLsbRsRsmbRsLsbRsLsbR
sbRsbRsRsmbRsRsLsLsmmbRsLsbLsbRsbsbRsbRsLsRsLsbRsLsbRsbRsbRsLsbLsLsRsL
sRsLsmbRsRsLsmbLsRsbLsbRsbLsbRsLsRsbLsbLsRsbLsbRsbRsbLsbLsbLsbLsbRsRsm
bRsbLsbLsbLsLsmbRsbRsRsLsmbRsbLsLsmbLsbRsLsLsRsmbRsRsmbLsRsbRsLsRsbRsb
RsbRsbLsbsbLsRsbRsRsmbLsRsRsmbRsbLsRsbLsRsRsmbLsbRsLsRsbLsRsLsbRsbRsbR
sbLsRsbRsbLsbRsbRsbLsRsbRsbRsbRsbLsbRsbRsLsLsmbRsbLsRsbRsbRsbLsbRsbRsR
smbRsbRsbRsbLsbLsbLsbLsbRsbLsbLsbRsbLsLsLsmmbRsRsmbLsbLsbRsbRsbRsbLsbR
sbRsbLsLsLsmmbLsbRsRsmbRsbRsLsbLsbRsLsRsLsLsmbLsbLsLsmbLsRsbLsbLsbLsbR
sbRsbRsbLsbLsLsmbRsbLsbLsLsmbLsbLsRsbLsLsRsmbRsbRsRsmbLsRsRsmbLsLsmbLs
bLsbRsbRsbLsbLsbLsRsbLsbRsbLsRsbRsbRsbRsbLsLsmbLsLsRsmbRsbRsbLsRsLsbLo
bLsbLsRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 31; Drug: PCAP2 3 然
bLibRsbLgLsbLsLsmbRsbLibLgbLibRibLgbLsbLibRsbLgRsbRgbLebLiRsbRsLsbLsbR
sbLgLgbLgbRgbLibRjbRgbRsbRgbRgbLsbLebLibLgbLgbLsbRibRsbRgbLgbRibRsbRsb
RsbRsbRgbLebLsbLsbLsbLsbLsbLsbLsLsmbRsLsbLgLsbLgbRsbRsbLsbLjbsbLgbLgbR
gbLsLsmbLgbLibRgbRiRsmbRjbLcbLibLgbRsLsbLgbLsbLsbLsbLgbLsbRsbLgbLsLsmb
LsLsLsmmbRsbLgbLgLsbLsbRsbLibRsbLsbLgbLgbLsbLsbLgbRsbLsLsmbLgLsLsmbLgb
LgRsbLibRiLsbLgbRgbLgbLhLsbRgbLibLiLsbLibLibLiLsbLibLsLsmbLgbLgbRcbLsR
ibRgbLgbRibRgbRgbRsbLsRgLsbRgbRgbLjbLcbLibLgLsbLsbRsbLjbLgbLgbLgbLsLsm
bLsbLsbLsLsmbLsbLsbLsbLgbRebRhLsbRsLsbRgbRgbRgbRgbRsbRgRsmbLjbRjbLebLo
bRibRsbRibRibRibRgbRsbRsbRhRsRsmmbRiLsbRgbRgbRsbLgbLgbLibLibLgbRebRgbL
hbLgbLibLsbRgbRsbLibLsLsmbLsLsmbLgbLgbRsbLsbLibLsbLgbLgbLgbLsLsmbLgbLg
bLsbLibLibRgbRsbRgbLsbLsbRhbRibRibRsbRsbLsbLgbLjLsLsmmbLiRsbLcLsmbLgbL
sbLebLibLgbLsbLgbLsbLgbLgbLgbLsbLsRsbRsbRhbRiRsmbRsRsmbLjbRibRsbRgbRsb
RibRibRibRgbLgbLgbLcbLgbRgbLibLiLsbLgbLsbLgbRsbLgbLgbLiRsbLobLibLibLgb
LibLsbRsbRjbRibRsLsbRsbRgRsmbRsbRsbRsbRsRibRibRjRsmbRebLsbLsbLgbRebRib
LebLhLsbLgLsbRsbRsbRebLsbLsbRsbRibRibLsLsmbLsbLsLsmbRcbRsRsmbRgbRgbRgb
RgbRibRiRsmbRsbRgbRsbRibRgbRiRsmbRgRsLsmbRebRsbRebRsbLcbLiLsbLsbLsLsmb
LsbLiLsbLibLsbLsbLgbLsbLgLsbLsbLgbLsbLgbLgbLgbLgbLgbLgbLibRgbLcbLibLgb
LsbLibLgbLibLgbLsbLgbLsbLgbLgbLsbLsbLgRsbLgbLsbLibLiRsbLsbRsLsbRsbLgLs
bRebRcbLsbRgbRgbRsbRgbRsbRsbRsbRsbRsbRgbRsbRsbRgbRibRibRgbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 32; Drug: PCAP2 3 然
bRsRsmbReLibRcbLhLsbLsbLsbLsbLhbRsbRsbsbLhRsbLgLsbLsLgLsbRjbRoRsmbLgbR
ibRgbRgbRcRsLsmbRgbRoLsbLsRsbRsRsmbRhbRsRsmbRsbRgLsbRsbRgbRsbRgbLsbRgb
RhbRsbLsbLobLsbLsbLgbLsLsmbLgbLgbLgbLgbLgbLsbLgbLibLiRsbRgbLibLoRsbLgL
sbRsbRibRgbRgbLebRhbRsbRibLebRsbRhbRgbLcbLgbLibLsbRcbRibRsRsmbLcbRjbRi
RsmbRgbRgbRgbRsbRibLsbRgRsmbRgbRgbRgRgRsmbRgbRsRsmbRgbRibRoLsLhbLsbLgb
LebRgbLibLgLsbLsbLhRsRsmbLhbLgLsbLibLibLsbLgbLgLsbLgbLgbLibLgbLgbLgbLi
LsbLibLgbLgLsbLibRjbLgbLgbLgLsbLgbLgRsbLgLsbLsbLgLsbLgbLgbLgbLgLsbLgbL
gbRsbLgbLgLsbLsbLebRebRhLsbRibLoLsmbRgbLgbLgbLgbLgbLgbLgLsbLgbLgbLibLg
LsbLgbLsbLgbLibLgbLgbLgbLgbLgLsbLobLgbLobLgbRcbRgbRibRiRsmbLcbRsRsmbRg
bRgbRsRsmbRgbRsbRgRsmbLjbRsbRgbRjbLsbLibRgbLcbRsLsbLcbLibLibRgbRebRibL
sbRibRsLsRsbRiLsbLgbLebRebRibLcbLsbLibLgLsbLgbLgbLsbLsbLsbLgbLgLibRibL
gLsbLibRobRgbRhbLsbLebRebLsbRjbLebLgbLgbLsLsLsmmbLgbLcbLcbLcbLsbRjbRib
RibLjbRgbRibLjRsbRibLgbRhLsbLibRibRibRhbLibRibLgbLjbLobLibRibRgbRibRgb
LgbRjbRsRgRsmbRgbRgbRgbRgbRgbLsbRiLsbRoLsLsRsmbRgbRibRibRgRgRsmbRoLsLg
bLgbLsbLibLgbLgbLgbLgbLgbLgbLgLsbLgLsbLgbLgbLsbLgbLgbLgbLsLsmbLsbLgbLs
bLgbLsbRsbLgbLgbLgbLgbRsLgbReRsmbRcLsbLgLsbLjLsmbLibRsbLgLsLsLsmmbLgbL
gbLgLsbLsLsmbLgbLgLsbLgbLsbLsbLsbLsLsmbLibLibRjbRhbLobLsRcbLcbLhbRgbLi
LsbRibLgRsbRobsbRgRsmbRsbRibLgbsbRibLcbLgLsbLgbLgbLgbLgbLgbLgbLgbLgbRs
LgbLgbLgbLgbLgLsbLgbLsbRcbLobLgLsbLsbRsbRibRcbRgLsbLgbsbRibRsbRgbLsbLj
bLcbRcbLgLsbLjbLhbRobLgbRibsbRsbRiRsmbRhbLgbLcbLgbRsbLsbLiRsbLgLsbLgbL
gbLgbLgbLgbLgbLgbLsLsmbLgbLgbLgbLsbLgbLgbLgbLiLsbLgbLgbLgbLsbLsLsmbLgb
LgbLcbLgRsbLcbLgbLgbLgbLgbRsbLgbLgbLsbLgbLgbLgbLsbLgbLgbLgbRobRgRsmbRg
bRsbRgbLcbLgRsbLibLgbLsbLgLoRsbLsRsbRgbRiRsmbLjbsbRsbRgbRibLcbRgbRgRsm
bRgRsmbRgbLgRsbRsRiRsmbLgbRgbRsbRgbRsbRgbRsbRgbRgbRsbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 33; Drug: PCAP2 3 然
bLcLsmbRgbLcbLgbLhbLhLsRsbLcbRsbLibLcRsLsRsbLcRsLsRsbLcRsbLgbLiRsLsRsL
sbLibLgbLsbLgbLsLsmbLiLgLsbRhLsRgLsbRgbRgLsbRsbLobLgLsbLsbLibLgLsbLgbR
gbLgbLgbLgbLibLgbRcbRcLgLsbRibRgLsbRgRsmbLsRgbRgbRsbRgLsbLsbRgbLcRsbRs
LgbLiLsbLsbLgbLsbLgbLgbLgLgLsLsLgmbRsbLiLsbLgbLgLsbRsLsbLgbRobRgbRibLj
bLebLsbLibLsbLgbLgLsbLsbLgbLgbRgbLibLgbLsbLgLsbLgbLsLsmbLgbLgLsbLsLsmb
LgbRsbLibLgbLsLsLsRsmmbLgbLgbLsLsmbLgLsLsLgLsRsmbLgLsRsRsmbLgRsLsLgbLs
bLgbLgbLibLcbLcLsmbLhLsbLiLgRsLsbLhbRsbRsbLsLgbLsbLgLsbLgLsbRsbLgbLgLg
bLsLsmbLibRsbLgbLibLsRsbLgbLiLsLsmbLgLiLsLgbLgbLgLsLsmbLsLsmbLgbLgLsLg
bLsbLiRsbLcRsLsRsbLibLcbRsbLeLsLsmbLiLsRgbLiLsLgbLsLsRsmbLsbLibLsLsmbL
iLsLsRsmbLibLgLsbLsLsmbLsLsmbLgbLgbLgbLsbLgbLsLsRsmbLgbLgbLgbLgbRsbLsL
sLgLsmbLgLgLsLgbLgbLgLsbLgbLgbRcbRsbLcbRsbRcbRibLebRibRibLcbLsLsmbLibs
bLsLsmbLiLsbRjbRsLsbRhbRibRgbRiRsmbsbRcRgbRibRibLsbRgRsmbRgbRiLsbRcLsb
LsLsmbLcbRsbLsbRcbRibLcLsmbRsLsbLibLsbLgbRgbLiLsbLgbLgbLgLsbLgbLsbLiLs
LsLsmmbLiRsbLsbRhbRcbRibLsbRsLsLsmbRibLsRsbRsRsmbRgbRibRgbLebRsbLcbRiR
gbRiRsmbRgLsbRgLsbRsRsmbLsRiLsbLsbRsRsmbRiLsRsbRsbRiLsbRiLsbRibRibRhLs
bRgLgbRcbRsRsmbRgbRgbRibLebRsLsbRjbRibRsbRgLsbRgbRcbLcbsbRgbRibRibRgbR
ebRsbRjbRsbRcRsRsLsRsmmbRebLibRsbLhRgbLcRsbLsbLcbRhbRcbLsbRiRsmbRsbLcb
LsLibRibRgbRibRjbLibRebRsbLsbLgbLsbLsLsmbLgLsbLgbLgLsbLgbsbLgLsLibLgbL
gLsLsmbLsbLgLsLsmbLsLsmbLibRhbLcLsmbRsbsbRibRibRsRcRsmbRcbRiLsbLiLsbLj
bLgbRsbLgbLgLsbRjbLhbLiLsLsmbLsLsLsmmbLsbLiLsLsmbRsLgbLgLsbLsbLibRgbLi
bRsbLiLsbLgbLsbLhbLibRebLibLsLsmbLsLsmbRjbRebLibLgbRgRsmbRcbLcLsmbLsbL
cLsRsRsmmbLjbLgbLgbLibLibLiLsLsmbRcbRgLsbRjRgbLsbRiLsbsbRsbRiLsbRiLsbR
gbRcbLgbLhbLgLsbLgbLsLgbRcbRiRsmbLcbLibLibRsLsbLgbLgbLsLsmbLsbLibLgbLi
bLsLsLgLsmbLsLgbLiRsbLibLgLsbLgLsbLgLsLsLimbLgLsRsLgbLgbLgbRjbRcRsmbRi
RsmbRiLsbLjbLcbLgLsLsmbRjbRobLcbLibLsLsmbLibLgLsbRsLsbLgLsbsbLgbLsLsmb
LgLsbLgbLsbLgLsLsmbLgLsbLgLsbLgbRsLgLsbLgbLgbLsbLgbLsLsLsmmbLgbLgbLgLs
bLgbLsLsmbLgbLgLsRsbLgLsbLsLsLsmmbLgbLsbLgLsbLgbLgbLiLsbLsLsLsmmbLgLsL
smbLgLsbLgbLsLsmbLgLsLsmbLgbLgLsbLiRsbLcbLgbRcRsmbLcbLibLsbLgLsbLsbLgL
sbLsLsmbLibLhbLsLsmbRcbLgbRibLsbRibRcRiLsbRcbLgRsbRibRibLjbLcbLgbLgLsb
LgLsbLgLsbLgbLsLsmbLgbLiRsbLhLsbRgbLcbLibRcbRhbLjbRoLsbRhLsbRhbRiLsbRs
bRcbLsbRiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 34; Drug: PCAP2 3 然
bRsbRhbLiLsbLibLsbRibRsbRgbRsRsmbRsbRsbRgbRsbRsbRsbRsRsmbRgbLsbRibLibR
gbRgbLsbLobLgbLgLsbLgbLgbLibRsLsbLcbRsbLsbLsbLgbLgbRcbRobRsbRgRsmbRsbR
gbRsbRjbRsbRsbReLsbRsbsbsbRsLsbLhLsbRgbRjbRcbRcRsmbRgRsmbRibLcLsmbLibL
sbLsbLgLsbLsbLsbLsLsmbLsRsbLgbLgbLsbLgbLgbLsLsmbLgbLsbLgbLsRsbLsbLgRsb
LgbLsbLsbLgbLsbRsbLgbLsLsmbLgLsbLgbLsbLsbLsbLgbRsbLgLsbLsbLsbLgbLgbLgb
LsbLgbLsbLgbLsbRsLsbLgbLgbLgLsbLgbRoRsmbRsbRsbRiLsbLgbRibRibRsbLsRsbRg
RsmbRsbRsbRgRsmbRgRsmbRsbRgbLsbRsbRgRsmbRsbRsbRgbRgRsmbRsRsmbRgbRsbRsb
RsRsmbRgRsmbRsbRsbRgbRgbRsRsmbRgbRsbLsbRgbRgbRsbRgRsmbRgbRgRsmbRgbRgbR
gbRgbRgbLsbRsbRgbRibRebRsbRsbRgLsbRgbRgRsmbRsbRgbRgbRjbRobRibRjbRgRsmb
RsbRsbRibRsbLcbRhbRgbRgRsmbLsbRgbRgbRgbRgbRsbRgRsmbRsbRgbLsbRiRsLsmbLs
bRgbRgbRsbRibLcbRhbRibRhbRsbRgbRgbRgbRsbRgbRsbRgbRgbRgLsbRgbRgbLsbRsbR
ibLgbRiRsmbLsbRgbLsbRsbLebLsLgRsbLibLgbRiRsmbRsbRgbRsbRgRsmbRgbRgLsbRg
RsmbRgbRsbRgbRgLsbLsbRgbRsbRgRsmbRgRsmbLsRibRsbRsbLgbRcbLcbLobRsbLiRsb
RjbLibRhbRsbRsLsbRgbRsLsbRgbRgbLsbRgbRsbRgbRsbRgRsmbRgRsmbRsbRgLsbRgbR
sbRibRgbRgbRgbRgbLgbRibLsbRgRsmbRsbRgbRgbRsbRgbRsbRgbRsbRsbRsRsLsmbRgb
RibRsbRgRsRsmmbRgbLsbLsbRiRsmbRsRsRsmmbRgbRhRsRsmmbLcbLcRsbRjbLgbRobRi
bLjbRibRsbRsRsmbRgbRgbLsRsbLgbRgbRsbRgRsmbRsbRsbRgbRsbRsbRgRsmbRsbRsbR
gbRsRsmbRgbRgbRgbLsbRsbRsRsmbRsbRgbRsbRgRsmbRsbLsRsbRgRsLsRsmbRsbRsbRg
bRgRsmbRsLsbRgbRsbRsRsmbRgbRgbRsbRgbLsbRsbRsbRgbLjbLibLiRsbRgbLcbRebRi
bRgLsbRgbRgRsmbLsbRgbRgbLgbRgRsmbRgRsmbRsbRgbRsbRsbRgbRsRsmbRgbRgbRgRs
mbRsbRgbRsbRgbReLsbRobRibRsbLsbRibRsRsmbLsRsbRgbRsbRsRsmbLsbRgbRgbRsbR
sbRgRsmbRgbLcbLcLsmbRgbRcbRgbRiRsRsmmbLsRsbRsRsmbRgbRgbLjbLoRsbLibLsbR
gbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 35; Drug: PCAP2 3 然
bLsbLgbLsbLcLsmbLgLsLsmbLsbLgbLgLsLsmbLgbLgbRgLsbLgLsbLsLsmbLgbLgLsbLg
bLgbLgbLsRsbLibLibLgbLgbLgbLibLgLsbLgbLgbLgLsbLgbLgbLsLsmbLgLsbLgbLgbR
gbLsRsLsLsmbLgbLgbLsLsmbLgbLcbLibLgLsbLsbLcbRgbLgbLgLsbLsLsmbLgbLgbLgL
sbLgbLgbLgLsbLiLsbRsLsbLibLsbLgbLgLsbLgLsbLiLsbLebLibLsbRsbRcRsmbRgbRs
bRgRsmbRgbRgbRgbRgLsbRgbRgbRgbRsbRsRsmbRsRsmbRgbRsbRgbRgLsbRgLsbRsbLsR
sbRgbRsRsmbRgbLeLsLsmbLibLiLsbLgRsbRsRsmbRsbLibRebRjbRgLsbRgRsLsmbRgbR
gbRgbRsbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsbLsbRsbRgbRgbRgRsmbRgbRgRsm
bRgbRgbRebLsLsmbLeRsbLgbLibLhLsbLibLcbLgbLiRsLsLsmbLibLgRsbLsRsbLiRsLs
bLcbLibLsbRhbRiRsmbRgbRgbRgbRsbRsbRsbRgbRgbRgbRsbRsbRsbRgbRgbRgbRgbRgb
RgbRgRsmbRsbRsRsmbRsbRgbRgbRgbLsRsbRgLsbLeRsbLiRsbLibLgbLgLsbRsbLibLsL
sRsmbLgbLhLsbLhLsbLibLgLsbLibLsbLgbLgbLgbRjbRcRsmbRiRsmbRgbRgbRgbRgbRs
bRgbRgbRsbRgbRsbRgbRgbRgbRgbRgbRsbRgLsbRibRibRgbRgbLgLcbLibLcbLibLibLi
bLgbLgbLgbLgbLgbLcbLiLsbLiRsbLsbLiLsbLgbLgbLgLsLsmbLsbLgLsbLgbLsbLgbLg
bLibLcbLibLgbLgLsbLibLcbRsbLhbLibLiLsbLgLsbLsbLgbLsbLgbLgbLsbLsLsmbLgb
LgbLcbLiLsbLgbRsLsbLhbLsbLibLgbLgbLgRsLsbLgbLsLsmbLsbLgLsbLsbLsbLsbLgL
sbLgbLgRsbLgLsbLsbLsbLgbLgLsbLsbLgbLsbLgLsbLgbLsbLsbLgbLgLsLsmbLgLsbLh
LsLsmbLgLsLsmbLgbLhbLgbLsLsmbLgLsbLgbLgbLgLsbLsbLsbLgbLsbLgbLgbLgbLibL
cbLiLsRsbLsbLiLsbLibLsbLgLsbLgbLgbLsbLsbLgbLsLsmbRobRjbRibRgbRgRsmbRsb
RsbRsbRgLsbRgbRsbRsbRsbRsbRsRsmbRgbRsRsmbRgbRsRsmbRgbRgbRgbRsbRgbRgbRg
bRsbRsbRsRsmbRgbRsbRsbRsbRsbRgbRsRsmbRgRsmbRgRsmbRsbRsbRsRsmbRgbLcbLib
LgbLgbRoRsmbRsbsbRiRsmbRcbRibRgbRcbRsbRsbRsbRsbRgRsmbRgbRgbRsbRgbRgbRg
bRgbRgRsmbRgbRgbRsbRgbRgbRgbRgbRgRsmbRsLsbRgbRgbRgbRgbLoLsmbRebRhbRgbR
gbRsbRgbRgbRgbRgLsbRsbRsbRgLsbRgbRgRsmbRgbRhbRiRsmbRgbRsbRibRgbRgbRgbR
gbRgbRgRsmbRsRsmbRgbRgRsmbRgbRcbRsRibRgbRibRgbRgbRgbRsbLebRgRsmbRgbRgb
RsbRgRsmbRgRsRsmmbRgbRgbLebLgbLgLsbLgbLgbLgbLgbLibLiLsLibRgbRgbLibLibL
gbLgbLibLgbLsbLsRsbLiRsbLgRsbLsbLgbLgbLsbLgbLsbLsbLgbLgbLgbLsbLgLsRsbL
sbLsbLsbLgbLgbLgbLcbLibLgbLsLsmbLibLgbLgLsbLgbLiLibLibLgbLsbLibLgbLgbL
gbLsLsmbLibLiLsbLiLgbLsbLiRsbLiLsbLgbLgbLcbLgLsbLgbLibLgbLgbLsbLsLsmbL
gbLgbLgLsbLsLsmbLgbLgbLgbLgbLgLsbLgLsbLgbLsbLgbLgbLiRsbLibLibRsbLcRsLs
LsmbLgbLgLsbLgbLgbLgbLgLsbLgbLgRsLiRsbLgbLsbLgLsbLgLsbLgbLgLsbLgbLsbLs
bLsLsmbLsLsLsmmbLgbLgbLsbLgbLsLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 36; Drug: PCAP2 3 然
bsbLgbLgbRjbRhbRgRsmbRgRsmbRgbLgbRgbRgLsbLobLcbRcbRcbRibLjbLhbLsbLgbLg
bLgbLsRsbLgbLsbLgbLgbLsbLgbLsbLgbLgbLsbLgbLsbLsbLsbLsbLsLsmbRsbLsbLgbL
gRsbLsbLgbLgbLgRsbLsLsmbLgRsbLsbLgbLibRsbRsbRibRgbRgRsmbLsbRibLcbLiLsb
LsbLgRsbLsbLgbLgbLsbLsbLsbLsbLsRsbLsbLsLsmbLsbLsbLgRsbLsbLgbLgbLsbLsLs
mbLjbsbLgRsbLgLsLsmbLgbLgbLgbLgbLsbLgbLsbLgLsbLsbRsbLgbRjLsLsmbLgbLsbL
gLsbLgbLgbLgbLsbLsLsmbLgLsbLsLsmbLsbLgbRcbRgbRsbRibRgbRsRsmbRsbRsbRjbL
sbRsbRgbRgbRsbLsbLsbRibRhbRibRgbRjbRibRebRhRsmbRgbRgbRhbLgbLibLjbLsbRs
bLsbLgLsbLjbLsbLsbLsbLgbLgbLgLsRsbLgbLgLsbLsbLsbLsbLgbLsbLgbLgbLsLsmbL
sbLgbLsbLsbLgbLsbRsbLgRsbRgbRcLsbRgbRgbsbsbRsRsmbRibLsbRgbRgRsmbRsbRgb
RibRibRgbRgbRsbRgbLibLgbLgbLgbLgbLcbLebLgbRgLsbRgbRgbRibRcbRibRsRibRgb
LibLiLsbLgbLgbLgLsbLsbLsbLhbLcbRsbRgbRsLsbRgbRgbRibLebLsbLibLsbLgbLsbL
sbsbRsRsmbLgbLgbLsRsbLgbLgbLsbLsbLsbLsbLsbLsLsmbRsLsbRsRsLsmbLsLsmbLgb
LgbLsbLsbRsbLgbLgbLgLsbLgRsRsmbLgbLsbRsbLsbLsLjbLsbLsbLsbLgLsbLgbLgLsb
LsbLsbRsbLgbLgbLgbLsbLsbLgbLgbRsbRsbLibLgbLsbRsbLsLsmbLgbLsbLsbLgbLsbL
gbLsbLgbLsbLsbLsRsbLsbLsbLgbLsbRsLsbLsbLgbLsbLsbLsLsmbLsbLgbLgbRsbLsLs
mbLsbLibLhbLsbLgLsbLgbLgbLsbRsLsbLsLsmbLsbRsbLsbLibLibRgLsbLsbLcbRgbLi
LsbLgbLsLsmbRsLsbLsbLgbLsbLsbLgbLgbLsbLgRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 37; Drug: PCAP2 1 然
bsbRgbRhbLsbRiRsmbLsbRgbRgRsRsmmbRsRsmbRsbRgRsmbRsRsmbRgbRgbRgbRgbRsbR
sbRiRsmbRgbRgbRsbRgbRgbRgbRgLsbRgbRgbRgbRgbRgbRsbRibRibRgRsmbLjLcbLibL
ibRcbRibLsRsbRibRsRsmbRgbRsRsRsmmbRsbRgbRibRgbRsbRgbRibLsRgbRibLgbRibR
gbLsbRgbRiRsmbLibLhbLiLsbLcbLgbLsbLibLsLsmbLiRsRsmbLibLgbRsLsbLibLgbRg
bRcbRibLgbLcbLsbLiRsbRjbRhbRibRsbRgRsmbRgbRgbRibRibRsbLgbRobRibRibRibR
ibRgbRiRsmbRsbRgRsmbRgRsRsmmbRgRsmbRibRgbRgbRsbRgbRgbRgbRsbRgbRgbRsbRs
RsRsmmbRgRsmbRsbRgRsmbRgbRgbRgRsmbLsLsmbRgbRgbRgbRsbRsbRgbRgRsmbRgbRsb
RgbRgbRsbRsRsmbRgbRsbRgRsLsRsmbRgRsmbRgbRsRsmbRibRgbRibRiRsmbRsRsmbRgb
RiLgbRiLsbLcbLibRjbLebRcRiLsLsmbRibLjbLcbLibRcRsmbRcRsmbLgRsbRibRgbRib
RhbLhbRgbRoRsmbLgLsbRibRgbRsbRibLsbRgbRsRsmbRsRsRsmmbRgbRgRsmbRgRsRsmm
bRsbRsbRibRsbRgbRgbRgRsmbRgbRsbRiLsbRgbRsbRiLsbLsbRibRibLgbRibLsbRhLsb
LgLsbRhbRsbLcLsmbLibLoRsRsLsmbLgbRsLsbLhRsbRibLibLgbRgRsmbLibLgbLibRjb
LibRgLsbLibRgbLobLcbLcbRibRcRgbRgbRibRiRsmbRgbRgLsRsbLsbLebLcRsRsmbRgb
LgbLibRibRhRsmbRgbRsbRiRsmbRsbRgbRiLsbRhbLebLjbLobRiRsmbRgbLjLiLsbLgbL
gbRcLsbLibLgbLiLsbLgbLgRsbRsbLgLsbLibLsbLiRsbRsLsbRebRibLgLsbRibRsbRgb
RsRsmbRgbRgbRgbRgbRsbRgbRgbRgbRsbRgRsmbRgbRgbRgbRgbRgbRsbRgbRsbRgbRgRs
mbRsLsbRsbRgbRgbRibRsbRgbRgbRgbRgbRgbRgbRgRsmbLsbRibLsbRgbRgRsmbRsbsbR
gbRgRsmbRgbRsbRgRsmbRgbLgbRibRsbRgbRgbRgbRibRgbRgRsmbRgbRgbRgRsRsmmbRg
bLsLsmbRgbRgbRsRsmbRsRsRsmmbRgbRsbRibRsRsmbRgbRgbLgbRiRsmbsbRiLsbRobLe
LsbLibRibLhbRsbLgbLsLsmbRsbLibLobLcbLhbLsbRcbRiLsRsbLgLsbLsbRiRsmbRgbR
gbRsRsRsmmbRgbRgbLsbRsLsbRibLsbRgbRgbLjLobLiRsbRhRsmbRobRcbLibRsbRoLsb
RcbRibRgRsmbRhRsmbLsbRcbLsbRhLsbRibRibLgbRgbRjRsRsmmbRsRsmbLsRsbRgbRsb
LsRsRsmbRsRsmbRgbRsbRgbRgbLsRsbRgRsmbRgbLsbRsbRgbRgbRgbRsbRgbRibRsbRgb
RgbRsbRgbRsbRgRsmbRgbRsbRgRsmbRgbRgbLsbRibRsRsmbRsbRgbRgbRgbRsbRibRgbR
gbLcbLiRsbLibLcbRebRcbRsbRgRsmbLgbRibRgbLeRsbLgLsbLgbRcbRibRsbLsbRgbRs
bRgbRgbLsRsRsmbRgbRgbRgRsmbRgbRsRsmbRgbRgbRgbRgbRsbRgRsmbRgbLcbRsLiRsL
hRsRsmbRoRsRsmmbLobRobRiRsmbLgLsRsbRibLsRsbRiRsmbRsbRgbRgRsmbRsLsRsbRg
bRgbRgbRsbLsbRgbRgRsmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 38; Drug: PCAP2 1 然
bRsbLsbLibLgbLgbRgbsbLiLsbLgbLsbLibRsbRcRsmbRiLsbLgLsbLsbLgbRhLsbLgbRc
bLgRsbRibRcbLsbRgbLsbRhbRsbRibLgbRiLsbLgbRiRsmbRsbRsbRgbRgbRgbRsbRiLsR
sbRgbRgbLgLsbRgbRibLsbRgbRibLgbLibRcbRgbRgRsRsmmbRgRsRsmmbLsbRgRsmbRgb
LsbRsRgbRgbLsbRgRsmbRgbLsLsmbsbRgLsRsbRsLsbRgbRgbLgbRgbRibLsbRgLsbRgbR
gbLsbRgbRgRsmbRsRsmbLjbRibRibLcbLibLibLhbRiRsmbLhbLibLgLsbLsLsmbLgLsbL
gLsbLgbLsbLgLsLsmbLsbRsLsbLgLsLsmbLgbLgbLgbLsLsmbLsbRgbLgbLsbLsbLiLsRs
bLsbLsbLgbLgbLsbLsbLgbLsbLgbLgbLgbLsbLgbLgLsbLsLsLsmmbLgbRsbRobRcbLsbR
hLsLsmbRibRibRgLsbLibRhbLcbLibLgRsbRcbRcbRibRgbLiLsbRhbRsLjbRcbLsbRibL
sbRgbRcbRibRgLsbRcLsRsbLjbLibLibLsLsmbLgbLsRsbLgbRsbRcbLgLsbRiRsmbLsbR
gbRiLsbRsbLsbRhbLsbRhbLiLsbRcLsbRibLjbRjbsbRibRgbRsbRsbRsbRhLsLsRsmbRs
LsbRiRsmbRibLgbRiRsRsmmbLsbRgbLsbRgbRibRiLsbLsLsmbRgbRgbRgbRiLsbRsbLsb
LjbRibRiRsmbRsLsbRibLsbRibRibLgbRgbRibLgRsbRibLsbRgRsmbRsRsmbRgLsbRsLs
bRgRsmbRsbRgbRgbRgbRgbRsbLsbRgbRiRsmbRsRsmbRgbRsRsmbLobRiRsmbRgbLsbRgR
smbRgbRgbRsbRiRsmbRsbRgRsmbRibRiLsbRgbRibRgRsmbLsbRgbRibLibLcLsmbLibRc
bRibRcbRcLsbLgbRgbRcbLhbLiLsLsmbLgRgRsmbRsbLibLsbLhbRibRcbLsLsmbRibLsb
RhRsmbRgbRgbLgbRcbRibLgLsbLsbLgbRcbRcbRgbLibRobLgLsbLsRsbRcbLsRsbRibLg
RsbLsRibLsRsbRgLsbLgbRgbRgbRsRsmbRibRsbLsbRgRsmbRgRsmbRgbRgbRsLsRsbRgb
RsbRgbRsRsLsmbRgbRgbRiLsLsmbRsbRsbRhbRhLsbRibRsbLiLsbLibRcbLhbLibRcbLc
bRcbRcbLgLsbRiRsmbRhbLibRibLsbRibRsbRhRgRsmbRgbRgbRibLgRsbRiRsmbRiLsbR
sbLsbRibLgbRibRgbLjbRgLsbRgbRgbRgbRiLsbRibLcbRibRiRsmbLsbRibRiLsbLjbRg
bRgbRsbRsbRgbRgbRgbLsbRgbRiRsmbRgbRsbLsbRibRgbRsRsmbRgbRsbRgbRgbRgbRgR
smbRgbRgbRsbRsbRgbRgbRsbRsbRgbRgbRgbLsbRgRsmbRsRsRsmmbRgbRgbRgRsmbRgbL
gbRibLsbRiRsmbRgbRgLsbLgbLcbRsLsbLgRsRsmbLhLsbLcbLgbLibLhbRgLsbLiLsbRg
bLgbLgbRsbRsbLibRsbLiLsbLgbRsLsbLibLibLgLsbLgbLhRgbLcbRgbLcbLibRiLsbLc
bLcbRjRsmbLiLsbRsbLibLibRgbLcbLibLibLsbRsbLgbLhbRgRsmbRjRsmbLcbLibRsbR
gbLiLsbLibRjbLgbLgbLsbLiRgbLgLsbLsbLiRsbRgbLibLibRgbLhbLibRgbLibRjbLib
RsbLibLsbLsbLsLsmbLgbLsbLsbLgbLgLsLsLsLgmmbLgbLsbLsLsmbLsbLgbRsbLgbLgb
LgbLgbLsbLgbRgRsmbRsbLgbLgbRgbLibRgbLgbLobRgLsbLhbRgbLibLibLibRgbRjRsm
bRibRibRibLgbRsbRibLsbRgbRhbLgbRcbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 39; Drug: PCAP2 1 然
bLibRgbLobLiRsLsbLgLsbLibLsRsbLsbsbLgbLgbLgRsbLgLsbLgbLgLsbLgLsbLgbLgb
RsbLgLsbLgbLgbLgbLgbLsbRsRsmbLsbsbLgbLgbLgbLgbLsbsbLgLsbLsLsmbLsLsmbLg
LsbLgbLgbLsbRgbLhRsbLgbLgLsbLgbLgbRsbRobRgbRgbRibRgbLjbRibRibLsbRibsbR
gLsbRsbRgbRgRsmbRgLsbRgbRgRsmbLsbRgbRgbLsbRgbRgbRgbRsbRgbRgLsbsbRiLsbL
gbLebLgbLgbRsbLsbLgbLgbLsLeLgbLgbLibLgbLhbLgRsbRcbRibRibLhbLibRjbRibRg
bLobRebRgbLjbLibLgbRcbLsRcRsmbLgbLjbLiRsbLgbLgbLhRsRsmbLibLibRsbRjbRib
RgRsmbLcbLgbLgbLgLsbLgbRcbRibLcbRibRibLjbRibRibLobRcbRsbRgLsbLsbRibRiL
sLsmbLibLcbRjbRibRibLobRcbLgbRgbRgbRgbRsbRsbRgbRsbRgbLebsbLiRsbLoLsLim
bRgbLcLsmbLgRsbRsLsbLgbRgbLsLibLgRsbRsLsRsbLsbsbRgbRgbRcbLjbLcbRcbLcbR
jbRsbRcRsmbLibRibRgbLobRsRsmbLibRoRsmbRibLibRibsbLobRcbRiLsbLhbLhbRhbR
gbRgbRsLsbRgbRgbRgbRsbRgbRgbRsbRsbRsRsmbRgbsbRgbRsbRsbsbRgbLgRsbLcbLgb
LgbLgbLgbLsbLgbLgbLgbLsbLsLsmbLgbLsbLgbLgbLsbRgbRhbRibLjbRibRgbRibLobL
gRsbLgLsbLgRsbLsbLgLsbRgbLgRsbLiRsbRgbLsRsRsmbRcbRsbRgbLcbRcbRgLsbRgLs
LsmbRcbLcbLgbLibRgbLgbRebRhbRsbLgRsRsmbRgbRgbRsbRibLjbRibRobLhbLgbRgbL
gbRiRsmbRgbsbLsbRibRgRsmbLsRsRgRsRsmmbRgbRgbRcbLjbRcLsbLjbRcbLcbLsbLob
LobLsbRibRibLjbRibRibLsbRibRgbLcbRsbLgbLgbLgLsbLsbLsbLgbLsbLgRsLsbLgRs
bLsLsmbLgbLgbLgbLsbLgbLgbLgbRsLsbLsbRsbRsRsmbLgbRsbLgLsbLgLsbLgbLgbRsb
sbLsbLgLsbLgbLiRsbLcbLgbRobLibRjbRcbLobLhRsLsbLgbRgLsbLhRsbLsbLgbLgbLg
bLgbLgbLsbLgLsbLgbLgLsRsbLsLsmbLsLsmbLgbLgbLgbLsLsmbLgbLgLsbLsbsbsbLsb
LsLsmbLgbLgbLgLsbLgbRhbRibLobLsbLgbLgbLsbLgLsbLgbLgbLgbLibLhbLgbLgbLsb
LobRiRsmbRibRiRsmbRsbsbLobLgRsbLgLsbLsLsmbLgbRsRsmbLgbLgLsRsLsbLgbLgbL
gbLgbLgRsbRsbLgLsbLgbLgbLgbLgbLsbLgbLgbLgbLgbLsbLgLsbLgbLsbsbsbRsLgLsR
sbLgLsbLgbLgLsLsmbLgbLibLgbLibLgbLibLhRsbLsLsmbLsbLobRsLgbLoRsLsbLibRi
bRiLsbLjbLcbRcbRcbRobRibLhRsbLgRsLsbRsbLsbRjbLgbLsRsbLgLsbLgbLgbLgLsbL
gbLgbLgLsbLsbRjRsmbLgbLiLsbsbLgLsbRsbLibLgLsbLgLsbLgbLgbLsbLsbLgbsbLsb
RhbRibsbRobRiRsmbRgbRgbRibRsbRgbRiLsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 40; Drug: PCAP2 1 然
bLgbLcbRsbLiLsbRsLsbLibRsbLgbRgbLgbLibRgbLgbRsRsmbLgLsbLgbRsbsbLgbRsbL
gbLibRgbLgLsLsmbLgLsbRsbLgbRsRsmbLgLsbRjbRiRsLsmbRiRsmbLgbRibLjLsmbRiR
sRsmmbLgbRiLsbLjbLcLsmbRgbLiLsbLgLsRsbRjLsbLiLsbLgbRibLobRebRibRhbLsbR
gbRsbRgbLgbLsbRibRsRsmbRgbLjbRibRgbRgbRibLhbLebLsbsbLsLsmbLgbLgRsbLgbR
sbsbsbLsbLibRsbLibLiLsbRjbLibLsbLgbLgbRsLsbLibRgbLiLsbRsRsmbLgbLgbRgbL
gbRsbLibRsbLgbLgbLsLsmbLgbLsbRjbRcbLcbLgbRibLiLsbLgbLsLsmbLsbLiLsbRsbL
gbLiRsbRsbLibRgbRsbRsbRibLcLsmbLgbLiLsbRjbLgbLgbRobsbRibLsRsLsbRibLgRi
bLjLsmbRibLcbRsbLibRsLsbLgLsbRsLsbLsLsmbLgbRsbLgbLgLsbRsbLgbRsbLsbLsRs
bLibRsbLgbLgbLgbsbsbLibLsbLibLibLibLcLsmbLcbLiLsbLgbLibLsbLgbLgbLsbLgL
sbLgbRsbLgLsbLgbLgbRsbLibRgbLgbLsbLgbLgbRgbLgbRsbLibLsLsmbLgLsbLgbLibR
jbLhbLjLsmbRcbLgbRcbLibLebLibLsbLibLgbRsbLsbRoRsmbLsbRibLiRsbRiRsmbLjb
RibRiRsRsmmbLjLcLsmbLsbLibLgbRgbLibLsLsmbLgbRgLsbLsbRsRsmbLhbLiLsbLibR
gRsmbRsbLcbRcRsmbRiRsmbLsbRibRgbRsRsmbLibLcbLibRjbRcbLebLibLjbRhbRsbLc
bRjbLibLgbLgbLebLibRgbLibLibRhbRhbLsRsbRcbRibRgbLcLsLsmmbLibLibLibRibR
jbRibRgbRibLjbRcRsmbLgbLjbLcLsmbLgbRibRjbRibRibRgRsmbLsRiLsbRsbLcLsmbL
gLsbLgLsbRsRsRsmmbLcbRibRsbLcLsmbRgbLgbLcbLiLsbRiRsmbLsbLhbLiLsbRjbRgb
LcbRibLibLsbRcbRoLsLsRsmbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 41; Drug: PCAP2 1 然
bLsLsmbLgbLsbLgbLsbRsbRsbRsbLgbLsbLgbLsbRsbRjbRcLsRsbLgbRcbRibRsbsbRgb
RgRsmbRsbLgLsbRgbRibRgbLgbRibRgbRgbLibLsbRhbRgbRibRsbRiRsmbRsbRsbRsbLg
bLsbLsLsmbLsLsLsmmbLsbLgbRgbLcbLiLsbLgbLgbLibLsbRgbLgbLhbLsLsmbLibRgbR
ibsbRobRibLsbRibsbRsRsmbRgbLgLsbLgbLcbLsbRsbLhbRgbRgbLcbLibLibLsbLsbRg
bRgbRgbLgbRhbRsbLibRibRiLsbLibRgbRsbRgbRsbRsbRgRsmbLjbLcLsmbLibRgbLibL
gbRjbRcbRibRsbRhbRibRibRsRsRsmmbRsbLibLiLsbLsLsRsmbLgbLhbLibLgbLiLsbLs
bLcbLiLsbLsbRiLsRsbRsbLibLsbLibLgbLgbRsRsmbLcRsRsmbLgbsbRgbRibRebRgbLi
bRgbRsbRsRsmbRgbRibRsbRsRsmbLsbLsbRsbRcbRgbRgbsbRsRsmbRsRsmbRsRsmbLgbR
cbRsbLgLsbRiRsmbRgbRibRibsbLsbRgRsmbRgbLgLsbRcbRibRsRsmbLgbRibRgRsmbRs
RsmbRgbRgbRibLsbLsLsmbRsbRgbRhbRibRgRsmbLsLsmbLsbRsbRibRsbsbRgbRibRgbR
sbRgbLsbLsbsbRgbRsbRgbRsbRsRsmbRsRsRsmmbRsRsmbLibRibRsbRgbLgbsbRgbRibs
bRiLsbRgbsbRsbRsbRsRsmbRibRsbRgbRsbRgRsmbRsbRgbRgRgbLgLsbLgbLibRibRibR
ibRibsbLsbRsbRobRibRibRsbRibRgbRgbRiRsmbRgbRgRsmbRgbLibRsbRgRsmbRibLhb
LgbLhbLgbLgbRibRgbRcbRhRsmbRibsbsbLsLsmbsbsbLsLsmbLgbLgbLsLsmbLsLsmbLs
bRsbLibLgbsbRsbRsRsmbRsRsmbLibLjLsmbLgbsbRsbRobRgbRgLsbRsbLgLsLsmbRgRs
mbRjLsRgLsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 42; Drug: PCAP2 1 然
bRibRcRgbRgbRiRsmbLsbLcbLiLsbLibLgbLsbLiLsbLgbLgbRsbLgbLgbLgbLgLsbLgbL
gLsbLgLsbLgbLgLsbLgLsbLgLsbRebRsbRiRsmbRsRsmbRibRibLhLsbLsRsbLgbLsLsmb
LgbLgLsbLgLsRsbLgbLgbLsbLibRcbRobRsbRibRiRsmbRhLsbRgbLcbLhbLibLiLsbLgL
sLsmbLgbLhLsLsmbLgbLgLsbLgbLgbLgbLgRsLsbLsLsmbLgbLgbLgLsbLgLsLsmbLgbLg
bLgLsbLgbLgbLgLsbLgbLgLsLsmbLsLibLgbLgbLgbLgbLgbLgbLibLiLsRsbRsbRjbRcb
LsbLsRsbRibLsbRcRsmbRibRibRgbLsRibRgbRibRgbRgbLsbRgbRhbLjbRhbRiLsbRsbR
ibRiRsLsRimbRibRibRsbRgRsmbRgRsmbRgRsmbRgRsmbRgbRgbRgbRgbRgRsmbRgbRgbR
gbRsRsmbRgbRsbRgRsmbRgRsmbRgRsmbRgbRgbRgbRgbRgbRgbRibRiLsbRgRsLsmbRibR
gRsRsmmbRgbRgRsmbRgbRgbRgbRgbRsbRibRgbRgRsmbRibRgRsLsmbRgRsmbRgRsmbRib
RgbRibRgbRibRgbRsRgRsmbRgbRgRsmbRgbRgbLcbLiRsbLibLgbRsbLibLsLsRsmbLibR
jbLsbLibLsbLgbRjbLibLgRsbLgLsbLibLgbRsLgbLsbRsLgLsbLgbLgbLgLsbLgLsbLgb
LibRcbLcbRebRobLjbRibRibLgbRiRsmbRgbLsbRiLsbRgbRgRsmbRgbLgRibLebLiRsbL
gbLiLsbRsRsmbLibLgbLgLsbLgbLgLsbLgbLgRsbLgLsbLgLsbLgLsLgLsLsmbLgLsbLgb
LgbLgbLgbLgLsbLgbLgLsbLgbLgLsbLgLsbLgbRsbRcbRgbLsbRiRsmbRgbRgRsmbLsbLi
bRsLsbLiLsbLgLsbLgbLgLsLsmbLibLgbLhRsbRhbLcbLsRsbLcbLiRsbRsbLcbRgbLcbR
sbRsbLiLsbLsbLgLsbLgLsbLgbLsLsRsmbLsbLgbLgbLgbLgbLgbLgLsbLgLsbLgLsRsbL
gLsbLgbLgbLgbLgbLgbLgLsbLgbLgLsLsmbRsLsbLgbLgLsbLgbLgbLibLgbLgbLgbLgbR
jbRjbLibLiLsbLsbLgbRobRibRgbLsbRiLsbLcbLgbRgbRibRibRgbRsbRsbRgbRsbRgbR
sbRibLsbRiRsmbRgbRgbRgLsbRgbRgbRgRsmbRgbRgbRgbRgbRiRsLsmbRgbRgbRgRsmbR
gbRgbRgbRsbRgRsmbRgbRiRsmbRgRsRsRsmmmbRgbRgbRgbRgRsmbRgbRgbRgRsmbRgbRg
bRgbRibRgRsmbRgbRsbRsRiRsmbRgbRgbRgbRiRsRsmmbRibRgRsmbRgLsRsbRgbRgbRgb
RgbRiLgbLsLcbLgbLgbLibRgRsmbLcbRjbLcbLiRsbRcbLibLiLsbLgbRjbRcbRsbRiRsm
bLcbLobRiLcRsLsbLibLobLgbRibRgbLcbLgbLgbRsbLgLsLsmbLgbLgbLsbLsbLgbLiLs
bLgLsbLgLsRsbLgbLgbLgbLgbRjbRcRsmbLcbLoRsRhbsbRcRsmbLebLsbLsLhRsbRibRi
RsmbLcbLcbLgLsbLibRgbLcbRjLsbLibsbsbRsLsbRcbLcbLobRcRsmbLgbsbLobLhbLib
LcbLsRsbLibLgbLiRsbLsbLibRgbLibLgLsbLsbLgLsbLgLsRsbLgbLgLsbLgbLgbLgbRc
RsmbRibsbsbLcbLibRsRsmbLibLgLsbLgbLibRgbLibRjbLsbLiRsbLibLgbLgbLgbLgbL
ibRibRcRsmbRgbLsbRhbLsbLsbLibLcRsRsRsmmbLibLsbLgbLgbLgbLgLsbLgLsRsLsbL
gLsbLibLgbLgLsbLgbLgLsbLgLsbLgbLgbLgLsbLgbLiLsLsmbRoRsmbRgbLsRsbRgbRiL
gbRiRsmbLcbLgbsbRsbLibRsbLiLsbLgLsbLgLsRsbLgLgbLsbLgLsLsmbLgbLsLsmbLgL
sbLgbLgbLgLsbLgbLsLsLsmmbLibLgbLgbLgLsbLgbLgLsbLgLsbLgbLgbRsLgLsbLgbLg
LsLsmbLgbLgLiLsbLgbLgbLgLsbLgbLgbLgLsbLgbLgLsbLgLsbLgbLgLsbLgLsbLgbLgR
sbLsbLibLsbLsLsLsLsmmmbLgLsbLgLsbLgbLgLsbRsbLgbRjbRcbsbsbsbLjbRhLsLsmb
LcbLhbRgRsmbLibLiLsbLsbLgbLgbLgbLgbLgbLibRhbRcbLjbRibRiRsmbRsRsRsmmbRg
RsRsmmbLoLsmbLsbLgbLgbLgRsLsbLgbRibRibLeLsbLgLsbLgbLgLsbLgbLgbLgbLgbLg
bLgbLgbLgbLgbLgRsbLsLsmbLgbLgbLgbLgbLgLsbLgbLgbLsbLgbRsbRcRsmbRgbRsbRg
b

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 43; Drug: Control
bRibLgbRgbRgbRiLsbRsbLgRsbRibLgbRibRsRsmbLsLsmbLsbRibLgbRibRgbLjbLibRj
bRebLsbLgbLsbRhbRibRgbLsbLibRibRcbLgbRiRsmbRibRibLibLcLibRjbLibLhbLgbL
gbRibRibRibRgbRibLhbRibLsbRcbLiLsbLsbRhbLjbRibLsbRcLsbLsLsmbLgbRibRibR
sbLsbRibRebRsbLiRsbLsRsbRhbRiLsbRibLsbRiLsbLgbRhbLgbLjbLcbLcLsmbLgbRib
RibLjLibLjRsLsbRgbLiLsbLibLsbLibRsbLibRjLsbRjbRcbLjbRhRsmbLgbRiRsmbRsR
sLsmbRsbRgbRsbRsbRgbRgbRsbRgbLsRsbRgbRgLsbLgRsbRgRsmbRsbRsbRgbRsbRgbRg
bLsbRgbRgbRsbRgbLsbRiLsbLgbRgbRgbRgbRgLsbLgbRgbRibLgbRibLjbRiRsmbLgbRi
bLsbRgbRgbRgbLgLsbRgbLjLibLibRebLhbLcbRsbRibLibLgbLgLsbLgbRjbLiLsbLsbL
sLsmbLgbLiRsbRibLgLsbLgbRjLsbLgbLgLsbLibRsLsbRgbLhRsbLgbLcbLcbLgbLgbRs
bLgbLgbLgLsbLsbLgbRsbLgLsbRgbLgbLgbRjLsbLiLsbRgbLgLsbRsRsmbLgLsbLgbRsb
LgbLgbLgbLgbLgLsbLgbLgbRsbLgRsbLsLsmbRsbLiLsbRsbLgbLsLsmbLgLsbLgbLsbLs
bLgLsbLgRsbLgLsbRgbLgbLgLsbRsbLiRsbRgLibLgbLgLsbLsLsmbRsLsbLgbRsbLgbLg
bLgbLgbLsbLgbLgbLsRsbLibLsbLgbRgbRsLiLsbLgbRsbRjbRibLsbRibLgbRibRsbRib
LjbRiRsmbRsLsbRiRsmbRiRsmbLcLsmbLsbLgbLgLsbLsLibLgRsbRgbLhbRibLcbRebLi
bRsLgbLgbLgbRgbLgbLgbLgbLhbLibRhbRebLjbRcRsmbLjbLibRcbLjbLcLsmbLcLsmbL
cbLhRsLsbRjbRcbLjbRibRcLsbLeLsbLgbRcbLibLibReLsbRibRsLsbLgbRcbRhbRebRi
bLgbRcbRibReRsmbLsbLibLibRebRgbRsbLhbLhbRcbRobLcbLhLsbRjRhbRibLcbLhbLj
LsmbRebLgLsbLibLsbLibRgbLgLsbLgbLgbLgbRjbRcbRibLjbRibLsbRibLgbLjbLcbLi
bLhbLgLsbLiLsbLsLsmbRgbRibRhbRgRsmbRgbLgbLsbRgRsmbRibRsbRcbRibLibLibLs
bRibLsbLgbRjbRcbRibRsbLhbLibRjbRjbRibLjbRibLcbLibLhbLibLhbLhbRsbLhLsbL
iLsbLsLgbRsbLgLsbLgLsbRsbLgbRebRibLsbRibLsLsmbLsbRibRgbLiLsbLsbRjRgbRi
bRsbLsbsbLsbsbRibRibRibRibRsbLiLsbRsbLgbRjbLcbRibLgbRcRhbLhbLcbLcbLibR
hRsmbRibRsLgLsbRibLjbLjbLhbLgbLgbRibRsbLibLibRjbLiLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 44; Drug: Control
bRibRibRibRgbRgbLsRsbsbRibRgbLsbRgbRsbRgbRgbRgbLebRcbRgbLsbRgbLsRcRsmb
RibRibRibRgbRibRsbLibRibRibRsRsmbLgbRibRibRhbLsRsbLgbRgbRcbRibRgbLsbRi
bRsbLsbLsbRhbRibRibRgbRgbRgbRcbRsbRgRsmbLibLsbRgRsmbRibLgbRibLibLebLhb
RiRsmbRjbRiRsmbRgbRibLgLsLsmbRsbRhbRsbLsbRibRsRsmbRsbRgRsmbRibRsbRsRsm
bRgbRsbRibLsbRgbLsLsmbLjbLobRhbRiRsmbLgbRgbRgbRsbRsbRgbRgbLsbRgbRgbLjb
LobRsbLibLsbLsLsmbRsLsbLsLsmbLgbLsbLsbLsLsmbLgbLsLsmbLsbLgbLsbLgbLsLsL
smmbLsbLsbLsLsmbLgbRsbLgLsbLsbLsLsmbLsbLgbLgbLsLsmbLsLsmbLsbRsbsbLgLsb
LgbLgbLgbRsbLsbLgbLiLsbLsbLgbLgLsbRjbRjbRcRsmbRgbRiRsmbLhbLcLsmbRgbRib
LobRsbLibLgRsbRibLibLibLgbLibLibLgbLsbLibLgbLibRjbLiRsbRgbLsbLhbRgLsbR
cbRiRsmbRsRsmbRgbRgbLsbLsbRibLsRsbRsbRgRsmbLsbRgRsmbRsbLsbRgbRsRsmbRib
RhbRibRiRsmbRibLsbRgRsmbRgbLcbRibRiRgbRgbLjLsmbLcbLibRsbRibLcbRgbLeLsb
LibLsbRgbLsRsbLjLsLsmmbRgbRsRsmbRsbLobRgbLgLsLsmbLgbLgbLibLgbLsRsbLhLs
bLsLsLsmmbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 45; Drug: Control
bRibLgbRiRsmbRgbRgbRiRsmbRgbLibRgbRibRiLsbLcbRjbRibLoLsmbLiRsbRjbRgbLj
bLibLgLsbLibRgbRibRgLsbLsbRgRsmbRgbLgLsbLcbLibRcbRgRsmbRgbRgbLgbRibRgb
LsRsLsbRgbLsbRiRsmbLsbLsbRgbRgRsmbRgbRsbRsbRgbRsbRgbRgbLjLsLsmmbRcbLgb
LcbRjbRibRgbRgRcbLjLsmbLjbLgLsbLcbRibRibLibLibLibRcbRgbRgbRgLsbRgRsmbL
gbRibLsbRgbRgbLsbLebLgbLhLsbRjbLibLobLibRgRsmbRgbLsbRgbRgbsbLebLgbRobL
jbRibRibRsbLibLgbRcRsmbRhbRibRjRsmbRgbLgRsbRcRsmbRhbRcbLebLjbRibRibLib
LgbRebLgbRhbLhbRjbRibRobLhLsbLibRcbRgbRibRgbLsbLiRsbRgbRibRcLsbLgLsbLs
bRgbLjbRibLcbRibRgbRgbRgbLsbRgbLgbRgbRgbRibRiLsbRiRsLsmbLhbLgRsLsbRcRs
mbLcRsbLibRcbRjRsmbLibRcRsmbLibRjRsmbRibRibRhbRgbLibRibRhbRgbLjLgbRhbR
gbRgbRsbLgbRsbLsbRjbRibLgbRibRiLsbRibRhbLgLsRsbLgbRgbRgbLjbLjLsmbLhbRh
bRibRibLsRsbLcbRcbLgbRibRcbRcbLibLibRibLibLgbLsbLsbRebRhbRgbRgbRgbLgbL
sbRcbLibRebRgRsmbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 46; Drug: Control
bRibLjLsmbLhbLebRhbRibRobLjbLibRjbRhbRibLjbRebRibLsbRgbRgbRsLsbLebLgLs
bLgbLgbRsLsbLgbLgbLsbLgbLgbLibRibLsbRgbRibRgbRsRsmbLibRiLsbLsbRgbRsbRs
bRsbRgbRsbLsbRgbRgbRgbRgbRsbRsbRgbRsbRsbRgbRsbRgbRsbLgRsbRgbRsbRgbRsRs
RsmmbRgbRsbRgbRsbRgbRsbRgbLsbRgbRsbRsbRgbRsbRgbRgbRsbRsbLgbLcbRobRsbLi
bLgbRsbRibLgbLsbRjbRibRgLsbLgbRibRibLsLcbLibLcbRgbLibRgbRjbLsbLcbRjbLe
bLibRibLibRcbRjbRhbRjbLgbRebLcbLibRcbRgbLobLibRibRjbRjbLcbLcbRebRibRib
LjbRiLsbLsbRibLgbRgbRsbRsbRsbRgbRsbRsbRsbLgbLcbLhbRibLibRcbRibRgbRhbRg
bLibLsLsmbRibRobLibRibLgbRgbRgbRgbRgbLebRibRgbRgbLcLsmbLiRsbRgbLjLsmbR
jbLibRobRobRibLgbRgbRsbRsbRgbRgbRsbRgbRsbRgbLsbRgRsmbLgLsbRgbRsbRgbRgb
LsLsmbRsbRgbRsbRsbRsbRgbRhLsbLcbLsRsbRobLgbRibRgbRgLsbRgbLgbLgLsbLibLs
bLgbRobRibRhRsmbLibRibRgbLjbRhbRgbLsbLsbRgbRsbLjbsbRibLjbRibLgbRibLsbR
gbLsbLgbRsbRgbLsbRgbRgbRgbRsbRgbRgbRgbRgbRsbRsbRgbRgbRsbRsbRsbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 47; Drug: Control
bLgbRibLsbLhbLibRcbRcbLcbRcbRgRsmbLsbRiLsRsbRsRsmbRgRsmbLgbLsbLcbRcbRi
bRcbLhLsbLsLsRsLsmbRsLsbRcRsmbRibLgbLsRibRgRsmbRgRsmbRgbRsRsmbRgRsmbRs
LsbRiRsRsmmbRsbRgbRgbRgRsRsmmbRgbRgbRgRsRgRimbRgRgRsRgRsRsLsmmmbRgbRgR
smbRsRsmbLsbRibRsLsbRiRsRsmmbRgbRgRsRsmmbRgbRgbRsbRsLsbRsbRibLcbRhbRib
RgbRgRsmbRgbLsbRgbRsRsRsmmbLgbRgRiRsmbRgLsbRsLsbRgRsmbLsbRgbLgLsbRibRg
bRgbRsbRgRsmbRgbRgbRgRsmbRgRsmbRgbRgbRgRsRsRsmmmbRgRsmbRgbRgLsbRgRsmbR
ibRgRsmbRibRiRsmbRgRsmbRgbRsbRsbRibRgbRgRsmbLsLsmbRgbRgbRgLsbRsbRgRsmb
RgbRsbLsRgbRsRiLsRsbRgbLgbLhbLgbLibLgbLsbLgLsbLgbLgbRjRjbRcbRibRsbRsbR
ibLgbRibLebRcRsmbRibLjbLcbRsLsbLibLsRsbLsbLibLibLhRsbRgbLhLsbLobLibLgL
sbLibLcbLgbLsbRibRiRsmbRsbRgRsmbRgRsLsmbRgLsbRibRsLsRsbRgbRsbRiRsmbRgR
smbRsbRgbRgbRsbRgbRgbRsbRsRsmbRgbRgbRiRgRsmbRgRsmbRgbRgbRgRgbRgbRgbRgb
RiRsmbRsRibRgRsmbRgRsmbRgbRgRsmbRgbRgbRgbRgbLcbLcbLobLibRgbRcbRobRibLs
bLcbLiRsbLsbLibLgbLgbLgbLcLsmbLhRsbRibLobRjbRhbRibRhbRsbRibRhRsmbRibLs
bLgbRibLsLsmbRgbRgbRibRgLsbRsbLibRcbRibRgRsmbRsbLsbRibRsbRsbLjbRibRiRs
mbRgbLsbRhLibRgbRsbLcbLiRsbRjbLhbLgbLgbLgbLgbRgbRibLcbLgbLcbLgbLibRsbL
iLsbLgbLsbLobLibLsbLiLsbLgbLgLsbLgRsbLgLsbLgbLibLsLsmbLgbLobLibRiRcbRs
bRibRsLsbRgbRibLcbLibLsbLgLsbLsbLgbLgbLgbLsbLgbRoRsmbRsRibLcbLibLgRsbL
sLsmbLgbLgbLobLcbRhRsRsRsmmmbRiLsbRgbRgbRcbLcbRiLsbRgLsRsbRgbRobRibRsb
LibLgbLgbLgbLgbLgLsbLgbLgbLibRsbLgbRiRiRsmbRsbRgRsmbLgbLcbLibLgRsbRsbL
gbRsbLgbRcbRibLcbLsbLgLsbLobRebLgbRoLsbRgbLgbRcbLjbRhbRibLcbRgbRgRsmbR
sbRgbRgbRgRsmbRgRsmbRgbRgRsRimbRsRgbRsbRgbRibRsLsbRgbRgRsRsmmbRsbRgbRg
RsRgmbRgRsRsmmbRibRgbRibRgbLsbRgbLcbLgbLgbLsbLgbLibLgbRsbLibLgLsbLgRsb
LgbRgbLgLsbLiLsbLgbsbLgbLsbLgbLgbLgRsbLsRsbLsbLsbLibRebLsLsmbRibLibLjb
LibLibLgLsbRcbRobLibLibRcbRibLsRsbRgbRsbRgbRgRsmbRgbRgRsmbRgLsbRgRsmbR
gbRgRsmbRgbRgbRgbLsbRgbLcbLgbRcbRobLibLjbLibLsbLgbLgbLgbLsLgLsbLgbLgbL
sbLgRsbLsbLgbLiRsbRsLsbRoRsmbRgbRiLsbRgbRsbRibRgbRgRsmbLsbRgbRsbRgbRgb
RgbRgRsmbRgbRgRsmbRgRgRsmbRgRsmbRgRsRsmmbRgbRgRsmbRgbRgbRgbRgbRsRsLsmb
RsRsmbRgLsRgbRgbRgbRgbLsLsmbRsLsbRgbRgbLjbLibRhRsmbRibLjbRsbRiRsmbLjbR
sbRhbLibLcbRjbLobLibLsbLibRsLsbLsLgbLsbRcbRcLsbLcRsbLcbLsbLoRsbRibRhbR
gRsmbLsbRibRgbRgRsRgRsmmbRgRsmbRgRsmbRgbRgbRgLsbRgRsRgmbRgbRgRsRgmbRgb
RgbRgbRgRsmbRgRsmbRgbRgbRgRsmbRgbLgbRsbRgbRgbRgbLsRgbLsRgRsmbRsbRgRsLs
mbRgRsmbRgbLsbLjLibRcLsbRibLsbRibLjbLcbLoRsbLibRhbLsRsbRibRibRibLsbRsb
RgRsmbRsbRsRsRsRgRsmmmbLgRiLsbRsRsmbRgRsmbRsbRibLcbLiLsbLhbLsbLobLcRsb
LibRsLibLibLsbLibLgbLsbLgbLgbLcbRibRgbLgbLgbLgbLgbLgbLsLsLsmmbLgbLsLsm
bLsbLgbLgbRsbLgbLgRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103059; End: 103559;
Recording: 3-1; Individual: 48; Drug: Control
bLhLsbLgbLgbRcbLcLsmbLsbLibLgLsbLgbLgbLiRsRsmbRcbRobsbLsbRsbRoLsLsmbRi
bLcbRgbRjbRibRgbRgbRhbLibRibLeLsbLibLgbLsRsbLgbLgbLgLsbLgbRsbLibLgLsbL
gbLgbLsLsmbLgLsLsmbLgbLgLsbLgbLgbLsbLgbLgbLgbLgbLgbLgLsbLsbLgLsbLgbLgL
sbLsbLgbLgbLgbLgbLibLebLobRcRsRsmmbLcbLiRsbLiLsbRibLibRcbRebLebLcbLiLs
bRsbLibRsbLibLgbLhbLgbRibRjbRibLcbLiLsbRibRiLsbRsbRcLsbLebLcbLiLsbLsbL
gLsbLsLsmbLgbLgbRgbLiRsbRibRobLhbRoLsbRcLsbRcbLiLsbLiLsRsLsbLgbLgbLgbL
gbRcbRhLsbLhbLhbRgbRcbRibLibRiLsbLcbLgbLgbRjbLibLiLsbLsbLebRgbRcbLsbRi
bLgRsbRcLibRiRsmbRgbRgbRgLsLsmbRsbRgbRhRsmbLibRcbLibRcbRcbRhbLgbRjbRcb
LcbLibLgbLgbLsbLgbLcbRcbRoLsbLsRsbRgbRcbRcbLhbLgLsbRibRcbLibLcLsmbLobR
gLsRsbRibRgbRhbLibRibLsLsmbRibLgbRiRsmbLgbRobLibLjbRgbRobLcbRcbRsbLcbR
sRsmbLcbRiRsmbRobRibRcbRcbRibRcbLibRibRgLsbLsbRgbLjbLibLgbLiLsbRcbLgbR
cbLgbRgRsmbRibRsbRcRsmbRhbLhLsRsbLsbLcLsLsLsRsmmmbLgLsbLcbRsbLcbLibLgb
RjbRibRsLsbRibLibRgbRibRibRcbRsbRiRsmbRcLsbLsLsmbRjbRcbLjbRhbLcbLgbLib
RgbRjbRibLjbRsbLcbRsLsbRjbRiRsmbRgRsRsmmbLsLsmbLsRobRhbRgbRibRcbRebRib
RibRibRibRsbLcLsmbLgLsbLsbLgbLgbLibLgbLsLsmbLiLsLsLsmmbLgLsbRgbLibLibL
gbLibLsbLsbLgbLsLsLsmmbLgbLcLsmbRibRcbLjbLsbLjbLcRsbRgbLcbRibRjbLcRsbL
cRsbRgbLiLsbLgbLsLsmbLibLgbLgbLgbLgbLsRsbLgLsbLgbLgbLgLsbLgbLgLsbLgbLg
bLgbLgLsbLgbLgbLsLsmbLgbLgbLsRsbLgbLsbLgbRsbLgbLcRsbRcbRsRsmbRibLibLib
LgLsbRjbLibLgLsbLgbLsbLgbLgLsbLgbLgbLgLsbLgbLsbLiRsRsmbRibLjLsmbLibRsb
LibLcbLiRsbLibLibLsbLgbLgLsbLsbLgbLgbLgbLgbLgbLgbLgbLsbLgLsbLsbLibLgbL
gbLgbLgbLgbLgbLsbLgbLsbLsbLgbLgbLgbLgLsbRsbRiLsbRibLjbLcbRsbLibLsbLgbL
gbLgLsbRcRsmbLcbLibLsbRgbRjbLsLcbLgRsbLibLibRibRcbRcbLhbLsRsbRcbRgbRib
RsLsbLibRibRgbLcbLcbLsbLgLsbLibRebLibLibRjRsmbLhbLsbLiLsbRcbRcbLibLibL
gbLsbLgbLgbLgbLsbLgbLibLsbLgLsRsbRsbLibLsbLgLsbRsbLiLsbLgbLsLsmbLgbLgb
LgbLgbLgbLgbLgbLgbLgbRgbLgbLgbLgRsLiLsLsmbLgLsbLgbLgbLsbLgbLgbLgbLgbLg
bLibRsbRsbRjbRhbLjbRcbRhbRcbRibRibRcbRibRibRobRebRcbRibRsLsbLsbRcbLcbL
cbRibRiRsmbRgbRgLsbLobLibRgbLibLgbLgLsRsbRsbLgbLsbLgbRibLhbLcbRgRsmbLg
bLgbLgbLobLsbRcbRhbRgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 1; Drug: PCAP2 10 然
bRsbLgRsbLgbRsbRsRsRsmmbLibLgLsRsbLgbRsRsmbRgbLiRsbRsbRsbLhbLgLsbRsbLs
bRjbLcLsmbLcbRsbRsbRsbLhbLiLsbLsbLiRsbRibRibRgRsmbRsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 2; Drug: PCAP2 10 然
bRobLcbLobLebRobRobLsbRsbRsbRsbLebRsRsmbRsbRebLebLcbLebRebRobRcbLobRjb
RebLeLsbLebRobRsbLebLebLebRobLebLsbRobRobLsbRsbRobLobLobLsbRobRcbLsbRo
LsbLebLsbRsbLsbLsbRcbLebLobRsRobRobRebRsbRsbLcbLebRsbLobLobLhbLsbRobLe
bRobLebRobRebRoLsbRsbRsbLsbLebLjbLsbLobLsbRjbLebRebLebRsbRsbLhbLcbLobR
jbRobRsbRobRebRobLcbRsbRebLobLebRsbLebRobRebRsRsmbLobRsbRebRcbLobLsbLs
bRsbLibRobRsRobLsbRsbLjbLjbLgbLsbLebLebRcbRibRebLsbRebRsbLobRebLsbRebR
ebLobLsbRsbLsbRobLebRobLobRebLobRebRoLebRibLibRgbRsbRjbRebLjbLsbRobLsb
LebLebRobLsbRsbLsbLcbLobLobRsbRjbRsbLsbRjbRgbRobRcbRobRobLsbRebRsbLobR
obRsbLsbRsbRcbLobLsLsmbLsbRsbLebLsLsmbRobRsbLsbRsRsmbLgbLcbRsbRobRsbLs
bLobLebRsbLcbRoLjbLsbRobRsbRebLsbRsbLebRsbRcbRebRobLobRcbRsbLsbRsbRsbL
ebRobLsbRibRcbRsbRgbRcbRobRobLobRgbLjbRebRobLgbLcbLgbLebLjbRjbLobLcbLe
bRebRobLebLebLobRebRobRibLebRobRsbLobRsbLebLebLebRsbLsbRobLebRobLcbLsb
RcbLcbRebLcbLsbLsbRebLebLobRobLobLjbLobRebRibLobRcbLebRebRobLhbRobLcbR
ibLebLcbLebLebLcbLsbLibRobRsbRobRgbLebLsbLebLsbRcbLgbLobLsbLobRobRobLs
bLebLobRobLibRsbLibLebLebLobRsbLebLebLebLebRebLobLebRcbLsbLebRibRobLcb
LebLsbLobRibLobLcbRobLcbRebLcbLcbLobLebLebLebRobRsbLjbRgbRhbRhbRsbRgbL
cbRobLobRobRobRsbLjbRobLibLcbRjbRibLibLebLcbRgbRobRsbRobLobLibLjbLobRe
bLgbRobLcbLobRobRibLebLsbRjbRobLebLobLibRobLebLibRobLobRobLibLobRjbRcb
LobLebLobLebLobLjbRobRebLobLcbRobLebRobRobRebLebRjbRjbRobLebLhbRebLibL
ibLobRsbRobLebRebRcbRhbRhbLebLobRebLsbRebRibRebLcbLsbRobRcbLjbRobLobLe
bRebRcbRsbLhbLcbLebLebLebRebLjbLobRjbRobLebLsbLobLebRebRebLebLgbLobRob
RobLjbRobRobLebLobLcbRsbLebLebRsbRobRibRsbRobLcbLebLobLebRcbLgbRebLibL
obLobRobLjbRcbRsbLjbLebRsbRebLgbLcbLobRcbRebRgbLcbRobRgbRebLibLebLcbLe
bLebRjbLjbRobLsbLebRgbLgbLcbRebLebRobRibRebLsbLgbLjbLobRobRobLobLibReb
LobRobRobLobRobLjbLebRibRobRobRcbLobLobLebRcbRcbRibLcbRcbLebRebLebLebL
obLcbRobLibRcbLebLobLgbLebLebLibRsbRobRobRjbLobLibRsbRsbLobRobLebLobLc
bLebLebLebLobLcbRebRcbLibRibLobRhbLcbLobLobLsbRobLsbLebLebRobLobLebRsb
LsbLsbRebLcbRobRebRobRebLsbLgbRebLsbLebRgbLcbRobRebRebLsbRcbLjbRobLsbL
cbRcbRcbLobLcbRebLebLjbLibLsbRobRobLsbRebLjbRibRobRgbRibRcbRsbRebLsbRs
bRgbLibRhbRobRobRebLobRsbRhbLobRobRobRebLebRebLgbLobRjbRjbLsbLebRobRob
LobRibLjbLgbRgbRobRobLsbLebLobRobRebLobLibLcbRibRsbRcbLoRobRebRobLsbLo
bRobRcbLsbRsbLcbRgbLebLebRobRsbRgbRgbLebRgbLobRcbRcbRsbRjbRobLebLcbReb
LobLobRgbRebLsbRsbLobLibLobRebLhbRobRobLcbRsbLobRebRibLebLjbLobLobRobL
obLebLebLebLcbRebLebRcbLobRibLibLsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 3; Drug: PCAP2 10 然
bRobRhRsmbRgbRgbLsbRiRsmbRiRsmbRgRsmbRsbRcbRibRgRsmbRsRsmbRsRsmbRibRgR
smbRibRsRsmbRcbRebRsRsmbLcLsmbRcbRgRsmbRgLobLsRsbLsRsRsRsRsLsRsmmmbRsL
sbRsRsLsRsRsmmbsbRsRsmbRsLsbsbsbsbRsbLsRsLsbsbLsbLsRsRsLsLsmmbsbLsRsRs
mbRsbRsbLsbLsbLsbLsLsmbLebRgbReRsmbLsbLsbRgbRcRsmbRibRjRsmbRiRsmbRsRsm
bRsbRsbLsbRobRsRsmbRsRsmbLsbRsbRsbLjbRcbRsRsmbRiRsmbRcRsRsmmbRgbRsbRsb
LsLsmbRibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 4; Drug: PCAP2 10 然
bLgRsbLjLsmbLsLsLsmmbRiRsmbRsRsmbRsRsmbLgLsbLibLgLsbRsRsmbLgRsLsbLibLi
LsbLsbLiLsbRsRsmbRgbRgbLeRsbLibLsbLgLsbRsRsmbRiRsmbRsbLjLsmbLgbLgbLsbR
iRsmbLebLibLibLsLsmbLsLsRsmbRgRsmbLibLiLsbLsLsLsmmbLcbsbRgbRibRgbLebLc
bRsbRjbRibRsbLjbLcbLhbRsbLhbLgRsRsmbRsbRgbRiRsmbLobLsbLibRsbLgLsbLsRsb
RgRsmbLibRsbRsbLiLsbRsbLsbLsLsmbLibLsbRgbLgbLsbLsbLsbRsLsbLgbLibLsbLsb
RgbLobLhLsbRgbRgbLgbRsLsbLgbLsbLcbLsbsbLsLsmbLgbLiLsbLsLsmbRgbLgbLsbLi
LsbRsbRgbRsbLibLibRsLsbLibRsbRsbLgbLsbLhbRsbRsbLsbLsbLgbLsLsmbLsbLsbLg
bRsbLsLsmbLiRsLsbRsLsbRsbLiLsbRsbRsbRsLsbLcbRsLgbRsbRsbLhbRgbLgLsbReLs
bRibRgbRsbRsRsmbRgRsmbRsRsmbRgRsmbRhbLgbLsbLcbRsRsmbLiLsbLsbLsbLsRsbRi
bRcbRobLgbLsbRsbLgbRcbRhbLsbRhLsbLsLsRsmbLsbLjbLiLsbLsbLgbLsbLsbLsLsmb
LsbLsbLgbLgbLsbLgRsbLsbLsbRsbLibLsLsmbRsRsmbRcRsmbRibLsLsRsmbRgbRibRsR
smbLsbRgbRgbRsLsbRgbLsLsRsmbRsbRgRsmbRgbRsbRgbRsbRgRsmbLebLgbLsbLsbLgb
RsbLsbLsLsmbLsbLsbLsbLibRgbLoLsRsmbLhbLcbLsLsmbLgbLsbLcbRgRsmbLhbLibLi
bLib

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 5; Drug: PCAP2 10 然
bLsbsbsbRiRsmbRsbLsbRiLsbRsRgbRiRsmbRhLsbRgbRgbRibRibRgbRgRsmbRgbRebRg
bRsRsmbLsbRgRsmbRobRcbRgbRibRgRsmbRgbRgRsRsmmbRgRgRsRsLsmmbRgbRgRsmbRh
bLsRsbRgbRgRsmbRcbRcbRsRgRsmbRiRsmbRgbRgbRgbRgRsRsmmbRibRgbRgbRibRgReb
RebRgbRibRibLibLcbLgbLebLgbLeLsbLsbLsbLgbLgLsbLibRjbLsbLcLsmbLcbLgLsbL
sbLgbsbLebLcRsbLebRcbRibLsbRgbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 6; Drug: PCAP2 10 然
bLhLsLsmbLcbLgbLgLsbLiLsbRjbRjbLibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 7; Drug: PCAP2 3 然
bLgbLgbLgbLsbLsLsmbLgbRgRsmbRgRsRsmmbRsbRgRsmbRgbRsLsbRibLsbRibRibLiLs
bLjLsmbRibRgbLsbRgRsmbsbRgbRsbRsbRsRsmbRgbRsRsRsmmbRsRsmbRgbRsbLsbLsbR
sbRgbLsRsbRgRsmbLsbLsLsLsmmbRibLgbRsbRibLebRgbLsbRsbLsbsbRgbRsbRsRsmbL
ebLsbLgbRjRsmbLsLsRsmbRsbRsRsmbLsbLsbsbLsbsbRjbRjbRsbRgbLsRsRsmbRsRsmb
LgbLsLsLsmmbLibLsbLsbLsbRsLsRsbRsbLibLgbLibLgLsbLiLsbLjbRiRsmbRsbLsbLi
bLgbLsLsmbLsbLsLsmbRjbRcbRsbRgbRsRsRsLsmmbLsLsmbLsLsmbRsRsRsmmbRsbLsbL
ibLsbRibRsRsRsmmbLiLsbLibLsbLibLgbsbLsLgbLsLsmbLsbLsbRibLhLsbRsLsbRsbL
sRsbRsbRsRsmbRgbRjbLjLsmbLibLcLsmbLcbLgLsbLsbRjbLjLsmbLsLsmbRsbRsbRjbL
ib

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 8; Drug: PCAP2 3 然
bRgRsmbRgRsmbRgbRiLsLsmbRgbRgbRgbRiRgbRgbRgbLsLsmbRsbRibRgRgRsmbRgbRgR
ibRgRiRsmbRgbRgRgbRgRsRsmmbRsRsRhmbLibLebLibsbLgLsbLgLsbLgLgbLgbLgbLsL
smbRebRgbRsbsbRgbRgRsmbRibRiRsmbRgbRgRsLsmbRgRsLsmbLibLibRcbRgRsRsmmbR
sbRsRsLsmbLibLoRsbLibRcRsmbRsRgbRsRsmbRsbRgbLsLsmbRgbLsbRsRsmbRgRsmbRg
bRgRsmbRgbRgbRhbRcRsmbRcbLcbLiLsLsmbRsbRcbLsRsbRgLsbRibRgLsbRgRiRsmbRg
bRgbRibRgRsmbRgRsmbRgbRobLcbLibLgLsbsbRobRibRiRsmbRibRgRsRgmbRgRibLsRg
bRgRsmbRgRiRiRiRsmbRgRsmbLsRgbRgbRgbRsbRgbRgRsLsmbRgbRsRsmbRgbRgbRgRgb
LcbLibLibRjbRebRgbRgbRibLgRsbRgLsbRgbRiRsRsmmbRsRsRsmmbRgbRgRsRsmmbRgb
RgbRgRiRsRgRsRgRsmmmbRsRsmbRibRgRsmbLcbsbRibLiLsbLgbRoRsmbRgbRgRsRsmmb
RsbRgbRgRsmbRgbRgbRgRsmbRsbRgbRgRsLsmbRgRsmbRgRsmbRgbRgbRgRsmbRsRsmbRg
bRgRsmbRgRsmbRgbRgRsmbRgbRgbRgbRgbRgRsmbRsbLobLibLiRsbLibReRsLsmbRgbRg
RsRsmmbLgRsbRsRsmbLcLsmbLgbLoLsmbLjbLcbLsLsmbLsbLsbRgRsmbRgRsmbRgbRsRs
mbRiRgbRgbRgRgRsRsmmbRiLsbRgRsmbRgRsLsmbRgLsbRsRsmbRgRsmbRgbRgbRibRgbR
gRsmbRibRcRsmbLhRsbLibsbRoRsmbRsbRsRsmbRgRsmbRgRsmbRgRiRsmbRibRiRsmbRg
bRcRsRsmmbLcbLgLsbLibLsLsRsmbLobLsRsRsmbRibRgbRgRiRiRgRsmbRibRoLsLgbLi
bLgbLgLsbLgbLgbLgbLgbLiRsLsbLsbLiLsbLgLsbLgbLgbLsbLgbLgbLgLsbLgLsRsbLg
LsbLgLsLgRsbLsLcbLcbLsbRiRsmbRgLsbRgbRsbRsRsmbRsbRibRsLsbRibRoRsRgmbRh
RsmbRsbLgbRsbRibRgbLsRiRsmbRgbRibRsRsmbRibRcbLibLgbLibRcbRibRgRsRsmmbR
ibRgbRibRgRsmbRsbRiRsmbRgRiRiRsRsRgmmbRgbRhbLgbRhbRcbRsbLhLsbLgRsbLsbL
ibRsbLibsbRobsbRgbRiRsRhRsmmbRiRibRiRsmbRiRsmbReRsmbRgbRgLsLsmbLgbRobR
cbLsRsbLiRsbLiLsbLgbLgbLcbRsbRsRsLsmbRgbRibRgbRsRsmbRgRibRiRsmbRgbRiRs
mbLcbLibLibLgbRcbRibLsbRiRsRsmmbRiRsRiRiRsmmbRgRsmbRiRsmbRsRsmbLcLgbRe
RgRgbRsbRiLsbRgbRgRsmbRgRsRgmbRgbRibLgbRgbRiRsmbLsRsbRgLsbLsbRgbRgLsbR
sRsmbRibRgbRgbRgRsmbRgRsmbRgbLsRsbRgRsmbLsbsbLsbLjbRgLsbRibLgRsLsbRsRs
mbLgbLgbRibRsbLjbLiLsbRibLsbLjbLgLsLsmbsbRgbRsbLsRsbLsbLsbRjbLsbRibLjb
LgbRsbLsbsbRgbsbLgbLsbsbRgRgbRibRsRsRsmmbRsbLsbRsbRsRsRsRsmmmbRsRsRsmm
bRsRsRsmmbRgbRgbRsRsRsRsRiRsRsmmmmmbLsLsLsRsmmbLsRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 9; Drug: PCAP2 3 然
bsbRsbLjbLcbLibLgbLgLgLsRsRsmbLsRsbLibLgbRcRsmbRibRsbLebLsbRjRjbRcRsmb
RsbRiLsbRgbRiRsmbRibRgbLhLsbLgbLgLsbLsLsmbLsbLgbLsLsmbLhbLgbLgbLgbLgLs
bLsLsRsmbLibRsLsbLibRsbRebRibRsbRsbRgbLsbRibRgbRsbRsbRsbRsbLsbRibLsRsR
smbRsbRsbRibLsbLsbRgbLsLsmbLjbLibLsbLgbLibLiLsLsmbLgbLsbLsbLibLgbLibLg
bLsbLsbRgbRibRgbRcbRibRgbLgbRebRgbRibLgbRibRibRgLsbRgbLgbRgbRiLsbLgRsR
smbRibRgbRgRsmbRsbLsbRsbRgbRgbRgbRsbRgbRgbRgRsmbRsbRgbLsbRgbLsbRibLjbL
ibLgbLgbLibRjbRibRgbRgbRgbRibRebRgbLgbLibLibRgbLcbRgbLhbLsbLgbRgbLgbLg
LsbLgbRsbRjbRibRgRsLsmbLsbRibLgbRgbRsbLebLcbLibLiLsbLiLsLsmbLeLsbLibLi
bLgbLgbLgbLibLcbLibLgbRiLsbRgbLsbRgbRsbRibRsbLibRibRgbRibRgbRibRgbLgbL
gbLsbRcbLsbLsbRsbRgbRibRsbRsbRsLsbRibRgbRsLsbRsRsmbRgbRgbRsRsmbRsbRgbR
gbRsbLsbLjbLsRsbsbRibRgRsmbRsbRgbRgbRgRsRsmmbRsRsmbRsbRsbRgbLsbLhbLibR
eRsmbRhbRibLcRsbRcbRiLsLsRsmbLsbRhbRibRgbRgbRsbRgbRgbRgbRgbRgbRgbRgbRs
bLeRsbLiLsbLgbLsbLgbRcbRiRsmbLibRgbRibLiRsbRibRsLsbRgRsmbRgbRsRsLsmbRg
bRsbRsLsbRsbRgbRgbLsbRgbRibRgbRgbRgRsmbRsRibRgbLhbLcLsmbLcbLiRsLsbLgbR
ibRsRsmbRsRsmbRsbRsRsmbRsRsmbRgRsmbRsbRgbRgRgRsmbLjbRgbRgbRgRsmbRsbRsb
RgbRgRsmbsbRsbRsbRgbRgLsbRsbRsbRsbRsbRsbRgbRsbRgRsmbLsbRibRcbRhbRiRsmb
RibRgRsmbLsRsbsbRibRsRsmbLsRsbLsRsbRgLsbLsRgbRsbRsRsmbRsbRsbRsbRsbRsLs
bRsRsmbLjbRsbRibRsbLjbRhbRsbLsbLsbRsbRiRsmbRgRsRsmmbLjbRsbLcbLibLgbLgL
sbLsbRgbLibLsbLgbLgbRjbRibRgbRibRgbRgbLgbLgbLibLcbLiLsbLsLsmbLgbLcbLsb
RibRhbLhbLibRsbRhbRhbRcbRibRhbLsbRhRsmbLsbLgbLsRibLsbRsbRsbRsbLhbLibLg
bLgbLgbLsbLibRebRgbRgbRsbRsbRgRsRsmmbRiRsmbRgbRgRsmbRgbRgbRsRsLsmbRiRs
mbRgbRgbRgbRsbRsbRsbRiLsbLgbRsRibRiLsbRibRgbLgbLcbLsbRsbRgRsmbLhbLibLs
bLgbLsbLsbLgLsbLgbLgbLgbRsLsbLgbLgbLhbLsbLibLcbLibLsbLsbLsbLibLsbLgbRs
bLibLsLsmbLibLgbLcbLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 10; Drug: PCAP2 3 然
bLsbLgbLgbLsbRsbRsLsbRsRsmbRibRibLhLsbLsbRsbRsbRgbRgbLibRsRsRsmmbRsbsb
LsbRsbRsRsmbRsbRibRgbRgbRibRgbRgbRgbRsRsmbRibRsRsmbRsRsmbLibLgbLibLsbL
sbLsbLiLsbLgbLgbLgbLgbRibLgbLgbLgbLsbLibLsLsmbsbLsbRsRsmbRsbLibLiLsLsm
bLgbLsbLsbLsbLgLsbLsbRgbRsbRsRsmbLibRsRsRsmmbRsbRsbLsbRgbRsRgbRgRsmbLs
bLebLgbLgbLsbLiLsRsbLsbRgbLsbLibLibLsbRsbRsbLsbLibRsbLgLsbLsbLgbLiLsbL
gbLsbLgbLibLgLsbLsbLgbRsbLibLgbLsbLsbLgbLsbLsLsmbLgbLgbLgbLsLsLsmmbLsL
smbLsLsmbLsbLsbRsLsbLsbLgbLsbLsRsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 11; Drug: PCAP2 3 然
bRibRibRgbRsRgLsbRsbRgbLibRibRgbLsbsbLsbRcRsmbRiRsmbRibRsbRsRgbRibRibR
gbRsLsbRibRsbRsbRibRibRgbRsbRsRsmbRsbRgbRsRsmbRgbRgbRsbLgLsLsmbLgLsbRs
RsmbRsRsmbRsRsmbRgbLsbLsbRgbRibRsbRsbRiRsmbRsbRibRsRsLsmbLsbLjbLiLsbLs
bReRsmbRibRgRsmbRsbRiRsmbRsRsRgmbRsRsmbRibRsRsmbRiLsbRsbRcRsmbRibRsbRs
bRibRgbRjRgbRsRsmbsbRsbRgbsbLsbLsbRgbRsbLsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 12; Drug: PCAP2 3 然
bRsbRsbRgbRsRsmbRgRsmbLsbRsRsmbRsbRsbRgRgbLsbRgRsmbRsRsmbRgbRgRsmbRgbR
gbRgbsbRsbRsbRgbRsbsbsbRgbLsbLgbRgRsmbRgbRgbRsbRsbRgbRsRsRsmmbRgRsmbRg
RsmbRgbRgbRsbRgRsmbRgbRgbRsbRgbRgbRsbRgbRsRsRsmmbRsbRsbRgRsmbRgbRgbRgb
RgbRsRsmbRsRsmbRgbRgbRsbRibRsbLsbRgbRsbLjbLsLcLsmbLibRhbLiLsbLjbRsbsbs
bLgbLsbLgbLsbRsbLibRjbLhbRjbLgbLgbLibLibLibRsbRgbRgbLgbLsbLsbLcbLcbLgb
LsbRgbRsbRgbLcbLgLsbLgbLgLsbRsLsbsbLsbLgbLgbLgbLsbLgbLgbLsbLsbLsbLgbLs
bLgbLgbRsbLgLsbLgbLgbLsbLgbLgbLsRsbLjbRsbRsbRjbRcbRiLsbRsbRsbLsbRgbRgb
RgRsmbRsbLsbRsbLsbRgbRgbRsbRgRsmbRgbRsRsmbRsLsbRsLsbLsbRsRsmbRgRsmbRsb
RgRsRsmmbLsbRsbRsbRgRsmbRgbRgbRgbRsLsbRgbRsbRsbRsRsmbRgbRgRsmbRgRsmbRg
bRsbLsbRsRsmbRsbRgbRsbRgRsRsmmbRgbRgbRgbRgbLsLsmbLsRsbRgbRsRsmbRgRsmbR
sRsmbLsRsRsmbRgRsmbRgLsbRgbRsbRgbRsbRsbRsLsbRsbRsbRgRsmbRgbRsRsmbRsbRg
bRgbRgbRgbRgRsmbRgbRsbRgRsmbRsRsLsmbRgbRsbRsbRsRsmbLsbRgbRgbRgbRsbRgbR
gbRibRgbRgRsmbRgbsbLsbsbLsbLsbRsbRsbLsbRsbLcRsbRcbLcLsmbRgbRsbLgbRsLsb
RebLsRsbsbRsbLjbRibLgLsbLsbLgbRgbRcbRibRsLsbRgbRsRsmbRgbRsbRsbRgbRsbRi
bRsbLsbRsbRcbRgbLsbLsRsbRgbRibRibRsbLgbLsRsbRgbRhbRhbRcbRebRcLsRsbRebR
iLsbLgbLcbLgbLsbRsbRobRebRhbRhbLcbLobLiRsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 13; Drug: PCAP2 1 然
bRsRsmbRgbRsbRjRsRsmmbLjLsmbLjLsmbRibRcbLcbLibsbLjLsmbRsRsmbRhbRcRsmbR
ebRsRsmbRhRsmbRcRsmbRebRgRsmbRcRsmbLjLsmbLgbLgRsbLsbLgLsbLiLsbLgbRsbRg
bRgbRibRebLgbRsbRsbLcbLgbLiLsbRiRsRsmmbRibRgbRsbReRsRsmmbLgbRibLsbRgbR
iLsbRibRgbLsbLgbLibsbRgbLobLibRgRsmbRgbRsbRsRsmbLjbRibRsbLsRsLsbRgbLcb
LibLibLgbLsbRsbRsbRgbRjRsmbLsbRgbRibLsbRgLsbRgbRsLsbLsbRibRgbRibRsbLib
RsLsbLsbLibRsLsbRebRcbLgLsbRibLsbLsbRhbRsRsmbRsLsbLsLsLsmmbRibRgbRgbRs
bRgRsmbRgbRhbRgbLibLsbRibRibRsLsbLsRsbRsbRsbRsbRgLsbRgbRsRsmbLgbRgbRgb
LibRsbRjRsmbRjRsmbRibRsbLsbLsbRsbRjRsmbLibLsbLsLsmbRsbRsbLsLgbLgbLgLsb
LsbLsLsmbLsbsbsbLjLsLsmmbLsbLsbRsRsmbRsbRsbLgRsbLsbRjbLsbRcbsbRhbLgbLs
bLsLsLsmmbLsbRhbsbLsbRsbRsbRibRsbRsbRsRsmbRgbsbRsbRibLjLsmbRhLsbRiRsmb
LgbLsbRibsbLsbRgbRsRsmbRgbRibRibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 14; Drug: PCAP2 1 然
bRibRibLsbRibRgbRibLsbRibRjRsRsmmbRsbLsbLsbRibRsbRgbRsbLebLgbRsbLibLgb
LgbsbRjbLgbLgbLgbLgbRsbRgbRgbLibLgbLsbLsLsmbRgLsbLibLibLgbLsbRsbRsbLcb
LgbRsRsmbRsLsbRgbRsRsmbRsbRibLebLsLsmbLsLsmbLgbLsbRsRgbRsbRibRgRsmbRsb
LgbLsLsmbLsLsmbLgLsLsmbLsbLsbRsbRgRsmbReRsmbLsbRsRsmbRgbLgbLgLsbLsbRgb
RiRsRsmmbRibRgbRsbRibRgRsRsmmbRgbRsbLsbLgbRcbRsRsmbRgRsmbRgbRgRsmbRsbR
gbRsbRsRsRsmmbRgbRsRsmbRibRjRgbRgbRgbRgRsmbRibLsLsmbLsbLibLgbLsbsbRsRs
mbRjbLjbRebRsbRiRsmbRgRsmbRgbRgRsmbsbLgRsbLsbRibRjRsmbLgLsbRiRsmbRsbRs
RsmbLsRsbRjRsRsmmbRibRgbRgbLjLsmbRgbLsbRsbLsLsmbLsbRibLjLsmbLibRsbRiRs
mbRibRibRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 15; Drug: PCAP2 1 然
bRgbLsbRgbRibRsbRgbLgbRjRsmbRoRsRsmmbLibRhbRoRsmbRebLgbRibRgRsmbRgbRgb
RgRsmbRgbRgbRgbLjbRibRgbRgbRgRsmbRgbRgbLsLsmbRibRgRsmbLgbRiRsmbRgLsbRg
bRgbLgLsbRiRsmbRgbRgbRgbRsbRgLsbLgbRgbRgbRsbRgRsmbRibRsRsmbRiLsbRsbRgR
smbRgbRgbRgbRgbRsbRibRgbLsbRibRgbRiRsmbLsbRgbRiLsRsbRgbRgbLsbRiRsmbRsb
RiLsbLgbRiRsmbRsbRgbLsbRsbRiRsmbRsbLsLsmbRibRgRsmbLsbRgbRsbRgbRsbRibRg
bRsbRgbRsbRgbRsbRgbRgRsmbRgbRiRsmbRsbRsbRibRsbRgbRgbRgbLjbLhbLcbRebRib
RgbRibLibRiLsRsbLsbRibRgRsmbRgbRgbLgbRgbRgbRgbRibRgbRsbRgLsbRsbRibRsbR
gRsmbRgbRgRsmbRgbRibLibRibRibLsRsbRiRsmbRsbRsRsmbRibRgbRgbRgbRgbRsLsbR
ibRiRsmbRiRsmbLjbLcbRsRcbRhbRsbRibRgbRhbLiLsbRibLsbRiRsmbRsLsbRibRsbRi
bRgRsmbRiRsRsmmbRsbRgbRgbRgbRibRiRsmbLcRsbRcbRobsbLebRgLsbLsbLobLgRsbR
iRsmbRibRiLsbRibRsbRgbRgbRibRsbRiLsbReLsbLibLgRsbLibRjbRobLibLgbRibRgb
RibLsbRhbRibRhbRibRibLjbRjbRibRgbRibRsbRgbRsRsmbLgbRibRgbLsbRsbRgbRgbR
gbRgbLgRsbRibRgbRibLsbRibRgbLcbLhbLibRcbLcbLhRsbRhbRiRsmbRiRsmbLsbRsbR
ibRsRsmbLcbLibLibLibLgbRgRsmbRibRgbRiRsmbRgbLsRsbRgbRgbLsbRgLsLsmbRibR
sbLsbRgbRgRsmbRsRsmbRgbLsbRibRsRsmbRibRsbRgRsmbLsbRgbRgbLgbRiRsmbRsLsb
RiRsmbRsbRibLgbRiRsRsmmbRsbRiLsbLjLsmbLjbLhbRjbRhbRibRibRgbRgRsLsmbRsb
RgbLoRsbLgbRibRiRsmbRibLgbRibLgbRhLsbLgbRiRsLsmbRgbRsbRsbRgbRsLsRsbRgb
RgRsmbRgbRgbLsRsbLsbRiLsbRsRsmbLgbRibRgbRgbLsRsbRgbLsbRgbRsRsmbRgbRsbR
gRsmbRgLsbRgbRsbRgbRgbRsbLsbRibLgbRgbRgRsmbRgbRsbRibRgbRgbRiRsmbRgbLgb
LhbLobLibRiRsmbRhRsmbRibRibRgbRgbRsRsmbRiRsmbLsbRgbRgbRsbRgbRsbRgbRsRs
mbRgbLgbRibLgbRibLsbLgbRiRsLsmbRsbRibRgbLjbLjbLcLsmbLiLsbLibLibRcbLibR
ibRibRsbRibRsbRibLgbRgbLsbRgRsmbRgbRgbRibRgbRgbRgLsbRgbLgbRibLsbRibRsL
sbRibRgbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 16; Drug: PCAP2 1 然
bLcRsbLebLgbLebLhbLgLsbRiRsmbLgbRsbRgbRgbLebLiLsLsmbLebLebLeLsbLgRsbRc
bLsLsmbRgRsmbRsbLobRsbRgbLsbRgbLsRsbRsbRgbRsRsmbRgRsmbRsbRsRsmbRgbLsbR
sbRgbLsbLebLcbLsbLgbRsbRsbLiRsbLsbLsRsbRsbRsbLsbRsbRsbRgbLsbRsbRgbLsbR
gbRgbRhbLsRcbLcbRcRsmbRjbRsbRiRsmbRgbRsbRsbRsbRsbRgRsmbLsRsbRgbLgbRgbR
gbRsbRgbRgLsbRjRsRsmmbRgRsmbLsbLibLiLsLsmbLgbLgbLeLsbLebRcbLcbLgbLsbLg
bLjLsLsLsmmmbRibReRcbLsbLiLsbRiRsmbRcbRgLsbLsbRiRsmbRobLsbLgbRsbRgRsmb
RsbRgbRsbRsbRsRsRgmbRsbRsbRsbRsbRsbRgbLcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 17; Drug: PCAP2 1 然
bLsbLgLsbLgLsLsmbLgbRsbLibLibLhbRgbRgbRcbLibRsbRcLsbLgbLjbLibLgbRsbLgb
RebLjbLiLsbLgRsbLgbLsbLgbLgbLsbLgbLgbLgbRsbLibLsbLgbLgLsbLsbLgbLgLsbLg
bRsRsmbLibLgbLgbLsLsmbLgbLsbLgbLgbLsbLgbLgLsbLsbLgbLgbLgbLgbLgbLsRsbLg
bLgbLsbLiRsbLsLsmbRibRibRgbLcbLgbLsbLgbLsLsmbLgbLgbLgbLgLsbLgLsbLsLsmb
LgLsbLgbLsLsmbLsLsmbLiLsLsmbLgLsbLibRjbRcbRiLsRsbRgbRgbLcbLiLsbLgLsbLs
bLgbLgbLsbRsbLgbLgbLgbLsLiLsbLgbLgRsbRgbRjbRiLsbRibLobLibRsbLhLsbLsbLi
bRgbLibRebRibLcLsmbLhbLsbLsbLibRsbLsbRsbLibLsLsmbLgbLgbLsbLgbLgbRjRsmb
RiLsRsbLjbLebRebRibLsbLebLsbLibRjbLibLgLsbLgbLgLsbRsRsmbLgbLibRhbLhRsb
sbsbRgbLsbLgbLgRsbLgbLgLsbLgbLibRhbRcbRgRsmbLcbRsbLibLsbLgbLsbLgbLgLsb
RgbLibLgbLgbLsbLgbRsbLgLsbLgbLgbLgbRsbLgLsbRhbRibLcbRgbLibLgbRsbLgbLgL
sbLgbLsbLgbLgbLgbLsbLgbLgbLgbRsbLibLgLsbLsbLgbLgLsbLgbLsbLgbLgbRsLsbLg
LsbLgbLsLgLsRsbLsbLgbLgbLsLsmbLgbLgLsbLgbLsRsbRsbLibLgbLgbRsbLibLgbLsL
smbLgbLgLsbLibRgbRhRsmbRiLsbLhbLcbRsbLebRsbLibLgbLsbLgLsbRgRsmbLibLsbL
gLsbLgLsbRsbLibLsbRsbRibLcbLiLsbLsbRsbLiLsbLgbLsbLsbLgbRsLsbLgbLsbLsbL
gLsbLibRgbRjbsbRibLgRsbRibLjLsmbLcbRjbRcbLobLibRgbLcbRsbRgbLhbLsbLsbLg
LsLsmbLsbLgbLgbLsLsmbLsbLgbLgbLsbLgLsbRcbRgbRibLcbLibLsLsmbRgbLibLsbRs
bLiLsbLsbLibLsbLibLsLsmbLsLsmbRsbLgbLsLsmbLgLsbRsbLgbLgbLsbLgbLgbLgRsb
LgLsbLgbRsbRcbLcbLgLsbRsbLsLsmbLsbLgbLsLsmbLgbLgbLgbLgbLsLsmbLibLibLsb
RsbLibRsbRebRgRsmbRibRcbLgbLgbLgLsbLhLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 18; Drug: PCAP2 1 然
bLjbLhbLcbLjLsmbLsbLsLsmbLibRgRsmbRsbLgbRgRsmbRsLsbLgbRjRsmbLgbLcbLcLs
LsRsmmbLsbRsbLiLsbLibRjRsmbLsLsmbRgLsbLsbLgbLsLsmbLcbLibLgLsRsbLgbRgRs
mbLgbLibLsbLsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 19; Drug: Control
bRibRgbRsbLsbRsRsmbRsbRsRsmbRsbRsbLsbRsbLsbRgbRsbRsbRsbRgbRgbRsbRgbRsb
RsbRsbRsbLgbRsLsbLgbLibLgLsbLsbLgbLgbLibRsbLsbLgbRsRsmbLgbLgbLgbLgbLsb
LsbLgLsbLsRcbLibLgbLsbLibLcbLobLsbLsRcbLjbLibRgbLgbLgLsbLsbRiRsLsmbLcb
LhLsbLibLobLibRibRsLgbLgbRjbRgbRgRsmbRgbRgbRsRsmbRgbRsLsbRsbRsbRsbLsbR
sbRjbRsRsmbRsbLsbRgbRgbRsbRgbRgbRgbRgbRsLsbRsbLgbsbRgbRsRsmbRgRsmbRsbR
sbRgbRsbRgbRgbRsbRgbRsbLsbsbRsbLsRsbRsbRsbsbRsRsmbRsbRsbRsbRgRsmbRgbRs
bRgbRsRsmbRgbLjLsmbRibRsbLjbRibLgLsbLcbRsbRgbLsbRhbLcbRibRgbRibRgbRsbL
gbRsbRsLjbReLsbLjbRjbRibRsbRsbLjbRjbLcbLsbLgbRsbLsLgbRsbLiLsbLibLsLibL
jbRibRibLjbLebLcbRsbRjbLcbLiLsbRgbLgLsbLsbLgbRjbLgbLgbLhbRibLjLibLibRg
bLibLgbRgbLgbLgbLgbLsbRcbLebRsbLibRcbRhbLgbsbLjbLsbLgLsbLsbLsbLgbLsLsm
bLgbLgbLsbRibsbRcRsRsmmbLibLiRsLsLsmbRhbRhbLibLhLsbLibLgbRgRsmbLhLsbLs
bLsbsbLcbRibLibRsbLgbLgbLgbLsbLgbLgbLsbLgRsbLsbRsbRgbsbRibLsbRgbRgbRgR
smbRsbRsbRsbRibRcbRhRsmbLibLibLgbRhbLibLibLsbLhRsRsmbRsbRibRcbLsbRgbRi
bRibRgbRgbRsbRgbLgRsbLgRibRiLsbLcLsmbLibLsbRjbLibRcbRibLgbRgbRibLgbLcb
LcbLsRsbLsbRgbLgLsbLgbLgbLgbLobLcbLibLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 20; Drug: Control
bLgbRsbRsbLibLgLsbLgbLgbLgbLgbLgLsRsbLgbLgLsbLgbLgbLgbRsbLgbsbLsbRsbLi
bLibLgbLgbLsbLsbLgLsbLgbLgbRsbLibLgbLsbLgLsbLibLsbLgbRsbLgbRsbLgbLgLsb
LgbLgLsbLsbLgRsLsbLibLgbRjbLiLsbLgbLsLsmbLgbLgbLgLsbLsLsmbLsbLgbLsbLgb
LgbLgLsbLgbLgLsbLgbLgbLgbLsLsmbLibRjbLibLgbLsbLgbLgbLgbLgRsbLgLsbLjbRs
bLsbLgLsbLgbLsbLgbLsLsmbLgbLgbLgbLgbLgbLgbLsbRsLgbLsbLsbLgbLsLsmbRsLjb
LsbLsbLsbLgbLsbLgbLgbLgbLgbLsLsmbLgbLgbLgbRsbLgbLsRsLiLsbLsbLgbLgbLsLs
mbLsbLsbLibLgbLgbLgbLibRsbLibLgbLgbLgRsbRsbLhbLgbRjRhbRgbRiRsmbLgRebLg
LsbRiRsRsmmbLcbLiLsbRsLsbLibLgbLgbLsRgLsbLgbLsbLsbLsbLsbLgbLgbLgbLsbLg
bLsbLgbLgbLsLsmbLsbLsbLsbLgbLgbLgLsLsmbLgbLsbLgbLsbLgbLsLsmbLgbRsLsbLg
bLsbLsbRsLsRsbRgLsbLsLsmbLsbLsbLsLsLsRsmmbLgbLgLsbLsLsLsmmbLgbLsbLgRsb
LjbLsbLgLsbsbLsbLsLsmbLgLsRsbLsLsmbRsbLsbLsbLgbLgbRsbLsbLsLsmbLgbLsLsm
bLgbLsbLibRsbLgbLgbLgbLgbLgbRgbLibLsbLgLsbLgLsLsmbLgbLsbLsbLsbLgbLsbLi
bLgbLsbRebRibLgLsbRcbRcbLsbRibLsLsmbRcbRsbRibLgbRiRsmbRsbRibRibLgbLgbR
cbLsbRibRcRsmbLibLebLcbLsbRibLobRsRsmbRibRibRgbRgbRsbRibLjbRibLgbRsRib
RobLiLsbLibLibLgbLsbLjbRgbLjbLgbsbRgLsbLiLsbLsbLgbLsbLsbLgbLsLsmbLgbLg
bLgbLsbRsbLsbLibRsbsbLjbLsLsmbLsbLgbLgLsbLgbLgbLgbLgbLgbLgRsbLsbRsbRsb
LjbLsbLgbLgbRsbLsbLsbLgbLsbLgbLgbLgbLgbLsbLsbLgbLsbLgbRsbLsLsmbLsLsmbL
sbLsbLsbLgLsbLgbLgbLgbLgbLgbLgbLsLsmbRsbLgRsbLsLsmbLgbLjbLsbLgbLgbRsbL
sLsmbLibLgbLgbLgbLgbLgbRgbLgLsbLgbLsRsbLsbLsbLsbLsbLsLsmbLgbsbLgbLgbLs
bLgbLsLsmbLibLgbLgbRsLsbLgbLgbLgbLgbLsbLgRsbLgbLgbRgbLgLsRsbLgbLgbLsbL
sbLsbsbLsbLgbLsbLgbLsbLgRsbLgbsbLsLsmbLsbLsLsmbLsbLgbLgbLibLgLsbLgbRgb
LibLgbLgLsbRobLsbRcRsLsmbLgbRobRsLsbRobLsbLgbRcbLgbRibRgbRgRsmbRsbRibR
gbRgRsmbRgbLsbRsbRgbRgbRsbLgbRibLsbRiLsbLsbRcLsRsbLiLsbRobRgLsbRgRsRsm
mbRcbLsbLsbRibRgbRgbRiLsbLiLsbRcLsbLgbRobLsbLsLsmbLibLgRsbRgbLhbLsbRsb
RcbRibRhRsmbRibLebLiLsbLgbRebRsbRhbLgRsbRibRsbRsbRgbRsbRgLsbRgbRgbRsbR
gbRsbRibLibRiLsbLgRsbLgRsbRibLibLibLgbLsbLgbsbRsbLgLsbLgLsbLgbsbLsbLib
LgbLgbLgbLgbRsRsmbLibRcbRsbRibLjbRibRibLgRsbRgRsmbRibRsRsmbRgbRiLsRsbL
gbLjbLibLsbLgbLgLsbRgbLgbLiLsbLgLsbLsbLgbLsbLgbRgbLgLsbLgbLgbLsbLgbLsb
LsbLsbLsbLsbLsbLgbsbLsbLsbLsLgbLibLgbLsbLgbLgbLgRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 21; Drug: Control
bLgbRibRgbRgbRgbRgbLsbRgbRgbRgbRsbRgbRsbRgbRsbRgbRsRsmbRgbRgbRgRsmbRgb
LsbRiRsmbRgbLibLobLgbLibRjbLgbLgLsbRjbLcRsbLgbRsbRibRgbRgbLjbRgbRgbRgb
RsLebRiLsbRibRgbRsbRgbRgbRgbRsbRgbRgRsmbRgbLgbRibRgRsmbRsbRgRsmbRgRsmb
RsbRgbLsbRsbRsbRgRsmbRgbLsbLcbLibRcbRgRsmbRsRsmbRgbLgbRjLsbLcbLcbLibRi
bLgbRjbRhbRsbRgbRgRsmbRgbLjbRcbRibLibLsbRobRcbRibRgbRibRgbRgbRsbRgbRgb
RgbLgbRcbLhbLsbRhbRsbRgbRsRsLsmbRgbRgbRsbRsbRgbRgbRgbRgbLgbRibRgbRgbRg
bRibLiLsbLsbRiLsbRibRsbRgbRsRsmbRsRsmbRgRsmbRgbRsbRgRsRsmmbLsbRgbRgLsL
smbLsbRgbLcbLcbRgbLgbLsbLgLsbRsbLgbLgbLsRsbLsRsbLibRibRjbRibRgbRsbRsbR
sbRgbRgRsmbRsbRgbRsbRsbRsRsmbRgbLgbRgbRgbLsbRsbRgRsmbRgbRgbRgRsmbRsbRs
bRgbRsRsmbRgRsmbRsRsmbsbRgbRsbLjbLiLsbLjLsmbRjbLhbRiRsmbRcbRgbRibLgbRs
bLgbRcbLsLgbLcbLibLhbRibRsbRcbRcbLgLsRsbRgbRibRgbLgbLjbLjbLhbRsbLiLsbR
gbLcbRgbLgbLibLsbLsbLsbLsLsmbLsbLgbLsbLsbLgbLsbLgbLgbRjbLibRibLcbLhbLi
bLjLsmbRibRjRsmbRgRsmbRjRsmbLhLsbRgbRgbRgRsmbLgbRjbRgRsmbRibLibLgbRibR
gbRgbRsRsmbLgbLgbLcbRsRsmbRsbLcbRsRsmbLcbLsbRgbLgbLsbLsLsmbLsbLibLcLsm
bRgbRgbRgbRgRsmbRgbLsbLsbRgbRsRsmbRgRsmbRgbRhbLgLsbRibRibLibLgLsbLsbRj
bRcRsmbLjbRcbRibRgbRgRsmbRgbsbLsbLjLsmbRjRsmbRsRsmbRsRsLsmbRibRgbRgRsm
bRgbRgRsmbLgLsbLgbRibRibRgRsmbLgbLjbLhbRjbRhbLgbRhbLsbRgRsmbRgbLsbLgLs
bRgbRiRsmbRsbLsbLibRcbLcbLhbLgLsRsbRsRsmbLibRjbRgbRgbLcbLibRjbLibLibRs
bRsbLgbRsbLgbLsbLsLsmbRgbRsbsbsbRhbLsRibRsRsRsRsmmmbRgRsmbRsbRgbLsbRib
RjRsmbLebLibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 22; Drug: Control
bLsLsLsmmbRibsbRiRsmbRibsbsbRiLsbRgbRgbRsLsbRibRgRsmbLgbLsbRibRsRsmbRs
RsLsmbLsbLgbRcbRibRgbRgbLibsbLibLcbRibRibLhbLibLcbLsbLgbLgbLoRsbRgbRcb
RhbRibLgLsbRgbRibRgbLjLsLsmmbRgbRibRsRsmbRgbLcbLibLsLsRsRsmmbRsbRcbRcb
RgbRgbRsbRgbRgbRgbLjbLsbRhbRgbsbRgbRiLsbRibLgLsbRcbRgbRibRiRsmbRibLcbR
hbRcbRibRsbRibRsRsmbRgbRgbLgbRibRibLgLsbRsbRgbRgbRsbRgRsmbRibRgbRgbLiL
sbRcbRibRgbLgbLjLsLsmmbLjbRibRgbRibRsRobLibLobRgbRibRcbRibRsbRgbRgbLjb
LgbRoLsbRibRiRsLsmbRibRgbRgbLgbRsbRgbRgRsmbsbRibRjRsmbRibRibRibRsbRibR
jbRsRsmbRsbLgLsbLsbRobRsRsmbRibRjRsmbRsRsmbLsbRgbRcbRcbRibRibRgbRibLsb
LgbLsLsmbRjbLibLsbRsbLgbLcbRgRsmbRsLoLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 23; Drug: Control
bLhbLibLhbRcbLoRsbLibLibLibLgbRhbLiLsbLibLsbRsbRibLjbLibRobLjLsmbLibLo
bLibLibLibLgbRsbLgbLgbLgbLibLiRsbRibLcbRibRobLsbLiLsbLsbRibsbLgbsbLgbL
sRcbLgbRgbRgRsmbRgbRiLsbLsbRibRgbLgbRcbLgbRgbRjbRsbRibLgLsbRgbLsbRgbRs
bRgbRgLsbLgLsbRgbRgRsmbRgbLsbLsbRsbRcbLsRsbRgbRgbRsbLsbRgbRgbRgRsmbLsb
RgbLsbRgbRsbRgbRsbRgbLgbRgbLsRsbRibRsRsmbLsbRgbRibLjbLsbRgbRgLsbLsbRgb
RgbRsbRgRsmbRgbRgbRsbRgbsbRsbRgbLgbRiLsRsLsbLgbLsLsmbRgbRsRsLsmbRibLsR
sbRgbRsbRsRsmbRgbRsbRgbRgbRgbLsRsbLibLiLsbLiLsLsmbLibRhbLibRiLsbRibRgb
LgbRgbRiLsbLjbRiRsmbRsbsbRgbLjbRsbRibLjbRgbLsRgbLibLibRebRgbRibLsbRibR
gLsRsbRsbLgbLcLsmbLhRsbRcbLibLibRibLcbLcbLibLgRsbRibLibLibLibRcbRcbLib
RobLibRsLsbRibRibLsLsmbLjbRcbRiLsbLgbLsbRibRgbRibRsbLgbLhbRcbRsRgbLhbL
hbLibLcbRebRcbLgbRibRgbRgbRsbRibRgbRsbRgbRgbsbsbRcLsbLibRgbRgRsmbRgbRc
bLgbLibLibLsbLgbRgbLibLibRibRjbRibRgbRiLsbLjRsbRcbLjbLhbLibRjRsmbLibLg
bRsbLgbRjbRibRgbLjbRgbRibLgbRibRsbRgLsbRgbLsbLsbLcbRibLsRiRsmbRgbsbLgb
RgbRsbRgbRsLsbRibRsbLsRsbRgRsmbLgbRgbRgbRgbLobLgbLgbRebRiLsbRgLsRsbRgb
RgRsmbRgRsmbRsbLsbsbRjbLsbLgbLgbLsLsmbLibRibLjbRibRsbRcbRibRibRsbRgbRs
bLjbLibLibRgRsmbLgbLibRjbLcbRiRsmbLobRhbLgbLibLibRjbLibLsbRjbRcLsbLibR
ibRsRsmbRgbRgRsmbRgbRgbsbLgbLsbRgbRjbsbLgbRgbRgbRgbLgbRgbLsbLsbLgbsbRs
bRgbLsbLsbRgbRsbRgbRsbRgbRcbLiRsbRibLsbLsbLgRsRhbLgbLgLsbRibRgbRsbRgbL
sbLsbRiLsbLsbLjbLibLsbRsbLsRsLsbRgbsbLibRibLibLobRcbLcbRjbLcbLibRjbLob
RjbLibRgbRgbRgbRibRsRsmbRiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 24; Drug: Control
bRibRsRsmbRsbRgLsbRgRsmbRibRgbRgbRsbLsbRibLsRsRsLsRimbRsbRgbRgbRsbRiLs
bLsbRibRgbLcbLiRsbRcRsmbRibLcbLcbLcLsmbLgbLgbRjRsmbLibLcbRcbRcbLgbRcbL
gbLebLhbRibLcbRgbLgbLibRcRsmbRhRsmbLgbLsbLjbRebRiLsbLsbRibLgbRibLsbRib
LjbLiLsbRjRcbLebLjbRebRcbLebRiRsmbLcbLgbRebRhbLgLjRsbRibLhbLgbReLsbLjb
LcRsbLgbLgLsRsbLsRsbLsbLsbLiRsbRsbLgbRsbLhRsbRjbRebRgLsbLsbRibRsLsbRsb
sbRiRsmbLsbRgbRgRsmbRsbRibLjbRsLsbRibLsbRsbRiLsbRibRsbRgbRsRsRsmmbRgRs
mbRsbRsbRgbRsbRibRsbRgRsmbLsLsmbRibRsbRgbRgbRsbRsbRsRsmbRibRsRsmbRgbLs
bLjLsLgmbLgbLibRcbLhbLibLhRsbLibRsLgbLgbLgbLgRsbRcbRibLjRsbLsbLjbLgbLi
bLsbLibLsbLiRsbRgbLgRsLsbLgbRjbLsRcbLsbLjbLibLgbLgbLgbLgbLsbRjbLgbLsbR
gRsmbsbRsbLibRebRibLobLjbLcbLgbRebLsRcbRiLsbLgLgbRibRibRsbRgbRgbRgbRgb
sbsbLsbRibRsbRsbRibRgbLgbRgbRsbRgbLiLsRsbLgbsbLiRsbRebLsbLhbRsRsmbLgbL
hbRsbRsbRgbRobRsbRiLsbLgbLhbLiLsLsmbRhbRobRhbRhRsmbLhbRcRsmbLsLsmbRibR
sbRsbRsbRhLsbRsbRibLgRsbRhbLibLsRhbRcbLgbLsbRjbLgbLsbRjbRiLjbRibLsbRib
RsbRsbRsbLsbRiLsbRsbRsbRsbRsbLcbLsbLgLsbLsbRsLjbLgbRibRiLsbLgbLcbRibLc
bRcbRsbLsbRjbRibLjbLjbLibRgbRgbRobLsbLjRsbRibRcbLcbRsbRibRsRsmbRgbRsbR
iLsbRsRsRsRsmmmbRcbLibRcbRgbLibLibRjbRibRgbLsLsmbRibLsLsmbRibRgbRsbRib
LsbRgbRsRsmbRibLgbRjbRiRsmbLcbRebRcbLsbRibRcbRibRgbLhRsbLgbLhLsbLcbLgb
LibRibLhbLiRsbRhbLibLiRsLsbLgbLgbRsLsbLgbRjbLsbLgbLsRsbLsbLibRjbRjbRsL
sbRhbLjbRibsbsbRibLsRsbRgbLsbRibRsbRsbRgbRgRsmbLsLsRsmbLgbRobRgLsbRgLs
bLgbLsbLsRibsbRibRsLsbRsbLjbLhLsbLsLsmbLgbsbRjbLcRsbReRsmbLsbLsLsLcmbR
gbLibLhbRgRsmbLhbLibLgbRsbRgbRsbRcbRhbRgbLibLcbLsbLcbRibRgbLcbRhRsmbRj
bRibLsbRgbRgbLsbRsbRgRsmbRsbRsRsmbLsbRibLgRsbRiRsmbRsbRgRsmbLsbRsbRibR
gbLsbRgbRgbRgbRgbLsbRibRgRsmbRsbRibLgbsbsbRsbRgbLhbRcbRgLsbRgbRgbRsRsm
bLsRsbRsbRsbRsbRiRsmbLsLsRsmbRgbRsbRsbRgbRgbRsbRgbRgRsmbLsbRgbRsbRsbRs
LsRgbRsbRsRsmbRsbRibRsbLsbRgbRgRsLsmbRsbRsbRibRsbRgRsmbRsbRibLgbRiLsbL
gRsbLibRjbRibRiLjbRibLjbLjbLgbLgbLgbLgbLsLsmbRgLsbLhbRcbLgbLibLsbRjRsm
bRcbRgLsbRobRibLsRsbRsbRcbLgbRgbLsbRibLjbRibRsbLsbRhLsbRsRsLjmbLibLgbL
gLsbRsbLgbRibRjbLgRsbLjbLsbRsRsmbLgLsbLsbLsbLcRsbLgbLsbLsbRjbLibLgLsbR
sbRjbLcbRhbLhLsbLhbLgbLsbRsbLobRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 25; Drug: PCAP2 10 然
bRsRsmbsbLjbLsRsRsmbLoLsmbLgbRhbLcbLibRgbRsbRjbRobLsbRibRibRibRsbReLsb
ReRgbRiLsbRgbRsbRgLsbRiRsmbRgRsRsmmbRgbLsbRibRibLebLgbRiRsmbRgbRsbRibL
ebLsLsmbsbLeLsbsbRiRsmbRibsbRsbRsRsmbRsbRjbRsbLebRcbRcbLcLsmbLhbLeLsLs
mbLsbRgbRgbRgLsbRgRsmbRsRsmbRsbRgbRgbLsLeRsLsbRebRibRiRsmbRgbRsbRsbRgb
LgbLcbRsbLjbRgbRibRgbRgbRsRsLsmbRsbLsLsmbRsbLibLsbRebRgbLgbRgbRcbLebLi
bLiLsbRsbRcRsmbLsbRibRsbLcbRebLjbLcbLsbRsbLgbRsbRibRjbRsbRgbRiRsmbRsRs
mbRsRsRsRsmmmbRgbRgbRjbRjbRgbLsbLjbRcbRgbRgbLsbRgbRsbRgRsRsmmbRgbRgbLs
bRsRgbRcRsmbRhbRibRgbRgRsmbRsbRsbLsbRsbRgbRsbLsbRsbRsbRgbRgbLjbLebLgbR
sbRebRgRsmbRsbRgbRgbRgRsmbRgbRgbRgRsmbRgbRgbLgbLjbRibRgbRgbRgbRgRsmbRg
RsmbRsRsRsmmbRsbRgbRsbRgbRsbRsbRgbRgbRgbRiLsbRsLsbLebLsbRcbLobRgRsmbRg
RsmbRgRibRgbRgLsbRsbRgbRsbRgbLsbRsbRgLsbRgbRgRsmbRgbRsbRibRgRsmbRgbRsb
RsbRgbRsbRgbRgbRgbRgbRgbRgLsbLgbRsRsmbLsRsbRgRsmbLcbRibRiRgbRgRsmbRgLs
bRgbRgbRsbRgbRsbRsbRgbRgRsmbLsbRiLsbRgbRgbRebRgbRgRsmbRgbRibLebLgLsLsm
bLsbReRsmbRobRibRgbRhbRgbRgbRibRsbRgLsbRgLsbRgbRjbLsbRcRsRsmmbRcRsmbRg
RsRsmmbRgbRgbLsRgRsmbRgbRsRsmbRgLsbRiLsbRibRibRgbLsbRibRiRsLsmbRsbRgRs
mbRgbRgLsbLsLjbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 26; Drug: PCAP2 10 然
bLgbLgbLsbLsbLibLoRsLsRsbLibLgbRcRsmbRiRsmbLsRsbRsbsbRgbLsbRgbRsbLsbRg
bRsRsmbLsRsbRgRsmbRsbRgbRgbLsRsLsbRibRgRsmbRgRsmbsbRgbRgbLsbRobLibRcbR
hbRgRsmbLcbLgbRsRsmbLcLsmbLcLsmbLgbLgbLiLsLsmbRsRsmbRcbRhbRibLsbLsbRib
RiRsmbLobLibLgLsbLsbLsbLgLsLsmbRsbLsLsmbLgbLgRsbLgLsbLgbLgLsbLgbLgbLsb
LcbsbLcbLsbRgRsmbRsLsbRibRgbRoRsmbLsLsmbLsbLibLgbLsbLgbLsbLgbLgbLgbLgb
LgbLgLsbLsLsmbRcbsbRhLsbLsbRiRsmbRibRsbRgbRsbRgbLeRsbLibLgbLgLsbLgbLsb
LgbLgLsbLsbLsbLsLsmbLgbLibLgLsLsLsmmbLgLsbLgbLgbLgRsbRgbLibLobLiLsbLsb
LjbLcbLgbRgbRcbRsbRgbRiRsmbRsbRgbLgbRgbRsbRgbRibRgbRibRcbRibRsbRebLcbL
ibLcbLgRsbsbRiRsmbRsbRgbRgbRsRsmbRhRsmbRibRhbLsRsbLebLibLgbLgbLgLsbLsb
LgbLgbLgbLgbLsbRsbLgbRjbRcbRiRsmbRoRsmbRcRsRsmmbRiRsmbRgRsmbRsbRibRgbR
gRsmbRsRsmbRgRsmbLgbRgRsmbRgbRibLhLsRsbRjbsbRibRibRgbRgRsmbRgbLobLcbRg
bLhbLgbLsLsmbLiLsbLoRsRsmbRgRsmbRhbLjbRgbRcbRcbRiRsmbRgbRjbRiRsmbRsbRs
LsbRibLsRsbLsbLsbRgbLsRsbRiRsmbLibLhbLhbRcRsmbRcLsbLiLsbLsbRcbRgbRsRsm
bRgbRgRsmbRgbRiRsmbLsbLsRsbRhbLsbLgbLibLoRsbRsbRgbLobLhbRcbRcbRgbRsRsm
bsbRgbRibLsbLgbRcbRcbRgbRgRsmbRibLsbLsRsbRgRsmbRgbRsbRibRcbRhbRgRsmbLs
bLcbLibLiLsLsmbRgbRcRsmbRsbRgbRgbLebLiLsbLsbLsLsmbRcbRibRsbLibLjbLcbRc
bRsbRsbRsbLcbLcbLibRsLsbRcbLsLsmbLsbRgbRibRibLsbRgbRiRsmbRgbRgbRgbRgbR
gbRgbRgbRsbLsRsbRiRsRsmmbRcbRhbRsbLcLsmbLgbLsbLsbLiLsLsmbLsbLgLsbRcbRg
bRgRsmbLgbRgbRsbRsbRgbLibRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 27; Drug: PCAP2 10 然
bRjbLgbLsRsbLsLsmbLsRobRhbLibRibRgbLsbRibLsbRsbRgLsbRsRsmbRgRsmbRsbRsb
RgbRgRsmbLgbLgRsbRsbRsRsRsRsLsmmmbRiLsbRsRsmbLibRoRsLsmbRebRgRsRsmmbRg
bLjbLsbLsLibLgbLsLgbLgbLgLsLsmbLsbLgRsbRsbLebLgbLiLsbRgbRsbRiRsmbRgRsm
bLgbRgRsmbRgbRibRibRsLhbLgbLgbLgbLgbLiRsbLibLsRsbLgLsbLibRgbLgbLgbLgbL
gbLgbLgbLsbLoLsmbLgbLcbLhLsbLhbLhbLibRebRsbLgLsbLsRsRsmbRgRsmbRgbLsRsb
RsRsmbRsbsbLibLgbLibRhRsmbLibLibLgbLsLsmbRsbRsbLgbLgbLgbLsbLgbLsbLsbLg
bRgbRoLsbLjbLsLsmbLgLsbLgbLsbLgbLsbLgbLgbLgLsbLgbLsLsmbRsRsLsmbLsbLgbL
sbRjRobRcbRsLsbRsbLibLsbLibLibLibLebLibLgbLcbLcbLibLgbRsbRsbRsbsbLsbLg
bLibLibLibLgbLgbLsbRgbLsbLhbRsbLgbRsbLgLhLsbLgbLgbLsLsmbLgbLgbLsLsmbLg
LsbLgbLsLsmbLgbRobRgRsmbLcbLsbRibRobLhLsbLsbLcbLibLcbLgLsLsmbLibLgbLib
RsRsmbLgbLgbLgbRjbsbRobLsRsbLjbLcLsmbLgbLcbLibLgLsLsmbLibLgbRsLsbLgbRs
bLsbLibRjRgbLibLgbLsLsmbLsbLsLsmbLsLsmbLgRsbRgLsbLsbLgLsLsmbLsLgbLgbLs
LsmbRgbLgbRsLsLsLsmmbLgbLgbLgbLgbLsLsmbLgbLgbLgbLsLsmbLsbLcLsmbLsbLibL
sbLibLgbLsLsmbLsbLgbLsLsmbLgbLsLsLsmmbLsbLgbLgbLgbLsLsmbRgbLgbLgbLgbLg
LsbLgbLsbLgbLgbLgLsbRebLgLsLsmbLjbsbLebLibLiRsbLgbLgbLgbLsLsmbLgbLgbLs
Lsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 28; Drug: PCAP2 10 然
bRhbRgRsmbRsbRgRsmbRjbRibRgbRgRsmbRsbRsRsmbRgRsmbRsRsmbRiRsmbRcbRgbRgR
smbRgbsbLcbLiLsbLgbRgRsmbRsRsmbLcbRsRsRsmmbRebRsRsmbRsbRsRsmbRsbsbLsbL
sbRsRsmbsbRibRgbRgbRcRsmbRibRsRsRsmmbRsbLjRsbRibRsRgbRgRsmbRsbRiRsmbRc
RsmbRsRsRsmmbRgRsmbRsbRsbRsbLjbLsbLcbLjLsLsmmbLcbLsLsmbRsbRiRsmbRgbReR
smbRhbRsbLjbRhbRgbRsRsmbLsbRcRsmbRgbRcbRgLsbLjLsmbLsbLsbRjbRjRgbRgRsmb
RsRsmbLsbRibRsRsmbLibLsbLsbLobLsLsLsmmbRhbRibRsRsRsRsRsmmmmbRsRsRsmmbR
sbRsRsmbRsRsRsmmbRgbRoLsLsmbRsbLoLsmbLsRsbRsRsmbRsbRgRsmbRgbRsLsbRsbsb
RgRsmbRsRsRsRsRsmmmmbRsbRsbLobLgbLsbLsLsmbLhbLgbRsbLibLgLsbRsbLcbRsbRs
bRsRsmbRgRsmbLebLsbLgLsbLsbLibLhbLsbRsRsRsmmbRsbRsRsmbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 29; Drug: PCAP2 10 然
bLsbLsLsmbLiLsbLcbLcbLjbLibLgbLgbLgbLgbLgbLgbLgbsbLgLsbRsLsbLgbLsbLgbL
sbLgbRjbLgLsbLgbLgbLgbLgbLgbLsLsLsmmbLsbLgbLgbLgLsbLgbRjLsRcbLsbRsbRhL
sbRsLjbLibLgLsbLgLsbLsbLsLsmbLgLsLibLsLsmbLgbLgbLsLsmbLgLsbLsLsLsmmbLs
RibLgLsbLgLsbLsbLsbLsbLsLsmbLgbLgLsbLgLsLsmbLgLsbLgbLibRebRibLhbLgLsbL
sbLsLsmbLgLsbLgbLgbLgbLgbLgbLgLsbLgbLgbLiLsbLgbRsbRsbLibRgbLsbLgbLgLsb
LgLsbLibRsbRgbLibLgbLgbRjRcRsmbRibsbRsLsbRsbRibLsbLjbLebLibsbRsLsbLibR
sLsbRsLgbLgbLgLsLsLsmmbLsbLgbLibLcbLiLsbLibLibLgbLgbLsLsmbLgbLgLsbLgbL
sbLgLsbLgbLgbLgLsbLgbLgbLibRcbRibRgbRibRhbLsbLgbLgbLgbLcLibLsbLgbLgbLg
bLgRsbLgbLgLsbLeRsbLgLsbLjbLibLsbLiLsbLgbLgLsbLsLsmbLgbLgbRsbLgbLsLsLs
LsmmmbLgRsbRgbLsbRiRsmbLjLsmbLhRsbLibRibLsLsmbLcLsmbLgbLsbLgbLibLgbLsL
sLsmmbLgbLsbLsbLgbLgLsbLgbLsbLgbLobRcbRcbRcbRsbLsbRsbLgbLibLiLsbLgbLgb
LgLsbLgbRhbRebLsLsmbRibRgbRgbLjbRcbRhbRcbRcbRgbRsbRgbRgbRiRcbRcRgbRsbR
ibRhbRcLsbRcbLsbRibRgbRgbRgRsRsmmbRhRsRsRsmmmbRiRsmbRgRsmbLsbRibRgbRgL
sbRiRsRsmmbRcbRhRsmbRgbRsbRgbRiRsmbRcbRcRsLsLgmbLiLgbLgbLgLsbLgbLibLgb
RgRsmbLoLsLgLsLsmmbLsLsmbLgbLibLibRgbRsbsbRhbLsRiRsmbRsbLjLsmbLcLsmbLh
bLcLsmbLsLcbLibLgbRibRjbLcbLgLsbRgbLsbRjbRibLobLgLsbLgbRsLsbLiLsbLgbLg
LsbLsLsLsmmbLgbLgLsbLgbLsLsmbLgLsLsmbLsLsmbLsbLgbLgbLgbLgLsbRgbRibRhbR
sRsmbRsbRoRsmbRiRsmbRsbRgbRiRgRsRsmmbRsRsRsmmbRiRsRsmmbRgbRsbRiLsbRiRi
bRgRsmbRhbRcbLebLgLsbLibLsbsbLgLsbRsLibLcLsLsmmbLiLsbLibLgbRsbLgRsbLsb
LgLsbLsbLibLjbLiLsbLgbLgLsbLgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 30; Drug: PCAP2 10 然
bRobLcbRcbLobLobLobRebLcbLsbRobRebRcbLobRebLobLgbRobRobLcbLibLcbLobLeb
RobLsbRobLebLgbLcbLobLcbRobRgbLobLebLcbLibRobRcbLobRibLobRcbRgbRcbLsbL
ibLibLobRobRibLcbRebRibRobRibRobRobRcbRobLebRebLobRcbLobRebLobRobRcbLo
bLjbRgbRjbRobRsbRibRobRibLcbLobRebLobRcbRobRjbLcbRgbLebRsbLebRobLebLob
LgbLobRebLebRcbLcbRebRebLebRibRobRobLsbLsbLebLobRebLhbLebRebLobRebRjbR
cbLobLcbLobLebRobRebRebLjbLobRjbRobLobLsbLobLibLobLobRobLobRsbRobRobLo
bLobRhbLebLobRjbLcbRcbLjbRcbLcbRobRobRobRobLobLobRcbLjbLobRcbRibRobRib
RsbLebRsbRebRhbLibLobLcbRobRgbRebLibRsbLobRcbRobRobLobLobLobLobLobLcbR
ebRobRobRobLgbRcbLobLobLjbRebRcbRobRobRjbRcbRebLibLobLobRebLebLjbLobLo
bRgbLcbRcbRebRebLobLcbLjbLobLibRobLcbRobLobLebRobLjbRebLebRobLebRjbLob
LebLsbLcbRebRobRebLcbLobRobRgbLsbLjbLcbRebLebLcbRcbLjbRibRobRobLobRibL
ebRebRobRebRebRebRjbLobLobLgbRobRebRcbLobRobRcbRobLobRobRobLcbLibRcbLs
bRcbLebLibLcbLjbLobLebLobRebRebRhbRobLebRebLebRobRobLibLgbRobRobRgbLgb
RobLcbRcbLebLebLebLcbRebLobLjbRobLobLebLgbRebRobRibLebLibRobRobLjbLcbR
ebRobLobLobRebRjbRcbRsbRobLobLebLcbRobRebRobLobLebRebRobRobLobLjbLobRh
bLebRsbRcbLobRobRobRebRobRjbLgbLibRobRcbRobLcbLobLcbRcbLgbRobLobRebRob
RebLcbRcbRibLcbLebLobRobRobLebRibRobRobRgbRobRobRebRobLibLcbRebRobRobL
obRcbLebLobLebLcbLebLcbLcbRobRobRcbRibRibRjbLebLebLcbRebRebRcbLcbLobRo
bLobLibLobRgbLebLobLobLobRobLcbRobRobRcbLebLobLsbRcbLebLobRebRcbLcbRob
RobRebRgbLebLobLebLobRobLobRobRobLibRobLgbLibLebLcbLebLgbLobRobLobRcbR
ibLobRibRobRebLcbLebRobLcbLobRobRobLebRebLebLebLcbLebLobLebLebRobLobRg
bLobLcbLibRcbLobRobLibLobRebRibRgbRcbRobRobLobLobRebLebLebLobRgbLcbLcb
RebRebRebLhbLhbRsbRebLobRsbLebRebLobLobRgbRobRgbRobLobLobLobLobRobRobL
ibRebRebLsbLobLcbRobRibLebLibLebLebRobRobLcbLsbRcbLibRobLebLhbLobLebLc
bLobLibLobLobRebLgbLhbLcbRhbLebLebRjbRebLobRebRobLobRibRobLgbRgbLsbLeb
LebRebLebRsbRibRcbRcbLebRobLobLhbRgbRobLcbRcbLobRsbRcbRebRibLsbRsbLcbR
ebLobLobRobRibRobRsbRobLgbRebLhbLibLgbRobRobRebRobRcbRobRcbLcbRobRobLc
bLibLcbRobLobLobRebRgbRebRcbLebLobRobLobRcbLsbLgbRebRobRhbRcbRebRobRsb
LobLebLobLibRobLobRibRobLcbLobLibLobRebRobLebRobRgbLgbLobRebRebRebLcbR
obRcbRsbRsbLibLobLobRgbRobLcbRebLebLebLcbLebRobLibRgbRcbLgbRebLobRobRo
bRobRebLcbRebRobLcbRebLobLebLobRgbLebRgbRebRobRobLobRobLibRobRebRobLob
RobRebLgbRebLobLibLcbLebRsbLcbRobLobRgbLobRebLibRebLobLcbLhbLobRobLibR
obRobRcbLobLcbRebRobLcbLcbRcbLcbRgbLobRobRobRcbRhbLibLibLibRcbRobLebRs
bLobLcbRgbLobRobRgbRobRgbLibLobRobLibRcbLebRobRcbLsbRebLsbLobRebRebLib
RebLebLcbLsbRgbLgbLibRobRobRobLobRobRobRobLebRebLobRobLibLgbLibRgbRobR
sbLcbRibLobLebRibLebLgbRcbLgbLobRebRcbLcbRobLgbLobLobRebLobRebRobRobLc
bLobLobLobRebRebLebLebRsbLobRibRobLobLobRcbLgbRebRobLobLsbLcbRobLobRcb
RobLcbRobLobRgbLobRgbRcbRcbRcbLebLobLebLibLobLebRsbRobLobLobLebRobLobL
ebRobLgbLebRebLcbLobRobLobLobRobRebRsbLebLcbLibRebLibLebLsbLcbLcbLcbLs
bLebLobRgbLebRebLobLcbLcbRebLcbLcbLebRcbLobRobLibLsbLibLebRobRibRcbReb
RebRobLobRobLcbLobRobLobRobRobRebRibLobRob

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 31; Drug: PCAP2 3 然
bRgbRgbRsbRgbRibRgbRsbLsbLsbRibRsbRibLebLobLsbRsbLgbLgbLgbLsbLsbLsLsmb
LgbLsbLsbRsbLebLsLcbRibRgLsRsRsmbLsbLebLcbLjLebLibLsbRgbRibRgbRsbRgbRs
bLsRsbReRsmbLgbRsbRebRhbReRsmbRsbRsbLcbLiLsbLcRsbRsbLibLebLiLsbLsbLcbL
sbLsLsmbLsbLsbRsbLgbLgbRsbLsbLgbLibLsbRsbLsbLsLsmbLgbLgbLsbLsbLgbLgbLg
bLsbLgbRsbLgbLibLcbLibLgbLjbLibLgLsbLsbLgLsbLsLsmbRsbLcbLgbLhbLiRsbRsb
LjbLjLibLsbLsbLgLsbRsbLsbRsbRsbLsbLgbLsbRsbRobRgbRgbLgbLsRsbLgRsbLgbRi
bRgbRgbRsbRgbRgbRgbRsRsmbRgbRsbRsbRsbRsbRgbRgbRsbRsbRsbRsbRgbLsbRjLsbR
gbRjLsbRcbRgbRsRsmbLsbsbRsbLibRgRsmbReRsmbRgbRgbLsbLsbRibRsbRsbRgRsmbR
sbLgbRsbRgbLobLiLsbLgLsbRsbLsbLgbLgbLgbLsbLsbLsbLsbLgbLgbLsbLgbLsbLsbL
gbLsbLgbLsbLgRsbLcRsbLibLsbRsbLibLibLsbLgLsbLsbLsbLsbLgbLsbRsbLgbRsbLg
LsbRsbLgbLsbLgbLgbLgRsbLsbLgbLgbRgbRsbLhbLgLsbRiLsbRgbRebRiLsbRibRhbLh
bLeLsbLgbLsbLgbLgbLsbLgbLgbLsbLsbLibLgLsbLgbLsbLsLsLsmmbLsLsmbLsbRgbLj
RsbLgRsbRjbRcbRibRgbLsbRgbRgbRsbRgLsbRsbRsbRsLsbRiLsbRsRsmbRsbRgbRiRsm
bRgLsbRsRsmbRsLsbRsbRgbRsbRsbLsbRjbRibLebLebLibLgbLjLsmbRebRjbLsLsmbsb
LgbLsbLgbLgbRsLgbRsbRgbLgLsbLgbLsLsLsmmbLgbRsRsmbLgLsbRsbLgbLsbLgbLsRs
bLsbLsbLsLsLembLibRsbRiRsmbRgbRgbLsRsbRiRsmbRsbRgbRgLsbRsbRgbRgbRsbRsR
smbRgbRsbRsbRsbRgbRsbLsbRibRgbRibRsbLibLgbLibLibLgbLibLgbLgbRsbLgbLgbL
gbLgbLsbLsbLebLibLgbLsbRsbRsbRgbRsbLcbRsLsbLgbLsLeLsbLhbLibRjbRibLgbRi
bRgbRgbRibRibRib

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 32; Drug: PCAP2 3 然
bRgbLgbRgbRgbRgbRsbLibLgbLobLoLsRsmbLibRgbLibLgbRhbsbRibRgbRgbRgRsLsmb
RsbRsRsmbRgbRsbLsLsmbLsRsbRsbsbsbsbsbsbRgbRsbLgbRiRsmbLgbLobRgbRgRsmbR
gbRgbLgbRgRsmbRgbRsbRgbRgbRgRsmbRgbLsbRgbRsbRsRsmbLsbRgRsmbRsbRsbLsbRg
bRgbsbRsbLsbRgbRsbRsbRsbRsRsmbRgRsmbRgbRgbRsbLsbRgbLgRsbRibRsbRsbRgRsL
smbsbLjbRibRcbRibLibRsbLsbRjbRhLsbRsbLjbLoRsbLhbRgRsmbRgbRcbRhbRgRsmbL
sbLgbRsbRsbsbLibLsLsmbLsLsmbLsbRsLsLsmbLsbLgbLgbLsbLsLsmbLgbLsbLsbLsbL
gbLgbLgbLgbLsbRcRsmbRcLsbRhbLgLsbLsbRibRibLjbLjbLcbRgRsmbRobRsbRgbRsRs
mbRsbLjbLibLsbLsbLgbLgbLgbLgbLsbRsbsbLsbLgbLgbLgbLgLsbLsbLgLsbLibLobRc
bLsbRsbRgbRsRsRsmmbsbRibLcbRcbLibRibLibRsbLibLibLsLsmbLsbLgbLsbLsbRsLe
bRgbRsbLgbLgRsbLsLsmbLsbLsLsmbRsbLgLsbLgbRsbLgLsbRsbLgbLsbLsbLsbLgLsbL
sLsLsLsmmmbLgbLgbLsbLoRsbLibLsbLibLsbLgbLgbLgbLsbLibRebRibLjbsbRoLsbLg
bRibRsbRcbRiRsmbRsRsmbLsbLsbLgbLsLsmbLibLgbLsbLsbLsbLsLsmbLgbLgbLgbLgR
sbLibRsbLgLsbLsLsmbLgbRsbLgbLgRsbLsbLgRsbRsLsbLgbLsbLsbLgbLgbRjbRcbRsb
RcbRibRsbLsbLsbRibRibRsbRsLsbLgbRsLsLsRsmbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 33; Drug: PCAP2 3 然
bLsbRcbRibLsbRiRsmbRcLgLsLsmbLgbLiLsRsLsbRebLsbRhLsbRgRsRsLsmmbRgbRsbR
ibRgbRgbRiLsbRgLsbRibLsbRcbRgbLsbRiLsRsbRsbRgbRgbRibRibLibLjLgbRgLsbLg
bLibLgLsbLgbLsLsLsmmbLgLsLsmbLgbLsLsmbRsbRoRiRsmbRibRgbRgbRgLsbRgbRgbR
iLsbLibLjbRcRsRgmbRiRsmbRgbRgRsmbRgRsmbRgbRgbRiLsbRgbRsbRibLibRhbsbRgR
smbRsRsmbRgRsmbRgRgRsmbRibRcbLibLcbRgbLiLsbLgbRsLsLsmbLgbLgbLsbLgbLgLs
LsmbLgbLgbLsLsRsLiRsLsmbLgbLgbLgLsRsbRsLsbLiLsbRsbLiLsbLgLsRsbLgbLiLsb
LiLgLsbLgbLsbLgbLgbRobRibRsRsmbRsbLcbLsRsbLibLiLsLsmbLgbLgbLgLsbLgbRsL
sbRsRsmbLiRsLsbLgLsbRsLsbLsbLiLsLsmbLgLsbLsbLibLgLsbLsLsmbLiRsbLiLsRsb
LgLsbLsLsRcmbRiRsmbLsbRibLebRsbLgbLsLsLsmmbLgLgbLgLsLsmbLsbLgLsbLgbLsb
LiLsbLsRsLsbLgLsLsmbLsbLgbLgbLgbLiLsLsmbLiLsbLsbLiRsbRsLsLibLgLsbLgbRs
RjbRjRjRsmbLjLgbLebLjLsmbLhLiLsbLgbRcbRcbRsRsLsmbLiLsLsmbLgbLibLeLsbLg
bRiRsLsmbLcbLsLsLsLsLsmmmmbRebRsbRsLsbLcbLgbLibLcbLgLsbLcLsmbLibRjRsmb
RgRsRsLsmmbRsRsLsmbLcLsLsmmbRiLsLsmbRcbLcbLsLsmbLsbLiLsbLcLsmbLgbRibRc
bRiLsbRsbRiRsmbRiLsbLiLsbRcbRhbRjRgbRgbLcbLcLsLsmmbRibRsbLsbsbLsbLeLsb
RgRsmbRsLsbLebRgbLibLgbRsbLhbLgbLsbRcRsmbRibLsbLsbsbRiRsmbRsRsmbLsRsbL
sRibLebLebLhLsbLgbRiRsmbLsbRiRsmbRgbRsbRibRsRsmbLeLsbLsLsLsLsLsmmmmbLi
LgbRibLebLsbLsbRjRsmbRsbRcLsbRibRiRsRsmmbRgbLsLsmbLjLgLsbLjLibLgLsLsRs
mbLsbLsbLcbsbLjLgbLgLsLsmbRiRsLsmbRsRsLsRcLsRsmbRiRsmbRiRsmbRsbLsbLcbL
ebsbRiRsmbRgbRcbRgbReLsbRgRsmbRsbLsbRcbLsbsbRsLsLsmbsbRhbLjbLcLsLsLsmm
mbLgbLcLsLsmmbLsbRgRsLsmbRcRsmbRhLsbLsbLsbRcbRibLsLsLsmmbRobRibRibRgbR
hbLsLsRsmbRibRsRsmbRiLsbRsbRhbRsbRhRsmbRsbRibRibLsbRibRsRsmbRgbRibRsbR
ibLsbRiLsRsRsmbRibLsRsbRgbRibRiLsbRibRcbRhbLgbLibRhbRcbRibLibLeRsLsbRj
bLibLiLsRsbRibLgbLiRsbLgbLsbLgbLcRsbRsbRsRcbLsbRiLsLsmbRiRsRgmbRsbRgRs
mbRgbRgRsmbRgbLoLsLsmmbLsRsbRhbRibRgbRgbRsRibRiLsbLsbLcbLgbRjbRibRibLo
bLgbLgLgLgbLsLsmbLgLsRsbRsLsbLgbLibRsLsbLgRsLgbLibLgbLgLsbLsLsmbLiLgLs
bLgRsbLgbLgLiLgLgbLgbLgbLgbRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 34; Drug: PCAP2 3 然
bRgbRibRhbRibRgbRgbRibRibLgbLibLcbLibRgbLobRgbRibRsbLcbLgbRgbLibLsbRob
RobRcbLhbLibLsbRobRgbLsbRgbRgbRsRsmbRsbRsbRibLgRsbRsbRiRsmbLsbRgbsbRhb
LsbLobRgRsmbRsbRibLgbLgbLhRsbRgbLsbLgbRcbRibLsbLibRibRgbRsbRsbRsbRgbRg
bLsbRgbRsRsmbRgbRsbLsbRgRsmbRsbRsbRgbRsbRgRsRsmmbLsbRsbRsbRsbRgbRgRsmb
RgbRgbLsRsbRgbRsbRgbRsRsmbRgbRsbRsbRgbRgbRsbRgbRsbRsbRgRsmbRgLsbRsRsmb
LsRsbRgbLibRibRgLsbLjbRibRgbRgRsmbLsbRsRsmbRsbRsbRgbRgRsmbRgbLcbLibLiL
sRsbsbLgLsbRsLsbLgbLgbRibRiRsmbRsRsRsmmbRgbRsbRgbRgbRsbRgbRsbRgbRgbRsb
LsbRgbLhbLibRsbRsbRoRsmbRibRoRsLsmbLibLibRebRgbRsbRgbRgRsmbRsbRgbRsRsm
bRgbRgbRsbRsbRgbRsbRsbRsRsmbRgbRsbLjbRhbRgbRgbRsbRgbRsbRgbLibRgbRgbRsb
RsbRsRsmbRsbRsRsmbRgbRgbRgbRgbRibLsbLcbRsbLhbLibLsbLiLsbLsLsLgmbLsbLgb
RjbLibRgLsbLgbLgbLsbLibRjbLibLsbLgLsbLsbLgLsbRgbLgLsbLsbLgbLgbLsbRsbLg
bRsbLgbLgbReRsmbLgbRgbRsbRgbLibLgRsbLgbLgbLsbLsLsmbLgbRsLsbLgbRsLsbRsb
LgbLgbLsLsmbLsLsmbLgbLgbLiRsRsmbRibLcbRebLiLsbLebLoLsRsmbLiLsbLibLsbsb
LibLgbLibLgbLgbLgbLsbLsbRjbLgRsbLgbRsLsbLgbRgbLsbLgLsbLgbLgbLsbLsbRsbL
gLsbRgbLgbLsbRsbLgbRsbLibLibRibRsbRsbRsbLsbRgbRgbRgbRgbRsRsmbRsRsmbRgb
RsbRgbRsbLsbRgbRgbRgbRgRsmbLsbLcbLcbLcbLhLsbLibLiLsbLibLibLsbLgbRsbReb
RsbRibRgbRgbRsbRsbRgRsmbLsbRsbRgLsbRgbLsbRsbRgRsRsmmbRsbRsbRgbRgbLsbRs
RsmbLsRsRsmbRgbRgbRsbRgbRsRsmbRgbRsbRgbRsbLcbLgbRsbRcbLsLibRiRsmbRgbLg
bRgbRsbRsbRgbRgbRsbRsbRgbLgbRibLsRsbRsbRgbRibRsbRsbRgbRsbRgRsmbRsbRgRs
mbLcbRjbRibRcbRobRcbRhbRobLiLsbLgbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 35; Drug: PCAP2 3 然
bLsLsmbLsbLgbLiRsbLiLsbLibLgbLsbLgbLgLsbLsbLgbLsbLsbLgbLgLsbLsbLsbLsLs
mbLsbLibLcbLiLsbLgbLibLgbLsLsmbLgRsbLgbLsbLgbLgbLgbLgbLsLsmbLgLsbLgLsb
LgbLgbLsbLgLsbLgbLsbLsLsmbLibLcbLiLsbRsbLhLsbLgLsbLsbLibLsbLibLhbLgbRs
bLsbLhbLgLsbLgbLgbLsLsmbLgbLgbLgbLsLsLsmmbLgLsbLgbLgbLgbLsLsmbLgbLiLsb
LcbLibRsbRjbRcbRgbRgbRsbRgbRsbRgRsmbRgbRsbRgbLebRgRsRsmmbRgbRsRsmbRsbR
cbRiRsRsmmbRgbRsbRgbRgbRgbRsbRgbRsbRgbRsbRsbRsbRgRsmbRsRsmbRsbRsbRsbRg
bRgbRsLsbRsbRsRsmbRsRsmbRsbRsRsLsmbRsbLsbRgbRsbRgbRhbLcbLibLibLibLsbLg
LsbLsbLsbLsbLsbLsbLsLsmbLgbLsbLsbLsbLgLsbLgbLsbLsbLsbLsbLgbLgbRsbLgbLg
RsbLgLgbLsbLsbRgbLgbLgbLcbLcbLibLsLsmbLsbLsbLgbLsLsmbLsbLgbLgbLsRsbLgR
sbLsLsmbLgbLsbLgbLsLsmbRsLsbLsbRsRsmbLsbLgbLsbLgbLgbLgbLgbLsRsLsbLgbLs
bLsbLiLsLsmbLgbLsbLgLsbRcLsRsbRiRsmbRgRsmbRgbRgbLsLsmbLsbsbRsRsmbLcbLe
bLibLsbLsbLsLsmbLsbRgbRebRhbRgbsbLsLsRsmbLgbLsbLibLibLiLsRsbLsbRjRsRsm
mbRibRibRgbLeLsbLcbLibLsbRsbRsRsmbLiLsbsbLgbLsbRsbLsbRjLsbRjbRebRhbRib
RsbLcbLsbRsbRsbLgRsbRhbRhbRibRsbLgbRibRgbsbRsbLjbLibLsbRsbLsLsmbLibsbL
cLsLsmmbLjbLibLjLsLsmmbLgbLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 36; Drug: PCAP2 3 然
bLiRsbLgLsbLsbLibLsbLsbLsbLsLsmbLsbLgbLgbLsbLgbLsLsmbLjbRsbLgbLsbLgbLg
bLsbLgLsbLsbLsLsmbLgbLgbLgbLgbLgbLgbLsbLsbLgbLsbRsLsbLjbLgbLsbLsbLgbLg
bLgbLsbLsbLsbLgbLgbLsbLsLsmbLsbLsbLsbLgRsbLgbLgbLgbLsbLsbLsbLgbLjbLsbL
gbLgbLgbLgbLsbLsbLsLsLsLsmmmbLgbLsLsmbRsLsbLsbRsbLgbLsbLsbRsbLsLsmbLsb
LjbLsbLiLsbLhbLgbRgbLgbLibLsLsmbLsbLgLsbLsbLsbLsbLgbLiRsbLibLgLsbLgLsL
smbLgbLsbLgbLibRsRsmbRgbLsbLjbLsbLsbsbLgbLgbLgbRsbLsbLsbLsLsmbRsLsbRsL
sbRsbLobRiRsmbLjbLhbLibLibLhbLhbLgbLibLsbLsbRsbLsbLsLsLsmmbLhbLhbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 37; Drug: PCAP2 1 然
bRgbLcbLcRsbLibLgbLsbLgbLibLsLsmbRjRobRcRsmbsbRiLsbLsbLibLcbLcRsbLibRi
LsbRoRsmbLgLsbRibLsbRibRibRsbRsbRibRsbLsRsRsmbRsbRsRsRsRsmmmbLsbRgRsmb
RgbLsRsbRibRsLsbRibRgbRgbRsRsmbRsRsmbRsbRgbRsbRiRsmbLsRsRsmbRgbRgbRsbR
iRsRsmmbRgbRsLsbRsbRsRsmbRsbRgbRsRsmbsbsbRibRgRsmbRsRsmbRgRsRsRsmmmbRs
RsLsmbLsbRgbRsbRgRsmbRsRsRsmmbRgRsmbRgLsbRgbLjbLcbLiLsbRjbRcbLcbLgbLgb
LgRsbLcbRsRsmbLibRjbLcbRcbRobRiRsmbLibRibRiLsbRhbRgbLsLsLsmmbRibRsRsmb
LsRsLsRsbRgbRgbRgbRsRsmbLsbRgRsmbRsbRibRiRsmbRhbRcbRibRgbRiRsmbRgbRsbR
sbRgbRgRsmbRgbRibRgbRcbRibRgbRibRgbLsRsRsmbRsRsRsmmbRsbRsbRgRsmbLsbRgb
RgbRgbLsbRibRgRsmbRsbRsbRgRsmbRgRsmbRgbLsLsmbRgbRgbRgbRgbRsRsmbRgbRsbR
ibRibRsRsRsmmbRsbRiLsbRgbLibLhLsbLgbLibLgbLgRsbRhbRhbRgRsRsmmbLsbLsbRi
RsmbRsRsmbRsRsmbRgbLsRsLsbRgbRgbRsRsRsmmbRgbRgbRgbRgbRgbRsbsbRsbRgRsmb
RgbRgbRgbRgbRgbRsbRiRsmbRsbRsRsmbRgbRgbRsbRgbRgbRgbRgbRsRsmbLsLsLsmmbL
sRiRsmbLsbRgRsmbRgbRgbLsRsLsbRibRgbRgbRgbRgbRgbRsbRgbRsbRgbRgbRgbLsbRs
RsRsmmbRgbRgRsmbLsbRgbRgRsmbLsbRgbRsbLcbLibLibRcRsmbRcbLgbRobLsbRhbRcb
RcbLjbRhbRoRsmbLsbRibRgbLgbRgLsbRibRgbRgbLjbLobRcbRibRgbLsRsbRiRsRsmmb
RgbLsLsmbRgbRgbRgbRgLsLsmbRgbRgbRgbRgbRsbRgbRibRgbLsbLsRsRsRsmmbRgbRsb
RgbRibRcbRcbRiRsmbRgbRgbRgRsmbLsbRgbRibRsbRgbRgbRgbRsbRsbRgRsmbRgbRgbR
gbRgbRgbRibRgbRhbLjbRcbRjRsRsmmbLgbRiRsmbRsRsmbRsRsmbRgbRsRsRsmmbRsRsR
smmbRsRsmbRsbRsRsLsmbRiRsmbRgbLsRsbRsRsmbRgRsmbRgbRsRsmbRsRsmbRgRsmbRs
bRgbLsRsRsRsmmbRsbRgbRgRgRsmbRibRgbLsLsmbRsRsRsmmbRsbLsRsRsRsmmbRibRgR
smbLsbRgbRsbRgbRgRsmbRgbRgbRgbRgbRgbLsbRibRgbRgbRsbRsbRgRsmbRgRsmbRgbR
gbRgbRgbRgbRsLsbRibRgbLsbRgRsmbLsbRcbLibLsLobLgbLgbLgbRjbRcbLibLcbLhbL
cRsbLibLiLsbRgLgRsRsRsRsmmmbRcbLgbLibLibLsLsmbLibLsRsbLibLsbLiRsbRiRsR
smmbRcbRibLsRsbRgbRibLsRsbRsRsmbRgbRgRsLsmbLsRsbRsRsmbRsRsmbRsRsRsmmbR
gbRiRsmbLsRsLsbRgbRibRgbRgbRiRsmbRgbRgRsmbRsRsmbRsbRsRsRsmmbRgbRgbRgRs
mbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 38; Drug: PCAP2 1 然
bRcRsmbLgLsLsmbLsbLgbRibRibRcbLibRcbRsRsmbRsbRhbLiLsbRibRgbRgbRiRsRsRs
mmmbLsbRgbRibLgRsLsbRibLgbRiRsmbLgRsbRgRsLsRsmbRsbRsbLsbRiRsmbLibRibLs
RsbRsbLjbLiLsbLsbLgbLsLsmbLgbLsbLsbLsLsmbLsLsmbLsbLgLsbLsbLsLsLsmmbLgL
sbLgbLsbLsbLgLsbLgbLsbLgbLibRibRibRibRibRiLsLsmbLjbRibLjbRgbRiRsmbLgLs
bRsLiLsbLibLibLgLsbRgbLgbLibRgLsbLgbLgbLsbLsbLiLsbLgLsRsbRsRsmbLiLsbLs
bLgbLsbLgbLgbLsbLsLsmbLgbLsbLsbLsbLgbLsbLgbLsbLgLsbLgbLgbLsbLgbLgRsbLg
RsbRgbRcLsbRiRsRsmmbRibLsbRcbRsbLsbRsbRcbLgbRhRsmbLiLsbRcLsbLibRhbRcbR
hbLgbRibRhRsmbLgbRibLsbRiLsbRsbLsbRibRibLgbLcbLibRiLsbLcbRgbLgLsbLgbRs
bRjbRibRiRsmbLgbRgbRsbRgRsmbRsRsmbRgbRgbRsbLcbLibLsbLgbLsLsmbLgbRgbLiL
sbRsLsbLgbRsLsLsmbLgLsbLgbLsbLsbLsbLsbLsbLgbLgbLgLsbLgbLsbLibLgbLsLsmb
LsbLgbLsbLgbLgbLgbLgLsbLsLsmbLgbLsLsmbLiLsbLgbLsbLgbLgbRsRsmbLiRsbRgbR
jbRibRibRgbRgbRibRibLgbRcRsmbRibRsRsmbLjbRcbRcbLibRgbLhbLoRsLsbLcbRsbR
gbRcbRcbLgbRibRhbRgLsbRibRibRgbRgbLsbRgbRgbLgRsbRgRsmbRgbLsbRibRsbLsbR
iRsmbLsbRcLsbLgbRgbRgbLsLsmbRibLsbRgbRgbLsRsbRgbRibRibLgbRgbRsRsmbRsbR
gRsmbRsbLsbRsLsLsmbLibLibRgbLibRgbLibLgbLibRgbLcbLibLgbRsbRiRsmbRcbLib
RcLsbLgbRcLsbRibRgbRsbRsbRsbRiRsmbRiLsbRsbRsLsbRhbLsbRibRsbRgbLjRsbRiL
sbRgRsmbRsbRgbRgbsbRgRsmbRsbRsbRgbRgbLsbRgbRsbRgRsmbRgbLsbsbRsbRgbRgbR
gRsmbRgbRgbLsLsmbRgbRgbLsbRibLgbRibRiLsbLgbRsRgbRgLsRsbLgLsbRibRsbLsbR
sbRibRsbRiRsmbLiRsbRhbRibRgbRgbLjbRsbRiLsbRgRsmbLsbRgbLgLsbRgRsmbLsRsb
RgbRgRsmbRibLgbRibRsbRgRsmbRgbLgLsbRhRsmbRgbRgbLgbRgRsmbRsbRgbRsbRgbRs
bRgbRgbRgbRsbRgRsmbRgbLsbRgbLgbRibLgbRhbRgbRsbRcbRgbRibRibLgbLhbLibRgb
RibRgbLsbRgRsmbRgLsRsbRsbRgbRgbLsbRibRgbRsRsmbLsLsmbRcbRibRsbLibLibRgb
LjbLibRsbLobLhRsLsbRibRgbRhbRgbRsbRsLsbRhbRhbLgbLibRsbRjbRgbRgLsbRsbLc
bLibLibRgbLibRgbLibRsbLiLsbLibRgbLsbLiLsbLgRsbLgLsbLibLsRsLsbLsbLiRsbR
sbLhbLobLibRibRsbRgbRibRgbRsbLsRsbRibRgbRgbRgbLgbRibLsbRgbRsRsmbRgRsmb
RgbRgLsbRgLsbLsbRibLsRsbRgRsmbRibRgbRibRibRsbLsbRcbRgRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 39; Drug: PCAP2 1 然
bRsbLgbLsLsmbLgbLgbLgbLsbsbRobRcbRibLgbRgbRsbRgbRobRibRcbLeLgbLgbLgbLg
bLgbLgLsbLgbLgbLgbLsbLibLgbLgbLgLsbLgbLsbLgbLgLsbLgLsRsbLgbRsbRsbRsLsL
smbLibRjbRcbLoLsmbLibLgbsbLsbLsbLgbLgbLsLsmbLgLsbLgbLgRsbRgbLsLsLgmbLg
bLgbLsLsmbLgbLsbLgbLgbLgbLgbLsLsmbLsbLgbLgbLgbLgLsbLgLsbRsLsRsbLgbLgbL
gLsbLgLsbLgbLsbLgbLsbLgLsbLgbLgLsbLgLsbLsLsmbLsLsRsmbRsLsbLgLsbLgLsbLg
bLgLsbLgLsbLgbLgLsbLgbLgbLgLsbLgbLgbLgRsbLgbLgbLgRsLsbLhLsLgbLgbLgLsbL
gLsbLgbLgbLgbLsbLgbLgbRsRsmbLgbLgbLgRsLsbLsLsmbLgbLsbLsLsmbRsbLgbLsbLs
bLgbLgbLgbLgbLgLsbLgbRsbLgbLgLsbLgbLgbLsLsmbLsbLgLsbRgbLgRsbLgLsbLgbLg
bLsbLgbLsbLiLsbsbLsbLsLsmbLgbRsbLiLsRsbLgbLgbLgbLgbLsbLgbLsLsmbLgLsbLg
bLgbLgbLcbRhbRcbRobRcbRibRgbRibRgRsmbRgbLoLsmbLiRsbLibLibLibLgRsbRgbRh
bRobRiLsRsbRibRibRgRsmbRgbRibRsbRsbRgbRgbRgbRgLsRsbLsRsRiLsbLcLsmbLgbL
gbLgbLgbLgbLsbLgLsbLgbLgbLgbRsbLgbLibLibLcbRgbLibLhbRcbRobRibRcbRibRib
RgbRibRsRsmbRgRsmbRgbLoLsmbLibLgbLgbLsbLiLsbLgbLgbRsbLgbLgbLsbLgbLgbLg
bLgbLsbLgbsbLgLsbLgbLgbLgLsbLgbLgbRjbLgbLgbRsbLgbLgbLgLsbLgbLgbRsRsmbL
sLsmbRsRsLsmbLgRsbLgbLsbLgbLgRsbLgbRsbRsbLgLsbLsbLsRsbsbLgLsLsmbLsbLsb
RsLsRsbLsbLsbLsbLgbLgbLgLsbLgbLgLsbLgbLiRsbLibLgbLhbRcbRhbRiRsmbRgbRsb
RiRsmbLobLgbLgbLibLgbLgbLgbLsRsbLsbLgbLgLsbLgbLsbLgbLgbRsLgLsbRebRhbRc
bRgbRgbLibLcLsmbLgLsbLgbLgLsbLgbLsbLgRsbsbLgbLgLsbLsbRsbLsbLgbLsLsmbLs
LsLsmmbLgLsbRsLsLsmbRsbLgbsbLsLsLsmmbLsbLgLsbLgbLgRsbLgLsRsbLsLsmbLgRs
bRjbLgLsLsRsmbsbsbLsbLgbsbLgbLgbLgbLgbLgbRsbLsbsbRsbLgbRsLsbLsbLgLsRsb
LgbLsLsmbLgLsRsbLsLsmbLgLsbLgLsbLgbLsbLsbLgLsLsmbLgbLgbLgbLgbLsLsmbLgL
sbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 40; Drug: PCAP2 1 然
bLibLgbRgbsbsbRsbRsbLibLcLsmbRebRgbRebLibsbRibRjRsRsmmbLcbLjLsLsmmbsbR
jbLjLsmbRibRsRsRsmmbLcbLibLibRsRsmbLibLjLsmbsbLibLsLsmbLsbLsLsmbLgLsbR
ibRsbRsLsbLcbLgbRsbLgbLibLjLsmbRgbsbLibLibLgbLsLsmbLsbLiLsbRobRibRsbRi
bLgbLiLsbLibLibLgbLsbRgRsmbsbLgbLcLsmbLibLsbLsLsmbLibLsbLsbLcbsbLjLsLs
mmbLibLibLgLsbRcbLjbLcLsmbLibLibRsbLgbLibLgLsLsmbsbsbRgbLibRsLsLsmbLeb
LgbsbRibRibLcbLjLsmbLibLibLsLsmbsbLgbLhbLgbLsLsLsmmbRibLsbsbRsbLibLsLs
mbLsLgbLsbLsbLsbsbLjLsmbLjLsLsmmbLsbLibsbLibLgbsbLsbLgbLibRsRsmbsbRsbR
gRsmbLeLsbLiRsbsbRgbsbsbLhbLiLiRsLsbsbLgbLsbLcbLibsbsbLgbRiRsmbRsRsmbL
cLsmbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 41; Drug: PCAP2 1 然
bLsLsmbRibsbRhRsmbLsLsmbLsbLgbLsbsbRibRgRsmbsbsbLsbLcbLsbLibLsbsbLgbsb
LcbRsRsmbLibLsbsbsbRsbRsbRcbRgbsbRgRsmbRsRsmbRsRsmbRsRsmbRsbsbRsRsmbLj
LsmbRibLgbRhbRgbRsbLsbsbLsbsbRhbRgbsbRgbRsbRsbRsbRgbRibRsbRgbRsbLgbRgR
smbRibsbsbRsbRsRsmbRsRsmbRsRsmbRsRsRsmmbRsbRgRsmbRibLsbRsbRsbRgbRsbRgb
RibsbLsbRsbsbRsRsmbsbsbRgbRibRsbLgLsbLsbsbLibLsLsmbLibLsbsbsbRsRsRsmmb
LjLsmbRjbRsLcLsmbLsRsLsbsbRsbLsLsmbsbLibsbLgLsbLsbLibLsbLsLsLsmmbsbRgR
smbRgbsbRcbRibRgbRibRibsbLsbLsRsbLsbRcbLsLsmbRibLgbRibRgbRsbRgbLsLsmbR
ibLsbLsLsLsLsmmmbRgRsmbRibRsbRibRgbRsbLsLsmbRsbRsRsRsRsmmmbRsbRibLsbRg
RsmbRsbRsRsmbRsRsmbLjbRhbRsbRgbLsbRsbRibRibRsRsmbRsbRgbRsRsRsmmbLgbLib
LgbsbsbLgbLsbLsbRsbRsRsLsmbLibLsbLsbsbLibLsbLsbLsLsLsLsmmmbRsLsRsLsbRc
RsmbRibsbRibRsRsmbRsRsmbRsbRsRsRsmmbRsbRsbRgbRgbRsbLsLsLsmmbRsbRcbRibR
sbRgbRsbRsRsmbsbsbsbsbLibLsLsLsmmbLsbRsRsmbsbLibsbsbLsLsmbLsbRsbRsLsbR
gbLibLsbLgLsbLsLsLsmmbLsbsbRgbLjLsLsmmbRsbsbLgbRsbLsLsLsRsmmbLiLsbLsbL
sbLsbsbsbLjLsmbLsbLsbRsbLibRjbLibLsbsbLsLsLsmmbRsLsLoRsbLibLibLsbLsbLs
LsmbLsbLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 42; Drug: PCAP2 1 然
bRgbRsbRgbRsRsmbRibRgRsmbRgRsmbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRsRsmbRib
LcbLhbLsbLiLsbLgbLgbLgLsbLgLsbLgbLgbLgbLgbLgbLgLsbLgbLgbLgRsbLgbLgbRgb
LibRsbLiRsLsbRsbLsLsmbLsbLibRgbLgLsLsmbLgLsbLgLsbLiLsbLgbLgbLgbLgbLgbL
gbLgbLgbLgbLgbLgbRsRsmbLiLsbLgbLgbLgbLgbLgbLgbLgLsbLgLsLsLsmmbRcbRibLj
bRhbLcbLcbRsRsLsmbLiLsbLgLsLsmbLgbLgLsbLcbRsLsbLhbLcbLibLibLibLgbLgRsb
LibLsbLgbLsbLgbLgLsLsmbLgLsLgbLgbLgLsbLiLsbLgbLcRsbLcbLibLgbLibLgbLiLs
LsmbLibRgbLiRsbLibLgbLgLsbLgLsbLgbLiRsRsmbRcbLjbLhLsbLgbsbRcRsmbRiLsRs
RsmbRsbRibRibLobLgLsbLgbLiLsbRsLsbLiLsbLgbLibRgLsbLibLsbLcbRiLsbLcbRjb
LobRsbLcbLgRgbLcRsbLsbLsbLibRsLsbLgLsbLsbLgbLgLsbLgLsbLsLsmbLgLsbLgbLs
LsLsmmbLgLsbLgbLsbLgbLgbLgbLsbLgbLsLgbLsbLgbLsLsmbLgbLgbLgbLgbLgbLgLsb
LgbLsbLgbLsLsmbRgLsbLgbLgbLgbLgbLgbLgbLgbLgbLsLsmbLgLsbLgbLgbLgbLgbLgL
sbLgLsbLgbLgbLgLsbLgbLgbLgbLgbLgbLsRsbLgLsRsbLgbRibRibRhbRsLsbRhbLcbRj
bRhRsRsmmbLcbLgbLgbLgbLgLsbLgbLgLsbLgbRhbRcLsbLjbRcbRibRcRiRsmbRsbLibL
gRsbLgbRcbRgRsLsmbLebRcbRibLjbRiRsmbRsLsbRgbLhbsbLcRsbRsLsbLibLgbLgLsb
LsbLgLsLsmbLsbLgbLibLibLcbLcbLibRcbLoRsbLsbLgbRgbRjbRhbRiRsmbLcbLibsbL
gLsbLgbLsLsLsmmbLgLsLsmbLgLsbLgbLgLsbLgbLgbLsbRjbLgbLibLgbLgbLgLsbLgbR
sLgLsLsmbLgbLgbLsbLgbLgbLsbLgbLgbLsbLgLsbLgbLgbLgLsbLgbLgbLgLsbLgRsLsb
LgbLgbLgbLsbLgbRsbLgbLgLsLsmbLsbLgLsLsmbLgbLgLsbLgRsbLgbLgbLgLsbLsLsmb
LgRsbLgbLsLsLsRsmmbLgLsbLgbLgbRgbRjbRcLsbRcbRiRsmbRsbLhbLibRjbRibRiRsm
bLgbRgbRgbLjbRgRsmbRgbLsbRgbLobLhbRgbLiRsbLhbLobLcbLobLsbLgbLgbLgbLsbL
gLsbLgbLgLsbLsLsmbLibRjbLsbLiLsbLsbLgbLsLsLsRsmmbLcbRsbRcbRhRgbLeLsbRj
bRiRsmbRibLcbLcLgLsbLibLgbLgLsbLgbLgLsbLgLsbLgbLgbLgbLgLsbLgbRgRsmbLgb
LgbLgbLgbLibLgbLgbLgbLibLgbLibRhbLhbLgbLgbLsbLgbLgLsbLgbLgbLsLsmbLgLsL
smbLgbLsbLgLsbLgbRsbLgbLgbLsLsmbLgLsbLgLsbLgbLgbLgbLgbLgbLgbLsLsmbLgbL
sbLgRsbLsLsmbLgLsbLgbRgbLibLgRsbLgbLgbRsbLgLsbLgbLgbLgLsbLgbLsbLsbLsbL
gLsbLsbLgbLsLsmbLgLsLsmbLgbLgbLgLsbLgbLgbLgLsbLgbLgbLgbLgLsbLgbLsbLsLs
mbLgbLgbLgLsbLgLsbLgbLgbLgLsbLgbLgbLgbLgLsbLsbLgbRgbLgLsbLgbLgbLgbRsbL
gLsbLgbLgbLgbLsbLgbLsbLgLsbLgbLgbLgLsbLgLsbLsbLgbLgbLgbLsbLgbLsRsbLgbR
sbLsbLgLsbLgbLgbLgbLsLsmbLgbLgbLsbLgbLgbLgbLgbLgbLsbLgbLgbLgbLgLsbLgbL
gbLgbLgbRsLsbLgLsbLgbLgbLsLsmbLgbLsRsbLgbLgbLgbLsLsmbLgbLgbLsRsbLsLsmb
LhbLcbRhbRgbRibRiRsmbRsLsbRibLsRsbRiLsRsLsbLhbLibLiLsbLgLsbLgbLsbLgLsb
LgbLsLsmbLibLgbLibRjbRhbRibRgbLjbLoLsLsmmbLibRjbLcRsbLgLsbLsbLiLsLsmbL
gLsbLhbLcbLhLsbLibLgbRjbLsRcRsmbLobLsbLgLsbLsbLgLsbLgLsbLgbLsbLgLsbLsb
LgbLgbLgbLsbLsbLgbLsLsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 43; Drug: Control
bReRgbLibLgbLhLsbRibLcbRibLibLsbLgbLgbLsbLsbLgbLsRjbLibLgbRcbLjbRjbRiL
sbLcLsmbLibRgRsmbRibRsLsbRsbRgLsbRjbRibLhbLcbRjbLibRjbRjRgRsmbRibRsbRs
bRibRgbLibRibRgbLgbRibLgLsbRibLgbRiLsbLsbRsbRibLsbRibRibLcbLibLibLgbLs
bRibLgbLgbLgbLsbLgbLibRsbLgbLgbLgbRjbLgbRhbRibRgRsLsmbRibRgRsmbRsbRsbR
gbRjbRcLsRsbRcbRebLebLhbRibLgbRjReRsmbRibRsbLsbRsbRgLsbRsbRgbLgbRiRsmb
LsbRsbRjbRibRsbRibRsbLsbLjbRibsbRsRsmbRgLsbRsbRhbRsbLsbRgbRsbLibRiLsbR
gRsmbRgbLgbRibLgbRgbRsbRsbRgbRgbLgbRsbRgbRgbRgbRibRiRsmbRgbRsbRsbLsLsm
bRibLsbsbRgbLjbRibLsbLjLcbLibLgbLsbLibRsRsmbLgbRcbRgbRibLsRsbLsbLiLsLs
mbLsbLsbLsLsmbLgbLsbLibLsbRjbLiLsbLiLsbRsbRjLibRsbsbLgbLsbLgbRibLibLgL
sbLgbLsLsmbLsLsLsmmbsbRsbLgLsRsbRgbLibLsLsmbRjbLgbLgLsbLsLsmbRgbLibLgb
LsbReRsmbRhbLgbLsRgLsRsbRibLgbRibLsbLsLsmbRhLsbRsbRgbLibLgLsLsmbLcbLib
LsbRjRsmbRgbRsbRjRsmbRhRsRsmmbRibRibRsLsbRsRsmbRibRjbLibLgbLsbLsLsLsmm
bLibRsLjLsLsmmbLsLsmbRjbLibLgbLsLsmbRibLgbLibLsbLsbLgbLgbLsbLjLsmbLsLs
LsmmbLgbsbRibRibRiRsmbRsRsmbRsbLgLsbLsbLsLsmbLsbLsLsmbLsLsmbsbRibRgbLs
bLsbRhbRsbsbRsbRibRsRsmbRsbRibsbRsbLsbRgbRsLsbRhLsbRiRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 44; Drug: Control
bLgLsbLgRsbRgRsmbLiLsLsmbLibLsbLgbLgLsbRgRsmbRsLsRsbLsLsLsmmbRgRsmbRsb
RibRgbLibLsLsmbLgbRjLsbLibLsLsmbsbLibRibRjbLhbRsRsmbLcbLibLgbLgbLsbRsb
LgbLiLsbLgbRsRsmbRgRsmbRgbLsbRgbRgRsmbLgLsbLsbRgbRibRgbLsLgLsLsmbLgbLs
LsmbRjbLiLsbLgLsbLsLsmbRgRsmbLibLsLsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 45; Drug: Control
bRgbLsLsmbRjbLgLsbRjRgbRjbRgbRiRsmbLgbLgbLgLsbLsbRsbLibRcbRhbLjbLgLsbR
gRsmbLcLsmbLjLsmbLsLsLsmmbLsRsbLgbLgLsbLsbLgbLsbLgbLgbLibRsbRsbLiLsbLs
LsmbRsbLgbLsRsbLibLsRsRsmbLsbLgbLgLsbLsRsbLsLsLsmmbReRsmbRsRsmbRsbLsRs
bRcbRhbLjLsmbRibRsbRsbRgRsmbRsbRsRsmbLsLsmbLsLsRsmbLebLsbLsLsmbLsbRobL
sRsbRsbRgbRgRsmbLibLsLsRsmbRiRsmbRsbLgbRsLsbLsbRgbRibLsbRgRsmbRibRgbLs
bRibRsbRsLsbLsbRgbLsbLsbRebRibRgbLsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 46; Drug: Control
bRjbRgRsmbRsbRiRsmbLsbRsbRgbRsbRgbRgbRsbRgbRgbRsRsmbRsbRgbRsbLsbLjLibR
jbRjbRibRibLsbRsbRsbRgbRgbLsbRsbRgbLsbRsRsmbRsLsbRgRsmbRsbRgbRgbRgbRsb
RgRsmbLgbRibLsbRiLsbsbRsRsmbLsbLoLsmbLsbRsbRgbRgbRsbRsbRgbRsbRsbRsbLsb
RgbRsbLsbRgbRsbRsbRgRsmbLsbRgbRsbRsbRgRsmbRsbRgbRsbRsbLgbRgbRgbRgRsmbL
sbRibRibRgbRgbLgbLibLsbLgRsbLsbRsLeLsbLhbRibRibLsbLsbLgbLiLsbRgRsmbLgb
LsLsmbRsbLgLsbLsbLiRsbLgbRoRsmbsbRgRsmbsbRibLgbRsbRgRsmbLsbRsbRgbRsbRg
bRgbLsbRgbRsbRgbRsbRsRsmbRgLsbRsbRgbLebLgLsbLibRsbRibRibRibRsbRsbRgbRs
bRsbRsbRgLsbLcbRsLhLobRsbLsbLibRoRsRsmmbRgbRgRsmbRibRiLsRsbRgbRsbLsbLs
bRsbLebLsbLsLsmbRsRsmbLsRsbRebLibLhbLsbLgbLgbLibRsbLgbLgbLcRsbRibLhRsb
LjbLjLsmbRhbRsbLhRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 47; Drug: Control
bsbLgbLiLsbLgLsbLgbLgLsLsmbLgLsbLgbLgbLsbLgbLsbLgbLgLsbLsbRsbRcbRiLsbR
ibLibRibLjbRibRsbLsbRgbLsbRgbRgbRgbRsRsmbRgRsmbRsbRsbsbRgbRibRsRsmbRgR
smbRgbLcbsbLiLsbLgRsbRibLgbLobLcbRcRsmbRcbRibRgbLsbLebLgbLgLsbLgLsLgbL
gbLgRsbLgRsbLgbLsbLgLsbLsbRebRgbLebLhbLgbRsbLiLsbRsbLsbLgbLgbRcbRiRsmb
RibRgbLsbRiRsmbRsbRsbRgRsLsmbRgbRgbRgRsmbRgbRsLsbRgRsRsRgmmbRgbRgbRgRs
mbRgbRgbRgbRgbRgRsmbLsRsbRgbRgbRgRsmbRiRsmbRgRsmbRgbRgbRgRsmbRgbRgbRgR
smbRgbLebLhbLsRhRsmbRibLgbRgRsmbRgRsmbRgbRsRsmbRgRsmbRsRsRsLsmmbRgRsmb
RsRsmbRgbRgbRgbRgRsmbRgbRgbRsRsmbRgRsRsRsmmmbRsbRgRsmbRibRgbRgbRgRsRsR
smmmbRibLsbRsLibRjbRhbRcbLsRibLcbLhRsbLcbRibLibLhLsbRjbRcbLsbRibRhbRgL
sLsmbRgbRgbRsbRibLjbLibRsRsmbLgbLsbLsbLsLsmbLgLsbLibRibLcbRebRcLsbLsRs
LsLsmbRgbRcbLibLhbLibLoRsbLcLsmbRsbLobRsbLiRsLsRsLsbLsbLsLsmbLgbLsbLgL
sbLibRibLobLsbLibLgbLoRsbLsbRsbRiRsRsmmbRgRsmbLsbRgRsRsRsmmmbLsLsmbLsb
LiLsbLgbLgbRjbLiRsbLibRebRiRsmbLjbRcbRgRsmbRsbRgRsmbRgbLsbRsbLebLibLsb
LsbLgbRjbLhRsbLhbRgbRiRsmbRcbLebRibLoRsbLsLsmbLsbLgLsbLgLsbLgbLsbLiLsb
LsbLgbLsbLgbLsbLsLsmbLgbRsbLgLsbRsbLsbLgbLsbLsbLsbLgLsbLgbLgLsLsmbRsLs
bLgRsbRsLsbLibLsLsmbLgbLsLsmbLgbLgbLgbLgbLgbLsbLsLgbLgbRsbLgbRcbRgRsmb
LeRsbLibLgLsbLgbLsbRsbLiLgLsbLgbLsbLgbLgbsbRcbRibRgbRgbRgbRgRsmbRsRsmb
RgbRgRsmbLsbLcLibLibLhLsbLsLsmbLcbRgbLgbLoRsRibRcbLoLsmbLgbLoRgbLgbLib
LibLibRgRsmbLhbRjbLibLgbLgbLgbLsbLgLsbLgbLsbLsLsmbLgbLgbLgbLgbLsLsmbLi
LsbLgLsbLgRsbLgRsbLsbLgbLgLsbLoRsbRibLsbRibRiLsRsbLebLgbLhbRgLsbLgbLgb
LgbLgbLibRsLsbLgbLgbLgLsbLibLibRgbLsLsmbLibLgbLgbLgbRgbRcbRibLcbLibLob
LhbRsbLhbLgbLgLsbLibRsbLgbRjLsbRibRgbRsbRibLsbRgbRgbRgbRgbRgRsRsmmbRsb
RgRsLsRgmbRgbRsRsmbRgbRgbLsbRibLibRobLcbRibRibRgbLebRcbLcbRcbLobLhLsbR
ibRobLgbRibRgbLebLibLgbLsLsmbLgbLgLsbLgbLgbLgbLsbLgbLgbLgbLibLhbRibLib
LgbRibRibRhbLcbLgbLgbLhbRgbLsLoLsmbLobLgbLibLhbRhbRhbLsbRiRsmbLsbRibLc
bLcbRsbLgbLgbLiRsbLgbLsLsmbLgLsbRsbLibLgbLgbLsLsmbLgbLsbLgbLgbLsbLgbLg
LsbLsLsmbLgbLgbLsbLgLsbLsbLsRsbLgbLgbRjbRibRibRgRsRsmmbLsRsbRebRjbLcLs
mbLgbLgLsbLgLsbLgbLsbLgbLgbLgbLgbLsbLgbLgbLsbLsbRjRcLsbRebLgbLobRjbRhR
smbRibRibLhbRibLjbLhbLibsbLsbLgbLsbLsRsbLgbLgbRsbLgbLgLsbLgbLsbLgbLgbL
gLsbLgbLsbLgbLgbLgbRsbLcRsbRsbRgLsbLibLgbLsLsmbLgLsbRsbLobRgbRibRibRgb
RsbLcbLgbLsbLsbLsRsbLgbLsLsmbLgbLgbLsLsmbLsLsmbRsbLgbLgLsbRsRsmbLgbLib
LgbLgbLibRsbLibRibLobRsbRebRibLjbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 103601; End: 104101;
Recording: 4-1; Individual: 48; Drug: Control
bRsbLgbLgLsbLsLsLsmmbLibRgbLiLsbRsRsLsmbReRsmbRiLsbLebLcRsRsmbRsbRjbRh
bRgbLcLsmbLibRsbLgbLcRsbLgbLgbLibRgbLibLsbLsLiRsRsmbRgbRgbLibLcbLcbLib
RgbRgbRsbRibLcbLiLsbLsbLgbLgbLgLsbLsbLgLsLsmbLgLsbLgbLgbLgbLgbLgLsbLsb
LgbLgbLgLsbLgbLgbLsbLgbLgbRoRsRsmmbRcRsmbLhbLibRcbRcbRhbRibRibRgbLsbRi
LibRibRgbRiLsbLibLhLsLsmbLibLgbLgbLoLsLsmmbRibRcbLcbLhbLiLsbLibLibLgbL
ibRcbLcbLcLsmbLsRsbLcLsmbRgbRcbRhbRgbRcLsbLibLgbRgbRibLjbRcbLibRcbRibR
gLsbLibRibRgRsmbRgbRgbRgRsmbLcbLibLiLsbRgbLibLcbLcbLhbLibLcbLibRjbLhbL
ibLgbLgLsbRibRibRgbRcbRcbRiLsbRcLsbLgbRcbLgbRgbRgLsRsbRgbRgbRgbRgbRgbR
sbRgbRhbRibRsLsbLsbRsbLcRsbRhRsmbRibRsbRiLsbRibRibRsbRibRcRsmbsbRcbLcb
LiLsbLiLsbRebLcbLibLibLoLsmbRibLcbRcbLsbRibRgbRgbRibRhbLhbLsbLibLibRgb
RcbRibRibRgbRcbLibRgbLgbLgbLgbRsbLgLsLsmbLgLsbLsbLgbLsLsmbLgbRsLsbLgLs
RsbLgbLsbLgbLsbLgbLgbLsLsmbLiRsbLgbLgbLgLsbLgLsbLgbLgbLgbLsbLgbLgRsbLg
bLjbLcbLcbLhbLibLcbLibLibRgbRsbRiLsbRjbLcbLibLgbLsbLgbLgbRgbLiRsLsbRsL
sbLibRibLiLsbLgLsbLibLgbRibLiLsbLgbLgbLgbLgbLgRsbLgbLgbLgLsbLgbLgbLgLs
bLibLgbLgbLibLgbLgbLgbLibLgbRibLsbRjbRiRsmbLeLsbLcbRibRcbRsbRcbRobRcbR
ibRgbLsbRcbLjLgLsbLiLsbLcLsmbRsLsbLsbLgLsLsmbLgLsbLgbLsLsmbLsbRsbLgbLg
LsbLgbLgLsbLgbLgbLgLsLsmbLgLsbLgbLgbLgbLgRsbLgbLgbLgRsLgRsbLgbLgbLgLsb
LgbLgbLgLsbLsbLgbLgLsbLgbLgLsbLsbRjbRcbLjbRcbRjbRcbRcbRcbRibRgbRgLsbLg
bLcbRhbRiRsmbRibRsLsbLcRsbLibLsRsLsbLsbLgRsbRsbLgLsbLsbLgbLhbLcbLcbLcL
sRsmbLibLgRsbLiRsLsbRcbRoLsbRcLsbRcbRsbRgbRjRsmbLcbRsbLcbLobLhbLcbRibL
cbRgLsbRjbRcRsmbRobRcbRibRgbRsbRcbRcbRgbRgbRibLsbLcLsmbLiRsbRebLobLiRs
bLcLsRsmbLcbLiRsbLiLsbLgbLgbLgLsbLsbLgbRsbLibLsbLgLsbLgbLsbLgLsbLgLsbL
sbLgbLgbLsLsmbLgbLgbLgbLgbsbRhbRsbLiLsbLsbLibLsbLgLsLsmbLgbLgLsbLgLsbL
gbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 1; Drug: PCAP2 10 然
bLsRsLsbRgbLcbLibLgLsbLsbRsbRcRsmbRgbRcRsmbReRsmbRgbRgRsmbRgbRsRsmbRsR
smbRgbRsbRgbRsbRgbRsbRsbRsbRsbRsbRsbRgbRgRsmbRsRsmbRgbLsbLsbLsbLsbLgbL
sbLiRsLsbRibLgbLsbLgbLsbLgbLcbLcbLsbLgbLgbLgbLgbRjRsmbRibRsRsmbRsbLgbL
sLsmbLgbLgLsbLobLgbLgLgbLgbLgbLsbLgLsbLibLebRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 2; Drug: PCAP2 10 然
bRsbRsRsmbRsbLsLsmbRsRibRhbLsbLsbRsLsbLsbLsbRsLsbRsbLsLsLsmmbRsLsbRsLs
bLsRsbLsbLsLsmbLcLsmbLiRsLgLsLgLsbLiLsLsmbLsbLgbLsbLibLgLsLsmbRgbLsbLe
bLiLsbLoLsmbLsbRobRiRsLgmbLcbLsbLsbLiLebLiLgbRibRsbRhRsmbRebLsbLsbLebL
ibRjbLcLsLsmmbLgbLsbLgbLebLsbRsbLgbLebLsbLiLgbLiLsbLgbLgLsbLcbLibLsbLg
bLsbLsLsmbRsbLgRsLgbRgbLjLsmbRibLsLsmbLiLsbLgLsbLgbsbRgbRibRgbLibLhbLs
bRsRsmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 3; Drug: PCAP2 10 然
bRcbRibRoRsmbRhRsmbRsRsmbRgRsmbRcbRgbRiRsmbRsRsmbLsbRobRsbRsRsmbRsbRsR
smbRiRsmbRsRgRsmbLsbLsbsbRgRsmbRobRsLsLsmbRsbsbRjRsmbRsRsmbRsbRsbLsLsm
bRsLsbsbsbsbRgbLsRgbsbRsbLjbRobLobRsbRsRsmbLsbRsRsmbRsbRsbsbsbLsbRsbsb
RsRsmbRsbRebLsbRsbRobRiRsmbRsRsmbRsRsRsmmbRjRsmbRobRibRebRibRoRsRsRsmm
mbRcRsmbRsRsmbLsbLcbLsbLsLsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 4; Drug: PCAP2 10 然
bRsRsRsmmbLcbLibRsRsmbRsbRobRgbLsbLsbRgbRsbRcbLsbLsbLgLsbRibRsRsmbRibL
gbLobRsLsbRgbLcRsbRsbRgbLibLsbLibRgbLhLsRsbLsbLibRsbLsLsmbRsbLgbRsbLgb
LsbLsbLsbLsbLgbLsbLsLsmbLgbLgbLgbLsLsmbLsbLgbRsbLsLsmbRibLsbRgbRibRsbR
gbRgbRsRsmbRsbRgRiLsbRsbLsbRibRsRsLsmbReRsRsmmbLiLsbLgbLgbLgbLsLsmbLgb
LsbLsLsmbLsbLsbLgbLgbLgbLobRsRsmbLjbLsbLsLsLsLsmmmbRgbLgbLsbLsLsLsmmbL
sLsmbRsbLgLsbRsLsbLgbLhbLcbLsbRsbLiRsbLibRsbLsbLgbRsbLibLsbLiLsbRgRsmb
RsbRgbRoRsRsmmbLsLsmbLgbLgbLgbLsbLsbLsbLsbLsLsmbRoLsbRgbRgbRgbRsRsmbRs
RsRsmmbRsRsmbsbRgbRgbRsbRsbRsbRsbRgbsbLsbsbRsbRsbRgbRgbRsRsmbRgbRsbRgb
RoLsbRsRsLsRsmbLgbLhbLsLsRsmbRgbLibRsbLsbLibRsbRebRibRgbRsRsLsmbLsRgbR
gRsmbRsbLsbRgRsmbRgbLsbRgRsmbRsRsmbRgbRsbRiRsmbLgbRebRgRsmbLjbLiLsbLsb
LgbLgLsbRgLsRsbLsbLsLsRsmbLgbLsLsmbLgbLsbLgbLgLiLsbLibRgbRgbRgbRibRgbR
eLsbRgbLibLsLsmbLgbLsLsmbLgbLgLgbLgLsbRsbLhLsbRgRsmbRibLcRsbRgbRsbLcbR
jbLgbLgbLgRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 5; Drug: PCAP2 10 然
bLsbLsbLgLgbLibLobLgRsbRibRgbRsbRoRgbRcbRgbLsRsbLsbLsLsmbRsbRsbLiLsbRs
LsbLsbLsbLgbRsbRgbRibRgbLsLsmbLsbRsbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 6; Drug: PCAP2 10 然
bRobLiLgbLsLsLsmmbRoRsmbRsRsmbRgbRobLibRobRibRgRsmbRhRsRsRsmmmbRgbRcLs
bLsbReRsRsRsmmmbLgbRibRcbLgLsbRebRgbRebRobRgbRibRgbRgbLsbRgbRsbRsbLibL
gbLgbLgbLibLebLsRsRsLgLimbRobLebLsbRgRsLgmbRsLsbLibLsLsLsLsmmmbLgLsbLc
bLgLsbLgbLobRcbRobLsbLgbRebRsbRiRsmbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 7; Drug: PCAP2 3 然
bRjbRsRsmbRjRsRsmmbRsbRsbRibRsRsmbLsbLsRsbLcbLgLsbLsLsmbLgbLibLibLsLsm
bLgbRjbsbRebLcbLcbLsLsLsmmbLsLsLsmmbLsbLeRsRsmbLsbLibLsLgbLsLsLsmmbLgL
sbLgbLibRjRsmbRgbRsRsmbLsbLebRsRsmbLibLsbLebLibsbRgbRsbRgbLsbLsRsbRsbL
sbsbRsbRgLsbRsRsmbLsLsRsmbLsLcbLgLsbRsbLiLsbRsbRsbRsbLsRsbsbRjRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 8; Drug: PCAP2 3 然
bRgbRgRsmbLsbLsbLhRsbRsLsbLcbLsLsmbLsLsmbLgRsbRjRsmbRcRsmbRiRsmbRsLsbR
sRsmbRgbRsRsRsmmbRgLsbRgbRsbLsRobLgLsbLgRsbLgbRsbRebLsbRsbRgRsmbLsRsbR
cbLebLhRsbLgbLgbLibRgbRcRsRsRsRsmmmmbRsRsmbRiRsmbRcRsmbRgRsmbRsbLhLsbL
gLiLsbLcRsbLgRsLsRsLsLsmbsbLiLsbLsLgLsbLgRsbLsbLgLsLgLsLsmbLiLsbLgbLiL
ibLgbRcbRsbRjbRcbRgbRibRsbRiRsmbRsbRsRsmbRiRsRsmmbRgbRiRsmbRsbRibRgRsm
bRsRsmbLsbLhRsbLibRjbRgRsmbLibLibLgbRebRgbRsRsmbRsRsmbRsRgbRgbRiRsmbRg
RsmbRiRsmbLibLcbLsbLgbLoLsmbRibRsRsmbRsRsRsRsmmmbRsbRgbRgbRiRsmbRgRsmb
RgbRsbRsRiRsmbRgRsmbRibRgRsmbLsRsbLgRsbRibLsbsbRgRsmbRibLgbRibRhbLsbRc
RsLsmbsbRsbRcRsmbRsbRgRsmbRgRsmbLsbsbRsbRibRsRsRsRsmmmbRibLsbRgRsRsRsm
mmbRgbRcbRsbLsbRiRsLsRsRsmmbLgbRcbLsbRsRsmbRsbRsRsmbRiRsmbLsbLsbLcRsbL
gbLsLsLsmmbRsbRsbReRsmbLsbRgbRsbRhbRsRsmbLsLsmbRsbRgRsmbRsbRsbRgbRgbRg
bRsRsmbRsRsmbRsbRgRsmbRsbRgbRgbRsbRsRsRsmmbRsbRsbRsRsmbRgRsmbRibRgbRgb
RgbRgbRgbLsbRsRsRsmmbRsbRsbRsbRgRsmbRgbLsbLsRsbRsbRgbRibRsRsmbRsbRgRsm
bRsRsRsmmbRsRsmbRgbRsRsmbRgbRgbRsRsRsmmbRgbRsRsmbRgRsmbRgbRsbRsRsmbRsL
sbRgbRgRsmbRgbRsbRsbRgRsmbRsRsRsmmbRgbRgbRgbRobRsbRhbRgRsmbRsbRsRsmbRi
RsRsmmbRcbLsbRsbRcRsmbReRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 9; Drug: PCAP2 3 然
bLibLgLsbLgbLgbRhbRibRsbLsRsbRsbRgbRsbRgbRgbRgRsRsmmbRibRsbLsbRibRsRsm
bRgbRibLsbRgbRsbRsbRgbRgbRgRsmbRgRsmbRsbRgRsmbRgRsmbRsLsbRgbRgLsbRgbLs
bRsRsmbRsbRgbRsbLsRsbRgRsmbRsRsmbRsRsmbRgbRcbRibRibRgbRibRiRsmbRgbRsbR
gRsmbRsbRgbLsRgbRsbRsbRgbRsbRsbRgbRsbRgbRgbRgRsmbRgbRgbLebLcbLgbRibRib
RgRsmbLgbRgRsmbRgRsmbRsRsmbRgbRgbRsbRsRsmbRsRsRsRsmmmbRgbRgbRsbRsRsmbR
sRsmbRgbRsbLsRsbRsbRgbRsRsmbRsbRsbRgbRgRsmbRgbRsRsmbLsbRgbLsLsmbLsbRib
RsRsRsmmbRsbRgbRgbRgbRgbLhbLcLsmbRgbLibRjbLhbRjbRcRsmbRibsbRsRsmbRsbRs
bRgRsRsmmbRgRsmbRgLsbLsbRsbRibRsRsmbRsRsmbRsRsRsmmbRsbRgbRgRsmbRgRsmbR
gbLgbLjbLcLsmbLgbRjbRcRsmbLsRsbLsRsbRibRcRsmbLsLsmbLsbLiRsLsbLhbLcbLiL
sbLsbRebRibLsbLjbRcRsmbRsLsbRsbRgRsRsmmbRsRsmbLsbRgbLsRsbRgRsmbRgRsmbR
gRsmbRgRsmbRgRsmbRgRsmbRgbRgbRsbRgbRgbRgbRgbRgbRgbRsbRgbRiRsmbRgbRgbLi
bRiRsmbRibLjbLcbRjbRcbRibLsbRjbRgbLsRsbRsRsRsmmbRsbRsRsmbRsbRgbRsbRgbR
sRgbRsbRgLsbRgbRgRsmbLsbRgRsRsmmbRgbRsbRgbRcbLibRibRgbRgbRhbRgbRgbRgRs
mbRgbRgbRsbsbLsbRgbRibRgbRiRsRsmmbRgbRgbRgbLgbRibLsbRgbRgLsbRsbRsbRsbR
sRsRsmmbRgbRgbRsbRsRsRsmmbRsbRgbLsRsbLsRsRsRsmmbRgbRsRsLsmbRsbLsbRsbRs
bRsRsmbRsRgbRsbRsbRgbRibRsbRgbRsbRsRsmbRsbLsRsbRsRsmbRibRsbRsbRgbRiLsb
RsRsmbRgbRgRsmbRgbRgbRsbRgbRsbRsbLsRsbRgLsbRgbRsRsmbRsbRsbRgRsmbRgbRgb
RsbRgbRsLsLsmbRgbRgbRsRsmbRsRsRsmmbRsbRsbRsRsmbRsbRsRgRsmbRsbRgbRsbRiR
smbRsbRsRsmbLsbRiRsmbRsbRibRsbRgbRgRsmbRsbLgbRsbLsbRsbRsRsmbRgbRsRsmbL
jLgbsbRjbRjRsmbLibLsbLgbLsbLibRgbRibLsbLcbLiLsbLibLgLsbLsLsmbLsLsmbLgL
sbLgLsbRsbRhbRiRsmbLsbLjbLsbRsbRibRsbRgbRsLsbRgbRsbLsRsRsmbRsbRgbRsbRg
bRsbRgbRgRsmbRsbRsbRsbRsbRiRsmbRgRsmbLsbRsbRsbRgbRgbLsRsbRsbLsbRgbRsLs
bRgbRsbRgbRgbRgbRsbLsbRgRsmbRsbRgbRsbRsbLsbRsbRsRsmbRsRsmbRgRsmbRgbRgb
RgbRsbRgRsmbLsRsbRsbRsbLsRsbLsbRsbRsRibRgbLjbLjbLibLibLcbLsRsbRgbRibRs
RsmbRsRsmbRsRsmbRgbRsbRsRsmbRsbLsRsbRcbLgbLsbLsbRibRibRgbRgbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 10; Drug: PCAP2 3 然
bRsbLsbLgbLiLsRsLgbRsLsbRcbRsRsmbLsbLsLsRsmbRgRsmbRgbRgbRsbRsRgbLsbRsR
smbRsbLsLsLsmmbLsbLsLgLsbRsbLsbLgbRsbRsbRsRsRsmmbRsRsmbRsRsmbRgbRgbRsb
RgRsmbRsbRsbLsbLsbRibRebRgbRgRsmbsbLgbRsLsbLsbRgbLsLsLimbRsbRgRsmbLsbs
bRsbRjbsbRsbRsbsbRsbLsLsmbLsLsmbLsbRsLsbLsbLsbLsLsmbRsRsmbRsbsbRgbLsbs
bLsLsmbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 11; Drug: PCAP2 3 然
bLsbLsbRsbLebLibLsbLsbLibRibRibRsRsmbRibRgRsmbRiRsmbRsbRebLsbRsbRsbRib
RsRsmbRsbLsbRgbLgbLsbLsbRibRgbRsbRibRsbRsbRiRsmbRsbLsbLsbRibRjRgbRgRsm
bLsbLsbRibRsbRgbRsRsmbRsLsbRiRsmbRsbRsbRgbRibRsbRsbRsbRjRgbRibRsbRgbRs
RgbRsbRibRsbRibRsbRsbRibRsbLsbRgbRsbRsbRsbRiRsmbRsRsmbRsbRibLsbRsbLsbR
gRgbLsbRsbLcbRsbRgbLgbLgbRsbRjbRcbLsbRcRsmbLcbLcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 12; Drug: PCAP2 3 然
bRsbRsbRiRsmbRsbLgbsbRsbRsbRsbRgbRsRsRsmmbRgbRgbRsRsmbRsLsbRsRsRsmmbRs
bRsRsmbRsbRgbLsbLsbsbRsbRibRsbLgbRibRsbLsbRsbRsbRsbRgLsbRsRsmbRsRsmbRs
LsbRsbRsbRsbRgbsbRsbRgbsbRibRsbRgbLsbRgbRgbLsbsbRsbRgbRgbRsbRgRsmbRgbR
sbLsRsbLhbLsbLibLgLsbLgbLsbLsbLgbLsRsbLsbLgbRsbRsbRcbRibLsbLsbRsbRgbRs
bLsbRsbRgbRsbRsbRsbRsbRsRsRsmmbRibRhbRsbLgbLgbLsRsRsmbLgbLibLsLsmbLgbL
gbsbRsbLgbLgbLsbLgbLsLsmbRcRsmbLgbLibLcbLebLibLsLhbLsbRsbLibLsLsmbLsbL
jbLsbRcRsmbRcRsRsmmbRsbRsbRsbLsbLsbsbLcbLcbLsLsmbLsbRsbRsbLsbRiLsbRgLs
bRsbRsbRsbRsbRsbRgbsbsbRsRsmbLsbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 13; Drug: PCAP2 1 然
bRsbLsbRsbRsbRgLsbRsbLsRsbRgRsmbRgbRsbRsRsmbRgLsLsRsmbRsbsbRsbRgbRsRsm
bRsbLhbsbLibLibRibRgbRgbRiRsmbRibLsbLgbRibRibRgbRsbRsbRsbRgbRgRsmbRsbR
sRsmbRsbRgbRgbLsbRibLcbLebLibLsbLibRgbLcLsmbRgRsmbRsbLibLsbLibLgbRgLsb
LsbLsbRsbLjRsbLgbRgbLibLibRsbLgbLsbRsbLebRgbLhbRsRsmbLgbLsbLebLsbLsRsb
RiRsmbRsbRsbLgbRsRsmbLsbLgbRsLsbsbRjRjbLsbLsbsbsbLjLsmbLeLsbRsLsRsbRsL
sbRgRgbRsbRsRsmbRhbLsLsmbLibRibRibLgbRibRgbRsbLgbLsbsbLcLsLsmmbLeLsbLi
RsbRsbRiLsbRibRsbRgRsRsmmbLsRsbRibRsRsmbRgbLgbRsbRibLgbRibRsbRsbRibsbL
sbRgLsbRsRsLsmbRibRsbRsbRjRsmbRgbRsbRcbRhLsbRcbRiRsmbRebRgbRjRgbRsRsmb
RgbRibRsbRsbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 14; Drug: PCAP2 1 然
bRsbRibRhbRibsbLgLsbRgbRiRsmbRsbRsbLsbRhbRjRsmbRgbRgbRsbRgbsbLsbRsRsRs
mmbRgbRibRgbRgbRgbRsRsmbRsbRgRsRsmmbRiRsmbRhbRgbRsbRsbLgbLsRsbRibRcbRs
bRiRsmbLsbLgbLgbLsbLgbLcRsbLibLsbLsbRsbLgbLcbLibLibLsbRsRsmbsbRhbRibRs
bLsbLsbLsLsmbLjbRibRjbRgbRibLibLibLgbLsbRibRibRgbRsbRibRgbRsRsmbRsbRsb
LgLsbLgbLgLsbLsbLcbRsRsmbRcbRjRsmbLgLsbRjRgbRsbRiLsbRgRsmbRhbRibRhbRsb
RsbRjRsmbRgbsbLsLsmbRjbRgbRiRsmbRsbLsbLsbRjRsRsRsmmmbRgRsmbRgbRsbsbRsb
RsRgbRgbRsRsmbRsRsmbRgbRgbRsLsbsbLsbRgbRsRgbLsRsbRibRgRsmbRsbsbLsbLgbL
iLsbLibsbRgbLibLsLsmbRcbRibLsbRibRsbLjbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 15; Drug: PCAP2 1 然
bRibLsRsbRibRgbLsbRibsbRgbRibLibLibLhbLiRsbLsbRhbRiRsmbRibRgbLsbLgbRib
RiRsmbLgbRcbLsbRibLjbRibRibLgbRibRgbRgbLgbRcbRgbLhbLgbLcbLsLsmbRjbRhbL
sLsmbRhbRibRgbRibRibRgbRibLsbRibRgbRibRibRsRsmbRgbLsbLcbLebRcbRcbRibRc
LsbRibRibLgLsbRcbLsbRibLibRoRsRsmmbLsbLibRhbRcbLsbLgbRsbRcbRgbRibRiRsm
bRibRgbRibRsbRsRsmbLcbRcbRibRgbRgbRgbLsbLibLgbRjbRiRsmbRiLsbLsbRiRsmbL
sLsRsmbRibRibRsbLgbRgbRibRsbRhbRsbLiLsbLgRsbRcbLhbLibRsbRebRcRsmbLgbRo
LsbRiLsbLibRibRibRgRsmbLsbLgbRibRibRsbRgRsmbRgbLgbRgRsmbRibLsbRgbRibLg
bRiRsmbRsbRgRsRsmmbLsLsmbRgbRgbRgbRgbRgbRsbRgbLsbLsbRgLsbRibRsRsmbRgbR
gbLgbRibRsbRsRsRsmmbRgbRsbRgRsmbRgbLsbRibRsbRibLgbRibRgbRibRgbLsbRobRi
bRiRsmbRgbRiRsmbLsbRibRgbRgbRgbRgRsmbLsLsmbRgbRsbRgbRsbRgRsmbRgbRgbLcb
LhbLibRebLjbRibRgLsbLsLsmbRsbLsbRibLsbRibRsbRgbRibRgbLgRsbRibRgbRgbRsR
smbLcLsmbLhRsbLhbRjbLibLcbRhbLcbRgbLcbLgbRgbLhbRjbLhbRcbRcbRibRiRsmbRs
RsmbRibRhRsmbLgbRibRibRgRsmbRgbRgbLibRgRsmbsbRibRsbRgbRiRsmbRsbRsbRibL
sbLsbRibRgbRgbRgbLsbRibLgbRgbRgbRgRsmbRsbLsbRibRsbRsbRgbLsbRgbRibRsbRg
bLgbRiRsRsmmbRsbRgbRgRsmbRgbRgbLsbRibRgRsmbRgbRgbRgRsmbLsRgbLgbRgbRsbR
gbRiRsLsmbRsbRgbRgbRgbRgbRgbRgbRgbsbLhbRibRibRsbRibLgbRibRobLgLsbLsbLh
bRjbLibLcbRgbRjbRhbLcLsmbLibLgbLgLsbLgbLsbRibRcbLibRcLsbLibRcbRsbRibRi
RsmbRhbLcbLgLsbRibRgRgbRgLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 16; Drug: PCAP2 1 然
bLsLsmbLsbLibLeLsbLgLsbLsbLcbLgbLoLsmbLibLgbRsbLibLgbLebRjbLsbLgLsRsRs
mbRgbRjbRebRsbLsbLsRsbRibLsRsbRsbRsRsmbRgbLsbRibRsbLsbRsbRibRgbRsLsbRs
bLsRsbRsRsRsRsRsmmmmbRsbLebLsbRcRsmbRcRsmbRiRsmbLsLgbLibRhbRgbRsbRiRsm
bLgLsbLsbRgbLsbRgbRgbRsbsbRsbRsbRebRsbRsbRoLsbRgbLgLsbLsbLsbLgbRsbRgbL
sbLibLgbLibLsbLsbRcbRsbLsbLcbLebLsbLgbLsbRsbRibLgbReLsbLcbLebLibLibLsR
sbLgbRsbLgbLgbLsbRibRibLhbLibLebLibLhbLsLsRsmbLgbRsbLibLsRsbLsbRgbRjbL
gbRebRiRsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 17; Drug: PCAP2 1 然
bRsbLhbLgbLiLsbLgbRgbRsbLcbLcbLsbRsbRsbLsRsbLsLsmbLhbLgbLsbRsbLsbRsbLg
LsbLgLsLsmbLsLgbLsbLsLsmbRsRsmbRsbRsLsbLibLsLsLsLsmmmbLsbLsbLsLsmbLgbL
gLsbLsbLsbsbLsLsmbRsRsmbLgLsbLsLsmbLsbRsbLgbLgbLgbsbLsbLsbLjLgbRgLsbLg
RsbLsLsLsLsmmmbLsLsmbLsbRsbLiLsbLgbLgLsbLsLsmbsbLsLsmbLibLgbLsLsmbLsbL
sbLsLsLsLsmmmbLgLsbLsbLgbLgbLsLsmbLgbLsLsmbsbsbsbRsRsmbLsbLibLsbRsLsbL
ibLgbLsLsmbLgLsbLsbLsLsmbLgLsbLsLsmbLgbsbLsbLgbLgLsbLgbLsbLsbRsbLibLgL
sbLsbLsLgLsLsmbLgLgLsbLsLsLsmmbLiLsbLsbLgLgbLgLsbLsLsmbRgLsbLibLgbLsLs
mbRsbLibLsLsmbLsLsmbLsLsmbLsbLgLsbLsbLsLsmbLsLsmbLgLsbLgbLibRgbLhbLgbR
gbLhbLsbRsLsbLgbRsbRsRsRsmmbsbsbLgbLsbLjbLhLsbLsbRsRsmbLibLibLgbRsRsRs
RsRsLsmmmmbLgbRsbLiLsbRsLsbRsRsmbRsRsLsmbLiLsbLgbLsbLsbLsbLsLsmbLsbRsb
RsbRsLsbLsRsLsLsLsmmbsbLgbLibRsbLgbLsLsLsLsmmmbLgbRsLsbLsbLibLsbLgbLsL
sLsmmbLsbLibLsbLsbRgRsmbsbLgLsbLgbLsbLgLsbLgbLsbLgLsbLsLsmbRsbLibLsLsm
bLsLsmbRsbLgbLgbLsbLgbLsLsmbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 18; Drug: PCAP2 1 然
bLhbRoRsmbRibLhbLsbRcbRhRsmbRibRsbLiLsRsbLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 19; Drug: Control
bRgbRjbRobRibLgbLgbRgbRcbRibLcbLgbRsbRjbLgbLjbLgRsbLsbRsbLgbLjLsmbLsbL
sbLsbLsLsmbLgbLsbLgbLsbRgbLgbLsbRsbLsbLgRsbLgLsbRibRsLsbLsbLsbLibLsbsb
LoLsmbLobRiRsmbRsbLobLsbLobRsbLsbLsbRsbLiLsbLgbLgbRsbLgbLgbLgbLibLsbRg
bRsbLiLsbRibLobRsbRibLsbLgbLsbLibLgbLgbLgbLgLsbRsLgbRjbLiLsbLjbRibLjbL
iLsbLsbLsbLgLsbLsbLgbsbLsbsbLsbLgbLsbLgLsbLgbLsbLsbLgbLgbRgbLsbRsbsbsb
LsbRsbLsbsbsbLsLsmbLsRsbRsbRsRsmbRsLsbRsbRoLsbRibRgbRsbLibRibRgbRsbRsb
LibRebLiLsbLsLsmbRsRgbRibRjRsRgmbLcbRsLhbRcbLiLsbLsbRsbLibLiLibLoLsmbL
iLsbLgbLsbRsbLibLgbLgbLgbRsbRiRsmbsbLsRsbsbsbsbLsbsbsbRsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 20; Drug: Control
bLsbLsbRibLjbLcbLgbLibLgLsbLgLsbLsRsbLibLsRsbLsLsmbLsLsmbLsbsbLgbLgbLg
LsbLsbLgbLgbLgbRsbLgbLgLsbLsbLgbLgLsbRsbLsLsmbLsbsbLgbLgbLgbLgbLgbLsbL
iLsbRgRsmbLibLgbLgLsbLsbLgbLgLsbLgbLgbLsbLsbLgbLoLsRsLsmbRibRgbRobLsbL
iLsbLgbLebLibLsbRobLsLsmbRcbLsbRibLgbRsbLebLgbLjbLibLsRsLsbLgbLsLsmbLg
LsbLiLsbLsbLsLsmbLsLsmbLsbLsLsmbLgbLgbLgbLgbLgLsbLgbLsbLsRsbLgLsbLgLsb
RsbLsRsbLiLsRsbLgbLgbLgbLgbLgbRsbRiRsmbRgRsmbRibRsLgbLcbLsRsbRsLsbRsbL
gLsbRsLsbLgLsLsmbRsbLgRsbLgbRsbLsbLsbRsRsmbLsbLsbLsbLsbLgbLgbLgbLsbLsL
smbLsbLsbLgLsbLgbLgbLgLsbRsLsbLibRgbLsbLibLsbRsbLgbLgbLgbLgbLiLsLsmbRo
bRibRhbLgbRcbRibLcbLhbLsbLgLsbLgbRsbLsLsmbLgbLgbLgRsbLsLsmbLgbLiLsLsmb
RjbRcbsbRhbRcbLgLsLsmbLiLsbLibLgbRsbLgbLgbLgbLcbLobLgbLiLsbRsbLgbLgRsb
RgbRjLsbLgbLibRsbLgbLgbLsbLgbLgLsbRsbLsbLgRsbRsLsbRjbRcbRcbLiLsbRcLsbL
gRsbRcbLgbRibLjbLcbLhbRsLsbLsbLcLgbRibRsLsbRsLibLsLsmbRsLsbLsLibRgbLgb
sbLsLsmbLsLsmbRgbLsbLsbRcRibsbRsbRsLjbLibRcRsmbRiRsmbRibRibRsbLgbRjbRi
bRsbRiRsmbRsbRgbRgbRsLsbRgRsmbRgbRsRgbRsbRgbLgbLebLsbLsLsmbLsLsmbLsbLg
bsbLsbLsbRsbLsLsmbLgbLgbLibLgbLsbLgbRgbLiRsbLgLsbLgbLgLsRsbLsbLsbLgLsb
LgbLgbLgbRsbLgbLgbLsLsmbLgbRgbRibLiLsbLiLsbLcbLibLibRcbRibRibRgbLgbLib
LgbRcbRgLsbLsbRibLsbRibRgbRgbLhbLcbLgbRibLibLgRsbLsbLgbLsbLsbLsLsmbLgL
sbRjRsmbLiLsbLgLsbLsbLgbRgbRsRsmbLsbLsbLsbLiLsbRcbRgRsmbLeLsbLgLsLsmbL
gbLcbLibLobLibRhbLcbRsLsbLgLsbRsbLgbLgbRsbLgbLibRjbLsLgbLibLgbLgbLgbRi
bRobRibLjbRcbRiLsbRgbRibLsbLgbLibLgbLgbRsbLgLsbLsbLgLsbLgRsbLsbLgbLgbL
ibLsbLiLsbRibRjbLjLjbLibLgbLgbLgbRsbLgbLgbLgbLsbLsLsmbLgbLgLsbRsbLibLg
bLgbRgRsmbRjbLjbLibRsbRsbLgbLgbLsLsmbLhbLsbLibRsbLsbLjbLsbLsbLgbLsLsmb
LsLsmbLgbLgbLgbLgbLsbLgbLsbLgLsRsbRjbLgbLibRgbLjbLsLsmbLsLsmbLsbLsRsbL
gbLgbLgLsbLsLsmbLgbLgbLsbLgLsbLgbRsbLibLsbLsbRsbLsLsLsmmbLsLsRsmbLgbLg
bLsbLgbLsLsmbLgbLsbLsbLgLsbRgbLibLgbLgbLgLsbLsbRsbLgbLgbLgbLgbLgbLgbLg
bLsbLgbRcbRiRsmbLibRib

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 21; Drug: Control
bRgbLibLhbLibLibLsbRsLsbRgRsmbRcbRgRsmbLibRsLsbRiRsmbRsbLsbRibRsbLsbRg
bRiRsmbRgbLgbRhbLsLsmbRibLsLsmbRhRsmbRibRsbRgbRsbLsbLgbLgLsbRjbLcbLsLs
mbLhbLsbLcbLibRgbRibRibRibRibLibRjbRgbLsbRsbLjbLibLhLsRsbLibLgbRibRsLs
bRcbRibLsRsbRgbLsLsmbsbRibRoRsmbRibLsbLsbLsbLsbRcLsbRgRsmbRsRsmbLsRsbR
ibRibLgbLjbRjbLgbRibRgbLjLsmbRjRsRsmmbRsRsmbRgbLsbLjLsmbRcbRibRgbsbRgR
smbLsbRjRsmbRgbLsLsmbLjbLcbRsbLgbRgbLgbLsLsmbRgRsmbLibLcbLibLiLsbRibRg
bRibLgbRcbRjRsmbLsbRgbRsbLsLsmbLgLsLsmbLibRgbLcbRgbLibRsRsmbRgbRsbRcbR
ibLsbLibRibRsbLgLgbRgRsmbLjbRgbRsbLibLhbLgbRibRiLsbRhRsmbRgbRgRsRsmmbR
ibLsbRjbRjbRgbRjRsRsRsmmmbRsbRgbRjRsmbRsRsmbsbRjRgbRjRsmbRgRgbRjbRgbRj
RsmbRgbRibLsLsmbRjRsRsmmbRgRsRsmmbRjRsRsmmbRjRsmbRjRsmbRgbRibRibRibLgL
sbLsbLgbRibLjbLjbLsLsmbRgRsmbRgbRjbRgbsbLjbRjbRjbLibRjRsmbRgbRgbRgbLgb
LsbRgbRibRgbLsbsbLsbRgbLsbRcbRibRgbRgRsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 22; Drug: Control
bRibLsLsLsmmbLgbLgbLsbLsbLsbRgbRobsbLgLsbLcbLgLsLsmbLsbLibRcLsbLgbRjbR
cbRibRgRsRsmmbRsbLgLsbRjbRobRibsbRiRsmbLgbRibRibRgbRgRsmbRcbLibLcbLgbR
ibRcbRcbRibRgbLibLsbLgbRgRhbLsLsmbRjRsmbRgRsmbRibRsRsmbRgbRsbRgbRsbRjb
RgbRsbRgbRibRiRsmbRcbRibRgbRgRsmbRjRsmbRibRibsbLsLsmbLjLsmbRjRsRsmmbRg
bRsbsbRhbRhRsmbRibRjRsmbRibRjRsmbLsbRjLsbLiLsbRobRhbRcbRiRsmbLgbRgbLcb
LgbRhbLgLsbLsLsmbRsbRgbRiRsmbRibRgRsmbRcbRcbRiLsLsRsLsmbRsbRsbRgbRgbRg
bRiLsRsbRiRsmbRgbRibRibLsLsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 23; Drug: Control
bRsbLsbRgbRgbLjbRibRgbRgbLgbRgRsmbsbLsbRgbLsRsbRsbRgbLsbLsRgbRgbLsbRsb
RgbRgLsbLgbLsbRgbsbsbLjbLsbRgbLgbRsbRgbLsbLjbLsbLibLsbsbsbLibRjbLcbRib
RcbLgbRiLsbLsbLcbRcbLcbLcbRebLcbLibLgbLcbRcbRhbLibRgbRibRibLsLsLsmmbRg
RsmbRgbLsbRhbLjbRhbRgbRibLjLsmbLcRsbRhbLgbLjbRibRhbRibRgbRgbLgbRibRhbL
ibRibRibRsbRiLsbRsbRsRsmbRgbRgRsmbRgbLgbRibRsbsbRiLsbLibsbRibLsbRibsbL
sbLgbRgbLsLsmbRgbRjbRgbRsbRsbRgbRgbRgbRgLsbRibRgbLsbLgbRjbLsLsmbLjbLcb
RjbsbRibsbRjbRsbRjbsbLsbRgbRgbRibRiLsbRgbRgbLgbRibRsbLsbRgbRsbRgLsbRgb
LgRsbRibRsbRibLsbLjbLjbsbLibRsbsbRibRibLsbRsbRsRsmbLsbsbRsbLjbsbsbsbRg
bRibLsbRibRgbRsbRsbsbRgbRgRsLsmbRgbRgbLsbLgbRsbRsRsmbRjbsbLsbRgbLsbRsR
smbRsbLgbRsbsbRsbRgbRsbLsbRibRiRsmbRgbLsbRgbLsbRibRgLsbRsbRgbsbsbRgbLj
bRibRgbRgbRibRsRgRsmbRsbRsbLsRsbRsbRsbRgbRgbRgRsmbRsRsmbRgbsbLsbRsbRsb
sbRgbLgbRjbRsRsmbRibRgLsbRgLsRsbRgbRsbLsbRsRsmbRsRsmbLsbRgbLsLsmbRgbRg
bRsbRgbLsRsbRgbRgbRgbRgbLibRibRibRiRsmbRsbRsbRgbLjbLcbLgLsbRjbLibRjbRg
bRibRsbRgLsbLjLsmbRibRibLsbRgbRgbRsbLcbsbLsbLibRibLsbLibLiLsbLibLiLsbL
gLsbLgbRsbRsbLiLsbRibLibLcLsmbLcRsbLiLsbRsbRgbRibRibLgbRsbRibRibLgbRgb
RibLjRsLsbRibRiRsmbLsbRcbLibRcbLsbRibRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 24; Drug: Control
bLcbLcbRebLibRcbRoLsRsLhbLcRsbLgRsbLgLsbRhbRiRsmbLsbRgbRsbRgRsRsmmbsbR
sbRsbRibLsbRibLsLsmbLjbLibLsbLibRjbLibRsbLsbLibLsLgRsbsbLsRsbLgLsbRsbL
ibLsbLgLsbLgbLgLsbLsbsbLsbLgbLsLsmbLsbRsbLiRsbRgbLibRjbRcbRiLsRsbRgbLh
bLcbRibLibLgLsRsbRsRsmbRebRhLsbLcLsmbRibRiRsmbRcbRcbRhbRhbLcbLgbLibRgb
LcbRgbLsbLhbRibLibRgbLibRibLsRsbLibsbRsLsbLcbLcbLhbRibLcbLsbLiRsbLgbRs
bLgbLibRiRsmbLibRgbLgbLsLsmbLsbRgRsmbLgbLsLsmbsbLsbLgbRsRsmbLsbLgbRibL
eLsbLgLsbRsbLibLgbLgbLsLsLgmbRsbRjbLjbLcbsbLibLsLsRsmbRsRsmbLgbRjRhRsm
bLobLjbsbLcbRebLsbLsbLsbLibLjLsmbLiRsbLiRsbRibLgbLgbRjbRcbLsbRsbLibLhb
RhbLsRgbRgbRgbLcbRibRhbLobLgbLcbLsbLsbRebRibRgRsmbLsbRibLsbRibRsbRgRsm
bRgbsbLiRsbLibLgbLsbLgbLgbLgbLgbLgbRsbLsbRibRgLsbRsbRgRsmbLsbRgLsbRgbR
sbRsbRsbRibLsbLsbRgbRsRsmbRsRsLsmbLsRsbRgbRgbsbsbRsLsbRsRsmbRgbRsbRsbR
gbRsbRsbRibRsbLjbLibRebRibLsRsRsRsmmbRsbRsbRobRcLsRsbRhbRiRsmbLiRsbRsb
RcbLibLsbsbsbRcbRsLsbRsbLsbRiRsmbRgbRsbRsLsbRgbRsbLsbRsbRsbRsbRsbRgbRs
bRgbRsbRgRsmbRsRsmbRgRsmbRgRsmbRsLsbRsbRgbRsbRibRsRsmbRgbsbRsRsmbRgbLs
bLjbLiRsbRjbRsRsmbLibRjbReLsbRcbLibLibRgbRcbLebLsbLcbRibLibRcbRcbLgbLg
bRibLcbLgbLgbRsbLsbRhbRibLsbRgbRsbRsbRgbLsbRibLsLgbRibLsbRibLsLsmbRgbL
jbLiRsbLgbLiRsbRsbLgbLgbRibLiRsbLgLsbLsbLgLsbLgbRgbLgbRobRgLgbLibLgbRs
LsLgbLgLsbLgLsbLgbRsbRsLsbLjbLsbRgRcLsbRiLsbsbRsRsmbRgbLsLsmbRsbRiRsmb
RsbLsbRgbRsRsmbRgRsmbLgbsbRgbsbRsbRsRsmbRgbLsbLgRsbRsRsmbRsbRgbRibRgRs
mbRgbRsbRsbsbRsRsmbLsbRsbLsRsbRgRsmbRgbRibRgbRgbRgbRsbRsbsbRsRsmbLgLsb
RgbRsbRsbRibRsbRgbRsbRgbRsbRgRsmbRsbRgbRsbRgbRgbRsLsbRgbRgRsmbRgbRgRsm
bRsbRsbRgbRsbRsRgbLsRsRiRsmbRsbRjLgbRebRiLsbRgbLsbRiRsmbRsbRibLgbRibLg
bLjbLhbRcbLebRibRcbLjbRcbRcLsbRebRgbRcbLjbLebLibRhbLcbLibRibRibRibRgbR
sbRgbRibRibLsbRibLgbRibRsbRsbRgbRsbRgRsmbRsbRgbRgLsbRgbRgRsmbLsbRgbRgR
smbLsbRgbsbRgbRsbLgbRsLsbRsbRsLsbRgbRgbRgbRibRgbLsbRsbRgbRsbRsbLsRsbRg
bRgbRgRsmbRgbRsbRgbRsbRgRsmbRgbRgbRgbRsbRgbRsbRsbRibRsbRsbRsbRgbRgbRgL
sbRsbRibLjbRjbRsRsmbsbRgbRsbRgRgbRsbRgRsmbRsbRsLsbLjbRibRgbLsbRcbLsbRg
bLsbRgbsbsbRibRgbRsbRgbRgRsmbRgbRgbRsbRgbRibRgbLsLiRsbRcbRgLsRsbRgbRib
RgbRsbRgRsRsmmbRgbRsRsmbRsbRibRgbRsbRsRsLsmbRgbRsbsbRsbRgbRsRsmbRgbRsb
RgLsbRgbRgRsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 25; Drug: PCAP2 10 然
bRcRsmbRsbRgbRgRsmbRcbRibRsRsmbRgRsmbLgbLgLsbLsLsRsmbRsRsmbLgbLiLsLsRs
mbRibRjbRjRsmbLgbLgbLgLsbLgbLibRcbRiRsmbRibRibRgRsRsmmbRgRsmbRgRsmbRsb
RgLsbLsbRsbRsbRsRsmbRgbRsRsmbRibRsRgRsmbLsLsmbRcbRebRiLsbRsbLsLsmbsbsb
RsbsbRsbsbsbLsbRsbRgbRsbRibRcRsRsmmbRjbRgbRsbRgbRsbRsbRsbLgbRcbRgbRsbR
cRsmbRibLgbLsbRcbRsbRibRsbLgbLsbRcbRgRsmbRsbRiRsRsmmbRgbRcRsmbRgbRgbRi
bRjbRsbRsbRibRgbRsbRsbRgbRsbRgRsmbRgbRgRsmbRiRsmbRcbRhbRgbRgbRsbRiRsmb
RcbLebRgbRcbRsbRsbRgbRgbRsbRsbRgbRjbLsRsbRgbRgRsmbRoRsmbRhbRiRsmbRgRsm
bRgRsmbRsbRgbRsbRsRsmbRsbRsbRsRsmbRgbRgbRgbRsbRcbRcbRsbLobLibRsbRsbRsb
RibRiRsLsmbRgRsmbRgbRgbRgbLsbRsbRsRsmbLsbLjbRsRsmbRgbRsbRjbRgbRgbRgbRc
bRcbRibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 26; Drug: PCAP2 10 然
bRgbRsRsRsmmbRgRsmbLsbLhbRsbLcbRsbLiLsbLsbLsbLjLibRcbRibRibRibLsRsbReb
RgbRcbRcbRibRibRsbLsbRobLgLsbLgbRcRsmbLjbLsRibRsRsRsRsmmmbRibRcbRibRsb
RcRsmbLsbLgbRiRsmbRsbLsRsRsmbRcRsLsmbRebRsbLsbLhRsbLiLsbLgbLgbLgLsbRjb
RcbRgbRibLsRsbLsbLsbLsbRsbRibRgbRgbRiRsmbLsbRgbRsRsRsmmbRhbRsbLgLsbRiR
smbRgbRsbRgbRhbRgRsRsmmbRgbRgbRgRsmbRsbRiRibRgbRhbRcbRgbLsbRgbReRsmbRg
bRiLsRsbLsLsmbLsbRsbRiRsRsLsmmbLsLsmbRgbRgbRgbRsbRgbRsRsRsmmbRgbRgbRiR
smbRgRsLsmbLobRsRsmbLsbLcbLsbLgbLgRsLsbLobLgbLibLibLgbLgbLgbLgRsbLgbLi
bLjbLgbRsbRibLibLgLsbLgbLgbLsbLjbRobRsRsmbRjbRiRsmbRjRsmbLebLcLsmbRcRs
RsmmbRibLebLobsbLgbLsRhbRjRiLsbRiRsmbRibRgbLcLcbLgbLhLsbLcbRcbRibRebRh
RsmbRsbRsRsmbLsbLgbRebLjbLgbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 27; Drug: PCAP2 10 然
bsbLibLobLgbLgbLcbLibLiRsbLsLsLsmmbRsbLiRsbLgbLsLsLsLsmmmbLgLsbLgbLoLs
mbLibLibLgbLcbLiLsbRsbLsRsRsmbLibLgbLgbRcbLibLhbLgLsLsmbRsbRsbLibLsbLi
bRsLsbLgbLgLsbLgbLcbLebLgbLsbLsLsmbRsbRsbRsLibLsLsmbLgLsbLgLsRsbLsLsLs
mmbLgbLgbLsLsLsmmbRsRsRsmmbLsbLsbLgbLgRsbLsLgLsbLsLsmbRsRsmbLcLsmbLiLs
bRiRsmbRgbRsbRsbRsRsmbsbsbLcbLsbsbLibLgRsbLsbLgbRsbLgbLsbLgbLsLsmbLgbR
sbLgLsbLgbLoLsLsmmbLibLgbLgLsbLhbLiLgLsbLiRsbLgLsbLibLibLgLsLsmbLiLsbL
gbLibLcLsmbLhLsLsmbLsLgLsbLsbRsbLibLgbLgLsbLsbLgbLgbRsLsbRsLsbLgbLsbLg
RsbLsLsLsmmbRobLjbLibsbsbLgbLibLsbLibLibLibLsbRsbLibLgbLibLoLsLsmmbLiL
sbLgbsbRsbRsLgbLgbLsbLgbLgbLsLsmbLgbLcbLebLibLsbLsbLibLibLibLgRsbRsRsm
bRgbLjbLgbLibLgbLgbLgbRsRsmbRsbLibsbsbLsbLgbLsbLgbRsbLgbLgLsbRsbRsRsmb
LgbLibRgRsmbLibLgbLibLgbLobLjbLgbLgbLgbLgbsbLgRsbRsbLsbLibRsRsmbRsbLgb
LgbLgLsbLgbLgbLgbLibLibLibLsbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 28; Drug: PCAP2 10 然
bRcbRgbRsRsmbLcbLebLsbRsbLsbsbLcbLsLsmbLcLsmbLsbLsbLibRcbRgRsmbRsbReLs
bRsbLsLsmbRjbLgbRcbRgbRibRebRiRsmbRsbLgbRjRsmbRgbRiRsRsmmbLsRsbRsRsmbR
sRsmbLhbLhLsbLgLsbLiLsbLgbLcbRsbRsRsRsRsmmmbLgbLcbLiLsbLsbLcbLsbLsbLiL
sbLibLiLsLsmbLsRsbLcLsmbRibLcbRsbRsRsRsmmbLgbLgbLiLsbLiLsbLgLsbRsbLcbR
jbLgbRsLsbLcbLgbLcbLsbRcbRsRsmbLgbLsbLoLsmbRsbRsbLcRsbsbsbLgbLgbLsbLoR
sRsmbRsRsmbsbRgRsmbRsbRsbRsRsRsmmbRgbRsRsRsmmbRcRsmbRsRsRsRsmmmbRsRsmb
LibLsbRsbsbsbLibLsLsLsmmbsbLcbLibLsbLcLsmbRsbRgbLsbLibLhbLibLibLsbRiRs
mbRibRsRsmbRsRsRsmmbRsbRsRgbRsbRgbLsRsbLsRsRsmbRgRsmbRgbRgbLhbLsbLsbLg
bLgbRibLobRsbRiRsmbLsbLibLjbsbLibLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 29; Drug: PCAP2 10 然
bLjbLsLsmbRsbRsbRsbLsbLsbLsbLsbRsbRgLgbLibLsbRgRsmbLsbLgbRsbLibLsbLgbL
gb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 30; Drug: PCAP2 10 然
bRgLsbRsRgbRgbReLobLibRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 31; Drug: PCAP2 3 然
bRsRgbLibLibRgbLibLgLsbRgRsmbRsbLcbRibLibLibLibLibLibLibLibLibLibLgLsb
RsbRgbLjbLjLjLsmbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 32; Drug: PCAP2 3 然
bRibLsbRgbRgbRsRsmbLsRibLgbLjbsbLobLibRsbRgbRgbRibLsbLobLiLsbRgbLiLsbL
sbLsLsmbLgbLsbLgbLsLsmbLgbLsLgbLsbLsbLsbLgLsbLsbLgbRsbLgbLsLsmbLgbLsbL
gbLibLsbLsbLsbLiLsbLgbLsLsmbLsbLgbLgbLsbLsLsmbLsbLsbLgbLgbLgbLsRsbLgbR
gbLcbLgbLsLsmbLgbRsbRcbRobRgbRsbRgbRiRsmbLsbRibRsbLobLgLsbLsbLgbLibRsb
LsLsmbLsbLibLgLgbLgbLsLsmbRsbLgbLgbRsbLsbLsbLiRsLsbRsbLsbLgLsbLsbLgRsb
LsbLgbLsbLgbLgLsbLgbLgbLibRgbLgbLgbLsbLgLsbLgbLgLsbLgbLgbLsbLgbLgRsbLg
bLgbLgbRgbLsLgLsbLibLsLsmbRsbLibRcbRibRgRsmbLcbLsbRcbLsRibLgLsbRiLsbRg
bRsbRsbLsbRibRsbRgbRibLiRsbRcbLjbsbLcbRsbLsbLgRsbLibLsbLsbLgbLgbLhbRsR
smbRsbLsbLgbLsbRsRsmbLibLsbLoRsbRibLobLsbLgLsbLsLsmbRsbLgLsbLgbRgbRebR
hbRsRsmbRsbRibRsbRsbLcbLgLsbRcbRsRsRsmmbRgbLjbRibRcbRsRsmbRgbRibRgbLsb
RibLgbRsbRcbRcbRsbLsbLjbLibLgbLgLsbLgbLgbLsbLgLsbLibLsbLsbLgLsbLgLsbLg
bLsLsmbLgbLgbRobRgbLcRsbLjbRhbLjbLgLsbRgLsbLgbLgbLgLsbLgbLgbLjbLgbLhbL
hbLiLsRsbLsbLgbLgLsbLgbLsLobLhRsbRgbLibLgLsbLsbLgbLsRsbLgbLsbLgbLsbLgL
sbRsbLgbLgbLgbLgRsLsbLgbsbLsbLsbLgbLgbLgbLgbLgbLjbRobRibLsLsmbRsbRibRi
LsbLgbLsLsmbLgbLsbLgbLgLsbLsbLgbLsbLgbLsbLgbLgbRsbRcbRobLgbLsbLgbsbRjb
RobsbLjbsbLiLsbLibLsbLsLsmbLgbLgbRobRibLgLsbLsbRibRibRhbRobLsbLsbLibLg
bLgbLgbLsbLsLsmbLsbLgbLsRgLsLsmbLsbRibRsbRsbLobRsbRgbLobRsbLibLgbLgbLs
bLgbLgbLgbLgbLiLsLsmbLibRsRsmbLsbLiLsbLgbLgbLgbLgbLsbLgbLgbRsbLobLoLsm
bLsbLiRsbLibLgbLgbLgbLsbLsRsbLgbLgLsbLsbLgLsLsmbLsbRsbLsLcbLibLgbLgbLs
bLsLsmbLgLsLsLsmmbRibRob

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 33; Drug: PCAP2 3 然
bLgLsLsmbLsLsmbLsbLcbLiLsbLcbLcbLsbsbRsLsbRsLsbLobLsLsmbLsbLgbLhRsbRsb
sbLgbLiLsbLgLgLgLgbLgbRsbLhbLcbLgbLjbRcbLobsbLcbRgLsbLeLsbRibLhLsbLsbR
jbsbRcRiLsbRibLsbLcbRsRjbLebRgLsbRsLibLsbLgLgLsbLsbLgLsbLibLgRsLsbLcbL
obRibRcLsbRoLsLsmbLebRibLhbRgbLiLsbRsbLiLgLsLsmbLsbLgbLgbLgLsbLgLgLibR
sRsmbLibLgLsLsmbRhbRgbRgbRgbRiLsLsLsmmbLgLsbRcLsbLibLcbRgbLibRsbLgLsbR
ebLeLsLgbLgbLsLsmbLgbLsbLgbLgLsbLgbLgLsbRsbLobLhbRcbRsbRcbLhbLgLsbRcbR
sbLjbLcbRgbLiLsbLsbLiLgLsbLsbLgbLiLsbRobRibRsbRgbRibRsbRebLebRebRhbRsb
RcLsbLgbRcbRsbRebRsbRsbRcbLcbRgbRsbRibRsRsmbRgRsmbRsRsmbRjbRcbRgbRgbRg
bRsLsbLiLsbLgbRgbLibLsLsLsmmbLsLsmbRsRebLhLsbLibLgbLsbLiLgLiLsbLgRsRsm
bRiLsLgbRhbLsRsbRibRhbRgbRhbRcbRcbRibsbRhLgbRibRgbRibRibLsbRgbRibRgbRi
bRgLsbRiLsbRsbRsbRibRhRsLsLsmmbLsRsbRgbRibRsRsmbRgbRsRsmbRgRsmbRgRsmbR
gLsbRgRsmbRebLgbRsLsbRsRsRsLsmmbRiLsbRhbRibRcbRsbLgRsbLcLsmbRsLsbLsbLi
bLgLsbLgLsLgLsLsmbLgLgLsLgLgbLgLsLsmbLgLsbLgLiLsLgLsLsmbLgbLibLsRsbRjb
RcbRsbRibRibRsbRgbRibLcbLcbLiLsbRgbLcRsbLiLsLsRsmbRhRoLsLsLsmmbRcbLjbL
obRsbRgbRobRibRsbRcbLsbLcLsLsmmbLgLsbRgbLobRibLsbRcLgbRcbLjbRibRgbRiLs
LsmbRiLsbLsbRibRgbRibRsLsbLobLsLsmbLgLsbLsbLsbRcRsmbRibRgbRsbRgbLcbLiL
sbLsLsmbLgbLgLsbRsbLibLsLsmbLsLsmbLgLsbLgbLgbLgbLgbLgbLgLsbRebRibRiLsb
LgbRgLsbRiLsbRgbsbRibLebRcbRobLsbRsbRhLsbsbRiRsmbRsbRsbRgRsmbRgRsmbRgb
RgbRgbRsbRgbRgbRgRsRsmmbRsbRgbLsbRcbRcRgLsbRcbLsbRiLsLsRsmbRcbRibLgbLc
bLsbRiLsbRcbRibRibLgbRibRcbRgLsbLsbRibRsbRibRcLsbRcLsbRsbRibRiLsbLibRh
bRgbRgbRsRgRsmbRgbRgbRgRsmbRgLsLsmbRsRgLsbRgRsmbRsLsbRsbLcbLgbRcbRhLsb
LgbRibRgbRiRsLsRsmbRgbRgRsmbRibLsLsmbLebLsLsLsLsmmmbRgLsbLoLsmbRgbRibR
iLsbRhLsbRcLsbRgbRcbLebLibLsbRebRcbLgLsbRcbRiRsmbRibRsbRibRsbRibRsbRiL
sRsbLsRsRsmbRgbLjbRiLsLsmbLsLsmbRibLsbRgRsmbLsbRgRsRsmmbRgbRgbRgbRgbLs
bRibLsbRsbRiLsbRsbLebLgbLsbsbLsLsmbLgbLibRsbRcbRibRgbRsbRsbLsRsRsmbRgR
smbRsLsbRgbLjbRhbRgRsmbRgbRsbRsbRibRsbRsbRibRcbRcbRgbRcbLsLsLsmmbLsbRi
bLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 34; Drug: PCAP2 3 然
bRiRsmbRgbLgbRgbRsbRoLsbRibRgbLsbRibRsbRgbRgbRsLsbRgbRsbRobRcLsbRjRcbR
gbLgbLjbRobLsLsmbRcbRiLsbLsbRgbRiRsmbLsbRgbRsbLsbRgbRsbLsbRgbRsbRsbRsb
RgRsmbRgbRsbRgbLsbRgRsmbRgRsmbRgbRsbRsbRgRsmbRsbRsRsmbRsRsmbLsbRsbLsbR
gRsmbLsRsbRgbRsbRsbLsbRsbRgbRgbRgbRgbRsbRgbLsbRsbRsbRgLsRsbRsLsbRgRsmb
RgRsRsmmbLebLibRobRcRsLsmbRibLsbLibLibRjbRhbLeLsbLiRsbRcbLiRsbRcbRiRsm
bLsbRibRsbLsbRsRsmbRgbLsRsRsmbRsRsmbRsbRsRsmbRsbRsbRgbRgbRsbRsRsmbsbRs
bRsbLgbRgbRgRsRsmmbRsRsmbRsRsmbRsRsmbLsbRgbLsbLsbLgbLcbRgRsmbRgbLsbRgb
RsbRsbRgbRsbRsbRgbRgbRsRsmbRsbRsbRgbRsbRsbRgbRsbRsRsmbRgbRsbRgbRsbRsbR
sbRgbRsbRsbRsRsRsmmbLsbRsRsmbRsbRsbRgbRsbRgRsmbRsbRsbRsbRsbRgRsmbRsRsm
bRsbRgbRsbRgRsLsmbRibLgbRgbLsbLsbRgbRgbRsbRsLsRgbRgbRsbRsbRsLsbRsbRgRs
mbRsbRsRsmbRsbRgbRgbRsbRgbRgbLsbRsbRgbRsRsmbRgbRsbRsRsmbRgbRsbRgRsmbRs
bLsbRsRsmbRsbLsbRgbRgbRgbRgbRgbRgbRsbRsRsRsmmbLsbRgbRgbRgbRsbRgbLsRsbR
sRsRsmmbRsbLsbRgRsmbRgbRsRsmbRgbRgLsbLsRsbRgbRgbLjbLhbRsbRsbLgbLgbLgbR
gbRsLsbLiLsbRsbLhbRobRgbLebReRsmbLsbRgbRsbRgbRsbRsbRsRsmbRgbRsbRgbRsRs
mbRsbRsbLsRgbRsbRsbRsbRsbRsRgLsbRgbLjbLoLsmbLibRsbLiLsbLibLgbRcRsmbRib
RobRsRsmbLibRsbRjbLgbLgbLgbLsbRsbLgbLsbLsbLsbRjRobRcbRobLibRobLsbRsbLs
bRsbRgbLgbRgRsmbRsbRsRsmbLsbRgRsmbRsRgbRibLsbLjbLebLiRsbLcbRibLiRsbRsb
LcbRiRsmbRsbLcbLcbLibRsbRgbRibRsRsmbRsbRsbRsRsmbRgbRsRsmbRsbRgLsbRsbRs
bRsbRsbRsbRsRsRsmmbLsRsbRsbRsbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 35; Drug: PCAP2 3 然
bRibRibRgRsRsmmbLjbLgbRjbLibLcLsmbLsbsbLsbLgbsbRibRgbsbsbLobRibsbLebLs
bRsbRsbRsbRsLsLsmbRsbRgbLeRsbRsbRsbRsRsmbRgbRcbRibLjbLcLsmbLiLsbLcbLib
LibLsbLsbLgRsbRibRsbLjbRgRgbLibLsbRibRsbRgRsmbRsbLsbRsbRobRsLsbRsRsRsm
mbRsRsmbLcbLgLgbLsbLsbsbRsbsbsbRcbRsRsmbRiRsmbRibRgbRsbsbsbLibLsLsmbsb
LjbLibLcLsmbLibRibRsRsRsmmbRgbRsRsmbsbsbRsbRgbRebRjRgbRsRsRsmmbRsbRobL
sbLsbLsbLsbLgbRsbLsbRgbLsRsRsLsmbLsRjbLhbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 36; Drug: PCAP2 3 然
bLsbsbLgLsLsmbRgRsmbLsbRsbRsbRsLsbRsbRgbRsRsmbRgRsRsmmbLibRjRsmbLcbLsL
gLsLsLsmmbLjLsmbRcRsmbRhbRhbRhRsmbRibRjRgbRgbRcLsbLeLsLsmbLebRibLjbLhR
sbLobLjbLibRibRibLsbLcbLhbLsbLgbRsbLgbRsbsbsbsbLsLsmbRgbLsLsmbsbLgLsbL
sbLsRcbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 37; Drug: PCAP2 1 然
bLibLgbRcbLgbRhRsmbRiRsRsmmbRgbLsbRsRsRsmmbLjbRgRsmbRcbRsbRibLgbRibRsR
smbRgbRgRsmbRsbRsbRibLsbRgLsRsbLjbLoRsbLibLiLsbRcbRcbRsbLsRsRsmbRibLsb
RsRsmbRibRsbRsbRgRgbRsRsmbRsRsRsmmbLsRsRsmbRsRsmbRgbRgbLsLsmbRgRsmbRgb
RsbRgbRsRsmbRsRsmbRgbRgbLsRsbRsRsRsRsmmmbRgRsmbRgbRsRsmbRsbRgbRsbRsbRg
bRgLsbRsbRsRsRsmmbRgbRgbRgbRsbRsRsmbRsRsRsmmbRsbRsbRsRsmbRsRsRsmmbRsRs
RsmmbRsbRgbRsbRsRsRsRsmmmbLsRsRsmbRsbRgRsmbRsRsmbRsRsRsRsRsRsmmmmmbRsb
RsbRibRgbRgbRgbRgbRibRgRsmbRgbRsRsRsmmbLsRsbRsRsmbRsRgRsmbRsRsRsmmbLsR
sbRgbLsRsbRsRsmbRgbRgRsmbRgRsmbLgbRgRsRsmmbRsbRsbLsRsbRiLsbRgbRgRsLsmb
RgLsbRgbLsLsRsRsmmbLcbLibLgLsbLgbRsbRcLsbRiLsbRibLsbRiRsmbRgbLsbRgbLsb
RsRsmbRgbRgbLsRsbLsbRiRsmbLsbRgbRgbRgbLsbRiRsmbRsbRgbRsRsmbRgbRgbRgbRs
LcbLgbLgLsbLgbRjRhbRibLgbRhbLgbRibRsbRgRsmbRgbRsbRgbRoRoRsmbRcbLgbRjRs
mbLgbRcLsbRsbLsbLgbLjLsmbLgRsbLsLgbRiRsmbLibLibRjbLcbLcLsmbLibLgbLsbLc
bLiLsLsmbLgLsbLgbRibRgbRcLsbRiRsRsmmbLsbLgLgLsLsmbRgRsmbRibsbRsRsRsmmb
RsRgRsmbRhbLgLsLsLsmmbRiRsmbLsbRgRsmbLsRsbRsRsRsmmbRsRsRsmmbRsRsmbRsRs
RsmmbRgbsbRsbRsbRgbRsRsmbLsRsRsmbLsRsRsLsmbRgbRgRsRsmmbRsRsRsmmbRsRsRs
mmbLsbRgRsmbLsLsRsRsmmbLsRsbRgbRsbRsbRsbRsbRsRsRsRsmmmbRsRsRsRsRsmmmmb
sbRsRsmbRsRsmbRsRsRsmmbRsRsmbRsRsRsRsmmmbRsbRsRsRsRsmmmbRsRsmbsbLsRsbR
gbRsRsmbLsRsbRsRsmbRsRsmbRgbRsbRsbRsRsRsmmbRsbRsRsRsRsRsmmmmbRsRsmbRsR
smbRsRsmbRsbRgbLsRsRsmbRsRsmbRsRsRsmmbRsRsLsmbRsbRgRsmbRsbRsRsLsRsmbLs
RsRsmbRgbRsRsRsmmbRgRsmbRsbRgRsRsRsmmmbRsRsRsmmbRgRsmbRsRsmbRgbRgRsmbR
gbRgbLsLsRsmbRgbLsRsbRibRgRsmbRgbRsRsRsmmbRsbRibRsRsRsmmbRsRsRsmmbRgbR
gbRgbRgbRgbRsRsmbLsLsmbRiRsmbLjLsmbRibLsRsbRiRsmbLsRsbRgbLsLsRsRsRsmmm
bRsbRsRsRsRsmmmbRsRsmbRsRsRsmmbRgRsmbRsRsRsmmbRsRsRsmmbRsRsmbLsRgbRsbR
gbRgbRsbRsRsRsmmbRsbRsbRibRgbRsbRsRsRsmmbRgbRsbRsbRgbRgbLsbRgbRgRsmbLs
RsbRsRsmbRsRgbRgbRsRsRsRsRsmmmmbRsbRsRsRsRsmmmbLsbRsRsmbRgRsLsmbRgbLsR
sRsmbRsRsRsmmbLsRsbRsbRgbRgRsRsmmbRsRsmbRgRsmbRgRsLsmbRsbRsbRsbRibRsRs
RsmmbLsLsLsLsmmmbRgbRgRsmbRgbRgbRgbRgbRsRsmbLgRsbRgRsmbRgRsmbRgRsmbRgb
RgbLebLibLibLsLsmbRsRsRsmmbLibRgRsmbLibLibsbLiLsbLibRsLcbLibLgbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 38; Drug: PCAP2 1 然
bLsbRhbLibRibRibRsLsbLsbRcbRcRsmbLiLsbLsbRsbRibRibRgbRgbRsbLsLsmbRgbLg
bRgbRgbRgbRgRsmbLsRgRsmbLsLsmbRgbLsRsbRgRsmbRgRsmbRgbRgbRgbLgRsbRgbRgb
RcRsmbRhbRibRgbLjbLgbLibRcbRcbLgbRibLgbRibLgbRiLsbRibRhbLibRgRsmbRibRg
bRibLhbRiRsmbRibRsbRgbLsbRgbRgbLgbsbLhbLsbRsLgLsbsbRjbRibLibLgRsbLgbLg
RsbRgbLsbLsbLgbLgRsbRsbLgbLsLsmbLibRgbLiLsbLibRgbLhbLhbRsbRcbRgbRgbRib
RobRcbRsbRibRsLsbRcbRgbLjbRibRiRsmbRgbLsRsbRibLgbRhLsLsmbLgbRibRgbLsbR
gRsmbLsbRiLsbLjbRgbRibLsbRsbRsbRgbRsbRgRsmbLsbRgbRgbRgbLsbRgbRgbRgLsbL
sbRgbRgbLsLsmbRiRsmbLjbLjbLibLsLsmbRcRsmbLjbRobRsRsmbRsbLgbRcbLsbRibRi
bRgbLsbRsbRgbRgbRgRsLsmbRsLjbLjbLibLgbLibLhLsbLgLsbRgbLhLsbLjbLibRsbLs
bRsbsbLgbLgLsbLsLsmbLgbLibLgbLibRgbLgbRibRibRgbLsLsmbRgLsbRgbRibLcbLhb
LgbRjbLibLiRsbRgbLcRsbRgbLcbLhbLsbLsbLgbLcbLgbLsbRgbLhbRibLibLibLgbRsb
LibRgbLsbRjbRhbRhbRsbRsbRsLsbRibRgbRgbLsLsmbLcbLibRjbLibLgbLibRjbLgbLg
bLibRgbLgbsbLibRsbLcRsbLcbLgbLsbRsbRebRibRcbRgbRgbRgbLsbRibRiLsbRcLsbL
gLsbRibLgbRibRgRsmbLgbRiRsmbLgRsbRsbRibRsbRgbRgbLsbRgbRgRsmbLsLsRsmbRi
bRgbRibLibRcbRcLsbRgbLgbRcbRibLcbLibLgLsbLgbLibRgbRjbRibLsbRhLsbLsbLsb
RgbLhbLiRsbRcbRjLsbRgRsmbLhbLcLsmbRhbRibRgbLsbRgbRiLsbLsbRgbRgbRsbRsRs
LsmbLsbRgbRsLsbRgbRgbsbRsbRgRsmbRgbRgRsmbRsbRgbLsbRgRsRsmmbRibRgLsbLgb
LcbLiRsbRsbLibsbLobLibRgbLsbRebRibRsbRgbLsbRsLsbRiRsmbLgbRgbRhbRgbLsbL
ebLgLsbRsbLibRsRsmbRgbLgbLibLiLsRsbRibLjLsmbLgLsbLibLibRsLsbLgbRgbRibR
iLsbRcbLsRgbLsRsbLsbRgbLcbRsbLibRsbRjbLcbLcbsbLsbRsRsmbRibRibLgbRgbRib
RsbLsbRhbLgbLgbRcbRibRgbRibLsbRibLsbRibRsbRsbRgbLsbRgRsmbRgbRsRsLsmbRg
bRgbRsbRgbRsbRsbRgRsmbRsbRsbRsbRgbRgbRsbRgLsbLsRsbRibRsbRgbRgRsmbRgLsR
sbRgRsmbRibLsbRibRgbRibLibRcbLcbLhRsbLcbLcbLsbRcbRcbRibLgbRibRiLsbRgbL
ib

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 39; Drug: PCAP2 1 然
bRsbLsbLsbLsbLgbLgbLgLsbLgbLsbLgbLsbLgbLsLsRsmbLgLsbLgbLgbLgbLsbLsbsbL
gbLgbLgbLgbLsbsbLsLsmbLgbLgbLsbLgLsbLgbLgRsbLgbLgbLgLsRsbLgbLgbLgLsbLg
bRsbLgLsbLgbLgbLgbRsLsbLgLsbRsLsbLgbRcbRibLcLsmbLibRoRsmbRibRcbRibRgbR
cbRhbLsbRhbLcbLobLsbLibRgbLcbRgbRcbRibRgbRgbRgbRibRibRgbRsbRibRgbRgbRg
bRgRsmbRoRsmbRhbRibRgbRgbRgbRgbRgRsmbRgRsmbRgRsmbLobRgbRhLsbLobRcbRhbR
gbLibRcbRibRhbRiRsmbRibRgRsmbRibRgLsbRsbRgbRsLsbRgbLjbRibRiRsmbRgbRcbL
sbLhbLgbLgbLgbLsLsmbLgbLgLsbLgbLgbLgbRsbLgbLebLgbLgLsbLsbLgbLgbLgbLgbL
gLsbLgbLsLsLsmmbLgbLgbLgLsbsbsbLgbLgbLgbLgRsbLsbLsbLgRsbLgLgbLibLgbLgb
LiRsbLgLsbLgLsbLibLgbLgLsLsmbLgbLgLsbRsLsbLsLsmbLsLsmbLgbLgbLgbLsbRsbL
gbLgbLgLgbLgbLiRjbRsbLiRsbLsbRsLsbRsLsLsmbRsbLibRoRsmbLsbRibRhRsmbRibR
ibRcbLobLibLgbRgbLhRsbRgbLcbRiRsmbLhbRhbRgbRibRgbRgRsmbRibRcbRibLsbRcb
RgbLjbRcbRibRibRgbLsbRhbRibRcRsmbRibRhbRgbRibRgRsLsmbLsRsbRibRsbRibRob
RibRgbRibRgbLgbRibRgbRgRsmbRgbRgbRibLobLgbLgLsbLgbLsbLiLsbLgbLgbLsbLsL
sRsLsmbLgbLsLgbLgbLgbLsLsmbLgbLsLsLsmmbRsLsLsmbLsLsmbLgbLgbLgLsbRgbLib
LibRgbLibRhRhbRgRsmbRibRsbRibLsLsmbLgLsbRoLsbLjbLcbLibLgLsbLsbLgLsLsRs
LsmbRsLsbLgbLsLsmbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 40; Drug: PCAP2 1 然
bsbLgLsbLgbLsLsmbLhLsbRgbLsbLgbLgbLsbLgLsbLgbLiLsLsmbLiLsbLibsbRibRcbR
iLsbLsLsmbLiLsbLiLsbLiLsbLibLsbsbRsbRsRsRsRsmmmbLiRsbLibLgRsbRiRsmbLiL
sbLcbLsbLibLsLsmbLsbLgbLgLsbLibRgbLibLsbLsbLsLsmbLsbsbLgbLcbLibRgbRgbs
bLhLsLsmbLsRsbLgLsbLsbLiLsbLgLsbRibLsbRsRsmbLsbsbLgbLhLsbLibLsbsbRgRsm
bLhbLibLgbLsbsbRibsbLsbLibLibLibLsbLgbRgbLibLebLsLsmbRiRsmbRgbRsLsRsbL
cbLibRgbRsbRiRsmbLsbLiRsbLhbsbLiLsbsbLsLsmbLeLsbLsLsmbsbsbsbLgbLgLsbRg
bLsbLiLsbLsLsmbLgLgLsbRcbRibLoRsbLibLsbLcbLjLsLsmmbRgbsbsbLibLcbLhbLsb
RsbRgbsbLibLibLsbLgbLsbLsbLgbRsbRsbLibLgbLsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 41; Drug: PCAP2 1 然
bRsRsmbLsbLibLsbLsbLsLsmbLsRsbLgLsbLgbsbsbLibLsbLgbRsLsbRobRibsbLsbRsb
RibRsbRsbLgLsbRibRgRsmbsbLsbRhbRibRgbRsbRibRsRsmbLjLsmbsbRibsbsbsbRsbL
jbRgbRoLsbRsbLsbRibsbRsbLjLgbLjLsmbRiLsbRcbRjRsmbRsRsRsmmbRibsbRsbRsbR
sLsbRsRsmbLgbLcbLgLsbsbRgbRjRsmbRsRgbsbRgbRsbLsbsbsbRibRgbRsbRgRsmbsbL
sLsmbRobLibLjLsmbLgbRsRsmbLibLgLsLsmbsbsbRsbRgbRgRsRsmmbsbRsbRgbRsbRsR
gbLibLsLsmbLhbLgLgbRgbLgbsbLsbsbLjLgbsbsbLsbLcRsbLsbLiLsbLsbsbRgbLsLsL
smmbLgbLgLsbLsbLibLsbRgRsLsmbRgRsmbsbLsbLsLsmbRsRgbRiRsmbLgbLcbRgRsmbs
bLibLgbLsbLgLsLsmbLsbLgLsbLsbLsLsLsmmbLsbLgbLsLsmbLibsbsbsbsbRsLsbRsRs
mbRsbRiRsmbsbsbLsLsmbLsbLibLibLsbsbLsLsLsmmbLsLsmbLsbLgbLsLsmbsbRsbRsR
sRsmmbRibRgbRjRsmbsbsbRgRsmbRsRsRsmmbRsRsmbRsRsmbRsbLjbLgLsbLsLsmbLsLs
mbLsLsmbLsbRsbRsbRgbLcbLgbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 42; Drug: PCAP2 1 然
bLcbLcbLibLibLiLsbLgbsbRjbLibRsLsbRhbRiLsbRcRsmbLoLsmbLgLsbLgLsbLgbLsb
LgLsbLgLsbLgbLgLsbLsbLgbLgbLhRsbRsLsLsLsmmbRcbRcLsbLgbLcbLiLsbLsbLgLsb
LgbLgLsbLgLsbLgbLgbLgLsbLgbLsbLgbLsLsmbLgbLgbLgbLgbLsLsmbLgbLgbRgbRjbR
ibRcLsLsmbRibRibLgbLobRcbRcbRsRsmbRhbRgbLcbLiLsbRsbLiLsbLgbLgbLgbLgbLs
LsmbLgLsbLgbLsLgLsbLgbLgbLgbLgbLgbLgbLgLsbLgbLgbLgbLgbLgbLhbRibRsbRcRs
LsmbLcbLsLgbLgbLgbLsLsmbLsbLibRgbLgLsbLibRcbRoRsmbLgbLcbLgbLgbLgbLgLsb
LgbLgLsbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLsbLsbLgbLgbLgLsRsLsbLsbLsRsbLgb
LsLsmbLgbLgbLgLsbLgbLgbLgbLgbLgLsbLgLsbLgbLgbLgLsbLgbLgbLgLsbLgLsbLgbL
gbLsbLgbLgbLgLsLsmbLgLsbLsbLgbLgLsbLgbLgbLgbLgLsbRsbLgbLsLsmbLgbRcbRiR
smbRibLsbLcLgbRcbRcbLjbLcRsbRsLsbLibLgbLsbLgbRsbLgbLgbLsLsmbLgbLsbLgbL
sbLgbLgbLgLsbLgbLgbLsLsmbLgbRebRibRgbRiRsmbLcbLsbLgbLsbLgLsbLgbLgbLgLs
bLgLsbLgbLgbLgbLsbLgbLgLsbLsbRsbLgbLgLsbLsbLgRsbLgRsbRsbLsbLgbLsLsmbLg
bLsbLgLsbLgbLsbLgbLgbLgbLgbLsbLsbLgLsbLgLsbLgLsbLsbLgLsbLgbLgbLiRsbLgb
LgbLgbLgbLsbLgLibLibLgbLgbLobLcbLgLsbLibLgbLsbLgbLsLsmbLgLsLsmbLgLsbLg
bLgLsbLgbLgbLgbLgbLgbLgbLgbLgLsbLsbLgbLgLsbLcbLobLgbLibLibLgbLsbLgbLsL
sLsmmbLgLsbLgbLgbLgRsbLgbLiLgLcRsLsbLgLsbLibRgbLiLsbLgbLgbRsbLgbLgbLgb
LsbLgLsLsmbLgLsbLgbLsLsmbLgbLgbLgbLgbLgbLibLsbLgbLgbLgLsbLgbLgLsbLsLsL
smmbLgbLsLsmbLgLsbLgbLsbLgbLibLsbLgbLsLsmbLgbLgbLsbLgLsbLgbLgbLsbLsRsb
LgbLsLsmbLgbLgbLgbLgbLgbLgbLgbLsbLgbLgbLgLsRsbLgRsbRsbLgLsLsmbLgbLgLsb
LsbLgbLsbLgbLgbLgbLgLsbRsLgbLgbLgbLgLsbLgbLgbLgbLgbLsbLgbRjbRcbRiRsLsm
bLcbLsbLgLsbLgbLsbLgbLsLsmbLgbLgbLsbLgLsbLgbLgbLgbLsLsmbLgbRsbLgLsbRhb
RhbRibRsbLcbLsbLhbRibLcLsRsmbRibLcbRebRgbRobLgbRiLsbRgbRibLcbLgbLgLsbL
gbLgbLgbLsbLgbRsbLiLsbLgbRsbLgbLcRsbLibLgbLgbLcbLgbLgbLgbRsLsbLjbLsbLs
bLgLsbLsLsRsmbLgbLgbLgbLgbLsLsmbLgbLgbLgLsbLsbLgbLgbLgbLgbLsbLgLsbLsbR
jbRcLsbLcbLgLsLsmbLgLsLsmbLgbLsLsLsmmbLsbLgbLsbLgbLgLsbRgbLgbLgbLgLsbL
gbLgbLgbLsLsmbLgbLsbLgbLgbLgbLgbLgLsbLsLsmbRjbLibLgbLsbLgbLgLsbLgLsLsm
bLgbLgbLgbLgbLgbLgbLgbLgbLsbLgbLsbLgbRjLsbRhRibLcbLiLsbRjbLibLgbLgbLgL
sbLgLsbLgbLgLsbLsbLgbLgbLgbLsbLgLsbLgLsLsmbLgRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 43; Drug: Control
bLsbLsbRcbRibRsbRsbLgbRibLjLsmbLiLsbsbLsLsmbLgbRgbLgbLsRsbLgbLsbLgLsbL
gbsbRsbLgLsbRjbRjbRiRsmbLsRsbRibLjbLoLsmbLibLsbRibLibLiLsbLsbsbLsbsbRs
bLsbRgbRsbLjbsbLhbRgbRsbLgbLgLsbRsbLgbLsbRsbLsbLsbLgbLsbLgbLsbLgbLsRiR
smbLcbLibLsbRgbLsbLsbRsbLgLsbLgbRsbRsbLgbRgbsbLibLgbLgLsbLgbsbRibLgbLg
LsbLgbLiLsbLgbLgLsbLsbsbLgLsLsmbLsLgLsbLsbLgLsbsbLibLgbLgbLjLsLsmmbLsb
sbRgbLgLsbLsbLgbLsbLsLsLsmmbLgbLsbLgbLgbRiRsmbLsbLjLsLsmmbLibLsbLibLgb
RsbLsbRsbLgbLsbLsLsmbLgbRibRsRsmbLsbLgbLcbsbRsLsbLsbLjLsmbLibLgRsbLiLg
RsbLibLcbLgbRsbRsbLiLgbRibLibLsbLsbLsbLcLsLsmmbRjbRibRibLjLsmbRibLsbLj
LjbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 44; Drug: Control
bRsbLsbLsLsRsmbLgRsbLsbRsbLgbLgbRsRsRsmmbLiLsbRibRsbRsRsmbLiLsbLgbLsbL
sLsmbLgbLsRsbRgbsbLgLsbRsRsmbLsbLgbLgbRjbLgLsbLsbRgbLgLsLsmbLgLsbLsRgb
LoLsmbLgbLgbLgbRibRjbLcLsLsmmbRsbRibLjLsLsmmbRsRsmbLsbRsLsbLibLgbRsLsb
RgbLibLsLsLsmmbLsbLgRgRsmbLhLsbLibLsLsmbLsbRsbRgRsmbRsbRgbRgbLgbRsRsmb
LsRsbRgbLsbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 45; Drug: Control
bRsRsmbLjbLsbRgRsRsmmbLsbLjLsLsmmbRsbLcbRsRsmbLsLsmbLsbRsLsbLsRsbLgbLc
LsmbRibLhbLgbLsLsmbLgLsbLsbRsbLgbLgbLsbLsbRhRsmbLsbLsLsLsLsmmmbLgbLhbL
gbLgLsLsmbLsbRsbRsRsmbLgbLsbLsbLiLsbLcbLgLsbsbRsRsmbLsbRcbRgbRibRsbRsR
smbRsRsmbRibRsbLhbLsbRgbRsbLsRsbRjbRiRsmbLgLsbRsLsRsbRibLsRsbRgRsmbRsb
RgbRgRsmbRsbRsbRibRgRsmbRcRsmbRhRsmbRibRiRsmbRsbRgbRibRsbRgbLsbRiRsmbR
ibRgbRsbRibRgbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 46; Drug: Control
bRcbLibLgLsbRjbRjbsbRjbLebLiLsbRsbLsLsmbLgLsbLgbLsbLgbsbLsRsbRgbRcbLsb
LgbRiRsmbLgbLsbLjbLgbRiLsbsbRsbRsbLsbLsRsLsbRgbRgbRsbLsbLsbRsbRsbRsbRs
RsmbRsbRsbLsbLsRsbLsbRsbsbRsbRsbRsRsmbsbRsbRsbRsbLsbRiRsmbRsLsbRsbRgbR
gLsbRsbRsRsmbLsbLsLebLsbRsRsmbLsbLsbLgbLgLsbLsbLgbLsbRsbLsbLsbLgbRsRsR
smmbLgRsbLsLsmbLgbLgbLgbRsbRsRsmbLsbLsbRobRgbRgRsmbRsbRsbLsbRsbRsbsbsb
LsLsmbRsbRgbRsRsmbsbRsbRsbRsRsmbRsLsRsbLsbRsbLsLsmbRsRsmbRsRsRsmmbLsRs
bRsbRgbLsbsbRsbRsbRsbsbRgbRsbRgbRsbRsbRsbRsLsRsbRsbRsbsbLsRsbRsbRsbRgb
RsbRsRsmbRgLsbRgbRsbRgbRsbRsbRsbRsRsmbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbRs
bRsbRsbRgbRsbRsbRsbRsbRsbRsRsmbRsRsmbRsLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 47; Drug: Control
bRibRibLibLiRsbRsbLiLsLsLiLsmbRjbLibLgbLgbLgRsbLsbLgbRjbRjRibLebLibLgL
sbLgbLsLsmbLsbLgbLgbLgbLsLsmbLgbLgLsbLgbLgbLsbLgbLgbLgRsbLgbLsbLsbLsLs
mbLgbRsLgbLgLsbLgbLgLsbRebRhbRibRibLjbRibRgbRsbRgRsmbRsbRgRsmbRgbRgbRs
LsbRsRsRimbLsbRsbLsLcbLibRjbLibReRsmbRgbRhbLhbLgbRsbLsbLiRsLsbRjbRcbLc
bLobRsLsbRjbLhRsbLcbLhbLsRsbLcbRhbRibRgRsmbLiLsbLibLgbLsRsbRebRgRsmbLe
bLibLgRsbRsbLgbLiRsbRibLhLsbLiLsbsbRsbRobLsbRsRgbRgbRgLobLgbLibLobLibL
hbLcRsbLibLcbLiLsbLjbLcbRjbRhbLcbLibLibLgbLgbLsbLsbRcbRsRibLebLiLsRsbL
gbLsbLsbLsbLgLsbLgbLgLsRsbLsLsmbLgbLgbLsbLgbLgbLgbRgbLgbLsRsbLiRsbRsbL
ibRhbRobRibRcLsbLgbRsLsbLgbLibLgLsbLgLsbLgbLgbRsbsbLgbLsbLgbLibLcbLcRs
bLiRsbLsbRhbLsRsbRcbLgRsbRiRsmbRsLsbLsRibRgbRgbRsbRgbRgRsmbLcbLgbLgbRg
bRcRgbRgRsmbRibRsbLcLibRobLcbLibLsbLgbLibRibLcbLibLgbRjbLsbLibLgLsbLsb
LgRsLsbLiRsbLibLgRsbRgRsmbLhbLgLsLsmbLsbLgLsbLsLsLsmmbLibLsbLgLgLgbLgb
LgbLgbLsbLgbLgRsbLgLsbRhbRibRsbRibRgRsmbLgbRibLgbRsbRgbRsRsRsmmbRgbRgb
RgRsmbRgbRgbRsbRsbRgbRgbRgbRsbRgbRgbRgbRsRsmbLibLibLsLibLsbLibRcbLibLi
bLibLcbLsbLibRgbLiLsbLgbLgbLsLsmbLgbLhbRgbLibLgLsbLiRsbLsbLibLgbRsbLgb
LgLsbLgbLgbLsRcbRhbLsbRibRibRsbRiRsRsmmbRsRiLsbRsRgRsmbRgbRsbRsbRgbRsR
smbRgbRsbRgbRsbRsbLjbRcbRibLjbRcLsbLibRiRsRimbLjbLcbLibLibLgbLgLsbLgbL
oRsbRhbRgRsmbRcbLibRibRibRsLsbRgbRsbRsbRgbRgRsRsmmbRgbRsLsbRiRsmbRgbLj
bRhbLsbRibRgbRsRsmbRsbRhbLibRibRhbRsbLgLsbLcbLibLsbLibLgbRjbLibLibRibL
hbLibRjbLgbLibLgbLgLsbLsbLgbLgLsbLgbLgbLgbLgbLgbLgbLgRsLsbLgbLgbLsbLsb
LgbRgbLgbLgbLgbLsbLsbLgbRsbLibLgbLgbLsbLgbLsLsmbLiLsLsmbLsbLgLsbsbsbRj
bLibRcbRiLsRsbsbRibLgbRhbLgbRibRsbRiRsmbLjbLibLgbLgRsbRcbRibRsbRgbRgbL
gbRgbLhbLibLgbLsbLgRsbLiRsbLibLgbRjbLibLibLsbLgbLibLibLjbRsbRgLsbLgRsb
LgbLgbLgLsbLsbLgbRsbRebRsbLjbRibRsRsmbRsbLsbRgbRsbLcbRhbRhbLjbRibRgbRg
bRgRsmbRgRsRsmmbLsRsbRgbRgRsmbRsbRsbRsbRhLsbLibRcLsbRiLsbRibRsbRibRgbR
gbRgbRgbRgbRsbRgbRgRsRsmmbRgbsbLsRsbRgbRsRsmbRgbLjbRibRgbLsbRibRgbRgRs
mbRsbRgbRgbLsbLibLibsbLgbLibRsLsbRsbLsLsmbRjbsbLgbLgLsbRgbLgbLgbLgLsbL
gLsbLgbRsbLibLibRibLjbLiLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104102; End: 104602;
Recording: 5-1; Individual: 48; Drug: Control
bLsRsbLsbLgbLgLsbLgbLgLsbLgbLgLsbRcbRibLgbLcbLiRsbRcbLjbLibLgbRgLsbLgb
LsbLcLsmbRibRibLibLhbRibLhbLsbLgLsbLsbLgLsbLsbLgLsbLsbLibRgbLgLsbLgbRg
bLsRobRcbRcbRcbRibRibRgbLobLcRsbRcbLcbLibLcbLgbRiLsbLgbLcbRjbLobLiRsLs
bLhbLibLhbLcbRibLobRjbLsbRiRsmbRiRsmbRibLsbLjbLibLgbRsLgLsbLgbLgbRjbLg
bLsbLgLsbRcbRsbRibRibRsbLhbLgLsbLibLsbLiLsbLibRgbRjRsmbLibLjbLibLibLib
RibLibLgLsbRobRibLgbLibRcbLebLiLsbLgbRcbRibLjbRcbLcbRebRsbRgbRibLgbRcL
sbLsLsmbRobRsLsbRibRcRsmbRgRsmbRgbLjbLhbLibLibLcbLhbRhRsmbLjbRhbLcLsmb
RcLsbLobLiRsLsRsbLibLgbLibLhbRibRibRibLoLsmbLcbLgbLiRsbLgbRgbLsbRibRgb
RgbRgRsmbLsbRgbLgbLcbLcbRsbLhLsbsbRgbRcbRibLcLsmbRhbRcbLibLcbLibRgbLgb
LgbLgbLsLsRsLsmbLgLsbLgbLgbLgbLsLsmbLgLsbLgbLsLsmbLgbLgLsbLgbLgLsbLgbL
gbLsbLgbLsbRsRsmbLebRgbRibRsbRcbLgLsbRhbLcbLiLsbRgbLcRsLsbRgbRibLibLgb
LsLsmbLgbLsLsmbLibLibRcbLcbRgLsbRcbRcbLhbLcbRgRsmbRcbLibLcbLibLgbLgbLg
bLsLsLsmmbLgbLgbLsbLibRgRsmbRcbRcbLibLibLibLgbLiRsbLsLsmbRhbRcbLobLobL
sbRgLsbLiLsbLgbLgbLsbLgRsbLgbLgLsLsmbLgbLgbLgbLsbLgLsbLgbLsbLsbLsLjbRc
bLgbRgbLhbLgbLsbLgbRsLgbLgbLgbRgbLgbLgLsbLcbLgbLsbLiLsbLsbLsLcbLcbRhbR
ibRgbRgbLibLgbRsbLjLsmbRiLsbRobLeRsbLhbLhbLcbLgbLhLsbLibLgbLibLibLibLg
bLiLsbLibLibRjbLiRsbLgRsbLgLsbLgbLgLsbLsbLgbLeLsbLibRibLgRsbRcbRcbRcbR
ibRibLgbRgbRgbLgbRibRgLsbLsbLcbLgbRibRhbRibRcLsbRcbRcbRibRgbLsbRhbLgbR
jRsmbLjbRoLsLsmbRcbRcLsbLhRsbRcbRibRhbReRsmbLgbRcLsbLibLgbRhbRcLsLsmbR
ibRcLsRsbRibRgbRhbRcbLhRsbLcbLhbRgbLiRsbLiRsbRsRsmbLsbLiLsbLgbRgbLobRg
bLibLsbRgRsmbRjbLhbRjbRibRibRsbRjbRcbRgbRibRjbRhbLeRsbLibLgbLgbLgbLsbL
gbLgLibLsbLiLsRsbLgbLgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 1; Drug: PCAP2 10 然
bLibLcbLsbLgbLgbLsLsmbRsbRsbLsbLgbLgbLhLiLsbLebLhbLsbLgbLeRsbLsLibRsbs
bLobLjbLgbLsbRsbsbsbLsbsbsbsbLsLsmbRsbRsLsbRsbsbLsbRsLsbLsbRsLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 2; Drug: PCAP2 10 然
bRgbLhbRsRsmbRebRsRiRsmbRibRibLsbRsbRoRsmbLsRsbLsbLeLsbLgbLgbRoLsbLhLs
bLcLsmbLgLgbRjbLjRsbLcLsmbLgbLsLsmbLsLsmbRsbLsbLibLgbLoLsLsLgmmbLsLsmb
sbsbLibRsbRsbLgbLibLcLsmbLcLsmbLcLsLsmmbsbLgLsbLcbRjbRcbRsbRgbRgbRhRsm
bLebLcbLgbLsbLgbRgbLsbLiLsLgLsbLsLsLsLsmmmbLsbRsbRsbLcbRsLsbLgLsbLgLsb
RsLsbLibLhLsLsmbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 3; Drug: PCAP2 10 然
bLgbRibRibsbRgbRsbLsbLsRsRsmbsbRgRsmbRsbLcbLgLsbLsbRcRsmbRgbLcLsmbRsbR
cbLgbRebRgbReRsmbsbLoRsLgLcbLgbLgbRiRsmbRsRsLsmbRcbLeRsbLsbLgRsRsmbRgR
smbRgRsLsmbRgRsLjmbLsbRcbRsRsRiRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 4; Drug: PCAP2 10 然
bRgbLsbLgbLgbLgbRgRsmbRgbRsbRcLsbRcbRsbRibRsRsmbRsbsbLcLsmbLsbLsRsbLsb
RsbLibLgbLsLsRsmbsbRsRsmbLsbLsbsbRsbRsbRsbRsbLsbRsbLgbLsbLsbRsbRoRsRsm
mbLsRsbLsbsbLsbRsbLsbRgbLsbRsRsRsmmbsbsbLsbLsbRsRsmbRsbRsbRsbRsbRgbRsL
sbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 5; Drug: PCAP2 10 然
bLgbRsbRsbRsbRsbLhbRsbRoRsmbRgRsmbRsRsmbRsbRhLsbRsRsmbRsRsmbRsbsbLsbRs
bLsLsLsmmbRsRgLsbRgbRsbRibLgbRsbRgRsmbRsRsRsmmbRgbRsRsmbLsbRsbLsbsbRsR
smbLsbRsLsbLsbLsbRsbLibRebRcbLsbLibLgRsbRsRsRsmmbLsbLsRsbsbRgLsbLsRsbL
sbLgbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 6; Drug: PCAP2 10 然
bRcRsmbRgRgRsmbRgbLobLebsbsbsbRcLsLsLsmmbLgbLsbsbRgbLhLsbLgbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 7; Drug: PCAP2 3 然
bLhbRhbLibRibRjRsmbLsbLibLsbRcbRcbsbRibRsbRgbRsbRgRsmbRgbsbRsLsbLsbLsL
sRsmbRsbRsbsbsbLsLsmbsbsbsbLjbRsLsbRsbRsbLsLsmbRgbsbRsbRsbRsbRsRsmbLsb
RibRibRcbRgbLsbRibRiRsmbRsRsmbRgRsmbRsRsmbRsbRsbLsbRgbRsLsbRsRsmbRsbRs
bLsRsbLsbsbsbsbLsRsbRcbLsbRsRsmbRjRsRsmmbRgbLgbRjRsmbRsbRsLsbsbsbLsRsL
sbRibRsbLsbLcbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 8; Drug: PCAP2 3 然
bsbRsRsRsRsmmmbLgbRhRgRsmbRsbRcbRsbRibRsRsmbRsRsmbRibLjbLobLibRsbLibLg
bLgbLgbLsLsmbRgbLjbLgLsbLsbRsbRgRsmbRibLsbRgbRiRsRsmmbRsbRgbRhbLsbRcRs
RsmmbLobLsbLibsbLgRsbLiLsbLgbLsLibLsbLhbLsbLhRsbLgbRsbLibLiRsbLsLsmbLi
bLgLsbLibLiLsRsLsLsmbLibLsbLgbLsbLgRsLsLsmbLgLiLiLsLsmbLgLsbLibLgbLsLs
LsmmbLsRsbLjbLsRsbLoRsbRhbLsLgbLiLsbLgbLsbLsbsbLiRsLsbLibLsbLgbLiLsLsL
gmbRsbLebLcbRsbRsbRsRsmbRsbRibRgRsRembsbLeLsbLgbsbRgbRiRsmbRgbRgRsRsRi
mmbLcbLsbRsbLsbLibLsLsmbLebsbLsLsmbLgbRebRsbRsbRsbRgRsRsmmbRgbRgbLobLg
bLgbRsbLgbLibRsLsbLibLsLsmbLoRsbLsbLcLsLgLsmbLgbLsbLiRsbLiRsLsLsmbLibL
iLsLsmbLgbLiLsbLgbsbLgbLgLsbLgbLhLsbRsbLgLsbLcbRsbRsbLoRsLsLgbLiLsbLiL
gLiLsbLgLsLgLgbLsLgLsbReLsbRsbRiRsmbRgbRgbRgRsmbRsRgbRibRgbRiRsmbRibRi
RsmbRibRiRsRiRsRsRimmmbRiLsLsmbLgbLobLsbRgbLibLiLsbLgbLgbLgbLgbReRsmbR
gbRgbRgbRgRsmbRiRsmbRibRiRsmbRiRibRiRgbRibRibRhbRsbRiRsmbLjbLhbLsbLebs
bLsbsbLgLsbLibsbLiLsLsmbsbRgbLgbLgLsbLsLsLsmmbRcbLsRsbRsbRsRsmbRgbRibL
gRsbRsbRsbRiLsbRebRhRgRsmbsbLgbRcRsmbRsRsmbLsbRsbRsbRibRgRsmbRgRsmbRgR
smbRgRsmbRgbRgbRsbRsRsRsmmbRiRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 9; Drug: PCAP2 3 然
bRsbLsLsmbRgRsmbRgLsbRgbRsbRgbLsbLsbRsbRsbsbLgRsbRiRsmbRsRsmbRgRsmbRsb
RcbLgbRebRsbRgbRgbRsbRgbRgbRsbLsbRibRgbLiRsbLjLiLsbLgbLgbRsRibRiRsmbLs
bLsbRibRsbRsbRsRsmbRsbRsbRsbLsRsbRsRsRsmmbRsRsmbRgRsmbRsbLjbsbLcbRsbLh
LsbLibLiLsbLsbLibLibRgbLibRsRsmbLgbLsbLsbLgbRsbLgbRsbRsbRhbLsLsmbLsbRg
bRgbLsbRibRsRsmbLsbLsbRsRsRsmmbRsbRsbRsbRibRsRsRsmmbRsRsRsmmbLsbRgLsRs
bRsbRsRsmbRsbRiRsLsmbRgbRiLsLsmbLhbsbLcbLgbLgbLibLgLsbRsLsbsbLgbLibLgb
LsbsbRsLsbLjbsbLgbLhbRsRsmbLibLibLhbLiRsbRsbRhbRgRsmbRsRsmbRgbRsbRsbRg
bRsbRgbRsbRsbRgbRgbRibLgbLjbLcbLiLsbLgLsbLsbRgbRgbRgbLebLgLsbLgbRoRsmb
LjbLgLsbRjRsmbRhbLsbLsLsmbLsbLsbRsRsmbLoLsmbLiRsbLgbLibLsRsLsbLgbLibLs
bsbLsLibsbLhbLibLsLsRsmbLsRsbLcbLibLiLsbLgbLobLibLgbLgbLcbLgbLibLibRsb
LibRsbLibRjbLgbLibLibLsbRsbLsbLibLgbRsRsmbLgbLhbLcbLsbLsbRcbRibLsbLsRs
bRsRsmbLsRsbRsRsmbRgbRiRsmbRsRsmbRsbLsbRjbRibRsRsLsmbRsbRsbLjbLiLsbLgb
LsLsmbLsLsmbLgbLsLsmbLgLsbLgbLibLgLsbLgbLgbLhbLibLsbLgbLgbLsbLibLgbLib
LibLgbLsbLsbLgbLgbLgLsbLibsbLcbLibRsbLsbLsbRhbRgRsmbRiLsbLsbLgbLjbRcLs
bRsbRgbRibLsbRgRsmbRiLsbLsLsmbLgbRjRsmbRgbRgbRgbRgbRsbRgbRsbRsRgbRgRsm
bRgRsmbRgbRgRsmbRiRsmbLgbRibRibRsbRsbRsRsRsmmbRgRsmbRsbRgbRsbRgbRibRsb
RiRsmbLsbLsbRibLsbRgbRgbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 10; Drug: PCAP2 3 然
bsbsbRgbRsbRsbLsLsmbsbRsbLsLsmbsbRsRsRsmmbRsRsmbRsbLgLsbLgbsbLibLsLsmb
LsbRsLsbLsbLsRsbsbLgbLsLsLsmmbLsLsmbsbsbLsLsLsmmbLsbLsbLsbLsLsmbLgbRsL
sbsbLgbLsbLsbLsRsbLsLsmbLgLsbLibLibLsbLgLsbLsbLgLsbLsLsmbRsLsLsLsLsmmm
bLsbsbLsbRsLsbLsbRsbsbRsbRsLsbRsbsbsbsbsbRsbRsbLsbLsbsbsbRsbRsbRsbLsbR
gbsbLsbLsbRsbLsbsbLsbsbsbLsbLgbLsbRsbLsbLsbRsbRsLsbsbLsbLgLsbRsbsbLgLs
bLgbRgbRgbsbRibsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 11; Drug: PCAP2 3 然
bRsRsmbRibsbLsbRsRsRsmmbRgRsmbRjbLjRsbLsbLsbLsbRcbRgbLgbRibLsbRgbRsbLg
bRgbLsRsbRibRsRsLsmbRibRsbRsRgbRgbLgbRsbLgbsbRsbRjbReRsmbRsbLjbRsbRsbR
sbRsbRsbRgbRsbRsRgbRsbLsbLsbRsbRsbRgRsmbLsbRgbRgbRgbLsbLsbLsbRsbReRsmb
RsbLsRsbRgbRgbRsRgbLsbRsbLsbLsbLsbRsRgbRibRsbRsRgbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 12; Drug: PCAP2 3 然
bRsbRgRoLsbRjbRibRsbRgbRgbRsbRgbLsbLsbLoLsmbLebRgbRsbLsbLibLsLsmbLhRsb
LsbLibLsbRsbRsbLsbLibLgbLsbLsLsmbsbLsLsmbsbsbLgRsbLsbLsbLsbLsbsbRjbLcb
LebsbLebLgbLibRsbLhbLibLsbLsLsmbLcbLsbLsbLsbLiLsLsmbRsbRibRsbRsbLcbRsb
LcLsmbRsbsbRsbLsbLsLsmbLibLgLsLsmbLsLsLsmmbLsbLsbLsLsmbLsLsmbLgbLsbLsb
LsbLobLibRibLgbRgbLjLcLsmbLsbRebRiRsmbLgbRsbRobRibRgbRsLsbLibLsLsmbLsb
LgLsbLgLsbLgLsbsbRsbRebLebLgLsbRobRhbLgbLsbRgbRgbRsbRgbRsbRgLsbRgbRibR
gbLsbLgbLibLibLibRsbsbRsbLgRsbLsbsbsbsbLjbLibsbLgbLsbRcbRsbRibRsRsmbRs
bLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 13; Drug: PCAP2 1 然
bRgbLjbRcbRsbLjbLjLsmbLcbLiLsLsmbLsLsmbLibLgbLsLsmbLibRsbLsbLgRsbLsRsb
LgbRjRsmbLsbLgbLgLsbLgbLsbRsbLobsbRsRsmbRibRcbRsLsbLsbLgbLsbsbRcbRsbRs
bRhbRsbLsbRibRsRsmbLsRsRsmbRsbRgbRsRsmbRsbsbRgbRsbRgRsmbLjbRiRsmbRgbRg
bsbRgbRsbLjbLsbRsbsbLcbLgbLibRibRsbRobRsRsmbRibRsRsmbRsbRiRsmbLsRsbRsb
RsbRsbRsbRgbRgRsmbLsRsbRgbRsbRhbLiRsbsbRiRsmbRsbRgbLsbRgbLsbLsbLsbRsbR
gbRsbLsbsbRgbRsbLsbRgbRsbRgbRsLsbRiLsLsmbLjbLgLsbLgLsbLibsbsbLgbRibLcb
LsbRjbLgbLcbRsRsmbLsbLgLsLsmbsbLsbLgbLgbRsbLsRsbRsbsbLoRsbLsbLsbRgbLib
sbLsbsbRgLsbLibRsLsbRsbLibLgbRgbLibLcbLsbLibLsbLsbRsLsbLibLgbRgbLobLib
RsbLjLsLsmmbRsRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 14; Drug: PCAP2 1 然
bRgbRsbRsbRgbLsbRibRgbLgbLgbRebRsbRibLjLsLsmmbRibLgbRibRsLsbRgbRsbsbLg
bLsbRsbRgbRsbRiRsRsmmbLsLsmbRsbRjRsmbRibRgbRsbRibRgbRsRsmbRsbRgRsmbRgR
smbsbRsbRsbLibLsbLgbLgbLjLsmbRsbRsbLibLibLsRsbRsbRsbRjRsRsmmbRsbRsRsmb
RiRsmbRsbRsbRjRsmbLsbLsbRsbRsbRebRgbRgbRsRsmbRsbRsbLsbRjbLhbRsbRgbRiRs
mbRsRsmbRibRgRsRsmmbsbRsbRibRibRgRsmbRsbLgbRibRgRsmbRsbsbLibLgbLgbLgbL
sbLjLsmbRgbsbRgbRgbRcbRiRsmbRsbRgbRsbRsbRsbRibRgRsmbsbLgbLgbRibLsbRibR
sbRibsbRcRsmbRgbRsbRsbRgbRgbLsRsbRgbLsbRibLsLsmbLsLsRsmbRgbRgbRsbLsLsm
bRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 15; Drug: PCAP2 1 然
bLibRibRibRjRsmbRgLsbLjbLsRiLsbRiLsbLsbRsbLsbLsbRgbRiLsbLsbRibLgbRibRg
bRibLsbLsbRiRsmbRgbRibRgbLgbRibRibRibRibRgbRgbLgbRgbRibLsLsmbRgbRsbRib
LsLsmbRgbRibLsRsbRgbRsbRgbRgbRibRgRsmbRsbLhLsbLjbLhbRebRhbRsbRibRsbLgb
RhRsmbLobsbLcbRjRsmbRobLgbsbRibRgbRsbRibLsRsbRibLsbLsbRibLibRiRsmbRsbR
ibRgbRsbLgbRibRsRsmbRgbRgbRgbRgbRgbRgbRsbRsbRgbRgbLsbRgbLgbRibLsbRgbLe
bRjbRcbLjbRibRhbLgbRiLsRsbRsbRibLsbLsbsbRibLsbRgbRgLsbLsRsbRibRsbRsbRg
bRsRsmbRsbRgbRibRgbLjLsmbRibLsRsbRgbRgbRgbRgbRgbRgRsmbLsLsmbRibRgbRgLs
bLgbRibLsbRsbRsRsRgmbLsRsbRgbRgbLgbRiRsmbRsRsmbRsbRgbLgbRiRsmbRgRsLsmb
RsbRgbRgRsmbRgbRsbRsbRiRsmbRgbRgRsmbRsbRgbLsbRsbRgbLsbRibRgbRgbRgbRgbL
sbRibRsbRgRsmbsbRgbRgbRgbRgRsmbLcbLcRsbRibLcbRhbRhbRsbRibLgbRibsbRiRsm
bRgbLgbLgbRcbRiRsmbLjbRibRgRsmbLgbRiRsmbRsbLgbRgbRgbLgLsbRgRsmbRibRgRs
mbRjRgRsmbLsbRiRsmbRibLgLsbRsbRobLibRcLsLsmbLebRibRibLsbRgbRgbRgbRsbLs
bRcbRibRebLibLibRcbRhbRibRgRsRsmmbRgbRibLsbRsbRobRhbLcbRibRibLjbRibLcb
RcRsmbRebRcbLsbRsbLcbLcbLiLsbLsbRsbLcbRjbRjRsmbLcRsbLcbRhbLcbLibLhbRsR
smbLsbLibRibRebLgbLjLsmbLcbLibsbLiLsbLcbLibRgbLjLgbRibLibRgbLjLsLsmmbR
obRiRsmbLhbRibRcbLiLsbLibLsLsmbLcbLiLsbLsLsmbLsbLjLsmbLsLsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 16; Drug: PCAP2 1 然
bRsbRgRgbRgbRgRsmbRcbRibLsbLgbLgLsbRsbRgbRgbsbRsbRsbsbRgRsmbRsbRgbsbsb
sbRgRsmbRsRsmbRibLsbRgbLsRsbRsbRsbRiRsmbRgbLsbRgbRsbLsbRsRsmbRsbRibLsR
sbsbRiRsmbRsbRsbRcRgbRhbRgbRgbRsbRsbRibRibRgRsRsRsmmmbRgbRibRhbRsRsmbR
oRsmbRsbRsbRsbRsbRsbRsbRgbRgbRsbRgRsmbRsbRsRsRsmmbRsbRgbLsRsbRiRsRsmmb
RgbRgbRcbLgLsbRcbRgbRsbRsbRsbRibLsbLsbLsbRgRsmbLsRsRebLsRsbRobRgbLsRib
RsbRsbRsRsRsmmbRgbRgbLsbLsbRsbRjRsmbLsbRsbRgbRcbRsbRibRgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 17; Drug: PCAP2 1 然
bRhbLgbRsbsbLsbLcbLsbLibLibLgbLgLsLsmbLhLsbLsLsmbLgbLgbRsbLibLibLsLsmb
RgbLhbLgLsbLgRsbLsbLgbLsbLgbsbsbRsLsbLibLgbLsbsbLgbsbLsbLsbLgbLhbLsbLs
bsbLgbsbLsLsmbLsbLgLsbLgbLsLsLsmmbLhbLsLsmbLsLgLsbLgbLsbLgLsLsLsmmbLgL
sbLsbLgRsLsbRjbRiRsmbLebLibLsbLsbRgbLhbLgbLsLsmbsbRsbLgbLgbLsbLgLsbLgb
LsLsmbRsRsmbRgbLhLsbRjLsbLsLsmbLiLsbLibLsLsmbsbLsbLsbRsbRsRsmbLsbLsbRs
bLcbLsLsmbLsLsmbLeLsbLsbLgbRgbRsbLebLsbLsLgLsbLgbRgbRsRsmbLiLsbLsLsLsm
mbLsbLsLsLsmmbRgbLsLsmbLsLsLsmmbLgbsbLsbsbLsbLgbsbLgbLsbRsLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 18; Drug: PCAP2 1 然
bRjRsmbRsbLibRsbRgbRsbLgbRgbRgbRcbRcbRsbLsbLgRsbLsbLsbLibRcLsbRsRsmbLj
bLhbLibRsRgbReRsmbLjbLhbLcbLcbLjbLiLsbLsbLibLebsbRsbRobRiLsbRsRsmbRsbL
sbRibLcLgbLhbLsRcbRgbRgbRsRsmbRgbRsbRgbRsbRsbLjbRcbRsbLsbLgbRibRsbRsRs
mbLibLibLsbsbsbRibRsbsbRsbLgbLsbRsbRsRsmbLsbRgbLiLsLsmbLsbRcLsbsbRsbLs
bRgRsmbRsRsmbsbRsbLsRsLobLibLsbRjRgbRsbRcbRiLsbRgLsbLibLibsbsbLgRsbRgb
RobLibLcLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 19; Drug: Control
bLebRibLcbLebLgRsbLsbLibLgbLcbLibsbRsbLgbLgbRgbRibRsbRibRsbLgbRgbRsbRs
bLsbLhbRsbRgbRgbsbRsbRibRsbRgbRgRgbRgbRsRsmbRgbRgLsbRjRsmbRgbRsbsbsbsb
LsbsbsbsbLsbRgbRgbLibRsbsbsbLibLibLgbLsbLgbLgbLgbRsbRsbsbLhbLgbLgbRsbs
bLgbLsbLgLsbRgRsmbRsbsbRsbsbRgbRjbRsbLjbLgbLgbLgbRgbRibLhbLsbLsbLsbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 20; Drug: Control
bLiLsLsRsmbLgbLcLsmbRsbLsbRcRsmbRsRsmbRcbLibRjbRibLsbRibRsbLibRsbLibRs
LsbRjbsbLsLibLsRsbLebLsbLgLsbLibLsbLgbRebRsbRhbLsbRhbLgbsbRgRgRsmbLjbs
bLsRhbRgRsmbLsLsmbLcbLiLsbLiLsbLgbRsbLjbLibsbLgLsbRgbLgLsbLibRgbLibRsL
gbLiLsbRjRsmbRibLjbRgbRibLsRsLcbLsbLgbLsbLsbLgbRjbRcbRhbRcbLgbRsbRsbLg
bLeLsbLobLobLibLibLgbLcRsbLcLsmbRgbRsbRibRsbRgLobLgbLgbRibRcRsmbLobLgb
LgbRgbLibLibRgbRsbLsRibRibRsbRibLebLsLsmbLgbLsbLsbRgbLjbRsbLsbLjbRsbLs
LsmbLsbLibLsLsLsmmbLgbRcbRcbsbLgLsbRgbRiRsmbRgbRgbRsbLsbRsbLsLsmbRsbRs
bRsbRsLsbRsbRsbRsRsmbRsbRsbRgbRgbRgbRgbRgbRgbRsLsbLsbLeRsRsLsmbLibLiLs
bLgbLgbRsbLgbLgbLibRgbRjbLhbLgbRsbLsbLiRsbLsbLgLsbLgLsbLgbLgbLibLhbsbR
cRsmbLibLgLsbLcbLgbRsbRcbLebLibLsbLsbLgbRsbLgbLibLgbLiLsbLsbRsbRhRsmbR
oLsbRcRsmbRibRibLcbLcbRibLibLgbRsbLibRgbLibLgLsLsmbRsbLsbLsbLsRsbLibLs
bLsbsbLgbLsRsbLsbLgLsbLgLsbLgbRebsbRhbRcLsbsbLsLibRhbLibsbLhbLgbLgbsbR
sbRobLhbLiRsbLgbRsbLibLgbLsbsbLgbLsbLsRsbRgbLsLsLgmbLibLsbLibLsLgbLgbL
gbLgLsbRsbLgbRsbLibLsbLibLsbLgbLgbLgbLgbLsbLgLsbLgbLgbLsbLiRsbLcbsbRcR
smbLgbLhbLcbRibRsbRobLibsbLjLiLsbRsbLgbLgbRgbLibRobRhbRiLsbRsbLsLcbLiR
sbsbRsLsbLobRsbRebLjbLhLsRsbLsbLgbLgbLsbLgbLsbReRsmbLsLsmbLsRibLebRsbs
bLgbLsLsRsmbRsbLibLsbLgbRjbRibRibRibLibRibRibLcbLhbLgbRjbLibLsbLibLgbL
gLsbLsLgbsbRsbRgbRebRgbRgbRgbRgbRobLibLgbLibLibLibLsbRsbLgLsbLibLobLib
RibLobLiRsbRjbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 21; Drug: Control
bsbLjbRgbLsbRiRsmbRsRsmbRgbRgRsRsmmbRsbRgRsmbRsbRgbsbRgbRgbRjbRjRsmbLj
LsmbRgRsmbRsbRjRsRsmmbRjRsRsmmbsbRibRcbsbLsLsLsmmbLgbRsRsmbsbLjbRjRsmb
RgRsmbsbLsbRjbLsbLgbRsRsmbLsLsmbRibLhbsbLcbRibLibsbLgbRjRsmbLjbsbRgRsm
bRsRsmbRsbsbLsbRgRsmbRibRsbsbRiRsmbRsbRibsbRiRsmbRsbRibLjLsmbRibRsbRsb
RcRsmbRibsbLsRsbRibLsbRibRsbsbRcbRsRsmbLsbLsbLsLsmbRjbLibLjLsmbsbLgbRs
bRcRsmbRibRsbLjbRjbLibRibRjbRgbsbRsbLsbsbLjbRibRhbRibRiLsRsbRsbRsbRgbs
bRcRsmbRjRsRsmmbsbRjbLsbLsbRgbRsbRsRsRsmmbRgbsbRgRsmbLsbsbsbLsbRgRsmbR
sbRsbRgRsRsmmbRjRsmbRgRsmbsbLsbRiRsmbLjbRsbRhbRiRsmbsbRgbLsRsbLsbLsLsm
bLjLsmbsbRjRsmbRsbRjbsbRjRsmbRjRsmbsbLhLsbsbRgRsmbRsbRsbRgbLebLibRjRsm
bLebsbsbsbLsbLiLsbLsbLcbLsbLjbRsRsRsmmbLjbLsLsmbRibRcbRgbRjRsmbRsbLgbL
sbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 22; Drug: Control
bRsRsmbLobRgbRsbLibRjRsmbRsbLgbRgbLjLgbRgbLsbsbsbLgbLcbLobRgbRgRsmbRcb
sbRhLsLsmbRsbRgbRsbRcbRgRsmbLsbRgbRibRibRgbRsRsLsmbRsbRcLsbRibRiRsmbRs
RsmbRcbRibRiLsbRsLsbLjLsmbLsbRcbRgbRsLsbRibRcbRhbRibRgbRgbLsLsmbsbRsLi
bLgLsbRiRcbRibRibRsRsmbRgbRgbRgbRgbsbLsLsLsmmbRjRsmbLgLsbLibRsRsmbRgbs
bRgRsmbRsLsbsbLjLsLsmmbLsLsmbLsbRsbRsbRjRsmbsbLsbsbsbLsbsbRjRsmbLjbRjL
sbLibRjRsmbRibLibLsbLibLsbLgbLgbLibLgbLoLsLsmmbLibRgbLsbLgbLsbRibRibLj
LsmbRibLgbLjLsmbLsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 23; Drug: Control
bLgbRcbRibLjbRibRibRsbRgbLjLsLsmmbRcLsbRibRgLsbRgbRgbRsbRibLjbLcbRibRj
bRibLsbRibLsbRgRsmbLsbRsRsRsmmbRgbLsbRgbRgLsbRgRsmbsbRsRsmbRgbLsbLgbRh
RsmbLibLsbRgbLsbRjbsbLsbRibsbsbRsbRibRibLsRibLjLsmbLibRibLhbRgbRjbRgbR
ibRgbRibLobLibLibRhbLiLsbLgbsbRibRsbLhRsbLgbRibLobLgLsbRgbRsbLcbRgbRcb
LebLcbRjRsmbsbLibLsbsbLibLibLibRjbLibLgbsbLgbRjLsbLiLsbLgbRjbLobRibRjb
LibLgbLgbLsbRgbRebLibLjbRcLsbRibRgRsmbLsbLjbLibRgbRsbLibRcbLcbLgLsbLob
RibRibRibRjbRsbLgbLebLibLibLgbLibRibsbRsbRjbRsbRiLsbsbRgbRsRsmbLjbLsLs
RsmbLjbLibRjbsbLhbRjbRibLibLgbRjbRjbRgbLebLhbRcRsmbLjbLgbLibRjbLgbsbRs
bRsbLibRgRsmbLgbLibLgbRebRcbRibLsbsbLsbLgbRibsbRgRsmbRsbRsbLsbRibRsbLg
bRgRsmbsbRgbLsbLjbRibLjbRiLsbsbRgbLhbRsbLsbLibRsbLibLgbLgbLgbLgbRsbRsb
RgbLhbRjbRibRgbLsRsbRgbLsbRgbRjLsbLgbLjbRgbLjbLiLsbLgbsbRgbLgbLsRsbLsb
LsbLibsbLsLhbRsbRjbRibRgbRibLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 24; Drug: Control
bLhbLhbLcbLgbRsLsbLjbLcbRibLhbRgbRobRobRiRsmbRiRgbLhRsbRgbRcbLsbLgbLsR
iRsmbLjbRsbRhbLjbRiRsmbRgbRgbLsbRgbRsbRgRsmbRsRsRsmmbRibRsbRgbLsLsmbRg
bRgRsmbRgRsmbRsbRsbLhbRsbRebsbRcbLsbLgbRhbLsbRibLgLsbLibRcbLjbRcbRcbRe
bRgbLcbLhbRebLcbLgbsbsbLibLcbRgLsRsbRibLibRcbRsbLjbLcbLcbLsRsbRjbLibLg
bLgbLsbLgbLsbLgbsbLgbLsLsmbLgbRsRsmbRjbRsbLhbRibLebRibRsbRibLsRsbRcbLs
bLgbsbRsbLibLcbLgbLsbsbRsbLibLiRsbsbRsbRsbRsbLgbsbLsbLgbLgLsbLgRsbLibL
jbRgbLjbRcbRibLjbLjbLsbLgbRebLhbRgbLibRibRcLsbLgbsbLsbLjbRcbRebRibRsbL
cbRibLibLgbLgbRjbLibRebRibLjbRibRiRsmbLjbLcbRcLsbLgbRgLsbRebLgRsbLibRg
bRsbRgRsRsmmbLsRgLsbRsbRgbRsbRsbRgbRsRsmbRsbRgLsbsbRsRsmbRgbRsbLjbLgbR
cbRibRibLjbRgRsmbRsbRgbRsRsmbRgbRsbRgbRsbRgRsmbRsRgbRsbLsbRsbRgbLibLjb
LsLsLjmbRhRsmbsbLcbLcbLsbRjRgbLiRsbRobRibRibLibLgbRcbRgbRibLibRsbLibRs
bsbLibLgbRsbRebLsbLgbRsRibLsLsmbRgbLjbRsbLebRgLgbLgbRsbLgbLsbRsRsmbLsb
LgbRhRsmbRsbRibLsLsmbRhLsRsbLjbLibRibLsbLsLsmbsbsbLhbLibRsbLibLsbLgRsb
sbRjbLibLgLsbRsbLsbLgbRgLsbLgbRjLsbRiRsmbRibRiLsbLsbRibLiRsbRiLsbLgbRg
bRsbRgbLsbsbRsbRsLsbRsbRsbRsbRgbLsbLjbRcbLgbReLsbLsbRibLsbRgbRsbLsbRsb
RsbRgbRgbRgbRsRsmbRgbRgbLsLsmbRgbRsbLjbLhbLibRebRibRcbLjLsmbLcbReRsmbL
cbLcbRcRsRsmmbRibRibLsRgbRsRsmbRsbRsbRsLsbRsbLsbRsbRsRsmbRgbRsbRsLsbRg
bRgRsmbRgbsbsbRgbsbsbsbRgbRsbRibLibLeRsbLgbRjRsmbsbRhbLgbRcbRiRsmbRsRs
RsRsmmmbLiLsbRebRhbLjLsmbsbRcbLsbLhbRibLcbRgLsbLcbLgbRhbRsbsbRibLsbRib
sbLgbRobLibRgbLsRoRsRsmmbRibsbLsbRsRsmbRsRsRsmmbRcbLgbRgLsbLebsbLhbLgb
LeLsbRiRsmbLcbRobLsLsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 25; Drug: PCAP2 10 然
bRiRsmbLsbRsbLsbRgRsmbRgRsRsmmbRgbLgbRsbRsLsbRsLsbLsLsRsmbLsRsbRsbRsbs
bsbRgRsmbLgbLgbRgbRibRcbRibRsbRgbRgbRgRsmbRsbRsbRgRsmbRgbRsbRgbRsbRgbR
sRsmbRgbRgRsmbRibRcbRibLgbLsbLsbLgbsbRsbRsbRjbRgbsbRgbRsbsbLsbRsbRsbRs
RsmbRsRsmbRsbRsbRsbRjbRsbRgbLsbRsbRsRsmbRgbRsbRsbRsbRibRsLsbLsbRebRsbR
cbLgbLgbLibLsLsmbLsLsmbLgbLebLibLhbLgLsbRjRsmbRibRsRsmbLsbsbLgLsbRsbRg
RsmbRsRsmbRsLsbRgbLsRsbsbRgbRsbRgRsmbsbRsbRsbsbsbsbRgbRgRsmbRgRsmbLgbR
jbRgbLsbLjbRgbLsbLsLsLsmmbLjbLgbLsbLsLsLsmmbLsRsbRjbLiLsbRibRibRcbRebs
bRsbLsLsmbLjbLgbsbRebRibRibRgRsmbLsbLcbLgbLsbLsbRebRcbRsRsmbRsbRsbRgbR
gb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 26; Drug: PCAP2 10 然
bLsbLeLsLsLsmmbsbRsbLhbLgbLebLgLsLsmbRsbRsbLgbLgLsRsbRgbRebsbsbLsbRsbR
jbLsbsbLsbLcbRsLsbLsbLsLsLsmmbsbLsbLibLsbLsbRsRsmbsbsbRsbLsbLsLsmbsbsb
LsbsbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 27; Drug: PCAP2 10 然
bLibLgbLsLsLsmmbLsLsmbLsbLsbLsbLgbLsbLsbLgbLhbLcbLjLsLsmmbLgbLgbLgLsbL
sbLibLgbRsLsbLgbLgbLsLsmbLsbLsbRsbLibLsbLsbRsbLiLsbLsbLgLsbRsRsmbLgbRs
bLgLgbRcbRiRsmbLsbRsbLibLiRsbRsbLsLsmbLibLsLsmbLiLsbLcbLibRsRsmbLhbLsb
LgbLgLsbLsbLsbLsLsmbLcbLibLgbRsbRsRsmbRsRsmbLsLsmbLgbLibLsbRsbRsbLgRsb
LgLsbLsbLsbRsbRsbLgbLsbLsLsmbLiLsLsmbLsbsbLgbsbLsLsLsLsmmmbLibRsbRsbRs
bRsbsbLsbsbLgbsbLjbsbsbLiRsbLsRsbLsbRsbLsbLsbRsbLibLibLsLsmbLgbLsbLibL
ebLiRsbRsbRgbLibLgbLsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 28; Drug: PCAP2 10 然
bLgLsbLgbsbLcbRsbRgRsRsmmbRgRsmbRgRsmbRsRsRsmmbLsRsbRsbLjLsmbLsbRibRgb
RsbsbLjbLibLgbLsbLiLsbLsbRsbRsLsbLsRsbLsLsmbLsbRcbRgbRcRsRsmmbRsbRibRs
bRsbRiRsRsmmbRsbRsRsmbRgRsmbRgRsmbLebLsLsmbLsbLibRsbRibRsbsbsbsbRebRsR
sRsmmbRsRsmbRsbLibLsRsbLebLoLsmbLgbLhLsRsbRsbLobsbRsRsmbLgbLiLsbRjbLgb
LgbLgbLjLsmbLsLsmbLgbLgLsbLsbRgbRsRsmbRsbLhbsbLcbLsbRsLsbsbLsbLibLsbLs
bLgbLgRsbLcLsmbLibRsbRgbRsRsmbRsbRsRsmbLsbRhRsmbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 29; Drug: PCAP2 10 然
bsbsbRsbsbsbsbsbsbLsLsmbsbsbsbsbsbsbsbsbLsLsmbLgRgRsmbLsbsbRsbRjbLgLsL
smbRsRsLsLsmmbsbsbsbRibLsbLobRsRsLsLsmmbLsLsLsmmbRgbLgLsbLsLsLsLsmmmbL
sbLobRobLibLsbRsbLhbLsLsmbsbsbRsRgbLibLsbLsbLibRsbsbLgbRsLsLsLsmmbLibL
obLgLsbLcbLgbLgbLsbLsbLgbRsbLcbRibRiLsbLsbRobLsbLsRsLsbLebRibRsbRsbRsL
cbRobLsLsmbsbLibRiLsbRiRsmbRgbRibLsRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 30; Drug: PCAP2 10 然
bLsbRebLjbRebLobLebRobLcbLsbLebLjbLjbLebRgbLjbRebLobRebRcbLjbRcbLsbLob
LsbRsbLsbRjbRsbLobLjbLjbRcbRsbRsbRsbRsbRebLsbRsbLjbRebRsbLsbRjbLsbLobL
jbRjbRjbRobLsbLsbLcbRcbLebRebRjbRebRobRsbRcbRjbLsbRjbLcbRebLebLebLobRs
bRobRobRobLsbLobRjbLsbRobRjbLsbLobRebRobRjbRobLsbLobLjbRcbRobLebRobReb
LsbLobLcbRebLcbLsbLebRjbLsbLsbRjbRsbRsbRsbsbLsLsmbRobRjbLsLjbRobLjbLjb
LoLsmbRjbRebLjbLsbRebLobLebLcbLsbRjbLjbRebLcbLebRobRobRebLobRobLsbLobR
obLebLsbLebRobRibLobLobLebLobLobLcbRobRobRcbRobLebRebLsbRibLjbLebLebLo
bLsbLobRsbLsbRebLsbLcbLobRobRsbRcbLcbRcbLsbLebRebLobRcbRsbRobLjRsbLebL
ebLobLebRsRsmbLjbLsLsRsmbRsRsmbLsbLsbLsbRsLsbLsbRsLsbRsbRoRjbRebLobRsb
RobLcLsmbLebLsbLobLsbRsbRsRjbLsbLsbLebRsbLebLobLcbRobLebLobRobRobRsbLs
bRebRobRobLgbRjbLobRobLibLebRobRebRgbRjbRsbLsbLcbRobLobRibRobLobRebLob
RobRobRebLobRsbRobLobRsbLobLsbRobRcbRobLsbRebRobReRsmbLcbRebRsbRsbRgbR
ebRobLobLcbLgbRobRsbRebRebRobLeLsbRjbLsbLsbLebRebRobRsLeRsLsbRsbLsbLsb
LobRebLsbLsbRobLsbRobLobRsbRebLsbLebLsbLsbRcbRsRebRsbLsbRsbRjbRobRebRe
RebRsLsbRebLobRobRebLebLobRsbRsbLebRebRobLsbRobLibRobLsbLobLobLsbLibRo
bRcbLebRcbLebRobRsbRsbRgbRcbRsbRsbRobRobRjbLebRobLsRsbLebRebLsbLsbRsLs
bLcbRebRsbRobLobRsbLjbLsbRsbRsbRsbRsRsmbRsbRobRsLsLobRsbRobRsbRsbLobRs
bLsbLebRobRebRobRsRcRsmbRcbLsLsmbLobLsbRsbRsbLsbRobRobRebLcbLsbLcbRjbR
ebRcbRobRobRobLebRobLobRsbRebRobLobRobLibRebRobRsbLebRjbRebRebLcbRsbRj
bRsbLcbLsbRebLjbRebRgbLjbRgbRobRebLsbRcbLobLjbRsbLobLebLobLibRobRebRsb
LebRcbLobRsbRebLebRsbRobRobRsbLcbRobRcbLobRgbLobLobRjbLebRobLsbRcbRobL
obRjbRsbRebLsbLcbLgbLobRibRobRobRobRsbRobLjbLsbLebLsbRsbReRsmbRsbRobRe
bRobRhbLobRsbLobLsbRobLsbLsbRobLsbRsbRsbLobLobRobLsbLsbLobRsbLebRsbReb
RsbLeRsbLsbLsbLobRsbLsbsbRobLsbRsRsmbRsbRsbLsbLsbRobLebLebRsLebRobRsbL
ebRebRebRobLsbRobRobLcbRobLebLobRebLebRgbLgbLobRobRjbLibLobLobLobRebLo
bLcbLebLsbRebLebRebRjbRobLsbRobRobLcbLebRebRobRebLsbLobLobRgbLobRsbLob
LobReb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 31; Drug: PCAP2 3 然
bLsbLjbRsbLebLobLsbLsbRsbRebRobRjbRjbLjbLebLjbRjbLobLebLsbRsbLjbLobRjb
LjbLjbLjbRebLjbLebLobRcbRebRjbLobLebLcbLcbRsbLsbRjbLjbLcbLcbRsbRcbRebL
ebLjbRebRjbLebRobLsbLcbRebLjbLobRsbLebRsbRsbLobRebRebRsbLebRsbRjbRobRo
bLebLobRcbRebRebLobLobLobLcbRebLsbRebRebLjbLhbRjbLjbLebRcbLgbLsbLcbRcb
LobRobRobLobRebRobRobLcbLcbRibRobLcbLobLcbLebLobRobLobLjbRcbLjbLobRjbL
gbLobRebLcbRcbLcbLebRobRibLcbRjbRobLobRcbLcbLcbLobRcbLibLobRobLhbRobLc
bRobLibLcbRcbLibRobRebRibRobRobRobLobRebRgbRcbLebRebLcbLhbLcbLobRibRgb
LobRobLhbLebRsbRobLibLgbRibRcbRsbRebLobLgbRcbRcbRobLobLobRobLobLobLebL
obRobRobLobLobLebRcbRcbRobLobRibRobRobRgbLobLsbRsbLobLobLibRobRebRsbLs
bLobLsbLobLobRcbLebLibLcbRobRsbRsbRsbRebLhbLebLcbLobLcbLgbLgbRobLobLeb
LebRebLobRsbRgbRsbLobRcbLcbRebRibRgbLcbLebLobRibLebRebRobLobLgbLgbRobR
obLobLobLobLcbRsbRobLobLebRobRobRebLebRgbLobLhbRcbLsbLebLebRcbLebRjbLs
bLobRjbLjbRobLobRobRebRobLcbLebRobRebRebLcbLcbLobLibRobRobRobLgbRsbReb
RcbRjbRobLcbLobRibRebRobRcbLebRgbLebLebRgbLobLobLobRjbLebLebRcbLobRibL
cbRgbRcbLobLebLobLcbRebRgbLobLobRobLobLcbLebRgbRobLobLebRebRcbLsbRobLo
bRjbRcbLcbLsbRcbRobRcbRebRebRebRobRobRobRebRobRebRsbLebRibLsbLobLcbLcb
RebRobRebRgbRebRebRjbLcbRibRsbLobLcbRibLobLebRobLhbRobLebLobLobLcbLebR
obLcbLcbLcbRsbLobRebLibLebLobLhbLgbRibRibLobLcbLcbRobRgbRebRobLobLebRo
bRobLcbLebLobLobRebLobRcbLebRobLcbRsbLjbLcbRobRobRhbLsbRobRobRjbRgbRob
RcbRobRebLobRcbLebRobRobLebRsbRcbLobRebRobLebLobLibRebRobLsbLebLobLobL
hbRobLobRebLebRebRebRobRobLobRobLobLebRobLobRebLgbRobRebLebLobRcbLobLe
bLgbRobLobLcbRsbRobRcbRobRobLebLobRobLibLobRobLobLsbRobRobRebLobLibLob
RobRobLebRobRibRobRobLcbLobLobRebLhbLobLobLcbRobLebRibLobLobLebRobLcbL
ibRobRcbRobRobRibRobRgbRobLebRebLebRhbLobLcbLobRebRebRobRobRobLobRebRc
bLobLgbRsbLobRobLibLebRobRobLobLjbLsbRobRjbLobLobLobLobLobRobLobLjbRcb
LobRcbLebRobRebLobRebLebLobRebRsbRjbRebRgbLobRebRobLebLcbRcbLobRebLcbR
obRebLhbLgbLobLibLobLobRgbRobLibRcbRobLobRobRobRebRebLebLebRsbLgbRobRg
bRibLgbRobRcbLebLobRobLobLobRobRebRjbLobLcbLcbLobRibLsbRebRcbRobLsbLob
RgbRobRgbLibRebLcbLcbLobRobLjbRgbRobLjbRobLgbLibRobRsbRobLsbLobRebRobL
obLcbLebRobRobRebLcbLsbRobRobRebRobRebLobRobRgbLobLcbLobRebRobLobRibRe
bRobLgbLobRobLsbLibRobRobLebRebRobRjbRcbLobLobRobLcbRebRebLcbLobLebLeb
RobLibRibLcbLobLebLobLibLebLcbRebLobLobLobRobRobLcbLobRebLgbLobRobLobL
obRcbLcbRobLobRcbLobRcbLobLebLobLobLcbLibRibRsbLobRobLhbLcbLebRobLhbRo
bLebLebLobLebLebLobRobRobRobRobRobRebRobRobRobRsbRobRobRebRsbRobRobLob
RebRobRobRobRcbLebLcbRsbLobRobRobRjbLobLjbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 32; Drug: PCAP2 3 然
bLgbLgbLgbRebLibRsbRibRsbRsbRgbRgbRgbLsbRsRsRsmmbRgbRgbRgbLeLsbLsbLsbR
sRsmbLobLhbLcLsmbLsbLsbRibLcLsmbRcbRgbRgbsbRsbRgbRibRsbLsRsbRsbRibLsbR
gbRgbRsRsmbLhbsbRgbRibLobLgbLgbLgbLsbLgbLgbLgbLgbLgbLsbLgbLgLsRsRsmbRj
bLibLsbLsbRgLsbLibLsbRgbLgbRebLoLsmbRsbLsLsmbLgbRcbRgbRsbLjRhbsbsbsbsb
LsRsbRsLsbRsLsbLsbLsRsbsbsbRsRsRsRsRsmmmmbsbsbsbsbLibLsbRibRsbRgLsRibR
ebLsbRcbRibLgbLjbLgLsbRcbRgbLcbLhbRcbRhLsbLjbsbRhbRsRsmbRcbLsLsmbRsbLc
bRebLsLsmbRiRsmbLsbLsbRgbLsbLsbRgbRcbRgbLsbLebRsbsbLsbRcRsmbRsbLgLsbLc
bLobLhbLhbLsbLjbLibRcbsbRoRsLsmbLsbLsbLsbRibRgbRsLsbLibLibRcRsmbLsbLsb
RgbLsbRsbLjbRibLsRsbRsRsmbLsbLjLsmbLobLibLsbLiRsLsbLsbLgbLgLsRsbReRsmb
LiLsbLibLsbLgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 33; Drug: PCAP2 3 然
bRsRsRsmmbRgbLgbRcLsbLgbRcbRhbRcbRgbRgbRsbRhbRsbRhbRcRsmbLcbLsLsmbRiRs
mbRsRsmbRhbRiRsRsmmbRgRsmbRgbRgbRobRibRsbRsRsmbsbLjbLcbLgbRcbRiLsRsbRi
bRsRsmbRgbRgbRgbRsbRgbRiLsbLhbRcbRgLsbRgbRiRsmbRjbLsbLsbRcbLsLsmbRhbLs
RsbRibRhLsbRgbLsbRhbRgbRgbRgRsmbLjbRoRsRsmmbLjbRcLsbLsbRibRsLsbLgRsbRg
LsbRsbRsRsLsmbRgbRsbRibRgRsmbRgLsbRibsbLjbRoLsbRgbLsbRibsbRsbRgRsmbRgR
sRsmmbRgbRgLsRsbLsRsbRibRsbsbRgRsRsmmbRgbsbRiLsbLsbRiRsmbRsbRsbRgbRgbL
jbLcLsmbRsbLibLsbRcbRiRsmbRsLsbRsbRsbRgbRgbRsbRsbRgRsmbRgRsmbRgbRiRsmb
LsLebLhbRsbRibsbRcbRiLsbRsbRiRsmbRsbRgbRsbRgbLsLsmbLcbLsbLgbLibRgbLibR
sbRcbRiRsLsRsLsmbLsRgbRsbRgbRgLsbLcbLhLsbRsLsbsbRebRiLsLsRgRgmbRgbRsbR
gbRsbRgbRgbRgbLcLsmbLiLsLgLsRsbLiRibRcbLsbRibRsbLsbsbRsbsbRsRsmbRgRsmb
RgLsbLsbRgbRgbRsbLsRsbRsbRiLsbLjbsbRibLhLhbLgbRsLibLgLsbLsbLiLsbLsRsLs
bLsbLgbLsLsLiLsmbLgbLgbLgLsLsmbLgbLcbLhLsbRcbLeLsbLgbLsbRsbLobRibRsbRs
bRcbLsbLsbRsbRgbRgRsmbRgRsmbRobLcbLiRsbLsLgLsbRcRsmbLjLsmbLjLibLgLsbLs
LsmbLcbLebLhLsbLgbLgbLcbLgLsbLgLsbLgLsLsmbLcbLjLsLsmmbLgLsbLsLibLsLsLs
mmbRgRsmbRsRsRsRsmmmbRsRsmbLgbLebLgbLgLsbLibLgLsbLgbRibRsLsbRsLsRsbsbs
bsbLjbRhbsbsbRgbRsRsmbRsbRobRibLgbLcLsmbsbRsRsLsmbRgbLcbRsbLgLsLsLsmmb
RsRsmbLgLsbLiLsbLsLsLsmmbLsbLebRgbLsbRgRsmbRgbLcbLgbLsLsLsmmbRgbLcLsmb
sbLhbLhLsLsmbLsLsLgmbLeLsbsbRiLsbLsLsmbLcbLsbRsLsbLcbRgbsbLgbLsLsLsmmb
LibLsRsLsbLsLibLsLsLsmmbLgbLsbLiRsbLhLsbRiRsmbLgLsLsmbLiLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 34; Drug: PCAP2 3 然
bRoRsmbsbRgLsbLgLsbLiRsbRjRsmbLsbLgbLibRjbsbsbLgLsbLgLsbLgbLgbLsLsmbLg
bLsLsmbLgbLsbRsLsbLsbLsbRsLsLsmbLgLsbLsbLsbLsbLgbLsLsmbLsbLsLsmbLsbLgb
LgRsbRiRsmbRsbLgbLibsbRoRgbsbRsbLgbLibLgbLgbsbLjRsbLibRsbLsbLgbRsbLsbL
gbRsLsbLsbLsLsmbLsbLsbLgbsbLsbRsbsbLgbLgbLgbLsbLgbLsbLsbLgbLsbLsbLgLsL
smbRsbRjRibLjbLobRobLebLgbLsbLgLsbLsbLsbLsLsmbLsbLgLsbLgbRsLsbLsbLsbLg
bLgbLsbRsbLgbRsLsbLsLsmbLgLsbLsbLsLsmbRsLsRsbLgbLsbLgbLsbLsbLgbRsLsLsm
bLgbLsbLgbLgRsbRsbLsbRgRobLibRjbsbLibRibsbRsbRibLebsbsbsbLgbLjLsmbLiRs
bRjRsmbLgLsRsbRsbLsbLgbLsbLebLjLjLsmbLsbLgLsbsbLsbLsbLsbLsbLsRjbLcRsbL
cbLibRcbLibsbsbsbRgbRibLjLjbsbRgbRibRoRsmbRjbRibRsbRhLsbLiLsbRgbsbsbsb
sbRibRsbRsbRgbRsbRsbRsRsmbRsRsmbRsbLgRsbRiLsbLcbLcbLcbRsbLsbRsbRjbRibL
sbRibLjbRcRsmbRoRsRsmmbRsbRsbsbRjbRgbLsbRjbRsbReRibLcbsbLeLsbLsbLsbLgb
RgbRibLsbRobRobRibLsbRgbRsRsmbRsRsRsmmbRsRsmbRsbsbLsbLjLjbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 35; Drug: PCAP2 3 然
bRjbRgbLsbRcbRibRsbRgbRsRsRsmmbRgbRsRsRsmmbRsbLjbLsLgbLsbLsbLgbRibLsbL
jbLsbRjRsmbRgbRsbLsRsbsbLjbLibRjRsRsRsLsmmmbRsRsRsmmbRsbLsLsRsmbRjRsmb
sbsbLsbsbsbRhbRsRsmbRsRsmbsbLsLsmbsbRgRsmbRgbRgbLsLsmbRsbRgbRgbRsbRsRs
mbRgbRsRsmbRgbRsbRsbRsbRsbRgbRgLsLsmbRsRsLsmbRgbRsRsmbRgbRsbRgbRsbRsRs
mbRsbRiLsbRgbRsRgRsmbRsRsmbRgRsmbRsbRsbRsRsmbRibsbRiRsLsLsmmbRsbRgbRsb
RibRsRsmbRgbRsbRgbLsbRsRsmbRsLsbRsbsbRsRsmbsbRsbRgbRgbRsbsbRsbRibRsRsm
bRsRsmbRsbRsRsmbRhbRgbRsRsmbRgbLgbRgbRgbRgbRsbRgbRgLsbRgLsRsbRgbRibRgb
RgbRgbsbRsbRsRsmbRsRsmbRsbRgbRgLsbRsbRsbLsRsRsmbRsRsmbLebLiRsbRgbLsbLj
LsmbLsbLsLsmbLsbLsbLsbLsbLsbLgRsbRsRsmbLsbRgbsbRjbLsLsRsmbsbLsbLgbLsLs
LsmmbLsbLsLsmbRsbRiRgbRjRsmbRibRsbsbLgbRsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 36; Drug: PCAP2 3 然
bsbLsbRsbLjRsbRhbLiLsbRgRsmbsbLsbRgLjbsbRsbRsbRsLsbRsbRsbRsbRgbRobRibR
sbRibsbRgbLsbRgbRgRsmbsbRgbRgRsmbLcLsmbLsLsmbLsbRsbLsbLsLsmbRsLsLsmbsb
sbsbsbLsbLsbRsbRgbRsbLsbLgbLsbLgbLsLsmbLsbLsbLgbLsbRgbLsRsbsbRgbRsbRsb
sbRsbRgbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 37; Drug: PCAP2 1 然
bLgLsbLibRjbLiRsbLgbRjbRcLsbLsLsRsmbRibLjLsmbRjRsmbsbLsLsLsmmbRjRsRsmm
bLsLsmbRibRsRsRsmmbLsLsmbRgbRsRsmbRsRsmbRgRsmbRgbLsRiRsmbRibLcRsbLcbLj
LgbLgbRhRgbRobRgbRgRsmbLibRibRgRsmbLsbRgbRgbRiLsbLiLsbLibLibLgbRgbRiRg
RsmbLjbLcbRsRgRsRsmmbLjLsmbRibRobLgbRcbLgLsbRibRgRsmbLsbRcbLjLsmbLibLi
bLsLsRsmbLhbLgLsLsmbLgLsbRsbRsbRsbLcbLjLsLsmmbRsRsRsmmbRgRsmbLcbLsLgbL
gbLibLgLsLsmbLgbLsLsmbLgLsbsbLjLsmbRgLsbLibLibLibLsLsmbRgRsRsmmbRcbRib
sbLsRsbRsbRibRsRsmbRsRsmbRsRsmbLsRsRsRsmmbRsRsRsRsmmmbRgbRgbLsRsbRgbRg
bLsbRsbRsbRgRsRsRsmmmbRgbRgbRsbsbRsRsmbRsRsmbsbRgbRsRsmbRsbRsRsRsmmbsb
RgbRsbRsRsmbRsRsmbRsRsmbLsLsRsmbLsbRibRgbLsbRsbLsRsbRibRgbLsRsLsbRibRs
bRiLsbLsLsmbRgRsRsmmbRsbLsbRibLjbLcbRjRsmbLhbLgbRgbLhbRsbLibRjRsmbLibR
ibRcbRibLsLgbsbsbRiRsmbLsLsmbRiRsRsmmbLjLsmbLcbRjRgbLcbsbRcbRcbRsbRsbL
sbRsbRibRgbRgbLsbRsRsRsmmbRgRsmbRgRsRsmmbRsbRsRsRsmmbRgbLsbRgRsmbLsRsb
LgbRibRgRsLsLsmmbRiRsmbRibLsbRgbRgRsLsmbLsLsmbRibRiLsbLsbLsRsbRgbRibLs
bRsRsmbRibLgbLsbRibRsbRsRsmbRgRsmbRsbRsbRsRsmbRsLsbRsRsmbRgRsmbLsRsbRs
RsRsmmbRsbLsbRibLsRsRsmbRsbRgbRsRsmbRgbRsbRgbRsRsmbLsLsmbLsLsmbRgbLgbL
cbLgbLibLgbRsbLibRgRsmbLhbsbRgRsLsmbLjLsmbsbLsbLsLsmbRsRsRsRsmmmbRsLsb
LibLsbLgbLgbRgRsmbRsbLcbLsLsLsLsmmmbLgbLsLsmbsbLgbRgRsmbLjLsLsmmbLsbLi
bRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 38; Drug: PCAP2 1 然
bRsbLiRsbLsRsbLgbRsbLibLibLcbRebRhbRibLsbRibLgbRjbRibRgbRgbRsRsmbRsRsm
bRsbRgbRsbRgRsmbRgbRgbRgbRgbRsRsmbRgbRsbRgbRsbRgbRgbRsRsRsmmbRiRsmbLib
RibRgbLsbRgbLsbRgbRsbRsbRsLsbRibRgbRgbRsbRsbRgbLsbRgRsmbLcbLiRsbLgbRsb
LibLgbRibRjbRiRsmbRgbLjbLobLibLsbLgbLcbLhbRiRsmbRgbLcbsbRibRiRsmbRibRi
LsbLhbLiLsbLsbLibRgbsbLibLiRsbLgbRibLcRsbRgRsmbRibRibLcbLhbLibRjbLiLsb
LgbRjbLibRgbLobRgbRhbLcRsbLcbLibLibLgbLgbRibRiRsRsmmbRibLsbRgbRgRsRsmm
bRgbRgRsmbRgbRgbRgLsbLsbRsbRsRsmbRgbRsbRgRsLsmbRibLgbRgRsmbRiRsmbsbRsR
smbRgRsmbRsbRgbLjbLibLsbRcbsbRcLsLsmbLsbRhLsRsbRgLsbRibLgbRcbLibRhbLsb
RsbRibLjbRcLsbLjbRibLsbRibRsbRsbRsbRibRibRibRsLsbLibLibLhRsbLibLibLgbL
sRsbRsRsmbRsbRjbRibsbRgbRgbRibRgbLgbRcbLibLjbRiRsmbsbRibLsRsLsbRiRsmbR
sbRsbRgRsmbRgbRibsbLsLsmbRsbRibLsbRgbRgRsmbRsbRgbLsbRgbRgbLsLsmbRgbRgR
sRsmmbRsbRgbRgbLjbLcbLibLobLcbRgbRcbLibRibRibLcbRjbRhbRhLsbLsbRsLsbRsb
LgbRibLjbRibRobRgLsbRsLsbLgbRibRgbLgbRgbRgbLsbRsbRsbRgbRgbRgbRgbLcbRib
RgbRgbsbLsbRgbRibLgbRgbRibsbRgbRibRcbRiRsmbRgbLibLgbLhbRgbLcRsbLibRgbL
sbRsbLcbLsbLibsbRsbRsRsmbLcbLibRsbLgLsbRsbLibLgLsbLibRgbLibRgRsmbsbLib
RgbRcbRcbRsbLgbLsbLibRsRsmbLcbLhbRibRgbRgbRibRhbRgRsmbLgbRsbRibRibRgRs
mbLsRsbRsbRibLsbLgbRibLsbRgRsRsmmbRsbRgLsbRsRsRsmmbRgbLsRsbRgbsbLsbRsL
sbRsbRgbsbRgRsmbRsbsbRgbRgbRgbRsbLsbsbRsRsmbsbRgbRsRsmbRgbRgbLsbRgLsbL
sbLsLsmbLhbLiRsRsmbLibsbLiLsRjbRsbsbLiLsbRgbLcRsRsmbRgbLibLibLibRgbLib
LhbLcbLibLgbLgbRgbRibRgRsmbRhbLibRcbRibRgRsmbRsbRgbRsbRibLcbLiRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 39; Drug: PCAP2 1 然
bLsbLgbLgbLgbLgbLsbLgbLsbLgbLgbLgbLsRsbLsLsmbLsLsmbLgLsbLgbLgLsbRsbLsL
sRsLsmbLgbLgLsLsmbLsLsmbLgbLgbLgbLibRiRsmbRgRsmbLsbLsRgbRcbRibLjLsLsLs
mmmbLsbRgbRiRsmbRjRsRsmmbLsbRoRsmbRsLsbRhRsRsmmbRibRgbLibLgbLibsbLsbLg
LsbLgbLgbLgbLgLsLsmbLgLsbLgbLsLgLsbLgbLgLsLsmbLgLsbRsbLsbLgLsbsbLsLsLs
LsmmmbLsLsmbLgbLgbLgLsbLsbLsLsmbLgbRsbLsLsLsRsmmbLsbLsbLsbLgLsbLgLsbLg
bsbsbRsLsLsRsmbsbLgbLgbLgbLgbLsbLgRsLsbLsRsbLgbLibsbLgbLsbLibRsLsbLgbL
sLsmbLgLsbLgbLgbLsRsbLgLsbLsLsLsmmbLsLsmbLgbLgLsbLsLsmbLgLsbLsbLgLsbLs
LsmbLsLsmbRhbRgbRgbLobLibsbsbLgbLgbRjbLhbLsbLibLhbRgRsmbRsbLoLsmbLibsb
LgRsbRibRhbRiLsbRgbRibRgbRsbRcbRibRibRgLsbRcbRcbRibRgbLibRgbRcbRcRsmbR
sbRibRgbRsRsmbLgbRjRsmbRibLibRsbsbRiRsmbRgbRgbLsbRgbRgbLcLibRcbLcbLibR
gbLcbRsbRibRibLjbRiRsmbRibLsRibRgbRgbLhbRsbLibLsRsbLsLsmbLgRsbLgRsbLsb
LgLsbLsbRsLsbsbLgbLsLsmbLsbLgbLgbLgbLgLsbLgLsbRsbLgbLsLsLsmmbLsLsLsmmb
LgbLgbLsLsmbRsLsLsLsRsmmbLgbLsbLgLsbLgLsbLgbLgbLgbRobLcbRjbRhbRoRsmbRg
bRgbRcbRgbsbRibRgbLiLsbLsbLibLsLsmbLgbLgbsbLgbLhbLgbRsRsmbLsLsLsmmbRjb
RjbRibRsRsmbRgRsmbRgbsbRgRsmbRsRsRsRsmmmbRgbLgbLgLsLsmbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 40; Drug: PCAP2 1 然
bLiLsbLgbLiLsbLsbRsRsmbRgRsmbsbLcLsmbLibLibsbLsbLgLgbLsLsmbLsbLsbLiLsb
LsbLeLsbLibLsLsmbLsbsbRgbLsbLcbLibLsbLsbLibLsbLsLsmbLibLgLsbLsLsmbLibR
jRsmbLiLsbLibRgbLhbLibsbLsbRgbLhLsbLibLibLibRgRsmbRsbLhLsbLsbRibRobsbL
sbLhRsbLiLsbLsbRgbLibLibRgbLsLsmbLiLsbLgbLsbRgbRebsbLjLsmbLcbLiLsLsmbR
ibsbLibLobLsbLibLsRsbLibLgbLgbLsbLjbRibRsbRibLsbLeLsbLhbLgbLsbLibsbRjR
smbLibLsbLsRsbLiLsbLgbRibRsbLgbLcbsbLgbLgRsbLsbRibRibRgbsbLgbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 41; Drug: PCAP2 1 然
bLsLgbsbLgLsLsmbLsbLsLsmbLsLsLsmmbLsLsmbsbRgbRcbRibRsbRsRsmbRsbLsbRcRs
mbsbLjbLibRibRsbRsbRgbRibRsbRhbsbRjRsmbLsbRsbsbRgbRsRsRsRsmmmbRoLsbRsR
sRsmmbRsbRibRsbRsbRsbLgbLsLsmbRiRsmbRsRsmbRsRsmbRjRsmbRgRsmbRsbRiRsmbR
ibsbRgbsbRgRsRsmmbRsbRjRsmbRsbRhbRsbRsRsmbsbRgbRgbRsbLsLsLsLsmmmbsbLsb
RibRgRsmbRiRsmbRsbsbLsLsmbRcbRgbsbRsbsbLsLsmbsbLsLsmbLgbRsLsbLjbLsLsLs
mmbLsLsmbLsLsmbLsLsmbsbLsLsmbLsLgbRgbsbsbLgLsbLgLsLsmbLsLsLsmmbsbsbLib
LgLsbLsLgbLgbLgbLgbLsbLibRsLsbRsRsmbRsRsmbLcbLgbLibLibLsLsmbsbLsbRcbsb
RebLsbLgbRsRsRsmmbRsbsbsbsbRcbRsRsRsmmbRgbLsLsmbLsbRgbRgbRsRsmbsbsbRgR
smbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 42; Drug: PCAP2 1 然
bLgbLsbLsLsmbLsbLgbLgbLgbRgLsLsmbLgbLgbLgbLgbLgbRsbLgbLibRsbLibRcbRiLs
bRibLobLsbLibLsbLgbLgbLsLsmbLsLsmbLgbLgbLgbLgbLsbLgbLibRsbRebRcbLcbLhb
LsbLgLsbLgbLgbLsbLgbLgbLsbLgbLsbLgbLgLsbLgbLgbLibLsbLgbLibRgLsbLgbsbsb
sbLgRsLsbRsRsmbLgbLgbLsbLcbLsRsbRcbLjbRiLsRsbRiLsbLgbLgbLobLsbLgbLgLsb
LgbLgbLibRibRibRgbRgbRgbRibLjbRgbRgbLcbLcbRibLhRsbLgbLgbRsbsbLgbLgLsbL
sLsmbLsLsmbLgbLgbRsLgbLgbLsbLgbLibLibRhbRcbLhbLhbLgLsbLgbLsbLsLsmbLsbL
gLsbLgLsbLgbLsbLsbLgbLsbLgbLsbLiLsbLsbLgbLiRsbRcbRcbsbLgbRcbLcbLcbRgbL
oRsbLsbLsLsmbLhLsbRgbLcbLsbRobRgbRsbRgbRgbRgbLsbRcRibLgbRsbLibLibLsbRs
bLibsbLgbLgbLgLsbLgbRsbLiLsbLsLsmbLibLgLsbLiLsbLsLsmbLgbRsbRcbRsbRhbLj
bRibRibRcbLgLsbRgbRcbRiRsmbRgbRsbRibLsbRgbRgRsmbRgbRgRsmbRsbRiRsmbLgbR
ibLgLsbLjbLcbRgbLibLsbLgbLgbRsRsmbRjbsbRobLcbRibRiRsmbRgbRgLsRsbLgbRiR
smbRgbRsbRgRsmbRgRsmbRsbRsRsmbRgbRsRsmbRsbRgLsbRgbRgRsmbRgLsbRgbRgbRgb
RgbRgbRsbRgbLjbLgbRibRsbRibRgbLsRsbRibLjLsmbLsLsRsmbRsbRgRsmbRgbLsLsRs
mbRgbRsRsmbRiLsbRgbRgbRsbRsbRiRsmbRibLgbRibRiLsbLiRsbRgbLcLsLsmmbLhbRg
bLiLsbLibRjbLiLsbLgLsbRgbLibLsbLgbLhbRsLsbRcLsbRiLsbRsbRgbRgLsbLsbRibR
gbRgbRgLsbRgbRgbRgbRsRsmbRcLsbRgbLgRsbRcRsmbLsbRibRibRhbLsbLgbLhRsbRgb
LgLsbLgbLgbRsbRcRsmbRibRibRsbRibRsbRsbRsbRsbRsbRsRsmbRgbRsbRgbRsbRgbRg
RsmbLsbRgLsbRsRsmbRgbRgbRgbRgbRgbRsRsmbRgbLjbRgbRgbRgbRsbRgRsmbRsRsmbR
sRsmbRgRsmbRsRgbRgRsmbRgbRgbRsbRgbRgbRgbsbRsbRsbRgbRgbRsbRsRsmbRgRsmbR
gRsmbRsbRsbRgRsRsmmbRgbRgbRgRsmbRgbRgbLsbRgRsmbRgbRsbRgbRgbRsRsmbRsRsR
smmbRsbRgRsmbRsRsmbRgbRgbRgbRgbRgbRgRsmbRgbRgRsmbRgRsmbLsRsbRsRsRsmmbR
sRsmbRgbLsRsbRgRsRsmmbRsbRgbRgbRgbRgbRsbRgbLibLsRibRgbRsLsbRgbRgRsmbLs
bLgRsbRgLsRsbRsLsbRsbRsRsLsmbRgbRsbRgbRgbRsbRgbRsbRsbLebLibsbRjbRebLib
LhbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 43; Drug: Control
bLgLsbLgLsbRjRsmbsbLibRibLiLsbRjbLgbLsbLgbLsbLibRibRsLsbLibsbLjLsLsmmb
LsbRjRsmbRiRsmbRsbLsRsbLeLsbRibsbRiLsRsbRibsbRsRsLsmbsbRgbRsRsLsmbRsbR
gbRibRsbRsLsbLsbLsbRsbRsRsmbRgbRsRsmbLcLsmbRgbLiLsbRjbsbRjbRjRsmbLjbLc
bLgLsbsbsbLgbRibsbLjLsmbRjbLibLibLsbRibLgbRsbLoLsmbLibLsbLsbLsRibLsbRs
bRsbRibRibRsbLsbRsbRgbRjRsRsmmbsbRibRsRsmbsbRibRgbRibRibLgbRcbRsRsmbRe
bRibRgbRsbRsbRsbsbRhbRjRsmbLsLsmbLsbRsRsmbRsRsmbRsRsmbRjRsRsmmbRsRsmbR
sbRsbRsRsmbRsbsbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 44; Drug: Control
bLibLhbsbsbRcbLhbLgLsbRsLibLgbRgRsmbRgbRsRsmbRgRsmbRibsbsbLhbLsLsmbLsb
sbRgbLgLsLsmbLsbLsbsbLsLsmbLgbLsLsmbRgbRsbLibLgLsLsmbRgbRsbLgbLibRgbLi
bRgbRsbRsbRsbLsbLgbRsbsbLjLsmbLsbRsbLgLsbLgbLibLsbLsbRsbLsbLsbLgbLgbRs
LsbLibLhbLgbLgbLgbsbRsbLsbLibRsbLgbLsLgbLsbLsLsmbRsbLgLsbLgbLsLsmbLgbL
gbLsbLsbLsLsmbLgbLgbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 45; Drug: Control
bLsLsLsLsmmmbRsbRibRsbLgbRiRsmbRgbLsbRibRgbLgbRiRsmbsbRgbRsbRsbLibRgbR
ibRgbRsbLgbRibRsbLgLsbRgbLsLgbRibRgbLsRsbLebLsLsmbLsRsbRsbRsbLibLsbsbL
cbRjbRsbLsLsmbLsLgLsLsmbLsbLsRsbLsbLibLibLibRsbLsbLsbLcbLibLsbLsbRhRsm
bLjbRhbRoRsmbRiRsmbRsRsmbRgbRgRsmbsbLsLsmbsbRgbRgbLibRsbLsbLsRsbLibRsb
LgbsbLsbRsbLgLsbRsbLsbLibLsbsbLsbLgbsbsbsbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 46; Drug: Control
bRsbRsRsmbRsRsmbRgbRsbRgbRgbRgbRgbRsLsbRsbRsbRgbRsRsmbRgbRgbRsbRsRsmbR
sRsmbRsRsmbRsbRsbRsbRsbRsbRsRsmbRgbRgbLsRsbRsRsmbRsbRsbRsbRgbRsbRsbRsb
RsbRsbRgbRgbRsbRsbLsRsbRgbRgbRgbRgbRsbRsLsbRgbRsbRsbRgbLsbRsbRgRsmbRsb
LsbRgbLcbLsbLgbLsbRsbLgbRjbRebRgbRsRsmbRgRsmbRsbRsRsmbRsbRsbRgbRsbRgbR
sRsmbRsbRsbRsbRgbRsbRsLsbRgbLsbsbRsRsmbRgbRgRsmbRgbRsbRgbRsbRgRsmbRgbR
gbLsbRsbLsbRgbRgbRsbRsRsmbRgbRsbRsbRsbRsbRsbRsbsbRsbRsbRsbRsbRsbRgbRsR
sLsmbRsbRgbRsbRsbRsbRsbRsbRsbRgLsbRsbRsbRsbRgbRsbRsbRsbRsbRsbRsRsmbRsb
RsbRgbRsbRgbRgbRsbRgbRgRsmbRsbRsbRsbRsbRsbRsRsmbRsbRsbLsRsbRsbRsbRsbRs
bRsbRsbRsbRsbRsbRgbRgbRgbRgbRgbRgRsmbRgbRsbRsbRsbRsbRsbRsbRsRsRsmmbRsR
smbRsRsmbRsRsRsmmbRsbsbRgRsmbRgbRgRsmbRgbRsLsbRsRsmbRgbRgbRgbRgbRgbLsR
gbRsbRsbRgRsmbRsRsmbRsbRsRsmbRsbRsbRsbRsRsmbRsbRsbRsbRsbRsbRsRsmbRgbRg
bRsbRgbRsbRgbRgRsRsmmbRsbRgLsbRgbRsbRsbRsbRsbRsbRgbRgbRsbRgbRsbRgbRsbR
sbRgbRgbRsbRsbRgbRgbRgbRgbRsbRgbRgbRgbRsbRsbRsbRsbRsbRsRsmbRsRsmbRsbRg
bRsbRsbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 47; Drug: Control
bLgbLgLsbRgbLgbLgLsbLgRsbLgbLgLsbLsLsmbLgbsbLgbLgbLiLsbLgLsbRjbRsbLhbR
gbLgbLhbRjbRcRsmbLgRsbRibLgbLebLgbRsbLgbRebRcbLcbLibLgLsLsLsmmbLgbLgbL
gbLgbLgbLgLsbLsbLsbLgbLibRgLsbLsbLgLsbLgbLgLsbLgbRhbRhbLebLibLobLgbLib
LiLsbLgbLgbRebRsbsbRiRsmbLcbsbRcbRhbLibLibLgbRjRsmbRibLhLsbRhbRgRsmbRs
bLsbRibLsbsbRgbLjbRibLgbRibRsLsRsRsmbRcbLhRsbRibRsRsmbLjbLhbLibsbsbRhb
RiLsbRgbRgbRgbRsbRgRsmbsbRsbRsbRsbLjbRhbLibLibLhbRibRibLcbLgbRhRsmbRib
LsRgbRgbRsbLjbRibRgbLjbLoRsbLibLgRsbLgbLgLsbLsbLgbLgRgbLgbLgLsbLsbLsbL
sbRibRiLsbLgRsRsmbRsRibLgLsbRgLsbLsbRibRibLcbRjbRhbLsbRibsbRgbLsbRibRg
bRgbRsbRgbRgbRsbLsRsbLjbRjbRibRsbRibRgbRsbRgbRgRsRsmmbRgRsmbRgbLsLsmbL
sbRgRsmbRgbRiLsbLcbRibLhLsbLcbsbRibLibLsbLsbLhbLgbLgbLsLsmbLsLsmbLiRsb
LsbLjbRgRsmbLhLsbRgbLibsbRjbRcbLjLgbRcbRjRsmbRsbRsRsmbLiLsbRsLsbRcbsbR
sRhbLsbRobLhbLiLsbLgbsbLgbLsbRsbLibLgbLgbLgRsLsbLgbLsbLgbLgbLgbLgbLgbR
cbRhbLhbRcbsbLjbLcRsbLiRsbLgLsbRjbLsbRcbRsbRhbRibLhbRsbLobsbRsbLibRsbL
cbRcbRcbLhRsbLjLsmbLibRjRgbRcbLcbLebLgbLgbRjbRcbRhLsbLhbLibLhbRgRsmbRs
bLcbLsbRjRsmbRcbLibLcbLibLcbLibLgbLgbRcbRsbRiLsLsmbRiLsRsbLjbLibLgbLgb
LgbsbRgbRjbRcbLsLsmbLcbRcRsmbRiLsbLjLsmbLcbLsRsbsbLhRsbsbRibLcbLibLgLs
bLsbLgLsbLsbLibLgbLibLiRsbRibLiLsbRcbRibLsbRibsbLgbLhbLgbLibRjbLibLcbR
ibRgbRiRsmbLcRsbRsbLibRgbRsbLhbRebRcLsbLgRsbRcbLsRsbLcbLoLsmbLcRsbLobL
sRsbLibLgbLgbLgbLsbLgbLgbLgbsbRgbLgbLgbsbLibLibLsbLjLsLsmmbLsbRsbLgbRe
RsRsmmbRibRibLcbLibLibLgbRsLsbLsLsmbRcLsbRibLcbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 104604; End: 105105;
Recording: 6-1; Individual: 48; Drug: Control
bRcbRcbLjLsmbLjbLibLgbLgbsbLibRibLcbLgbLibLsbLcbRgbLgbLgbLhbLcbLgbLgLs
RsbLhbRhbRgbRgbRcbLiLsbLgbRcbLsbLjbRibRobLibLsbRsbRiLsbRgbRgbRgbRsbLjb
LsbRiLsbLibRibLsbLcbLibLsbLibRibLiRsbRjbRibRibRsbRgbLobLibRjbRcbRcbRcb
RebRgbRcRsmbRcbRgbRsbRibRibRsbLobLibRgLsbLgbLibRgbLsbLgbLsbLgbLgLsbLgb
LgbLgbLgbLgbLgbRsbLsbLibLgLsbLgbLgbLgbLgbRjbRcbRgbRcLsLsmbLibLgbLsRcbL
cRsbRgbLibLobRjbRibLjbRsbRjbRjbLeLsbRcRsmbsbRsbRcLsbRoLsbLcbRgRsmbLgbR
sRsmbRcRsmbLsLsmbLsbRibLgbRoLsLsmbLibLgbRibLobLgLsbLibRsbRsbLibLiRgbLg
bLsbLsbLgbLgbRibRhbRgLsbRsLhbLiRsbRebLobLobLcbLibRgbRcbLcLsmbLgbLibRjb
LibLgbLgbLcRsbLcbRibRgbRgbRibLcbRsbsbLhbRibRjbRibRgbLebLibLgbLsbLgbLgL
sbLgLsbLgbLsRsbLsbLgLsbLibLgbLgbRgbLgbLgbLgbLgbLgbLsbLgLsbRgbLgbLibLsb
LgbLibRgbsbRcbLibRibRcbRcbsbRhbRebsbRibRibRgbLibLibLgbLibLcLsmbLsbRoRs
mbRhbLjbLibRgbRhbRibLcbLgbLgbLgbLsbLsbLgbLgbLsbLgbLsbLgbRjbRcbLjbLibLg
bLgLsbLgbRjbRobLibRhbLjbLcRsLsbRsbLibLsbRsbLibRsbLgbLsbLgbLgbLgLsbLgbL
sbLsbLgbLgbLgbLgbLgLsbLsbLgbRsbLibLgbLibLgLsbRgbReRgbLibRibRhbLibLeLsb
LcbLibRibLebLhbLgbLsbLobRiLsbLcbLsLibLibLgbRgbLcLsmbLgbsbLiLsLsLsmmbLg
LsbRhbRcRsmbRcbRhRsmbRebLhbLibLhbLoLsmbLibLibRjbRcbRsRcRsmbRhbsbRhbRgL
sbLjbLcLsmbRsbRjbRcbRcbLiLsRsbLhbLibLiRsbRiLsRsbLiLsbRebRcbLjbLcbsbLhR
sbRibLcRsbRjbRcRsmbsbLjbRcbRcRsmbRcbRsLsbRibRsbLobLibLcbLibRibLibLgbLi
bLgbLsbLiLsbLibLibsbLgbLjbLgbLibLsbLgLsbLibLgbLsLsLsmmbLgLsbLgbLgbLgRs
bRcbRgbLcbLiLsbRgbRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 1; Drug: PCAP2 10 然
bRsbRgbLebRcbRoRsmbRoRsRgLsRgmbRgbLsbLsbLsbRsbRoRsmbLobRibLsbLsbRsbRsR
sRsRsmmmbRsRsmbLibRebLsbLebLsbLobLsbRjbLobLsbsbsbRsbLebRsbLsbRsbRsbLsb
LsbLgRsRsmbRjbRgbRjbRibLobLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 2; Drug: PCAP2 10 然
bsbsbLsbLjbsbLsbLjbRsbRjbRsLgbLsbRsbRsRsRsLsmmbRsbRsRsmbLsbRsbRsbLsbRs
LjbLsbRsbRjRsmbLsRsbRjbLsRsbLsbRsbRsRsmbRsbLgbLjLsRsmbRebRgRsmbLsRsbLg
LsbLsbRsbLsbsbLibRsbRsRsmbLsbLsRsLsbRsRsmbLsbLsbsbsbLgbLsbLsbLgbRsbRsL
sbLibRsLsbRsbsbLsbRsbRsbLsRsbLsbLsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 3; Drug: PCAP2 10 然
bRjRibRgbRgRsmbRgbRibRgRsmbLsLsRsmbLsRgbRhbRsbLsbLsbLgbsbsbsbRibRsbsbs
bsbsbRsbRebsbsbRgbLiRsbLebRcbRgRsmbRsRsmbRsbsbLsbRoLsRsLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 4; Drug: PCAP2 10 然
bRsbRsRsmbRsRsmbRoLsLsmbsbLgLsbsbsbLsLsmbRsbsbLsLsmbLgbLjRsRsmbRsbLgbL
sLsmbRsRsmbRsbLobLsRsbLsbsbLsbsbLsbsbLsbsbRsLsbLsRsLsLsmbRsbLsLsRsmbLs
bLsLsmbLsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 5; Drug: PCAP2 10 然
bRgbRgRsmbRsbRsRsmbRcRsRsmmbRsLsbLsLsRsmbLsbRgbLgbLsbLsbLsbLibRsbLgbRg
bsbLibRjbsbLjLsmbLsbLgLsbLiLsLgbsbRsbsbsbsbLsbsbLiLgbLgbsbLobLiLsbLjbL
gbLgbRsLsbLsbLsbLsbLsRsbRsbRsbsbsbRgbLsRsbRsbRgbRsbsbRgbsbsbRiRsmbRgbR
sbRibRiLsRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 6; Drug: PCAP2 10 然
bReLsLsmbLgLsLsRgmbRgRsmbRgbLobLiRebLsRsbLibLebRibRsRgbRcbLsbLsbRsLsbL
ebsbReRsRsmmbRgbsbRgRibRsbLobRobRjbRebLib

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 7; Drug: PCAP2 3 然
bRgbRsbsbsbLibRgbRsLsbsbRsbLsLsRsmbLgRsbRsbsbRsRsmbRsbLsLsmbLgLsbRsbsb
sbRsbLsbLsLsRsmbRjbsbRibRsRsmbRjRsRsmmbLsLsmbsbsbRsRsRsmmbRgbRsRsmbRsR
smbsbRsbRsbRsbLsbLsbRsbRgLsbRgbLsRsbRsbRsLsbRsLsbRgbRsbsbRgRsmbRibRsbL
sbRsbRgbRsbLjLsmbRsbLsbRsbsbLsbsbRsbLsbsbLsbRsRsmbLgbLsbLsbRjbLsRsbRsb
sbsbsbsbsbsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 8; Drug: PCAP2 3 然
bRgRsmbRgbRibRibReRiRsRsmmbRibRgRsmbRoLsLsmbRibRibRgRsLsmbsbRsbRsbsbRi
bsbLsbReLsRsLsbLcbRsRsmbLsbLibLsbLgbLgbLgbLiRsbLsbRhbRobsbRebRgbRsRsLs
mbRoRsRgRsRsRgmmmbRsLsbRcRsRsRsmmmbRoRsRsRsmmmbRiRsmbRiRsmbRgRsRsmmbRi
RsmbRibRcRsLgmbRibRgbRibRibRsbsbRiRsmbRgbRiRsRsRimmbLobLsbLsLsmbLibRcb
RibRgbRiRsmbRgbRgbRgbRgRsmbRcbLsLsmbRsLsRsRgbRhRsmbRsRsmbRsbRibRibRgbs
bsbsbsbRsbRgLsbRsbRgRsmbRibRibRgbRsbLgbLhbLgbLgbLgLsbRgbLsbLiLsbLgbLgb
LhbRgRiRsmbRsbsbRsbLcbLibLsLsLgmbsbRgbRgbRebLhLsbLgbLsbRibRjbRcbRsLsLs
LgmbRsbLsbRibRsRsmbLobRgbLsbLsbRiRsmbRgbRgbRcLsbRgbRiRsmbsbLgbRjRsmbRg
bRgbRgRibRobRsbRgbsbLibLiLsbLgLsbsbLgbLsbRsbsbLiLsbLcLsLsRsRgmmbRoRsLs
LsRsmmbLsbLgbLibLgbLgbRsbLiLsLsLgmbLiRsbLoLsRsmbRsbLcRsRsmbRcbRsRsmbRh
RsRsLsRsmmbRgbRoLsLsmbLcLgLsbLgbLgLibLgLsRsbRsbLibLibLgbRsLsbLibLgLsbR
jbLibLibLgbLgLsbRgRsmbLoRsRsmbRibRcRgRsmbRoLsbLiLsbLgLeLsbRjbLcRsbLsbL
gbLgbLiLgbLsLsmbLibLgRsbLoLhRsbRsRsRgmbRsbRiRsmbRgRsLsmbRiRiRibRgLsRsb
RibLsbRiLsRsRsLsmbLcbsbLiLgLiLsbLgbLsbsbsbsbRcbRsbLjbLibLebLoLcbLiLsbL
gLiLiLgLsLgbLgbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 9; Drug: PCAP2 3 然
bRgbRibRgbRsbRsRsmbRgbRgbRgbRgRsmbRgbRgbLsbRgbRsbRgbRiRsmbLsbLsRsbRibR
ibRiRsmbRgLsbRiRsmbRgbRsbLsRsbRsRsmbRsbRsRsRsmmbRsbRsbRgbLibsbRibsbRsb
RsbRebRibRsRsmbRiRsRsmmbRebRjRsRsmmbRsRsRgRsmmbRsRgbRsRsRsmmbRebRibRgR
smbRcbRiRsRsmmbRsbRiRsRsmmbRjRsmbRgbsbLsRsbRsbRobRibRsbsbRsbLsbRcRsRsm
mbRsbRiLsbLsRsbLsbRiRsmbLsbRsbRgRsmbRsbLcbLsbLibLsLsmbLsbLcbLiLsbLsbLc
bsbLibLgbRsbRsbRsbsbLcLsmbLibLgLsbLsbLgbLibRsLsbsbLhbLsbRebRibRibLsRsb
RgRsmbRsRsmbRsRsmbLjbLcLsLsmmbLsLsmbLgbRjbRsRsmbRhbRcbRsbRsRsLsLsmmbLg
bRibRgbRibRsbRcRsRsmmbRgbLibLcLsmbsbLcbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 10; Drug: PCAP2 3 然
bsbRgbRsbLsbLsbRgbRsbsbRsbsbsbRsbsbRsbRsbRsRsmbsbLsbsbRgbRsRsmbLsRsbRs
RsmbLgRsbRsbRgbRsRsmbLsRsbRsRsRsRsmmmbRsbLsbRsbRsbRsbLsbRsbRsbRsbRgbRs
RsRsmmbLsLsLsmmbLsbRibRsbRsbLsbRibRsbRsRsmbRsbRsLsbsbsbsbsbRgbsbsbsbLs
LsLsmmbLgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 11; Drug: PCAP2 3 然
bRibRsbRsbRibRgbsbRsbRibRsbRgbRsRsmbRgbRsbsbLsLsmbRgbRsRsmbRsbLsbRsbRg
bsbRsbLsbsbLsbRgbsbRgRsmbRsbRsRsRsmmbRsbRsbLsbRsbsbRsbRsRsmbRibRsLsbRs
bLsbLsbRsbRsRsmbLsbRsbLsbLsbRsbRjRsRsmmbRsbRsbLsbsbLsbLsbRsbRgRsmbRsbR
ibRgRsmbRsbRsbRibsbRsbLsbsbRiRsmbLsbRsbRibsbRsbRsbRgbRsbLsRsbRsbsbRgbR
sbRsbRsRsmbLsbLsLsmbRcbRsbsbLibLsbLsbsbsbLgbLgbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 12; Drug: PCAP2 3 然
bLsbRgbRsbLsbLsbLsbsbLebLsbRsbLcbLgbLsbLgbLgbRjbRgbLcbLibsbsbRjbRcbLsb
RsLsbLcbLsLsmbLsbRsbLibRsbRsLsbRjbRsbRcbLsLsLsLsmmmbRibRsbRsRsmbLgbLsb
RiLsbsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 13; Drug: PCAP2 1 然
bLgLsLsmbLsLsmbLsLsmbsbLgbRsbLsbLgRsbLsbRsRsmbLgbLsbsbRsLsbLsRsbLsbLiL
sbLiRsbLcbLsbLgbLsbLiLsbLsbLsbRsLsbLsbLgbLsLsmbsbLsLsLsmmbLiRsbsbRibLi
bLgbRiRsmbLcbsbLhbRsbRgbsbRibLsbsbRsRsmbRsbsbRgbRsRsmbRsRsmbRgbRgbLsbR
gbsbLibsbLobLhbRsbLsbLibLgbLsLsmbRsbLgLsbLgRsbLsbLgbLgbLsbLsLsLsmmbRgb
LjbsbRsLsbLgbLsbRsRsmbLibRsbsbLobLgbRsbRsbLsLsmbRjbsbRcbRsbLsRsbRibRgb
RsbLsLsmbLgbLiLsbLiLsbRjRjbRgbRsbRgbLibRibRgbLhbLsLcLsmbLibLsbLibRsbLh
LsbLsbRgbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 14; Drug: PCAP2 1 然
bRsRsmbRgbRgbRsbRgbRibRgbLsbRsbLsLsmbLsbLibLibsbLcbLgbLjLsLsmmbRsRsmbR
gbRsbRgbRgbLibLgbLgbRsRsmbRgbRsRsmbLsLsmbsbLcLsmbRgbLgLsbRibRgbLsLsmbR
sbRsbLhRsbLsbRsbsbLsLsmbRoRsmbsbsbRgbRgRsmbRsbLcbLgbLgbLsbsbLsbLsRsbLg
bLsLsmbRsLsbRsbRgbLcbsbRsbsbLibRgLsbRjbRjRsmbLsbsbsbRiRsmbRgRsmbRsbRsb
sbRsbRgRsmbsbLsRsbRibRgRsmbRsbRsbRsbLsbRgbLsbRibRgbRsbRsbRsRsmbRgbsbRj
RsmbLsRjRsRsmmbRsbRgbsbLsRsbLibLibLsLsmbLsbRsbRjRsRsmmbRjRsmbRsbRsRsmb
LgRsbsbsbRibsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 15; Drug: PCAP2 1 然
bLibLjLsmbLebsbRjRsRsmmbRsbRgbRgRsmbLsbLjLsmbRcbsbRgRsmbLibRibRsbRiLsb
LsbLibLgbLjLsmbLsbRsRsmbLcbRibRhbRsbRhRsmbRjRgbLiLsbRgbLsLsmbRgRsRsmmb
RgRsmbRgRsmbLsbRsLsbLgbLsbRhbLhbLcbRiRsmbLiLsbLibLsbRsbRsbLibRibRgRsmb
RgRsmbRsbRgRsmbLsbLgbRebRhRsmbRgRsmbRgRsmbLsbLcbRsbLgbRebRhRsmbLibsbRi
RsmbLsRsbRgRsmbRgbRiLsbRsbsbLsbRiRsmbLsRsbRsbRsRsmbRgbRsRsRsmmbRibLibL
gbRcbRgbRgbRgbLibLibLibLhbLhbRsbRjbRsbRsRgRsmbsbRsbsbRsRsmbRsRsmbRgRsR
sRsmmmbRibLgbRhbRgRsmbRsRsmbRhRsmbRgRsRsmmbRgbRsbRsbLsLsmbsbsbRgRsmbRi
bRibRgRsmbRsbRsbRgRsmbsbRgRsRsRsmmmbRgRsmbRsRsmbRsbRsbRgbRgbLjLsLsmmbL
jbsbLibRcbRiRsmbsbRibsbLibsbRgbLsRsbRcbRibLsbRsLsbRhbLgbsbRjbRibRsRsRs
RsmmmbRsRsmbRibRgbRgbRsbRcbLgbRibRsRsmbsbLsbRibLsbRibRibRsbRsbRsbRsRsm
bRibLibRibLsbRibLsLsmbRibRsbRsbLsbRibLsbRiLsbRibsbsbRibRgbsbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 16; Drug: PCAP2 1 然
bLcbLsbLgbLebLgbLsbLsbRsbRsbRgbRibLgLsbRsbRgbRgbLcbsbLgbRgbRibRgbLsbRj
RsRsmmbRgbRiRsmbLsbLsbRsbRsbLsbRsbRgbRgbRsbRsbRgbRgbRsbRsRsRsmmbRsRsRs
LsmmbRsbRhbLsbLsbRsbRgbRgbRsbLsLsmbLsbRgbLobRgRsRsRsRsmmmmbRsRsmbRsbRs
bRsbLsRsbRsbRsbRgbRgbLsbRiRsRsmmbRibLsRsRsmbRsbLsbRgbRgbLgbRgbRsRsmbRg
bLsbRsbRgbRsRsmbRsRsmbRsRsRsmmbRsbRiLsbRobRgbLsbRjbRhRsmbLsRsbRsRgRsmb
RsbRgRsLsLsLsRgmmmbRsbRsRsmbRsbRsRsmbRgRsmbRsbRgbRgbRsRsmbRgbLsRsbLsRs
b

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 17; Drug: PCAP2 1 然
bRjRsmbLjLsLsmmbLsbLsbLsbRsbLsbLgLsbRsbsbRsbsbRsbsbLgbLsLgbRsRsmbLiLsb
LgLsbLsbsbLsLgLsbLgbLsbLsLsmbLsLsmbLgbRsbLhLsbLsbLsbLgbLgbRjRobRsbRcRs
mbLibRcbLsbLjbLcbLebsbRgRsmbRsRsmbLoLsLsmmbRibLhbLjLgbLibLgbLsbRsbRgbL
cLsmbLsbLsbRgbLhbLsLsmbLgbLsbsbLibRgbRsLsbLiLsbRibLsbsbsbLibLsbLsbLiLs
bLgbLgbRsbLibRsLsbsbLgbRsRsmbLibRsRsLsmbRsbLcbRsbRsbRsRsRsmmbLsRsbRobs
bLcLgbsbLsLgLsbLebLsbLsLsLsLsmmmbLgbRsRsmbRgbRsbRobsbRibLsLsmbLsLsLsmm
bLsLsmbLsbLjLsLsmmbLjLgbLgbRgbsbRibLjbRsLebLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 18; Drug: PCAP2 1 然
bRiLsbsbRibRsRsLsmbLsbRibRgbRibRcbLebsbLcbRsRgbLcLsLsmmbLibRsbsbRgRsmb
LjLsLsmmbLsLsLsmmbLsbRebRibLibRcbRsRsmbRsbLhbLibLgbRibRsbLibLsLsmbLsbR
sbRsbLgbRjLsbRiLsbLsbRsbRsbsbLcLibLcLsmbLcbLjLsmbRibRsbRgbsbRsbLgLsbLs
bLhLsbRcbLsbLsbLsbRibRcbsbRibLsbLgbRibRcLsLsmbRgbRiLsbLsbRsbLgbLcbLgbL
sbRsRsmbLibsbLibRgRsLsmbRgRsmbLhbRjbsbLibRibLsbLsbReRibRsbRiLsbRsbRsLs
bRibRsbRcLsRsbLgbLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 19; Drug: Control
bsbsbLgLsbLsLsLsmmbRsbRsbRsbLsbLibLgbRsbLcbRobRsbRsbLgbsbsbLsbRibsbRgb
RgbRsbLsbLebsbsbRgRsmbRjRcRebLcbRsbRsRsmbRsbLsbsbRsbLibRsbsbRsbsbLsbLc
bLgLsbLsbRsRsmbRsbRsLsbsbLgbLsbRsbsbLsbLsbLibsbsbLsLsmbLsLsmbLgbLgbsbL
gLsRsbLsbRsbRsbRsbLhbRsbLibsbLgbRgbRsLsbRgbsbRiLsbsbsbRibLsRsbLjbRgbsb
LibLsbRsbRgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 20; Drug: Control
bLsbLgbRsLsbLsLsmbLgbLibRsbLgbLsbRsRsmbLsLsRsmbsbLgbsbLsbRsbRsbLibLsbR
jbRoRsmbRsbLebLiLsbLibLsbLgbsbLjbRsRsmbLibLgLsbLsbLgbLgbRsLsbRsLibLgbL
gbLhbRgbRibLobRsRsmbRsbLibLgRsbRsbRsLsbLgbRsbRsbsbRgRsLsmbRgbLiLsLsmbL
sbLgbLgbLgbRsbLiLsbRcRsmbsbRgbsbRobLgbLhRsbLgLsbLhbsbLcbRibLsbLjbLiRsb
RjbLgLsbLgbsbRgbRcbRsbRiRsmbLgbsbLibRsbsbRjbsbLgLsbRsbLsbRjbRjbRcbRgbR
ibRjbLibRibLeLsbLibLhLsbLsbsbLgRsbRsbLibRgbLsRsbLjbLsbLgbRobRobRibsbLi
bRibRibRsbRibRgRsLsmbRsbRibLsRsbRgLsbRsbRgbRsbsbRsRibRgbRsLsbRgRsmbsbR
iLsbLsbLsbRiRsmbsbLsbLjbLebLibLsbLsbLibLsbLgbLsLsLsmmbLgbRgbLibLgbLsLs
RsLsmbLsbLsbLsbRsbsbRsLsbRsbLsbRsbLiLsLsmbLgbLgbRsLsRsbLsLsmbLgbLibLgb
RsbLgbLgLsbLsbRsLsbLiLsbLsLsmbLgbLgbLgbLibRibLiLsbLgbRsbLibLibLgRsbLgb
LgbsbLgbLsbRjbLibRjbRobLibRcbRgbRgLsbRgbRsRsmbLhbLibLibLgbsbRcLsbLsbLi
bLgbLgbLgbLgbRsRsmbLgbLgLsbLgbLgbLgbLcLsLsmmbRgbRibLsbRsbRiRsmbLobLcbs
bsbsbLcbLsbsbLgbRcbLsRsLsbRgbRsRsmbLjbRjbRsbLsbLgRsbLgbLebLibLcbRgbLiL
sbRsbsbLsbLcbRgbLibRsLsbLibRibRibLsLsmbRgbRhbLjbRibLcLsmbLibLibRibRjbL
iLsbLgLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 21; Drug: Control
bLhRsbLsbRsbRgRsmbRsRsRsmmbLcbRjbLhbLsbsbRsbsbsbRjbLibRgRsmbRsRsmbLsRs
bLjLsLsmmbLibLsbRsbRsbLsbLsLsLsmmbLgbsbsbRjRsLsmbLgbLsbLgbRhbRsbLibLib
RgbLcbLhbLibRhbRibLcbLgLsLsmbLgRsbRgRsmbRgbRsbLjbLsbRgbRcLsbRsbRibRobR
ibRgRsmbRgbsbLgbLibLsbsbRgbRjRsmbRjbsbsbsbsbRibRgbRsbRibRibsbLgbLhbLcb
LibRgbLcLsmbLsbLsLsmbLgLsbLsbLgbRibRibRcbRibRsbRsbRjbRiRsmbLsbRjRsmbRi
bRsbLsbLsLsLsmmbRgRsmbRsRsmbRjRsmbRsRsmbsbsbsbLsbRibRibRsbRgRsmbLgbsbR
gRsmbLsbRjRsmbLsbRoRsmbsbLgbRjRsmbRgbLsLsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 22; Drug: Control
bRibRgbRobLsbsbLibLcbRgbRibRiRsmbRgbRjLsbLibLcbLcRsRsmbsbLiRsbRsbLiLsL
smbRsbRgRsmbLcLsmbLsbLcbLibLsbLibLcbLibLibLcbLjbLibLsbLcbRjbLoLsRsmbRg
RsmbLgbLsLsLsmmbsbRiRsmbLgbLgbRsbLsbLsbLjbLgbRgbLiLsbLibLsbRgbLobLibRg
RsLsmbRiRsmbLjLsmbLsbLsbRgbRgbRsbRsbRsbRjRsmbLgbRcbRibRjbRgRsmbLsRgbLh
RsRibRgbRcbRgbLsbRcRcRsLsmbRgbRsRsmbRgbRgbLsbRgLsbLhLsbLibRsbLobRgRsmb
RibRobRsLsbsbLgbRibLibLsbRgbLsbLsLsmbLcbLgbLcbRgRsmbLsbLsbLhbLiRsbLsbs
bLsbLgbsbLibLsbLgbRsRsmbLsLsLsmmbLgLsLsmbLsbLibLsbRibRoRhRsmbRgRsmbRsb
LsbLsbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 23; Drug: Control
bRiRsmbRsbRsbRsRgbsbRsbRibRsbLgbRibRibLibRsbLsbRiRsmbRgbRgRsmbRgbRgbLi
bRgbLcLsmbLibLibLgbLgbLibsbsbLsbLsbLibLsbLsbLsbLgbRsbsbLgbRsbsbRcbRgLs
bLjLsLsLsmmmbLjbLibLgbsbRsbsbLgRsbLgbRgLsbRjbRibRiLsbLjbsbLsbRhLsLsmbL
jLsmbRcbLibRobLgbsbRgbRsbRgLsRsbLsbRibLgbRibLibLsbRibRiRsmbLjbsbLcbLcb
sbLibLsbLsbRgbRgbLcbRjbLibLhbRibsbRsbRsbsbLibsbLjLsmbRibRibLibLibLgbRi
RsRsmmbLsLsRsmbLsbRsRsmbLhLsbLsbLgbRsLsbLsRsbRsbLgbLgbLsbRsbRsLsbsbLgb
RjbsbLibLsbLsbLgbLgLsbLsLsmbRibLsbLsbRsbLibRgbRjbsbsbsbsbRhbLcbLsRsLsb
sbLibsbLsbLsbLgLsbRjbRsRsLsmbLcbLsbLgbLibsbLjLsmbRjbsbLsbRgbLibRsbLibR
jbLjLsmbsbLgbLiLsbsbLgbLsbLgbRsLsbLsbLgbLgbLsbLsRsbLibLibRsbLibLsbsbLs
bLgbLgbsbRibRsbsbRhbRsRsmbLsbRsLsbLsRsbLsbsbLibRibLcbRsbRgbLcbLgbRsbRi
bLhbLcbsbsbLgbRsRsmbsbsbLgLsbLgbLsbLsLsmbLsbRgbLgbRgbRsbLsLsmbLsbRsLsL
sLsmmbLsbLibLsbLgbRjbRsbRcRsmbLsRsLsbRibRsbLgbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 24; Drug: Control
bRgbLsRsbRsbRgbRsRsmbRgbRgRsmbRgbLsbRgbRsbRsbLsRsbRsbsbLsRiRsmbsbLgbsb
LibRsLeRsbLgRsbLcbLgbRsbRebRcbRsbRsbRibRgbRsbRsRsmbsbsbRibRhbsbLgbLsLs
mbLgLsbLsbLsbRsbsbRebRibRibRibRiRsmbLgbRsbRsbRsbLsRsbRcbLgRsbsbRsLsbRi
bRsbRhbLibRibLcRsbRjbLibLibLsbLgRsbRsbRcbRcbRcbRsbRhbRibsbRiRsmbLsbRib
sbLsbRgRsmbRsRsmbRgbRgbRsbRsbRsbRibRsbLsbRgRsmbRibRibLgbRsbRgbRjbLjbLh
bRsbLibRibLcbLcbRgbLibLgRsbRgbLiLsbRsbRcbRiLsbLgbRgbRgbRgRsmbRsLsLsRsm
bRsbLsbRsbsbRibRsRsmbRgbRgbRgbRgbRsbRsbRsLsbRgbRgbRgbRsbLgbRcRsLsmbsbL
ibRsLsRsLsbRibLsRsbRoLsRsLsbRcRsmbRgbLebLebLibRibLgLsbRsbRcbRcbRiRsmbL
sLsmbLgbLibRibLgbLcbRsRgbLiRsbLsbLiLsLsmbLiRsbLibRsbRsbLcbLibRjRsRsmmb
LcLsmbRibLiLsbLsbRjbRsbRcbRcbRcbsbLsbRebLhbLjbLgbLibLsbRgbRhbRgbLsbRib
LsRsbRgbRsbLsRgbRsbRsbRgbRsbRibLsRsbRgbLsbRgbRsbsbRgbRgRsRsmmbLiRsbRcR
smbsbRibLcbLhbLiRsbsbRebRcbRgRsmbRcbLgbRibRebLibLcbLgbLsbLgbLgbLsbRgRs
mbLgLsbRcLsbLjbLibRcbRcbRsbRhbRibLgbRibRiRsmbRsbRsbLsbLcbsbLibRibRhbLg
bsbRiRsmbLsRsLsbRibRsbLsbRibRsbLsbRibRsRsmbRgbRgbRsbRgbRgRsmbLgbRsbsbR
sbRsbRsbRsbRgbRsLsbRsbRsRsmbRgbRgbRibRsbRsbRgRsmbRgbRsbLiLsRsbLjbLibRc
bRsbRcLsbRibLiLsbLgbRgbLibLgbsbsbLiRsRsRsmmbRcRsmbsbsbRibRsbRsRsmbRsRs
mbRibLgbLsbRgbRsRsmbRibLgbRgbLsbsbRibLgLsbRibRibRgbRibRgLobRgLsbLibRjb
LibLgbsbLhbRebRibRgRsmbRcbLibLjbLibRgLsbLhbRibRgbRgLgbRibRibsbLjbRibLs
bRgRsmbRgbRgbRsbLhbsbRcbLsbRiLsbRsLsRsbRgbRgbLsbRsbsbRsLsbRsbRsRsmbRgb
RsbRgbRsbRsbRibRsbRgbRsRsmbRgRsmbLsbRgbRsbRgbRgbRsbRgbRgbRgbLsbRgbRsLs
bRsbRgbRgbRgLsbLebRebRibLjbRsRgRsmbRsbRhbLgbRsbRibLgbsbRcbLibRcbLsRsbR
iLsbLsLsLsmmbRhbRibRgbRibLgbLhbLiRsbRsbLsbRcbRcbLjLgbRcbLhLsbLcbRiRsRs
mmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 25; Drug: PCAP2 10 然
bRsRsmbRsbLsRsbLsbRgbLsbRsLsbLgLsbLgRsbLebLsbLsbLsRsbLibRcLsbLsLsmbRhb
sbLgbLsbRsbRsbLgbLsbLjbRsbRjbsbsbRcbRgRsRsmmbRsbsbRsbLjbRsRsmbRgbRgRsm
bLsLsmbRsbsbLsbRgRsmbRsbLjbRsbRgbsbLsbRsbLsbRcbRgbRgbRgbLsbRgbLsbRibRi
bRiRsmbRgbRsbsbRsRsmbRsbRsbRsbsbLsbRsbRsbRsRsmbRobRibRjbRgbRgbRebLgbLs
RsLsbRsbLiLsbsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 26; Drug: PCAP2 10 然
bsbLsbsbLgbLibLsbLsbsbRsLsbLsbLgbRsbLsbLsbLsbLsbRebLsbRsbsbLsbsbsbsbsb
RsRsmbLsbsbsbsbsbRsbsbLsbsbLsRsbsbRsbLsLsmbLsbLsLsmbsbLsbRsLsbsbsbLsLs
mbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 27; Drug: PCAP2 10 然
bRsRsmbRgRsmbRgbRsRsmbLhbLgbLibLsLsmbLcLsmbRsbRsRsRsmmbLsRsbLsLgbLsbLg
LsLsmbLsLsmbRsRsmbRsbLibLeLsLsmbLsbRgRsmbRsRsmbRsbLebLibLsbLsbLsbRsbLg
bLsbRsbLgbLiLsLsmbLsbLhbRsRsRsmmbRsRsRsRsmmmbLsRsRsmbLibLsbLibLsbsbLsL
sLsmmbLiLsbRsbLsLsmbLgbsbRobLjbRsbLgLsbLsbsbLcbLgbRsbRsRsmbRsbRsLsbLcb
RsbLibsbRsbLsbsbsbLsbLsRsbLsRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 28; Drug: PCAP2 10 然
bLcbLibRcbRgbRhbLobLsRsbLsbLibRgbRiRsRsRsmmmbRsbsbRsLsRsRsRsmmbRsbLsbR
sbLsbLsRsbLoLsmbsbLibRjbLjbRsbLibLhbRsLsbRsbRsbLibLsbLsbLsLsmbLsLgbLob
RjRgRsmbRsbRsbRhbLsbLiLsbRsRsmbLcbsbRjbLcbRsbLgRsbLsbLsLgLsbLsLsmbLsbL
sLsLsmmbRobRiRsmbRhbsbLhbRsbsbRsLsbLibLsLsmbLsbLcRsbLcLsmbLsLsmbLoLsRs
mbRsbRsbLobRjRsmbRsbRsbRgbRgbsbRgLsbRsRsmbLsRsRsmbLsbRsbRgbRsbsbsbsbRs
RsRsRsmmmbLsbRgbRgbLobLsbLiLsLsmbLgLsbLibsbRgLsbsbLsbLebLsLsLsmmbLsRsb
LiLsbLibLibRibLcLsmbLgLsLsmbLsLsmbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 29; Drug: PCAP2 10 然
bsbRsbsbsbLgLgbLsRsbRsLsbLibsbLgLsRsLsbsbLibLiLsbsbRcbRgbRgRsmbRsbsbLj
bRhRsRsmmbLsbRsRsmbsbsbsbRcbRgRsmbRsbRsRsmbsbLjLcLsLsmmbLsbsbLsLsLsRsL
smmbLsLsmbRcRsmbRsLsbRsbRgbRsLcbLibLsbsbsbLgLsbLsbRsbLsbLsbLgbRsbsbLgb
LgLsLsLsLsmmmbsbRobRsbsbsbsbsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 30; Drug: PCAP2 10 然
bReRsmbRsbsbLgbRsbRebRibRsbLjbLcbLsbLsLgLsbLhbRsbRsRsRsRemmbRgbLsbRoRs
mbRsRgRsmbsbLgbLsbLsLsRsmbsbLsLsmbsbRhbRiRsLsmbLcLsLsLsmmmbRgRsmbRobLs
bLsLoLsLsLsmmmbLgLsbLiRsbRhLsbRcRsmbRoLsbLibLgLsRsbLsbLsbLsLsRsmbLgLsL
smbLsLiLsbLobRsLsbLsbRjbLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 31; Drug: PCAP2 3 然
bLibRsbsbsbsbLsbLgbLsbLoLgRsbRsbRgLsbLsbLsbLibLiLsLgRsbLibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 32; Drug: PCAP2 3 然
bLgLsLsLgmbLsbLsbLsbsbLgbLgbRobLsbRibRgbRsLsRsbsbRcbsbRjbRsbLsbLiLsbLs
bRsLsbLsbLgbLobLsbLcbLiLsbRsbLsbLgbLgbLiLgbsbLsbLsbLibLgbRcbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 33; Drug: PCAP2 3 然
bLcbLhLsbLgbLjLsmbRcLsbLebLcbLsRsbRsbLcLsmbLiLsbLiLsbLsLsLsmmbLjLsLgLs
mbLjLgbLgLsbRjRsmbLsbLhLsbLsLsLsLsLsmmmmbLsbLjLsLimbRcbLsbLhbRjRsRsmmb
RgbLeLsbRjRsmbLsbLsbRcbRgbRibLgbRgbRibsbRsbLibLjbLsbLgbLsLsmbLiLsbsbRs
bLcbRsbLiLsbLiLsbLgLsLsmbLibLgbLsbLobLcbLsbRebRcbLiLsLsmbLsbLsbRcbRjRg
bRsRsmbLsLsmbLiLsbLsLsmbLsLsLsLsmmmbLsLsmbLsLsmbLsLsmbLcLsmbLibLsLsLsm
mbLsbsbRhbRibLhbLsLgbLebLiLgbRibRsRsmbLjLsmbLsbsbRsbsbRjRsmbRsRsmbRcRs
mbRsRsmbRhbLiLsbLsLsmbLgLsbRibsbsbRcbLcbLgLsLgbsbRgbLiLgbLsLsmbRgLsbRe
bRsbsbRcbRibLjLsLsmmbLsLsLsLsmmmbsbLsRsbRsbRjbRhLsLsmbRsbRibRsLsRsbLsL
smbRhbLsLsmbRhbRsRsRsmmbsbLsbRgLsbsbLsbRhbRsbRsRsmbsbRsLsbsbLsLsRsmbLs
bLsRsbLsRsbsbsbLebLcbLgLsbRgRsmbRsRsmbLcbLsbLhRsbLsLsLsmmbLsbLsbLsLsmb
sbsbLhbLcLsmbLsbRgbRcbRsbRiLsbLsbLsbRsbLsbLsRsLsRsRjbRhLsbRsbLsLsmbRcb
RiLsLsmbRcbLsbLsRsbRsRsRhmbRsbRgbRiLsbRsbsbRsbRcbLsbRcLsbLsbRgRsmbReRs
RsmmbRgbRgbRsbRgRsmbRsbRsbRibRsLsbRiRsmbRibLsbRibRgRsmbRibLgbRcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 34; Drug: PCAP2 3 然
bRsbLsLsRsmbRsbReRsmbLibRsbRcbRoRsmbRhbRiRsmbRsRcbRobRcbRsbRgbsbRsRsmb
sbLsLsmbsbRgRsmbRsbRgbRsbRsbRsbRsbLsLsmbRsbRsRsmbRsbsbRsbLsbRsLsbLiLsb
LsbRebLsbRsbRsbLsbLsRsbLsbLibsbRibRibLibRsLsRsbRsbRsbLsbLsRsbRsbRsbLib
RsbRibLsbsbRibRsbLjbLsbLcbLsLsmbLsbLebLcbLhbsbRsRsmbRgbRgLsbLsLsLsmmbL
cbsbRsRsmbLibRcbRibRsbRsbLebLsRsbLcbLcLsmbRsRsmbLsLsmbLibLsbLsbLsLsLsR
smmbsbRsbRsRcbRcRsmbRcbLsRsbRsRsmbRsLsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 35; Drug: PCAP2 3 然
bsbRcLsbRsRsRsmmbsbLjbLgbsbsbsbLebLgbLsLsmbRcbRgRsRsmmbsbRiRsmbRsRsRsm
mbLsbLibLiLsbLgLsbLsbsbRjbRsbsbRsRsRsRsRsmmmmbRsbLsbLsbRibRsRsmbLsbRsb
RsRsmbRgLsbLsbLsbReRsmbRjRsRsmmbRgbsbsbRibLsbRsbsbRsRsRsmmbRiRsmbRjRsR
sRsmmmbRgRsmbRsbLgLsLsmbLsbLgbRjbRiRsRsmmbRsRsRsmmbRsbRsbRebLsbLsbRibR
sbRibRsRsmbRgbRiRsmbRsRsRsmmbsbRiRsmbRgbRjRibLebLhbLsbLhLsbLgLsbLgbLgL
sbRsbLgbRgRgRsmbLgLsLsmbRjbLsbLsbsbRhbsbRsbsbsbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 36; Drug: PCAP2 3 然
bRsRsRsmmbRsbRsbRsLsbsbRsLsbsbRsbsbLsbsbLsLsmbRsbsbRsbsbRsRsmbRsbLsbRs
bRgbRsbRsRsRsmmbRgbsbsbLgLsbLsbLsLsmbsbsbsbsbLsLsmbRsbRgLsbLsbRsbLsRsb
sbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 37; Drug: PCAP2 1 然
bLsLsLsmmbsbRsRgRsRsmmbRjRsmbRcbLsbLgLsLsmbReLsbLebLgbRibLsLsLsmmbLibR
ibLhbsbRjbLsLsmbLsbsbLsLsLsmmbLsLgbsbLsbLsbLibLgbsbRgRsmbsbLgLsbLsLsmb
LsLsLsmmbLgRsbLgbsbsbsbLjLsmbLsbLsLgbLsLsLsmmbsbsbsbLsbLiLsbRsbLsLsLsL
smmmbLsbsbRjbLcbLsbLhbLsbRsbLiRsbRsRsRsmmbLibLsbLgbLibRjbLibLgLsbRsRsR
smmbLhbLsLsLsmmbLiRsbLsLsmbsbLsbRsbLgbsbsbLsLsmbLibRsbLibLgLsbRcRsmbRi
bLsbRibsbRsLsbRgbLsLsRsmbRsRsmbRgbsbLsRsbRsRsmbRsbRsbRgbRsRsmbRsbRsbRs
RsmbRgRsmbRgbLsRsbRibLsLsmbRsbRgbRsRsmbRgbsbRgbLsLsLsmmbRcbRsbRsRgbLsb
RibRhbsbRiRsRsmmbRibRibsbLsbsbLcbLibRjbRcbRcLsbLgbRcbLsbLsLsmbRcbsbsbR
jbLsLsmbLgbRsRsRsmmbRsbRibRsbsbLsLsRsmbsbRiRsmbsbsbRgbLgbRibRgRsRsmmbL
sLsmbLsLsmbRibRsbRgRsRsRsmmmbRsbRgbRsRsmbRgbRsbRgbRgbRsbLsRsbRsLsbRgbR
ibLjLgbLsbRibLsRsRsmbRsRsRsmmbRsbLsRsbRgRsmbLsRsRsmbRgRsmbRsbRsRsRsmmb
RsbLsLsmbRiRsmbRgRsmbRsRsRsmmbRsbLsRsbRgbRsbRgbRgRsmbRgbRgLsRsbLsLsmbR
ibLsbRibLjbLsLsmbLjbsbLjLsLsmmbLsbLjLsLsmmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 38; Drug: PCAP2 1 然
bLgbRgRsLsmbLsbRjbRcbRgbRgRsmbRsbRgRsmbRgbRgbLsbRgbLcbLhbLibRibRjbRibL
gbRibRibLsbLibRgRsmbRibLsbLsbRibRiLsbRgbRsbLgbRibRibRsbLsbRiRsmbLjbRib
RsLsbRiLsbRgLsbRgLsRsbLsbLsRgRsmbRibRsbRgbLsbRsbRgbLsRsbRgbRsbRgbLsbsb
RcbRsbRgbLgbRcbRhLsbRiRsmbRsbLibRsbLhbLiRsbLgbRgRsmbRgbRibRgbRgbRsbLsb
RgbRsRsmbRsRsmbRsbRsbRgbRgbsbRgbLsLsmbRgbLsbRiRsRsmmbLsbsbLsbRgbRgRsmb
RsRsmbRgbsbLcbRcbLhbLibRjbRcbLgbLjbLibLiLsbLibLobRcbRgLsbRgRsmbRgRsmbL
sLsRsmbRgbRgbLsbRgRsmbRgbLjbRibRibLgRsRsmbRgRsmbRgRsmbRgLsLsmbLjbRjbRg
bRgbsbRgLsbRgbRgbRsbRsbRsRsRsRsmmmbLsRsbRibLsbRgbLjbLobLhbLhbRibRgbRsb
LcbRibLibLiRsbRsRsmbLcbRgbRgbLhbRjbLibRsRsmbLgbLgbRsbLibRsbLhRsbLcbLib
LiLsbRibRiRsmbsbRcbLgbRcbsbRcbsbRgbRibLgbLhbLcbLibLsRsbLgbRcbRcLsbsbLg
bLsLsmbRhRsmbsbRibsbRgLsbLsbRsLsRsbLgRsbRhbLgbRhbLgbRsbRibLsbRibLjbRib
LgRsbRgLsbRgbRgRsmbRgbRgRsmbLsbRsRsmbRsbRibLsbRgLsbLsbRgRsmbRgbRgbRgbR
sbRsRsmbsbRgbLibLcbLcRsLsbLibRsLsbLsLsmbRgbRcbLgbRibRgbLgbsbRgLsbLibLi
RsbsbRcbRibsbsbRgbRibRgbLjLsmbLsbRibRibLsbLsRgbRsbRgbLsbRgbRgbRsbRgbRs
bLsbRhbsbRgRsmbRgbLsbRiRsmbRsbRgbsbRgRsmbRgbRgbLgbRibLgbRhbLgLsbLsbRib
LsbLsRgbRsbRsbRgbRsRsmbRsRsRsmmbRsRsmbRgbRgbLsLsmbRgRsmbLsbRgLsRsbLgbs
bsbRibLgbRgbRsLsbRgbRgbLcbLibsbRebRgbRibRsbLgbRibLsRsbRsbRgRsmbRgRsmbs
bRgbRsbRgbLsbRgbRibRsRsmbRgbLgbRibRsbRgbRsbLjbRiRsmbRsbRibRibRgbRibRgb
RsbLcbLiRsbLcLsmbRsbLgbRgbRgbRibRgbRsbRsRsmbRgbLsbRgbRsLsbRgbRgbLsbRsb
RgRsmbRsbRsRsmbLjbsbLiLsbRcbRgbRgbLgbsbRibRgbRgbRgbsbLhbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 39; Drug: PCAP2 1 然
bRibRebRhbLgLsbLsbsbRibRgbRsRsRsmmbRsbRgbRgLsbLsbRgRsmbsbRsbRsRsmbRgbR
gRsmbRgbRgbLoRsbLgbLiRsbLsbLsbLgbLgbLgbLgLsbLsRsLsbLgbLgbLgbRsRsLsmbLg
bLgbLgRsbLgbRsbLibRsRsRsRsmmmbLgLsLsmbLgRsbLgLsbLgbLibLgLsbLsLsLsmmbLs
LsLsLsmmmbLsLsmbRjbRibLobLhbLgRsbRibRibRhbRoRsmbRibRcbLjbLcbLibRgbLhLs
bLgbsbLsLsLsmmbLgLsbLsbLsLsmbLgLsbLgbLgbLgRsLsLsmbLsbRsLsbLgbLgLsbLgbL
gbRsRsmbLibLsbLgbLgbLgbRsbLiLsbLsbsbLsbLsRgbsbsbsbLibLsbLibLibLgLsbLsL
smbLgLsbLgLsLsmbLgbLsbLsbLgbLgbRsLsbRhbRgbLcLibRjbRcbLebRcbLobsbRsbRsb
sbLsbLibRibLibLsbLgbsbLgbLsLsmbLgLsbLsLsmbLsbLgRsbLgbRsLsbLgLsbLsRsbLs
LsmbLgbLsRsbLgbRsbLsLhbLibRibRsbRjRsmbLjLsmbRcbLiLsLsmbRgbRibLcLsmbLib
RsRsmbLgLsbLiRsbRibLcbLsbLsbLgRsbRsRsmbLsbRsLibRgbLcbsbLiLsbsbRhbRibLg
bRibRgbLsLsLsmmbRjRsRsmmbRiRsRsmmbRgLsRsbRgRsmbRiRsmbRjRiRsmbLibRcbRhR
sRsmmbLibRsbsbsbLgLsbRjbRibRsbLjbLcbLjLsmbRjRsmbRjbRcbLcbRibRcbRcbRiRs
mbRibLsLcbRsRsmbLsbLhbLsLsLsmmbRsRsLsmbsbLibsbLgbLgbLgbLgbLgbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 40; Drug: PCAP2 1 然
bLsLsmbRgRsmbRsLsbLibLhbLibRjbsbsbLsbLcbLsbLsLsmbRiRsmbLgLsbLibLgLgbLg
bRgbRsbsbLibRgRsmbLiLsbLibLsLsmbLibLsbLsbLiLsRsbLgbsbRgbsbLibRsbsbLhbs
bRgbLcbsbLibsbLsLsmbLsbLcRsbRgRsmbLebRsbLibLiLsbLibLsbLgbLsRsbLebRsRgb
LjLsmbsbLibLsLsmbLibLsLsmbRjbLsLgbLsbLsbRgbRibLsbLibLhbLhbRibLcbLhbLib
LiLsbLiLsbLhbLgLsbLsbRgbLsLsmbLsbLibLibRgbLgbLgLsLsmbLgbLgbRsbLcLsmbRg
bsbRsbLhbRsRsmbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 41; Drug: PCAP2 1 然
bRsbsbsbRgRsmbLgbsbRgRsRsmmbLsbRcRsmbRgRsmbRsbRsRgbRsRsmbRsbRebRgRsmbR
ibRsRsmbRgRsmbRsbRsRsmbRsbLcLsmbsbLsbLsLsmbsbLsLsLsmmbsbRsbRsRsmbRsbLi
LsbsbLgLsLsmbLsLsLsmmbRgbRgRsmbsbLsLsmbRiRsmbRibRsRsRsmmbLsLsLsmmbsbLj
LsLsmmbLgLsbLgLsbLsLgbsbLsbLibLsLgbsbsbsbsbsbsbLiLsbLsbLjbsbRsRsmbsbsb
LsLsLsLsmmmbsbRsRsmbRsRsmbLobLsLsmbRsbLgLsbLsbLgLsbLsLsmbLsLsLsmmbsbsb
RsbLhLsbLsbLgLsbLsbLiLsLsmbLsbsbRsRgbRgbsbRsRsmbsbLsLsmbRjRgbLsbRjbRsR
smbRgbRsbLiLsbRjRsmbsbRobRgRsmbRsbRgRsmbRgbRsRsmbRiRsmbRsbRibsbRsRsmbs
bLsbsbRcbsbsbRibRsbsbRsRsRsmmbsbLsbLjLsmbRgbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 42; Drug: PCAP2 1 然
bLgbLgLsbLsLsmbLsbLgLsbLgLsbRsbRobsbRibRgRsmbRhLsbLobLgRsbLsLsmbRgLsbL
ibRgbLgbLgLsbLsbLsbLgbLsRsLsbLgbsbLsbLgbLgbLibRibRibRgRsmbLsRsbRgbsbLs
RsbRgbRgbRsbRgbRgbRsLsbRgRsmbRgbRsRsmbRgRsRsmmbRgRsmbRgbRgbRsbRgbLgLcb
LiRsbLcbRjbLibRcbRibLsLsmbLsRsbRgbRgbLsbLsbRgRsmbRgRsmbLsbRsLsbLsRsbRg
RsmbRgbRgRsmbRgbRgRsmbRsbRsbRgbRgbRgRsmbRgRsmbLsLsRsmbRgbLgLsbRiLsbLgb
RibsbLgbsbsbRiLsbsbLgbRgRsmbRgbLsbRgbRibLgbRibRsbLjLsmbRgLsbRibLsLsmbR
ibsbRgbRcbRibRsbRibRibsbLgbRhbsbRgbRsRsmbsbRgbLsbRibRgbRgbRsbRcbRjRsmb
RcRsmbRhRsmbRjbLgbLhLsbRcRsmbRhRsmbLsbLhbLiLsbLibRibLibLgbLsLsmbLsbLgb
LgbLsLsmbRsbLgbLgbLsbLgLsbLgbLgbLgbLgbLgbLgbRjRsmbLhbRsbLcRsbRcbLsbRcb
LgbRiRsmbRgbRhbRcRsmbsbLgbLibLgbRsbLsRsbRsRsmbLiLsbsbLgbRsbRgbRcRsmbLs
bRibLsbRobRibRsbLsbLhbLgLsbLsRsLsbRsbLgbLsbLgbLgRsLsbLgbRsLsbLibRsLibR
sbLiLsbLsbLgbLgbRsbRsbLgbLgbLsbLgLsbRcbRgbRsbRgRsmbLjbRibRiRsmbRgbRgRs
RsmmbLgbRhLsbLsbRgbRgbRgRsmbRsbRsRsmbRsbLsbRgbRgbRgbRsbLsbLsbRgbRsbRiL
sbLgbLcbLgbLsbLsbLgbLgbLgbLsbRjbLhbLhbRsbRgbsbLibsbRcbRgbLgbRcbLcbsbRg
bLcbLsbLsbRhbRhbLjbLibLiLsbLsRsbLsbLgbRcLsbRhbLebLibLsLsmbLgLsbLgbsbRs
bLgbLsbLgbLgLsbLgLsbLgbLgbLsRsbLgbLgbLgbLgbLgbRsbLibLgbLgbLsbLgbLgbLsb
LgLsLsmbRgbRcRsmbRgbRsbRibRiRsmbLcLsmbLgbLsLsmbLgbLsbLsbLsbLgbLgbLsbLg
bLgbLgbLsbRgbLgLsbLgbLgbLsbLgbLgbLgbLgbLgbLgbLgLsbRjRsmbLcbRcbLgLsbLhb
LgbLsbLgbLgLsbLgbRjbRcbLoLsmbLgbLibLsbLsbLibLgbLgbLsRsbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 43; Drug: Control
bLgbRgbsbsbLsRebLsbsbLsbsbRibLsbRgRsmbRsRsmbRibRsRsmbRsbRsbLsbLsbRgRsm
bRgbLsbLsbRgbRsbsbRibsbsbsbRcbLebRibLsbRcbRsbLsLsmbRibRsbRibRgbRsbRgbR
sbRibRibRsLsbLsbRsbRibRgLsbRibRsbsbRsRsmbRsLsbRsbRsbRsbRibRsbRgbRsbRsb
RsbRgbRibLsbsbsbRibRgbRgbLsbRgbRsbRgbLgLsLsmbLsLsmbsbLgLsbLsbRgbRhbRib
RcbRsRsmbLsbLsbRiRsmbRsbsbsbRiRsmbRsbRsbRsbRiRsmbsbRibRsbLsbLsLsmbRcRs
mbRsbLsbRgbRsRsmbRsLsbRibsbRibRsRsmbLsbRsbRcbRsbRgRsmbRsRsmbRgbRgbsbLs
bRsRsmbsbLibLsbRibRibRsbRjRsmbsbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 44; Drug: Control
bLgLsbRsbLsbLgLsbLgbLgRsbLgbLsbLsbLgbLsbLsRsbRsbLgbLgbRgbRjbLjbLjbLibL
hbLsbLgbLgbsbLsbLgbLgbRibLsRsbLsbsbsbsbLebLsbRgbLsLsmbLsLsLsmmbRsbRsbL
sbRjbRsLsbsbsbsbsbsbLsbsbsbsbLsbsbsbRsbLsbsbLsRsLsbLsRsbLgLsLsmbLgbLgb
LgRsbLsbLgbRgRsmbLgbLsLgbLgbRjbRsRsmbRsbsbLgLsbLsbLsbRgbLgLgbsbLibLibR
cbRsRgRsmbRsbLjLsmbRgbsbLibsbLgbLsbLsLsmbLgbLsbLsbLsLsmbLsLsmbLibRsbLg
b

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 45; Drug: Control
bLgRsbLibRsbLsLsmbLsLsLsmmbRsbRebRiRsmbRgRsmbRcbRibRsbRgRsRsmmbRgbRgbR
ibRgRsRsmmbRgbRgbRgbRsRsRsmmbRsRsmbLgbRibRgbRibLsLsmbRcbLgbRjbRiRsmbRi
LsbRibsbLsLsLsLsmmmbRsLsbRibLcbLgbRibLsLsmbLgbsbRiLsbLsbRibRibLsbRsbRi
bRsbRsbRsbRibLsbRhLsbsbLibLsbLgbLibLibLcbRebRibLibsbLgbLgbLsbLsbLgbLgL
sbRebRebRhRsmbLgbRsbRibRsRsmbRibLgbLsLsLsmmbLsbLsLsLsmmbLgLsbLsbsbRsRs
mbLgLgbLsbRgbRsbLgLsbRsRsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 46; Drug: Control
bRgbRgRsRsmmbLsbRgbRsbLsRsbRgbRsbRsbRgRsmbRsbRsbRsbRsbRsbRsbRsbRgbRgbR
sbLsbRgbRsRsmbRsbRsbRsbRgbRsbRgbRsbRsbRsbRsbRsbRgRsmbRsbRsbRgbRgbLsRgb
RsbRsbRgRsmbRsbRgbRgbRsbRgLsbRsbRsbRgbRgbRgbRgbRsbRsbReRsmbLsRsbLsRsbR
sbRgbRgRsmbRgbRsbRsbRsRsmbRsbRsbRsRsmbRsRsmbRsbRsbRsbRsbRgbRgbRsRsmbRg
bRsbRsbRgbRsbRsbRsbRsbRgRsmbRsLsbRsbRsbRsbRsbRsRsmbRsbRsLsbRsbRsbRsRsm
bRsbRgbRsbRsbRsbRsbRgbRgbRsRsmbRgbRgbRgLsbRgbRsbRgbRsbRsbRgbLsLsmbRsRs
RsmmbRsbRsbRsbRgRsmbRgbsbRsbRsbRsbRsLsbRsbRgbRgbRgbRgRsmbRsRsmbRsRsmbR
gbRgbRgbRgRsmbRgbRgbRgbRgLsbRgbRsRsRsmmbsbRsbRsbRgLsbRgbRgbRgbRgbRgRsm
bRgbRsRsmbRsRsmbRsbRgRsmbRgbRgbRgbRgRsLsmbRgbRgbRgbRsbRgbRgRsmbRgbRsbR
sRsmbRgbRgbRgbRgbRgbRgbRsbRgbRsLsbRgbRgbRgbLoLsmbRebLibLsbLgbRsbRjbLiL
sbRsbRibLibRebsbLebLgbLgLsbLgbLsLsmbLsbLibLsbLgbRsRsmbLiLsbLsRsbLgRsbL
sbRsbLibLsbLsbLibRgbLiLsbRhbRoRsmbLsbRibRibsbLibsbRibRcbLsbLsbLsbLgbLi
bLibRsRsmbLgbLsbLsbLsbLsLsRsmbLgbLsbLgLsbLjLsmbsbLsbsbLiLsbLsbRsbLgbLi
bRgLsbLgbLgbsbLgbLsbLgbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 47; Drug: Control
bRiLsbsbsbLobLhbRhbLibLibLgbLsbLgRsLsRsbLsbLsbLgbRsLsbLgbLsbLsbLgbRsLs
bLgbLibRhbLiLsbLobsbRsbLobLibLgbLgbLgbLgLsbLgbRjbLgbLgbLgLsbLsbLgbLsbL
sbLibLiLsbRsRsmbLsbLcRsbsbRsbLhbRibRcbRibLibLibsbLsbLibsbLsbRsLsbLgbRs
bLgLsbLiLsbRgbLibLiRsbLgbLgbLgbRsLsbLgRsbLgbRobRgRsmbLibLgbLgbLgbLgbLi
bLsbLgLsbLgbRsbLgbLgLsLsmbLsbLsLsmbLgbLsbLgbLgbRsbLibRgbLibLsbLibLgbLs
bLgbLsbLgbLgbLsbLsbLgbRgbRibRgbRibLgRsbLibLgbLgbRsbLgbLsLsmbLsbRjbRgbR
sRsmbLcbLibLgLsbLsbsbRsbRhbRhbRibRgbRsbRgbRobLibRsbLibRsbLobLcRsbLibLi
bLsbRcbLcbRjbRcbLgbRiRsmbRhbLsbLsbRibLibRoLsbRibRsLsRsbRibLjRsbRibRibL
sbLsbRibRiLsbLjbRsbRibRibLibRgbRiLsbRgbRsbLsLsmbLcbLgbLgbLgbsbRsbLibLg
LsRsbLsLsmbLgbLiRsbLibLgLsbRjbLcbLsbLibLsbLibsbLsbLsbLgLsbLsLsmbLgbLgb
LgbLgbsbLgbLgLsbLgLsbLgbRsbLgbLgbLgbLgLsbRgRsmbLsbLgbLgbReRsmbRcbLcLsm
bLcbRcbRcbLcbLibLibRsbRsLgbLsbLibRgbLibLsbLsbLgLsbLibLsbLgbLibLgbsbRjb
LibLsbLgLsbLgbLsbLgbLgbLgbLsbLgRsbLibLsbRjRsmbRcbRibRibLibRibLjbRcbLgb
LjbLhbLibRgbLsbLiLsbLsbRjbRibRibRsRsmbLjbLcLsmbLibLsbLhbLibRsbLsbLiLsb
LgLsbRhbRcbRcLsRsbLsRsbRiRsmbRhbLibRcbRgbLsbLgbRibRsbRibRgbRsbRgbLsbRi
bRgRsmbLsbLibRjbRibLsbLebLgbLgbRjbRcLsbRiLsRsbLibLcRsbLsLsLsmmbLgLsbLg
bLgbLsbLgbLgbLgbLgbLgLsbLgbLsLsLsmmbLgRsbLgbLsbLsbLibLgLsbsbsbsbsbLgbL
ibLhLsbLcbRcbRcbLgbRsRsRsmmbRgbRcbLibRibRiRsmbLgbLjbRcbLgbRcRsmbRgbRsb
LgbRcLsbRsbLsbRibLjbLiRsbLhbRibRjbRgRsmbRibLjLsmbRgbLhLsbLibRhbRibRgbR
ibRgbRgRsmbRsRsmbRsRsRsmmbRgbRgRsmbLsbRgRsmbRgbLsRibLsRsbRiLsbLjRsbRiL
sbRjLsbLjbLjbLibRsbRsbsbLsbLsbLhbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 105106; End: 105607;
Recording: 7-1; Individual: 48; Drug: Control
bLgLsbLgbLsbLibRjbRsbRcbRhbLhbLiLsbLgbLsbLgbLiRsRsRgRsmmbRsbRibRcbLgLs
bLibRcRsmbLobLcRsbRgbRcbLcbLibLgbRgbLibLjLsmbLiRsbLcbRibLibLsLibLibLgb
LgbRjbLgbLgLsbLgbsbsbLgbLsbLgbLsLsmbLiLsbRsbLibLhbLibRebLgbLjbLiRsbRcb
RgRsmbRgbRsbLsRcbLcbRoLsbRcbRiRsmbRibRebLebRcLsbLiLsbRcbLhbLcbLsbLibLg
bLsbRcbRcbsbRgbLgbRcbRhbRiRsmbRcbRhbRcbRebRjbRibLibLhbLcbLcbLcbLobLibR
gbRibRhbLibLebLiLsbLgbLgLsbLgLsbLgbLgLsbLgbLgLsbLgbLsLsmbLiLsLsmbRsLsb
RgbLcbRiLsbLcbRibLiLsbLibLibsbLibsbLcbLhbsbLgbLibLgLsbLgbRgbLibLgbRsLs
bLgbLsbLgLsbLgbRcbLibLibRcRsmbRobLibsbRcRsmbLsbRibLsbLibLibRibRobLebLh
bRjbRcbRibLcbLcbLcbRcbLobLcbsbLcbLcbLsbRjbLsbLcbRebLjLgLsbRgbRjbRobRcR
smbLjbRhRsmbLgbsbRcbRcbLibRgbRgbRcRsmbLcbLobRgbLgbLgbLiRsbRcbRibRcLsbL
iLsbRsbRibRgbRoLsbLgbRsbRsbRcbRiLsbRsbLsbRsbLibLibLsbLgbLiRsRsmbLcbLcb
LgbLibRsLibLgbRgbLgbLsbLgbLgbLgLsbLgbLgbRsbLibLgbLiRsbLcRsbRibRobLgbRo
bsbLjbLsRhLsRsbRibLibLjbLhRsbRibRhbRobRsbRgbLsLsmbRhRsmbRibLjbRcbLcbRc
bRsbRcbRhbRgLsbLibRibRsbLiRsbLgbLgbLgbRcbRcLsbLgLsbRgbRiLsRsbLsbRgbRsb
Rcb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 1; Drug: PCAP2 10 然
bsbLsbLsRsbLhbLcLsmbRcbRiRsmbRcRsRsmmbRibsbRsLsbRibRsbRsbRsbLsbsbRsbRg
bRibLsRsbLoLsmbRsRgbRsRsmbRsbRgRsmbRgbRsbRsbLsLsmbLoRsRsRgRgmbLebLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 2; Drug: PCAP2 10 然
bLsbRjbLjbLjbRjbLjbRsbRebLobRjbRjbLsbRgbRsbRjbRsbRsbRjbRsbRjbLjbLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 3; Drug: PCAP2 10 然
bLgbRgRsmbRgbRsRgRsmbRsbLsbLsLsmbRsbLcLsmbRgRsmbRebRhRsRsmmbRgRsRsmmbL
sbRcbRcbRsbRgbRsbLsbRgRsRsmmbLcLsRsmbLsRsbsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 4; Drug: PCAP2 10 然
bLsbLsbRsRsLsmbRsbRsbLsLsmbLoRebRsbLsbLsRsRsmbRsLsRsbsbRsbRsbRgbRgLsbR
obLsbLsbsbLsbLsLsmbLsbLsbRsLsbRsLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 5; Drug: PCAP2 10 然
bRgbRsRsmbRgbRsbRgbsbLibLsLsmbLsLsmbLsLsLsmmbRsbLebRsLsbLsbLjRsbLsbsbL
sbsbRsbsbsbsbRgRsmbLsLsLsRsmmbRsbRcbRiLgbsbLiLgbLibRibLsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 6; Drug: PCAP2 10 然
bLcbLoLgbRsRsmbRcLiLsbLgLsbLsLsmbLhbLebRjbRobsbsbRiRsmbLcbRcbRgbReLjbL
iLsbRgbRoLsbsbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 7; Drug: PCAP2 3 然
bLsbLsLsmbLsbRsRsmbRsLsbLsbRsRsLsmbLsbsbsbsbLsbRsbRsLsbsbRgbLsbLebRobR
jbRsbLobsbsbsbsbLsLsmbLsbLjLobLsbLsbRsbLjbLobsbLsbRsbsbsbsbsbLgbRsbLsL
sRsmbLsbLsbsbRgRsmbLsbLsbLsbRsbRsRsmbLsbRsLsbLsbRsbLsRsbLsbLsbLsbLsbLs
LsmbRgLsbLhbsbsbLsLsmbLgLsbRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 8; Drug: PCAP2 3 然
bLgbRibRgRgbRgbRgRsmbRibRgbRsbRsbRgbLsLsmbLjbLibLibLgbsbLibRobRsbsbLsb
sbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 9; Drug: PCAP2 3 然
bRobLebLjbRobRebRgbLebRjbLobRebRjbLibRjbLobLobRobLibRobLsbRsbRsbRcbRob
RebLobRcbLobRsbLjbLobLobLebLjbRebLobLobRobRobRobLgbLobRebLjbLsbRgbLobL
jbLjbLcbRobLebRcbRebRobRhbLebLobRobRcbLebRobLobLcbLebLobRcbRebRobLobRi
bRcbRobLgbRobRobRobRobRjbLgbRobRebLcbLobRibRobLobLobRebLcbRebLebRebLob
LobLobLobLobRibRebLobLebLobLjbLobLcbRsbRcbLcbRsbRobRsbRobRobLobRobLjbR
cbRjbLobRhbLobLcbRobRebRjbLobRjbRcbRebRebLsbRjbLcbLobLobLibRobRobRobRo
bRobLobLobRobRjbLebRobRsbRobLcbRebLobLebRobRcbLebRebRibLcbLsbRjbLgbLeb
RobRcbLobRcbLobLobLebLsbLebLebRobLebRcbLcbLsbRsbRibRcbRjbLgbRjbRebRcbL
obLgbRobLjbRsbLobRebLobLobLcbLobLobRcbLobRcbRjbRobRcbRibLobRobRebLobLc
bRebLebRobRibLgbLobRobLobRebLobLebLibLibRcbRobRobLobRobLobRobLobLcbLeb
RhbRobRcbLsbRsbLebLobLebLobLobRobLobRcbRobLcbLobLebRibLcbLobRobLobLobR
ebLebRcbLsbLobRobLobLebRibLibRcbLobRobLobRjbLjbRobLobLobRobRobRibLcbRi
bRcbLobLobLgbLibRsbLobLobLibRibLsbLebRsbRobRebLibLebRobRcbLgbRibLcbRib
RhbLcbRcbRgbRebLobLebRobRcbRcbLobRobLebLobRsbRsbRebRebRebRebLobLobRobL
obRibRcbLsbRobRobRcbRobRebLgbRobLcbLcbRebLcbLobRcbLcbRcbLebLsbRebRobLg
bLebRebLebRobRobRsbLebRcbLebRebLobRgbRebRebRobLobRobRhbRobLobLsbRibLob
LcbLobRibLjbRgbLsbLgbLebLjbLibLebLcbLobRebLcbLcbRebLebLebLibLobLgbRebL
obLobRebLcbRgbRobLebRebRebLobRhbLebLsbLsbLcbRcbRebLobLobLgbRsbLobRgbRo
bRcbRebRsbRhbLobLgbRebLobRebLibRebRebLgbLobRobRcbRcbLobLobRobLibRobLib
LibRobLobLebLobRgbLebLobRhbRgbLsbLebRobLobLjbRebLhbRcbRibLobRgbRcbLobR
ebRobLobRjbLcbRebRgbRsbRcbLobRcbLobRobLebLobLsbLebRgbRobRgbRobRobRcbRg
bLsbRobLobRobRobRobLebLobLgbRobLebRsbRibLcbLobRobRcbLgbRhbRibLebRebRob
LobLcbLobRcbLobLcbRobRobLobRobRcbRsbLobLobRobRebLcbLcbLcbRjbLgbLcbRebR
obLcbLcbLebLibLgbRebRobLobRobRobLebLobRobLobRcbLsbRcbRobLebRobRibRebLi
bRobRebRobLebRibLcbLcbRgbRobRcbLebRobLobRobLcbLsbLobLobRobLibLibRebLob
LobRcbLibLobRibLcbLebLebRcbRibLobRhbLebRcbRebLobRebRobRcbRcbLhbLibLcbR
ebRobLobRebLcbRcbLobLobRobRcbLebLebRgbLibRebRobLjbLobRebLobRobRobLebLo
bRobLebLebLcbLebRsbRebLibRobLcbLcbLobLobLobRgbLobRibRebLibRcbLgbLebRcb
LebLobRebRcbLobRjbLcbLebRobLobLobLobRobRobRibRobLsbRobLebLgbLcbLobLhbR
ibLobLebRobLebRobLgbLobLibLcbRobLobLcbLibRcbRobLcbRsbRsbLibLgbLobLjbRo
bLebLgbRgbLhbLobRobRibRgbRobLobLibRebRcbRobRebLobRhbRcbLobRebRobLibLsb
RobRobLebLcbRsbRibLobRobLsbRobRobRobLobLsbRobRgbLhbRgbRibRebRcbLgbLobL
ebLibRobRobLobLsbLobRobRcbRibRgbRebRcbRobRobLebRebRibRobRebRgbLgbRcbLc
bRebLebRobLobLgbLobLobRobRebRobLebRcbLobRebRobRcbLjbRsbLcbRcbLgbRebRcb
LobRobLobLobRebLgbLcbRgbRibRhbLcbRgbRjbLcbRobRibLcbRobRebLgbLebLobLcbR
obLcbLobRebLibRcbRobLcbLobLcbRgbLcbLcbRcbRcbRgbRobRibLhbRgbRgbRcbLibRo
bRcbRebRobRcbLobLcbRgbLgbRobLcbLebLobLobRebLebLebRgbRobRcbRcbRobRobReb
LibRcbLebLobRebRcbRebRobLhbLobLobLhbLobRebLsbLobRebLobRobLobRcbRcbRibR
obRebLobLebRobRgbRcbLcbLobRebRebLibRobLobRobLobRebRcbRcbLobRcbRobLobLo
bLobRobLebRob

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 10; Drug: PCAP2 3 然
bRgbsbRoRsmbsbsbRsbRcbRsbLsbsbLiLsbLsLsmbRsbRgbLsbLsLsmbRsbLebLsRsLsbR
obsbRiLsbRcRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 11; Drug: PCAP2 3 然
bRsbLsbsbLgbRsbLsRsRsmbLgbRibRsbRsRsmbLsbRsbRsbLgbLsbRobRibLsRsbLsbLgb
LsbRgbRibRgbsbRiRsRsmmbRsbRsbRsRsmbRibRgbRsbRsRsmbRibRsbRsbRsbRsbRsbLs
bsbRgRsmbRsbRsRsmbRsbRsbRsbLsbLgbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 12; Drug: PCAP2 3 然
bsbsbRibRsbLhbLsbLibLsbLsbLsLsRsmbsbRebsbLobLjbLibRgbsbsbLsLsmbLsbLgbL
sLsmbRsbLsbRsRsmbRcbsbsbsbRcbRsbLsbLsRsbLgbLgbLcLsmbsbLgbLsbRsbLeLsbLe
bLgbLsbRcbLgLsbLibLjbLibRsbLsRsbLsbLsRsbLcLsmbLsLsmbRcRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 13; Drug: PCAP2 1 然
bLiLsbRsRsmbLibLsbLgbLgbLibLsbRgbLiLsbLibLebRibLcbRsbsbLiLsbsbsbRgbLib
LsbRsbLgbLibLsbRsLsbLgLsbRsbRsbLgLsbLgbLsLsLimbLibLgbLgbLgbLgbLgbLhbRi
bRibRobRgbLsbLeRsLiLsbLgbRcbRibRsbLoLsmbRsbLibLsbsbRsRsmbLibRiRsmbRsbL
sbRibRgRsmbRgbLgbRibRgRsmbRgbsbRsbRjbRsbRsLsbRgbRsRsLsLsmmbRibRsRsmbsb
LsbsbRsbRsbRibRsbRgLsbRcbRgRsmbRgbLsbRjRgbRsRgRsRsRsmmmbsbLsbRibRcRsmb
RsRgbRsbLsbsbRibRcbRsRsmbRsbRiRsmbLibLsRsbRibRibsbRibLgbRcbLgbRsRcLsbR
gRsmbRsbRsbRgRsRsmmbRsbRgbsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 14; Drug: PCAP2 1 然
bLibLgbLjbRobRhRsmbRgRsRsmmbRsbRsbRsRsmbRsbsbRsbRjRsRsmmbLsbsbRsbRhbRg
bLibLsLsmbsbRibRsbLsbRgbRcbLgbRgRsmbRsbRsbRgbRgbRibRgRsmbLsLsmbRgbRgbR
sbRsbRgbRibRsbRsbsbRgRsmbsbRgbRibRiRsmbRgbRibRsbsbRsbRgbRgbRcLsbRsRsLs
mbRsbLjbLsbRgbRiRsmbsbLgLsbRibLgbRibRgbRsbRsbLsbRibRgbRgbRjRsmbRsbRsbL
gbLsbLsLsmbsbRhbRibRsRsmbRsbLgbRgbRibRgRsmbLsRsbRsRsmbRibsbRsbRsbRsbRs
bRsbRgbRgbRgLsbRgbRgbLgLsbRsbRgbRgbRsbRiRsmbRibRgbLgLsbRsRsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 15; Drug: PCAP2 1 然
bRcbRibLgbRibRgRsRsmmbLjbRibLsbRgbRgbLsbRsbRibsbLgbRgbRgbRgbRsbRsbLsbL
gRsbRgbRgRsRsmmbLsRsbLsbRibRgbRiRsmbRgbRgbRgRsRsmmbRgbRgbRsRsmbLsbLjbR
cbLsbRcbLgbRhbRgbRgbRgbRibLgbLgbLcbRgRsmbRobRibLhbLhbLibRjbLcbLebRiRsm
bLhbLsbRhbRgbLibLhbRjRsmbLhbLgRsLsbLgbRgbLcLsmbLgRsbRgbRibRhRsmbLcbLib
RsLsbRsRsmbRjbRcLsbRsLsbRsbRsbRibsbRsRgbRgLsbRsRsmbRsRsmbRebRiRsmbsbRg
RsmbRibRibLibRsbRcbLsRsRsmbRibRgLsbRhbLcbLibLsbLjLsLsmmbLsbRsRgbsbLgLs
bLjLgLsLsmbRjRsRsmmbLiLsbRsbRibsbLsbLiLsbLsbLiRsbRsbLsRsRsmbLebsbRsbRs
bLgbRsbLiLsbLsRsLsbLsLsLsLsmmmbRsbLibRjbLcbLibLsbLsLsLsmmbLsbLibLsLsmb
LibLgbLebRsbRgRsmbRgRsmbRibRsbRgbRsRsmbLsbRgbRsbRsbLsLsmbRhbLgbsbRibRg
bRsRsmbLsLsmbsbLsbLsLsmbRgbRibRsbLsbLsLsmbLsRsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 16; Drug: PCAP2 1 然
bRsbRsRsRsRsmmmbRsRsmbRsRsmbRsbRsbRsRsRsmmbRsRsmbLsbRgRsmbLsbRsbsbLsbL
sbRsRsmbRgRsmbLsbRgbLsRsbRgbRgbRgRsmbRgbRgRsmbRsbRcRobLsbLgbRebRiRsmbL
sbRgbRgbLsbLsbRsbRsRsmbRsbRgbLsbRgbLebRobLcbLiLsbRsbRsRsmbRsbRcbLsbLsR
sbRsLsbLsLsmbLsbRcRsLsmbRcbRebRibRibRsbLibLjbLsbRibLeLsbLcbLibLibLiLsb
LsbLsbRsbLsbLsbLgbRcbLsbRsbsbRgbLsbRebRgbRsbRibLibRgbLebLgbLsbRgbReRsR
smmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 17; Drug: PCAP2 1 然
bRsbLhLsLsmbLsbLsbLsbRsRsmbLgLsbRgbLsbLsLsmbLgbLsLsmbLgbRsbRjLsbLibLsL
smbLiLsbRsbRgbLgbLgbLsLsmbLsLgLsLsmbLsbLgLsLsLsLsmmmbsbLibLsbRsbLsLsLs
LsmmmbsbLibRsbLsbLgbLsbRsbLibLgbLsbLsbLsLsmbRsbLibRgbLibLgbLsbRsbLsLsL
sLsmmmbRsbLgLsbLgbRsbLgbLsLsmbLgbRsbsbRgRsmbLibRsbRsbLibLsLsmbLgLsLebL
gLsbLhbLsLsmbRcbsbLcbLsLsmbRsbsbRsbRsbRibRibLsbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 18; Drug: PCAP2 1 然
bLsLsmbLgLsbRsbRsbsbRibRcbsbRsbRgbRsLsbLsLsLsmmbRhbRsbRiLsbsbLjbLjbLsL
sRsmbsbRsLsRsLsRsRsLsmbRsbsbLibLgbsbRsLsbRgRsmbLsbRcbLjbLjLsmbsbLsbLgL
sbLgbRgbLgLgLsbLsbLeLsbsbRgRsmbRcRsmbRiLsbLsbLsbLsLsmbRebRibLibLsbRsbL
gbRjbRsbLibRcbLcbLibsbLgbLcbRjbRcbLebLcLsLsmmbLsbLibLsbsbLgLsLsmbLsLsm
bLsbLebLsLsmbRebRcbRibLibRibRsbRgbRsbRsRsmbLsbRgLsRsbLjbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 19; Drug: Control
bRibRsbRsbLsbLgbRgbRibRibRibLsbLjbLhbLibRsbLsLsmbReLsbRibLjbRobRibRsbL
ibRgbLgbRibRsbRsLsbsbRsbLsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 20; Drug: Control
bLgbLgbLsLgbLsbLgLsbRsbLgbLgbLgbLsbLgbLsbLsbLsbLsbLgbLgbLgbLsRsRsmbLib
RibLsLgLsbsbRsbLgbLsbRsRsmbRcbRebRsbLsbRgbRsbRgbLjbRibRsbRsLsbRsbsbRsR
smbLsLsmbRsbRsbRgRsmbRgbRsbRgbRgbRgLsbsbLcbLcbRibLibLgbLiLsRgRsRsmmbLj
bLibRobLiLsbLobLgLsbRsbRgbLobRgbLcbLgbLibLgbsbLjLsmbLibLsbLsbLgbLgbLsb
LibRsbRsbLibLibRgbLgbLsbLgbLsbLsbLiLsbRgRsmbLgRsbLsbLgbLsbLjbLsbRgLsbL
sbRsbLiLsbRsbLgbLgbLsLsmbLsRsbLsLsmbLgbLgbLiLsbRsbLgbLsbLgbLgbLgbRjbLi
RsbLsbLsbLsbLsbLibLgbLgbLsbLsbLgRsbRsLsRsbLgbLsbsbRebLibLsbLgbLgbLsLsm
bLsbLgLsbLgbLgbLgbLjbLsbLgbLgbRsbRebLebLhLsbLgbRibLgbLjbRsbLsbLgbLsbLg
bLgbLsbLgbLsbLgbLsbLgLsbLgbLsbLsbLgLsbRsbLsLsmbLgbLgbLgLsbLgbLgbLgbRsb
LgLsLsmbLsbLgbLgbLsbLgbLsLsmbLgLsbRcLsbLsbRcLsRsRsmbLebLibRsRsLsmbLibR
ibLgbsbLibLgbLsLsmbLgbLgbRsbLibLgbLsbLsbRsbLibLsLsLsmmbsbRsRgbLsbRsbRj
bLiRsbLobLgbLibsbLoLsmbRgbLgbLsbLibRebLibLoLsmbRcbRoRsmbLibLebsbLcLsmb
RsRsRsmmbRgbLsLsmbLcbsbLsbRsbRgbRobRibRgRsmbRebRiRsmbRgbRibLjbRcbRsbLh
bLibRibRiLsbRcbLibRsRsmbLjbRhbRobLcLsmbRgbLobRsbRibLobRibRibLsRsbsbLcL
smbRsLsbLsRsbRjLsbRobLsLsRsmbRcRsmbRiLsbRiRsmbRgRsLsmbLsbLsRsbRebRsbRh
bRibsbLibLoRsbRsbRgbRjbRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 21; Drug: Control
bRgbRgRsLsmbLsbRgbRjbsbLgRsbLjbRgbRjRsRsmmbRhRsmbRsbRjbRgbLibLgLsbRhbR
cRsmbRiRsmbRibRsbRsRsmbLsbRcbsbRsRsmbsbLsLsmbRibRibLgbRhbRibRgbRgbRjRs
mbLibLgbRsbRsbRjRsmbLjLsmbRgbLsbRibRjbRibLgbLsbRibLsRsbsbRjRsmbRsbRgbs
bsbRgRsRsmmbRgRsmbLjbLsbRgRsLsmbLoLsmbLsbRsRsRsmmbRgRsLsmbLobLsbRgbRsb
RjbRcRsmbLjRsbLgbRsRgbRgbRibRgRsmbsbRibsbsbsbRgRsmbRgbLgLsbLsbLcbRsbLi
bsbLsbRgRsmbLibsbLsLsmbLgbRgbRgbLhLsbRsbRgRsmbRebRibRiLsbRsbLgLsbLsbLs
LsmbLsbRjbRgRsRsmmbRgRsmbsbRhbRgbLsbRibRgbLsLsmbRgRsmbLsbRsbRgbLsLsmbR
hbRsbsbRgRsmbRsRsmbLsbsbRgRsmbsbRibRgbRjRsmbRibLsbLsLsmbLsLsmbLsbRcRsm
bRibRgbsbsbRibLgbsbsbRhbRiRsmbLsRsbLsRsbRsRsmbsbsbsbRgbRibsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 22; Drug: Control
bRgbRsbRsLsbRgRsmbLsbsbLibLobLsLsmbLsbLgbRgbLibRgRsmbRjRsmbsbRjRgbLgLs
bLsLsmbRibLgbsbLsLgLsbRiRsmbRgbRgbRjRsRsRsmmmbRsbRgbRibLibLoLsRsLsmbLs
LsmbRgbRsbRsRsRsmmbLgLsbLgbsbRgbLjLsLsmmbRjRsRsmmbRgRsmbLjLsmbLibRibsb
RjRsmbLibLsLsmbRgbRibLibRgbsbRjRsmbLibRgbLgbRsbLibRgRsmbLsbLgbLgbLgLsb
RjbRibRoLsLsmbLgLsbLjLgbLsbRjRgbRibRhbRiRsmbsbLjbLoLsLhRsmbRgbRibLcRsb
sbsbRcbRcLsbRgRsmbLoLsmbRjRsmbRibLibLiLsbRjRsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 23; Drug: Control
bRgbRgbLsLsmbLsbLjLgbLcbsbRgbRsbLibLibsbLibsbRibRsbLiLsbRibLhbLibRsbsb
LsbLgbLgLsbLsbRsLsbsbLgbLiLsbLsbLgbsbLgbLgbLsbRsbLgbLibRcbRgRsmbLobRjb
LibLiRsbRjRcRsmbRibLcRsbLiLsbLcRsbRibRibLcLsmbLgbLibRsbLgbLsbLgbLibLcb
LibLibLgbRibLibRsRsmbRjbRsbLjbLibRsbLgbLsbLgLsbLgbLsbLgbLgbLgbsbRgbReb
RsLsbRgbsbRsRcLsbsbLgbLsbLjbLibLsbRgbLibLsbsbLoRsbRsbRgbRsbRgbLsbRgbRs
LsbRsLsbRsbRibRsbLsbsbRibRibLiLsbRibRibRsbLgbRibLsRsbRibRgbRsbRsbRsLsb
RsbRsbRsbsbsbRibsbRibRsbRgbRsRsRsmmbLsRsRsmbRhbRgbRsLsbRsbRsbLgLsbRcbR
ibRibRibRsbLsbRibRiRsmbRsbLsbRsbLibRsbLibRibRhbRobLsbRibLgbRibLsbLsRsb
sbRsbRiRsmbsbRsRsmbRsbRgbLsbsbRgbRibsbLgRsbRibRsbRhLsbRgLsbsbLibLcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 24; Drug: Control
bRcbRiRsRsmmbLsbLcbRjRsmbLiLsbRsRsmbRsRsmbLjbLgbRiLsbLcbsbRhbLibRibLib
LcbRhbLgbLoRsbRgbRsbRibRcbLgbRibRibLgbLsbRgRsmbRgbRsRsmbLjbLhbRebRsLib
RsLgbRsbRjbLjbLcbRsbRsbLcLgRsbLibRiRsmbRobLibRhbRibRcbRiRsmbRibLgbLgbR
cbRibLsbLibRibRibLsLgbRgLsbRsbsbRibsbRsbLsbRiRsmbRsbRsbLjbLgbsbLgbLsbR
gbsbLgbLhbLibLibLsbRjbRibLjbRcRsmbLsbsbRsbRsbRcbLsbLibLibLcbLibRgbLgbR
sbLgbRhbLcbRhbLgbLsbRibRibRibLsbRgbRsbRsbRgbRsbRgbRsbLgLsbLibLcbRiRsmb
sbLhbRjbRhbLibsbLcbLgbLgbRjbRcLsbLgbRhbLgbLsbRibsbLgbRsbRhbsbLgbRibsbR
sbRsLsbRsbLsLsmbRsLsbRgbRoRsRsLsmmbLcbReRsmbRebRsbRibLiLsbLgbsbsbLibRg
bsbRsbRcLsLsLsmmbLibLibLsbsbsbsbLibLsbRcbsbsbRcbRibRsRsmbRsbLcbLsbRsLs
bLiLsbRjRgbRhbRhbRgbLsbRibsbRgbRiRsRsmmbLibLhbLgbRcbRcRsmbLhLsbLibsbRi
bRibsbRsbLsbLgbRibLsbRgbRsbLjRsbRgbRobReRsmbRgbRgbLsbRsbRsbRgbRsbRgbRs
RsmbRsRsmbRsbRibRsbRsbRsbRgbRgbRgRsmbRgbRsRsRgmbRsbRgbRgbRsRsmbLibRjbR
sbRiRsmbRgbRsLsbLsbRsRsmbLsbRsbRsbRibLibLhbRjRgbsbRcbsbLgbRgbRgbRibRgb
RsbRsbRibRsbRsbRsbRgbRgbLgbsbRgRsmbRsbRgbRgbRgbLsbRgbRsbRgbRsbRsbRgbRs
bRsbRgbRgbRsbRsbRsbRgbRgbRgbRgbRgbRgbRsbRsbRsbLsbRsLsbLgbRgbRgRsmbRgbR
sbRsRsmbRsRsmbRsbRgbRsRsRsmmbRgbLgbsbRibRibLgbRgLsbRsbRgbRsbRsbRgbRgbR
gbRsbRsbRgbLsbsbRsbRsbRgbRgRsmbRiRsRsmmbRsbRgbRgbRgbRsRsmbRgRsmbRsbRgb
RgbRgbRgbRgbsbsbRgbRgbRgbRgbRsbRgbRgbRsRsmbRsbRsbRsbRgbRgbRgbRgbRgbRgb
RgbRsbLgbRiLsbLhbLibsbRjbLibLsbRjbLhbLgbsbLgbLiRsbRjbRcbRibLgLsbRibRsL
sbRcRsmbLsLsmbRcbRiRsRsmmbLgbLcbRibRibRibLibRcbLobLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 25; Drug: PCAP2 10 然
bRsbsbRsbRebsbLgbsbRsRsmbRgbRhRsRsmmbRebLiLsbLsbsbLsbsbLsLsmbRsbRebRsb
LsbLsbRsbRebLsbRsbsbLsbRsRsmbRgRsmbRsbRsbLgbRgbRgbRsRsmbLsbLsbRsRsmbLs
LsmbLsbLsbLsbRsbRsbRsbRiRsmbRebLsbLsbLsbsbRcbsbsbRsbRgbsbRgRsmbReRsRsm
mbRibRibRibLsbRsbReRsmbReRsmbRcLsbRgbsbRcbRgRsmbRgRsLsmbRgbRsRsLsmbsbL
sbRsbRsbRcbLsbsbLsRsbLsbRjbLibsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 26; Drug: PCAP2 10 然
bRcbLgbLsRsbRsLsRsbReLsbsbRsbLsbLsbLsbsbLsbRsbLgbLsbRsLsLsmbsbsbRsLsbR
sbLsLsmbLsbRsbRsbLsbRsbRgLsbRsRjbRgRsmbRhbRcbLsRsbLjbRgbRibLsLsmbLsbRe
RsLsmbRsbRgbLsbRibRoRsRsmmbReRsmbsbRgbRsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 27; Drug: PCAP2 10 然
bRibLgLsLsmbLsbRsbLsLsRsmbLgLsbLgLsLsmbLsRsbsbLgbLiLgLsbLiLsLsmbRsLsbR
sRsmbLsbRsLsbRsbRsbLcLsmbRsbLhLsbsbLcbRsbLcLsmbLjLsmbLsRsRsmbLsbLsbLjL
gLsbLjLsLgLsmbLsbsbLoLsmbRsbRsbRsbRsLsbRsbLsRsRsmbRsRsRsmmbRsbRsRsmbRs
bLsRsRsmbLjLjbLibLibLibLsbRsLsbLgbLgRsbLsbLsLsmbLcbRsbRsbRobLjLsLsmmbL
gbRsbLibLgbLgLsbLsRsLsbLibsbLibLcbRsRsmbRsRsRsmmbLebLsLsmbRsbsbRsbLhbL
iLsbLcbRsbRsRsmbLsbsbRsbLsbLsbLebLsbLsbLhbLsbLibRsbLibRgbRgRsmbLsLsLsL
smmmbsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 28; Drug: PCAP2 10 然
bsbLsLsmbLsbRibLsbRsbLgbLibLsbsbLsbRsbLsbLgRsRsLsmbLsLsmbLsbLcLsmbLcLs
mbLgbLgbRsRsmbLsbRsbLcbLsLsmbLhbLiLsbLgbLsbLsbRgRsmbReRsmbLsLsmbLhbLgb
LsLsmbLoLsmbRsbRgbLhLsbLsLsmbLcLsLsmmbLcbLsLsmbRgRsmbRsbRsbRobRhbRgRsm
bRsRsRsRsmmmbRsbsbRgRibRsRgbRsRsmbRsbRsbRsbRgRsmbRsRsLsRsRsRsLsmmmbLsb
RcRgLsbLcbRsbRsbLsLsmbLsRsbLhbLcbsbRibRsbRsbRgRsRsmmbRgbsbsbsbLsLsmbRs
bRsbsbRsbRgRsRsmmbLoLsmbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 29; Drug: PCAP2 10 然
bRgRgbLibRsbRiRsmbRsRsmbsbRsbsbRsRsmbLsbLsbsbRsbLsbsbsbLsbLsbsbRsbsbsb
sbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbRsbLsbRsbLsbRsbsbRsbRsbLsbLsbsbRsLsbLsb
sbLsbsbsbsbsbsbsbLsbLsLsmbsbsbsbLsRsbLsbsbsbLsbsbsbsbsbLsbsbsbsbLsbsbs
bsbRsbsbsbLsbsbsbsbRsbsbsbLsbLsbsbLsbsbLsRsbRsbRsbsbRsbsbRsbLsRsbLsbRs
bsbLsbRsLsbsbLsbLsbRsbRsRsmbRsbsbsbsbLsbsbLsbsbsbsbsbsbsbsbsbsbsbsbLsb
sbLsbRsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 30; Drug: PCAP2 10 然
bLebLsbsbsbsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 31; Drug: PCAP2 3 然
bRsRsRsmmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 32; Drug: PCAP2 3 然
bRcbLgbRhbLsLsLsmmbLsbLsbLsbsbRibRsbRsbsbRsbRsbsbsbsbLsbLsLsRsmbsbLsRs
b

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 33; Drug: PCAP2 3 然
bsbLgbLcbRsbRgbLhRsLsLsmbRsbLebLgbLgbRsbLsbRobRcbsbRibRcbRgbRsbRiRsmbs
bRsLsRgRsRsmmbRgbRiRsLsRsmbLsbLsbsbRgbRiRsmbRsLsbRsbRgbRhLibLcbRgbLhRc
bLjbLobLsbRcbLsLsmbRgbLebLibRsbLsbLsbRcbRcbRgbRoRsmbRibsbRgbLsbRcbRcbR
sbLibRsbRsRsmbRsbLsLsmbLsLsLsmmbLsbReLsLsLsmmbLsbsbRibLebRjbRibRibRobR
ibLsbsbLiLsbLiRsbLsLsmbLcbLgbRsbRgbRibRibLsLsmbRgLsRsbRsbRsbLsbLsbRgbR
sbRcLsbLebsbLgbLcbLsLgbLsLsmbLsbLjLgbRgbLgbRgRsmbLebLgLsbLsLsLsmmbsbRg
bLsbLsbLjLgLsbLiLsbLiLgbLgLsLsmbRcbLcbLcbLibLibRgLsbRsbsbsbsbLcbLgLsbL
sLsLsmmbLsLsLsmmbRgbRjRsRsRsmmmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 34; Drug: PCAP2 3 然
bRsbLsbLiRsbLsbLsbRoLsbLgbReLsbRsbLsLsmbRsbRebLcbLiLsbLsbRcbLjLsLsmmbL
sbLsbRcbLsbRgbLsRsbRsbRsbLsRsbRsRsmbRcbRiRsRsmmbRsRsmbRibRsRsmbsbLgbsb
RsbRsRsmbRiLsLsmbLsbRiRsmbRsbLsLebRsbsbLibLcbLiLsbsbLsbRsbRcbRsRsmbRgb
RgbRsbRgbRgRsmbLsbRsbRsbReRsmbRcbRcRsmbRsbRcRsRsRsmmmbRhRsmbLgbRgbRsbR
sbsbRgbRsRsmbRsbsbsbsbLsLsmbRsbRsbRsbRsbRsRsmbRsbLgbRsbsbLjbRsbsbLsRsb
RsbsbsbsbsbRsbLsbsbRsbRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 35; Drug: PCAP2 3 然
bRgbRsbRsbRiRsmbRgbRebLsbRgRsmbRsbRsRsmbsbRgbLgbLgLgbLsbRsbRibRcbRsRsm
bRsRsmbRsRsmbRgRsmbRsbRsRsmbRibRibRgRsmbRsRsRsmmbLgLsbsbRiRsmbRsRsRsRs
mmmbRsRsRsmmbRsRsmbRsbRgLsbRgbRgLsbRjRsmbLsbLibLsLsLsmmbRgRsmbRgRgbRsR
sRsmmbLsbRgbRsRsmbsbLibsbRhbRsbRsbRsbRiRsmbLsbLsbRgbsbRhRsmbLsLsmbLsLs
mbRgRsRsmmbRsRsmbRsbRsRsmbLsRsRsmbRsbsbRgRsmbRsbLsbRsbLsbLsLsmbLsRsbsb
LjbsbsbLsbLgbRgRsmbRsbRsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 36; Drug: PCAP2 3 然
bRgbLsLsLsmmbLsLsmbLgbRsbRsRsmbsbsbsbsbsbRsbLsbsbsbsbRsbsbsbLsbLsRsbLs
bsbLjbLsbLjbRsbLsbLsbRcRsmbRsbRsbRsbRgbRsbLsRsbLsbRsbRsLsbRsbLsRsRsmbR
sRsmbRsbRsbLsbRsLsbRsbLsbLsRsbRgbRsbRsbRsbLsRsbRsbsbsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 37; Drug: PCAP2 1 然
bRjbsbRsbsbRsRsmbLsLsLsmmbRgbRsRsmbRibLsLsmbRgRsmbLgRsbRgbLsbRibsbRgbs
bLsRsbRgRsmbRibsbRgLsbLcbLjLsLsmmbRjbRcbRsRsmbRjbRsRsRsRsmmmbLsbLsLsLs
mmbLiLsbLibLsRsbRsRsmbsbLjLsmbLjbLsLsmbRsbRibLobsbRsbLiRsbLgLsbLsLsmbR
gbRsbLsLsLsmmbLsLsLsmmbLibRsRsRsmmbsbLjLsmbLibLiLsLsLsmmbLiRsbLsbRjRsm
bLiLsbsbsbLgbLgbRsbLjLsmbLgLsbRgbLjLgLsLsmbLsbLgLsbLsbLsLsmbLsLsmbRsRs
mbLgLsbLsLsmbRsRsmbsbLibLsbLsLsRjLcmbLgbsbLgbLsLsRsmbLsbRsLsbLsLsLsmmb
LsLsLsmmbLsbLsbLibsbLgLsLsmbRgLsbLibLgLsLsLsmmbRsbRgRsmbRobLgbRebsbRsR
sRsmmbRsRsRsRsmmmbRsbRiRsmbLgLsLsmbRiRsRsmmbLgbRibLsLsmbRibLsLsRsmbRsb
RibLsbRgRsmbRgbLsbRgbsbRsbRgRsmbsbRsRsRsRsRsmmmmbRsbRsbLsLsmbLjbLibLib
sbLhbLgLsbRgbLgLsLsmbLsbRgRsRsRsRsmmmmbsbLgLsbLsLsmbLhbRsRsmbsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 38; Drug: PCAP2 1 然
bsbRjRsmbLiLsbRcbRibRibLgbsbRsbRgbRibLsRsbRibLsbRsbRgbRgRsmbRgbLsbRgbR
gbLsbRgbRsbRgbRgbRsRsmbRgbRsRsmbRhLsRgRsmbLgbRibRgbLsbRgbRsbRgbRsbRsbR
gbRgbRgbRgbRsbRsbRgbRsbRgbRgLsbLsbRgbLsbRgbRgbRhbRcbRgbRibRgbLsbRibLsb
RgbLsbRgbRgbRsbRgRsmbRgbRgbRsRsmbRgbRgbLgbRiRsmbLsbRsRsmbsbRsRsmbRgbLs
bRgRsmbRsLsbRgbRsbLsRgbLjbRobRsbsbLsbsbRiRsmbRsbRgRsmbLgbRibLsbRibRgbR
gbRgRsmbLjbRibLjRsbRgbRgLsbRsbLibLibLibsbsbRcbLhbLibLsbRsbRsbLhbRsbLhL
sbLibRsbRibLcbLiLsbRibRsbRjbRibLcbLhbLcbLgbLsLsmbLsbLsbRcbRibLgRsLsbRi
bLsRsbRgRsmbRibLibRsLsbRibRgbLsbRsbRgbRgbRgbRgbRgbRsbLsbLsbRgbRsbRgRsm
bRgbLsRsbRgRsmbRgbLsLsmbRgbLsbRsbRgRsmbRgbRgbRgbLsRsbRgbsbRgbRsbRsbRgb
RgRsmbRgbRgbRgbRsRsmbRgbLsbRgbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbLcLsmbLibL
oRsRsmbLhLsbLgbRsRsmbRibLibLiLsbLibLcbReRsmbRgbLjbLibLibRjbLsbLibLsLib
RsRsmbLgLsbLibLibLsbRsbLsbLibRjbLibLhbRcbLibLcLsmbLcbLsbsbLibLsbRgbRiR
smbRibLgRsRsmbRgbRgbRgbsbRgRsmbRgRsmbLsbRgRsmbLsLsmbRsbRsRsmbRgbRsbRsL
sbRgbRcbRgbLgbLiLsbRjRsRsmmbLgLsbLibRibRcbRibRgbLsbLgbRibRgbsbRsbsbRgb
RgbRsRsmbRgbRgbRgLsbRsbRgLsbLgRsbRsLibRsRibRgRsmbsbRgbLcbLcbLhLsbRibRj
bRibRgbLjbLcbLcbRibLhbLiLsbRsbRhbRgbRhbLjbRibRgbRiLsbRibRsbRgbRibRgbLg
bRibsbRsbRibLgbLsbRsLsRsbLsRibRsRsmbLsbRibLsbsbLsRsLsbLsbRsRiLsbLgRsbR
iLsbRcRsmbRibRibLgbLcbLhbLgbRsbRgbRgbsbRiLsbRiLsbRcbRgbLibsbLsbRibRibR
ibRgbLjbRsbRiRsLsmbRgbRibLibRibRsbRgbRgbLgbRgbLsbRiRsRsmmbLsbRgbRibLib
RsbRibLcbLhbLcbLibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 39; Drug: PCAP2 1 然
bLsbLsbLgbLgLsbRsLsbLgbRsLsLsmbLibRsRsmbLgbRsbLgbLsLsmbLgbLsLsmbLgbLsL
smbLgbRsRsmbLgbLgbLgbLsLsmbLgbRsbRsRsmbsbRsbLsLgbLsLsmbLsbLgLsRsbLgbLg
bLgLsbLgbLsbLgRsbLsbLgbLgbRsRsLsmbLebLiLsbRjRgbRgbRcbLsLgbLibLibLsLsmb
LgbLgbLgbLibRsbRgbRcRsmbRcbLsbLibLibLsLsLsLsmmmbLibRgbLgLsbLiLsbsbRsLs
LsmbLgbLgbLgbLgbRsLsbLibsbRsRsLsLsmmbRsLsbLgbLibLsbsbRsLsbsbRsLsLiLsbR
sLsbLsLsmbLgLsLsLsmmbLgLsbLgLsbLgLsRsbLgLsbLgbsbRsbLsbRsLsbRsLsbLsRsbR
sbLgbLgbLgLsbLjRsbLgbRsLsbLgLsbLgLsbLgRsbLgLsbLgLsbLgbRsLsbsbsbLsbLgLs
bsbsbLsLsmbLsLsLsmmbLgRsLsbLobRhbRgRsmbRgbRgbRsRsmbRiRsmbLjLsmbRibLjbL
obRjRsmbLcbRsRsmbLibRsLsbRsbReLsbLcLsLsLsRsmmmbLibLsbRibsbLibsbRsbRsbL
gLsbLsbLgbLsbRsbLibRebRjRsmbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 40; Drug: PCAP2 1 然
bLiLsbsbLsbLibLgRgbRsRsLsmbLhbLibsbRgbRiRsmbRgbLsbRibRibRibRsbLsbLgbLg
bLgbLcLsLsmmbLgbLsbLiLsLsmbLibLibLibLsbsbLgbRgbLiRsbRsRgbLsbLsbsbLsbsb
sbsbLiLsbLgbsbLibLsbsbsbLgbLgbsbsbLibLcbLhLsbLibsbLibRsLsbLjbRhbRibLgL
sbLsLsmbsbRjRsRsmmbRgbRsLsbRgbsbRobRiRsmbRgbsbsbsbsbRiRsmbsbLhLsbLibRg
bRiRsmbRsbRsbLobRibsbsbsbRibLcbLsbRcbRsbRsbRgbRsRsmbLhbLhbLibLiLsbLibL
ibLsLsmbLibLhbLgbsbLsbRsbRiRsmbLibLgLsbLibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 41; Drug: PCAP2 1 然
bRibRiRsmbRgbsbLsLsmbsbLsbRgRsmbRcbRsbRsbLsLsmbRcbsbRsbRgbsbRsRsmbRsbR
sbRibRsbRsRsmbsbsbRgRsmbRsbsbRibRsbRsbRcbRsRsmbRgbRgRsRsmmbRsRsRsmmbsb
RsRsRsmmbRsRsmbRsbsbRgRsmbRsbsbsbRiRsmbRibRgbsbRcbsbRsRsRsmmbRsRsmbRgb
sbLsbRibRsbLgbRcbRsbsbRjRgbRsRsmbRsbsbsbRibRsbRsbsbRgbsbsbRsRsmbsbLsLs
mbsbRibRsRsmbRjRsmbRsbLgLsLsmbLgLgLsbLsLsmbRcbLsbLsLsLsmmbRcbsbRsbsbsb
RsbRibsbsbRibRgRsmbRsbsbRgbRsbsbRgbRsbRsbRsbRsbRsbRsRsmbLsbsbRsbsbRsbL
sLgbRhbRgbRiLsbsbRsRsRsmmbRibRsRsmbsbLibLgbLsbLobsbRgbsbLibLebLsbRsbRs
RsRsRsmmmbLgbLsLsLsLsmmmbLsbLsbRsRsmbsbLsbLgLsbLsbLgRsbLgLsbLsLgbLsLsm
bLsLsLsLsmmmbRjRsmbRibRhLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 42; Drug: PCAP2 1 然
bLgbLgbLsbLgbRhbLcbLsRsRsmbLgbLsbLsLsmbLgbLsbLgbLgLsbLsbLgRsbLgbLgbLgb
LsbLgbLsLsmbLgLsbLsLsmbLgbLgbLgbLgbLgbLgbLsbLgbLgLsbLgbLgbLgbLsbLgLsbL
sbLgbLibLgbLsLsmbLgbLsbRsbLibRsbLgLsbLgRsbLgbLgbLgLsbLgLsbLgLsbLgbLgbL
gbLsbLgLsbLsLsmbLgbLgbLgbLgbLibRgRsmbLibLibRsbLgLsbLgbLgbLsbLgbLgbLsbL
sbLsRsbLsbLgRsbLgLsbLsLsmbLgbLsbLgbsbLsbLgbRhbRibLhbLiLsbRsbLgbLsbLgbL
gLsbLgbLsbLgLsbRsbLgbLsLsmbLgbLgbLgLsbLsbLgbLgbLgbLgbLsbLgbLsRsbLgbLgL
sbLgbLsLsmbRcbRhbRibRhbRibRgLsbRcbLsbRgbRcbLsRsbsbRcbsbLhbLobLibLsbRsb
RsLsbLcbRsbLiLsbLsbRsbLgbLsbLibRjbLibLibRsRsmbLgLsbLgbLgbLibsbRsbLibLc
bRiRsmbRiRsmbRcbLibRsbRcbRibLibLibLgLsbRobRibRcbRibLsbRoRsmbLgbRgbRibL
ibLcbLgbLcbLibLsbLoRsbLibRcbRibLibRcbLjbLgbLibLhbRcbRcbLibLjbLibLobReb
LibLsbLcbLsbRgbRcbLgbRibRobLibLgbLcRsbsbLibLsbLsbLcLsmbLibRsbsbRcbRcbL
sbLsbLjbLibRjbRcbRsbLiLsbLsLsmbRcbLgbLjbLibLibRsbRsLsbLgbLibLsbLsLsmbL
ibsbLgLsbsbRobLsbLibLjbLibLsLsmbRsbRsbLgbLsbsbRsbLsRsLsbLjLsmbLibLhbLs
bRiRsmbLsLsmbLhbRsbLibLsbLgbLsLsRsmbRsbsbRgbRcRsmbLsRcbLsbRsbLcbLebLsb
LgbLjLsmbLsLsmbLibLgLsbLsbRcbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 43; Drug: Control
bLibLsbLgbRibRsbLibLsbRgbsbRibLhbLsbLgLsbLsbsbLgbsbsbRsRsmbLsbLsbLibsb
RsbRsbLgLsbLsLsmbRsLsLsmbRsbLsbLsbLsLsmbLsbLgLsbLgRsLsbLgRsbsbRgRsmbLi
bLsLsLsLsmmmbRiRsmbsbLibLsbsbRgbLibLgbsbLgbLsLsmbRgbLibLsLsmbLgbRibLsb
LhbRsbLsbLjLsmbLjRsRsLsmbRjRsmbRsbRgbLjLsLsmmbLiLsbsbLibLsbsbLgLsbLsbL
gbsbLsLsRsmbsbLsbLsbLgLsbRjRsRsmmbLibsbsbLsbLsbLibLjLsmbLgRsLsbLgbLjLs
LsLsmmmbLgbLsbsbLsbRsbRibsbLhbLoRgRsmbLsRsLsbLcbLsLsmbRsbLibRsbLsLibLi
b

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 44; Drug: Control
bLsRsbLsLsmbLibRjbRsLsbsbsbsbsbsbRsRsRsmmbRgbRsRsmbRgLibsbRsbLsbRsRsmb
sbRibRsbsbRsbLsLsmbRoRsmbLsbLsbLsbsbReRsmbsbRibLgLsbLsbRsbRebLsbRgbLeb
LibRjbLgbLibRjbLibRebRibRsLsbRiRsmbLgRsbRgbLsbRibRsbRsbRgbRsbLsbRgbRsb
sbLsbRgbRgbRsRsmbRgLsbRsbRsbRibRgRsmbLsRsbRsbRibRsRsmbRgbsbRgLsbRsbLjb
RiRsmbRgbRiRsmbRgbRsbRhbRsLsbRibLsbRjbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 45; Drug: Control
bRibRjRsmbRsbsbRcLgLsbLjbRoRsmbRsbLsbRgbLgbLhbRebLjbLobsbRsbRibRcRsmbs
bLsLsmbRsLsbRsbRcbLgbRsRsmbRsbsbsbRebRsbRsbLsbRibRgbLiRsbRhbRsbRgRsmbL
sbRiRsmbLgLhbLibLsbLcRgbRhbRgRsmbRsbsbRsbsbsbLobLhbRsbLjLsLsmmbRjbLiLs
bsbLibLsbLgbLiLsbRcRsRsmmbRgbLsbLgLsbRsbsbRibRsRsmbLsRsbRsbRiLsbLgbRsb
RsRsRsmmbRobRsRsmbsbLibLsbLhbsbRsbLsbLibLgbsbsbRsbLjbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 46; Drug: Control
bLhLsbLsbsbRjbRibRsbsbRsbRsbRsbLsbRgbRsbLgbLsbRgbRgbRsbLsbRgRsmbRsbRsb
RgbLsbRiRsRsmmbRsbLsbLsbRibRsbRsbRsbsbRsbRsbRgbRgbRsbRsbLsRsLsbsbRgbRs
bLsbRsbRsbRsbRgbRsRsmbRsbRsbLsbRgbRgbRsbRsRsmbRsRsmbRsRsmbRsbRsbRsbRsb
RgRsmbRsbRsbRsbRsbRsbRsRsmbRsbRsRsmbRgbRgbRsbRgLsbRgRsmbRsbRsbRsbRsbRs
bRsbRsbRsbRsRsmbRsbRsbRsbRsRsmbRgbRgbRgbRsbRgbRgbRgbRgbRgbRibRsbRgbRgb
RsbRgbRsbRgbRsRsmbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbRsbRgbRgLsbRgbRgbRgbsb
RgbRgbRgbRgbRsbRgLsbRgbRsbRgbRsbRsbRgLsbRgbRgbRsbRsbRsbRsbRsRsmbRgRsmb
RgbRsbRsbRgbRgbRgbRgbRsbRgbRsbRsbRsbRsbRgRsmbRgRsmbRsbRgbRgbRgbRgbRgbR
sbRgbRgbRgbRgRsmbRgbRgbsbRsbRsbRgbRgLsbRgbRsbRsbRgbRgbRgbRsbRsbRgbRgbR
gbRgbRgbRgLsbRgbRgbRgbRgbRgbRgbRgbRgbRgbRibRsbRibRgbRgbRgbRsbRsbRsbRgb
RsLsbRsbRgbRgbRgbRgbRgbRsbLgbRibRsbRgbRsbRsbRgbRsbRgbRgRsmbLsRsbRsRgLs
bRsbRsbRsbRgRsmbRgbRgbRsbRsRsmbRgbRgbRsbRgbRsRsmbRgbRgbRsbLgbRsbRsbsbs
bRiRsRsmmbRsbRsbRsbRgRsmbRgbRsbRsbRsbLsbRsbsbsbRsRsmbRsbLsbLsbLsbRebsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 47; Drug: Control
bRjbLhbLhbRiLsbRsbLcLsLsmmbLibsbLgbLjLsmbRsbsbRibLcbsbLhbLiRsLsbLsLsmb
LgbLibLgbLibLiRsbRjbRcbRgbsbLiLsbLjbRjbRcbsbLgLsLsmbRcbLhbReLsbsbRgLsb
LgbLcbLibRcbRcbLjLsmbLcbLhbLhbRsbRgbLhbLgLsbLibLibRjbRibRibRhbLhbRcbLi
bLjbRibRibRgRsmbRgRsmbLsRsbLsbLibRobRsbRcbRgbLjLsmbRcbLiRsbRcbLsRsbRiL
sbRgbLjbLibLhbLcRsbLibRhRsmbLcbRcRsRsmmbRiLsbLjbRcbLibLcLsmbLcbLcRsbLg
bLgbLgbLgLsbLsbLsbLgbLsbLgbRjbRgbRibLebLibsbLsLsLsmmbRjbLibLsbRjbRhbLc
LsmbRobRibRgbRibLsbLsbRsbLjbLiRsbLsLsmbLgLsLsmbLgbLgLsbLsbLgbLjbLibRhb
RhLsbRibRiRsmbLsbRgLobRibRgbRgbLsbLebLhbRibLibLgbRgbLsbRibRibLsbLcbLob
RsbRibRibRsbRsbRibLgbRgbRgRsLsmbRsbRgbRibRibRsbRgbLgbRibRgbLjbRibLhbLi
RsbLgbLibRsbLibLsbLsbLsbRsLsbLibLhbRiRsmbRcbRhbLibLcbLibsbLibLsbLgbLsb
RjbRhLsbRibRgbLgbRibLjbRgbRibsbsbRibLsbRsbsbRibLsbRgbRibRiLsbLibLjbLgb
LibLibRgbLibLgbLgbLgbRgbRcbRgbLgbRiRsmbRsRgRsLsmbsbLsbLiRsbLiLsLsmbReb
LsbRiLsbRgbLcbLcbRibLhbLsbLibLsLsmbLsbLsbLgbLgbLgbLsbLgbRsbLiRsbLgbRib
RcbLjbLibLgLsbsbLibLsRsLsbLsbRsbLgbLgLsbLgLsbLgbLgbLgLsbLgbLsbLgLsbLgb
LgbRgbLhbLhLsbLibRsbRsbRjbRiLsbRsbRgbRgbLsbRgbRgbRgbRgbRgRsmbRsRsmbRhL
sbLibLcbLgbLgbLhbRibLibRsbLibLsbsbLsbLgbLiRsLsbRsbLgbLgbLibRsbLibRjbRi
bRsRhbLgbRibRcbsbLgbsbRgbRgbLcbLibLgLsbRgRsmbLsLsLsmmbsbLsLsLsmmbLgbRg
RsmbLhbLibLgLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 105608; End: 110108;
Recording: 8-1; Individual: 48; Drug: Control
bRcLsbLhLsbRcLsbLsbRcLsbRgbLibLibLgbLsbLibLgbLgbRjbLsLsmbLibRsbRobRiLs
bLhbLibRsbsbLibLgbLsbLgbLgbRsbLgbLgbLsLsmbLibLcbLcbRcbRibRgbRgbLsLsmbR
jbLcbLgbLiRsbLgbLobLhbLibRgbLsLibLiRsbRgbLiLsbLgbLsLsmbsbLiLsbLgbLgLsb
LgbLibRgbRibRcbLhbRobRcLsbRhbLgbLgbLsLsmbLgbRibLgbLgbLgbLgbsbRsbLibRib
LibLibLsbLgbLibRsbLsbLgLsbLgLsbLgRsbLgLsbLsbLgbLgbLgbLgbLgbLsLsmbLgbLs
bLibLobLiLsbLjbRjbRhRsmbLobLibRgLsbLibLsLcbLibLibRhbRcbRobRcbRgbRgbRgb
RcLsbLibRsbRgbRibLibLcbRcbRobLgbRobRcbRcbLibLcRsbLsbLsbLgbLgbLgbLgbRjL
sbLibRjbLibLibLgbRgRsmbLcLsmbLcbLibLgbLibRsRsmbLibRsbLgLsbLsbLgbLgbLgb
LgbRgLsbLibLgbRsbLibLgRsbRsbLgLsbLgbRsbLibLgLsbLgbLgbLgbLgbRobLjbLibLg
bLgbLsbLgbLcLsmbLcRsbRgbLebLibLibLsbLibLibLibRcbRobLcbRsbRobLsbRcbRcRs
mbLibLibLibLibRgRsmbRsbRgbLibLibRcbRcbsbLibLibLibLhbLobLobRjbRhbLcbLhb
LibLgbLgLsbLgbLhbRsbLsbLibLhbLsbLcbLobLcRsbLhbRibLhbLcbLsbRsLcbRibRibR
ibLhbLibLhbRgbLgbLibLhbLibRgRsmbLjbLcbLhbLhbLiLsLsmbLiLsbLcbLibRsbRsLs
bRibRiRsmbLgbLibLibLgbLgbLibLiLsbRgLsLsmbLsbLibLsbLsRsbLcRsbRcbRhbRoLs
bsbLcLsmbRibRcbRhRsRsmmbRcbRjbsbRibsbRhbRoRsmbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 1; Drug: PCAP2 10 然
bLibLiRsbLgbLibLebsbLsbLgbLgbLsLsmbLsbLsLgbLsbLeLsLibLsbLsRsbLsbLcLsRs
mbLgbRgbRebLsRsRsmbLsbLsRsbsbLsbsbRsbsbLsbRsbRiRsmbRebReLsLsLsLgmmbLeb
LsbRsbsbRsLsbsbLsbRsRsmbLebLsLsmbLsbRsbLjbLcLsmbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 2; Drug: PCAP2 10 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 3; Drug: PCAP2 10 然
bRsRsmbLcbRsbLgLgbLobRiRsRsmmbRsbRsbRoLgbLibLsbRsbsbLsRsbLeLsbsbsbRebR
cbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 4; Drug: PCAP2 10 然
bLsLsmbLsbLsbLsbLsbRsLsbLsbLsbRsLsLsmbLsLsLsmmbLsLsLsmmbLsbLsbLsLsmbRs
LsbRsLsRsbLsbsbRsbRsbsbsbsbLsbRsbLsRsRsRsLsmmbRsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 5; Drug: PCAP2 10 然
bRcbRgbReLsbLgbLgbLsRsbsbLgbLsbLgbLebLsbLibLhRsbRjRsmbsbRsbRcLsRsbRsbR
sbRsbRsbsbsbRsRsmbRgbLsbsbLobLsLsmbLsLsmbLsbLsbsbRsbLsbsbsbLiLsbLgLobR
sbRgbRgbRsRsRsmmbsbRsLsbRgbLjbLsbRibRgRsmbRgbLjbRsbLgbLsbLobRjbRsbRibL
sbRjbRsbRjbRiLsbRsbLsbLsbRsbRoRsRsRsmmmbLsbLsbRsLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 6; Drug: PCAP2 10 然
bsbLsRsLsbRsbRsbLiLgLsLgLsLsLgRsmbRgRsLsRsmbRsbRhbRiRsLsmbRjbLgLibLebR
sbLgRsbLiLsLsmbLsLsmbLebLiLsbRoRgbsbRsbsbLsbLiRjbLsbsbRsRib

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 7; Drug: PCAP2 3 然
bRgbLsbLjbLibLsLsmbRjbRsbRsbsbLsbsbRsbLsLsmbRgLsbRsRsmbLsRsbsbsbsbsbLs
bRsLsbRsLsbsbLsbsbsbsbsbsbLsRsLsRsbLsbRsbRsbLsLsLsmmbRsLsRsLsbLsbLsLsL
smmbLsLsRsmbRsbRsLsbLsbsbsbLsbRgbsbsbRsLsbRsbLsbsbRsLsRsLsRsLsRsLsbsbs
bLsbLcbLsbsbsbsbsbsbsbLsbsbsbsbsbsbsbRgLsbRsbLsbRsLsRsbRsbRgLsbRsbsbsb
sbLsbLsbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 8; Drug: PCAP2 3 然
bRsRgRgRgbRgbRsbRsRiRsRsRgRsRsRsmmmmmbRsbRsRsRsRgmmbRcbRiRgbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 9; Drug: PCAP2 3 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 10; Drug: PCAP2 3 然
bRsRsmbLsLsmbLgbRsbLsbRsbsbsbsbsbsbRgbsbRsbsbLgbLsLsLsmmbsbRsbRsbsbsbs
bsbsbLsLsLsmmbLibsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 11; Drug: PCAP2 3 然
bsbsbRsbRsbRgbRsbRsbRhbRsbRsLsbRsbRibRgbRsbRibRgbRibRhbRsbRcLsbRsbsbRs
bRsbRsbRibRsbsbReRsmbRsbsbRsbRgbRhbRsbRsbRsbsbLsbRsLsbRsbRsbRsRsmbRgbL
sRsbLsLsRsmbRsbRgRsmbLsbLsbLsbLsbRsbRsbRsRsmbRsbRsRsmbRsbRsbRgbLsLsLsR
smmbRsbLcbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 12; Drug: PCAP2 3 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 13; Drug: PCAP2 1 然
bRgbRibsbLsRsbRgbRsLsbRsRsRsmmbRibRgbRsRsmbsbRgbRsbRcbRibRsbLgbLsbRcbR
ibLgbLsbRsRsmbRibRgbLoLgbRsbLobLsbRsbsbRsbLibLgbLsRsbLgbRsbRsLsbLibLsR
sbLsbLsLsRsLcmbLsbLsLsmbLsLsmbRgbLobLsbRsbRsbsbRiRsmbRgbRsRsLsLsRommbR
gRsmbRsbRsbRsbRibLsbRgbRgbsbRgbRibLgLsbLgLsbLsLsmbsbRgbRsbLsbLsbLsbsbs
bLsbsbRcbRgbRgRsmbLgbRsbRsbsbRgbRsbsbLsRhRsRsRiLsmmbRibsbLsLsmbsbRgbLs
RsbsbRsRsRsmmbRgLsbRsbRsRsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 14; Drug: PCAP2 1 然
bLgbRsbLibLsbLsLsmbLgbLsbLsRsbRsbRgbsbsbRgRsmbRibLiRsbLgbLsbRsbLibRsbR
gRsmbRjbsbRhbsbRjRsmbRhRsmbRsbLsbsbsbRgbLsbLjbLiRsbLsbLsLsmbRsbLgbLjLs
mbRsbRsbRiLsbRibRiRsmbRgbRgbRgbsbsbLibLhbRsbLgbRsbRgRsmbLcbsbRgbRgbLcL
smbRsbRsbRsRsmbRgRsmbRcRsmbsbRhRsmbsbRjLsbLgbRibRsRsmbRsLsbRibLsbLibsb
LsbsbRjbRjbRsbRgbsbLsbRsbRgbRgbLsbsbRsbRsRsmbsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 15; Drug: PCAP2 1 然
bRibRsbRibLsLsmbLsbsbRobRsLsbRhRsmbRgbsbRibRgRsmbRgbRibRibRhbsbRibRibR
gbRhbRhbLsbLgbRsbRcbLsbLsbRgbRibRsRgbRsRsmbRsbLgLsbRhbRebsbRgbRgbRgbRg
bRsLsbRsbRsRsmbLjLsmbRiRsmbRgbRsLsRsbRsbRsRsmbRsbsbRiRsmbsbRgbRgbRsbRi
bsbRibRsRsRsRsmmmbsbLsRsRsmbRibRgRsmbLjbRibLjbRhbRiRsLsmbsbLibRibLsbRi
bLsLsmbLsLsLsmmbLsbRhbRiRsmbRiRsmbRsbLsLsmbLibLsbLhbRsLsbRibLebRjbLebL
ibRsbRsbRibRhRsmbLcbLiLsbRsLsbRibRcRsmbsbLibLsbLebRsLsbRibRiRsRsmmbLsR
sLsRsbsbRgbRsLsRsbLgLsRsbRjRgbRibRsbLgLsbRibsbRsbRiRsmbRibRibLiLsbLibL
eRsbRsbLsbRibLcLsmbsbLibLsbLsbRsRsmbRcbRcbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 16; Drug: PCAP2 1 然
bRgbRsbLsRsbsbRgbRsRsmbRsRsmbRjbRobLcbLgbLsbLgbRgLsbLgbLsbRebRjbRjbLsb
LoLsmbLsLsmbLsbRsbLsRcbRgbRsbLebRsbRjbRsbRcbLsbLsbLsRsLsbLibLgLsbRsbRs
bRsbRgbRcLjbRcbRgbLsbLsRsbRsbLsbLjbLjbLeLsbRsbReRsmbLgbRibRgbLhbRjbRgb
RjbLsbRobLsLsmbRibRiRsmbLgbLsRgRsRsmmbRsRsmbLibRsbRsbRsbLibLsLgbLiRsbR
ebRsbRsbRgRsmbRiRsmbLgbLgbRibLebLgbLsbLgLsbLsLsmbLhRsbRsbRcbRsRgbRsRsR
smmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 17; Drug: PCAP2 1 然
bLsbsbRjbLhbLsbLsLsmbLgbsbLgbRsbLibLsRsbLibLibLsLsmbRsbRgbRsbLsbRsRsmb
sbLsRsbRsRsRsmmbsbLsbLiLsbRobRsRgRsmbRsLsbRibRsbRsbsbRsbRibRgRsmbRsRsm
bsbsbLebLsbLsbLibLsbRsbsbsbLjLsmbLsbRsbRsbLsbsbLibRibLibLgbLsbLsLsmbLg
LsbLgLsLsmbRgRsRsmmbLjLsLgmbRjbLgLsbRibRibLjbLhLsbRgbLibRsRsmbLcbsbRsR
smbRsbRsbsbRgRsmbRsbLsbLsbLsbLjbLcbsbRsbRcRsmbsbLsbLsLsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 18; Drug: PCAP2 1 然
bLibReRsmbRcbLibLcbLjbLcbRcbsbRsbRsbRsRsmbRgbLgbRsbsbRgRsRsmmbLsRsLsbR
sRsmbLgbLsbLgbLebLcLsmbLsbLsbLsbRebRgLsbRsLsbsbRgLsbLgLsbRcbRsbLcbsbRi
bRgbRsbRgbLsLsmbLsRsRsmbLgLsbsbLsbsbsbRgbLiLsbLsbRcbRjRgbRobRibRiRsmbL
jb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 19; Drug: Control
bRgLsLgbLobsbLibLgRsbLsbRsbLiLsbLgbLsbsbLibLgbLsRsbLsbRsbLsbLgbLibRibL
gbLcLsmbLibsbsbsbsbRsLsbLcRsbLsbLsbRsbLgbLsLsmbRibLsRobRsbLgbLibRsbsbL
sbLsLsmbsbLibLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 20; Drug: Control
bRcbRsbsbRhbRcRsmbRibRgRsmbRgbRsRsmbRgRsmbLsLsmbRsbsbLjbRsLsbRibRsbRiR
cbRjRjbLgbLsbsbRjbRibRsRsmbsbLsbRibRhbLibLsbLibLhbLsbRgRsLsmbRibLsbRib
LcRsbLiLsRsbLgbLgbLsbLgbLsLsLsmmbRibsbLiLsbLibRgbLibRgbLjLsmbLsbRjbLjb
LsbLibsbLsbRibRgRsmbRiRsmbRsbRgbLjbLibLibRjbRhbRsbRibsbRgbRgLsLsmbRsbs
bRsbRibRhbLiRsbRebRibRgbRsbRgLsbLsbLsbRibRsbRgLsbLsLsLsmmbRsbsbsbLsbRc
LsbRsLsLsmbRiRgLsbRobLsbRsbRibRsbRsbLgbRhbRibLgbRgbRsRsmbRsbRibLsbLjbL
sRsLsbRsbLsbRsbLsLsmbLsLsmbLsLsmbRjRsRsRsmmmbLjbsbRsbRsbRsbsbsbsbLsbRc
RsmbRsbLsbLibLsbLoLsmbLsLsmbsbLibLsbLcbRibRgbRsbRibRibRsbLsbRgbRsbRibR
sbRgbRgbLibRcbRcbsbRsbLibLsbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 21; Drug: Control
bRjbsbRjbRgbLjbsbRjbLgbLgLsbRsRsmbRgbsbLgbRsRsmbRsRsmbRjRgbLsLgLsbRsLs
bLsbRiRsmbRsbRibRsbRgbRiRsmbRsbLgbLgbsbLcbLgbsbsbRgbLsbRcbRibRsRsmbRib
sbRsbRgbsbRibRsRsmbRsRsmbsbRgRsmbsbRgbsbLiLsbRgbLhbLgbLsbRgbLjbRjRsmbL
sbRjbRiRsmbRjRsmbRjRsmbRsbLsLsmbRgbsbRibRsRsmbLjbRibRsbsbRjbRjRsRsmmbR
jRsmbsbRibRsLsbRgRsmbLsbsbLgbLibsbLsLsmbLgLsbLsbsbLsbRgRsRsmmbRibRibRs
bLsbRibRhbRsbsbRgLsbRjbsbRgRsmbLgbsbRjbLgbRibRibLsbRgLsbRgRsmbRsbRjbLi
bsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 22; Drug: Control
bRsRsmbRsbLsLsmbLgbRoLsbRiRsmbRhbRcbRhLsbRjRsmbRgbLibLgbLibRjRsmbLsLsm
bsbRjRsRsmmbRgLsbLgbLiLsbRgbLgLsbsbRibLibLibRgbsbLibLgLsbRcbRcbRgbLibL
sbLibRibLibRiRsmbLsbLsLgbRgbsbRgbLsbRjRsRsmmbRsRsmbRsbsbRsbRgbRibRiRsm
bRibRibRgbRsbLjLsmbRjRsRsmmbLjLsmbRibLgLsbRgbRsbRgbRgRgbLebLsLsmbsbRsb
RsbsbRcbRsbLgLsbLibRsLsbLibLiLsbLcbLibLibLgbsbLjbLcbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 23; Drug: Control
bRgbRgbRgbLsbsbRhRsmbRsbRsbsbRibRibLgbLsbLsbRiRsmbRibRsbLcbRsbRjbLibLc
bRjbLibsbRcbRgbRsbRgbRgbRgbRsRsmbRhbLsbRsLsbRibLsbRibsbRgbRgbRibLhbsbR
ibRsbRcbLsbRgRsmbRiRsmbRgRsmbRgbRsbRsbRibRsRsmbsbRiRsmbsbRgbsbRgbRibsb
RsbRibRsbRgbRgRsmbRgbRsRsmbRgbRsbRsbRgbRsLsbRsbRgbRsbRgbRgbRgbRiRsmbRs
bRgRsmbRgbLsbLgbLhbRsRsmbRjRsmbRsbsbLsbRibRsbLjbLjbLjbRibRsbLjLsmbLsbL
ibRibLsbsbRgRsmbRoLsbLsbsbsbLsbsbRobLsLsmbLjLsmbRibRsbRibRsbRgbLjbsbsb
RcRsLsmbsbRibLsbsbLcbLibRsbRibLsbRsbReRsmbRgRsmbRsbRgbRsbsbRgLsbRgRsmb
LsbLsbRgbLsLsmbRsbRibsbsbsbRhbLiRsbLsbRsRsmbRiLsbRsbRsbRibRiRsmbRcLsbL
sbLibLibLgbLgbLibLsbsbLgbRsbRsbsbRgbRgbRgbRgbRgbRsbLjLjLsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 24; Drug: Control
bLhbRibLibsbLgbRebRibLjRsbRhbLgbRcbLgbsbRgbRcbLgRsbRcbRhbLibLebRebRhbL
ebRcbLibRcbRcbLgbLsbRgbRcbRiRsmbRgbsbRiRsmbRgbLgbLcbLcbsbRebLcbLgbLgbL
gLsbLibLjLsmbLibLgbLgbRibRcbLsbRcbRibRsbLibRcbRiRsmbLiLsbsbRjRsmbRsbRg
bLgLsbLcRsbsbLsLsRsmbLibLibsbLgbLgbRsRsmbLcbRgbLibLsbLcbRibLibRiRsmbRi
bLeLsbRcRsmbLcRsbsbLibRgLsbLhbRibRcbRcbRhbLgRsbRgbLsbLebLibRgRgbRjRsRg
mbRebLjbLgbRsbRsbRibLsbRsbRcbLgbsbLsbRjRgbLgbLcbLhbLgbLibLsLsRgmbLsLsL
smmbLsLsmbsbLhLsLsmbLsLsmbLibsbLsRsbsbRjRsRsmmbLsLsmbLjbLibLsLsLsmmbLs
LsmbLjLgbLgbLgbLiLsbLsbRsbRcRsmbLgLsbsbLgbLibRibLhbLibsbLsbLsLsmbLsLsm
bLsbLsLsLsmmbLebLsbRsbRsbLsbsbRsbRhbRcbsbLsbRgRgbLgbsbRibLgLsbLgbRcbLs
bLsbLsbsbRsbRsbRsLsbLjbLeRsbLibLiLsbLibLgbLsbsbLsbsbLhbLcbLgbLsLsmbLsb
LgbsbLjLgLsbLsbRibLibRjRgbRsbLibRjbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 25; Drug: PCAP2 10 然
bRsLsbRsbLsbLebLsbsbRgbLsbRibRsbLsRcbRhbRsLsRsbRgbLibRjbRebRiRsmbLeRsb
LsbRsRsLjmbsbRhRsmbLsRsbLsbLgbRsbRibRcbRsbRgbsbRsbRsbRjbLsbLsbLsRsbReb
LgLsbRcLsbsbsbRsLsRsbRcbRsbLsbsbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 26; Drug: PCAP2 10 然
bLobRiRsmbsbsbRobRgRsmbRgbRsbRibRgbRcbRsbsbLeLsbLcLsmbLsLsmbLcbLsbRobs
bLsLsLsmmbLsbLsbsbRsbLsbLsbRsLsbLgRsbLsRsbRgRcbRsbRobRibRsbRsbRgbLobLs
bLsbLibLibLsbLsbRsbLgbLsbLsbLsLsmbsbsbsbLgbLsbLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 27; Drug: PCAP2 10 然
bLsbRsbsbsbLsbLgLsbRsRsmbRsbRsRgbsbLgLsLsmbLsbLsLsmbLsLsmbLgLsbLjLcbsb
LibLgLsbLiRsLsbLsLsmbLsbLiLsbLgLsLsmbLsLsmbLsbRsbLibLsbRsbRsbLiLsbLibL
sRsbLhbLsLsmbsbLiRsLsbLiLsLsmbLibsbLsLsmbLhRsbRsbLsbRobRsRsRsRsmmmbRgb
RsRsmbRgbRsbRsRsmbLsRsbLcbLcbRibRsbRsbRsbRsbRsbLgLsbLsbRsLsLsmbLjbRsbL
ibLgLsbLibLsbRsbLsLsmbLsLsmbLsbLsbRsLsbRsbLgLsbLibLoLsRsmbLibLsbLgbLsb
LsbRsLsbLsRsbsbsbRsbLibLibRsRsmbLibRsbRsbLjbLgLgbLsLsmbLgbLgLsbLsLsmbL
sLsmbLsbLibLobRsbRobRebRsRsRsmmbRsRsmbLsLsmbLibRsbRsLsbsbLsbLjLsLsmmbL
iLsbsbLhbRsbRsRsLsRsmbRgbsbsbLjLsLsmmbRsRsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 28; Drug: PCAP2 10 然
bLibLsLsmbLsbLgbLsbLsLsmbsbRjbRiRsmbLebLcLsLsmmbLsbRsbRgbRiRsmbsbRsRsm
bLcLsmbLsbLsRsbsbRgbRgbRibRgRsRsmmbLsbLsbsbLsbLgbLcLsmbRjbLebRjbLsLebL
sLsmbRsbLcbLsbRsbLobRsRsRsmmbRgbRgbRsRgbRsbLsbRsRsmbLsRsbRsRsmbLjbLibL
ibRibLsbRsbLoRsbLsbLibRsbLsbLobRsbRsbLsbRjRsmbRobRhbRiRsmbRgbRibRgRsmb
LsRsbRsbRibLobRsbLcbLgLsbsbLsbLgLsbRsbLsLsmbsbLobRsRsmbLsbLsbRsbRsbLsR
gb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 29; Drug: PCAP2 10 然
bLiLsbRsLsbRgRgLgbRsRsRsLsLsLsmmmmbLiLsbRsRsLsmbLsbsbLibRsbRsRsmbRsbLs
RsbsbRsRsRsmmbRsbsbLsLsLsLsmmmbLsbRgRsmbLsbsbLgLsbLsbRsbRsbRgRsmbsbLgL
sbRcbRgbLsLsmbLsbLsbRsRsmbRsbsbRcRsmbLsLsmbLgbLsbLsLsmbRsbRsLsLsLsmmbR
sLsbRsLsbRgRsmbRsbLobsbRsbLsRsLsLsmbLgbsbRsbLgbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 30; Drug: PCAP2 10 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 31; Drug: PCAP2 3 然
bLsRsRsmbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 32; Drug: PCAP2 3 然
bRsbRsbLgbLsbLjLsmbLsLsLsmmbsbLsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 33; Drug: PCAP2 3 然
bRgbLsRsbLsbsbLoLsmbLebLsbLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 34; Drug: PCAP2 3 然
bsbsbRsbRsbLsRsbLsbRsbRsbLsbLsRsLsbRsbRibLobLiLsbLsbLsLsRsmbsbRsRsmbsb
LsRsbsbLibLjbRhbRibRiRsmbRsRsmbRsbLsbRibLsbRcbLibLibRsbsbLjbRsbRgbLobL
sbRsRsmbLsbsbsbLobRsbRiRsmbLcbRsbRsbRgbLobLsbRsLsbLgbRsbRsRsmbRsRsmbsb
Lsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 35; Drug: PCAP2 3 然
bRsRsmbRsbsbsbLsLsmbRsbLsbLeLsbRjbRibRsbLsbRhbRsRsmbRjRsRsmmbRsRsmbRjR
gRsmbRgRsRsmmbRsRgbRibRsRsRsmmbRjRsRsmmbRgRsRsmmbRsRsRsmmbLgLsbLsbLsbL
sRsbLsbsbLgLsbLgbLsbLsbRsLsbRhbRgRsmbLcLsmbLibLgbLsbsbRibRgRsmbsbRsRsR
sRsmmmbRgbRgRsmbRsbLjbRibRsbsbRgLsbRsbRsbRsbsbLjbRsLsbRsbRsRsRsmmbsbsb
LsbsbsbsbsbLiLsLsmbRsbRsRsRsmmbRgRsmbRsbRsbLsbRsLsbRgbRgbRsLsbLsbRsRsm
bLibRsbsbsbsbsbLjbLgLsLsmbRsLsbLsbLgRsLsbsbRjbRibRsbRebRibRibRgbRgRsRs
mmbRgRsRsmmbsbRebRibRsRsRsmmbLeLsbLibLiLsLsmbLiLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 36; Drug: PCAP2 3 然
bRsbRsRsmbLsbRsbLsbRgbLjbLibRsbsbRsbRsLsLsmbLsbsbLsLsmbLsRsbRsbRsRsmbR
sbRsRsmbLsbsbsbsbRsbRsbRgbRsbRsbRsbLsbLsbRsRsmbLsbLgbLsbsbLsbLsbsbsbLs
bsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 37; Drug: PCAP2 1 然
bLsbRgRsmbRsRsRsmmbLsLsLsmmbLjLsmbsbRiRsmbRcbRhbsbLsLsLsmmbLibLgbLsbRg
RsmbRsRsmbsbRgRsmbLsLsRsmbRibLsbLsbRhbsbRiRsmbRibLsbRgRsRsRsmmmbRsbLsb
sbRibLsbRibLsLsLsmmbRibLsLsmbRibLsLsmbLsLsLsLsmmmbRsbRibRsbRsbRsbLsbsb
sbRgbRsRsRsmmbRgbsbLsbRgRsmbLsRsbRgbRiRsmbRsLsbLsLsmbRsbRibLsRsbsbRsRs
RsmmbsbsbRgRsmbRsRsmbLsbRobRgbLsbRsbRsbRibLsRsbRibRibsbLsbRgbRgLsbRsbR
ibLsLsLsmmbLsLsRsLsmbRobRgbLgbRsRsmbsbsbsbRhbsbLjLsmbRgRsmbRcbsbsbLsbR
cbRsRsmbRgbsbRsRsmbRsRsmbRsRsRsmmbsbRibLsRsbRgbsbRibLgLsRsbRhbLsLsmbRi
bLibRsRsRsmmbRsRsRsmmbsbRgbRsbRgbsbRgRsLsmbLsbRjRsRsmmbLsLsmbLsbRibRsb
RsbLsbRibLsbRibLsLsmbRibRsbsbRsbRsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 38; Drug: PCAP2 1 然
bsbLgLsbRgbsbsbRcbLgbRjbRibLgLsbRsRsmbRsbRibRsbRibLgbRhLsbRgRsmbLgLsbR
ibLcbRcbRhbsbRgbLsbLgbRiRsmbRhbsbLgbRhbLsbsbRsbRgLsbLcbLgbRjbRcbLgbRib
RsRsmbRiRsmbLgbRgbRsbRsRsmbRibRgbRibRhbRsLsbLjLsmbLsbLcLsmbRgbRgbRgbRc
bLjbLcLsmbLsbLibRjbsbLsbLiLsbRebRoLsbRsLsbRibLgbRibRiLsbLgbsbRgbLsRiLs
bRsbLgbLibRcRsmbLcLsmbLcbLibRsLsbLsbRsbRgRsmbRsbLibLibRcbRcLsbRebRibsb
RgbsbsbRhbRibLsLsmbsbLjLsmbLibsbLiLsbLibRgbRgbLgbsbRsLsbLcbRjRsRsmmbLi
bLsbLsLsLsmmbLsbsbLgRsbLgbsbsbLibRsRsRsRsmmmbRsRsmbRgRsmbLjLsmbRcbLhLs
bsbRjbRsLsbsbRgRsmbLgbsbLcLsmbLcbLsbLhbRcRsmbRibsbsbRibLjbRcbLibRibLgb
RiRsmbsbLgbRsLsRsbRgRsmbRsbRsbRcbLgbLhbLcRsRsmbLgbRibLgbLgbsbRibLibLsb
RsbLgbLgRsLsbRsLsbLgbLsbLgbRjbLcbLgbLjLsmbLibRibRgbRsbLibLiRsbRjbRcbLh
bsbRibRhbLsLsmbRgLsRsbLcbLibLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 39; Drug: PCAP2 1 然
bRhbLcbRibRibLgbRibLsbRibRcbRsbLibLsbRsLsLsmbLgbRibLiRsbLgLsbsbLhRsbRi
bsbRibRgLsbLsbLsbLsRsLsLsLsmmbRsbRsRsmbRsbLjbLgbRhbRibLcbRjbRibLiLsLsm
bLcbRibLiLsbsbsbsbRsLsLsLsmmbLgbLgbRsRsmbLgbLgRsLsbsbRsLsbsbLgbRsLsLsm
bLgbLgbLgbLsRsbLgLsbLgLsbLgbLsLsLsmmbLgbLgRsbLgbRibRibsbRhbsbLobLibRjb
RcbRcbRgbRsbLsRhRsmbRgRsmbsbRgbRgRsmbRsbRgLsRsbRsbRgRsmbLgRsbRgbRgbLsb
RsbRhbLcbRibRgbsbLebLgRsbRsRsRsmmbRgbRibRibRgbLhbRiLsbLebLibLsbLgbLgbL
gLsbRsLsbLgLsbLsLsmbRsLsbLgLsbLsLsmbLgLsRsbLgbRcRibsbsbsbLcbsbLibLgbRs
bLiLsbLsbLgbRsLgbLsbLsbLsLsmbLgbLgLsRsbLsLsmbLgbLgbLgRsbLsbLsLsmbLgbLs
bLgbLsLsmbLgLsbRsbLgbLgbRsbLsbLgbLgLsbLgbLgLsbLgRsbRgbLgbLgLsbRjbsbLgb
LgbLsbLgbRsbLgLsbLgbLgbLgbLsLsmbRsbLiRsRsLsmbRsLsbLgbLgbLgbLgbLsLsmbLg
bLsbsbsbsbLgLsRsbsbLsLsmbLsRsbLibLgbRibRgbLsbLhbRhbRcbLibRcbRcRsmbRcRs
mbRibLibLhRsbLsbLsLsmbLgRsLsbLgbLgbLsbLgLsbLgbLgbLhbRsbRsLsLsLsmmbRhbL
ibLebLsbLgbLsLjLsmbLibLibLhbRiRsmbRsbLjLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 40; Drug: PCAP2 1 然
bLcbLiLsbLibLsLsmbLsbLibLibLsbLgbLsbLgLsbLgbRgbLgbLibLgLsbsbLsbRgbRjRs
mbRsbRsbRsRsmbRgbLgRsbRgbsbRjLsRsbsbLebLcbLsRsbLibLiLsbLgLsbLsbLsLsmbs
bRgbsbRsbLgbLibLgbLibLcbLibLsLsRsmbRsbLsbRgbsbRiRsmbRibRibRgbsbRsbLgbR
jbLsbLcbLcbLibLhLsbsbRsRsmbRsbRgbsbLsRsbRibLsbLcLsmbRebRibLcbRcbRobsbL
ibLgbLsbRsRsmbLibLgbLsLsmbLgbRgRsRsmmbsbLsLsLsmmbsbsbLibLiLsbLsRsbsbRg
bRobLibRibLsbLeLsbLgbLsbLgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 41; Drug: PCAP2 1 然
bRiRsmbRsbsbRibRsRsmbsbLsLgbRcbRsbLsbLsbRoLsbLgbRibRibRsRsmbRsbRibLsbL
gbsbRjRgbsbLgLsbsbLhbRsRsmbRibRgRsmbRcbLiLsbsbLjLsLsmmbRcbRhbRsbRsRsmb
RhbsbRsbRibRjRsRsmmbsbRsbsbLsbLsLsmbLsLsLsmmbLgLsbLjLjbLsRsLsbRibRsbsb
sbLsLsLsmmbLjLgbLsbLsbsbLgLsbLsLsmbLsLsmbLsLsmbRsLsbRgRsmbRgbsbLgbLjLg
LsbLgbLcbsbsbsbLobLsLsmbRgbRibRhbRsbRgRsmbsbRsbRgbsbRsbsbLsbRgbRibRgbs
bsbLgbRibsbRsLsbRcLsLsmbLsbRhbsbRsRsmbRjRsRsmmbLgLsbRgRsmbsbRsLsbRgbRo
bsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 42; Drug: PCAP2 1 然
bRibRgbsbRhbRsbLsRsbRcbRsbRjRsmbLsLsmbLsLsLsmmbRsbRsRsRsRsmmmbRsbRsbLs
bRiLsLsmbRhbLibRibLsLsRsmbRsRsRsmmbRibRsRsmbLsLsmbLsLsmbLsLsmbRsbLcbLg
bLsRsbLsLsmbRgbRibRibLsRsbRibLjbRibRibsbLcbLgbLsLgbLgbsbLsbRsbLhbsbRgb
LsbLobLsbLcbsbRsbRgbLcRsbRjbRibRsbRibRsbRsRsmbLsRsbRsbRibLoLsmbLsLsRsm
bLsLsmbRsLsLsmbsbRsbLebLsbRsbLibLgLsbRsbLsbLgLsbLgbLsbRgRsLsmbRhbRjbLs
bLsLsmbsbLibRgRsmbRhRsmbLebRibLcbLcbLibLgbLsbLgLsbLiLsbLsbRobLjbLhLsbR
jbRiRsmbRsbRsbLsbRgbLsbRibRebsbsbRcbRsbLhbLsbRsbLgbLsRsbRsbLgbLsbLgbLg
bLgbLsLsmbLgbLgLsbLsbLgbLsbLgbLgbLgbLgbLsbLgbsbsbRjbLcLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 43; Drug: Control
bLhbLsbLsbsbLsbRibLsbsbLsLsmbLsbLsbRgbsbRgbRgRgbRibsbRiRsmbRiRsmbRgbRs
bLgbLsLsmbLsLsmbLibsbLgbsbLsbLsbLiLsbsbRsbLgbLsbsbRsRsmbRsLsbLsbsbLsLs
RsmbLsRsbLsRsRsLsmbLsLsLsmmbLgLsbLsbLsbLgbRibRsbLjbLsbLgbLgLsbLgbLsbLs
LsmbRsbRsbLgbRgbLhbRsbLgbRsbLgLsbsbsbRiRsmbLgbLgLsbLsbLgLsbLibsbRsbLsb
LsLsmbsbLsbLiLsbLsLsmbLgbsbRgRsmbLsbLsbLsbLgbLgLsbsbRsbLgLsbLibLibRsbs
bRgbLcLsLsmmbLibLgLsbLsbLsbsbLgbsbRibsbLgLsbLsbLgLsbRgbLibRsbLgbLgLsbR
hbLhbLsbsbLgLsbLsbLsbRsLsbRsbRsbLsbLsLsmbLsLsmbLsbLsLsmbsbsbsbRiRsmbRs
LsRsbLjLsmbLsbLgbLsLsmbLsbLgLsLsmbRsRsmbsbLgbLibRgRsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 44; Drug: Control
bsbsbsbRibRiRgRibRiRsmbLsbLgLsbLsLsmbRebRiRsmbRibLsbRiLgbLibLsbLsbLgbL
ibsbRsbLhRsbLibRibLcbLebLsbLsbLsbLsLsLsRsmmbRgbsbLcbLsbRsLsbRjbRgbRobL
gLsbRsbLcbRsLsbLsbRsRsRsmmbLsbRsbLsbLsbLsbsbLsbRgbsbRiRsmbRgbRsLsbLsbR
ibsbRibRsbLsbLgbLibLiLsbLsbLjLsmbRgbsbLsbRsLsbRhbLgLsbsbRgbRgLsbLgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 45; Drug: Control
bRcbLsbLsbRsbRibsbLcLsmbRiRsmbRsbLibLsbLgbLgbsbLsbLsbLgbLgbRsbRiRsmbRi
bLhLsbsbLgbLsbLgbRcRsRsmmbRgRsmbRgbRiRsmbRibRsbRsbLsbsbsbRibRcbLgbRsbR
gbRibRsLsbRgbLsbRgbsbRsRgbRgLsbRsRsmbRsbRsbRibLgLsLsLsmmbLsLsmbRsRsmbR
gRsmbsbRsRsmbLsbLsbLjbLsLsmbLsLsmbsbLsLsmbRsbLsbLibRjbLcLsmbRjRsmbRibs
bRibsbLgbsbLsRsLsbRibLcbLiLsbLiLsbLgbLgbRsbLgbRsbLsbLibRsbRgRsmbLibLgL
sbLibsbsbLcbLibRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 46; Drug: Control
bsbLgbLgbRgbRebRsbRsbLeLsbLgbLgLsbLsRsbRgRsmbLiLsRsbLibLsbLsbLgbLgbsbL
sbLibLsbLsLsLsmmbLgbLsbLsbsbLsbLgbRjbLibRsbLibLsbRsLsLibRjbLibLgbRsbLi
bLsbRsbLiLsbLsbRobRibsbLsRsbRgbRsbRgbLsRsbRgbRsRsmbRsbRsbRsbLsbRgbsbsb
sbRgbRsbsbRsbLsbRsbRgbRgbRsbRgbRsbLsbRgRsmbRsbRsbRsbRsRsRsmmbRsbRsbRsb
RgbRsRsmbRsbRsbRgbRgbRgbRgbRsbRsbLsbRgRsmbRsbRsbRgbRsbRsbRsbRgbRsbRsbR
sbRgbRsbRgbRsbRsbRsbRsbRsLsbRsbRsbRgbRsbsbRgbRsRsmbRsbRgbRgbLsbRsbRgbR
gLsbRsbRgbRgRsRsmmbLsbRgRsmbRgbRgbLsbRsbRsbRsLsbRgbRsbRsbRsRsmbRgbRsbR
gbRsbRsRsmbRgbRgRsmbRgbRsbRgLsbRgbRgbRgbRgbRgbRgbRsLsbsbRsbRsRsmbRgbRg
bRgbRgbRgbRgLsbRgbRgbRgbRgbRgbRgbRsbRgbRgbRsRsmbRgbRgRsmbRgbRsbRgbRgRs
mbRgbRgRsmbRsbRgbRgbRgbRgbRgbRsbRgbRgbRgbRsbRgbRgbRsRsmbRgbRgbRgbRgbRg
bRgbRgbRgbRgbRgbRgRsmbRgbRgbRibRgbRgbRgbRgbRgRsmbRgbRgbRgbRgbRebLibLeb
LgLsbRsbRebRibRgbRsbRsbRsLsbRgbRgRsmbRgbRgbRsbRsbRsbRgbRsbRgbRsbRsbRgb
RgbRsbRgbRgbRgbRsbRgbLsbRgbRgbRsbRgbRgbRsRsmbRsbRsbRgRsmbRsbRgbRsbRgbR
sbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 47; Drug: Control
bsbLsLsmbLsLsmbLjLsmbRgbsbLgbLgbRsLsbLjbLgbLgLsbLsLsmbsbsbLsbRsRsmbRsb
RsbRsbRcRsmbLsbRibLjbRibRjRsmbLsbLsLsLsmmbRsRsmbsbLsbRsRsmbRgbLsLsmbLi
bLsbLobLsbLjLsmbRsRgbRibRsbRsRgRsmbLjbLjbLsbLhbRsbRgRsmbRsRsmbRiRsRsmm
bRsbRgbRsRsRsRsmmmbsbsbLjbLsLsmbRsbRibRjRsmbRjRsLsmbRibRjRsmbRjRsRsmmb
RgRsmbRjbsbRgRsmbRcLsbLgbRjbRiLsbLsbRiLsbLsbRobLjbsbRgLsbRgbRebRibRsbR
jbLcbLibsbLsLsmbLibLsbRsbLgbLjLsLsmmbLgbsbLsRsLsbLsLsmbLgLsLsmbLsbLibs
bRsbsbRcbLsbRiRsmbRsRsmbRsbLsLsLsmmbsbLibLsLsLsmmbLjLsmbLjbLibsbLgbLsL
smbLibLsbLcRsbLsLsmbsbsbLhbRjbRsbLcbLcbLsLsmbLsbLsbLcLsmbLgbLiLsbRgbLi
bLibLiLsLsRsmbRsbLsLsmbLsbLgbLgbLibRiRsmbLsbRsRsRsmmbLhbRjbRjbRsRgbRjR
sRsmmbRgbRsRsRsmmbLcbLgLsLsmbLcbLsLsmbLcLsmbRsbRsbRgbLcbLiLsbLibLibRgb
LsbLiLsbLgbRsbsbLibsbRgbLiLsbLiLsbLsLsmbLgbLsLsmbLgbLibLgLsbLgbLgbRobR
hLsbLibRibRibRsbRiLsbLsbRiLsbLhbLhLsbLibLhbRsRsmbLgbLibLiRsbRcbLjbLsRc
bRsbRcbLjbRcbLcbRcbRiLsbLjbRibRiRsmbRsRsLsmbLsbRibRgRsmbRgbRgbLjbLibLi
RsbLgRgbLsbLgbLgbRsbLsLsmbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110110; End: 110611;
Recording: 9-1; Individual: 48; Drug: Control
bRgbRcbRcbLcLsmbRcbRcRsRsmmbRcbRcRsmbRcbRcbsbRibLcbRjRsmbRebRibRjbRobR
sbRibLgbsbRsbLsbRhbRebRcbRibLsbsbsbRibRebRcbLiLsbRcRsRsmmbLgbsbRsRsmbs
bsbRgRsmbRgRsmbLiLsbLsbRgbRgbsbRhbRsbLobLibLiLsbRcbLobLcbRgbLobsbLibRc
bRcbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 1; Drug: PCAP2 10 然
bRgbLsbRsbLsbRsbRsbsbsbRsbsbsbsbsbsbLsbRsbsbLsbsbLsbLsRsbsbsbLsLibRsLs
RsbsbLsbLoRsRgbRibLsRsbRgRsmbRgRsmbRgLsbRhbRsRsmbRgbRsRsmbsbRgbLsbRgRs
RsmmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 2; Drug: PCAP2 10 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 3; Drug: PCAP2 10 然
bsbRsbRhbRsRsmbLgbRsRgbRsLsbLgbLsbLsbLgbRsbLeRsbRiRsmbRsbRgbLgRsbLoRsR
sRgRsRgmmbRoRsmbRsRgRsmbRgLsbLibsbRsRsmbRsLsbLibRsbLgbLhbRsbRcbRgbRsRs
mbRibLsLsmbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 4; Drug: PCAP2 10 然
bRsRsmbsbLsbsbRsRsmbsbsbsbsbRsbsbsbRsRsmbRsLsRsbRsbsbRsbsbLsRsRsmbRsbR
sbRsRsmbRibRgbRgbRgLsbRsbsbRoLsLsmbRobRgbRgbRgbRgbLsbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 5; Drug: PCAP2 10 然
bLsbsbsbLebLebLsbLsLsmbLgbsbRsbLoRgbRgbRsbLgbRsRsmbRsLsLsLsRsRsmmmbRsb
LsbRgbRsbRsbsbRgbLiLsLsmbLibLhRsbRsLgbLgbRsbLsLsmbRsbLgLsbRsLsbLsbLgLs
bLibRsbRsbRsbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 6; Drug: PCAP2 10 然
bRgRgbRoLsLgbLgbRsLgbLgbLsLiRsbReLsLgLiLsbLsbsbRobLsLsmbLibLsLsRsmbRsL
sbRsbLhLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 7; Drug: PCAP2 3 然
bLsbRjbLsbRsbLsbsbLsRsLsbsbsbsbsbsbRsbRsbsbsbsbsbsbLsbsbsbLjbLobRsbLsb
sbsbRsbsbLsbLsbLsbLsLsmbRsLsbLsbLsbLsbRsbLsbLsbLsbLsbsbRsbsbsbRsbLgLsb
LsbRjbLsbsbsbLsbRgbRsbsbsbLsbRsbsbLsbLsbRsbLsLsRsmbRsbLsbLsbRsbRsLsbsb
RsbLsbRsbsbRjbLsRsLsbsbLsRsRsmbsbsbsbsbsbLsbsbLsbLsbLsbLsRsbLsLsLsmmbL
gbLsLsmbsbRsbLsbsbRgbsbsbsbsbRsbsbRsLsbLsRsbRsbsbLsbLsbLsLsmbLgLgbLsbR
jRsmbsbLsbLsbRsLsbsbsbLsbLsbLsbsbsbsbLsLsmbRsbLsbLsLsmbLsLsmbRsbLgbRsL
sbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 8; Drug: PCAP2 3 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbL
sbsbsbsbsbsbsbsbRsRsRsRsRsRgRsmmmmmbRsRsRsmmbRsRsmbRsRsmbRsRgbRsbRsRsm
bRgbRgRgbRsRsRsmmbRgbRsbsbsbRsbRsbRsbRsbLsLsRsmbRsbRgbRiRsmbRgRsmbRcRs
RsRgmmbRsbRoRsRsLsmmbRebLsRsRsmbLsbRsRsmbLsbRgbRiRgbRgbRobRhbRsbRcbLsb
sbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 9; Drug: PCAP2 3 然
bRsbRgbLebLsRgRsRsmmbLsRsbLobRjbRsbRsbLsbLjbLobRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 10; Drug: PCAP2 3 然
bLcbLsRsbLsbRsbRibRsbLsbLsbsbRsRsmbRsbRsRsmbRsbRsbRsbRsbRsbsbLsbRsRsmb
sbRsbsbRsbRsbRsRsmbRsbRgRsmbLsRsbRsRsmbLsRsbLgbRsbsbRgbsbLsLsmbRgbRsbR
sbLhbLibsbLiLsbLsbLsbLsbLsbLibLsbLgbRsbsbRsRsmbLgLsbLsLsmbLsLsLsmmbLib
LsLsmbLgbLsLsmbLsLsmbLsbLibLsbLjbLibLsbRsbsbsbsbsbsbsbLsbLsbLgbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 11; Drug: PCAP2 3 然
bRgRsmbLjLgbRibRgbsbRsbRsbsbsbRsbsbsbsbsbsbLsbRsbRsbLsbRsbRsbRgbRsbLsb
sbLjbLsbRsbRsbRibRsbLsbRsbRsLsbRsbRgbLsLsRsmbRsRsmbRsRsmbLsbRsbRsRsmbR
sbLsRsbRsbRgbLsLsRsmbRsbRsbRsRsmbRsRsmbRsbRsbRsbRsRsmbRsbsbRsbRsRsRsmm
bRsbRsbRsbRsbLsRsRsmbRsbLsRsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 12; Drug: PCAP2 3 然
bsbsbsbRsbRsbsbLsbRsbLsbsbsbsbsbsbsbsbsbsbRjbLgbRgbRsbLobLibLsbRcRsmbR
gRsRsmmbLsbLebRsbsbLsbsbRgbsbLgbLobRcbLsbLsbLsbRsbRibRsbRsbLsbRsbsbsbR
ibLsbRsbRsRsmbRgbLobRsbLgbLsbLsbRsbRibRsbRgbRgRsmbRsbLsbRsbRgbsbsbRsRs
mb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 13; Drug: PCAP2 1 然
bLsbLsbRjRgRsmbRsbLibRibRsRsmbLsLsLsmmbLsbRsbsbsbsbsbsbRibsbRgbRsbsbLj
LsLsmmbLjbRsbsbsbsbsbsbLibsbLiLsbLgbLgLsLsmbLsbRgRsmbLgbLgbLsbRsbRsbLi
bLgbLcbRsbLjLsLsmmbLgbLcbLsbRgbRgRsmbRjRsmbRsbsbLsbLgRiRsRsmmbLsRsRsRs
mmbRgRsmbRsRsRsmmbRgRsRsmmbRsRsRsmmbRiRsmbRibRgbRgRsLsmbRhbRsbRsLsbRsb
RibRhbRsbLsbsbRebRjRsmbRgbRsbRgbRsRsmbLibLsbRsbRcbRsRsmbRibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 14; Drug: PCAP2 1 然
bLgbLibsbLgbLgbsbsbLsbRibsbRsbRsbLsbsbLsLsmbRhbRgRsmbRsbLgbLsbRibRibRj
RsmbRibRsbLgbLsRibRibRsRsRsmmbRgbRjRgbLgLsbLjLsmbLsbRgbRibRgbRgbRsbRgb
LsbLgbLibLgRsbRsbRjbRcbLsbsbRsRsRsmmbRgLcbLcbsbLgbRjbRsbRhRsmbRjbLgbLi
LsbLebRsbLsLsmbLibRsbLgbLsbsbLgLsbLgbLgbLsbRgbRgbRgRsRsmmbRgbLibLibLgL
sLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 15; Drug: PCAP2 1 然
bRibRibRibLgbRcLsbLsLsmbLsbRsbLjbLibLibRsbRgbLibRsbLcbLobLsRsbLsbsbsbs
bRibRsRsLsmbLsbRsbLhbLsbLibLsbRibRebRibLcbsbsbLsRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 16; Drug: PCAP2 1 然
bRsRsRsmmbRsRsmbRsbRsRsmbRhbRsbLsbRsRsmbRiRsmbRiRsLsmbRcbLsbRebRsbRsLs
RsbLsbRsbRibLsRsbRsRsmbLsbRsbRgRsmbRgbLsRsbRsbLgbRobLcbLgbRgbRsbRsRgLs
bRsbLsRsbRsRsmbRsbLsbRsbRsRsRsmmbRgbRsLsRsbRgbRsRsmbLebLibRsbLsbLsbLsb
RsbLsbLebLebLsbRsbRgbRgLsbRgbRgbLgbLsbLsbLgbRsLsbLsbLcbLcLsmbLobRoRsmb
LsRcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 17; Drug: PCAP2 1 然
bsbsbLsbRgRsmbsbsbsbRibLsLsmbLebLsbRsbsbRgbRsbsbRcbRgRsmbRibsbLhLsLsmb
LjLsLsLsmmmbLsbRsbRsbRiRsmbRsRsRsmmbRhbRhbRsbsbRgbRgbRsbLgLsbRsLcLsRsR
smmbRjLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 18; Drug: PCAP2 1 然
bRsbLsbLhbLsRsbRsLibsbLhbRsbRsRsmbsbsbRsRsmbsbLsbLeLsbLsLsmbsbRsbLibRs
RsRsmmbLsbLsbLibLibRsRsmbRhbLibLsbLibRebRgRsmbLgLsbLsRsLsbLiLsbLibLgbs
bRsbRsbRsRsmbLibsbLhbLibLgLsLsmbLeLsbRcRsmbRgRsmbsbLgRsbLsRibRgbsbLcbR
jRsmbRibsbLgbLsLsmbRibLgbRsRsmbLsRsbRsRsRsRsmmmbLsLsmbRgbLsbLsbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 19; Drug: Control
bLsbLsbsbLgbsbLgbLibLcbsbLsRsbLsbRsbLsRsbsbsbRsbRsbRsLsbLsbLgbsbLiLsbR
sbLobRibRsbLgbLibRsRsmbLgbRsbsbLibsbsbLsRsbsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 20; Drug: Control
bsbLgbLsLgbLiRsLsbLsbLibLgbRoRsmbRcbRsbRsLsbsbLgbRgRsmbRsbRjRsLsmbRsbR
gbLsbLsbRsbsbsbLsbRsbLiLsbLsbsbLjLsmbRibRsLsbRebsbRhbLibRiRsmbRsbLsRsb
RoLsbReLsbLeLsbLibRsbLsbsbLgbLsbLibRsbRsbLobLsLsmbRsbRgbRcRsmbLibRgbRh
LsbRsbLobLsbLhbRsLsRsbLsbLsLsmbLsbLhbLsbLjbLibRsbLsbLibLhbRgbRgbLgbLhb
LiLsbLsbLsbLgbRgbRsLsLsmbLsbLibLsLsmbRsbLhbLgbLibsbRsbRsbRsbLjbLibRsLs
bLibRsbsbRsbLgbLsbLsbLsbLgbLsLsmbRgbLibLsLiLsbLibRjbRsbLsbLgbRgbRsbLsb
sbsbsbsbRsLsbsbLebsbLiLsLsmbLgbLhbRsbRgbRsbLibsbLibLibRibRsbLibLibRsbR
sbLgbRsbRiRsmbRsbRibRsbLsbRsbRsLsbRsbLsbRsbRhbRiLsbRsbsbLibLsbLhbLcbRs
bRsRsmbRgbRibsbsbsbLebLsRsbLiLsbLsbRsbLibRsbRsbLsbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 21; Drug: Control
bLgLsbRcbsbRgbsbLgLsbRgRsmbLsbRibLsLsmbRgRsRsmmbRibsbRgRsmbLsLsmbsbRsR
smbRsbsbRgbsbRibsbsbRsbLsbRsRsmbRiRsmbRsbRsbRgbRgbsbsbRibLgbLiLsbLgbRs
bRjRsmbLsLsmbLcbLgRsbRsRsRsmmbLibsbLgLsbLsLsmbLsbLgbLsbRsbLsbLjLsmbLgb
RsbsbRibLsbRcRsmbRcbsbRgbsbsbRsbsbLsbRgRsmbLsbLsLsmbRhbRibRgbRsbRiRsmb
RsbRibRsbLgLsLsmbRibLsRsLsbLgbLiLsbsbLjLsLsmmbLjbRsbRgRsmbLjLgbLeLsbsb
LibLsbLgbLsLsLsmmbLibLsbLgbLgbRsbRjbLgbsbRsRsmbLgbLjbLjbLsbLjLsmbRgbRs
bLcbLsbLgbsbLsbLsLsLsmmbsbRsRsRsmmbLgbsbsbRiRsmbLsbLgbLhbRgbsbRsbLibsb
sbsbRsbRsLsbRsRsRsmmbLsbLgbLsRsbLsLgbRsLsbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 22; Drug: Control
bLibRobsbRobLjLgbRobRsbRiLsRsbRibRgbsbsbRsbsbsbRgbsbRgbLgbRsbLsbRsLsbR
gRsmbRgRsmbRgRsLsmbLgLsbRibLsbLjLsLsmmbLobRibLgbRobRjRsRsmmbRiRsmbLiLs
bRsRsLsmbLibRjbRobRibRgbRsbLjbReRsLsRsmbRgRsmbLsbsbRsbRcLsbRiRsmbRiLsb
RiRsLsmbRibLjLgbLgLsbRgbRibLgLsbRgRsmbsbLsLgLsbRsRsmbsbsbRgbRgbLjLsmbR
hbRgbLsLsLsLsmmmbRsRsmbLgLsbRjbRsbsbLiLsbLgbLgbLsLsLsmmbLgbRsLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 23; Drug: Control
bLhbLibRibRsbRgbLsbLsbLcbRibLgbsbLgbRiLsbLcbRsbsbLjLsLsmmbRjRsmbLgLsbL
ibLsbLsbLsRsbLsbsbLsbsbLsLsmbLsbLsbsbsbLsbsbLgbsbLjbsbLsbsbsbRsbLjbsbL
gRsbsbRgbLsbLjLsmbLsbLgbLiLsbLcLsmbRibLobLgbLsbRibLibLjLsmbsbRgbLgbLgb
LgbRjLsbRcbLsbRgbRgbRgLsbLsLsRsmbLsLsmbRsbLsRsbRgbRsbLgbRgLsbRsbLsbRib
sbRgbsbLcbLibLsbRsRsmbRsbLsbLsLsmbLibLhbRgbLgbLsbRsbLsbLsbLgbRjbLsbRib
RiLsbRgbLsbRibRgRsmbRsbLcbsbRibRobsbRcbLiRsbRgRsmbLcLsmbRibLcbsbRibLib
RsLsbLibLsbRsbRcbsbLibRsRsmbLjLsmbsbRgbRibRsbLsbLsLsmbRsbRsbRgRsmbRgbR
cbLhbRibsbsbLsbRsRgbLgbRibsbRibsbLsbRsbsbRsbRibsbsbsbLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 24; Drug: Control
bRgbRsbLgbRibsbLibRibRsRsRsmmbRsbRsbRsRsmbRibRgbLibLsRsbRcRsmbLgbsbLsb
RibsbsbLiLsbLcbsbsbRsbRsRsmbLibLsRsbRgbRsbLsbsbsbsbRsbRsbsbLsbRsRsRsmm
bRiRsmbRsbsbRjRsRsmmbRjbsbRsbRsLsbsbsbRjbRsbsbRibsbsbsbRsbsbLsbLgbRcRs
mbRgRsmbLibLsbRcbsbsbRibRsbRsbRibsbLebRsbRiRsmbRhbLgLsbLgbRibRiRsmbRsb
RsRsRsmmbLgLsbRhbsbRcbRsbRibLgbLjLsmbLsbLgbLgbLgbRgRsmbRsbLsbRsbLibLsR
sbLcbRgbRsLsbLibLgbLgbLgLsbLsbRgbLgbLiLsbLgLsRsbRsbsbLiRsbRsLsbLibRsbR
jbRiRsmbLjbLsbLhbLsLsmbLgbLiRsbLgbLsLsLsRsmmbLibRjbRibRibRhRsmbRsLsbLc
bLhbLibRhRsmbLsbLcLsRsmbRibRcRsmbLibLebLibRsbsbsbRgbRsbRjbRgbRibLsbLsb
RibRibRibRsbLibRibRsLsbRsbRibLgbRibsbRsRsmbRsLsbRibRgbLsRgbRsbLsRsbRib
LsbRibsbLgbRsbRsbRsbLsbsbsbsbsbsbsbsbLcbLcbLibRgRsmbRgbRibLsLsLsmmbRsb
RgbRsbRgbLjbLcbLhbRiLsbLsbRsLsbsbLsbLgbLgbLsbLiRsbLsbsbLibLibsbRhbRsbR
sbLsbsbLcbLibLsLsmbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 25; Drug: PCAP2 10 然
bLsbsbsbsbRsbLibRsbsbLsbsbRsbRjbsbRgbLgbLsbsbLsbRsbRsbsbRsbLsbRsbRsRcb
RsbRebRgbReLsbLcbRsRsmbRsLsbRsbLgbRsbRgbLsbLsbsbLsbLsbRebRsRibRsbRsbRs
bLsLsRsmbLgbLoRsRsmbLebRsbRgbRsbRsbLgbsbRsbRibLsbLsbRsbRsbRsLsbRsRsmbR
sb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 26; Drug: PCAP2 10 然
bsbLsbLsbsbsbsbsbsbsbRsbLgLsbsbLsbLeLsbRsbRsLsLsmbsbsbRsbLsbLsLsLsmmbR
sbRsbsbLsbRoRsRsmmbRsRsmbLcbLsbRsbRobsbRsbRsbsbsbsbsbRsbRgRsmbLgbRgRsm
bRebRoRsmbRsbRcRsmbRsbRsbRgRsmbRgLsbRobLsbLeLsLsmbLoLsmbLsLsmbLsLsmbRs
LsbRiRsmbRibRoLsbLsbLsbRsbLgbRsbsbsbsbLsLsmbsbRsbsbsbRibLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 27; Drug: PCAP2 10 然
bRibsbRsRgbRsRgRsmbRsRgRsmbRsLsbLibLebLiLsLsmbRsLsRsbRsRsmbLibLsbLsbLs
bRsLsLsmbLsbLjbLgLsbLebsbRsRsmbLibLsbLibLsRsbLsbLsLsmbRsbsbLsbRsLsbLsR
sbRsLsbRsbsbLoLsmbsbRsRsmbsbsbLibLgLgbLsLsLsmmbRsbLsbLgRsbLibRsbLgLsLs
LsmmbLeLsbRsRsLsmbLibsbRsbLibLsLsmbLsbLsLsLsLsLsmmmmbLsRsbRcRgbRgRsRsm
mbsbRgRsRgRsRsmmmbLsRsRsmbLsLsmbsbRsbRgRsmbRsbRsbRsbRsRsmbRsRsRsmmbRsb
RgLsbLjLgLsbRsRsmbLsbLjbLibLsRsbLgLsbRsbRsRsmbLsbLsLsmbLsLsLsLsmmmbLsb
LsLsLsmmbLsLsmbsbLsLsLsmmbRobRsRsmbLibRobRsLsbLsbLibLgLsbLsLsmbLsLgbsb
LsbLsLsLsmmbLgbRsRsmbRsRsLsmbLibLsLsmbLsLsmbLgbLsLsmbLcLsmbsbLgbLgRsbR
sbLsbRsRsmbRsbRsbsbsbsbsbsbsbsbsbsbsbRsbRsLsbRsbLsRsbRsLsLsRsmbsbsbsbL
sbsbsbRsbRsbRsbLjbLsbLibRsbRsbRsbsbLgbLsbsbLiLsLsLsmmbRsbLsbsbLibLobLi
b

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 28; Drug: PCAP2 10 然
bRcbsbRsRsmbRobsbsbLgbLsbLgbLgLsbLsbsbLcbRsbsbRsbsbsbsbsbsbsbsbRgbLoLs
mbRcbLsbsbsbsbsbLsbsbLsRsRsmbRsbLsRsbRoRgbRsRsLsmbLsbLibLhbLsbLsbLsbRs
LsbLobsbLsRsbLgbRcbRgbsbsbRsRsRsmmbRsbRgbRsRsmbRgbRgRsmbRhbLiLsLsmbLib
LsbLibLiLsLsmbLibLsLsmbRibRoRsmbLsLsmbRsbLobRsbRobRsbRsbsbRgbRgRsmbsbR
sRsRsmmbLsRsbRsbRsbLjbsbLsRsbRsRsRsmmbLsRsRiRsmbLebLcbRsbLobRsbLsbLcbR
gbsbLgLsbLiLsbRjbLgRsbsbsbRjbRgRsmbRsbsbRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 29; Drug: PCAP2 10 然
bRibRsRsmbRsRgbRibLgbLsbsbRcbRsbLsbRsbsbRsbsbsbsbsbsbRsbRsbLsbsbLibLgb
LsbsbsbLsbRsbLjbLgbLgLsbsbsbsbsbsbsbsbLsLgbLsbLsbLsbsbLsbRsbRsbsbsbRsL
sRsbLgbLibRsbRcbLsbsbLgbsbsbLsbLsbLiLsbLsbsbRsRgRsLsmbRsbRsLiLsbLsLgLs
bRsbRsbRsRsRsLsmmbLsLsmbLgbRgbLsbLgRgLsbLsbsbRsbsbLsbLsbLsLgbRebRsbRib
LsbRsbRgRsRimbRsbsbsbLsbLsbRgbRcbsbLsbRsbLsbLsbsbsbRsRsmbRsbsbsbLiLsRs
LsLsLsmmbRsRsmbLsLsLgmbsbsbLsbLgbLsLsmbLcbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 30; Drug: PCAP2 10 然
bReRgbLcLsmbRsbLgbRsRsLsmbLsbLjbRiLsbLsbLgLsbLibLibRsbLibRhbRhbRsbLcbL
sbRsbLgbLiLsLibLeLsLsLsRsLsmmbLiRsbRgbLcbRiLsbLibLgbLcbLcbRgbRibRsbsbR
gbRsRibRgbsbLsbLsbRsbLsLsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 31; Drug: PCAP2 3 然
bRsbsbRsbRsbRsbLsRsRsRsmmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 32; Drug: PCAP2 3 然
bsbLgbLsLsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 33; Drug: PCAP2 3 然
bLsLsLgmbLjLibLsLgbsbLsLsmbLeLsLsLsmmbLsLsmbLsbLjLgLsbLgbLsLgbLsLsLsmm
bsbRsLsLsmbLcbLgLsbLsLsmbLcbLsLsmbLibLgbRgbLsbLsLsLsmmbLjbLsLsmbLsbLsb
sbsbsbLsLsmbLsLsmbLsLsLsmmbLgbLsbLcbLsbRsbLhbsbLsbLsbLcbsbsbsbRsbRsbRo
bLsbLsbLcLsmbsbRsbRsbLsbsbLcbsbRsbRsLsbLhbsbRsbLcbLsLsmbLsLsmbLcLsmbRs
RsLsmbLsbLiLsbLibRjbLcLsmbLsLsmbRcbRgRhbRcbLsbLgbLcLsmbRibsbLcRsbLgbLs
LsmbLsbLsbLgRsbLobLsbLsbLsLcbRcRsmbRsbRsLsbRibLsbLsRsbRibLsRsbsbsbRibL
sRcbLsRsbRsbsbRsbLsbRsLhLsLsmbRsLsbRsbLiLsLsLsmmbRsLsLsmbsbLgbLgbLsbLg
bLsLsmbLsbRcLsbRibRebRgbRsbRsLsbsbRsbRsLsbRebLsbLibRhbRsLsRsRsmbsbRsRs
mbRgRsmbRsRsmbLsbLsbRsbRsbRcbRsLgbRibRsbRcRsmbRsbLgLsbRcLsbRiRsmbRsbLc
bLiLsbLsbRjRoLsbLsbLeLsbLgbLgbRjbRsRoLsbLsbLsLsmbRiLsbLjbRiRsmbRsRsmbR
iRsmbRsLsLsmbLsbRsbRsRsRsLsmmbLsLsmbRibLibRcbLgbRhbRibLsbsbRsbRsbRsLsb
RsRsRsmmbRgbRgbRcbLsLsmbLibLibRobRsbRibRsRsmbRiRsmbRsbRgRsmbRsbsbsbRiR
smbLsRsbRjLsLsLsmmbLsbRsRsmbRgbRsbRebLiLsbLgbRgbRsRsLcLsmmbLibRsLsLsmb
LsbRsRsmbLcLsLsmmbLsRgLsRsbRcbRsRsmbRgRsmbRgbRsbRsRsRsmmbRibRhbLjbRibR
gbRibLjbLibLiLsbLgbLgLsbRcbLcbLsLsLsmmbsbLsbLebLgLsLsmbsbRibLsbRsbLiLs
LsRsmbLsLsLgLsmbRjbRcbRiRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 34; Drug: PCAP2 3 然
bLsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbRsbsbRsbRcbRiLsLsRsRsmmbRhbsbRgbRcbLs
bRiLsbRcRsRsmmbRsRsmbRiRsmbRiRsmbRsRsmbRsbRsbRgbLsbReRsmbRcbRhbsbLsbRs
bRsbRgbRgRsmbsbRiRsRsmmbRcbLsbLsbLcbRiRsLsmbLsbRsbRgbRibRsbRsbRsbRsRsm
bRobLsbRcRsmbLsbRsbRsRsmbRibRsbRgRsmbRgbRgRsmbRsbLsbRiRsmbLgbRsbRsbRsb
RsbRgRsRsmmbRsbRgbRsbRsRsmbRsbRgRsmbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 35; Drug: PCAP2 3 然
bLebsbLebLjLsmbLsLsmbLiLsbLgLsLsLsmmbsbRiRsmbRsRgLsbLgbLsbLsbsbLsbsbRs
bLibRibRsbLgLsLsmbRjRsmbRgbRjRgRsmbRsRsmbRsbsbsbRsbRgRsRsmmbRsbLsbRebR
jRsmbRsbRjRgbRsRsRsRsRsmmmmbsbRgbRsRsmbRsbsbRsbRgRsmbRgbRibRgbRgbRsRsm
bsbLiLsbsbLibLsLsmbRjRsmbRsRsRsRsRsmmmmbsbRsbRibRgRsmbRsbRsbRsbRgRgbRs
RsmbRgbRsRsLsmbRsRsRsRsmmmbRibRibRibLcbLhbRiRsmbRibRsbRgbRibsbLibsbRgb
RiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 36; Drug: PCAP2 3 然
bLsbLsbsbRsLsbsbRsbLsbRsRsmbRsLsbRsLsbRsbLsbLsbLsbsbLsbLsRsbsbLsbsbRsb
LsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 37; Drug: PCAP2 1 然
bRcLsbRsLsbLcLsmbRgRsmbLibsbsbsbsbsbRsRsRsmmbRcbsbsbRgbRsbsbsbRsbsbsbR
sbRibRsRsRsRsmmmbRgbRsbsbsbsbLsbRcbLgbsbRoRsmbRhbRgRsmbRgbRsbRsRsmbRcb
LsbRibLgbRgRsRsRsmmmbRiRsmbRsRsmbLibRcbLsLsmbRcbLgbRcbsbsbsbRibRibLsRs
bRiRsmbsbRiRsmbRsRsmbRibRcLsbLgbLsbLsbLsbLsLgbsbRsRsmbLibLgLsbRgRsmbLj
LgbLsbLsLsLsmmbsbsbLsLsLsRsmmbLsLsmbRsbLiRsbLgLsbRjRsRsmmbRcbLgLsLsmbR
hbsbRibLgLsbsbRsRsmbRibLsbLjLsmbLeLsbRsbsbsbRsRgbLcLsmbLgLsbRgbLsbLibR
gRsRsmmbRsRsmbLhbRjbLcLsmbLgLsbsbRcbRcLsbRhbLgbRhbLgLsbRcbLsbRgbsbsbLc
b

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 38; Drug: PCAP2 1 然
bLcbLjbsbRiRsmbRcbLhbLcbLjLsmbRsbRsbRgRsmbRsbRibRgRsmbLibLiLsbLsbsbsbL
jbsbsbLibRcbLsLsmbsbLsbLibsbLsLsmbLgbRibRgRsmbRibLgbLjLsmbLcbLibRibLib
LhbLibLiLsbLgbLgbRsbRsbRsRsmbRibLsLsmbLcLsmbLjbLcbLibLsbLjbLiLsbLjLsmb
RjRsRsRsmmmbLibsbLjbRjRsRsmmbLgbLsbsbLsLsmbLsbLsbRsLsbLsLsmbLgbLgbLsbR
sRsRsRsmmmbRsbRibLjbRhbLsLsLsLsRsmmmbLjbRibRsbRiRsmbRsbLsbLgRsbRibLjbR
cbRgRsmbRsbRibRgbRcbRibRsbRgRsmbsbRsbRgbRsRsmbRsRgbsbRiRsmbsbRgRsmbRgL
sbRgbRgbLsbRgbRsbRsbRgbRgLsbRgbRsbRgbRgRsmbLsbRsbRgRsmbLsbRgbLsbRsRsmb
RgLsLsRsmbRgLsbRsRsmbLsbRgbRsRsmbLsbRcbLgbRsbRjRsRsmmbRgRsRsmmbRgbLsbR
sbRsLsbRhbRhbLsbLsbRjRsRsmmbRsbRsbRiRsmbLgbRsbRibRsRsmbRgbRsRsmbRgLsbR
gbsbRgbLgLsLsmbRibLcbLcbRsRsRsmmbLgbsbsbLgbLgbRgbLibLibRgbsbRsRsRsmmbL
ibLibLibRgRsmbRsRsLsmbLsLibRsRsmbLgbsbLhbLcbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 39; Drug: PCAP2 1 然
bRhbRgRsRsmmbLiLsbsbLgbRgbRgbRibRsbRgbLibLgbLsbRsbsbsbRcRsmbLgbLjbLsbR
sbLsRsbRjbLobRhbRgbRgbRiLsbRcbsbRgbsbRjRsmbLsbRibsbLsbRibRjRsmbRgbRjRs
mbRcbRjbLebLsbRobRhbLibRgbRjRsRsRsmmmbLsLsmbRgbLgRsbRibRsRcbRjRsmbLibR
iRsRsmmbRibRhbLgbRsbRsbRibReRsmbRibRibLobLgLsbRgbLcbRcbRobRgbRgbLiLsbR
sbRibLsbLjbRibRgbRsbRsLsRsbLsRsbRcbRibLgbRgbRgRsmbRgRsmbRgbRgbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 40; Drug: PCAP2 1 然
bRsbLgbRhbsbsbLsbRgbRsbRibRibsbsbRibLsbsbRsLsbsbLsbLsbRsbsbRsbsbsbRiRs
mbsbRgbRsbRsbRgbsbRsRsRsLsmmbLsLsmbRsRsmbsbsbLsbsbRsRsmbRsRsmbLgbLiLsb
LsLsmbLsbLsbLsbLgbLgbRgbRgbRsbRibsbsbLjbLsbRsbRsbLsbsbRgbLsbLsbLsLsmbL
ebLiLsbLibLcLsmbLsbLibLibLgbRsbRjbReRsmbRgbLsLsmbLsbRjRsmbRsRsRsmmbLjb
RiRsRsmmbLsLsmbRgbLhbsbLiRsbsbLgLsLsmbLibLsbsbLiLsbLsbsbLgbLsbLgbLgLsb
RcbRhRsmbRibRgbLsbLibRibRgbsbsbsbRibRgbsbRsbRsbRgbsbsbRsbRgbLsbRcbLibL
cbLibLgLsbsbsbLiLsbsbsbRibRgRsmbRsRsRsLsmmbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 41; Drug: PCAP2 1 然
bsbLgbsbsbLgLsbLgbsbRsbRsRsmbsbRsRibRibsbRsbRiLsbsbRsbRjbsbsbsbLgbLgLs
bRsbRsbRsbRsbRibRsbsbsbsbRsRsmbRsRsmbLgbsbLsLsmbLsLgbLobsbRsbLibRsbLgL
sbsbLhRsbLiLsbLsbsbRsLsbLsbRsbLgbLibLsbRsbLcbsbRgbLsbLsLgLsbLcbLsLsmbL
sbRsRsmbLibLsLsmbsbLsbLibLsLsmbLsbLsLgbLsbLsbLsbLgbsbRjRsmbLhbLgLsLsLs
mmbLsbsbRsRsmbRsbLgbLibLsbRsLsbLsLsRsmbsbLsLsLsmmbsbRsRsmbLgbsbRsLsbLs
LsmbLsLsRsLsmbLsbLsLsmbLgRsLsbLsLsLsmmbsbRsRsmbLgbRsRsRsmmbLibLsbLsbsb
sbLsLsmbsbRsLsLsmbLsbLsLsmbLsRsbLgbLsbRsLsbLgbsbLsLgbLsLsmbLsRsLsbsbRs
bLgbRsbRgLsbsbLibLsLsmbRgbLgbLcLsmbRjbLibsbLsbsbLgbsbRjbLibLgLsbLsbsbL
gbLgbsbLsLsmbLsbLsbRiRsRhmbRibRgbLgLgLsbRsRsmbLsbRibLsbsbRsRsRsmmbsbsb
sbsbsbsbRsbRgRsmbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 42; Drug: PCAP2 1 然
bReRsmbLibLibLgbLsbLgLsbLgbLgbLgbLgbLgbLsbLgbLgLsbLgbLsbRsLgbRgbsbLhbs
bRcRsmbRobLsbRhLsbRhLsbRibLibLsbLibRsbRhbRgbRhbsbsbLgbsbLobsbsbRsbLgbs
bLsbsbRebRsbsbLobsbRibsbsbLsbLsbsbLoLsmbRjbLibRsbsbsbsbsbLibsbLibRsbRs
bLibLsLsmbLgbLsbLgbRsbLhLsbsbLsLsmbRsLsbLgbLibLsbRibLibRjRsmbRibRibRsb
sbLsLsLsLsmmmbLsbRcLsbRibLsbLiLsbLsbRibRiLsbRsRsmbLjLsLsmmbLhbsbRcbRib
LsbLsbRibRibsbRsbsbLsLsmbRsbRibLsbRiRsmbRjRgbLsbLsLgbRibLebRibRiRsmbRh
LsbLsRsbLsbLsbRhbRiRsmbRsbRcbRsRgRsRsmmbRsbsbLibLsbRcbRibLsbLsbRsbRibL
sbRgbRibLsRsbLsLsmbRcbLsbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 43; Drug: Control
bRsLsbLhbLgbsbLsLsmbRsbLsbsbLjLsLsmmbLsbsbLgbLsLsmbLsRsbLsLsLsmmbLsbLs
bRsRsLsmbLsLsmbsbsbRsbsbRsbRsbLjbLsLsmbsbRibLgLsLsmbRsbRsbLsbRsLsbLsbL
gbLsbLsRsLsbLsbLsLsLsmmbLsbsbsbLjLsmbLsbLsbLgbLsbLgbLsbRsRsRsmmbRsRsmb
RgRsLsmbRibLsbsbsbRgbRsRsmbLibRhbRibsbsbRgbRsbsbsbLebLsbRsbRsbsbLiLsbL
sbLsRsbLsbLgbLsLsmbLsbRgbLgLsbLsbsbLjLsLsLsmmmbLibsbRgRsLsmbRsLsbRsLsb
LgLgbRsLsbRgbRibRiLgbLiLsbLhbsbLibRibRgbLgbLibLgLsLsmbLgLsbLgbLsbRsbRs
RsmbRsbRsRsmbRsLsbLgbLgLsLsmbsbsbRgbLibsbLgLsLsmbRibLibLibLsLsmbsbRsLs
bLibsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 44; Drug: Control
bRgbLgLsbsbLiLsbLhbRiLsbsbLgbLsLsLsmmbLgbRsbRsbRsbsbsbsbsbsbLsbLsbRsbL
sbLsRsbLsbRsbLgLsbRsbRjbLibLsbLcbLsbRgbLgbLsbRsLsbLsbLgbLsbRsbRsbLgbRs
LsbLsbRsbRsLsbLsLsLsmmbRsbLsRsbLsLsmbLsbLibLiLsbRgRsmbRsbsbLsLgbRiRsmb
sbRibRsbLsLsmbsbLgLsbLgLsbLsLsmbLsLsmbsbLibLibRsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 45; Drug: Control
bRsbLcbLibLgbLsLsLgmbLgbLibLibLiLsbLgbsbLsLsmbLgbLsbLsbLgLsbLiLsbRgbLg
bLgRibLgbRibRsbRgbRjbsbsbLcbLsbsbLibsbRsbLibsbLsbRgbLibLibLgbLgLsbRsbL
gbLibRcbRibRibsbRgLsbRgbRgbLgLsbLjbLiRsbsbRiRsmbsbLgbsbLjbRibsbLhbLsLs
LsmmbLjbLsbLgbLcLsmbRgbRjbRiRsmbLsbRsbsbsbsbLsbsbsbRsRsRsmmbRgbRsbRgbR
gbRsbRgbLsRsbRgbLsbRgbRobRhbLgbRibRiRsmbRsbRsbRgbRsRgRsmbRsbRgbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 46; Drug: Control
bRgbRsbRsbRsRsmbRsRsmbRsbRsbRsbRgLsbRgbRgbRgbRgbRgbRgRsmbsbRsbRgbRsbRg
bRgbRgbRgbRgbRgRsmbRgbRgbRsRsmbRsbRgbRgbRgRsmbRgbRgbRsRsmbRsbRsbRsbRgb
RsRsmbRgbRsbRgbRsbRgbRsbRgLsbRsbRsRsmbRgbRgbRsbRsbLsbRsbRsbRsbRgbLsRgb
LsbRsbRsbRgbRsbRsbRsbRsbRsbLsbRsbRgbRgbRsbRgbRibRsbRsRsmbRgLsbRgbRgbRg
bsbRgbRgbRgRsmbRgRsmbRsbRsbRgbRsbRsbRsbsbLsbRsbRgbRsbRgbRgbRgLsbRgbRgb
RgbRgbRgRsmbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRibRsRsmbRgbR
gbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgLsbRgbRgbRgbRgbRsbRgbRgbRgLsbR
gbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRibRgbRg
bRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsbRiRsmbRgbRgbRgbRgbRgbRgbRgbRgbRsbRsb
sbRgbRgbRgbRgbRgbRgbRgbRgbRgbRobLobLsbLgLsbRsbLsbLibRsbLibLsRhbRcbRgRs
mbRsRgbRgLsbRsbRibRhRsmbLsbLsbRibRgbRgbRgRsmbRgbLjLsmbRjbRiRsmbRgbsbRi
bRgbRsbRgbLsbRibsbRibRsbLcbLibRebLibRcRsmbLsbLsRsbLibRibRgbLsRsbRgLsbR
gLsbLsbRibRsbRsbRgbRsbLebRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 47; Drug: Control
bRobRsbRhbLibRcbLsbRibRgRsRgmbLjbLhbRjLsbLsLsmbLcbLhbRgbRsbRibRcbLibRi
bLcbLgbsbRsbsbRsLibLsLsLsmmbLibRjbLsbLgbLibRjbLibLgbLsbLgbRsbLgbLibLcb
RhbRibRgbRsbRobsbLsbLsbLsbsbsbsbLsbRibRsbRgbRsbLsLsmbRhbsbsbRgbLgbRjbL
ibsbsbLgbRsbRcbRiLsbLjbLcLsmbLgbLgbRsLgbRjbLgbLibsbLjbsbLgbsbsbLsbsbsb
sbLsbLgbLsbLgbLgbLsbRjbRcbRibLcbsbRjbLcbLcbLgbLgbLsLsmbLsbLgbsbRgbLgbL
sLsRsLgmbRgbLjbLgbLgbLgbLgbLsbLgbLsLsmbLgbLsbLsbLsbLgbsbLgbLsLsmbRsLsb
LgbLibRebLsbRgbRgbLgbLcbRibRsRsmbLsLsmbLsbRgRsmbLsbRiLsLsLsmmbRsbRgbLh
bLhbRjbRibLjbRhbRiLsbLjbRibRsRsLjmbLgLsRsbsbRsbLgbLsRsbLgbLgbRjbLibLsb
LgbLgRsbLgbRsRsmbLgbLibRebLsbRjbLibLgbsbLgbLsbRsbLibLebRibLhLsbLgLsLsm
bLobLcRsbLhbLibLibRcbRcbRoRsLsRsmbLsbRgbRibRiLsbRgbLjbLhbLibLsRsbLgLsb
LsLsmbRsLsbLibLhbRgRsmbsbsbLsbLibLibLgLsbRsLsbLgbLibLgLsbRsbLibsbRjbRs
LsbLjLsmbLgbRjbLhbRjRsmbLibLobLiRsbRiLsbLcbRibRsLobLibRjRsRsmmbLcbLcbL
hbLgRsbLsbRsRsRsmmbLibRjbLiLsbLiRsbLgbsbRgbLibLgLsbRibLsbLiLsbLibRsbLg
bLgLsbRsbRsRsRgmbLsbLhbLsLsLsmmbRsLsbsbRsbRsRsmbLhbRjbRgRsmbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 110612; End: 111115;
Recording: 10-1; Individual: 48; Drug: Control
bRjRsRsmmbRsRsmbRgbRhbRcbRgbLsbRgbsbsbsbRibRsbLsbsbLibsbRibsbsbLcbLibL
gbLsLgbRcbRibLibRgbRcbRcLsbLibRcbsbRcbRhbLcbsbLiLsbLsbLibRibLiRsbRhbLi
bLjbRoLsbRibLgbLiRsbLgLsbRcbRcLsbLcbLiRsbLibsbRcbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 1; Drug: PCAP2 10 然
bRgRsmbRgbRgbRsRsmbRgbLsRsbsbRsbRsbRsRsRsmmbRsRsmbRsbsbRsbRsRsRsRsmmmb
RgbsbRsbsbRibRsbRgRsmbLsLsmbLsbRsRsmbRgRsmbRsRsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 2; Drug: PCAP2 10 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 3; Drug: PCAP2 10 然
bRjbLgbLsbsbRgRsmbLgRjbLsbLsRsRsmbRsbRsbsbRsbsbsbRsbRsbRsLsLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 4; Drug: PCAP2 10 然
bRsbLsbRsRsmbLsRsRsmbLsLsLsLsLsLsmmmmmbsbLsLsmbRsLsRsbLsRsLsLsmbRsbRsR
smbRsbRsbReRsmbRsRsmbRcLsbRsbRsbRgbRsLsbRoRsRsmmbRcRsmbRgbRsbRebRoRsmb
RsLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 5; Drug: PCAP2 10 然
bLiLsbLgbLsbsbLgbLsbLsbLgLsbLsbRsbLsRsbLsbRibLgbLebRiRsmbLgbRsRsLsmbLg
bLhbLebRsbLgbRsbLsbLsbLhbRiRsmbRsLgbLgbRgbLebsbRsRsRsmmbLsbRgbLsbRgbRi
bRobLsbLsbRgbRsLsbRgbLsbRsRsmbRgbRsRsmbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 6; Drug: PCAP2 10 然
bRjbRobLsRsbRibRsLcbsbLoRsbLcLgRsbRsbRjbRgbLsbRiRsmbsbRsRsmbLeLsLsmbLg
bRgbLgbRebLebLsbRebLsbLgbLsRsbRsbRcbRibRcLgLgLibLsbsbsbRsbLsbsbsbsbLeb
LsLsmbLibLsRoRsRsRsRsmmmmbRsbRgbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 7; Drug: PCAP2 3 然
bLsLsmbsbRebLsbRsbRjbRoLsbLsbLsbsbsbsbsbRsbLsLsmbRobRebRsRsmbsbRsbLsRs
bRsLsbRsbRsbsbRsbsbsbsbLsbsbLsbLsLsLsmmbRsLsRsbLsbsbsbLsbLgLsbRsbsbLsb
sbLsbLsRsbLibRiLsbLgbRcRsmbLsbLgbLsbRsbLsbRsbLsbLsbsbRsbRsbLsbLsbRsLsR
sLsRsRsmbRsbsbRsLsRsbRsbRsRsmbRsLsRsLsbLsbLsbLsLsmbLsLsLsmmbLsbsbLsLsm
bLsbRsbLsbsbsbsbsbsbLsbsbsbLgbRjbRsbLsLsmbsbsbsbsbsbsbsbsbsbsbLsbLsbsb
sbsbsbsbsbsbsbsbsbLsLsmbRjbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 8; Drug: PCAP2 3 然
bRgRsmbRsbRsbRsRsmbRsbsbsbsbRsLsbRsRgRsLsmbRsRsmbRsRsRsmmbRsRsmbRsbRgb
RgbRsbRsRsRgLsRsRsRsmmmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 9; Drug: PCAP2 3 然
bLobLcbRebRcbLibRgbLebRobLibRibRcbLibRobLebRgbRobLebRgbRebRcbRebRobRob
LsbLobRibLcbLcbLebLcbRebLobRebLcbLsbRcbRobRibLebLibLobRebRobLcbRibLcbR
cbRobLebLsbLcbLobRobLcbLcbRobLebLgbRobRcbRebRebLobRcbLibLobLobLcbRobLo
bLebRebLobLobLobLobRobLsbLsbRgbRibRobLgbRobLsbLsbLobRebLibLobRsbRebLeb
RobLgbRobRebLebRcbRcbLgbRibRcbLobRebLobRibRhbLobLsbLcbRebRobRebLobRcbL
sbRibRsbRobRobRsbRibLobRobRobRobRobLibRgbRibLebLobLcbLobLebRobLsbRobLo
bLsbRobLobLibRobLcbRcbLobRgbRobLibRcbRobLobRebRobLobRibRobRobLebRebLcb
RobLcbLobRebRobLobLgbRebLcbLgbLobLebLobLgbRobLobRsbRebRobLobRobRebRebR
obRcbRibRcbLobRgbRobLebLebLobRebRsbLcbRsbRebRobLebLebLebRcbRebLebLobRe
bRobRobLobRcbLobRebLobLsbRobRgbRebRobLibLobLcbRobRobLebRcbLibRcbLobRob
LcbLebRgbRobLebRibLobLobRobLobLgbLobLebLobLebRobRobLcbLobLobLobRebLebL
sbLgbLobRobLsbLibLebRobLebRcbLobRobLobLobRobLobRibLcbRebRobLobRcbLcbLe
bLgbLcbLebLebLibRobRebLebRobLebLobRibRcbRsbRobRobLobRhbRobRobLjbLobLcb
RcbRibLobRobLobRsbLobRebRobRebRobLebRobRobRcbLsbRobRcbRobLcbLcbRobRcbR
ebLibLobLebRebRobLebRebRcbRcbLebRibLsbLobLobRobLobLobRebLibRobRebRibRh
bLobRobRgbLobRobRebRcbRobLcbLobLibLebLobRobRobLobRsbRibLebRcbLcbLobReb
LobRibRsbRcbLebLcbLobLobLhbLcbRgbLobLobRobLebLobLcbLebRgbLebLcbLcbLebR
ebRebRibLsbLobLebLcbLobRebLobLcbRibLjbRebRobLobRobRobLebRibLebLebRcbLo
bRobRobRobRobRcbLcbRobLibLcbLcbLsbRobLcbRobLcbRibRebLcbRobRsbRebLobLhb
RobLhbRebLobLebLobRobRebRobRobRobLebRhbRobRgbRebLebLobRobLobRobRibRobL
ebRcbLcbLcbLibRhbRcbRobRobRobLobLobLsbRobRobRobRgbLebRobRsbLgbRebLobLc
bRobLebLobLcbLcbLobRcbRobLgbLcbLebRebLobLcbRebRgbLebRobLobLebLobLobRob
LibLobLobLebLcbLobLobRebRcbLobLobLebLobLcbRibLcbRobLcbLibRcbLobRibLobL
ebRgbLcbRcbLobRobRobLibRibRobRgbLcbRgbRobRobLebLebLhbLgbRobRcbLibRgbRs
bLobLcbLebRebRcbRobRobRobLobLibLsbRobRobRgbRobLgbRobRgbLebRcbRobLcbLeb
RobLcbRcbLobLebLobRebLcbLsbRebLebRobLibRobLcbRobRcbRcbRgbRsbLobLebRibR
obRcbRcbRobLibLebRobLibLcbLcbLobLebLobLcbRobRebLobRobLobRobRobLobRgbLo
bRebLobLcbLgbLgbLobRebRebRibLobRgbLobRcbRcbRcbRcbRebLibLobRobRobRsbLib
RcbLibLobRebRobLebLobLebRobLebRobRebLebLobRobRobLobRibLebRibLsbRebLibL
gbRibLobRebRcbRcbLobLsbLibRobLibRcbRibLcbRobLobLgbLgbLibRebLibLobRebRo
bLsbLgbLobLebLebRcbRgbRcbLebLcbRgbRibLobLobRobLobLobLobRcbLcbRcbRebRob
LobLebLobLgbRcbLhbRobRobLebLebLebLobLobRcbRobLobRibRobLcbRcbRobRgbRobR
ebLebRobLcbLebRcbRobRebRebLebRebRcbRcbRebLhbLibLobRibRebLobRobLobLebRe
bLobRibRcbLobRcbRcbLibLobRibRcbRobRebRobLobRebLobRjbRobRobLobLobRcbRob
LebLsbRobLebRcbLobLcbRebRcbRgbLebRobRobRobLebRebRebLobLcbLebLsbLebRobL
obRobRebRcbLobLobLibRobLobLebRibRibLobLebLcbRobLebRebLhbLobRgbRebLobRo
bRebLobLebRobRgbLcbRsbRobRobLebLsbRgbRobLebLobRobLobLibLcbLibLibLsbRob
RcbRobLibLebLsbRhbRebRhbRebLibRcbLcbLobRobLobRobLcbRebRobLcbRcbRebRobR
obLcbLsbRibLobRobLgbLobLobLobRsbLobLsbRobLobRobLobLcbLebRibRebRcbRcbRc
bRobLgbRobRobLobRgbRobLcbLobLcbRobLobLhbLibLobRebRsbLobLobRobRobLebLob
RobLobRcbRebLebLcbLcbLebLobLsbLebLhbRobLobLobLhbRobLobRibRibRgbRebLobL
obLebLobLibRibRobRobRobLebLsbRebLobRobLcbRhbLebRcbRobLgbLcbRobLobRibLi
bRobLobLibLobLobLhbLobLcbRcbRobLgbRgbLobLcbLobRobRobRobLebLebLobLobRob
LobLobRobRobRobLsbLobLebLobLebRobLcbRobLobLobLebLibLobLobRcbRobLobRobL
cbLebRobRcbLobRebRebLebLobLobRcbLcbLobRibRebLobRsbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 10; Drug: PCAP2 3 然
bLsLsmbRsbLsbRsbLsLsLsmmbsbRsRsmbRsLsbLgbLsbRsbLgRsbLsLsmbRsRsRsmmbsbs
bLgLsLsmbLiLsbLiLsbLgbRsbLsLsmbRsbRgbRsRsmbRsRsmbsbsbLibLgbLsbLsLsLsmm
bLsbRsbsbRsRsmbLsbLjLgbLsbLsLsmbLsbLsRsbLsbLgbLsLsLsmmbLsbRsbLsLsmbsbL
sLsLsmmbLsLsmbLsLsmbLsbsbRsLsbRsLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 11; Drug: PCAP2 3 然
bLsbLsbRsbRsRsmbRsbRsbRsbRsbRsRsmbRgbRsbRsRsmbLsbRsbRsbRgbLsbLsbRsbLsR
sbsbsbRsbRsbRsLsbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsbLsbRgLsbRsbRsbRgL
sbRsRsmbRsbRsbLsRsbRsbRsRsRsmmbRsLsbRsbRsbLsRsRsmbRsbRsbRsbsbLcbLsLsmb
LsbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 12; Drug: PCAP2 3 然
bRsbLgbLgbLsbRcLsbRsLsbLsbsbLsbRiLsbRsRsmbRsbRsbRsbLsbsbsbLsRsbsbRsbRg
RsmbRgbRsbRsbRsbRsbLsbRsRsmbRsbRsLsbLgbRgbRibRsbLsbsbLhbLibLsLsmbsbRsb
sbLsbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 13; Drug: PCAP2 1 然
bRiRsmbRgbLsbRcRsmbRsbsbRiRsmbLgLsRsbLsbLjbRsRsmbRsbsbRgbsbLsbRjRgbRgb
LgbRgbRgbLsbLsbRcRsmbRsbRsbRsbsbRgbRgLsbsbRibRibRibLgbLsLsmbRsbRibRgbL
sbLsbsbLiLsbRgbLsbRsbRsbRsbsbRhRsmbRsLsbsbRebRsbRibRsRsmbRiRsmbRcbRsLs
bLebRjRgbLsbLcbLibRgRsRsRsmmmbRibRsbLgbLsLsmbLcbLibLgbRibRcbRsbRibRgbR
iRsmbRsLsbsbRsRsmbRibsbRsbsbLcbsbLgLsLsmbRsRsRsRsmmmbRsbLgbRsLsbLsLoLs
mbRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 14; Drug: PCAP2 1 然
bLgLsLsmbLsLsLsmmbRsbRibRibLsRsLsbRiRsmbRibRibLgbRsbRgbRgbRsbRjRsRsmmb
RgRsmbRsbRibRsbLiLsbsbLhbLibLsbLcbRibRjRgRsmbRsRsmbLibRgbRgbRsbLjLsmbL
iLsbRsbRjRgbRgbRgRsmbRiRsmbRsbLsbLsbLiRsLsbRjbRsbRgbLhLsbRhbsbLgbLibLj
LgLsbRsbRibRcbRhRsmbRgbRibRibsbRibRgRsmbLsbLsLsmbLsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 15; Drug: PCAP2 1 然
bsbsbsbsbsbsbsbLsbsbsbsbsbsbRsbLsbsbsbsbRsbLsbsbLsbRsbLsbLsRsbLsRsLsLs
mbRsbRsbRsLsbsbLibRcRsmbLjLsLsLsmmmbLsbLcbLsLsmbRsLsRsbsbLiLsbLibRsbRi
bRsRsRsmmbRgRsmbRsbsbRgRsRsmmbRgRsRsmmbsbsbLibLebLiRsbRcbRobRobLib

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 16; Drug: PCAP2 1 然
bRsbRsbRiLsbLsbRgbLsRsbLsbLsLsRsmbLebLcbLsbsbRhbRgbLsbLsbRsRobRobRgbLj
bLcbLgbRsbLsLsmbLsLsLgmbRebRcbLsRsbRgbRsRsLsmbRgbLsbRsRsmbRibLsRsbRcbL
sbRcRsmbLsbLsRsbRgbRsRsRsRsmmmbRsbRgRsmbLsbLiRsbReLsbRsbRhRsmbRobLgbRs
LsbLsbLsRsbRiRsmbRgRsmbRsbRsbRsbRsbRgRsmbRsbRsRsmbRsRsmbRsRsmbLsbLebLs
bLsRsbRsbsbLgLsbRsbLsbLsbsbLsLsmbLgRsbLsbLgLsRsbRsbRobRiRsmbLgRibRgbLg
bLsbsbRgbRsRsLsmbRsbRsbRgLsbRsbRsbRsbRsbLjbRcRsmbRsRsmbRhRsmbLsbRibsbs
b

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 17; Drug: PCAP2 1 然
bsbRsRsmbLsLsLsmmbRsRsmbRsbRibLsbLsbLcLsmbLsbLsbLsLgbLsbLsLsmbRsbRsLsb
LgbLsbLgbRsRsLsmbsbsbRebsbsbRsbRsbLsbRsRsmbLsbRsLsLsRsmbsbsbRgbLsbsbsb
sbsbLjbRcbRiRsmbLibLsbLeLsbLsbLcbLsbLsbRgbLsLsmbLsbLibLgbLsbRibLsbLcbL
jLsLsmmbRgRsmbLcLsLsmmbLsbLgbRsbLgLsbLsbsbRsbLibLibLibLsLsmbsbRsRsRsmm
bRsRgbsbLsbLcLsmbLibLsbRgRsRsRsmmmbsbRsRsmbRsbsbsbLsLsLsLsLsmmmmbLsLsm
bLsLsLsmmbLsLsmbLsbRjRsmbRsLsRsRsLsmbLibLsbRsbLgbLsLsmbLsbsbRgbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 18; Drug: PCAP2 1 然
bLcbLsLsmbRsLsbRsbRibRebsbRsbsbsbRibLsRsbRhbRsbRsbRcbRibRobRsbRsLsbRgb
LcbLibRjbLibLgbRsbRgRsmbRsRsRsmmbsbRsbLhLsbRsRsmbLiRsbLgbLibLsbLsbRibL
cbRibRsbRhbRsbRgbRsLibRgLsbLiLsbLsbLiLsbsbRcbLibRgbRsbRsRsmbsbLgbRsbLs
bLgRsLsbRcRsmbRsbLibLsbLsbRsRsmbRiRgbRcbRsRsmbRsRsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 19; Drug: Control
bLibLsbLsbRhbRsbRgRsmbRoLsbRgRsmbRgbRcbRobRsRsmbRgbLsbLibLsbLgbLoLsmbR
sbRgLsbLiRsRsmbRsbLiRsRsmbRsbRhbLgbLibRsRsmbRibRsbRsbRsbsbRgbRgRsmbsbR
ibLgbRgbLjbLebLsbLsLsmbRjbLgbLhbLsbLgbLsbLsbLgRsbRsbLiRsbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 20; Drug: Control
bLsbRcbRhbRsRsmbRsbRsbsbRgLsbRsbRcbRiRsmbRsLsbRsbRcRsmbRsbRsbRgbLgbLsL
sRsRsmmbRjbRcLsRsbsbsbLibLsbLgbLcLsmbLsbRsbRsLsbLibLsLsmbLeLsbLsbRsbLs
bLhbLsbLsbRsbLibLibLsbRsbLibLibLhbRgLsbLgLsbLsbLsbLgbLsbLgbRsbRsRsLsLs
mmbLgbRsLsbRsbsbRsbLsRsbLgbsbsbLsLgbRsbLsRsbLjbLsLibLhbLsbsbRsbRsRsmbR
cRsmbRsbsbLsbRsRsmbLsLsmbLibLsRsbRgbRsbLcbLsbLgbLsbLgbLibLgbLsLsLsmmbR
sLsbLcLsmbRsbsbLsbLibRebRhbRcLsbLgbLgbLgbLsLoLsmbRsbsbLsbRsbLcbRsbRsbL
gbLsLsmbLjLsmbLgbLgbLhbLsbRsLsLsmbRsbLobRsbRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 21; Drug: Control
bLgLsLsmbLsLsmbLsLsmbLgLsbLjLsLsLsmmmbLsbRsbRgbLgbLhbLsLsmbRibsbsbLsbs
bsbRsbsbLhLsLsmbLgbLjLgbLsbLsbLsbLsbRsbLibLhbLibsbLgLsbsbRsRsmbsbsbsbL
sbLgLgbLgLsbLjRsbsbLgbLibLsbLsRsRsmbLsbLibsbLibsbLgLsbRsbLgLsbLjbRgRsm
bLiLsbRgbLebLsbLsLsmbLsbLsbLhbLsbLibsbLsbLibRsbLibLcRsbLsbRgRsmbLsLsmb
LsbsbLibLibRsbRgbLibLgbRsRsmbLgbRsbLjLsmbRjRsRsmmbLibLhLsbLgbLsbLjLsLs
mmbLibsbLsbsbLgbLsLsmbLgLsbRsbsbRsLsLhLsbLiLsbLgLsbLsLsLsmmbLjRsbLsLsm
bLiLsbLgbRjbLobsbLgLsbLsbsbRgbsbLibLcbLsLsmbLsbLjLsmbRsbLjLsmbLsLsmbRs
RsmbRjRsmbRgbLsLsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 22; Drug: Control
bRsbLibLgbLsLsmbLgLsRsbRcRgRsmbRcRsmbRjRsRsmmbRgRsmbLsbRsRsmbRibRgbLgb
RjRsRsRsmmmbLgLsbLsLsmbRjRsmbRsbRgRsmbLgbLsbLcRsbLgbLgbRcbRobLsbLjLsLs
LsmmmbsbRiRsmbRsbRoLsbLiLsbRgRsmbRcbRhLsbRgbRgbRsRsmbRsbRsRsRsmmbRgbLs
bLgbRibLoLsmbLibRcRsmbRhbRsbLsbLobRibLcbLsRcbLiLsbRibLjLsmbRibLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 23; Drug: Control
bRibLsbRsRsRsRsmmmbRsLsbRibLsLgbRibRgbRgbRobLsbLgbLibRsbLibsbRsLsRsbRg
bLsbRibRgbLjbLcbsbLgLsLsLsLsmmmbLsbLgbLcbLibLcbLibLibLcbRibsbsbRcbsbsb
RsbRibRsLsbRsRibRsbsbRibLsLsmbLcbLibRsbLsLsmbLsbRjbsbLsbLsbLibLhbLsbLg
bLsbLsLsmbLiLsbLibLsbsbsbLgLsbLgbsbLobLibLibLgbLsbRsbRgbLjLsLsmmbLsbRi
bRsLsbRgbRibsbRsbRsbRgbRsbLjbRibLjRsLsbRhbLibRhbLsbRgRsRsmmbRgbRsbRsLs
bRsbLsRgbsbLgbRhbRgbRibRibRsLsbRgbRsbLsbLgLsbsbLibRgbRgbLsbRsbLsbLibLs
bsbLsbRjbRcbRsbLsbRgbLsbRsRsmbRgbLsbRibRibRsbLjRsbRibRsbLsbRiRsmbRibsb
sbsbsbsbLgbLsbsbsbRibRsbRibLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 24; Drug: Control
bLgbLsbRibLsbLgbLhbsbRjbLibLgbLhbRebLcLsmbRsbRsbsbLibLsLsmbLsbLsbLgbLg
bLsbRjRsRsmmbLibLsLsmbLsLsmbsbLsbLsLsmbLsRjbLsbLjLsmbRjRsmbLibLsbsbLib
LgLsbLsbLsbRgbRcbLoLsmbLjLgbLsbLsLsmbLgbsbLjLgbLsLsmbLiLsbLsbLsbLgbLcb
LcbRsbsbLsLsLsmmbLgbLiLsbLsbLibLsbLsbLgbLsbLgbsbLsbRsbsbLsRsbRjbRebLsb
RcLsbLiLsbLjLsmbLibsbLjLsmbRhbLcbRibRgbRgbLhLsbLsRsbLgLsLsmbLsLsmbLsLs
mbLgbLsLsmbRsbRcRsmbsbLibLsbRhbRjbLsRcbLsRcLsbRgRsRsmmbRsbRibLgbRhRsmb
sbLjLsmbLcbRgRsmbLcRsbsbsbRobsbsbRsbsbRhbLjbRgbLsbLsbRhbLjbRhbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 25; Drug: PCAP2 10 然
bRsRsLsmbLsbRgbRsbRsRsmbReRsRsmmbRebRsbRiRsRsmmbRgLsbLsbLgbRibLsbLsbLg
RsbRsbRcRgRsmbRsbRgbRsLsbRsbLsbsbsbsbsbsbsbLsbRsbRsRsmbLsbLsbRgbLsLsmb
RsLsbLsbsbLsbRsbRsLsbRsbRsbLgbRsbLsLsmbsbsbsbsbLsbsbRsbLsbsbsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 26; Drug: PCAP2 10 然
bRsRsmbsbsbRsbsbLsbsbLsbRgRsmbsbsbLsbLibLiLsbLsLsmbLsLsmbLsbRsLsbRebsb
RgbRsbRhRsmbRobRsbRcRsmbRsbRoRsmbLibRgbLsbLsLsmbRsbLsbLsbLsbReRsmbsbsb
RgbRsbRsbLsbRgRsRsmmbRsbRgbRsRsmbRgRsmbRsRsmbLsLsmbsbsbsbLsbsbsbsbRsbs
bRsbLsLsmbRibRsRsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 27; Drug: PCAP2 10 然
bLibLsLsLsmmbLsbRsbLobLcbLsLsmbLsLsmbLsLgbsbLebLjLgbsbLgbRsLsbLsRsbLsL
sLsmmbLcbLhbRgbsbsbLibLiLsbRsRsRsmmbsbRobRsRsmbRgbRsbRsRsmbRibRgRsmbLs
LsmbLsbRsRsLsmbLgbRsRsmbLgbLsbLsbLsbLobRibRgRsmbLgbRsRsmbRsbLsLibLsbRs
bLsRsbLgbRsLsbLsLobRsbRoRsRsmmbRsRsmbRsRsRsmmbRsRsmbLsbLiLsbLgRsbRgbRs
bLsLgLsbLsRsRsmbRsbLsRsRsRsmmbsbRsRsmbLcbLsbLgLsbLsbRsbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 28; Drug: PCAP2 10 然
bLsRsRsmbRgbLgRsbLsRsbRgbLgRsRsRsRsRsmmmmbRsbLgbRsbRsRsmbLsRgbRgbLsRgR
smbRsbRgRsmbLsLsmbRsRsmbsbRsRsRsRsmmmbLgbRiRsmbRobRsRsmbRsbRsLsbLcLsmb
LsLsmbLgLsLsmbLsbLsbRsbLgbLhbRsRsmbRsbsbLsRsbLgbsbLgbLgLsbsbRgbLibLgbL
gLsLsLsmmbRiRsmbLgbLoLsmbRcbRsbRobLsbRhLsRsbRgRsmbRgbLsbLsRsbRgbLsLsmb
RsbRsRsRgRsmmbLsRsbRgbRgbsbsbsbLsbLsbRsbLsRsbLjbLjbLsbLoLsLsmmbLgLsbLs
RgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 29; Drug: PCAP2 10 然
bLibRsbRcbRsRsmbLgbRsbRsbRsbsbRgbRsbRsbRsRsmbRgbRsbLsbsbRgbRsbRsRsmbRs
bRsbRsRgRsmbRsbLibRiRsmbLsbReRsLsLgmbLsbLcbLsLsmbRsLsLsmbRsLeLsbRsbRsb
RgLsRsRsmbRgbLsbRgbsbsbRsRsRsRsmmmbRsRsmbLgRsbsbsbRsbLsbRgRgRsmbRiRsLs
mbRoRsRsmmbLsbLiLsRsbLgLsbLsbsbLsLsLsmmbLgLsbRsLsbLsLsmbRgRsLsmbLsbRsL
sLgLsbRsbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 30; Drug: PCAP2 10 然
bRobLsLsLsLsRgmmmbRebsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 31; Drug: PCAP2 3 然
bRsRsmbRsRsmbRsbLsRsbRsLsbsbLsbRsRsmbLsbRsbsbsbRsbRsRsmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 32; Drug: PCAP2 3 然
bLsLsmbLsLsLsLsmmmbLgLsLsmbLgLsLsmbsbRsbLjLgbLsLgbLsbLsLsmbLsbLsLgbLsL
sLsmmbRsRsmbsbLsLsLsLsmmmbRsbsbLsLsmbsbLsbRsbRsbLsbRsbsbRsLsLsmbLsRsbR
sLsLsmbRsbRsbLsbLsRsbLsbsbLsLsmbsbLsbRgbRsRsRsmmbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 33; Drug: PCAP2 3 然
bsbLsbRsbsbLsLsmbRibLgRsbLsbsbRibLsRsbsbLcbLgLsbsbRgbLsbsbLsbsbLibRiLs
bsbsbsbRjRsmbsbRsLsbRsLsbLeLsbLiLsbLsLgLsbLsbsbRjbLsbLsbLibLhbLebLsLgb
sbRibRsRsmbLsbsbsbsbsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 34; Drug: PCAP2 3 然
bLsRsbRgbLsRsbRsRsmbRsbRsbRgbRsbRgRsmbRsbsbRsRsRsmmbRsbRsbRsbRgRsRsmmb
ReRsmbRsbRsbsbsbsbRsRsmbsbsbLsbLsbLsbRsbLsbRsbRobLsbLsbLsRsbsbRobRjbRs
bLsbRsLsbsbLcbLjbLsbRsRsmbRsbRsRsmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 35; Drug: PCAP2 3 然
bRsRsmbRgbRsbLsbRsRsmbLgbRebRjRsmbRsRsmbRsbRjRsmbRsRsmbRibLsLsmbRsbRgb
RsbRhbRibRsRsmbRsbRgRsmbRsRsmbLjLsmbLsbLiLsbLgbLsRsbLibLsLsLsmmbLsbLiL
sLsmbLsLgbLsbLsbRsbsbLsbLibLsbLgbRsbRiRsRsmmbRsRsmbRgbRiRibLiLsbLsLsmb
LibRsbRgRsRsmmbRcbRgbRibRgbLsbsbRibRibLgLsLsmbLsLsLsmmbRibRsRgbRsbLsbL
jLgLsbLsLgbRibRsRsmbRsRsLsmbRgRsmbRsRsmbRsRsmbRsRsmbRsRsmbLsLsmbRiRsmb
RgbRjRgRsmbRgbRsbLsbLsbLsbRgbsbsbRsLsbRsbRsbRsRsLsmbLiLsbLsLsLsmmbLsbL
sbsbRsLsbLsbLsbsbRsLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 36; Drug: PCAP2 3 然
bLsbRsbLsbLsLsmbRsRsmbLsbLibLsbLsbLsbLsLsLsmmbLsLsmbRsbLsLsmbsbLsbsbLs
bsbsbLsbRsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 37; Drug: PCAP2 1 然
bsbRsbLsbLgLsbLgLsbRsLsbLsbLsLsmbLibLsbRsbRsRsmbLsbLsLsLsmmbRgbLsbLjLs
mbLgLsbLibLsLsLsmmbRsbLgbRcbRibLsbsbRgRsmbRsRsRsmmbsbsbRsbRgbRsRsRsRsm
mmbRsbsbRgbRsRsmbRgbRsbRhRsmbLsbRsbRibLsLsLsmmbRsRsRsRsmmmbRgRsmbRsRsR
smmbRsbsbLjLsmbRjbLhbRsRsRsmmbLsbsbRsRsmbLjLsLsLsmmmbLsbLsbLibLsbRsbLj
LsLsmmbRsLsbLiLsbLsLsmbRsRsRsmmbsbLsbLgbLgLsbRcLsbRhbRsbRsbRsbsbLsLsLs
mmbRsbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 38; Drug: PCAP2 1 然
bLjLsmbRsRsmbRhbLjRsbRcbLjLsmbsbRcRsmbLsbLgbLsLsmbLcRsbLcbLgbRgbRsRsmb
RibRibRcbLibLjLsmbLcbLcbRgRsmbRsbRgbRcbsbRgbLibLjbLcbRgRsmbLibRjbLhLsb
LgbsbsbRgbLhbLsLsmbRsbRsbLiLsbRgbLjLsmbLiLsbRibRgbsbLibLcbLibLgbsbRsbR
sLsLsmbRcbLgbRgbRjRsmbRibRgbRgbLibLjLsmbRjRsmbRcbRsbRcRsmbRjRsmbRcbLcb
LibLgbLsbRsRsmbsbRibRgRsRsmmbRiRsmbRgbLgLsbsbLibLsbLsLsLsmmbsbLcLsmbLc
LsmbLsLsmbLibLjLsmbLsbLjLsmbRibRjRsmbsbLgbsbLcbLibsbLibLsLsLsLsLsmmmmb
sbRibLibLcbLibsbsbLibRgbLiLsbLiLsbRgRsmbRsbLcbRgbLsbsbsbRsbLsbRgbLsbLs
bRsbLcbLsLsmbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 39; Drug: PCAP2 1 然
bLibsbsbLjLsmbRsRsmbLsbRgbRgbRsbRsbRgbRgbLsLsmbRjLsbLgbLsRsbsbRsLsbLsR
sbRsbsbRsbsbRiRsmbLcbLobLhLsbRgbRgbLsbRcbLhbRjRsmbLjLsmbRsRsRsmmbRsbRg
RsmbLobRsbRjRsmbRsRsmbRsbRsbsbsbRgbRsbRgLsbRgbRgbRiLsbRsbRibRjbRibLibR
gbRsRsRsmmbLsbLobRhbRcbRgbRgbRiRsmbRgbLsLsmbRgbRsRsmbLsbLjbsbRjbLsbLsL
smbLsbLsLsmbLgbRgbLgLsbLsRsbsbRsbsbsbLgLsbRsbLgbRsLgbLgbLibLgLsbLgbLsL
sLsLsmmmbRgbLgbLgbLgLsbLsRsbLgLsbLsLsLsmmbLgbLgLsbLgLsbLgbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 40; Drug: PCAP2 1 然
bRcbRcbRgRsRsmmbLsbRgbsbsbLcLsLsmmbLgbLsbRgbLsbLhbRcRsmbLsbsbLeLsbRhRs
mbsbLibRhRsmbRsbRiLsbRsbRibLsRsbRgbLsLsLsLsRsmmmbLgbRsbLsbRsbLsLsLsmmb
RsbLgbLibLjRsbRsbRsbRsRsLgmbLiRsRsmbLibRibLgbsbRiRsmbRsbLsRsRoRsLsmbLe
bLiLsbRsbsbsbRgbLibLibLsbLiLsbLibsbLibLhbLgLsbRsbLsLsmbLibsbsbsbLiLsbL
hbLsRsbLsLsmbRgRsRsmmbLeLsbRsbLeLsbLsbRibRsbLobLiRsbRgbLcbLsLsmbLibLsb
sbLsbLgbsbLgLsbRjbsbLgLsbLibsbLiLsbLgLsbLsbLsbLgbLgbRibLhbRsbRsbLsLsmb
LibRgRsmbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 41; Drug: PCAP2 1 然
bRsbRsbRsbLsbLsbRgbRgbRsRsmbLgbRibRsbLsLsmbRsbRsbRsbRsRsmbLgbLsLsmbLcb
sbsbsbRsRsmbRcbRgRsmbLgbRcbRsbRsRsRsmmbsbLgbsbsbsbsbRsRsmbRsRsmbLgbRsb
RsRgbsbsbsbsbsbRsRsmbLsbLhbLsLsmbsbLsbRsRgbRcbsbRibRsRsRsmmbRsRsmbRsbs
bsbRsRsmbRsRsRsRsmmmbLgbLjbLibLgLsLsLsmmbLsLsmbsbsbsbLsRsbLibLsLsmbsbR
sRsmbRsLsbLsbsbsbsbsbLiLgbLjbLgbLibLsbRsbLsbRsbLobLsLsmbLibRsRsRsmmbLg
bLcRsLsbLsLsmbLsbLgbsbRsbLibRgbRebRibLsLsLsmmbLibLjLsLsmmbsbLsLsLsmmbs
bsbLgbLgLsbsbLsLsLsmmbLsbLsLgLsbLsLgLsLsmbLsbLcLsmbsbLsbRsRsmbRsbLgbRo
bsbRjRsRsRsmmmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 42; Drug: PCAP2 1 然
bLhbLsRsbRhbRibsbRsbRsRsmbRibRsbRsbRiRsmbLsLsRsmbLgbRcbRjRsmbRsbLjLgbL
sbRgbRsbsbRcRsmbLsbsbLsLsmbRsbRibLsbLsLsmbRibRsRsmbLsbRsbRsbRibRsRsmbR
sbRgRsmbLsbRsbLsbRgbLsbRsbRibLhbsbsbRsbRsbRsbsbsbsbRjbLsbRsRsmbLsbLsbR
gbLsbRcbLhbsbRsbLgRsbRcbRsRsmbsbLsbLjbRibLsbLsbLibRobLsbLibLsLsmbRsbLc
LsmbLgbRsbLibsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 43; Drug: Control
bLsLsmbsbLgLsLsmbRsLsLsmbLsLsmbsbLsLsmbLsbRgbsbLsLsLsmmbsbRiRsmbLibLcL
smbLsLsmbRiRsmbRsRsmbsbLhbRsLsbRsbRsbRibRibLsLsmbLibLhLsbRsLsbLibRsbsb
sbLsbLsLsmbLgLsLsmbsbLjLsmbRgbsbsbLgbLibsbRgbsbRsbLsbRsbsbsbsbRsbRsbsb
RsRsmbsbLsLsmbLsbLsLsLsmmbLsLsmbLsbRsbLsbRsbLsLsmbLsRsbLgRsLsbLsLsmbRs
bLgLsbRsLsRsbLgbsbRjbRebRibRibRibsbLsbLsbsbLiLsbsbLsbLgbRsLsbLsbLsbLsL
sLsLsmmmbsbsbRgbLibLsbLiLsbLgLsbsbLsLsLsmmbRgbsbLsbLibLgLsbLjLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 44; Drug: Control
bRjRsmbLibLibRsbsbLsbRhbLsbLhbLibLhLsRsbRsbRsbLjbLgRsbRibsbRsbRgbLgbRs
bRibLsbRgbRsRsRsmmbRgRsmbRibsbRsbRgbRsbRcbRgbRibRsLsbLibRgbRiRsmbsbRgb
RsRsmbRhbRgbRsbLsbRcRsmbRsbLsbLsRsbRsbRgbRjRgbRsRsmbRgbRsbRgbRsbLsLsRs
LsmbRgbRsbLsLsmbRgLsbLsRsbRgLsRsbRgbsbRgbRgbsbRsbRsbRibsbRibRsbRibRsLg
bRibLsbLjLsmbRjRsmbRebLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 45; Drug: Control
bLoLsmbRebLhbRjbRiRsmbRcRsRsmmbLibLsbRobRibRsbRsbRjRgbRsbLgbLcbRsbLibL
ibRsbLoRsbsbLebRcbRsbLebRsRsmbRsRsmbLibRjbLcbRsbRibLsbLibLgbLgbRgbsbLi
bRsbRebRsbRsbRsLsbRsbRsbsbLsRsbRiRsmbRsbRsbLsLsmbLsbsbsbRgbRsRsRsRsmmm
bRsbRsRsmbsbsbLsbsbLsbLcbRiRsmbLgbRcbLsbLsbRebRsbsbsbsbsbRibRgRsRsmmbL
gLsbLsbLgbLcLsLsmmbLibLgLsbRgbLsLsLgmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 46; Drug: Control
bLebRsbRsbsbLiRsbRsbsbLsbLsbLgbLsbLgbRsRsmbLsbLsbLibLhbRsbLibRgbLsbLgR
sbRsLsRhbRsbRhbRsRsmbsbsbRgRsmbRsbRsbRsbRsbLebRibRibRsRsLsmbRgLsbLsbRg
RsmbRsRsmbRsRsmbRsRsLsmbRsRsmbRgbRsbRsbRgbRsLsbLsbRgbRsbLsbRgbRsRsmbRg
bRsbLsLsmbLebRcbRgbsbRsbRgbRgbRgbRgbRsbRsbRsLsbRgbRgbRsLsbRsbRsbRgbRgb
RsbRsbRgbRsbRgRsmbRgbRgbRgRsmbRsbRsRsmbRgbRsbRsbRgRsmbRsbRsbRsRsmbRgbR
sbRsbRsbRsbRgbRgbRgbRgbRsbRgbRsbLsbRgbRgbRsbRsbRsbRsbRsbRgbRsbRgbRsbRs
bRsbRgbRgbRgbRsbRgbRgRsmbRgbRsbRgbRgbRgbRgbRgbRsbRsbRgbRsRsmbRsbRgbRgb
RgbRgbRsbRgLsbRgRsmbRsbRgbRgbRgbRgbRsbRgbRgLsbRsRsmbRsbRsbRsbRgbRgbRgb
RgbRgbRsRsmbRsLsbRsbRgbRsbRgbRgbRgbRsbRgbRsRsmbRgbRsbRsbRsRsmbRsbRsbsb
RgbRgbRgbRgbRgRsmbRgbRgbRgRsmbRgbRsbRsbRgbRsRsmbRgbRgbRsbRgbRgbRsbRgRs
mbRsRsmbRsbRobLsbRsbRgbLsbRsbRsRgbLibLhLsbRgRgbRibLsLib

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 47; Drug: Control
bLjLsLsmmbLgbLsbLgLsbLsLgbLsLsmbRibsbRsLsbRgRsmbLsbLgLsbLjLgbLsbsbLiRs
bLgbLsbRhRsmbRiRsmbLsLsRsmbRibLgbRcbRgbLsbLgbRibRsRsmbRgbLsRsbRjRsmbLj
bLobLhLsbLsLsmbLibRibLibRsbsbLsLsmbsbLsLjLgbLsbLsLsLsmmbLsbLiLsbsbRjRs
RsmmbLjLsmbLsLsmbLibsbRjRsmbLsbLsLsmbLjLsLsmmbLsbRsRsmbRgbLcbLhLsbLhbL
sbLsbLgbLiLsbLgbsbRgbsbRjbsbLibLiLsbLsbLsbLibsbRibLcbLibLsbsbLgbLsLsmb
RsLsbRjbLebLsbLsLsmbLibRjbRcbRcbLsbLgLsbLsbLiLsLsmbLibLsbRibLjbRibRibR
gbRgbRgbRibRsbLibLoLsmbLibLibsbLiRsbRhbRhbRsbRibLhbLhRsbLgbRsbLgbRcbRh
bRibRibRsLsRsbRsbRibLjbLcbLibLsbLsbLsLsmbLsbRsbLgRsbLgbLgbRsLsbRsbLgLs
bLsLsmbLgbLgbLgbRgbLgbLibRgbLgbLgbLgbRjLsbRsLsbRsLsbRcbRibLjbLcbRcbRhL
sRsbLcbLgbLhbRgbLibRcbRibLibRgbRibLiRsbLibLsbLsLsmbLsLsmbLgbLsbLiRsbLs
bLgbLsbLsLsmbLibLsbLsbLibRsRsLsmbLsbLgbRjbRhbLcbRsbLiLsbsbRsbLibRsbRsb
sbRsbRjbRibRgbRgbRgbRgRsmbLhbLibRsbLsbLsLsmbLsLsmbRsbLiLsbLgbLiRsLsRsb
Rjb

>ZF Recording 2016-04-15; tW: 300s; Start: 111116; End: 111617;
Recording: 11-1; Individual: 48; Drug: Control
bLobLibLhbsbLsbRgbRibRsbsbLsRsbRcbLhbRiLsRsbsbsbLcbLcLsmbLhbLibRsbLobL
gbLobLibsbLgRsbRjbRcbLiRsbRobLsLsmbsbLibRcbRhRsmbLgbLjbLgLsbLiRsbRsbRc
bRibLsbRsLiRsbRgbLjLgbRsbsbRibRhbRcbLibsbRcbLgbsbLibRobRibRsbLibLiRsbR
iLsbLsbLsbsbRsbLsbLsLsmbLobRsbLibLsbLiLsRsbLgbRjbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 1; Drug: PCAP2 10 然
bRgRsmbLsbRsRsRsmmbRsRsmbRgbRsbRsRsRsRsmmmbRsbRsRsmbRgbRsRsmbRibRsRsmb
RgbRsbRsRsmbRgRsmbRsbRgLsbRgRsRsmmbRsbRsRsRsRsmmmbRsbRgRsmbRgRsmbRgbRg
bRgbsbLsRsbRgLsbRgbRgbRsRsmbRsRsmbRsbRsRsmbRgbRibRsRsmbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 2; Drug: PCAP2 10 然
bLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 3; Drug: PCAP2 10 然
bRsbLobRiRsmbLsRsbLobLcbLsbRiRsLsmbLsbRsRsmbRgbLiRsLsRsbRsbsbRsRsmbLsb
LsbRiRsmbRsRsmbRsbRsbLsbRsbRcbRjRgbRgbRgbsbLjbRobRjbLsbRgRsmbRoRsmbLsL
smbRebRiRsRsmmbRgRsmbRobRgRsmbLsbLobLjbRsbRsRgbRsbsbLebRobRgbRgRsmbLgL
sbLsRsbLgLsbLsbsbsbLsLsmbsbRsbLsLsmbRsbsbLgbLsLsmbRjRgLsbRsRsmbLsRsRsm
b

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 4; Drug: PCAP2 10 然
bRsbRsRsmbRsbLobLsLgLsbLsbLoRsbsbLibsbsbsbRsRsmbRebRgRsRsmmbRsbRsbLsLs
mbLsbsbLsbRsbLsbRsbLsRsbRsLsbLibLgbLgLsbLsbLgbLgbLgLsLsLsmmbLsbLibRsLs
bLiLsbLgbLsbLsLsmbLsbLcbRgRsmbRsbLobRsbLibsbLgLsLsmbLgLsbLgRsbLgbLsLsm
bLiLsbRsbLsLsRsmbLgbLsbLiLsbLsLibLsbLsLsmbLsLsLsmmbLsLsmbLgbLsLsmbLsRs
bLiRsbRgbLobRsLsbRsbRsbLobRibLgbLiLsbLsbLgbRsLsLsLsmmbLsbLgbLgRsLsbLsR
sbLiRsbRgRsmbRhbRgbsbsbLjbLcbLgbLsbLsbLgbLsRsbLgLsbLsbLsLsmbLgRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 5; Drug: PCAP2 10 然
bRsbRgbRsbRsLsbRibRiLsLsmbRsLsbRgRgbsbRgbRibLsbLsbLsRsbsbsbRjbRgbsbsbs
bsbsbsbsbsbsbRsbsbLsbsbRsRsmbRsRsmbRsRgbRgbLsLgbRgbLgbRgbLsbLgLsbRsbRo
LgbRgbLsbRsRsLsmbRsLsbLsLsmbRsbLgRsbLsbLsbLebLsLsLsmmbLiLebsbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 6; Drug: PCAP2 10 然
bReLsLsmbsbsbLsbsbRiLsLsmbRcbRibLgLsbRsLsLibRibLsLsmbRebLcLsLgmbRcbLsb
LjbRcLsbLgLsbRiRsLgLgmbLhLsLsLgLsmbLsRsbRobRsbRibLobLsLgbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 7; Drug: PCAP2 3 然
bsbsbRsbsbsbsbRsbLsbRsbLsbRsLsbLsRsLsbLsbLsbsbRsbLsLsmbRsbsbLsbRsbLsbR
sbRsbLsbRjbRsbRsbsbLsbLsLsmbRsbsbRsbRsbLsLsLsmmbRsbLsbRsLsbLsbsbLsbLsL
sRsmbRsbLgbLsbLsbRsbLsbRsLsbLsRsbLsRgLsbRsbRsRsmbRsLsbRgbRsbsbRsbRsbRs
bRibRcLsbsbRsbLsLsmbsbLsbsbsbRjbRsLsbLsbsbsbsbsbRsLsbRsbRsLsbRsLsbLsLs
LsmmbsbLsbRjbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 8; Drug: PCAP2 3 然
bRgRsmbLebLsRsbsbsbRsbLsRsbRsRsmbRgbLsLsmbRgbRsbRsbLsRsbRsLsbLsRsbRsLs
RsRsmbRsbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 9; Drug: PCAP2 3 然
bLoLsmbRsRsRsRsmmmbsbsbLsbsbLibRgRsRsmmbRgbRsbRsbRsbLsbsbLsbsbLsbLgbLs
bsbRsbLsRsbRsbsbLibLsbRhbRhbRsbLsbLsbLebLgbsbsbRsbRsLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 10; Drug: PCAP2 3 然
bLsbRsLsbLgbRgLsbsbsbsbsbRsbLsbRsRsmbsbsbLsbLsLsmbLsLsmbLsLsmbLsLsLsmm
bLsLsmbLsbsbLgbLsbLsbLsbLsLsmbLsbLsbRsbRsbLsbLsbLgbLsRsbLsLsLsLsLsmmmm
bLsbRsbsbLgbLsbLebsbLgbLsLsmbRsbLsbsbRgbLsbsbLsbLsbLsbLsLsmbRsbLsbLsbL
sbLsbsbLsLsmbRsbLsLsLsmmbRsLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 11; Drug: PCAP2 3 然
bLsbRsbRgRsmbRgbRebRobRgRsmbRgbRgbRoRiRsRsmmbRgbRhRsmbsbRsbLsbLsbRsbRs
bRsRsRsmmbLjbRgbLjLgLsbLsRsbsbRsbLsbRsbRsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 12; Drug: PCAP2 3 然
bRsbsbLsbsbsbRsbLsLsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 13; Drug: PCAP2 1 然
bLsLsmbRsRgbRsbLibRsbsbRsbRjbReRsmbLsbRiLsbReLsbLsLsmbLsLsRsmbLsbLgbsb
LgbLgbsbRsRsmbRsbsbRcbRsRsmbRsbRsRsRsmmbRsbRibLcLsRsmbLcLsmbRsLsbsbLgb
RsbLsRsbRsbLgLsLsmbLjRsRsmbsbLgbsbLgLsbLsbRibLsbRsRsmbLcbLibLibLsbLcbR
gLcbLgbRsbLcbLibRsbRgbLiLsbLsbLsbsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 14; Drug: PCAP2 1 然
bRjRgbRgbRibsbRgbRgRsmbRgbLiLsbLibLgbRjbRcbRjbRsRsmbRgRsmbRgbRgLsbRsbL
gbLibLgbLgbLsLsmbLsbLhbLgbLsRsbRsbLgbsbRiRsmbRibRsbRibRibRgbsbRsRsmbRg
bRgRsmbRibRibRgbRsbLgbsbLsbRsbRsbRsbLsLsmbsbLibLjLgbLibLsLsmbLsbLsbRib
RsRsmbRgRsmbLsLgbRsbLibLsbLjLgbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 15; Drug: PCAP2 1 然
bRhbLgLsbLjLgbRcbRcRsmbRsLsbRsLsRsLsbLhbsbLsbLsbLcbLhbLcbRgbLgLsbRgRsR
sRsmmmbRsbLsbLibsbRcbsbLibLcbLibLsbLgbRibRebRgRsmbRsRiRsRsRsmmmbRgbRsb
RcRsmbRsbRibRgbLsbLeLsbRibLcLsmbLgLsLsmbsbLsbRgbsbLgLsbRibRiRsmbLcbsbL
sRsbRiRsRsmmbRsbRsRsRsmmbRsLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 16; Drug: PCAP2 1 然
bRhRsmbLsRiLsbRsbRcbLsRsbRcbLsbRiRsmbLsbRsbLcbLgbLsbLsLgbRsbRsbRgbLgbR
iRsmbRsbRsbLgbLsRsbsbsbLgbLgLsbLsbLsLsmbLcbLsbRsbRsbLsbLsbLhbLsLsmbLsb
LhbLiLsbRebRiRcbLibRebRcbRgbRsbRsLsbRsbRhRsmbRobRcLsbRsRsRsmmbRsbRgbRs
bRibLgbLsLsmbRebLsLsmbLsbRgRsmbLcbLgbLsbLsLibRobRibRgbLsLsmbLsRsbRibRo
bRibLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 17; Drug: PCAP2 1 然
bRgbLcbLgLsbLgbLgLsbsbLgbLgbLsbRsbsbsbLgbLsLgLsbLgbLgLsbLibLibRgbRobLs
LsLsmmbRibRsbRgbLsbsbLibLjLsmbRcbRcbLsbLjbLcbLsbLsbLiLsbLsbLsLsmbRgRsm
bLsbLsbsbRsbRsLsRsLsbRsbLcbLcbLsbRjRgbsbRgbRcbRgbLjbLhbLhLsbRjRgbRsRsm
bLgbsbRsRsmbLibLgbsbLsLsmbRsRsRsmmbsbLgbLebLibsbLsbLsbRgbLsLsLsmmbRibs
b

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 18; Drug: PCAP2 1 然
bRcbRsRsRsmmbRibLjbRsbRhbRsRsmbLsbsbsbRiLsbRgbRsbRibsbRcbLibsbLcbRsLcb
RgbLgbRsbLsbRsbRgbsbRsbLsbLgbRsbRsRsRsmmbRgbRibLobRsbRsbRsbRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 19; Drug: Control
bLibRgbLsbLgbLebLgbLgbLsbLiRsbLsbLsbsbRgbRgbLcbRobLsbRiLsbLsbsbsbsbLjL
sLsmmbLsbsbRhbLgbLsbRsRsmbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 20; Drug: Control
bLsbLibLsbLgLsbsbLsbLgbLsLsmbLgbLibRsbRgbLcbRibRiRgRsmbRsbRsbLjbLcbLib
RsbLgbRsbRgRsmbLgbRcbRibRsbRsRsmbRsRsmbRiRsmbLgbsbsbLjbLsbLsbRjbsbLeLs
bLgbRjRibLcbLgbLsLsmbLgbLgbLsbLgbLsbLgbLsRsLsbRsLsbLebLsbRsRsmbRgRsmbR
sLsbLhbLiLsLsmbRgLsbLgbLsbLgbLsbRsRsmbLibLsbRsbLgLsbLsbRsLsbLgbLgLsbLs
LsmbLgbLsbLsRsLsbLibLsbLgbsbRsbRsbLsLsLgmbLgbLsbLgbLsbLgbLsbLgbRsLsbLg
bLgbLsbLgbLgbLsLsmbRgbLibRsbLgbLiLibLsbLgbLgbLsbLsbLgbLsbLgbLsbLgbLsbL
ibReb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 21; Drug: Control
bLsbLsbsbLjLsmbLsLsmbsbRibRjRgbRsbRiRsRsmmbsbLiLsbLgLsbLsLsmbsbLsbsbLg
LsbLsbRsRsRsmmbLcbLcbLgLsbLgbRgbLsbRobRsbRcbRibRibLsbRgRsmbsbsbLsLsmbs
bRsLsbRoRsRsRsmmmbRibLobRgbRgbLgbRsbRsRsmbsbRsRsmbRgbRsRsRsmmbRibRcLsb
RjRsmbsbRgbRcbRhbRibRgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 22; Drug: Control
bLiLsbRsRsmbLibRhbRibRgbsbLgLgLsbsbRgLsbLibRgRsmbRibLsLsmbRgRsRsmmbLsb
RgRsRsmmbRsbLgbRibLjLgLsbLsLsmbRjRsRsmmbLgLsbRgbRcbLcbLhRsbsbLhbLoRsbR
sbRsbLiLsbRsRsRombRobRjRgRsmbRjRgbRsRsRsmmbRibLcLsmbLgbRsbLhbRibLgbRgb
LsLsmbsbRsRsmbRsRsmbRsbRgRsmbRjRsRsmmbRsRsmbRgbLjLsLsLsmmmbRgRsmbRgbLj
LgLsbRgRsmbLgLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 23; Drug: Control
bRsbLjLsmbsbLsbsbRcbRsbRgRsmbRsRibRibsbRibLibRsbRhbRibsbRgbLsbRhbsbRsR
smbRgLsbLibRsbLsbRgbLjbRgRsmbRjbLjbsbLjbLsbRgbRsbRibLsbRcbLsRsbLgbRibR
ibRsbRiLsbRgbLgbLebLsbLibLibLibsbsbsbsbLibLsbRjbLibLsbRsbRsbRsLibLgbRi
bRibRibsbRibRsbRsRsmbRgbRsbRiLsbLjbRibLsbRibRiRsmbLibRsbRcbLgbRsbRhbLs
bRsbLjLsmbRsbRsbRgbRsbRibRsbLsbRibRgRsRsmmbLgbRgbRgbRsRsmbRcbRsRsmbRsb
RiLsbRsbLsbLibLgbLiLsbRgLsbLsLiRsRsRsmmbRcbLgbRiRsmbLjbRibRiRsmbLgbLib
RsbLcbLsbLcbLgbRsbLibRibLcbRsbRsRsmbRgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 24; Drug: Control
bRsbLsbRsLsRsbRsbLsRsbRsLsbRsLsRcbLsbsbRebsbRsbLsbLsRsbRjRsRsmmbLgRsbR
hbLsbRhbLhbLgbsbsbRcbRjRsRsmmbLjLsLsmmbLgbLsLsmbLsLsmbLcbLibLsbRsbsbLc
bLgbLsbLsLsmbsbRcRsmbRsbRsbsbsbLjbRibLsbRebRebRsbsbLsbLsbsbLibLjLgLsRs
bRgRsmbRsbLsLsmbLcbLgbRcbRsRsmbRsbLibLcbLibLsbLsbsbRsLsbRsbLibLsbRsbLg
bRebRsbRcRsRsmmbLsbsbsbsbsbsbRsLsbRsbLsbsbLcLsmbLhbReLsbRsbRsbLibLsbLg
bRjbLibLsbRsbLgbLgbRsLsbRjbRiLsbRiRsmbRsbRibLsRsbLjRsbRibLgRsRsmbLjLsm
bLibLibLibLiLsbsbRibLgbLgbLeRgbLibLcbLibLsLsmbLgbLibLhbRgLsbsbLcbRjRsm
bLsLsmbLebRcbRcbRhbRibLgbRgLsbRibRibRiLsbRgbLibRjbLibLgbLibRsLsbLgbLgb
LgbLgbLsLsmbLsbLsbLsbRhbRjbRibRhbLsbRgbRcbLibRjbRsRsmbRsbRiRsmbLsLsLsm
mbLgLsbRoRsmbRibRgbRibRsbRibRibLgbRcbRiRsmbRhRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 25; Drug: PCAP2 10 然
bRgbLsbRsbRjbLsbLsbLsbLsbsbLsLsmbRjbRsbRsbsbRsbLsRsbsbRsbRsRsmbLsbLsbR
ibRsbLsbsbLgbRsbLsbRsbLsbLsbRjbRsbsbLsbsbLebRsbLgbRibRcbRsRsmbRsbRsbLs
bRsbsbRebRgbRgRsmbLgbLgRsbRgbsbRsRsmbLsbsbLsbRsRsLsmbReRsmbRsRsRsmmbLs
RsbRcbRsbRebRgbLsbLgbReRsmbRgRsmbRgRsmbLsbLsbsbsbLgbsbsbsbRsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 26; Drug: PCAP2 10 然
bRsbRoRsmbRsbRsRsmbRoRsRsRsLsmmmbRgRsmbRoRsmbLsbRsbRibRsRobLsbRsbsbsbR
iRsmbLoRsLsbLsbLsbLobRsbRsbsbsbsbsbsbsbsbRsbLsbRsbRsbsbRsbLgbLobLsbLgb
RsbRobLsbsbLsbsbLgbLsbLgbLsbLsRsbsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 27; Drug: PCAP2 10 然
bRsRsmbsbRgRsmbRsRgbRsbLibRgRsmbRgRsmbLgbRsbLsLsmbRgbRsRsRsRsmmmbRsbRs
bsbRsbRsRsmbLgbLsbLsRsbRsRsRsmmbsbLsLsLsmmbRsbLhbLsbLeLsbLsbLgbRsbLsLg
LsLsmbLsLsmbLsbLsLsmbRsbLcLsmbLebLsLsmbsbLiRsbLsbLsbLiRsbLsbLsbLgbLcbL
oLsRsmbRsbRoLsLsmbRsbRsRsmbLsbLibLibLibLsLsLsLsmmmbLsbLsbLsRsbLgbLgbLg
bLsbLsbLsbRoRsmbsbsbLsbLibLsRsbsbsbLsbLsLgbRsbRsbLibLsLsmbLsbLsbLsLsmb
LsLsmbRsRsmbRsbRsRsmbRsbLhbLgbRsRsLsmbLgbLoLsRsmbLibLgbLsbRsRsRsmmbRgR
sRsmmbRgbLgbRsbRgRsmbLgbLsbLsLsmbsbLgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 28; Drug: PCAP2 10 然
bLibRsbRcRsmbRgbRsRsRgRsRsmmmbRsbLsbLsbRgbRgbRgbRgRsmbRgbsbRsLsbLsbRgb
LebLsbLhLsbsbLsbLiRsbLgbRsbLgbRsbRsLsbRgLsbLibLhLgbLsbLobRsbRoRsRsmmbL
sRgbLobLoLcbRcbRgbRoLsbLsbLgLsbLgLsbLiLsbRsbLsbLsbsbRibRsbsbLoLsLsLsmm
mbsbLsLsmbLiLsbLsbLsbLgbLsLsmbsbLsbRgbLhLsbRsbRsbsbRsRsmbRobRhbLsbsbsb
LgRsbLiLsbLsbsbLcLsmbRsRsLsmbRsbRsbsbsbRsbRgRsmbLsRsRsmbRsbRsbRsRsmbsb
LsbLcbLgbRgLsRsbLsbRsLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 29; Drug: PCAP2 10 然
bLibLsLsmbRsbRsbLobLibsbLgbRsLsLsmbLsLsmbLsLsLsmmbLgbLoRsbRsRsmbRsbsbL
gLsbLgbLgLsRsbLsbLsbRjLiLsbRsLsLsmbLsbLsbsbsbRgbLsbsbLgbLsbLiLsLsmbLgb
RsLsbLibLsLsmbRgRsmbLiLsbsbLsLsmbLsLsLsmmbRsLsLsLsmmbLsbLsbRsRsLgmbLsb
LsLsmbLsbRoRsRsRgmmbLsbRgbRsRsmbRsbRsRsRsRsRgmmmbsbsbLgbLsbLsbLsbLhbsb
sbsbsbRsbLsbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 30; Drug: PCAP2 10 然
bLebLcbLibLibRebRobRobLcbRcbLobLebRibLobLobLibRebRebLcbRgbRebRobLebRib
LobLobRebLgbRobLhbLobRcbLobRsbRhbRibRobLgbLgbRcbRgbLcbRcbLobRobRgbLhbL
obRcbRobLobLhbLebLebRebLebLebRobRobLobRebLcbRebRsbLsbRobLgbLcbLgbLcbLg
bRobRcbRsbRobLobLobRebLibLibLcbLhbLibLobRsbLobRobLcbLsbLebLibLibRobLcb
LebLgbLobRobRebRibRobRebRibRobLcbRobLebLobRcbRobLobLobRgbLjbLibLebRsbR
cbLhbLebLebLcbRobRebRgbLebLobLebRebLebRobRibLobLcbLobLcbLebLobRobRgbLe
bRhbRgbLebRebLebRobRobRebLcbRobRsbRgbLcbLebRobRobLobRebLebRobLebLobLob
LobLebRcbRibLebRobLebRebLobRobRobRhbLobRsbRobLobRgbRobLobRebLgbRobRcbL
ibRgbLibRebLibLobLibRobRobLobRebRobLcbLebLcbLebRcbLebLebRobLcbLebLobLe
bRobRcbLibRobRsbRibLobRobLcbRibLcbLcbLobLcbRobRebRcbRebLebRsbLebRobLob
LcbRobLobRcbRebRobRgbLcbLobRobLebLjbLobLebRgbLebLebLobLgbLobLgbRobLebL
obRibRebRebRsbRobLgbRcbLobRobRibRebRobRcbRebRobRebRobRgbRcbRgbRcbRcbRe
bLibLobRobRcbLobRebLobLobRebLcbLsbLobLebRsbRebLobLobRobRibLgbLobRobLeb
RsbLcbRobLebRgbRobRebLobLgbLebLobLebRebRebRobRobLcbRebRobLgbLobRobRobL
obRibLebLobRgbRobRebLibRebRgbLobRobRibRibLobRobLobLibLibRgbLobRebRebLs
bRcbRgbLebLobLcbLibRebRgbLgbLobRobLcbRobLebRobRebRgbRsbRhbLebLibRgbReb
LobLebLobRebRobRobRebLobRgbRobLsbLobLcbRebLcbRebLibRebRcbRobLgbLobRcbR
cbRcbRebRebLebLobRgbLcbLebRsbRobRobLcbRsbRgbRcbLcbLobLsbLcbRgbLhbRibLo
bLibRcbRcbRcbRobLobRobRebLebLebRibRsbLcbRebRobLobRobRebRhbLgbLebLobRgb
RobRgbLobLebLebLibRobRebLobLhbLebRobRhbRobLebRcbLobLobLibLhbRebRcbLibL
ibRebRcbRgbRobRobRebRobRgbLcbRobRcbRebRibRebLebRcbRibRgbRhbLsbRobLebLe
bRobLcbLgbRobRobLobLebRobRobLobRibRebLibLcbRcbLcbLebRobRobRobLgbRebRcb
RobRcbRebRobLibRobRibLobRcbLobLgbRebLebRcbRcbRhbRibLobLobLsbRsbLebLebR
obLobRebLobLebRcbRibLcbRobRcbLibRgbRobLebRebLebRobLebRcbLobLobRhbRobLe
bRobLobLobRobRcbRobRebRobLgbLcbLebLcbLibRobLcbLebRcbLobLebRobRebLobLob
LobLebLhbRgbLcbLcbLgbLcbLcbLobLobLebLebLebRcbRobRibRhbRobLobRhbLhbLobL
sbRebRebRebLobRebLobLobLcbLhbLebRgbRobLsbRcbRobRibLibLobRgbLgbRibLcbRo
bRebRobRgbLibLsbLebLobRobLobLobRobLebRobRcbLibRobRebLcbLgbRcbRibRobLeb
LcbRobRobRobLgbLcbRebLobRebLobRebRebRobLobRcbRibLebRobRcbLcbRobLcbLobR
cbRibLcbLibLcbLebLebLobLobLebRsbLcbRebLobLobLgbRcbLobRcbRobLsbRobLcbRo
bLebRebRebLcbRebLobLobLebRibRobLcbRhbLobRcbRsbLobRebLgbLobRobRhbRebLgb
RgbRobLobLsbRebLcbRcbLcbLcbLibRobRebLobLgbRebRobLobRobRebRobRibLebRebR
obLobRebRcbLgbLobLebLobRobRobRcbLebLcbRcbLobLsbRebRobLcbRcbRsbRobLobRo
bLobLobRcbRcbLcbLebRcbRebRobRobLobLsbLibLhbRobRebRebRgbLhbRebRebLebRob
RebRibRcbLobLobRcbRibRcbRcbRebLobLobLobRobLobRobRebLobLibLobLobLobLgbR
hbRebRibLibRobRebRcbLobRsbLobRebLebLcbRobRobRhbRibLebRcbRhbLobLebRobLo
bLobRobRobRgbLobLebLgbRobLebRobLibLebRobRebRsbRobRobRgbLebLobLhbRebLeb
LcbRgbLobLebRebRebLibLgbLobLebRibLobLibLobRobLobLibRobRebLcbLgbLobLobR
ibLgbLebRcbLebLobLcbLcbLhbLcbLcbLebLcbLibRibRobRibRobRcbRebRebLebLebRg
bLibLobLgbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 31; Drug: PCAP2 3 然
bRsbLsRsbRsbRsbLsRsbRsbsbsbsbsbRsbLsbsbsbsbsbRsbsbsbsbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 32; Drug: PCAP2 3 然
bLsLsLgmbsbRgRsmbRsbRsRsRsLsmmbRgbRgRsmbLsbLjbLgbRgbLsLsLsmmbLsLsmbLsb
RsbsbLsbLsbLsLsLsmmbLiLsbLgbLgbLsbLsbLsLsLsmmbRcbsbLgbLsbLsLsmbsbRibRs
LsbLsLsLsmmbLsLsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 33; Drug: PCAP2 3 然
bLiLsbsbRsbRsbsbsbRsbsbRsbLsbLjbRibLsbRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 34; Drug: PCAP2 3 然
bRsRsmbRsbRsbsbLsLsRsRsmmbRsbRsbReLsbLsbsbRsbsbLsRsbLsRsbRsRsRsmmbRsbL
sbRsbRsbRsRsmbRsbRsbsbsbRsbRsLsbLsLsmbLsbLsbLsbLsRsbRgRsRsmmbRsbRsbRsR
sRsRsmmmbRsRsRsmmbRsRsRsmmbRsbRsbLsRsRsmbRsbRsbRsbRsbLsLsLgRsmbRsRsRsR
sRsmmmmbRsRsmbRsbRsRsmbRsRsmbLsbLsbLsbLsLsmbRsbLsRsbLsRsbRsbRsbRsRsmbR
sbRsRsRsmmbRiRsmbsbLhbLiLsbLjLsmbRsRsmbRsbRsbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 35; Drug: PCAP2 3 然
bRsbLsbRsbLsRsbRjbRsLsbLsLsmbLsLsmbLsbRsbsbRjRsmbRsbRgRsmbRsbRsbsbLsbR
sRsmbRsbLcbLibLibLiLsbLibLsLsmbsbLsbLsLsmbRibLiLsbRgRebRcbRsLsbRjbRjbR
sRsmbRjRgbsbLsRjbRsbRsbsbLjbLsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 36; Drug: PCAP2 3 然
bLsbRcbRiRsmbLsbLibRobLjbsbsbsbLsbsbRsbsbRsbsbRsLsbsbLsRsRsmbRsbsbLsbR
sRsmbRsRsmbRsbsbRsbLsLcbLsbRsbsbsbLsLsmbLeLsbLcbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 37; Drug: PCAP2 1 然
bLcbRsRsmbRsbLhLsbsbRjRsmbLsLsmbRsRsmbLgbRiRsmbRgRsRsmmbRsbsbLsbRgRsmb
RgLsbsbRcLsbLsLsLsmmbLsbRgbRgbRobsbRiRsmbRgbsbsbLsLsLsLsmmmbRgbRhbsbLj
bRibLsLsmbRsbRibRgbRgRsmbLsbRibLsbRcbsbLsbRiRsmbRgRsRgmbLcbLiLsbsbRsRs
mbLgbLsLsmbLgLsbsbLgbRgbRcRsmbRsLsbsbRibLgbRjRsRsRsmmmbRsbLsbRgbLsbRib
RgRsmbLgLsbRgbRgRsLsmbLsLsmbRobRibRhRsmbRibLsbRibRsLsbLsLsmbRibRsRsRsm
mbRcRsmbRiLsbRcRsRsmmbLgLsbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 38; Drug: PCAP2 1 然
bLgbRgbLibLibsbsbLjLsmbLsLsmbLsLsLsmmbLsLsmbRsbLibLsbLsbsbLgbRibLgLsbL
ibRgbsbRsRsmbRsbLibRcbsbRibRsbLcbLjLsLsmmbRgbLgLsbsbLcbLiLsbLgbRsRsRsm
mbLgLsbLsbRsLsbLgLsbLgLsbLibLibLiLsbLgLsLsLsmmbLibLsbRsRsRsmmbLsbRgRsm
bRsbRsbLjbLjLsmbRjRsRsmmbRibsbLsbLjbLgLsbRsbRibRgbLgLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 39; Drug: PCAP2 1 然
bLgLsbLgbLgbLsLsRsmbLgLsLsmbLsbLgbLgbLhbRiRsmbRcbRibLeLsbLobLgLsRsbLsR
sbLibLcbLibRjRgRsmbRgbRibRibRobRibRsbRjRsmbRgbLsLcbLgbLsbLgbLgLsbRiRsm
bRjbRibRiRsmbLjbLcbRgbRibLjbLoRsRsmbRsbRjbLjbRgbLgLsbRgbRcbRibRgbLcbRc
RsmbRjRsRsmmbLsbRcRsmbRgbRibRgRsmbRgbLsbLsLsmbRcbRhbRgRsRsmmbRsbRgbRib
LsbsbRibRgbRgRsmbRhbRgbsbRibRibLhbLibRsbsbRobLsRsbRgRsRsmmbRgbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 40; Drug: PCAP2 1 然
bsbRgbLhbRsbRgbRcbLsbRsRsmbRgbLjbsbRgbLsbLebRibRibLsbRsLsbRgRsRsmmbRgb
LhLsbsbsbsbRibLjbRiRsmbRibRiRsmbLibsbsbsbRiRsmbLjbLebLgbsbLibLsbLgbRsb
RgbRibLjbLgLsLsmbRjbRcbLiLsbLsRsbRiRsmbLebLsRsbLibRgbLiLsLsmbLsLsmbLgb
RsbLsbLgbRsRsmbLgLsbRgbRsLibLsLcbLgbRsRsmbLebLibsbLsbRibRgbsbLsbsbsbLc
LsmbRgbLibRcbRgRsmbLsLcbLsbLiLsbLsLsmbLibRsbRsRsRsmmbLsbLibLibLcbLsbRi
bRsbLsLsmbLgLsbRsRsmbLsRsbLebRsLsbRobsbLgLsbLiLsbLcbLsbsbLibRsLsbLgbLg
bLgbRgbRsLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 41; Drug: PCAP2 1 然
bLsLgbLsbLsbLsRsbRsRsmbRgLsbLsbsbsbLsRsbLsLsmbRgRsmbRgRsmbLibLsbRgRsmb
LibRibRsbsbRcbRsRsmbLsbLsLsLsLsmmmbRsRsmbLsbLsLsLsmmbRebLsbRsRgbRhbLsb
RsLsbRsbRsLsbsbLsbLsbRsLsLsmbRsbRsbLsLsmbRsbLsbRgbRsRsRsRsmmmbLsbRsbRs
RsmbRgbRgbLsbLsbsbRsbRgbRgLsbLsbRsbRgbRsRsRsmmbLgbRgRsmbRgbsbRsbRibsbR
gbsbLsbRibLsbsbsbLobsbLibRsRgbLhbLsbLiLsbRsLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 42; Drug: PCAP2 1 然
bRsbLibLsbLiLsbLsLsmbRsbRsbLibRsbLibLiLsbLgbRcbsbRgbRhbLgbRiRsmbRiRsmb
LsRsbRgbRsbsbLsbLoLsmbLgbLsbLsLgbRgbLibRsbRsbLoLsmbRgbLobLiLsbRsLsbLiL
sbLibLsLsmbLiLsbLsbLgbLsLsLsmmbRjbsbRgbLibLsbLsbLsLsmbLiLsbRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 43; Drug: Control
bLsbLsbLsbLgLgbLsbRgRsmbLgbRsbLsbLsLsmbRgbsbLsbsbRsbLgbsbRgbsbLgbLgLsb
LgbLsbLgLsLsLsmmbLsbLsLsLsmmbLgLsbRjRsmbRsbRsbRsbLgbsbLgLsbLsbLsbRibsb
RgbRgRsmbRsbsbLibLgLsbsbRjbRcbRcbRiLsRsbLsbLiLsbLgLsLsmbLsbLsbsbsbsbLg
LsbLsLsmbLsLsLsLsmmmbLsbsbLsLsmbRibRsbRobLsbLgLsLsmbRsbLsbsbLjLsLsRsmm
bsbRsLsbLsLgbLibLsbLsbLsbsbLsRsbLsRsbLiLsbLgbLsbRsbsbLsbLsLsmbRsbLibLs
bLsbLsbLibLsLsmbLsbRjbLiLsbLsbLgLsRsbLsLsmbLibLsLsLsLsmmmbsbsbRsRsmbRe
b

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 44; Drug: Control
bRibRsRsmbLibLsLsmbRibRibRiLsLsLsmmbRibRgbsbLgbRibRibRibRsbRobRsRsmbLs
bRibsbRibRibRsbRsRsmbRsRsmbRsbLsbRibLsbRibRgbLsbRibRibLsbLsbLsbRsRgbsb
RcRsmbLcbRgbLsbLsLsmbRiRhRsmbRgbRsbLjbLibLsbRsbRsbLsbLsbRsbLjbRsbLhbLi
bLsbRgLsbLsbLsbLsbLsLgRsbsbLgRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 45; Drug: Control
bLsLsRsmbRsRgbLibLsLsLsLsmmmbRsRsmbLhbRcbRhbsbRsbRgRsmbRsbRibRsRsRsmmb
LgLsbRsLsbRiRsmbRgbLgbRsbLebLcbLsLsmbRsRsmbRsRgRsmbRsbLsRsbRsRsmbLsbRs
bLjbRibLhbRsRsmbLebRibRsRsmbLgbsbLiLsbLsLsmbLsbsbRsbLgbLsLsmbsbLgLsLsL
smmbRgbLiLsbLgLsbRcbRibRibLsLsmbRhbRsRsmbRgbLobLgbRsRsmbRgbRsLibRibRib
ReRsmbRcbLsbRsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 46; Drug: Control
bRsLsbRibRgbRsbRgbRsbRsbRsbRsbRgbRgbRsbRgbRsbRgbRsRsmbRsbRsbRsbLsbRgbR
gbRsbRsRiLsbRsbLsbLcbLsbLgbRsLsbRobLcbLsLcbRsbRgbRjRsmbRibRgbLebRibLib
LjLsmbLsbRobLgbRcbRgbRsbRsbsbRibLsbRibRibRgbLsbRibRsbRsRsmbRgbRsbRsbRg
bRsbRgbRsbRsbRsbRgbRsbRsbRsbRjbRiRsmbLsLsmbLsbRibRsbRgbRgbRgbRsbRsbRgb
RgbRgbRgbRsbRsbsbRgbRsbRibRgbLsbRsbRcbLsbRhbLsbRsbRibRsbRsRsmbRgbRsbRg
bRgbRgbRsLsbRsbRgRsmbLgbRsRsmbLebsbLibRjbLgbLibLsbLsLsLsmmbLgbLgbRsLsb
LgbLgbLsbLgbRsbsbLsbLgLsbRsbLibLsbRgbLibLgbLgbRsRsmbsbsbRoLsbRsbRiRsmb
sbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 47; Drug: Control
bLgbRcbRibRibRgbLgbRibRsbRsbRsRgbLgLsbRsbRibLsbRgLsbRgbRsbsbRibLgbRgLs
bLsbLcRsbRcRsmbRgbLsbRiLsRsLsbsbRiLsbRibRibRiLsbLsLsLsmmbLsbLibLibLsbL
ibRgbLiLsbLgbLgLsLsmbLgbLgLgbLibsbRsRsRsmmbRsRgbRsRsmbRcbRibRibRsbLsbs
bRsbRhbLgbRhbLsLsRsmbRgLsbsbsbRsbLsbRsbsbLibLibLsbLsLsmbLsbRsRgRsmbLsL
sLsLsmmmbLjLsmbLsRsbLcbsbLjLsLsmmbsbLcbLsLsmbsbLsbLsbLsLsmbLsLsmbRcbLs
LsmbRsbRsbLsbRibRgRsmbRsLsbLibLebLsbLobRibRiRsmbRsLsbRgRsRsRsmmmbLgLsb
LgLsbRsbLibLsLsLsmmbLsbRibRsRsmbsbLsbsbRgRsmbRsRsmbRsbRsbLhbLjbLcbLjLs
LsmmbLcbLsbRsbLcbLibsbsbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 111618; End: 112118;
Recording: 12-1; Individual: 48; Drug: Control
bLcLsmbLiLsbRsRsLsmbLsLcLsmbLsbLibLibRibLibLcbLibLgLsRsbRgbLcLsmbRgbLo
RsbLsbRsbRibRgbLcbRibRsbRhbLcRsbsbRjRgbLibRiRsmbLibRhbRhbRcbLiRsbLcRsb
LibLcbLiRsbLibLgbLhbLibLibLsLsmbsbLibLibRibRoLsbLibLebRsbLiRsbRcLsbLib
RgbRibRobLiLsbRsbsbLgbRobLibLgbLibLcbsbLibLjLsLsmmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 1; Drug: PCAP2 10 然
bsbsbLsRibRsbRsbRsbRsLsbRsRsmbRgbRsRgbLsbRgbRsbRsRgRgbRgbRgbRgRsmbRgRs
mbRsbLsbRgbRgRsmbRgbRsbRgRsmbRsRsmbRgbRsRsLsmbRgbRgbRgbRsRsRsmmbRsbRgb
RsbLsbsbRgLsRsbRgRsmbRgbRsRsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 2; Drug: PCAP2 10 然
bLgbRsbLjbLsbLsbLsbLjbLsbRsbRjbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 3; Drug: PCAP2 10 然
bLgLsLsmbLsbRsbLsbLsbRibRsbRsbLgbRsbsbsbRsRgRsmbLibRsbRsRsRsmmbLiRsbLs
bLsbLsbRgRgbLsRsbLgLsbRsbLgbLsbLgLsbsbLsbRsbRsbRsLsbRsRsmbRsbLsbRsRgbL
gLsbLgLsbLsbRgbReRsmbsbLeRsbLsbRiRsmbRgbRgbLsbLsbRcbRgbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 4; Drug: PCAP2 10 然
bsbRsRsLsmbRsbRsLsbLsLsRsmbRsbRsLsbLsbLibLsbReRsRsmmbRsbRsbRsbRsRsLsmb
RsLgRgRibRgRsmbRgbRgbRsRsmbRsbLsbRsbRsbRgbLsRsbRsbsbsbRsRsRsmmbLsLsmbR
sbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 5; Drug: PCAP2 10 然
bRibLgbRsbRobRgbRsbRsbRsbRebRsRsmbsbRsbRgRsRsmmbRgbLsbRsbRsbLsLsmbRsbR
obLsbLsbLsRsbLcRsbLsLsLgmbsbRsbLsbLgbLsbLiLsbLgLsbRsLsbsbRsbLsbLgbRebR
sbLibLhbsbRgbsbsbsbRsLsLsmbRsbRgbLebLsbsbRsbsbsbLsbLsbLebLsLsmbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 6; Drug: PCAP2 10 然
bLebRgLsRsbRgbRgbRgbLsLsmbLsLsmbLsbLsLgbLsbLibsbLsbRsRsLgmbReLsLgbLebs
bsbsbRebLsLsLgLimbLebRebLgbsbsbLebRgLgLgbLsbLsRibRcbLgRsbRsbRgbLoRsbLg
LsbLsLgbLebsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 7; Drug: PCAP2 3 然
bsbsbsbsbLsbLsbLsbLgbRsbsbsbLsbsbRsbsbsbRsbRsbLsRsRsLsmbLsbsbsbLsbRsLs
bsbRjbLsbLsLsmbRsbLsbRsbLsRsbLsbLsLsLsmmbLsLsmbsbsbRsbLsLsmbLsbRsLsbRs
bLsbLsbsbRsbLsbLsRsbRsbsbLsbRsbsbRsRsmbsbsbsbsbRsbRsbLsbLsRsbLsbRsbsbL
sLsLsLsmmmbLsbsbsbsbsbsbsbsbsbRsbsbRsLsbLsbLsbLcbLobLjbRebsbLsbLgbsbsb
sbRsbsbsbsbLsbRsLsbLsLsLsmmbLsLsmbsbsbRsbRsbLsRsbLsRsLsbLsbLsRsbLgbsbR
jbRsbRobRgRsmbRgbLsbsbRcbLsbRsRsRsmmbLsLgbsbRjRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 8; Drug: PCAP2 3 然
bsbsbRgRsmbRsLsbRibRsbLgbRgbLsbLsbsbsbLsbRsbRsbsbRsRgbRiRsLsmbsbsbRgRs
mbRsLsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 9; Drug: PCAP2 3 然
bsbRsbLsLsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 10; Drug: PCAP2 3 然
bRsLsbLsLsmbRsbLsLsmbRsRsLsmbLsLsLsRsmmbLsRsbLsRsbRsbRgbRgbLgbLsbLsLsm
bLsbLsLsmbLgbsbLsLsLsmmbLsbRibLsLsmbLsbRsLsbLsbRsbsbLsLsmbReRsRsmmbRsb
sbLsbsbsbRsbRsRsmbRsRsRsRsmmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 11; Drug: PCAP2 3 然
bRsbRsbLsbsbRsbLsbLsbRsRsmbRsbsbRsbLsbRcbRsbRcRsmbRgRsmbRjbRsbRibLsbRs
RsmbLsLsRsmbRsbLibLsbRsbRcRgLsbRiRsRsmmbRoRsLsRsmbRsRsmbRgbRgbRibRsbRs
bRsbLsbLsbLsLsmbLsLsLsmmbRsbRiRsmbRibRgbRsRsmbRgbRsbRhRsmbRsbRgbLgbRsb
RsbRsbRsbRsbLgbsbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 12; Drug: PCAP2 3 然
bRsbLsbsbRsbLsbLsbsbsbsbsbRsbRsbRsbRsRsmbLsbLsbLobRibRibLsbRsbLiLsbLsR
sbsbLgbLsbsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 13; Drug: PCAP2 1 然
bLgbRgbRsLsbRcbsbRsbRsRsmbRibsbRgbRsbRiRsRsmmbRhLsbLgbRiRsmbRsbLjLsmbR
sRsmbRibRsbRsRsmbRgbRsbRsbRgbRgRsmbLgLsbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 14; Drug: PCAP2 1 然
bRoLsbRhbRjRsmbRibRjRgRsmbRjRgbRhbsbRgbRsbRsbRibRsRgbRgRsmbRgRsmbRibRg
bRgRsmbLibLgbRsRsmbRgRsmbLsbLsbRebRsRsmbRibRebRibLsbLsbLsbRibRibRgbRgb
RgRsmbRsRgbRibRsbsbsbRibRibRjbRgRsmbRgbRsbsbRcbRsRsRsmmbRsRsmbRgbRjRsR
smmbLjLgbsbsbRgbRjbRcbRsRsmbRibRgbRsRsmbRsRgbLsbRibsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 15; Drug: PCAP2 1 然
bLibLsbLsbRsbsbRcbRiRsmbsbRsbLsRsbLsbLsLgLsbsbsbLsbRsRsRsmmbRsRsRsmmbL
gLsbLoLsmbLgbLcLsmbLsbLsbLiLsbLgLsLsLsmmbRsRsRsmmbsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 16; Drug: PCAP2 1 然
bLsLsRsmbLgbLsRsbRsbRibRhbRsbRsRsmbRebLobRcbRiRsmbLsbRibRsRsmbRgLsRsbL
sRsRsmbRsRsmbLsRsbsbLcLsmbLgbLibLsLsmbLsLsLsmmbLsLsRsmbLsbLsLgbLsLsRsm
bLibLsLsLsmmbRjbRgbRsbLcLsmbLsbRsbRgbRcRsmbLsbRsbRsbLgbRsbLgbLsbRsbLob
LebRsRsRsRsRsmmmmbRsRsmbRgRsmbRsbRgRsmbRebRsbRsRsmbRsRsRsmmbRsRsmbRsbR
gbRsRsmbRsbLsLsRsRsmmbRgbRgRcRsmbRgbRcbRiLsbRibLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 17; Drug: PCAP2 1 然
bRgbRsLsbRgRsmbRgbLsLsmbLgbLcLsmbRsbRjbLibRsbRsLsbLiLsbRsLsbRgbRsbLibR
ibsbLeLsbLibLsLsmbLgbLsbLgbRsbLsbLsLgLsbLgbLgbRibLibLsbLeLsbLsbRsRsmbL
ibLgbLgbRgbRgbsbLsbLgLsbLsRsbLsbLhbLgbLsLsmbLcbRsbRjRgRsRsmmbsbLibRgRs
RsmmbRgRsmbRsbLgbRjbRsLsbRibLgLsLsmbLsbsbRsbsbRsbRsbLhbLcbRsbRgbRsRsRs
mmbRsbLiLsbRsRsmbLibLgbLsbsbRsRsRsRsmmmbRsRgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 18; Drug: PCAP2 1 然
bLobLebLcbLcbLsbsbRgbLsbRsbRsbLibLoRsbRsbRsbRsRsLsmbsbRsbRhLsbLibLgLsb
LcbLiLsbRsRsmbLibRsLsbLgLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 19; Drug: Control
bLcRsRsmbLsbRjbLsbLsbLgLsLsmbRebRibLgbRibLobLsbLibLsbsbRsbRgbsbLiRsbRe
bRjRsmbRibRsbRsbLibsbLsbRsbsbLsbLsbRgLsbLsbLgbLsbRsbLhbLsbRgbLibLsbRsb
RgLsbLgbLsbRsbLibLgbLoLsmbLsbLsbLsbsbsbsbsbsbsbRsRsmbLibLibLgbRsbLsbLg
LsbRsbRsbLsbsbLjbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 20; Drug: Control
bRsRsmbRgbRcRsRsmmbRsLsbLsLsmbRcbLjbLhbLhLsbRsRsmbLgbLibLibRgbRiRsRsLs
LsmmmbRsLsbRibRsbRgRsRsmmbRsRgbRgbRsRsmbRgRsmbRsbsbLsbRhbLsbsbLsLsRsmb
RhLsbRiRsmbRgbRsRsmbLgbRsbRiRsmbRibRgbRgbRgLsbLsLsLsRsmmbLsbRibRibRsbR
gbRiLsbLibLsbRsbRibLjbRibRhbRsbLgbLsbRsbRibLsRsbRiLsbLsbLjbRsbRsRsmbRs
bLsbRjLjbLebRsbLsbLsLgbLsbLsbLgLsbLsbLgbRsbLibLsbLgbRgbLsbLsbLsbLgbsbL
iLsbLgLsbLsLsmbLgbLibLsLsmbRjbLibLgbRgbLsbLgbRsbRsbRsbLgbsbLgbLgbRgbLj
LsLsmmbLsLsmbRsbLsLibLsbLsbRsbLibRsbsbRsbLibLsbLiLsbRsLsbLgLsbLsbRsLsb
LibsbRsLsbLgbLgRsbLsbRjbLibLgbRsbRsRsmbRsbRsLjbLsbLgbRsbLgbLsbRsbLgbRs
bLgbRsbRsbRgbsbLhbsbLsbLgLsbRsLsbLgbLsbLsLsmbRjRsmbLgbLibLibRgRsmbLsLs
mbLoLsLsmmbLgbRibLsbRsbLibLgbRsbRibLibLibLsLsmbLibLsLsLsmmbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 21; Drug: Control
bRibRobRcbLhbLibRjbLhbLiRsbLhbRibsbRibRcbRhbRibRgbsbRgRsmbRsbsbLgLsbRs
bsbRgbLsLgbRhbLsbRibLibLibRiRsmbRgRsmbRibLjLsLsmmbsbRibRibsbLsbLsRsbRg
bLsbRcbRsRsmbRsRsmbRgbRgbRibRgbsbLgbRsbRoLsbRgRgbRsbLsbsbLsbsbsbLgbLsL
smbLibRibRcbRsRsRsRsmmmbRsbRgbLgbRjRhbRcbRibLgLsbLgbRoRsmbRibsbRgbRgbs
bsbRibRjRsmbRjRsRsRsmmmbRsbRibRsbRgbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 22; Drug: Control
bLgbsbLsbRsbLsLiLibsbLhbLgbLsRsLsbLgbLhbRibsbsbRgRsmbLjLsmbRibLsLsmbLs
RsbRoLsbLcbsbRobLsbRsLibLcRsbRoRsmbRjRsmbLcbRjRgbRibLsbRsbRgRsRsmmbLgL
sbRgRsmbLgbRsRsmbLjLsmbLgLsLsLsmmbLsLgbRjRsmbRgRcLsLsLsmmbRobsbsbsbRoR
smbRgRsmbLobLjLsmbRoRsLsmbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 23; Drug: Control
bLibLibRgbRgbRibLsRsbRsbLsbsbRgbRcLsbsbRgLsbLsLsmbRobLgbRibLsbsbLsbLsb
LsbLsLsLsmmbLsLsLsLsmmmbsbLjLsmbLsbLsRsbRsRsmbRcbRgbRsbRsRsmbRgbRsbRsb
LgbLjbLsbLgbLsbLsbRibLsbLiLsbRsbRsbLgbLibRibRsbRjbLjbRsbsbLsbLcbRebRsR
smbLcbLsRsbLibLibLsbRsLsbRgbLibLgbLsbRjbLjLsmbLgbLsbsbLibLsLsmbsbRjbRc
bRibRsbRsLsRsRsmbRsRgbLsbsbLsRsLsbRhbRsRsmbLibLsbLobsbLsLsRsmbsbRsbLib
LibRsbRjbLibLiLsbLibRsRsmbRsLsbLibLsbLgbLgbLsLsmbLjLsmbLjbRobLsRibsbRs
RsmbLhLsbRsbLiRsLsbRsbRgbRsbRsbRibsbLiLsbRsbRgbRcLsbRgbRsbLibLsbRibLib
RcbRsbRsbRiRsmbRgRsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 24; Drug: Control
bLibLsLsmbLjLsmbRhbRebRgbsbRsbRiRsmbRgRsmbLsbLibLsbLhbRiRgbsbLsbLsbRob
RsLsbsbRhbLgRsbRsbRcbLgRsbRsRcbLgbRibRiRsmbRibsbLgbLibLobRebLiLsbLsbLi
bsbLgbLgbLgbLgbRjbRibRgLsbRcbLsbLgbLjLsmbRcbLobRhbRsbRjbLjbRibLgLsbRib
LsbRgLsbRsRsmbLsbRgbRgbRgbRgbRgRsmbRgbLsbRgbRsbRsbRgbLsbRibRgbRgbRgbRs
bRibLsbLsbRcbLgbLgbRebRibLsbLsbRibRsbRgRsmbRobRcRsmbsbLjbLhbLiRsbLgbsb
LgRsbLgbRgRsmbLgbLgLsLsmbsbLgbLsbsbsbRsbRsbsbsbLsbRsbLjLsmbRibLsLsmbLg
bsbLgbLibLsbLibRibRsRsmbLibsbRsbLcbsbLsbRsbLibsbRjbRibRsbRsbRibRgRsmbR
ibRsbLoLsmbRcbLgbRibRgRsmbRgbLsbRibRgbsbLjbsbRibLjbRibLsbRsbLjbLibRjbL
ibLibLiRsbLiLsbLsRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 25; Drug: PCAP2 10 然
bsbsbRsbRjRsmbLsRsbRsbRibRsbLsRsbLgbRhbRsbsbLsbRsbsbRsLsbsbLsbLsbRobRs
bReRsmbRcbRcLsbRsbRsbLhbRebRebLsbRsbLjbRobRobRiRsRsmmbRgbRsbsbLsbsbLsb
RsbLsRsbLsRsbRebsbRjbLgbLsbRsRsmbsbRsbLsbRsbLgbLgbRebLcbRsbLjbRsbRsbsb
sbLsbsbsbsbsbsbRsLsbRoRsmbLgLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 26; Drug: PCAP2 10 然
bRebRsbLobRobRsRsmbRiLsbRsbRgbRsbRobRiRsmbRsbsbLsbRsbLsLsmbLsbsbRsbLsR
sLsRsbLsbsbLsbsbsbLsbsbsbRsLsbsbsbsbLsbRcbRgbRjbsbRoRsmbRgbRoRsRsmmbRs
bRsRsmbLsLsmbRsbLsbsbRsbRsbRsbLobLibRgbRhRsmbRsbRsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 27; Drug: PCAP2 10 然
bLgbsbsbsbRsRsmbRsLsbRsbRsbLgbLsbLgbLoRsbRsRsmbsbRgbRgbRsRgRsmbRsRsmbs
bRsbRsbsbsbRsbLsRsRsmbRibLgbLsLsLsmmbLsRsbRsbRsRsRsRsmmmbRsRsmbRsbRsRs
mbRsbRsbRsbRsRsmbLsbRsbRsbLsbLibsbLsLsLsmmbLsbLgbLiLsLsmbLibsbRgbRgbRs
RsLsmbRgbRgbRsbRsbRoRsmbLsbRobsbLoLsmbLibRsRsmbRsbRgbRsbRsbRsbRsbLjbLs
bLibRsbLsbLsRsbLsLsmbLsLsmbRsLsbLsbRsRsmbRsbLsbRsbLobRsbLsbLgbLsLsmbLs
bLsLsmbLjLsLgmbRsbLobsbLhbLsbLsLsLsLsmmmbRsLsLsmbLsbsbsbLgLsbRsRsmbLib
LsLsmbLsRsbRsbLebLsRsLsRsbLsbLgLsbLsbLgbLsbLgbLibLsLsmbsbRsRsRgmbsbLiL
sLsmbLsbLgbLsbLsRsbLsLsmbLsbLsbRsbRsbLsLsmbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 28; Drug: PCAP2 10 然
bRcbRsbsbLsbRsRsmbRsbRsbRsRsmbLjbLsbLebRobLgbRgbsbLsbRhRsmbRgRsRsmmbRs
bLsbsbLsbRsbsbsbLsbsbsbLcbLsbLsRsLsbRjRsmbRsbRibRgbRgbRsbLsbLjbRjbLsbR
hbLjbLoRsLsLsmbLsbRhbRgbRibRgLsRsRsmbLsRsbRsLsbLebRsbLcLsmbLgbLsLsmbLs
bLsbRgbRgbRsbRibRsbRsbRgbRsRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 29; Drug: PCAP2 10 然
bRsRsRsRsRgmmmbLsbLsRsLsLsmbRsbsbRsRsmbLsbLsLsmbLgLsbsbRsbLgbLgbsbLsLs
mbLsLsLsLsmmmbRsbRebRsbRsbRsRsRsRsmmmbsbRsbRsbLsLsmbLsbLoLsLgLsLsLgmmb
LsbLsbLsbLsbLgLsbLsbRsbRsRsLiLsmbLgLsbLsLsLgmbLgbRsbLsbLsbsbRibLsbLgbL
sbLgLsbLgLsbLgbLsLsLgLsmbLgbLsbLibLsbReLsbLgbLgbLcLgbLcLsLsmmbLsbsbRgb
RgbLsLsLsmmbsbsbsbsbLgLsbLsLsmbLsLibsbRsbLgLsbRgbRcbRsbRsRsmbsbLsbLsRs
bRsbLibRsbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 30; Drug: PCAP2 10 然
bLiLsbRsLsLgLsbRoRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 31; Drug: PCAP2 3 然
bRsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsLsbLsbsbsbsbsbsbsbLsbLsbLsRsbLsbLsb
LsbsbsbRsbRsbLsbLsbRsbRsbRsbLsbRsLsbRsbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 32; Drug: PCAP2 3 然
bRsRsRsmmbLsbLiLsbLsbLsbLsbRgLsbLsLsmbsbLsLsmbLgbsbRiLsbLsbLsbLsLgbLsL
smbLsbsbRsRsmbLsLsLsmmbLibLsLsmbLsLsmbLsbLsLsLsmmbRsbsbsbRibLsLgLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 33; Drug: PCAP2 3 然
bLsbRsbLsRsbLjLjbsbLsbRhbLsRsbRhbLsLsmbRcbsbLsLsmbRhbsbRsbsbRjRsRsmmbR
sRsRsmmbRsRsmbRsRsmbRgLsbLsRsbRsRsmbRsRsRsmmbLsLsmbLebLcLgbRcbRgbRsRsm
bRsRsRsmmbRsRsLsRsLsmbRgbRsRsmbRgLsbRgbRgbRsRsmbLsLsmbLgbRhbRsbsbsbsbL
ebLibLgLsbRsbLgbRgLsbLsbLsLsmbLiLsbLsLsmbLsLsmbLiLsbLsLsmbLsbLsbLsLsmb
LsbLsLsmbRsLgbLgbRjbLiLsbLsLsLsLsLsmmmmbLsLsmbsbRgLsLsLsmmbLsLsmbLsLsL
smmbRjbLjbRcbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 34; Drug: PCAP2 3 然
bRobRsbLsRsRsmbRsbRsRsmbRsbRgRsmbsbsbsbsbsbsbLsbsbsbsbsbsbsbRsbLsbLsbL
gLsLsmbRsbRsbLsLsRsmbRgbRgRsmbRsbRsRsmbRsRsmbsbRsbsbRsbLsRsbsbsbRsbRsR
smbsbLgLsLsLsmmbRsRsmbRsRsRsmmbLsRsbRsRsmbRsbRsbRsRsmbLsRsbRgbRsbLsbLs
RsbLsbRsRsmbRsRsmbRsbRsbRsRsmbLsRsbRsRsmbRsbsbRsbRsRsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 35; Drug: PCAP2 3 然
bLsbRsbsbLsLsmbsbLsbLsLsmbLgbRsbLobLsbLsbRjbRhbRsbRsRsmbLsbRsbRsRebLiL
sbLsbLsbLsRsLsLsmbLsbLiLsbLgbLgLsbsbRgbRsRgRsRsmmbLcbLjLgbLsLgLsbRsbRi
RsmbRgRsRsRsmmmbsbsbsbsbLsLsLsmmbRsbRsRsmbRgbLsbLjLgbLcbLsbRsRibRibLsb
LjLsLsmmbRjLsRsbRjLsbLsbsbLsbsbLsbsbRjLsbLsbRjbRsbLsRsbsbLiLsbLsbRsbsb
RiRsmbRsbRsbRsbLsbRsbRsRsRsmmbRjbLsbRsRsmbRsbLsLjbRsRsmbLsbsbRgbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 36; Drug: PCAP2 3 然
bRsbLsRsbLjbLsbsbRsbLsbRsbLsbsbRsbsbRsbsbsbLsbsbRsbRsbRsbRsbRsbRsbLsbL
sbRsRsmbLsRsbLsbsbRsRsmbRsbLsbRsRsmbLsbRsRsmbLjbsbsbsbRsRsmbRsbsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 37; Drug: PCAP2 1 然
bRhRsmbRsRsmbRsbLgbLsLsRsmbRcbRibLsbRgRsmbRsRsmbRgbRsRsmbLsLsmbLsbRsbR
gbLsLsmbRiRsmbRgbLsbRibLjbLjLsLsmmbLjLsLsmmbRiRsmbsbLsbRibLsbRsbRgbRsR
sRsRsRsmmmmbLsLsLsmmbLcbRgbRsRsmbLjLgLsLsmbLjLsLsmmbLsbsbRgbRsRsRsmmbR
gRsmbRsRsmbRgbLibRjbLiLsbsbLsbsbRsRsRsmmbLsLsLsLsmmmbLsLsLsmmbLsLsmbLj
LsmbLsbsbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 38; Drug: PCAP2 1 然
bLgbsbRsbsbsbsbsbRsLsbLgbLiLsbLibLgbLsLsmbLhbLjLsmbLibsbLjbRgbRgRsmbLj
LsmbRjRsmbLsLsLsmmbsbLjLsmbsbLsbRsbRsbRcbsbLgbRsbLgbRcbsbLsbLsbRcRsmbR
cbLiLsbRibsbLjbRjRsmbRsbLibRgbLsbLsbLjLsmbLsLsmbRcbLgLsbLgbRjRsmbLgbRs
bsbLgLgbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 39; Drug: PCAP2 1 然
bLjRibLgLsbLgbRibRgLsbRsbLebLjRsbRcRsmbRibRgRsmbsbRibRibLgbRibLiRsbLib
LsbLgbLgbRsbsbLjLsmbLibRsLsbLgbLgLsLsmbLgRsbLgbLsbRgbsbLcLsLsmmbRibsbR
jRsmbLgbRgbRsRsmbLobRcRsmbLjbRibRibRobRiLsbRgRsmbLsbRsRsmbRiRsmbRibRjR
smbLsbLibsbLsLsmbRjRsRsmmbRgbLsbRgbRcbRibRjRsmbLsLsmbLjLsLsmmbRgbRgbLs
bsbRsbRjRsRsmmbRsbRsRsmbRsRsmbRibRsRsmbLibLsLsmbRgbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 40; Drug: PCAP2 1 然
bRjbLsbRsbsbsbLiLsLsmbLgbLgbRsbRsRsmbRsbLsbRjRsRsRsmmmbRsbsbRibsbsbsbR
sbLsLsRsmbLsbsbLsbLeLsbLcbLgLsbRgbLsbLsbRsbRsLsRsbsbLsbRiRsmbRibRsLsbL
sLibRgbsbRjRsRsRsmmmbsbsbLeLsbLeLsbLibsbLgRsbLsbRgbLsbLibsbLgbLsbRsbLg
bsbsbsbLgLsbLgbLgLsbLiLsbLibsbLsLsmbRgRsmbsbRsRsRsmmbLsRsbRsbRibRsbRsb
RgbsbLeLsbLsbsbsbsbLibLsbLgbLgbLsbLgbLgbLgbsbRgbLibLiLsbLcLsmbLgbLsbRs
RsmbLcLsmbLsbLibLgbLgbRsRsmbRgbLibLsLgbLsLsmbLsbRgbLibLgbLiLsbLcLsmbLg
bRgRsRsmmbRsbsbRebsbsbRibRsRgbRsbLsbRgbLsbLjbLibLiLsbsbRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 41; Drug: PCAP2 1 然
bLobLjLsmbLsLgbsbsbRsbLgLsLsmbLgbLibLsbLibsbLgbRsbsbRsRsmbRsLsbLgLjLsm
bLiLsbLsbRsRsmbRsbLsbsbLsbLsbLibLsLsLsLsmmmbLgbsbLsLgLsbRsRsmbsbLjLsLs
mmbsbLjLgbsbsbsbLsbRgRsRsmmbsbsbsbLsbLgbsbLgLsRsLsbLiLsLsmbLsLsmbLsbLi
bLgLsbRsLsbRsbRcLsLsmbRgRsmbRsbsbLsLsLsmmbLsbLgLsLsmbsbLgLsbRsRgbRjbRg
RsRsmmbLgLgbLjLgbsbRsbRsbRgbRcbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 42; Drug: PCAP2 1 然
bLgLsbLsLsLsmmbRgbsbLibRsLsbsbRjbLsRibsbRsRsmbsbsbsbLebLsbsbLsLsLsmmbL
sLsmbRgRgbLsbRjbRibLjbRsbRgbLsbRcbLhbLsLsmbLsbsbLsbRsbRsRsmbLsLgbLgRsb
LibLgbsbRibRsbsbLsLsmbLgbLgbRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 43; Drug: Control
bsbLiLsbLgRsbLsbLsRsbLcRsbLibsbRsbLsRsbLsLsmbLsbLgbLsbLsbRsbRgRsmbLsbs
bsbRgbsbRibRgbLsbLsbLsbRibsbsbLcbLiLsbLgbLibLibLsbsbsbsbRsbLsbLgbLsbLs
bRsLsbsbLgbLiLsbLgbsbsbsbLsbsbLsRsbLgbLiLsbsbsbRgbLibLibLsbLsLsmbLgLsb
LsbLsbLsLsRsmbLgLsLsmbLsbsbLjLsmbLsbRgbRsbLsbLgbLsbLgLsLsLsmmbRsbsbLgL
sbLgbLgbLgbLsbLibLsbLsbLsbLsLsRsmbLgLsbLibRsLsLsmbLsbLsLsmbsbLsbsbLgbL
gbsbLsLsmbLgbLsRsbsbsbsbLsbRibLsbRgbRsRsmbLgbRiLsbRibsbLgbRsbRsLsbRibR
sbLjbsbRsLsbsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 44; Drug: Control
bRsbRsRsmbLsLsmbRsbLgbRsLsbRsbLsLsmbLsLsmbRsbLsRsbRsbLgbLsbLibsbLibRgb
LsbLgLsbLgbRibsbsbLgbRsLsLsmbLsLsmbLgLsbRgbLibLibLsbLsLsmbsbLsbRsbRsRs
mbLibLjbLcbLgLsbLgbsbRgRsRsmmbLsbsbLgLsLsLsmmbLsbLsLsLsLsmmmbLibRibRgb
RibRsRsRsmmbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 45; Drug: Control
bRhbRsbLsbsbRcRsmbRiRsLsmbRibRsbRjRsRsRsmmmbRsbRsRsmbLsLsmbsbRgRsmbRsb
RjRsRsmmbLsbsbsbRsbRcbRsRsRsmmbRsbRgRgbRiRsRsmmbRsbRibLsbRsRsRsmmbsbRs
bRgbLgLsbLsbLibRsRsmbLcbsbLsRsbLsbRibRhbRsbRsbLsbRgbRsRsRsmmbLsLsmbLgL
sbLgLsbLgbRcbLobRibsbLcbLibRcbRcbRibRsbLsLsLsmmbRsLsbRcbLibRcbRhbRsRsm
bRibsbsbRsbRsRsmbRiRsmbRjbRsbLsbLsbRgRsmbRibRsbRsRsRsmmbRsbRgRsmbsbsbs
b

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 46; Drug: Control
bRgbsbRgLsbRsbRsbRsRsmbRsbsbRsbRgbRsbRgbRgRsmbLsbRsbRsbRsbRgRsmbRgRsmb
RsbRsLsbRsbLsbRsbRgbRsbRsbRsbRsbRsRsmbLsbRgbRgbLsbRsbRgRsmbRsbRsbRgRsm
bRsLsbRsbLsbLebRsbLsbLebLsbLsbLsbLsbLiLsbLsRsbLgLsbLsbsbLgLsbRsbLsbLgb
LgbRgbsbLsbsbsbLsbLsLsRsLsRsRsmmbLsRsRsLsRsLsLsmmbsbLiLsbLgbLgbLsbLgbL
sbLsRsbLsbLsbLgLsbLgbRsbLgRsbLsbLgbLsbLsbLgLsbLsbLgbLsbLgLsbLgbRsbLsbL
ibLsbRsbLibLhLsbLgbLgLsbLgbLcbRobLebLgbLhbsbRibRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 47; Drug: Control
bsbRsbLsbLsbLsbLgbRsbLibRjRsmbRhbRibRsbLsLsmbLjLgbLsbRjbRsRsmbRsbRibRg
RsmbRgbRsbRcbLsbLsLsmbRhbRgbsbLgLsbLgbRcbLsbLibRibLsbLsbRiRsmbRjRsRsmm
bRgRsRsmmbLjLsLsmmbRiRsmbLgbRgbsbRhLsbRibLgRsbRibRhbLsbLsLsmbRsRsmbLsb
LsbRsLsbRgRsmbRgbLsLsmbsbLjLsmbRibRiLsbRhbRsbRgbRgRsmbLjLgbLsbLsLsmbsb
RjRsmbLgbRcbLsbsbLgbLsLsmbLsbLsbRibRibRgbRibLsbLcLsmbRobRibRiLsbLsbLib
LibLibLhbLibLsLsmbLeLsbLibLgbLibLobRibLsbRsRsmbRibLsRsbRcRsmbRsRsmbRcb
RgbRsbLsbRcbLsbRsbRgLsbRgbLsLsmbLibRcRsmbRibRgbLsbRgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 112120; End: 112620;
Recording: 13-1; Individual: 48; Drug: Control
bLgbLhbRcRsmbRhLsbRgbRsbRjbRhRsmbLoLsmbLiLsLsmbRiLsbsbLcLsmbRcRsRsmmbR
sLsbRcbRcLsbRcbRhbLibLibRibRcRsmbRgbLibRcbsbLsbsbRibsbLsbRgbRgRsmbRgbR
gRsmbRgRsmbLsbRibLsLsmbRsbRgbRgbRsbRgRsmbRgbLsbRgbRgbRgbRsLsbRsbRgbRgb
RgbRgRsmbRgbRgbRgbLsbRgbRgbRgbRgbRsbRjbRcRsmbRsbLcLsmbLibLgbLcbLibLgbR
gbRhbRhbRhbRgbLcbRibRcbRcbRsbLibRiRsmbLhbLiLsRsbLibRsbRhbRcRsmbLhbLcbL
iRsbLgLsbLsRsbLibRsbLibLgbRjbRhRsmbRcRsmbLebRibRcbLsbLibLibLsbLgbLhbLi
RsbLgbRsbLiRsbLsbLibRibLibRgbRhbRiRsmbLibLcLsmbRcbLjbRgbRcbRcbLgbLibRs
bRjRsmbRgbRgRsmbRobLibRjbLcbLcRsbRgbLhLsbLibLgLsbLibLsLsmbLgbLgbRsbLcR
sbLiLsbRgbRibLiLsbLibLgbRjbLcLsmb

